Thus O O
, O O
EBV O O
binding O O
to O O
its O O
cellular O O
receptor O O
on O O
resting O O
B O O
cells O O
triggers O O
an O O
NF-kappaB-dependent O O
intracellular O O
signaling O O
pathway O O
which O O
is O O
required O O
for O O
infection O O
. O O

Activation O O
of O O
transcription O O
factor O O
NF-kappa O O
B O O
by O O
phagocytic O O
stimuli O O
in O O
human O O
neutrophils O O
. O O

Phagocytosis O O
represents O O
an O O
important O O
physiological O O
trigger O O
for O O
the O O
inducible O O
expression O O
of O O
several O O
genes O O
in O O
human O O
neutrophils O O
. O O

Here O O
, O O
we O O
report O O
that O O
a O O
DNA-binding O O
activity O O
primarily O O
consisting O O
of O O
the O O
classical O O
NF-kappa O O
B O O
heterodimer O O
, O O
p50 O O
/ O O
RelA O O
, O O
is O O
induced O O
in O O
phagocytosing O O
neutrophils O O
. O O

Under O O
these O O
conditions O O
, O O
NF-kappa O O
B O O
activation O O
was O O
found O O
to O O
be O O
a O O
rapid O O
and O O
transient O O
response O O
, O O
reaching O O
a O O
maximum O O
by O O
10-15 O O
min O O
, O O
and O O
returning O O
to O O
near-basal O O
levels O O
by O O
30 O O
min O O
. O O

In O O
neutrophils O O
undergoing O O
the O O
phagocytosis O O
of O O
opsonized O O
yeasts O O
, O O
the O O
onset O O
of O O
NF-kappa O O
B O O
activation O O
was O O
paralleled O O
by O O
a O O
decline O O
in O O
immunoreactive O O
I O O
kappa O O
B-alpha O O
protein O O
levels O O
, O O
and O O
the O O
cellular O O
I O O
kappa O O
B-alpha O O
pool O O
was O O
replenished O O
by O O
30 O O
min O O
, O O
in O O
agreement O O
with O O
our O O
gel O O
shift O O
data O O
. O O

We O O
conclude O O
that O O
NF-kappa O O
B O O
activation O O
could B-SPECULATION B-SPECULATION
constitute I-SPECULATION I-SPECULATION
one I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
mechanisms I-SPECULATION I-SPECULATION
whereby I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
kappa I-SPECULATION I-SPECULATION
B-responsive I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
enhanced I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
phagocytosing I-SPECULATION I-SPECULATION
neutrophils I-SPECULATION I-SPECULATION
. O O

To O O
our O O
knowledge O O
, O O
this O O
represents O O
the O O
first O O
demonstration O O
that O O
phagocytic O O
stimuli O O
can O O
induce O O
NF-kappa O O
B O O
activation O O
in O O
human O O
neutrophils O O
. O O

Surfactant O O
protein O O
A O O
activates O O
NF-kappa O O
B O O
in O O
the O O
THP-1 O O
monocytic O O
cell O O
line O O
. O O

The O O
expression O O
of O O
many O O
genes O O
for O O
which O O
products O O
are O O
involved O O
in O O
inflammation O O
is O O
controlled O O
by O O
the O O
transcriptional O O
regulator O O
nuclear O O
factor O O
( O O
NF O O
)- O O
kappa O O
B O O
. O O

Because O O
surfactant O O
protein O O
( O O
SP O O
) O O
A O O
is O O
involved O O
in O O
local O O
host O O
defense O O
in O O
the O O
lung O O
and O O
alters O O
immune O O
cell O O
function O O
by O O
modulating O O
the O O
expression O O
of O O
proinflammatory O O
cytokines O O
as O O
well O O
as O O
surface O O
proteins O O
involved O O
in O O
inflammation O O
, O O
we O O
hypothesized B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
SP-A I-SPECULATION I-SPECULATION
exerts I-SPECULATION I-SPECULATION
its I-SPECULATION I-SPECULATION
action I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
at I-SPECULATION I-SPECULATION
least I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
part I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
via I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
. O O

We O O
used O O
gel O O
shift O O
assays O O
to O O
determine O O
whether B-SPECULATION B-SPECULATION
SP-A I-SPECULATION I-SPECULATION
activated I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
THP-1 I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
line I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
monocytic I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
line I-SPECULATION I-SPECULATION
. O O

Activation O O
of O O
NF-kappa O O
B O O
in O O
THP-1 O O
cells O O
by O O
SP-A O O
doses O O
as O O
low O O
as O O
1 O O
microgram O O
/ O O
ml O O
occurred O O
within O O
30 O O
min O O
of O O
SP-A O O
treatment O O
, O O
peaked O O
at O O
60 O O
min O O
, O O
and O O
then O O
declined O O
. O O

This O O
activation O O
is O O
inhibited O O
by B-SPECULATION O
known I-SPECULATION O
inhibitors I-SPECULATION O
of I-SPECULATION O
NF-kappa I-SPECULATION O
B I-SPECULATION O
or I-SPECULATION O
by I-SPECULATION O
simultaneous I-SPECULATION O
treatment I-SPECULATION O
of I-SPECULATION O
the I-SPECULATION O
cells I-SPECULATION O
with I-SPECULATION O
surfactant I-SPECULATION O
lipids I-SPECULATION O
. O O

Moreover O O
, O O
the O O
NF-kappa O O
B O O
inhibitors O O
blocked O O
SP-A-dependent O O
increases O O
in O O
tumor O O
necrosis O O
factor-alpha O O
mRNA O O
levels O O
. O O

These O O
observations O O
suggest B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
SP-A I-SPECULATION I-SPECULATION
plays I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
pathogenesis I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
some I-SPECULATION I-SPECULATION
lung I-SPECULATION I-SPECULATION
conditions I-SPECULATION I-SPECULATION
and I-SPECULATION O
point I-SPECULATION O
to I-SPECULATION O
potential B-SPECULATION B-SPECULATION
therapeutic I-SPECULATION I-SPECULATION
measures I-SPECULATION I-SPECULATION
that B-SPECULATION I-SPECULATION
could I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
used I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
prevent I-SPECULATION I-SPECULATION
SP-A I-SPECULATION I-SPECULATION
induced I-SPECULATION I-SPECULATION
inflammation I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
lung I-SPECULATION I-SPECULATION
. O O

alpha-Tocopheryl O O
succinate O O
inhibits O O
monocytic O O
cell O O
adhesion O O
to O O
endothelial O O
cells O O
by O O
suppressing O O
NF-kappa O O
B O O
mobilization O O
. O O

The O O
adherence O O
of O O
monocytes O O
to O O
activated O O
endothelium O O
is O O
an O O
early O O
event O O
in O O
atherogenesis O O
. O O

Because O O
antioxidants O O
have O O
been O O
considered O O
to O O
be O O
of O O
antiatherosclerotic O O
potential O O
, O O
we O O
investigated O O
the O O
effects O O
of O O
alpha-tocopherol O O
( O O
TCP O O
) O O
and O O
its O O
acetate O O
and O O
succinate O O
esters O O
on O O
monocyte O O
adhesion O O
to O O
cytokine-stimulated O O
human O O
umbilical O O
vein O O
endothelial O O
cells O O
( O O
HUVEC O O
) O O
. O O

Endothelial O O
cells O O
were O O
treated O O
with O O
TCP O O
, O O
alpha-tocopherol O O
acetate O O
( O O
TCP O O
acetate O O
) O O
, O O
or O O
alpha-tocopheryl O O
succinate O O
( O O
TCP O O
succinate O O
) O O
before O O
stimulation O O
with O O
tumor O O
necrosis O O
factor-alpha O O
( O O
TNF-alpha O O
; O O
10 O O
U O O
/ O O
ml O O
, O O
6 O O
h O O
) O O
or O O
interleukin-1 O O
beta O O
( O O
IL-1 O O
beta O O
; O O
10 O O
U O O
/ O O
ml O O
, O O
6 O O
h O O
) O O
. O O

Cytokine-stimulated O O
cell O O
surface O O
expression O O
of O O
vascular O O
cell O O
adhesion O O
molecule-1 O O
( O O
VCAM-1 O O
, O O
CD106 O O
) O O
and O O
E-selectin O O
( O O
ELAM-1 O O
, O O
CD62E O O
) O O
, O O
but O O
not B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
intercellular I-NEGATION I-NEGATION
adhesion I-NEGATION I-NEGATION
molecule-1 I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
ICAM-1 I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
CD54 I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
, O O
was O O
time O O
- O O
and O O
dose-dependently O O
inhibited O O
by O O
TCP O O
succinate O O
but O O
not B-NEGATION B-NEGATION
by I-NEGATION I-NEGATION
TCP I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
TCP I-NEGATION I-NEGATION
acetate I-NEGATION I-NEGATION
. O O

TCP O O
succinate O O
( O O
200 O O
microM O O
, O O
24 O O
h O O
) O O
reduced O O
TNF-induced O O
VCAM-1 O O
and O O
E-selectin O O
expression O O
from O O
a O O
specific O O
mean O O
fluorescence O O
intensity O O
of O O
151 O O
± O O
28 O O
to O O
12 O O
± O O
4 O O
channels O O
and O O
from O O
225 O O
± O O
38 O O
to O O
79 O O
± O O
21 O O
channels O O
, O O
respectively O O
. O O

Succinate O O
alone O O
had O O
no B-NEGATION B-NEGATION
effect I-NEGATION I-NEGATION
. O O

Decreased O O
adhesion O O
molecule O O
expression O O
was O O
associated O O
with O O
a O O
reduction O O
of O O
monocytic O O
cell O O
adhesion O O
. O O

TCP O O
succinate O O
( O O
20 O O
microM O O
, O O
72 O O
h O O
) O O
, O O
but O O
not B-NEGATION B-NEGATION
TCP I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
200 I-NEGATION I-NEGATION
microM I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
72 I-NEGATION I-NEGATION
h I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
, O O
reduced O O
U-937 O O
cell O O
adhesion O O
to O O
TNF-alpha-stimulated O O
( O O
10 O O
U O O
/ O O
ml O O
, O O
6 O O
h O O
) O O
HUVEC O O
by O O
30 O O
% O O
( O O
P O O
< O O
0.025 O O
) O O
and O O
to O O
IL-1 O O
beta-stimulated O O
HUVEC O O
by O O
56 O O
% O O
( O O
P O O
< O O
0.010 O O
) O O
. O O

Electrophoretic O O
mobility-shift O O
assays O O
of O O
HUVEC O O
nuclear O O
proteins O O
revealed O O
a O O
decrease O O
in O O
TNF-alpha-stimulated O O
nuclear O O
factor-kappa O O
B O O
( O O
NF-kappa O O
B O O
) O O
activation O O
after O O
pretreatment O O
of O O
HUVEC O O
with O O
TCP O O
succinate O O
but O O
not B-NEGATION B-NEGATION
with I-NEGATION I-NEGATION
TCP I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
TCP I-NEGATION I-NEGATION
acetate I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
succinate I-NEGATION I-NEGATION
alone I-NEGATION I-NEGATION
. O O

In O O
conclusion O O
, O O
we O O
demonstrate O O
that O O
the O O
vitamin O O
E O O
derivative O O
TCP O O
succinate O O
prevents O O
monocytic O O
cell O O
adhesion O O
to O O
cytokine-stimulated O O
endothelial O O
cells O O
by O O
inhibiting O O
the O O
activation O O
of O O
NF-kappa O O
B O O
, O O
further O O
emphasizing O O
the O O
antiatherosclerotic O O
potential O O
of O O
lipid O O
soluble O O
antioxidants O O
. O O

Distinct O O
mechanisms O O
for O O
N-acetylcysteine O O
inhibition O O
of O O
cytokine-induced O O
E-selectin O O
and O O
VCAM-1 O O
expression O O
. O O

We O O
have O O
examined O O
the O O
effects O O
of O O
N-acetyl-L-cysteine O O
( O O
NAC O O
) O O
, O O
a O O
well-characterized O O
, O O
thiol-containing O O
antioxidant O O
, O O
on O O
agonist-induced O O
monocytic O O
cell O O
adhesion O O
to O O
endothelial O O
cells O O
( O O
EC O O
) O O
. O O

NAC O O
inhibited O O
interleukin-1 O O
( O O
IL-1 O O
beta O O
)- O O
induced O O
, O O
but O O
not B-NEGATION B-NEGATION
basal I-NEGATION I-NEGATION
, O O
adhesion O O
with O O
50 O O
% O O
inhibition O O
at O O
approximately O O
20 O O
mM O O
. O O

Monocytic O O
cell O O
adhesion O O
to O O
EC O O
in O O
response O O
to O O
tumor O O
necrosis O O
factor-alpha O O
( O O
TNF-alpha O O
) O O
, O O
lipopolysaccharide O O
( O O
LPS O O
) O O
, O O
alpha-thrombin O O
, O O
or O O
phorbol O O
12-myristate O O
13-acetate O O
( O O
PMA O O
) O O
was O O
similarly O O
inhibited O O
by O O
NAC O O
. O O

Unlike O O
published O O
studies O O
with O O
pyrrolidinedithiocarbamate O O
, O O
which O O
specifically O O
inhibited O O
vascular O O
cell O O
adhesion O O
molecule O O
1 O O
( O O
VCAM-1 O O
) O O
, O O
NAC O O
inhibited O O
IL-1 O O
beta-induced O O
mRNA O O
and O O
cell O O
surface O O
expression O O
of O O
both O O
E-selectin O O
and O O
VCAM-1 O O
. O O

NAC O O
had O O
no B-NEGATION B-NEGATION
effect I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
half-life I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
E-selectin I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
VCAM-1 I-NEGATION I-NEGATION
mRNA I-NEGATION I-NEGATION
. O O

Although O O
NAC O O
reduced O O
nuclear O O
factor-kappa O O
B O O
( O O
NF-kappa O O
B O O
) O O
activation O O
in O O
EC O O
as O O
measured O O
by O O
gel-shift O O
assays O O
using O O
an O O
oligonucleotide O O
probe O O
corresponding O O
to O O
the O O
consensus O O
NF-kappa O O
B O O
binding O O
sites O O
of O O
the O O
VCAM-1 O O
gene O O
( O O
VCAM-NF-kappa O O
B O O
) O O
, O O
the O O
antioxidant O O
had O O
no B-NEGATION B-NEGATION
appreciable I-NEGATION I-NEGATION
effect I-NEGATION I-NEGATION
when I-NEGATION I-NEGATION
an I-NEGATION I-NEGATION
oligomer I-NEGATION I-NEGATION
corresponding I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
consensus I-NEGATION I-NEGATION
NF-kappa I-NEGATION I-NEGATION
B I-NEGATION I-NEGATION
binding I-NEGATION I-NEGATION
site I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
E-selectin I-NEGATION I-NEGATION
gene I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
E-selectin-NF-kappa I-NEGATION I-NEGATION
B I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
used I-NEGATION I-NEGATION
. O O

Because O O
NF-kappa O O
B O O
has O O
been O O
reported O O
to O O
be O O
redox O O
sensitive O O
, O O
we O O
studied O O
the O O
effects O O
of O O
NAC O O
on O O
the O O
EC O O
redox O O
environment O O
. O O

NAC O O
caused O O
an O O
expected O O
dramatic O O
increase O O
in O O
the O O
reduced O O
glutathione O O
( O O
GSH O O
) O O
levels O O
in O O
EC O O
. O O

In O O
vitro O O
studies O O
demonstrated O O
that O O
whereas O O
the O O
binding O O
affinity O O
of O O
NF-kappa O O
B O O
to O O
the O O
VCAM-NF-kappa O O
B O O
oligomer O O
peaked O O
at O O
a O O
GSH-to-oxidized O O
glutathione O O
( O O
GSSG O O
) O O
ratio O O
of O O
approximately O O
200 O O
and O O
decreased O O
at O O
higher O O
ratios O O
, O O
the B-SPECULATION O
binding I-SPECULATION O
to I-SPECULATION O
the I-SPECULATION O
E-selectin-NF-kappa I-SPECULATION O
B I-SPECULATION O
oligomer I-SPECULATION O
appeared I-SPECULATION O
relatively I-SPECULATION O
unaffected I-SPECULATION O
even I-SPECULATION O
at I-SPECULATION O
ratios I-SPECULATION O
> I-SPECULATION O
400 I-SPECULATION O
, I-SPECULATION O
i.e. I-SPECULATION O
, I-SPECULATION O
those I-SPECULATION O
achieved I-SPECULATION O
in I-SPECULATION O
EC I-SPECULATION O
treated I-SPECULATION O
with I-SPECULATION O
40 I-SPECULATION O
mM I-SPECULATION O
NAC I-SPECULATION O
. O O

These O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
binding I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
its I-SPECULATION I-SPECULATION
consensus I-SPECULATION I-SPECULATION
sequences I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
VCAM-1 I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
E-selectin I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
exhibits I-SPECULATION I-SPECULATION
marked I-SPECULATION I-SPECULATION
differences I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
redox I-SPECULATION I-SPECULATION
sensitivity I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
allowing I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
differential I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
regulated I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
same I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
. O O

Our O O
data O O
also O O
demonstrate O O
that O O
NAC O O
increases O O
the O O
GSH-to-GSSG O O
ratio O O
within O O
the O O
EC O O
suggesting B-SPECULATION B-SPECULATION
one I-SPECULATION I-SPECULATION
possible B-SPECULATION B-SPECULATION
mechanism I-SPECULATION I-SPECULATION
through I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
antioxidant I-SPECULATION I-SPECULATION
inhibits I-SPECULATION I-SPECULATION
agonist-induced I-SPECULATION I-SPECULATION
monocyte I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
EC I-SPECULATION I-SPECULATION
. O O

Human O O
monocyte O O
binding O O
to O O
fibronectin O O
enhances O O
IFN-gamma-induced O O
early O O
signaling O O
events O O
. O O

Leukocyte O O
integrins O O
are O O
fundamentally O O
important O O
in O O
modulating O O
adhesion O O
to O O
extracellular O O
matrix O O
components O O
and O O
to O O
other O O
cells O O
. O O

This O O
integrin-mediated O O
adhesion O O
controls O O
leukocyte O O
arrest O O
and O O
extravasation O O
during O O
the O O
onset O O
of O O
inflammatory O O
responses O O
. O O

Moreover O O
, O O
integrin-ligand O O
interactions O O
trigger O O
signaling O O
pathways O O
that O O
may B-SPECULATION B-SPECULATION
influence I-SPECULATION I-SPECULATION
leukocyte I-SPECULATION I-SPECULATION
phenotype I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
function I-SPECULATION I-SPECULATION
at I-SPECULATION I-SPECULATION
sites I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
inflammation I-SPECULATION I-SPECULATION
. O O

In O O
the O O
current O O
studies O O
, O O
we O O
evaluated O O
the O O
combinatorial O O
effects O O
of O O
monocyte O O
adhesion O O
and O O
IFN-gamma O O
on O O
intracellular O O
signaling O O
pathways O O
. O O

IFN-gamma O O
triggers O O
a O O
well-defined O O
signal O O
transduction O O
pathway O O
, O O
which O B-NEGATION
although O I-NEGATION
not O I-NEGATION
directly O I-NEGATION
stimulated O I-NEGATION
by O I-NEGATION
monocyte O I-NEGATION
adherence O I-NEGATION
to O I-NEGATION
fibronectin O I-NEGATION
or O I-NEGATION
arginine-glycine-aspartate O I-NEGATION
( O I-NEGATION
RGD O I-NEGATION
)- O I-NEGATION
coated O I-NEGATION
substrata O I-NEGATION
, O O
was O O
enhanced O O
significantly O O
in O O
these O O
matrix-adherent O O
cells O O
. O O

Compared O O
with O O
monocytes O O
in O O
suspension O O
or O O
adherent O O
on O O
plastic O O
surfaces O O
, O O
monocytes O O
adherent O O
to O O
fibronectin O O
or O O
RGD O O
exhibited O O
a O O
greater O O
than O O
threefold O O
increase O O
in O O
steady O O
state O O
levels O O
of O O
IFN-gamma-induced O O
mRNA O O
for O O
the O O
high O O
affinity O O
Fc O O
gammaRI O O
receptor O O
. O O

By O O
electrophoretic O O
mobility O O
shift O O
assays O O
, O O
this O O
increase O O
in O O
mRNA O O
was O O
associated O O
with O O
a O O
5 O O
- O O
to O O
10-fold O O
increase O O
in O O
the O O
STAT1-containing O O
DNA-binding O O
complex O O
that O O
binds O O
to O O
Fc O O
gammaRI O O
promoter O O
elements O O
. O O

Furthermore O O
, O O
the O O
tyrosine O O
phosphorylation O O
of O O
STAT1 O O
and O O
the O O
tyrosine O O
kinases O O
JAK1 O O
and O O
JAK2 O O
was O O
enhanced O O
significantly O O
in O O
RGD-adherent O O
monocytes O O
compared O O
with O O
control O O
cells O O
. O O

These O O
results O O
suggest B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
novel I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
integrin-mediated I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
modulate I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
magnitude I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
cytokine-induced I-SPECULATION I-SPECULATION
signal I-SPECULATION I-SPECULATION
transduction I-SPECULATION I-SPECULATION
pathways I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
thereby I-SPECULATION I-SPECULATION
amplifying I-SPECULATION I-SPECULATION
cellular I-SPECULATION I-SPECULATION
events I-SPECULATION I-SPECULATION
leading I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
monocyte I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
inflammation I-SPECULATION I-SPECULATION
. O O

The O O
carboxyl-terminal O O
cytoplasmic O O
domain O O
of O O
CD36 O O
is O O
required O O
for O O
oxidized O O
low-density O O
lipoprotein O O
modulation O O
of O O
NF-kappaB O O
activity O O
by O O
tumor O O
necrosis O O
factor-alpha O O
. O O

The O O
binding O O
of O O
oxidized O O
low-density O O
lipoprotein O O
( O O
Ox O O
LDL O O
) O O
by O O
monocyte-macrophages O O
causes O O
pleiotropic O O
effects O O
, O O
including O O
changes O O
in O O
gene O O
expression O O
, O O
and O O
is B-SPECULATION B-SPECULATION
thought I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
represent I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
early I-SPECULATION I-SPECULATION
event I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
atherogenesis I-SPECULATION I-SPECULATION
. O O

The B-SPECULATION B-SPECULATION
integral I-SPECULATION I-SPECULATION
membrane I-SPECULATION I-SPECULATION
glycoprotein I-SPECULATION I-SPECULATION
CD36 I-SPECULATION I-SPECULATION
appears I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
play I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
physiological I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
binding I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
uptake I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
Ox I-SPECULATION I-SPECULATION
LDL I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
monocyte-macrophages I-SPECULATION I-SPECULATION
, O O
although O O
the B-SPECULATION B-SPECULATION
molecular I-SPECULATION I-SPECULATION
events I-SPECULATION I-SPECULATION
associated I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
CD36-Ox I-SPECULATION I-SPECULATION
LDL I-SPECULATION I-SPECULATION
interaction I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
unknown I-SPECULATION I-SPECULATION
. O O

To O O
approach O O
this O O
issue O O
, O O
we O O
used O O
CD36 O O
transfected O O
Chinese O O
hampster O O
ovary O O
( O O
CHO O O
) O O
cells O O
, O O
exposed O O
them O O
to O O
Ox O O
LDL O O
, O O
and O O
determined O O
changes O O
in O O
the O O
activity O O
of O O
the O O
transcription O O
factor O O
NF-kappaB O O
. O O

We O O
report O O
here O O
that O O
Ox O O
LDL O O
enhanced O O
DNA O O
binding O O
activity O O
of O O
nuclear O O
extracts O O
to O O
an O O
NF-kappaB O O
sequence O O
following O O
activation O O
of O O
CD36-producing O O
CHO O O
cells O O
with O O
the O O
proinflammatory O O
cytokine O O
tumor O O
necrosis O O
factor-alpha O O
( O O
TNF-alpha O O
) O O
. O O

This O O
enhanced O O
DNA O O
binding O O
activity O O
was O O
inhibited O O
by O O
coincubation O O
of O O
CD36 O O
transfected O O
cells O O
with O O
the O O
human O O
CD36-specific O O
antibody O O
OKM5 O O
. O O

We O O
also O O
determined O O
that O O
activation O O
of O O
NF-kappaB O O
DNA O O
binding O O
activity O O
required O O
an O O
intact O O
carboxyl-terminal O O
cytoplasmic O O
segment O O
on O O
CD36 O O
. O O

Our O O
results O O
support O O
the O O
idea B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
CD36 I-SPECULATION I-SPECULATION
mediates I-SPECULATION I-SPECULATION
signal I-SPECULATION I-SPECULATION
transduction I-SPECULATION I-SPECULATION
events I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
response I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
Ox I-SPECULATION I-SPECULATION
LDL I-SPECULATION I-SPECULATION
. O O

Transcriptional O O
regulation O O
during O O
myelopoiesis O O
. O O

The O O
coordinated O O
production O O
of O O
all O O
blood O O
cells O O
from O O
a O O
common O O
stem O O
cell O O
is O O
a O O
highly O O
regulated O O
process O O
involving O O
successive O O
stages O O
of O O
commitment O O
and O O
differentiation O O
. O O

From O O
analyses O O
of O O
mice O O
deficient O O
in O O
transcription O O
factor O O
genes O O
and O O
from O O
the O O
characterizations O O
of O O
chromosome O O
breakpoints O O
in O O
human O O
leukemias O O
, O O
it O O
has O O
become O O
evident O O
that O O
transcription O O
factors O O
are O O
important O O
regulators O O
of O O
hematopoiesis O O
. O O

During O O
myelopoiesis O O
, O O
which O O
includes O O
the O O
development O O
of O O
granulocytic O O
and O O
monocytic O O
lineages O O
, O O
transcription O O
factors O O
from O O
several O O
families O O
are O O
active O O
, O O
including O O
AML1 O O
/ O O
CBF O O
beta O O
, O O
C O O
/ O O
EBP O O
, O O
Ets O O
, O O
c-Myb O O
, O O
HOX O O
, O O
and O O
MZF-1 O O
. O O

Few O O
of O O
these O O
factors O O
are O O
expressed O O
exclusively O O
in O O
myeloid O O
cells O O
; O O
instead O O
it O O
appears B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
they I-SPECULATION I-SPECULATION
cooperatively I-SPECULATION I-SPECULATION
regulate I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
myeloid-specific I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
. O O

Here O O
we O O
discuss O O
recent O O
advances O O
in O O
transcriptional O O
regulation O O
during O O
myelopoiesis O O
. O O

Genomic O O
organization O O
, O O
sequence O O
, O O
and O O
transcriptional O O
regulation O O
of O O
the O O
human O O
eotaxin O O
gene O O
. O O

Eotaxin O B-SPECULATION
is O I-SPECULATION
an O I-SPECULATION
eosinophil O I-SPECULATION
specific O I-SPECULATION
beta-chemokine O I-SPECULATION
assumed O I-SPECULATION
to O I-SPECULATION
be O I-SPECULATION
involved O I-SPECULATION
in O I-SPECULATION
eosinophilic O I-SPECULATION
inflammatory O I-SPECULATION
diseases O I-SPECULATION
such O I-SPECULATION
as O I-SPECULATION
atopic O I-SPECULATION
dermatitis O I-SPECULATION
, O I-SPECULATION
allergic O I-SPECULATION
rhinitis O I-SPECULATION
, O I-SPECULATION
asthma O I-SPECULATION
and O I-SPECULATION
parasitic O I-SPECULATION
infections O I-SPECULATION
. O O

Its O O
expression O O
is O O
stimulus O O
- O O
and O O
cell-specific O O
. O O

We O O
here O O
describe O O
the O O
genomic O O
organisation O O
( O O
3 O O
exons O O
of O O
132 O O
, O O
112 O O
and O O
542 O O
bp O O
and O O
2 O O
introns O O
of O O
1211 O O
and O O
378 O O
bp O O
) O O
and O O
sequence O O
including O O
3 O O
kb O O
of O O
DNA O O
from O O
the O O
immediate O O
5 O O
' O O
upstream O O
region O O
of O O
the O O
human O O
eotaxin O O
gene O O
. O O

Among O O
the O O
regulatory O O
promoter O O
elements O O
potentially B-SPECULATION B-SPECULATION
regulating I-SPECULATION I-SPECULATION
eotaxin I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
mediating I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
effects I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
anti-inflammatory I-SPECULATION I-SPECULATION
drugs I-SPECULATION I-SPECULATION
we O O
identified O O
consensus O O
sequences O O
known O O
to O O
interact O O
with O O
nuclear O O
factors O O
like O O
NF-IL6 O O
, O O
AP-1 O O
, O O
a O O
NF-kappa-B O O
like O O
consensus O O
sequence O O
and O O
gamma-interferon O O
- O O
as O O
well O O
as O O
glucocorticoid O O
response O O
elements O O
. O O

Rel O O
/ O O
NF-kappa O O
B O O
transcription O O
factors O O
and O O
the O O
control O O
of O O
apoptosis O O
. O O

The O O
process O O
of O O
apoptosis O O
is O O
used O O
to O O
eliminate O O
unwanted O O
cells O O
from O O
a O O
wide O O
variety O O
of O O
organisms O O
. O O

Various O O
extracellular O O
signals O O
, O O
often O O
converging O O
in O O
common O O
intracellular O O
pathways O O
, O O
can O O
induce O O
apoptosis O O
in O O
a O O
cell-type-specific O O
fashion O O
. O O

Recent O O
work O O
from O O
several O O
laboratories O O
has O O
demonstrated O O
that O O
Rel O O
/ O O
NF-kappa O O
B O O
transcription O O
factors O O
regulate O O
apoptosis O O
in O O
many O O
cell O O
types O O
. O O

In O O
most O O
cells O O
, O O
Rel B-SPECULATION B-SPECULATION
/ I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factors I-SPECULATION I-SPECULATION
appear I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
mediate I-SPECULATION I-SPECULATION
survival I-SPECULATION I-SPECULATION
signals I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
protect I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
from I-SPECULATION I-SPECULATION
apoptosis I-SPECULATION I-SPECULATION
; O O
however O O
, O O
under O O
some O O
circumstances O O
, O O
activation O O
of O O
these O O
factors O O
may B-SPECULATION B-SPECULATION
also I-SPECULATION I-SPECULATION
promote I-SPECULATION I-SPECULATION
apoptosis I-SPECULATION I-SPECULATION
. O O

The O O
role O O
of O O
Rel O O
/ O O
NF-kappa O O
B O O
proteins O O
in O O
viral O O
oncogenesis O O
and O O
the O O
regulation O O
of O O
viral O O
transcription O O
. O O

Rel O O
/ O O
NF-kappa O O
B O O
is O O
a O O
ubiquitous O O
transcription O O
factor O O
that O O
consists O O
of O O
multiple O O
polypeptide O O
subunits O O
, O O
and O O
is O O
subject O O
to O O
complex O O
regulatory O O
mechanisms O O
that O O
involve O O
protein-protein O O
interactions O O
, O O
phosphorylation O O
, O O
ubiquitination O O
, O O
proteolytic O O
degradation O O
, O O
and O O
nucleocytoplasmic O O
translocation O O
. O O

The O O
sophisticated O O
control O O
of O O
Rel O O
/ O O
NF-kappa O O
B O O
activity O O
is O O
not B-NEGATION B-SPECULATION
surprising I-NEGATION I-SPECULATION
since O O
this O O
transcription O O
factor O O
is O O
involved O O
in O O
a O O
wide O O
array O O
of O O
cellular O O
responses O O
to O O
extracellular O O
cues O O
, O O
associated O O
with O O
growth O O
, O O
development O O
, O O
apoptosis O O
, O O
and O O
pathogen O O
invasion O O
. O O

Thus O O
, O O
it O O
is O O
not B-NEGATION B-SPECULATION
unexpected I-NEGATION I-SPECULATION
that I-NEGATION I-SPECULATION
this B-SPECULATION I-SPECULATION
versatile I-SPECULATION I-SPECULATION
cellular I-SPECULATION I-SPECULATION
homeostatic I-SPECULATION I-SPECULATION
switch I-SPECULATION I-SPECULATION
would I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
affected I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
variety I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
viral I-SPECULATION I-SPECULATION
pathogens I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
have I-SPECULATION I-SPECULATION
evolved I-SPECULATION I-SPECULATION
mechanisms I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
utilize I-SPECULATION I-SPECULATION
various I-SPECULATION I-SPECULATION
aspects I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
Rel I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
activity I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
facilitate I-SPECULATION I-SPECULATION
their I-SPECULATION I-SPECULATION
replication I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
survival I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
possibly B-SPECULATION B-SPECULATION
evasion I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
immune I-SPECULATION I-SPECULATION
responses I-SPECULATION I-SPECULATION
. O O

This O O
review O O
will O O
cover O O
the O O
molecular O O
mechanisms O O
that O O
are O O
utilized O O
by O O
mammalian O O
oncogenic O O
viruses O O
to O O
affect O O
the O O
activity O O
of O O
Rel O O
/ O O
NF-kappa O O
B O O
transcription O O
factors O O
and O O
the O O
role O O
of O O
Rel O O
/ O O
NF-kappa O O
B O O
in O O
the O O
regulation O O
of O O
viral O O
gene O O
expression O O
and O O
replication O O
. O O

Abnormal O O
apoptosis O O
and O O
cell O O
cycle O O
progression O O
in O O
humans O O
exposed O O
to O O
methyl O O
tertiary-butyl O O
ether O O
and O O
benzene O O
contaminating O O
water O O
. O O

1. O O
In O O
this O O
study O O
we O O
hypothesized B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
individuals I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
certain I-SPECULATION I-SPECULATION
genetic I-SPECULATION I-SPECULATION
makeup I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
MTBE I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
benzene I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
their I-SPECULATION I-SPECULATION
metabolites I-SPECULATION I-SPECULATION
act I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
adducts I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
induce I-SPECULATION I-SPECULATION
programmed I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
death I-SPECULATION I-SPECULATION
. O O

2. O O
Our O O
study O O
involved O O
a O O
group O O
of O O
60 O O
male O O
and O O
female O O
subjects O O
who O O
were O O
exposed O O
to O O
MTBE O O
and O O
benzene-contaminated O O
water O O
concentrations O O
up O O
to O O
76 O O
PPB O O
for O O
MTBE O O
and O O
14 O O
PPB O O
for O O
benzene O O
, O O
for O O
a O O
period O O
of O O
5 O O
to O O
8 O O
years O O
. O O

For O O
comparison O O
, O O
we O O
recruited O O
a O O
control O O
group O O
consisting O O
of O O
32 O O
healthy O O
males O O
and O O
females O O
with O O
similar O O
age O O
distribution O O
and O O
without B-NEGATION B-NEGATION
a I-NEGATION I-NEGATION
history I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
exposure I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
MTBE I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
benzene I-NEGATION I-NEGATION
. O O

3. O O
Peripheral O O
blood O O
lymphocytes O O
( O O
PBL O O
) O O
of O O
both O O
groups O O
were O O
tested O O
for O O
the O O
percentage O O
of O O
apoptotic O O
cells O O
and O O
cell O O
cycle O O
progression O O
using O O
flow O O
cytometry O O
. O O

4. O O
When O O
apoptotic O O
lymphocytes O O
from O O
exposed O O
individuals O O
were O O
compared O O
to O O
apoptotic O O
lymphocytes O O
from O O
the O O
control O O
group O O
, O O
statistically-significant O O
differences O O
between O O
each O O
mean O O
group O O
were O O
detected O O
( O O
26.4 O O
± O O
1.8 O O
and O O
12.1 O O
± O O
1.3 O O
, O O
respectively O O
) O O
, O O
indicating O B-SPECULATION
an O I-SPECULATION
increased O I-SPECULATION
rate O I-SPECULATION
of O I-SPECULATION
apoptosis O I-SPECULATION
in O I-SPECULATION
80.5 O I-SPECULATION
% O I-SPECULATION
of O I-SPECULATION
exposed O I-SPECULATION
individuals O I-SPECULATION
( O O
P O O
< O O
0.0001 O O
, O O
Mann-Whitney O O
U-Test O O
) O O
. O O

MTBE O O
and O O
benzene-induced O O
apoptosis O O
is O O
attributed O O
to O O
a O O
discrete O O
block O O
within O O
the O O
cell O O
cycle O O
progression O O
. O O

Because O O
cell O O
cycle O O
analysis O O
showed O O
that O O
in O O
PBL O O
from O O
chemically-exposed O O
individuals O O
, O O
between O O
20-50 O O
% O O
of O O
cells O O
were O O
accumulated O O
at O O
the O O
S-G2 O O
/ O O
M O O
boundaries O O
. O O

5. O O
One O O
of O O
the O O
signaling O O
molecules O O
which O O
mediates O O
programmed O O
cell O O
death O O
is O O
nuclear O O
factor O O
Kappa-B O O
( O O
NF-kappa O O
B O O
) O O
. O O

NF-kappa O O
B O O
was O O
examined O O
as O O
one O O
of O O
the O O
many O O
molecular O O
mechanisms O O
for O O
mediating O O
cell O O
death O O
by O O
MTBE O O
and O O
benzene O O
. O O

Indeed O O
, O O
addition O O
of O O
inhibitors O O
of O O
NF-kappa O O
B O O
activation O O
pyrrolidine O O
dithiocarbamate O O
( O O
PDTC O O
) O O
, O O
to O O
the O O
lymphocytes O O
of O O
the O O
chemically-exposed O O
group O O
was O O
capable O O
of O O
inhibiting O O
programmed O O
cell O O
death O O
by O O
40 O O
% O O
. O O

This O O
reversal O O
of O O
apoptosis O O
almost O O
to O O
the O O
control O O
level O O
by O O
inhibitor O O
of O O
NF-kappa O O
B O O
activation O O
may B-SPECULATION B-SPECULATION
indicate B-SPECULATION B-SPECULATION
involvement I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
signaling I-SPECULATION I-SPECULATION
molecule I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
MTBE I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
benzene I-SPECULATION I-SPECULATION
induction I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
programmed I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
death I-SPECULATION I-SPECULATION
. O O

Activation O O
of O O
a O O
novel O O
gene O O
in O O
3q21 O O
and O O
identification O O
of O O
intergenic O O
fusion O O
transcripts O O
with O O
ecotropic O O
viral O O
insertion O O
site O O
I O O
in O O
leukemia O O
. O O

We O O
have O O
identified O O
a O O
novel O O
gene O O
, O O
GR6 O O
, O O
located O O
within O O
the O O
leukemia O O
breakpoint O O
region O O
of O O
3q21 O O
, O O
that O O
is O O
normally O O
expressed O O
in O O
early O O
fetal O O
development O O
but O O
not B-NEGATION B-NEGATION
in I-NEGATION I-NEGATION
adult I-NEGATION I-NEGATION
peripheral I-NEGATION I-NEGATION
blood I-NEGATION I-NEGATION
. O O

GR6 O O
is O O
activated O O
in O O
the O O
UCSD-AML1 O O
cell O O
line O O
and O O
in O O
a O O
leukemic O O
sample O O
, O O
both O O
of O O
which O O
carry O O
a O O
t O O
( O O
3 O O
; O O
3 O O
)( O O
q21 O O
; O O
q26 O O
) O O
. O O

In O O
UCSD-AML1 O O
, O O
we O O
have O O
also O O
identified O O
fusion O O
transcripts O O
between O O
the O O
ecotropic O O
viral O O
insertion O O
site O O
I O O
( O O
EVI1 O O
) O O
gene O O
in O O
3q26 O O
and O O
GR6 O O
and O O
between O O
EVI1 O O
and O O
Ribophorin O O
I O O
that O O
maps O O
30 O O
kb O O
telomeric O O
to O O
GR6 O O
in O O
3q21 O O
. O O

All O O
fusions O O
splice O O
the O O
5 O O
' O O
ends O O
of O O
the O O
3q21 O O
genes O O
into O O
exon O O
2 O O
of O O
the O O
EVI1 O O
gene O O
, O O
an O O
event O O
that O O
is O O
similar O O
to O O
the O O
normal O O
intergenic O O
splicing O O
of O O
MDS1-EVI1 O O
and O O
to O O
those O O
previously O O
documented O O
in O O
leukemias O O
with O O
t O O
( O O
3 O O
; O O
21 O O
) O O
and O O
t O O
( O O
3 O O
; O O
12 O O
) O O
, O O
in O O
which O O
acute O O
myelogenous O O
leukemia O O
1-EVI1 O O
fusions O O
and O O
ETV6-EVI1 O O
fusions O O
, O O
respectively O O
, O O
occur O O
. O O

The O O
Ribophorin O O
I-EVI1 O O
fusion O O
in O O
particular O O
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
common I-SPECULATION I-SPECULATION
occurrence I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
t I-SPECULATION I-SPECULATION
( I-SPECULATION O
3 I-SPECULATION O
; I-SPECULATION O
3 I-SPECULATION O
) I-SPECULATION O
. O O

Alcohol-induced O O
regulation O O
of O O
nuclear O O
regulatory O O
factor-kappa O O
beta O O
in O O
human O O
monocytes O O
. O O

Acute O O
ethanol O O
exposure O O
has O O
the O O
capacity O O
to O O
modulate O O
immune O O
functions O O
, O O
particularly O O
, O O
to O O
down O O
regulate O O
monocyte O O
production O O
of O O
inflammatory O O
cytokines O O
. O O

However O O
, O O
the B-SPECULATION O
intracellular I-SPECULATION O
mechanisms I-SPECULATION O
for I-SPECULATION O
these I-SPECULATION O
effects I-SPECULATION O
of I-SPECULATION O
ethanol I-SPECULATION O
are I-SPECULATION O
yet I-SPECULATION O
to I-SPECULATION O
be I-SPECULATION O
understood I-SPECULATION O
. O O

Considering O O
that O O
nuclear O O
regulatory O O
factor-kappa O O
beta O O
( O O
NF-kappa O O
B O O
)/ O O
Rel O O
is O O
a O O
common O O
regulatory O O
element O O
of O O
the O O
promoter O O
region O O
of O O
the O O
inflammatory O O
cytokine O O
genes O O
, O O
herein O O
, O O
we O O
tested O O
the O O
hypothesis B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
acute I-SPECULATION I-SPECULATION
ethanol I-SPECULATION I-SPECULATION
affects I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
monocytes I-SPECULATION I-SPECULATION
. O O

Adherence-isolated O O
monocytes O O
showed O O
constitutive O O
DNA O O
binding O O
activity O O
of O O
NF-kappa O O
B O O
. O O

A O O
clinically O O
relevant O O
dose O O
( O O
25 O O
mM O O
) O O
of O O
acute O O
ethanol O O
treatment O O
in O O
vitro O O
increased O O
NF-kappa O O
B O O
binding O O
activity O O
in O O
monocytes O O
with O O
a O O
preferential O O
induction O O
of O O
the O O
inhibitory O O
, O O
p50 O O
/ O O
p50 O O
, O O
NF-kappa O O
B O O
/ O O
Rel O O
homodimer O O
, O O
and O O
resulted O O
in O O
no B-NEGATION B-NEGATION
induction I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
p65 I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
p50 I-NEGATION I-NEGATION
heterodimer I-NEGATION I-NEGATION
. O O

In O O
contrast O O
, O O
lipopolysaccharide O O
stimulation O O
primarily O O
induced O O
the O O
p65 O O
/ O O
p50 O O
heterodimer O O
that O O
has O O
been O O
shown O O
to O O
result O O
in O O
gene O O
activation O O
. O O

Thus O O
, O O
such O O
unique O O
activation O O
of O O
the O O
inhibitory O O
p50 O O
/ O O
p50 O O
homodimer O O
by O O
acute O O
ethanol O O
treatment O O
may B-SPECULATION B-SPECULATION
result I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
inhibition I-SPECULATION I-SPECULATION
rather B-NEGATION B-NEGATION
than I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
NF-kappa I-NEGATION I-NEGATION
B-regulated I-NEGATION I-NEGATION
inflammatory I-NEGATION I-NEGATION
cytokine I-NEGATION I-NEGATION
genes I-NEGATION I-NEGATION
. O O

Consequently O O
, O O
these O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
physiologically I-SPECULATION I-SPECULATION
relevant I-SPECULATION I-SPECULATION
concentrations I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
ethanol I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
affect I-SPECULATION I-SPECULATION
production I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
inflammatory I-SPECULATION I-SPECULATION
cytokines I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
such I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
tumor I-SPECULATION I-SPECULATION
necrosis I-SPECULATION I-SPECULATION
factor-alpha I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
interleukin-1 I-SPECULATION I-SPECULATION
beta I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
interleukin-6 I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
disrupting I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
signaling I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
monocytes I-SPECULATION I-SPECULATION
. O O

Four O O
P-like O O
elements O O
are O O
required O O
for O O
optimal O O
transcription O O
of O O
the O O
mouse O O
IL-4 O O
gene O O
: O O
involvement O O
of O O
a O O
distinct O O
set O O
of O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
and O O
activator O O
protein-1 O O
family O O
proteins O O
. O O

We O O
previously O O
identified O O
the O O
P O O
sequence O O
as O O
a O O
critical O O
regulatory O O
element O O
of O O
the O O
human O O
IL-4 O O
promoter O O
. O O

In O O
the O O
mouse O O
IL-4 O O
promoter O O
, O O
there O O
are O O
five O O
elements O O
homologous O O
to O O
the O O
human O O
P O O
sequence O O
designated O O
conserved O O
lymphokine O O
element O O
0 O O
( O O
CLE0 O O
) O O
, O O
P O O
, O O
P2 O O
, O O
P3 O O
and O O
P4 O O
. O O

To O O
characterize O O
the O O
role O O
of O O
these O O
P-like O O
elements O O
and O O
their O O
binding O O
factors O O
in O O
the O O
native O O
promoter O O
, O O
we O O
did O O
transient O O
transfection O O
and O O
electrophoretic O O
mobility O O
shift O O
assays O O
( O O
EMSA O O
) O O
. O O

Transfection O O
of O O
EL-4 O O
cells O O
with O O
the O O
IL-4 O O
promoter-reporter O O
constructs O O
carrying O O
mutated O O
P-like O O
elements O O
showed O O
that O O
four O O
P-like O O
elements O O
, O O
CLE0 O O
, O O
P O O
, O O
P2 O O
and O O
P4 O O
, O O
but O O
not B-NEGATION B-NEGATION
P3 I-NEGATION I-NEGATION
, O O
were O O
required O O
for O O
optimal O O
activation O O
of O O
the O O
IL-4 O O
promoter O O
. O O

EMSA O O
showed O O
that O O
both O O
constitutive O O
and O O
inducible O O
complexes O O
bound O O
to O O
CLE0 O O
, O O
P O O
, O O
P2 O O
and O O
P4 O O
, O O
whereas O O
only O O
a O O
constitutive O O
complex O O
bound O O
to O O
P3 O O
. O O

In O O
competition O O
and O O
antibody O O
supershift O O
assays O O
in O O
EMSA O O
, O O
complexes O O
formed O O
with O O
P O O
or O O
P2 O O
proved O O
to O O
contain O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
( O O
NFAT O O
) O O
family O O
proteins O O
as O O
major O O
components O O
. O O

Activator O O
protein O O
( O O
AP O O
)- O O
1 O O
family O O
proteins O O
interacted O O
with O O
CLE0 O O
, O O
P O O
, O O
P2 O O
and O O
P4 O O
. O O

NFAT O O
/ O O
AP-1 O O
complex O O
formed O O
only O O
with O O
P O O
and O O
P2 O O
. O O

Cross-competition O O
assays O O
among O O
the O O
P-like O O
elements O O
revealed O O
element-specific O O
and O O
common O O
complexes O O
. O O

Six O O
tandem O O
repeats O O
of O O
the O O
P O O
element O O
linked O O
to O O
the O O
SV40 O O
promoter O O
responded O O
to O O
phorbol O O
12-myristate O O
13-acetate O O
, O O
while O O
that O O
of O O
other O O
elements O O
did O O
not B-NEGATION B-NEGATION
. O O

It O O
would B-SPECULATION B-SPECULATION
thus I-SPECULATION I-SPECULATION
appear B-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
components I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
each I-SPECULATION I-SPECULATION
P-like I-SPECULATION I-SPECULATION
element-binding I-SPECULATION I-SPECULATION
complexes I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
not B-NEGATION B-NEGATION
identical I-NEGATION I-NEGATION
and O O
may B-SPECULATION B-SPECULATION
coordinately I-SPECULATION I-SPECULATION
contribute I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
transcriptional I-SPECULATION I-SPECULATION
activity I-SPECULATION I-SPECULATION
. O O

The O O
ability O O
of O O
BHRF1 O O
to O O
inhibit O O
apoptosis O O
is O O
dependent O O
on O O
stimulus O O
and O O
cell O O
type O O
. O O

The O O
development O O
of O O
resistance O O
to O O
host O O
defense O O
mechanisms O O
such O O
as O O
tumor O O
necrosis O O
factor O O
( O O
TNF O O
)- O O
and O O
Fas-mediated O O
apoptosis O O
of O O
transformed O O
or O O
virus-infected O O
cells O O
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
critical I-SPECULATION I-SPECULATION
component I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
development I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
disease I-SPECULATION I-SPECULATION
. O O

To O O
find O O
genes O O
that O O
protect O O
cells O O
from O O
apoptosis O O
, O O
we O O
used O O
an O O
expression O O
cloning O O
strategy O O
and O O
identified O O
BHRF1 O O
, O O
an O O
Epstein-Barr O O
virus O O
( O O
EBV O O
) O O
early-lytic-cycle O O
protein O O
with O O
distant O O
homology O O
to O O
Bcl-2 O O
, O O
as O O
an O O
anti-apoptosis O O
protein O O
. O O

Expression O O
of O O
BHRF1 O O
in O O
MCF-Fas O O
cells O O
conferred O O
nearly O O
complete O O
resistance O O
against O O
both O O
anti-Fas O O
antibody O O
and O O
TNF-mediated O O
apoptosis O O
. O O

In O O
addition O O
, O O
BHRF1 O O
protected O O
these O O
cells O O
from O O
monocyte-mediated O O
killing O O
but O O
failed B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
protect I-NEGATION I-NEGATION
them I-NEGATION I-NEGATION
from I-NEGATION I-NEGATION
killing I-NEGATION I-NEGATION
mediated I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
lymphokine-activated I-NEGATION I-NEGATION
killer I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
. O O

The O O
ability O O
of O O
BHRF1 O O
to O O
protect O O
MCF-Fas O O
cells O O
from O O
apoptosis O O
induced O O
by O O
various O O
stimuli O O
was O O
identical O O
to O O
that O O
of O O
Bcl-2 O O
and O O
Bcl-xL O O
. O O

Moreover O O
, O O
the O O
mechanism O O
of O O
action O O
of O O
BHRF1 O O
resembled O O
that O O
of O O
Bcl-2 O O
and O O
Bcl-xL O O
as O O
it O O
inhibited O O
TNF O O
- O O
and O O
anti-Fas-induced O O
activation O O
of O O
two O O
enzymes O O
participating O O
in O O
the O O
apoptosis O O
pathway O O
, O O
cytosolic O O
phospholipase O O
A2 O O
and O O
caspase-3 O O
/ O O
CPP32 O O
, O O
but O O
did O O
not B-NEGATION B-NEGATION
interfere I-NEGATION I-NEGATION
with I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
NF-kappaB-like I-NEGATION I-NEGATION
transcription I-NEGATION I-NEGATION
factors I-NEGATION I-NEGATION
. O O

A O O
putative B-SPECULATION B-SPECULATION
function I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
BHRF1 I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
EBV-infected I-SPECULATION I-SPECULATION
epithelial I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
protect I-SPECULATION I-SPECULATION
virus-infected I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
from I-SPECULATION I-SPECULATION
TNF I-SPECULATION I-SPECULATION
- I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
anti-Fas I-SPECULATION I-SPECULATION
- I-SPECULATION I-SPECULATION
induced I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
death I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
order I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
maximize I-SPECULATION I-SPECULATION
virus I-SPECULATION I-SPECULATION
production I-SPECULATION I-SPECULATION
. O O

Surprisingly O O
, O O
expression O O
of O O
neither B-NEGATION B-NEGATION
BHRF1 I-NEGATION I-NEGATION
even O O
though O O
they O O
increased O O
the O O
survival O O
of O O
serum-starved O O
cells O O
. O O

Thus O O
, O O
the O O
protective O O
role O O
of O O
BHRF1 O O
against O O
apoptosis O O
resembles O O
that O O
of O O
Bcl-2 O O
in O O
being O O
cell O O
type O O
specific O O
and O O
dependent O O
on O O
the O O
apoptotic O O
stimulus O O
. O O

NF-AT O O
activation O O
induced O O
by O O
a O O
CAML-interacting O O
member O O
of O O
the O O
tumor O O
necrosis O O
factor O O
receptor O O
superfamily O O
. O O

Activation O O
of O O
the O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
transcription O O
factor O O
( O O
NF-AT O O
) O O
is O O
a O O
key O O
event O O
underlying O O
lymphocyte O O
action O O
. O O

The O O
CAML O O
( O O
calcium-modulator O O
and O O
cyclophilin O O
ligand O O
) O O
protein O O
is O O
a O O
coinducer O O
of O O
NF-AT O O
activation O O
when O O
overexpressed O O
in O O
Jurkat O O
T O O
cells O O
. O O

A O O
member O O
of O O
the O O
tumor O O
necrosis O O
factor O O
receptor O O
superfamily O O
was O O
isolated O O
by O O
virtue O O
of O O
its O O
affinity O O
for O O
CAML O O
. O O

Cross-linking O O
of O O
this O O
lymphocyte-specific O O
protein O O
, O O
designated O O
TACI O O
( O O
transmembrane O O
activator O O
and O O
CAML-interactor O O
) O O
, O O
on O O
the O O
surface O O
of O O
transfected O O
Jurkat O O
cells O O
with O O
TACI-specific O O
antibodies O O
led O O
to O O
activation O O
of O O
the O O
transcription O O
factors O O
NF-AT O O
, O O
AP-1 O O
, O O
and O O
NFkappaB O O
. O O

TACI-induced O O
activation O O
of O O
NF-AT O O
was O O
specifically O O
blocked O O
by O O
a O O
dominant-negative O O
CAML O O
mutant O O
, O O
thus O O
implicating O O
CAML O O
as O O
a O O
signaling O O
intermediate O O
. O O

The O O
DNA O O
binding O O
domain O O
of O O
the O O
A-MYB O O
transcription O O
factor O O
is O O
responsible O O
for O O
its O O
B O O
cell-specific O O
activity O O
and O O
binds O O
to O O
a O O
B O O
cell O O
110-kDa O O
nuclear O O
protein O O
. O O

Expression O O
studies O O
as O O
well O O
as O O
the O O
use O O
of O O
transgenic O O
animals O O
have O O
demonstrated O O
that O O
the O O
A-MYB O O
transcription O O
factor O O
plays O O
central O O
and O O
specific O O
role O O
in O O
the O O
regulation O O
of O O
mature O O
B O O
cell O O
proliferation O O
and O O
/ O O
or O O
differentiation O O
. O O

Furthermore O O
, O O
it O O
is O O
highly O O
expressed O O
in O O
Burkitt's O O
lymphoma O O
cells O O
and O O
may B-SPECULATION B-SPECULATION
participate I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
pathogenesis I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
disease I-SPECULATION I-SPECULATION
. O O

We O O
have O O
therefore O O
investigated O O
the O O
transcriptional O O
activity O O
of O O
A-MYB O O
and O O
its O O
regulation O O
in O O
several O O
human O O
lymphoid O O
cell O O
lines O O
using O O
co-transfection O O
assays O O
and O O
show O O
that O O
A-MYB O O
is O O
transcriptionally O O
active O O
in O O
all O O
the O O
B O O
cell O O
lines O O
studied O O
, O O
but O O
not B-NEGATION B-NEGATION
in I-NEGATION I-NEGATION
T I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
. O O

In O O
particular O O
the O O
best O O
responder O O
cell O O
line O O
was O O
the O O
Burkitt's O O
cell O O
line O O
Namalwa O O
. O O

The O O
activity O O
of O O
A-MYB O O
in O O
B O O
and O O
not B-NEGATION B-NEGATION
T I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
was O O
observed O O
when O O
either O O
an O O
artificial O O
construct O O
or O O
the O O
c-MYC O O
promoter O O
was O O
used O O
as O O
a O O
reporter O O
. O O

Furthermore O O
, O O
the O O
functional O O
domains O O
responsible O O
for O O
DNA O O
binding O O
, O O
transactivation O O
, O O
and O O
negative O O
regulation O O
, O O
previously O O
characterized O O
in O O
a O O
fibroblast O O
context O O
, O O
were O O
found O O
to O O
have O O
similar O O
activity O O
in O O
B O O
cells O O
. O O

The O O
region O O
of O O
A-MYB O O
responsible O O
for O O
the O O
B O O
cell O O
specific O O
activity O O
was O O
defined O O
to O O
be O O
the O O
N-terminal O O
218 O O
amino O O
acids O O
containing O O
the O O
DNA O O
binding O O
domain O O
. O O

Finally O O
, O O
a O O
110-kDa O O
protein O O
has O O
been O O
identified O O
in O O
the O O
nuclei O O
of O O
all O O
the O O
B O O
, O O
but O O
not B-NEGATION B-NEGATION
T I-NEGATION I-NEGATION
, O O
cell O O
lines O O
that O O
specifically O O
binds O O
to O O
this O O
A-MYB O O
N-terminal O O
domain O O
. O O

We O O
hypothesize B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
110-kDa I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
functionally I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
cell-specific I-SPECULATION I-SPECULATION
co-activator I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
A-MYB I-SPECULATION I-SPECULATION
. O O

Evidence O O
that O O
calcineurin O O
is O O
rate-limiting O O
for O O
primary O O
human O O
lymphocyte O O
activation O O
. O O

Cyclosporine O O
( O O
CsA O O
) O O
is O O
both O O
a O O
clinical O O
immunosuppressive O O
drug O O
and O O
a O O
probe O O
to O O
dissect O O
intracellular O O
signaling O O
pathways O O
. O O

In O O
vitro O O
, O O
CsA O O
inhibits O O
lymphocyte O O
gene O O
activation O O
by O O
inhibiting O O
the O O
phosphatase O O
activity O O
of O O
calcineurin O O
( O O
CN O O
) O O
. O O

In O O
clinical O O
use O O
, O O
CsA O O
treatment O O
inhibits O O
50-75 O O
% O O
of O O
CN O O
activity O O
in O O
circulating O O
leukocytes O O
. O O

We O O
modeled O O
this O O
degree O O
of O O
CN O O
inhibition O O
in O O
primary O O
human O O
leukocytes O O
in O O
vitro O O
in O O
order O O
to O O
study O O
the O O
effect O O
of O O
partial O O
CN O O
inhibition O O
on O O
the O O
downstream O O
signaling O O
events O O
that O O
lead O O
to O O
gene O O
activation O O
. O O

In O O
CsA-treated O O
leukocytes O O
stimulated O O
by O O
calcium O O
ionophore O O
, O O
the O O
degree O O
of O O
reduction O O
in O O
CN O O
activity O O
was O O
accompanied O O
by O O
a O O
similar O O
degree O O
of O O
inhibition O O
of O O
each O O
event O O
tested O O
: O O
dephosphorylation O O
of O O
nuclear O O
factor O O
of O O
activated O O
T O O
cell O O
proteins O O
, O O
nuclear O O
DNA O O
binding O O
, O O
activation O O
of O O
a O O
transfected O O
reporter O O
gene O O
construct O O
, O O
IFN-gamma O O
and O O
IL-2 O O
mRNA O O
accumulation O O
, O O
and O O
IFN-gamma O O
production O O
. O O

Furthermore O O
, O O
the O O
degree O O
of O O
CN O O
inhibition O O
was O O
reflected O O
by O O
a O O
similar O O
degree O O
of O O
reduction O O
in O O
lymphocyte O O
proliferation O O
and O O
IFN-gamma O O
production O O
in O O
the O O
allogeneic O O
mixed O O
lymphocyte O O
cultures O O
. O O

These O O
data O O
support O O
the O O
conclusion O O
that O O
CN O O
activity O O
is O O
rate-limiting O O
for O O
the O O
activation O O
of O O
primary O O
human O O
T O O
lymphocytes O O
. O O

Thus O O
, O O
the O O
reduction O O
of O O
CN O O
activity O O
observed O O
in O O
CsA-treated O O
patients O O
is O O
accompanied O O
by O O
a O O
similar O O
degree O O
of O O
reduction O O
in O O
lymphocyte O O
gene O O
activation O O
, O O
and O O
accounts O O
for O O
the O O
immunosuppression O O
observed O O
. O O

Cooperation O O
of O O
binding O O
sites O O
for O O
STAT6 O O
and O O
NF O O
kappa O O
B O O
/ O O
rel O O
in O O
the O O
IL-4-induced O O
up-regulation O O
of O O
the O O
human O O
IgE O O
germline O O
promoter O O
. O O

Ig O O
heavy O O
chain O O
class O O
switching O O
is O O
directed O O
by O O
cytokines O O
inducing O O
transcription O O
from O O
unrearranged O O
CH O O
genes O O
. O O

Subsequently O O
, O O
such O O
primed O O
cells O O
can O O
undergo O O
switch O O
recombination O O
to O O
express O O
the O O
selected O O
new O O
isotype O O
. O O

In O O
the O O
case O O
of O O
IgE O O
class O O
switching O O
, O O
IL-4 O O
activates O O
the O O
IgE O O
germline O O
promoter O O
by O O
inducing O O
the O O
interaction O O
of O O
the O O
transcription O O
factor O O
STAT6 O O
( O O
IL-4STAT O O
) O O
with O O
a O O
responsive O O
DNA O O
element O O
in O O
the O O
proximal O O
region O O
of O O
the O O
promoter O O
. O O

This O O
study O O
describes O O
the O O
characterization O O
of O O
two O O
additional O O
cis-acting O O
elements O O
that O O
interact O O
with O O
members O O
of O O
the O O
NF O O
kappa O O
B O O
/ O O
rel O O
transcription O O
factor O O
family O O
in O O
an O O
IL-4-independent O O
fashion O O
. O O

Electrophoretic O O
mobility O O
shift O O
assays O O
show O O
that O O
the O O
nucleoprotein O O
complex O O
formed O O
on O O
the O O
upstream O O
site O O
( O O
NF O O
kappa O O
B1 O O
) O O
contains O O
the O O
classical O O
p50 O O
/ O O
p65 O O
heterodimer O O
. O O

The B-SPECULATION B-SPECULATION
complex I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
proximal I-SPECULATION I-SPECULATION
site I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
NF I-SPECULATION I-SPECULATION
kappa I-SPECULATION I-SPECULATION
B2 I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
appears I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
composed I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
p50 I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
relB I-SPECULATION I-SPECULATION
. O O

IgE O O
germline O O
promoter O O
reporter O O
gene O O
constructs O O
carrying O O
point O O
mutations O O
in O O
the O O
NF O O
kappa O O
B2 O O
site O O
were O O
largely O O
unresponsive O O
to O O
IL-4 O O
stimulation O O
in O O
transient O O
transfection O O
experiments O O
, O O
while O O
plasmids O O
with O O
similar O O
mutations O O
in O O
the O O
NF O O
kappa O O
B1 O O
site O O
responded O O
to O O
cytokine O O
stimulation O O
better O O
than O O
the O O
wild-type O O
promoter O O
. O O

The O O
NF O O
kappa O O
B2 O O
effect O O
was O O
dependent O O
on O O
the O O
presence O O
of O O
the O O
STAT6 O O
binding O O
site O O
, O O
demonstrating O O
that O O
the O O
NF O O
kappa O O
B2 O O
motif O O
is O O
necessary O O
but O O
not B-NEGATION B-NEGATION
sufficient I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
mediating I-NEGATION I-NEGATION
cytokine I-NEGATION I-NEGATION
up-regulation I-NEGATION I-NEGATION
. O O

In O O
addition O O
, O O
the O O
combination O O
of O O
a O O
NF O O
kappa O O
B O O
/ O O
rel O O
binding O O
site O O
and O O
the O O
STAT6 O O
response O O
element O O
conferred O O
IL-4 O O
inducibility O O
to O O
a O O
heterologous O O
minimal O O
promoter O O
, O O
while O O
the O O
individual O O
sites O O
had O O
no B-NEGATION B-NEGATION
effect I-NEGATION I-NEGATION
. O O

The O O
available O O
data O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
NF I-SPECULATION I-SPECULATION
kappa I-SPECULATION I-SPECULATION
B2 I-SPECULATION I-SPECULATION
nucleoprotein I-SPECULATION I-SPECULATION
complex I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
cooperate I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
DNA-bound I-SPECULATION I-SPECULATION
STAT6 I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
achieve I-SPECULATION I-SPECULATION
IL-4-dependent I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
IgE I-SPECULATION I-SPECULATION
germline I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
. O O

Dual O O
effects O O
of O O
LPS O O
antibodies O O
on O O
cellular O O
uptake O O
of O O
LPS O O
and O O
LPS-induced O O
proinflammatory O O
functions O O
. O O

Human O O
phagocytes O O
recognize O O
bacterial O O
LPS O O
( O O
endotoxin O O
) O O
through O O
membrane O O
CD14 O O
( O O
mCD14 O O
) O O
, O O
a O O
proinflammatory O O
LPS O O
receptor O O
. O O

This O O
study O O
tested O O
the O O
hypothesis B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
anti-LPS I-SPECULATION I-SPECULATION
Abs I-SPECULATION I-SPECULATION
neutralize I-SPECULATION I-SPECULATION
endotoxin I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
blocking I-SPECULATION I-SPECULATION
cellular I-SPECULATION I-SPECULATION
uptake I-SPECULATION I-SPECULATION
through I-SPECULATION I-SPECULATION
mCD14 I-SPECULATION I-SPECULATION
. O O

Ab-associated O O
changes O O
in O O
the O O
uptake O O
and O O
cellular O O
distribution O O
of O O
FITC-LPS O O
were O O
assessed O O
by O O
flow O O
cytometry O O
and O O
laser O O
scanning O O
confocal O O
microscopy O O
in O O
human O O
CD14-transfected O O
Chinese O O
hamster O O
ovary O O
fibroblasts O O
( O O
CHO-CD14 O O
cells O O
) O O
and O O
human O O
peripheral O O
blood O O
monocytes O O
. O O

LPS O O
core O O
- O O
and O O
O-side O O
chain-specific O O
mAbs O O
inhibited O O
mCD14-mediated O O
LPS O O
uptake O O
by O O
both O O
cell O O
types O O
in O O
the O O
presence O O
of O O
serum O O
. O O

O-side O O
chain-specific O O
mAb O O
concurrently O O
enhanced O O
complement-dependent O O
LPS O O
uptake O O
by O O
monocytes O O
through O O
complement O O
receptor-1 O O
( O O
CR1 O O
) O O
and O O
uptake O O
by O O
CHO-CD14 O O
cells O O
involving O O
another O O
heat-labile O O
serum O O
factor O O
( O O
s O O
) O O
and O O
cell-associated O O
recognition O O
molecule O O
( O O
s O O
) O O
. O O

Core-specific O O
mAb O O
inhibited O O
mCD14-mediated O O
uptake O O
of O O
homologous O O
and O O
heterologous O O
LPS O O
, O O
while O O
producing O O
less O O
concurrent O O
enhancement O O
of O O
non-mCD14-mediated O O
LPS O O
uptake O O
. O O

The O O
modulation O O
by O O
anti-LPS O O
mAbs O O
of O O
mCD14-mediated O O
LPS O O
uptake O O
was O O
associated O O
with O O
inhibition O O
of O O
LPS-induced O O
nuclear O O
factor-kappaB O O
( O O
NF-kappaB O O
) O O
translocation O O
and O O
TNF-alpha O O
secretion O O
in O O
CHO-CD14 O O
cells O O
and O O
monocytes O O
, O O
respectively O O
, O O
while O O
mAb O O
enhancement O O
of O O
non-mCD14-mediated O O
LPS O O
uptake O O
stimulated O O
these O O
activities O O
. O O

LPS-specific O O
Abs O O
thus O O
mediate O O
anti-inflammatory O O
and O O
proinflammatory O O
functions O O
, O O
respectively O O
, O O
by O O
preventing O O
target O O
cell O O
uptake O O
of O O
LPS O O
through O O
mCD14 O O
and O O
augmenting O O
uptake O O
through O O
CR1 O O
or O O
other O O
cell O O
receptors O O
. O O

Human O O
neutrophils O O
express O O
GH-N O O
gene O O
transcripts O O
and O O
the O O
pituitary O O
transcription O O
factor O O
Pit-1b O O
. O O

Since O O
GH O O
stimulates O O
the O O
development O O
and O O
function O O
of O O
granulocytes O O
, O O
we O O
investigated O O
the O O
expression O O
of O O
GH O O
in O O
granulocyte O O
subsets O O
. O O

By O O
immunocytochemistry O O
, O O
25 O O
± O O
7 O O
% O O
of O O
the O O
human O O
neutrophils O O
were O O
shown O O
to O O
express O O
immunoreactive O O
GH O O
, O O
whereas O O
eosinophils O O
were O O
negative O O
. O O

Reversed O O
transcription O O
( O O
RT O O
)- O O
PCR O O
analysis O O
demonstrated O O
GH O O
mRNA O O
in O O
neutrophils O O
. O O

Restriction O O
analysis O O
revealed O O
that O O
neutrophils O O
express O O
the O O
GH-N O O
gene O O
but O O
not B-NEGATION B-NEGATION
the I-NEGATION I-NEGATION
GH-V I-NEGATION I-NEGATION
gene I-NEGATION I-NEGATION
. O O

Furthermore O O
, O O
we O O
demonstrated O O
by O O
western O O
blot O O
analysis O O
that O O
neutrophils O O
express O O
an O O
alternatively O O
spliced O O
variant O O
of O O
the O O
pituitary O O
transcription O O
factor O O
Pit-1 O O
, O O
designated O O
Pit-1b O O
. O O

Interleukin-7 O O
upregulates O O
the O O
interleukin-2-gene O O
expression O O
in O O
activated O O
human O O
T O O
lymphocytes O O
at O O
the O O
transcriptional O O
level O O
by O O
enhancing O O
the O O
DNA O O
binding O O
activities O O
of O O
both O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
and O O
activator O O
protein-1 O O
. O O

In O O
the O O
present O O
report O O
, O O
we O O
studied O O
the O O
role O O
of O O
the O O
stromal-derived O O
cytokine O O
interleukin-7 O O
( O O
IL-7 O O
) O O
in O O
the O O
IL-2-gene O O
regulation O O
in O O
activated O O
T O O
lymphocytes O O
. O O

Production O O
of O O
IL-2 O O
requires O O
the O O
formation O O
of O O
transcription O O
factors O O
involved O O
in O O
the O O
IL-2-gene O O
regulation O O
. O O

T-cell O O
receptor O O
( O O
TCR O O
)/ O O
CD3 O O
engagement O O
results O O
in O O
the O O
activation O O
of O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
( O O
NFAT O O
) O O
, O O
activator O O
protein-1 O O
( O O
AP-1 O O
) O O
, O O
and O O
nuclear O O
factor O O
kappaB O O
( O O
NFkappaB O O
) O O
, O O
whereas O O
the O O
CD28 O O
responsive O O
complex O O
( O O
CD28RC O O
) O O
is O O
activated O O
in O O
response O O
to O O
the O O
CD28 O O
signal O O
. O O

Costimulation O O
of O O
phytohemagglutinin O O
/ O O
anti-CD28 O O
activated O O
T O O
lymphocytes O O
with O O
IL-7 O O
induces O O
a O O
fivefold O O
enhanced O O
IL-2-mRNA O O
accumulation O O
and O O
a O O
2.5-fold O O
enhanced O O
protein O O
secretion O O
. O O

The O O
IL-2-gene O O
transcription O O
rate O O
is O O
increased O O
3.4-fold O O
, O O
indicating B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
effect I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
IL-7 I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
part I-SPECULATION I-SPECULATION
mediated I-SPECULATION I-SPECULATION
at I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
transcriptional I-SPECULATION I-SPECULATION
level I-SPECULATION I-SPECULATION
. O O

The O O
molecular O O
mechanisms O O
underlying O O
the O O
IL-7 O O
effect O O
involve O O
the O O
upregulation O O
of O O
the O O
DNA O O
binding O O
activity O O
of O O
NFAT O O
( O O
60 O O
%) O O
and O O
AP-1 O O
( O O
120 O O
%) O O
, O O
without B-NEGATION B-NEGATION
affecting I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
activities I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
NFkappaB I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
CD28RC I-NEGATION I-NEGATION
, O O
which O O
was O O
confirmed O O
by O O
transfection O O
assays O O
. O O

We O O
also O O
show O O
that O O
the O O
IL-7-induced O O
enhancement O O
of O O
the O O
AP-1-DNA O O
binding O O
activity O O
is O O
not B-NEGATION B-NEGATION
cyclosporin I-NEGATION I-NEGATION
A-sensitive I-NEGATION I-NEGATION
. O O

Since O O
AP-1 O O
is O O
part O O
of O O
the O O
NFAT O O
complex O O
, O O
we O O
conclude O O
that O O
the O O
IL-7-signaling O O
pathway O O
is O O
involved O O
in O O
the O O
activation O O
of O O
the O O
fos O O
and O O
jun O O
proteins O O
of O O
which O O
AP-1 O O
consists O O
. O O

Analysis O O
of O O
myeloid-associated O O
genes O O
in O O
human O O
hematopoietic O O
progenitor O O
cells O O
. O O

The O O
distribution O O
of O O
myeloid O O
lineage-associated O O
cytokine O O
receptors O O
and O O
lysosomal O O
proteins O O
was O O
analyzed O O
in O O
human O O
CD34 O O
+ O O
cord O O
blood O O
cell O O
( O O
CB O O
) O O
subsets O O
at O O
different O O
stages O O
of O O
myeloid O O
commitment O O
by O O
reverse-transcriptase O O
polymerase O O
chain O O
reaction O O
( O O
RT-PCR O O
) O O
. O O

The O O
highly O O
specific O O
granulomonocyte-associated O O
lysosomal O O
proteins O O
myeloperoxidase O O
( O O
MPO O O
) O O
and O O
lysozyme O O
( O O
LZ O O
) O O
, O O
as O O
well O O
as O O
the O O
transcription O O
factor O O
PU.1 O O
, O O
were O O
already O O
detectable O O
in O O
the O O
most O O
immature O O
CD34 O O
+ O O
Thy-1 O O
+ O O
subset O O
. O O

Messenger O O
RNA O O
( O O
mRNA O O
) O O
levels O O
for O O
the O O
granulocyte-colony O O
stimulating O O
factor O O
( O O
G-CSF O O
) O O
receptor O O
, O O
granulocyte-macrophage O O
( O O
GM O O
)- O O
CSF O O
receptor O O
alpha O O
subunit O O
and O O
tumor O O
necrosis O O
factor O O
( O O
TNF O O
) O O
receptors O O
I O O
( O O
p55 O O
) O O
and O O
II O O
( O O
p75 O O
) O O
were O O
also O O
detected O O
in O O
this O O
subset O O
in O O
addition O O
to O O
c-kit O O
and O O
flt-3 O O
, O O
receptors O O
known O O
to O O
be O O
expressed O O
on O O
progenitor O O
cells O O
. O O

By O O
contrast O O
, O O
the B-NEGATION O
monocyte-macrophage I-NEGATION O
colony I-NEGATION O
stimulating I-NEGATION O
factor I-NEGATION O
( I-NEGATION O
M-CSF I-NEGATION O
) I-NEGATION O
receptor I-NEGATION O
was I-NEGATION O
largely I-NEGATION O
absent I-NEGATION O
at I-NEGATION O
this I-NEGATION O
stage I-NEGATION O
and I-NEGATION O
in I-NEGATION O
the I-NEGATION O
CD34 I-NEGATION O
+ I-NEGATION O
Thy-1-CD45RA I-NEGATION O
- I-NEGATION O
subsets I-NEGATION O
. O O

The O O
M-CSF O O
receptor O O
was O O
first O O
detectable O O
in O O
the O O
myeloid-committed O O
CD34 O O
+ O O
Thy-l-CD45RA O O
+ O O
subset O O
. O O

All O O
other O O
molecules O O
studied O O
were O O
found O O
to O O
be O O
expressed O O
at O O
this O O
stage O O
of O O
differentiation O O
. O O

Different O O
cocktails O O
of O O
the O O
identified O O
ligands O O
were O O
added O O
to O O
sorted O O
CD34 O O
+ O O
Thy-1 O O
+ O O
single O O
cells O O
. O O

Low O O
proliferative O O
capacity O O
was O O
observed O O
after O O
1 O O
week O O
in O O
culture O O
in O O
the O O
presence O O
of O O
stem O O
cell O O
factor O O
( O O
SCF O O
) O O
+ O O
Flt-3 O O
ligand O O
( O O
FL O O
) O O
+ O O
G-CSF O O
. O O

Addition O O
of O O
GM-CSF O O
to O O
this O O
basic O O
cocktail O O
consistently O O
increased O O
the O O
clonogenic O O
capacity O O
of O O
single O O
CD34 O O
+ O O
Thy-1 O O
+ O O
cells O O
, O O
and O O
this O O
effect O O
was O O
further O O
enhanced O O
( O O
up O O
to O O
72.3 O O
± O O
4.3 O O
% O O
on O O
day O O
7 O O
) O O
by O O
the O O
inclusion O O
of O O
TNF-alpha O O
. O O

In O O
conclusion O O
, O O
the O O
presence O O
of O O
myeloid-associated O O
growth O O
factor O O
receptor O O
transcripts O O
in O O
CD34 O O
+ O O
CB O O
subsets O O
does O O
not B-NEGATION B-NEGATION
discriminate I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
various I-NEGATION I-NEGATION
stages I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
differentiation I-NEGATION I-NEGATION
, I-NEGATION O
with B-NEGATION B-NEGATION
the I-NEGATION I-NEGATION
exception I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
M-CSF I-NEGATION I-NEGATION
receptor I-NEGATION I-NEGATION
. O O

In O O
addition O O
, O O
we O O
show O O
that O O
TNF-alpha O O
is O O
a O O
potent O O
costimulatory O O
factor O O
of O O
the O O
very O O
immature O O
CD34 O O
+ O O
Thy-1 O O
+ O O
CB O O
subset O O
. O O

Monochloramine O O
inhibits O O
phorbol O O
ester-inducible O O
neutrophil O O
respiratory O O
burst O O
activation O O
and O O
T O O
cell O O
interleukin-2 O O
receptor O O
expression O O
by O O
inhibiting O O
inducible O O
protein O O
kinase O O
C O O
activity O O
. O O

Monochloramine O O
derivatives O O
are O O
long O O
lived O O
physiological O O
oxidants O O
produced O O
by O O
neutrophils O O
during O O
the O O
respiratory O O
burst O O
. O O

The O O
effects O O
of O O
chemically O O
prepared O O
monochloramine O O
( O O
NH2Cl O O
) O O
on O O
protein O O
kinase O O
C O O
( O O
PKC O O
) O O
and O O
PKC-mediated O O
cellular O O
responses O O
were O O
studied O O
in O O
elicited O O
rat O O
peritoneal O O
neutrophils O O
and O O
human O O
Jurkat O O
T O O
cells O O
. O O

Neutrophils O O
pretreated O O
with O O
NH2Cl O O
( O O
30-50 O O
microM O O
) O O
showed O O
a O O
marked O O
decrease O O
in O O
the O O
respiratory O O
burst O O
activity O O
induced O O
by O O
phorbol O O
12-myristate O O
13-acetate O O
( O O
PMA O O
) O O
, O O
which O O
is O O
a O O
potent O O
PKC O O
activator O O
. O O

These O O
cells O O
, O O
however O O
, O O
were O O
viable O O
and O O
showed O O
a O O
complete O O
respiratory O O
burst O O
upon O O
arachidonic O O
acid O O
stimulation O O
, O O
which O O
induces O O
the O O
respiratory O O
burst O O
by O O
a O O
PKC-independent O O
mechanism O O
. O O

The O O
NH2Cl-treated O O
neutrophils O O
showed O O
a O O
decrease O O
in O O
both O O
PKC O O
activity O O
and O O
PMA-induced O O
phosphorylation O O
of O O
a O O
47-kDa O O
protein O O
, O O
which O O
corresponds O O
to O O
the O O
cytosolic O O
factor O O
of O O
NADPH O O
oxidase O O
, O O
p47 O O
( O O
phox O O
) O O
. O O

Jurkat O O
T O O
cells O O
pretreated O O
with O O
NH2Cl O O
( O O
20-70 O O
microM O O
) O O
showed O O
a O O
decrease O O
in O O
the O O
expression O O
of O O
the O O
interleukin-2 O O
receptor O O
alpha O O
chain O O
following O O
PMA O O
stimulation O O
. O O

This O O
was O O
also O O
accompanied O O
by O O
a O O
decrease O O
in O O
both O O
PKC O O
activity O O
and O O
nuclear O O
transcription O O
factor-kappaB O O
activation O O
, O O
also O O
without B-NEGATION B-NEGATION
loss I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
cell I-NEGATION I-NEGATION
viability I-NEGATION I-NEGATION
. O O

These O O
results O O
show O O
that O O
NH2Cl O O
inhibits O O
PKC-mediated O O
cellular O O
responses O O
through O O
inhibition O O
of O O
the O O
inducible O O
PKC O O
activity O O
. O O

HIV-1 O O
Vpr O O
suppresses O O
immune O O
activation O O
and O O
apoptosis O O
through O O
regulation O O
of O O
nuclear O O
factor O O
kappa O O
B O O
[ O O
see O O
comments O O
] O O

The O O
HIV-1 O O
accessory O O
gene O O
product O O
Vpr O O
can O O
influence O O
viral O O
pathogenesis O O
by O O
affecting O O
viral O O
replication O O
as O O
well O O
as O O
host O O
cell O O
transcription O O
and O O
proliferation O O
. O O

We O O
have O O
investigated O O
the O O
effects O O
of O O
Vpr O O
on O O
host O O
cell O O
activation O O
and O O
confirm O O
that O O
it O O
influences O O
cellular O O
proliferation O O
. O O

However O O
, O O
we O O
have O O
also O O
found O O
that O O
Vpr O O
modulates O O
T-cell O O
receptor O O
( O O
TCR O O
)- O O
triggered O O
apoptosis O O
in O O
a O O
manner O O
similar O O
to O O
that O O
of O O
glucocorticoids O O
. O O

In O O
the O O
absence B-NEGATION O
of I-NEGATION O
TCR-mediated I-NEGATION O
activation I-NEGATION O
, O O
Vpr O O
induces O O
apoptosis O O
whereas O O
in O O
its O O
presence O O
, O O
Vpr O O
interrupts O O
the O O
expected O O
induction O O
of O O
apoptosis O O
. O O

This O O
regulation O O
of O O
apoptosis O O
is O O
linked O O
to O O
Vpr O O
suppression O O
of O O
NF-kappa O O
B O O
activity O O
via O O
the O O
induction O O
of O O
I O O
kappa O O
B O O
, O O
an O O
inhibitor O O
of O O
NF-kappa O O
B O O
. O O

Further O O
, O O
Vpr O O
suppresses O O
expression O O
of O O
IL-2 O O
, O O
IL-10 O O
, O O
IL-12 O O
, O O
TNF O O
alpha O O
and O O
IL-4 O O
, O O
all O O
of O O
which O O
are O O
NF-kappa O O
B-dependent O O
. O O

The O B-SPECULATION
effects O I-SPECULATION
of O I-SPECULATION
Vpr O I-SPECULATION
could O I-SPECULATION
be O I-SPECULATION
reversed O I-SPECULATION
by O I-SPECULATION
RU486 O I-SPECULATION
. O O

Our O O
finding O O
that O O
Vpr O O
can O O
regulate O O
NF-kappa O O
B O O
supports O O
the O O
hypothesis B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
some I-SPECULATION I-SPECULATION
aspects I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
viral I-SPECULATION I-SPECULATION
pathogenesis I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
consequence I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
dysregulation I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
Vpr I-SPECULATION I-SPECULATION
. O O

The O O
tax O O
protein O O
of O O
human O O
T-cell O O
leukemia O O
virus O O
type O O
1 O O
mediates O O
the O O
transactivation O O
of O O
the O O
c-sis O O
/ O O
platelet-derived O O
growth O O
factor-B O O
promoter O O
through O O
interactions O O
with O O
the O O
zinc O O
finger O O
transcription O O
factors O O
Sp1 O O
and O O
NGFI-A O O
/ O O
Egr-1 O O
. O O

Transcriptional O O
up-regulation O O
of O O
the O O
c-sis O O
/ O O
platelet-derived O O
growth O O
factor-B O O
( O O
PDGF-B O O
) O O
proto-oncogene O O
by O O
the O O
Tax O O
protein O O
of O O
human O O
T-cell O O
leukemia O O
virus O O
type O O
1 O O
has O O
been O O
implicated O O
as O O
one O O
possible B-SPECULATION B-SPECULATION
mechanism I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
cellular I-SPECULATION I-SPECULATION
transformation I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
T-cell I-SPECULATION I-SPECULATION
leukemia I-SPECULATION I-SPECULATION
virus I-SPECULATION I-SPECULATION
type I-SPECULATION I-SPECULATION
1 I-SPECULATION I-SPECULATION
. O O

In O O
previous O O
work O O
, O O
we O O
identified O O
an O O
essential O O
site O O
in O O
the O O
c-sis O O
/ O O
PDGF-B O O
promoter O O
, O O
Tax-responsive O O
element O O
1 O O
( O O
TRE1 O O
) O O
, O O
necessary O O
for O O
transactivation O O
by O O
Tax O O
. O O

We O O
also O O
identified O O
Sp1 O O
, O O
Sp3 O O
, O O
and O O
NGFI-A O O
/ O O
Egr-1 O O
as O O
the O O
primary O O
nuclear O O
transcription O O
factors O O
binding O O
to O O
TRE1 O O
which O O
mediate O O
Tax O O
responsiveness O O
. O O

In O O
the O O
present O O
work O O
, O O
we O O
have O O
investigated O O
the O O
mechanism O O
( O O
s O O
) O O
whereby O O
Tax O O
transactivates O O
the O O
c-sis O O
/ O O
PDGF-B O O
proto-oncogene O O
. O O

In O O
vitro O O
transcription O O
assays O O
showed O O
that O O
Tax O O
was O O
able O O
to O O
significantly O O
increase O O
the O O
transcriptional O O
activity O O
of O O
a O O
template O O
containing O O
the O O
- O O
257 O O
to O O
+ O O
74 O O
region O O
of O O
the O O
c-sis O O
/ O O
PDGF-B O O
promoter O O
. O O

Electrophoretic O O
mobility O O
shift O O
assay O O
analysis O O
showed O O
that O O
Tax O O
increased O O
the O O
DNA O O
binding O O
activity O O
of O O
both O O
Sp1 O O
and O O
NGFI-A O O
/ O O
Egr-1 O O
using O O
a O O
TRE1 O O
probe O O
. O O

Analysis O O
of O O
Tax O O
mutants O O
showed O O
that O O
two B-NEGATION O
mutants I-NEGATION O
, I-NEGATION O
IEXC29S I-NEGATION O
and I-NEGATION O
IEXL320G I-NEGATION O
, I-NEGATION O
were I-NEGATION O
unable I-NEGATION O
to I-NEGATION O
significantly I-NEGATION O
transactivate I-NEGATION O
the I-NEGATION O
c-sis I-NEGATION O
/ I-NEGATION O
PDGF-B I-NEGATION O
promoter I-NEGATION O
. O O

Finally O O
, O O
co-immunoprecipitation O O
analysis O O
revealed O O
that O O
Tax O O
is O O
able O O
to O O
stably O O
bind O O
to O O
both O O
Sp1 O O
and O O
NGFI-A O O
/ O O
Egr-1 O O
. O O

Interestingly O O
, O O
co-immunoprecipitation O O
analysis O O
also O O
revealed O O
that O O
Tax B-NEGATION O
mutant I-NEGATION O
IEXC29S I-NEGATION O
is I-NEGATION O
unable I-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
interact I-NEGATION I-NEGATION
with I-NEGATION I-NEGATION
NGFI-A I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
Egr-1 I-NEGATION I-NEGATION
, O O
whereas O O
Tax O O
mutant O O
IEXL320G O O
is O O
able O O
to O O
interact O O
with O O
NGFI-A O O
/ O O
Egr-1 O O
. O O

Induction O O
of O O
endothelial O O
cell O O
surface O O
adhesion O O
molecules O O
by O O
tumor O O
necrosis O O
factor O O
is O O
blocked O O
by O O
protein O O
tyrosine O O
phosphatase O O
inhibitors O O
: O O
role O O
of O O
the O O
nuclear O O
transcription O O
factor O O
NF-kappa O O
B O O
. O O

Recent O O
studies O O
from O O
our O O
laboratory O O
have O O
indicated B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
tyrosine I-SPECULATION I-SPECULATION
phosphatase I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
PTPase I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
inhibitors I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
down-modulate I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
tumor I-SPECULATION I-SPECULATION
necrosis I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
TNF I-SPECULATION I-SPECULATION
)- I-SPECULATION I-SPECULATION
mediated I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
nuclear I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
ML-1a I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
monocytic I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
line I-SPECULATION I-SPECULATION
( O O
Singh O O
and O O
Aggarwal O O
, O O
J. O O
Biol. O O
Chem. O O
1995 O O
: O O
270 O O
: O O
10631 O O
) O O
. O O

Since O O
TNF O O
is O O
one O O
of O O
the O O
major O O
inducers O O
of O O
various O O
adhesion O O
molecules O O
in O O
human O O
endothelial O O
cells O O
and O O
their O O
expression O O
is O O
known O O
to O O
require O O
the O O
activation O O
of O O
NF-kappa O O
B O O
, O O
we O O
examined O O
the O O
effect O O
of O O
PTPase O O
inhibitors O O
on O O
the O O
TNF-mediated O O
induction O O
of O O
intracellular O O
adhesion O O
molecule O O
( O O
ICAM O O
)- O O
1 O O
, O O
vascular O O
cell O O
adhesion O O
molecule O O
( O O
VCAM O O
)- O O
1 O O
and O O
endothelial O O
leukocyte O O
adhesion O O
molecule O O
( O O
ELAM O O
)- O O
1 O O
. O O

Like O O
ML-1a O O
, O O
human O O
dermal O O
microvessel O O
endothelial O O
cells O O
( O O
MVEC O O
) O O
treated O O
with O O
TNF O O
rapidly O O
activated O O
( O O
within O O
30 O O
min O O
) O O
NF-kappa O O
B O O
; O O
this O O
effect O O
was O O
completely O O
abolished O O
by O O
co-treatment O O
with O O
phenylarsine O O
oxide O O
( O O
PAO O O
) O O
, O O
a O O
specific O O
inhibitor O O
of O O
PTPase O O
. O O

The O O
induction O O
of O O
ICAM-1 O O
, O O
VCAM-1 O O
, O O
and O O
ELAM-1 O O
by O O
TNF O O
in O O
MVEC O O
occurred O O
within O O
6 O O
h O O
and O O
was O O
also O O
completely O O
down-regulated O O
by O O
PAO O O
in O O
a O O
dose-dependent O O
manner O O
. O O

PAO O O
was O O
found O O
to O O
be O O
effective O O
even O O
when O O
added O O
3 O O
h O O
after O O
TNF O O
, O O
suggesting B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
rapid I-SPECULATION I-SPECULATION
mode I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
action I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
inhibitor I-SPECULATION I-SPECULATION
. O O

Besides O O
PAO O O
, O O
other O O
inhibitors O O
of O O
PTPase O O
, O O
including O O
pervanadate O O
and O O
diamide O O
, O O
also O O
blocked O O
TNF-dependent O O
NF-kappa O O
B O O
activation O O
and O O
induction O O
of O O
all O O
the O O
three O O
adhesion O O
proteins O O
. O O

Consistent O O
with O O
these O O
results O O
, O O
the O O
attachment O O
of O O
monocytes O O
to O O
MVEC O O
was O O
also O O
blocked O O
by O O
the O O
PTPase O O
inhibitors O O
. O O

Thus O O
, O O
overall O O
, O O
our O O
results O O
demonstrate O O
that O O
a O O
PTPase O O
is O O
involved O O
either B-SPECULATION O
directly I-SPECULATION O
in O O
the O O
pathway O O
leading O O
to O O
the O O
induction O O
of O O
endothelial O O
cell O O
adhesion O O
molecules O O
by O O
TNF O O
. O O

Because O O
of O O
their O O
role O O
in O O
cell O O
adhesion O O
, O O
PTPase O O
may B-SPECULATION B-SPECULATION
provide I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
novel I-SPECULATION I-SPECULATION
target I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
drug I-SPECULATION I-SPECULATION
development I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
treatment I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
inflammation I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
atherogenesis I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
tumor I-SPECULATION I-SPECULATION
metastasis I-SPECULATION I-SPECULATION
. O O

The O O
spatial O O
distribution O O
of O O
human O O
immunoglobulin O O
genes O O
within O O
the O O
nucleus O O
: O O
evidence O O
for O O
gene O O
topography O O
independent O O
of O O
cell O O
type O O
and O O
transcriptional O O
activity O O
. O O

The O O
three-dimensional O O
positioning O O
of O O
immunoglobulin O O
( O O
Ig O O
) O O
genes O O
within O O
the O O
nucleus O O
of O O
human O O
cells O O
was O O
investigated O O
using O O
in O O
situ O O
hybridization O O
and O O
confocal O O
microscopy O O
. O O

The O O
visualization O O
of O O
heavy O O
and O O
light O O
chain O O
genes O O
in O O
B-lymphoid O O
cells O O
showed O O
that O O
the O O
three O O
Ig O O
genes O O
are O O
differentially O O
and O O
nonrandomly O O
distributed O O
in O O
different O O
nuclear O O
subvolumes O O
: O O
the O O
kappa O O
genes O O
were O O
found O O
to O O
be O O
preferentially O O
confined O O
to O O
an O O
outer O O
nuclear O O
volume O O
, O O
whereas O O
the O O
gamma O O
and O O
lambda O O
genes O O
consistently O O
occupied O O
more O O
central O O
positions O O
within O O
the O O
nucleus O O
, O O
the O O
lambda O O
genes O O
being O O
more O O
interior O O
when O O
compared O O
with O O
the O O
gamma O O
genes O O
. O O

The O O
data O O
further O O
show O O
that O O
these O O
overall O O
topographical O O
distributions O O
are O O
independent O O
of O O
gene O O
transcriptional O O
activity O O
and O O
are O O
conserved O O
in O O
different O O
cell O O
types O O
. O O

Although O O
subtle B-SPECULATION B-NEGATION
gene I-SPECULATION I-NEGATION
movements I-SPECULATION I-NEGATION
within I-SPECULATION I-NEGATION
those I-SPECULATION I-NEGATION
defined I-SPECULATION I-NEGATION
topographical I-SPECULATION I-NEGATION
regions I-SPECULATION I-NEGATION
cannot I-SPECULATION I-NEGATION
be I-SPECULATION I-NEGATION
excluded I-SPECULATION I-NEGATION
by I-SPECULATION I-NEGATION
this I-SPECULATION I-NEGATION
study I-SPECULATION I-NEGATION
, O O
the O O
results O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
, O I-SPECULATION
rather O B-NEGATION
tissue B-NEGATION I-NEGATION
specificity I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
gene I-NEGATION I-NEGATION
expression I-NEGATION I-NEGATION
is I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
accompanied I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
drastic I-NEGATION I-NEGATION
changes I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
gene I-NEGATION I-NEGATION
nuclear I-NEGATION I-NEGATION
topography I-NEGATION I-NEGATION
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
organization I-SPECULATION I-SPECULATION
within I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
nucleus I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
primarily I-SPECULATION I-SPECULATION
dependent I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
structural I-SPECULATION I-SPECULATION
constraints I-SPECULATION I-SPECULATION
imposed I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
respective I-SPECULATION I-SPECULATION
chromosomes I-SPECULATION I-SPECULATION
. O O

Transcriptional O O
activation O O
of O O
the O O
vascular O O
cell O O
adhesion O O
molecule-1 O O
gene O O
in O O
T O O
lymphocytes O O
expressing O O
human O O
T-cell O O
leukemia O O
virus O O
type O O
1 O O
Tax O O
protein O O
. O O

Recruitment O O
and O O
extravasation O O
of O O
T O O
cells O O
through O O
the O O
blood-brain O O
barrier O O
are O O
favored O O
by O O
adhesion O O
molecule-mediated O O
interactions O O
of O O
circulating O O
T O O
cells O O
with O O
endothelial O O
cells O O
. O O

Since O O
a O O
common O O
pathological O O
finding O O
in O O
human O O
T-cell O O
leukemia O O
virus O O
type O O
1 O O
( O O
HTLV-1 O O
)- O O
associated O O
diseases O O
is O O
the O O
infiltration O O
of O O
HTLV-1-infected O O
T O O
lymphocytes O O
into O O
various O O
organs O O
, O O
we O O
have O O
looked O O
for O O
the O O
profile O O
of O O
adhesion O O
molecules O O
expressed O O
by O O
HTLV-1-transformed O O
T O O
cells O O
. O O

Flow O O
cytometry O O
analysis O O
indicated B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
were I-SPECULATION I-SPECULATION
expressing I-SPECULATION I-SPECULATION
high I-SPECULATION I-SPECULATION
levels I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
vascular I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
molecule I-SPECULATION I-SPECULATION
1 I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
VCAM-1 I-SPECULATION I-SPECULATION
[ I-SPECULATION I-SPECULATION
CD106 I-SPECULATION I-SPECULATION
]) I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
110-kDa I-SPECULATION I-SPECULATION
member I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
immunoglobulin I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
superfamily I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
first I-SPECULATION I-SPECULATION
identified I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
endothelial I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
stimulated I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
inflammatory I-SPECULATION I-SPECULATION
cytokines I-SPECULATION I-SPECULATION
. O O

This O O
adhesion O O
molecule O O
was O O
also O O
expressed O O
by O O
T O O
cells O O
obtained O O
from O O
one O O
patient O O
with O O
HTLV-1-associated O O
myelopathy O O
/ O O
tropical O O
spastic O O
paraparesis O O
but O O
not B-NEGATION B-NEGATION
by I-NEGATION I-NEGATION
activated I-NEGATION I-NEGATION
T I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
isolated I-NEGATION I-NEGATION
from I-NEGATION I-NEGATION
one I-NEGATION I-NEGATION
normal I-NEGATION I-NEGATION
blood I-NEGATION I-NEGATION
donor I-NEGATION I-NEGATION
. O O

The O O
role O O
of O O
the O O
viral O O
trans-activator O O
Tax O O
protein O O
in O O
the O O
induction O O
of O O
VCAM-1 O O
was O O
first O O
indicated O O
by O O
the O O
detection O O
of O O
this O O
adhesion O O
molecule O O
on O O
Jurkat O O
T-cell O O
clones O O
stably O O
expressing O O
the O O
tax O O
gene O O
. O O

The O O
effect O O
of O O
Tax O O
on O O
VCAM-1 O O
gene O O
transcription O O
was O O
next O O
confirmed O O
in O O
JPX-9 O O
cells O O
, O O
a O O
subclone O O
of O O
Jurkat O O
cells O O
, O O
carrying O O
the O O
tax O O
sequences O O
under O O
the O O
control O O
of O O
an O O
inducible O O
promoter O O
. O O

Furthermore O O
, O O
deletion O O
and O O
mutation O O
analyses O O
of O O
the O O
VCAM-1 O O
promoter O O
performed O O
with O O
chloramphenicol O O
acetyltransferase O O
constructs O O
revealed O O
that O O
Tax O O
was O O
trans O O
activating O O
the O O
VCAM-1 O O
promoter O O
via O O
two O O
NF-kappaB O O
sites O O
present O O
at O O
bp O O
- O O
72 O O
and O O
- O O
57 O O
in O O
the O O
VCAM-1 O O
gene O O
promoter O O
, O O
with O O
both O O
of O O
them O O
being O O
required O O
for O O
the O O
Tax-induced O O
expression O O
of O O
this O O
adhesion O O
molecule O O
. O O

Finally O O
, O O
gel O O
mobility O O
shift O O
assays O O
demonstrated O O
the O O
nuclear O O
translocation O O
of O O
proteins O O
specifically O O
bound O O
to O O
these O O
two O O
NF-kappaB O O
motifs O O
, O O
confirming O O
that O O
VCAM-1 O O
was O O
induced O O
on O O
Tax-expressing O O
cells O O
in O O
a O O
kappaB-dependent O O
manner O O
. O O

Collectively O O
, O O
these O O
results O O
therefore O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
exclusive I-SPECULATION I-SPECULATION
Tax-induced I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
VCAM-1 I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
represent I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
pivotal I-SPECULATION I-SPECULATION
event I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
progression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
HTLV-1-associated I-SPECULATION I-SPECULATION
diseases I-SPECULATION I-SPECULATION
. O O

Blockade O O
of O O
T-cell O O
activation O O
by O O
dithiocarbamates O O
involves O O
novel O O
mechanisms O O
of O O
inhibition O O
of O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
. O O

Dithiocarbamates O O
( O O
DTCs O O
) O O
have O O
recently O O
been O O
reported O O
as O O
powerful O O
inhibitors O O
of O O
NF-kappaB O O
activation O O
in O O
a O O
number O O
of O O
cell O O
types O O
. O O

Given O O
the O O
role O O
of O O
this O O
transcription O O
factor O O
in O O
the O O
regulation O O
of O O
gene O O
expression O O
in O O
the O O
inflammatory O O
response O O
, O O
NF-kappaB B-SPECULATION O
inhibitors I-SPECULATION O
have I-SPECULATION O
been I-SPECULATION O
suggested I-SPECULATION O
as I-SPECULATION O
potential B-SPECULATION B-SPECULATION
therapeutic I-SPECULATION I-SPECULATION
drugs I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
inflammatory I-SPECULATION I-SPECULATION
diseases I-SPECULATION I-SPECULATION
. O O

We O O
show O O
here O O
that O O
DTCs O O
inhibited O O
both O O
interleukin O O
2 O O
( O O
IL-2 O O
) O O
synthesis O O
and O O
membrane O O
expression O O
of O O
antigens O O
which O O
are O O
induced O O
during O O
T-cell O O
activation O O
. O O

This O O
inhibition O O
, O O
which O O
occurred O O
with O O
a O O
parallel O O
activation O O
of O O
c-Jun O O
transactivating O O
functions O O
and O O
expression O O
, O O
was O O
reflected O O
by O O
transfection O O
experiments O O
at O O
the O O
IL-2 O O
promoter O O
level O O
, O O
and O O
involved O O
not O O
only O O
the O O
inhibition O O
of O O
NF-kappaB-driven O O
reporter O O
activation O O
but O O
also O O
that O O
of O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
( O O
NFAT O O
) O O
. O O

Accordingly O O
, O O
electrophoretic O O
mobility O O
shift O O
assays O O
( O O
EMSAs O O
) O O
indicated B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
pyrrolidine I-SPECULATION I-SPECULATION
DTC I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
PDTC I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
prevented I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
NFAT I-SPECULATION I-SPECULATION
DNA-binding I-SPECULATION I-SPECULATION
activity I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
stimulated I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
either I-SPECULATION I-SPECULATION
phorbol I-SPECULATION I-SPECULATION
myristate I-SPECULATION I-SPECULATION
acetate I-SPECULATION I-SPECULATION
plus I-SPECULATION I-SPECULATION
ionophore I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
antibodies I-SPECULATION I-SPECULATION
against I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
CD3-T-cell I-SPECULATION I-SPECULATION
receptor I-SPECULATION I-SPECULATION
complex I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
simultaneously I-SPECULATION I-SPECULATION
activated I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
binding I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
AP-1 I-SPECULATION I-SPECULATION
. O O

Furthermore O O
, O O
PDTC O O
differentially O O
targeted O O
both O O
NFATp O O
and O O
NFATc O O
family O O
members O O
, O O
inhibiting O O
the O O
transactivation O O
functions O O
of O O
NFATp O O
and O O
mRNA O O
induction O O
of O O
NFATc O O
. O O

Strikingly O O
, O O
Western O O
blotting O O
and O O
immunocytochemical O O
experiments O O
indicated B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
PDTC I-SPECULATION I-SPECULATION
promoted I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
transient I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
rapid I-SPECULATION I-SPECULATION
shuttling I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NFATp I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
NFATc I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
leading I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
their I-SPECULATION I-SPECULATION
accelerated I-SPECULATION I-SPECULATION
export I-SPECULATION I-SPECULATION
from I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
nucleus I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
activated I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

We O O
propose B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
NFAT I-SPECULATION I-SPECULATION
kinase I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
PDTC I-SPECULATION I-SPECULATION
, O I-SPECULATION
and O I-SPECULATION
show O I-SPECULATION
that O I-SPECULATION
c-Jun O I-SPECULATION
NH2-terminal O I-SPECULATION
kinase O I-SPECULATION
( O I-SPECULATION
JNK O I-SPECULATION
) O I-SPECULATION
can O I-SPECULATION
act O I-SPECULATION
by O I-SPECULATION
directly O I-SPECULATION
phosphorylating O I-SPECULATION
NFATp O I-SPECULATION
. O O
could B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
responsible I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
rapid I-SPECULATION I-SPECULATION
shuttling I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
NFAT I-SPECULATION I-SPECULATION
, O O
therefore O O
transiently O O
converting O O
the O O
sustained O O
transactivation O O
of O O
this O O
transcription O O
factor O O
that O O
occurs O O
during O O
lymphocyte O O
activation O O
. O O

In O O
addition O O
, O O
the O O
combined O O
inhibitory O O
effects O O
on O O
NFAT O O
and O O
NF-KB O O
support O O
a O O
potential B-SPECULATION B-SPECULATION
use I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
DTCs I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
immunosuppressants I-SPECULATION I-SPECULATION
. O O

Suppression O O
of O O
nuclear O O
factor O O
kappa O O
B O O
and O O
CD18-mediated O O
leukocyte O O
adhesion O O
to O O
the O O
corneal O O
endothelium O O
by O O
dexamethasone O O
. O O

PURPOSE O O
: O O
To O O
demonstrate O O
that O O
leukocyte O O
adhesion O O
to O O
cultured O O
corneal O O
endothelial O O
cells O O
is O O
mediated O O
by O O
the O O
CD18 O O
antigen O O
, O O
and O O
to O O
determine O O
whether B-SPECULATION B-SPECULATION
dexamethasone I-SPECULATION I-SPECULATION
directly I-SPECULATION I-SPECULATION
suppresses I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
inhibiting I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
nuclear I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
NFkappaB I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
. O O

METHODS O O
: O O
Cultured O O
bovine O O
corneal O O
endothelium O O
was O O
stimulated O O
for O O
6 O O
hours O O
by O O
40 O O
micron O O
/ O O
ml O O
tumor O O
necrosis O O
factor O O
alpha O O
( O O
TNFalpha O O
) O O
. O O

Dexamethasone O O
was O O
added O O
1 O O
hour O O
before O O
TNFalpha O O
stimulation O O
in O O
the O O
dexamethasone O O
group O O
. O O

After O O
stimulation O O
, O O
neutrophils O O
separated O O
from O O
a O O
healthy O O
human O O
volunteer O O
were O O
added O O
with O O
or O O
without B-NEGATION B-NEGATION
anti-CD18 I-NEGATION I-NEGATION
antibody I-NEGATION I-NEGATION
. O O

The O O
culture O O
plate O O
was O O
settled O O
for O O
15 O O
minutes O O
at O O
37 O O
degrees O O
C O O
, O O
and O O
then O O
neutrophils O O
were O O
activated O O
by O O
N-formyl-methionyl-leucyl-phenylalanine O O
for O O
5 O O
minutes O O
. O O

Nonadherent O O
neutrophils O O
were O O
removed O O
by O O
sealing O O
and O O
inverting O O
the O O
culture O O
well O O
. O O

The O O
intracellular O O
localization O O
of O O
NFkappaB O O
after O O
TNFalpha O O
simulation O O
was O O
determined O O
by O O
confocal O O
immunocytochemistry O O
using O O
an O O
anti-p65 O O
antibody O O
. O O

RESULTS O O
: O O
Neutrophil O O
adhesion O O
to O O
cultured O O
corneal O O
endothelial O O
cells O O
increased O O
significantly O O
on O O
exposure O O
to O O
TNFalpha O O
( O O
451.4 O O
+/- O O
45.4 O O
cells O O
/ O O
mm2 O O
, O O
n O O
= O O
16 O O
) O O
compared O O
to O O
control O O
( O O
156.7 O O
+/- O O
27.3 O O
cells O O
/ O O
mm2 O O
, O O
n O O
= O O
16 O O
, O O
P O O
< O O
0.01 O O
) O O
. O O

This O O
increased O O
adhesion O O
was O O
suppressed O O
by O O
the O O
addition O O
of O O
anti-CD18 O O
antibody O O
( O O
157.6 O O
+/- O O
25.1 O O
cells O O
/ O O
mm2 O O
, O O
n O O
= O O
8 O O
, O O
P O O
< O O
0.01 O O
) O O
and O O
by O O
pretreatment O O
with O O
10 O O
(- O O
7 O O
) O O
M O O
dexamethasone O O
( O O
207.9 O O
+/- O O
31.5 O O
cells O O
/ O O
mm2 O O
, O O
n O O
= O O
10 O O
, O O
P O O
< O O
0.01 O O
) O O
. O O

Immunocytochemistry O O
60 O O
minutes O O
after O O
stimulation O O
revealed O O
that O O
NFkappaB O O
was O O
located O O
in O O
the O O
cytoplasm O O
in O O
unstimulated O O
cells O O
; O O
however O O
, O O
the O O
addition O O
of O O
TNFalpha O O
caused O O
NFkappaB O O
to O O
translocate O O
into O O
the O O
nucleus O O
. O O

Pretreatment O O
with O O
dexamethasone O O
tapered O O
NFkappaB O O
translocation O O
into O O
the O O
nucleus O O
. O O

CONCLUSIONS O O
: O O
Leukocyte O O
adhesion O O
to O O
the O O
corneal O O
endothelium O O
was O O
shown O O
to O O
be O O
mediated O O
by O O
CD18 O O
expressed O O
on O O
activated O O
leukocytes O O
. O O

Pretreatment O O
of O O
the O O
endothelium O O
with O O
dexamethasone O O
inhibited O O
leukocyte O O
adhesion O O
; O O
this O O
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
due I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
part I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
suppression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NFkappaB I-SPECULATION I-SPECULATION
entry I-SPECULATION I-SPECULATION
into I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
nucleus I-SPECULATION I-SPECULATION
. O O

Helenalin O O
, O O
an O O
anti-inflammatory O O
sesquiterpene O O
lactone O O
from O O
Arnica O O
, O O
selectively O O
inhibits O O
transcription O O
factor O O
NF-kappaB O O
[ O O
see O O
comments O O
] O O

Alcoholic O O
extracts O O
prepared O O
form O O
Arnicae O O
flos O O
, O O
the O O
collective O O
name O O
for O O
flowerheads O O
from O O
Arnica O O
montana O O
and O O
A. O O
chamissonis O O
ssp. O O
foliosa O O
, O O
are O O
used O O
therapeutically O O
as O O
anti-inflammatory O O
remedies O O
. O O

The O O
active O O
ingredients O O
mediating O O
the O O
pharmacological O O
effect O O
are O O
mainly O O
sesquiterpene O O
lactones O O
, O O
such O O
as O O
helenalin O O
, O O
11alpha,13-dihydrohelenalin O O
, O O
chamissonolid O O
and O O
their O O
ester O O
derivatives O O
. O O

While O O
these O O
compounds O O
affect O O
various O O
cellular O O
processes O O
, O O
current O O
data O O
do O O
not O B-NEGATION
fully O I-NEGATION
explain O I-NEGATION
how O I-NEGATION
sesquiterpene O I-NEGATION
lactones O I-NEGATION
exert O I-NEGATION
their O I-NEGATION
anti-inflammatory O I-NEGATION
effect O I-NEGATION
. O O

We O O
show O O
here O O
that O O
helenalin O O
, O O
and O O
, O O
to O O
a O O
much O O
lesser O O
degree O O
, O O
11alpha,13-dihydrohelenalin O O
and O O
chamissonolid O O
, O O
inhibit O O
activation O O
of O O
transcription O O
factor O O
NF-kappaB O O
. O O

This B-SPECULATION B-SPECULATION
difference I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
efficacy I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
correlates I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
compounds' I-SPECULATION I-SPECULATION
anti-inflammatory I-SPECULATION I-SPECULATION
potency I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
vivo I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
may I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
explained I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
differences I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
structure I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
conformation I-SPECULATION I-SPECULATION
. O O

NF-kappaB O O
, O O
which O O
resides O O
in O O
an O O
inactive O O
, O O
cytoplasmic O O
complex O O
in O O
unstimulated O O
cells O O
, O O
is O O
activated O O
by O O
phosphorylation O O
and O O
degradation O O
of O O
its O O
inhibitory O O
subunit O O
, O O
IkappaB O O
. O O

Helenalin O O
inhibits O O
NF-kappaB O O
activation O O
in O O
response O O
to O O
four O O
different O O
stimuli O O
in O O
T-cells O O
, O O
B-cells O O
and O O
epithelial O O
cells O O
and O O
abrogates O O
kappaB-driven O O
gene O O
expression O O
. O O

This O O
inhibition O O
is O O
selective O O
, O O
as O O
the B-NEGATION B-NEGATION
activity I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
four I-NEGATION I-NEGATION
other I-NEGATION I-NEGATION
transcription I-NEGATION I-NEGATION
factors I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
Oct-1 I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
TBP I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
Sp1 I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
STAT I-NEGATION I-NEGATION
5 I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
affected I-NEGATION I-NEGATION
. O O

We O O
show O O
that O O
inhibition O O
is O O
not B-NEGATION B-NEGATION
due I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
a I-NEGATION I-NEGATION
direct I-NEGATION I-NEGATION
modification I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
active I-NEGATION I-NEGATION
NF-kappaB I-NEGATION I-NEGATION
heterodimer I-NEGATION I-NEGATION
. O O

Rather O O
, O O
helenalin O O
modifies O O
the O O
NF-kappaB O O
/ O O
IkappaB O O
complex O O
, O O
preventing O O
the O O
release O O
of O O
IkappaB O O
. O O

These O O
data O O
suggest B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
molecular I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
anti-inflammatory I-SPECULATION I-SPECULATION
effect I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
sesquiterpene I-SPECULATION I-SPECULATION
lactones I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
differs I-SPECULATION I-SPECULATION
from I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
other I-SPECULATION I-SPECULATION
nonsteroidal I-SPECULATION I-SPECULATION
anti-inflammatory I-SPECULATION I-SPECULATION
drugs I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
NSAIDs I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
indomethacin I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
acetyl I-SPECULATION I-SPECULATION
salicylic I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
. O O

Involvement O O
of O O
different O O
transduction O O
pathways O O
in O O
NF-kappa O O
B O O
activation O O
by O O
several O O
inducers O O
. O O

Double-stimulation O O
was O O
used O O
to O O
demonstrate O O
that O O
, O O
in O O
a O O
T O O
lymphocytic O O
cell O O
line O O
( O O
CEM O O
) O O
, O O
phorbol O O
myristate O O
acetate O O
( O O
PMA O O
) O O
rapidly O O
induced O O
NF-kappa O O
B O O
through O O
a O O
signaling O O
pathway O O
which O O
did O O
not B-NEGATION B-NEGATION
involve I-NEGATION I-NEGATION
reactive I-NEGATION I-NEGATION
oxygen I-NEGATION I-NEGATION
species I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
ROS I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
and O O
was O O
different O O
from O O
the O O
activation O O
triggered O O
by O O
either O O
H2O2 O O
or O O
tumor O O
necrosis O O
factor-alpha O O
( O O
TNF-alpha O O
) O O
. O O

Since O O
these O O
latter O O
compounds O O
were O O
known O O
to O O
activate O O
NF-kappa O O
B O O
translocation O O
in O O
a O O
redox-sensitive O O
way O O
, O O
we O O
have O O
demonstrated O O
that O O
NF-kappa O O
B O O
activation O O
by O O
PMA O O
was O O
resistant O O
to O O
antioxidant O O
N-acetyl-L-cysteine O O
( O O
NAC O O
) O O
and O O
sensitive O O
to O O
kinase O O
inhibitors O O
staurosporine O O
and O O
H7 O O
while O O
activation O O
by O O
H2O2 O O
or O O
TNF-alpha O O
were O O
not B-NEGATION B-NEGATION
. O O

Dysregulation O O
of O O
monocytic O O
nuclear O O
factor-kappa O O
B O O
by O O
oxidized O O
low-density O O
lipoprotein O O
. O O

Nuclear B-SPECULATION O
factor-kappa I-SPECULATION O
B I-SPECULATION O
( I-SPECULATION O
NF-kappa I-SPECULATION O
B I-SPECULATION O
)/ I-SPECULATION O
Rel I-SPECULATION O
transcription I-SPECULATION O
factors I-SPECULATION O
may I-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
involved I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
atherosclerosis I-SPECULATION I-SPECULATION
, O I-SPECULATION
as O I-SPECULATION
is B-SPECULATION I-SPECULATION
suggested I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
presence I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
activated I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
atherosclerotic I-SPECULATION I-SPECULATION
lesions I-SPECULATION I-SPECULATION
. O O

The O O
aim O O
of O O
the O O
present O O
study O O
was O O
to O O
investigate O O
the O O
effects O O
of O O
oxidized O O
LDL O O
( O O
oxLDL O O
) O O
on O O
the O O
NF-kappa O O
B O O
system O O
in O O
human O O
THP-1 O O
monocytic O O
cells O O
as O O
well O O
as O O
adherent O O
monocytes O O
. O O

Our O O
results O O
demonstrate O O
that O O
short-term O O
incubation O O
of O O
these O O
cells O O
with O O
oxLDL O O
activated O O
p50 O O
/ O O
p65 O O
containing O O
NF-kappa O O
B O O
dimers O O
and O O
induced O O
the O O
expression O O
of O O
the O O
target O O
gene O O
IL-8 O O
. O O

This O O
activation O O
of O O
NF-kappa O O
B O O
was O O
inhibited O O
by O O
the O O
antioxidant O O
and O O
H2O2 O O
scavenger O O
pyrrolidine O O
dithiocarbamate O O
and O O
the O O
proteasome O O
inhibitor O O
PSI O O
. O O

The O O
oxLDL-induced O O
NF-kappa O O
B O O
activation O O
was O O
accompanied O O
by O O
an O O
initial O O
depletion O O
of O O
I O O
kappa O O
B-alpha O O
followed O O
by O O
a O O
slight O O
transient O O
increase O O
in O O
the O O
level O O
of O O
this O O
inhibitor O O
protein O O
. O O

In O O
contrast O O
, O O
long-term O O
treatment O O
with O O
oxLDL O O
prevented O O
the O O
lipopolysaccharide-induced O O
depletion O O
of O O
I O O
kappa O O
B-alpha O O
, O O
accompanied O O
by O O
an O O
inhibition O O
of O O
both O O
NF-kappa O O
B O O
activation O O
and O O
the O O
expression O O
of O O
tumor O O
necrosis O O
factor-alpha O O
and O O
interleukin-1 O O
beta O O
genes O O
. O O

These O O
observations O O
provide O O
additional O O
evidence O O
that O O
oxLDL O O
is O O
a O O
potent O O
modulator O O
of O O
gene O O
expression O O
and O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
( B-SPECULATION I-SPECULATION
dys I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
regulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
Rel I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
likely I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
play I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
atherogenesis I-SPECULATION I-SPECULATION
. O O

Suppression O O
of O O
MHC O O
class O O
II O O
expression O O
by O O
human O O
class O O
II O O
trans-activator O O
constructs O O
lacking B-NEGATION B-NEGATION
the I-NEGATION I-NEGATION
N-terminal I-NEGATION I-NEGATION
domain I-NEGATION I-NEGATION
. O O

The O O
class O O
II O O
trans-activator O O
( O O
CIITA O O
) O O
is O O
a O O
bi O O
- O O
or O O
multi-functional O O
domain O O
protein O O
which O O
plays O O
a O O
critical O O
role O O
in O O
the O O
expression O O
of O O
MHC O O
class O O
II O O
genes O O
. O O

We O O
report O O
that O O
removal O O
of O O
the O O
N-terminal O O
151 O O
amino O O
acids O O
, O O
encompassing O O
all O O
of O O
the O O
acidic O O
domain O O
but O O
leaving O O
intact O O
the O O
proline O O
/ O O
serine O O
/ O O
threonine-rich O O
domain O O
, O O
results O O
in O O
a O O
mutant O O
protein O O
with O O
potent O O
suppressive O O
properties O O
for O O
MHC O O
class O O
II O O
expression O O
. O O

HeLa O O
cells O O
stably O O
or O O
transiently O O
transfected O O
with O O
mutant O O
CIITA O O
constructs O O
showed O O
up O O
to O O
99 O O
% O O
suppression O O
of O O
MHC O O
class O O
II O O
antigen O O
induction O O
by O O
IFN-gamma O O
and O O
marked O O
suppression O O
of O O
HLA-DRA O O
mRNA O O
expression O O
. O O

Transient O O
transfection O O
of O O
a O O
B O O
lymphoma O O
line O O
resulted O O
in O O
up O O
to O O
89 O O
% O O
reduction O O
of O O
constitutive O O
MHC O O
class O O
II O O
expression O O
within O O
5 O O
days O O
and O O
suppression O O
of O O
HLA-DRA O O
mRNA O O
synthesis O O
. O O

CD30-dependent O O
degradation O O
of O O
TRAF2 O O
: O O
implications O O
for O O
negative O O
regulation O O
of O O
TRAF O O
signaling O O
and O O
the O O
control O O
of O O
cell O O
survival O O
. O O

CD30 O O
is O O
a O O
cell-surface O O
receptor O O
that O O
can O O
augment O O
lymphocyte O O
activation O O
and O O
survival O O
through O O
its O O
ability O O
to O O
induce O O
the O O
transcription O O
factor O O
NF-kappaB O O
. O O

CD30 O O
, O O
however O O
, O O
has O O
also O O
been O O
implicated O O
in O O
the O O
induction O O
of O O
apoptotic O O
cell O O
death O O
of O O
lymphocytes O O
. O O

Here O O
we O O
show O O
that O O
one O O
of O O
the O O
effects O O
of O O
CD30 O O
signal O O
transduction O O
is O O
to O O
render O O
cells O O
sensitive O O
to O O
apoptosis O O
induced O O
by O O
the O O
type O O
1 O O
tumor O O
necrosis O O
factor O O
receptor O O
( O O
TNFR1 O O
) O O
. O O

This O O
sensitization O O
is O O
dependent O O
on O O
the O O
TRAF-binding O O
sites O O
within O O
the O O
CD30 O O
cytoplasmic O O
domain O O
. O O

One O O
of O O
the O O
proteins O O
that O O
binds O O
to O O
these O O
sites O O
is O O
TRAF2 O O
, O O
a O O
signal O O
transduction O O
molecule O O
that O O
is O O
also O O
utilized O O
by O O
TNFR1 O O
to O O
mediate O O
the O O
activation O O
of O O
several O O
downstream O O
kinases O O
and O O
transcription O O
factors O O
. O O

During O O
CD30 O O
signal O O
transduction O O
, O O
we O O
found O O
that O O
binding O O
of O O
TRAF2 O O
to O O
the O O
cytoplasmic O O
domain O O
of O O
CD30 O O
results O O
in O O
the O O
rapid O O
depletion O O
of O O
TRAF2 O O
and O O
the O O
associated O O
protein O O
TRAF1 O O
by O O
proteolysis O O
. O O

These O O
data O O
suggest B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
model I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
CD30 I-SPECULATION I-SPECULATION
limits I-SPECULATION I-SPECULATION
its I-SPECULATION I-SPECULATION
own I-SPECULATION I-SPECULATION
ability I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
transduce I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
survival I-SPECULATION I-SPECULATION
signals I-SPECULATION I-SPECULATION
through I-SPECULATION I-SPECULATION
signal-coupled I-SPECULATION I-SPECULATION
depletion I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
TRAF2 I-SPECULATION I-SPECULATION
. O O

Depletion O O
of O O
intracellular O O
TRAF2 O O
and O O
its O O
coassociated O O
proteins O O
also O O
increased O O
the O O
sensitivity O O
of O O
the O O
cell O O
to O O
undergoing O O
apoptosis O O
during O O
activation O O
of O O
death-inducing O O
receptors O O
such O O
as O O
TNFR1 O O
. O O

Consistent O O
with O O
this O O
hypothesis O O
, O O
expression O O
of O O
a O O
dominant-negative O O
form O O
of O O
TRAF2 O O
was O O
found O O
to O O
potentiate O O
TNFR1-mediated O O
death O O
. O O

These O O
studies O O
provide O O
a O O
potential B-SPECULATION B-SPECULATION
mechanism I-SPECULATION I-SPECULATION
through I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
CD30 I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
well I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
other I-SPECULATION I-SPECULATION
TRAF-binding I-SPECULATION I-SPECULATION
members I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
TNFR I-SPECULATION I-SPECULATION
superfamily I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
negatively I-SPECULATION I-SPECULATION
regulate I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
survival I-SPECULATION I-SPECULATION
. O O

TNFalpha O O
cooperates O O
with O O
the O O
protein O O
kinase O O
A O O
pathway O O
to O O
synergistically O O
increase O O
HIV-1 O O
LTR O O
transcription O O
via O O
downstream O O
TRE-like O O
cAMP O O
response O O
elements O O
. O O

Activating O O
protein-1 O O
( O O
AP-1 O O
) O O
binding O O
TPA O O
responsive O O
elements O O
( O O
TRE O O
) O O
are O O
located O O
downstream O O
of O O
the O O
transcription O O
initiation O O
site O O
in O O
the O O
U5 O O
region O O
of O O
the O O
HIV-1 O O
long O O
terminal O O
repeat O O
( O O
LTR O O
) O O
. O O

These O O
downstream O O
sequence O O
elements O O
, O O
termed O O
DSE O O
, O O
can O O
bind O O
both O O
AP-1 O O
and O O
CREB O O
/ O O
ATF O O
transcription O O
factors O O
. O O

Recently O O
, O O
we O O
demonstrated O O
that O O
the O O
DSE O O
are O O
also O O
cAMP-responsive O O
elements O O
( O O
CRE O O
) O O
, O O
since O O
they O O
mediated O O
activation O O
signals O O
elicited O O
by O O
cholera O O
toxin O O
( O O
Ctx O O
) O O
, O O
a O O
potent O O
activator O O
of O O
the O O
cAMP-dependent O O
protein O O
kinase O O
A O O
( O O
PKA O O
) O O
signal O O
transduction O O
pathway O O
. O O

In O O
the O O
present O O
study O O
, O O
we O O
demonstrate O O
that O O
the O O
HIV-1 O O
DSE O O
can O O
mediate O O
the O O
transcriptional O O
synergy O O
elicited O O
by O O
the O O
combination O O
of O O
Ctx O O
and O O
TNFalpha O O
. O O

Ctx O O
combined O O
with O O
TNFalpha O O
or O O
IL-1beta O O
to O O
produce O O
a O O
synergistic O O
increase O O
in O O
p24 O O
antigen O O
production O O
in O O
U1 O O
promonocytic O O
cells O O
. O O

Transfection O O
studies O O
of O O
LTR O O
reporter O O
constructs O O
indicated O B-SPECULATION
that O I-SPECULATION
mutation O I-SPECULATION
of O I-SPECULATION
the O I-SPECULATION
DSE O I-SPECULATION
sites O I-SPECULATION
abrogated O I-SPECULATION
the O I-SPECULATION
LTR-mediated O I-SPECULATION
synergy O I-SPECULATION
induced O I-SPECULATION
by O I-SPECULATION
Ctx O I-SPECULATION
and O I-SPECULATION
TNFalpha O I-SPECULATION
, O O
whereas O O
the O O
synergy O O
induced O O
by O O
Ctx O O
and O O
IL-1beta O O
was O O
unaffected O O
, O O
suggesting B-SPECULATION B-SPECULATION
TNFalpha I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
IL-1beta I-SPECULATION I-SPECULATION
cooperate I-SPECULATION I-SPECULATION
differently I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
cAMP I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
PKA I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
pathway I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
induce I-SPECULATION I-SPECULATION
HIV-1 I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
U1 I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

Because O O
the O O
DSE O O
are O O
also O O
TRE O O
sites O O
, O O
we O O
assessed O O
the O O
effect O O
of O O
the O O
agonist O O
combinations O O
on O O
AP-1-dependent O O
transcription O O
. O O

TNFalpha O O
as O O
well O O
as O O
IL-1beta O O
cooperated O O
with O O
Ctx O O
to O O
produce O O
a O O
synergistic O O
activation O O
of O O
AP-1-mediated O O
transcription O O
. O O

These O O
data O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
TRE-like I-SPECULATION I-SPECULATION
cAMP-responsive I-SPECULATION I-SPECULATION
DSE I-SPECULATION I-SPECULATION
sites I-SPECULATION I-SPECULATION
within I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
5 I-SPECULATION I-SPECULATION
'- I-SPECULATION I-SPECULATION
untranslated I-SPECULATION I-SPECULATION
leader I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
mediate I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
transcriptional I-SPECULATION I-SPECULATION
cooperativity I-SPECULATION I-SPECULATION
between I-SPECULATION I-SPECULATION
TNFalpha I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
cAMP I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
PKA I-SPECULATION I-SPECULATION
pathway I-SPECULATION I-SPECULATION
. O O

Since O O
the O O
DSE O O
and O O
TRE O O
sites O O
cannot B-NEGATION B-NEGATION
bind I-NEGATION I-NEGATION
CREB I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
ATF I-NEGATION I-NEGATION
homodimers I-NEGATION I-NEGATION
, O O
we O O
propose B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
HIV-1 I-SPECULATION I-SPECULATION
DSE I-SPECULATION I-SPECULATION
bind I-SPECULATION I-SPECULATION
heterodimers I-SPECULATION I-SPECULATION
composed I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
both I-SPECULATION I-SPECULATION
AP-1 I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
CREB I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
ATF I-SPECULATION I-SPECULATION
proteins I-SPECULATION I-SPECULATION
. O O

Copyright O O
1997 O O
Academic O O
Press O O
. O O

The O O
Epstein-Barr O O
virus O O
oncogene O O
product O O
latent O O
membrane O O
protein O O
1 O O
engages O O
the O O
tumor O O
necrosis O O
factor O O
receptor-associated O O
death O O
domain O O
protein O O
to O O
mediate O O
B O O
lymphocyte O O
growth O O
transformation O O
and O O
activate O O
NF-kappaB O O
. O O

The O O
Epstein-Barr O O
virus O O
latent O O
membrane O O
protein O O
1 O O
( O O
LMP1 O O
) O O
is O O
essential O O
for O O
the O O
transformation O O
of O O
B O O
lymphocytes O O
into O O
lymphoblastoid O O
cell O O
lines O O
. O O

Previous O O
data O O
are O O
consistent O O
with O O
a O O
model O O
that O O
LMP1 O O
is O O
a O O
constitutively O O
activated O O
receptor O O
that O O
transduces O O
signals O O
for O O
transformation O O
through O O
its O O
carboxyl-terminal O O
cytoplasmic O O
tail O O
. O O

One O O
transformation O O
effector O O
site O O
( O O
TES1 O O
) O O
, O O
located O O
within O O
the O O
membrane O O
proximal O O
45 O O
residues O O
of O O
the O O
cytoplasmic O O
tail O O
, O O
constitutively O O
engages O O
tumor O O
necrosis O O
factor O O
receptor-associated O O
factors O O
. O O

Signals O O
from O O
TES1 O O
are O O
sufficient O O
to O O
drive O O
initial O O
proliferation O O
of O O
infected O O
resting O O
B O O
lymphocytes O O
, O O
but O O
most O O
lymphoblastoid O O
cells O O
infected O O
with O O
a O O
virus O O
that O O
does O O
not B-NEGATION B-NEGATION
express I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
155 I-NEGATION I-NEGATION
residues I-NEGATION I-NEGATION
beyond I-NEGATION I-NEGATION
TES1 I-NEGATION I-NEGATION
fail B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
grow I-NEGATION I-NEGATION
as I-NEGATION I-NEGATION
long-term I-NEGATION I-NEGATION
cell I-NEGATION I-NEGATION
lines I-NEGATION I-NEGATION
. O O

We O O
now O O
find O O
that O O
mutating O O
two O O
tyrosines O O
to O O
an O O
isoleucine O O
at O O
the O O
carboxyl O O
end O O
of O O
the O O
cytoplasmic O O
tail O O
cripples O O
the O O
ability O O
of O O
EBV O O
to O O
cause O O
lymphoblastoid O O
cell O O
outgrowth O O
, O O
thereby O O
marking O O
a O O
second O O
transformation O O
effector O O
site O O
, O O
TES2 O O
. O O

A O O
yeast O O
two-hybrid O O
screen O O
identified O O
TES2 O O
interacting O O
proteins O O
, O O
including O O
the O O
tumor O O
necrosis O O
factor O O
receptor-associated O O
death O O
domain O O
protein O O
( O O
TRADD O O
) O O
. O O

TRADD O O
was O O
the O O
only O O
protein O O
that O O
interacted O O
with O O
wild-type O O
TES2 O O
and O O
not B-NEGATION B-NEGATION
with I-NEGATION I-NEGATION
isoleucine-mutated I-NEGATION I-NEGATION
TES2 I-NEGATION I-NEGATION
. O O

TRADD O O
associated O O
with O O
wild-type O O
LMP1 O O
but O O
not B-NEGATION B-NEGATION
with I-NEGATION I-NEGATION
isoleucine-mutated I-NEGATION I-NEGATION
LMP1 I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
mammalian I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
, O O
and O O
TRADD O O
constitutively O O
associated O O
with O O
LMP1 O O
in O O
EBV-transformed O O
cells O O
. O O

In O O
transfection O O
assays O O
, O O
TRADD O O
and O O
TES2 O O
synergistically O O
mediated O O
high-level O O
NF-kappaB O O
activation O O
. O O

These O O
results O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
LMP1 I-SPECULATION I-SPECULATION
appropriates I-SPECULATION I-SPECULATION
TRADD I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
enable I-SPECULATION I-SPECULATION
efficient I-SPECULATION I-SPECULATION
long-term I-SPECULATION I-SPECULATION
lymphoblastoid I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
outgrowth I-SPECULATION I-SPECULATION
. O O

High-level B-SPECULATION B-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
also I-SPECULATION I-SPECULATION
appears I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
critical I-SPECULATION I-SPECULATION
component I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
long-term I-SPECULATION I-SPECULATION
outgrowth I-SPECULATION I-SPECULATION
. O O

Switching O O
gears O O
during O O
T-cell O O
maturation O O
: O O
RANTES O O
and O O
late O O
transcription O O
. O O

Although O O
much O O
is O O
understood O O
about O O
the O O
induction O O
of O O
genes O O
expressed O O
early O O
( O O
within O O
24 O O
h O O
) O O
after O O
T-cell O O
activation O O
, O O
little O O
is O O
known O O
about O O
the O O
regulation O O
of O O
expression O O
of O O
genes O O
expressed O O
' O O
late O O
' O O
( O O
three O O
or O O
more O O
days O O
) O O
post-stimulation O O
. O O

A O O
better O O
understanding O O
of O O
transcriptional O O
regulation O O
at O O
this O O
important O O
stage O O
of O O
T-cell O O
maturation O O
may B-SPECULATION B-SPECULATION
yield I-SPECULATION I-SPECULATION
new I-SPECULATION I-SPECULATION
insights I-SPECULATION I-SPECULATION
into I-SPECULATION I-SPECULATION
T-cell I-SPECULATION I-SPECULATION
development I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
new I-SPECULATION I-SPECULATION
immunotherapeutic I-SPECULATION I-SPECULATION
targets I-SPECULATION I-SPECULATION
. O O

Transcription O O
factor O O
NF-kappaB O O
regulates O O
inducible O O
Oct-2 O O
gene O O
expression O O
in O O
precursor O O
B O O
lymphocytes O O
. O O

The O O
POU O O
transcription O O
factors O O
Oct-1 O O
and O O
Oct-2 O O
regulate O O
the O O
activity O O
of O O
octamer-dependent O O
promoters O O
, O O
including O O
those O O
that O O
direct O O
transcription O O
from O O
rearranged O O
immunoglobulin O O
genes O O
. O O

Unlike O O
Oct-1 O O
, O O
which O O
is O O
constitutively O O
expressed O O
in O O
many O O
cell O O
types O O
, O O
Oct-2 O O
expression O O
is O O
restricted O O
primarily O O
to O O
B O O
lymphocytes O O
and O O
can O O
be O O
induced O O
in O O
precursor O O
B O O
cells O O
by O O
stimulation O O
with O O
bacterial O O
lipopolysaccharide O O
( O O
LPS O O
) O O
. O O

However O O
, O O
the B-SPECULATION B-SPECULATION
precise I-SPECULATION I-SPECULATION
factors I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
mediate I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
induction I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
remain I-SPECULATION I-SPECULATION
unknown I-SPECULATION I-SPECULATION
. O O

In O O
the O O
present O O
study O O
, O O
we O O
monitored O O
Oct-2 O O
expression O O
in O O
cells O O
arrested O O
for O O
the O O
activation O O
of O O
NF-kappaB O O
, O O
an O O
LPS-responsive O O
member O O
of O O
the O O
Rel O O
transcription O O
factor O O
family O O
. O O

Despite O O
stimulation O O
with O O
LPS O O
, O O
disruption O O
of O O
the O O
NF-kappaB O O
signaling O O
pathway O O
in O O
precursor O O
B O O
cells O O
led O O
to O O
the O O
loss O O
of O O
inducible O O
Oct-2 O O
DNA O O
binding O O
activity O O
in O O
vitro O O
and O O
the O O
suppression O O
of O O
Oct-2-directed O O
transcription O O
in O O
vivo O O
. O O

This O O
biochemical O O
defect O O
correlated O O
with O O
a O O
specific O O
block O O
to O O
Oct-2 O O
gene O O
expression O O
at O O
the O O
level O O
of O O
transcription O O
, O O
whereas O O
the O O
expression O O
of O O
Oct-1 O O
was O O
unaffected O O
. O O

The O O
finding O O
that O O
Oct-2 O O
is O O
under O O
NF-kappaB O O
control O O
highlights O O
an O O
important O O
cross-talk O O
mechanism O O
involving O O
two O O
distinct O O
transcription O O
factor O O
families O O
that O O
regulate O O
B O O
lymphocyte O O
function O O
. O O

Paternal O O
expression O O
of O O
WT1 O O
in O O
human O O
fibroblasts O O
and O O
lymphocytes O O
. O O

The O O
Wilms' O O
tumor O O
suppressor O O
gene O O
( O O
WT1 O O
) O O
was O O
previously O O
identified O O
as O O
being O O
imprinted O O
, O O
with O O
frequent O O
maternal O O
expression O O
in O O
human O O
placentae O O
and O O
fetal O O
brains O O
. O O

We O O
examined O O
the O O
allele-specific O O
expression O O
of O O
WT1 O O
in O O
cultured O O
human O O
fibroblasts O O
from O O
15 O O
individuals O O
. O O

Seven O O
of O O
15 O O
fibroblast O O
lines O O
were O O
heterozygous O O
for O O
polymorphic O O
alleles O O
, O O
and O O
the O O
expression O O
patterns O O
were O O
variable O O
, O O
i.e. O O
, O O
equal O O
, O O
unequal O O
or O O
monoallelic O O
paternal O O
expression O O
in O O
three O O
, O O
two O O
and O O
two O O
cases O O
, O O
respectively O O
. O O

Exclusive O O
paternal O O
expression O O
of O O
WT1 O O
was O O
also O O
shown O O
in O O
non-cultured O O
peripheral O O
lymphocytes O O
from O O
the O O
latter O O
two O O
individuals O O
. O O

The O O
allele-specific O O
expression O O
profiles O O
of O O
other O O
imprinted O O
genes O O
, O O
IGF2 O O
and O O
H19 O O
, O O
on O O
human O O
chromosome O O
11 O O
were O O
constant O O
and O O
consistent O O
with O O
those O O
in O O
other O O
tissues O O
. O O

Our O O
unexpected O O
observations O O
of O O
paternal O O
or O O
biallelic O O
expression O O
of O O
WT1 O O
in O O
fibroblasts O O
and O O
lymphocytes O O
, O O
together O O
with O O
the O O
previous O O
findings O O
of O O
maternal O O
or O O
biallelic O O
expression O O
in O O
placentae O O
and O O
brains O O
, O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
allele-specific I-SPECULATION I-SPECULATION
regulatory I-SPECULATION I-SPECULATION
system I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
WT1 I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
unique I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
controlled I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
putative I-SPECULATION B-SPECULATION
tissue I-SPECULATION I-SPECULATION
- I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
individual-specific I-SPECULATION I-SPECULATION
modifier I-SPECULATION I-SPECULATION
. O O

Characterization O O
of O O
CD40 O O
signaling O O
determinants O O
regulating O O
nuclear O O
factor-kappa O O
B O O
activation O O
in O O
B O O
lymphocytes O O
. O O

CD40 O O
signaling O O
to O O
B O O
cells O O
is O O
important O O
for O O
generating O O
an O O
effective O O
humoral O O
immune O O
response O O
. O O

CD40 O O
ligation O O
leads O O
to O O
B O O
cell O O
activation O O
events O O
such O O
as O O
proliferation O O
, O O
Ig O O
secretion O O
, O O
isotype O O
switching O O
, O O
and O O
up-regulation O O
of O O
cell O O
surface O O
molecules O O
, O O
as O O
well O O
as O O
the O O
generation O O
of O O
memory O O
B O O
cells O O
. O O

Many O O
of O O
these O O
events O O
are O O
dependent O O
upon O O
the O O
ability O O
of O O
CD40 O O
to O O
activate O O
the O O
transcription O O
factor O O
NF-kappa O O
B O O
( O O
NF-kappa O O
B O O
) O O
. O O

To O O
define O O
the O O
CD40 O O
signaling O O
components O O
upstream O O
of O O
NF-kappa O O
B O O
activation O O
and O O
the O O
functional O O
consequences O O
downstream O O
of O O
NF-kappa O O
B O O
activation O O
, O O
we O O
examined O O
mouse O O
B O O
cell O O
transfectants O O
expressing O O
wild-type O O
or O O
mutant O O
human O O
CD40 O O
. O O

Analysis O O
of O O
CD40 O O
cytoplasmic O O
domain O O
truncation O O
and O O
point O O
mutants O O
defined O O
a O O
10-amino O O
acid O O
CD40 O O
cytoplasmic O O
signaling O O
determinant O O
required O O
for O O
NF-kappa O O
B O O
activation O O
. O O

A B-NEGATION O
threonine I-NEGATION O
residue I-NEGATION O
at I-NEGATION O
position I-NEGATION O
234 I-NEGATION O
, I-NEGATION O
previously I-NEGATION O
shown I-NEGATION O
to I-NEGATION O
be I-NEGATION O
important I-NEGATION O
for I-NEGATION O
CD40 I-NEGATION O
association I-NEGATION O
with I-NEGATION O
TNF I-NEGATION O
receptor-associated I-NEGATION O
factor I-NEGATION O
2 I-NEGATION O
( I-NEGATION O
TRAF2 I-NEGATION O
) I-NEGATION O
, I-NEGATION O
TRAF3 I-NEGATION O
, I-NEGATION O
and I-NEGATION O
TRAF5 I-NEGATION O
, I-NEGATION O
was I-NEGATION O
not I-NEGATION B-NEGATION
required I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
NF-kappa I-NEGATION I-NEGATION
B I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
. O O

This O O
suggests B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
CD40-induced I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
occur I-SPECULATION I-SPECULATION
independently I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
TRAF2 I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
TRAF5 I-SPECULATION I-SPECULATION
association I-SPECULATION I-SPECULATION
. O O

NF-kappa O O
B O O
activation O O
was O O
independent O O
of O O
the O O
transmembrane O O
domain O O
of O O
CD40 O O
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
it I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
independent I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
p23 I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
molecule I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
associates I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
CD40 I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
region I-SPECULATION I-SPECULATION
other I-SPECULATION I-SPECULATION
than I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
cytoplasmic I-SPECULATION I-SPECULATION
domain I-SPECULATION I-SPECULATION
. O O

Proteasome-dependent O O
inhibitory O O
kappa O O
B O O
alpha O O
( O O
I O O
kappa O O
B O O
alpha O O
) O O
and O O
I O O
kappa O O
B O O
beta O O
degradation O O
occurred O O
downstream O O
of O O
CD40 O O
ligation O O
and O O
preceded O O
CD40-mediated O O
NF-kappa O O
B O O
nuclear O O
translocation O O
. O O

CD40 B-NEGATION B-NEGATION
- I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
pervanadate-mediated I-NEGATION I-NEGATION
I I-NEGATION I-NEGATION
kappa I-NEGATION I-NEGATION
B I-NEGATION I-NEGATION
tyrosine I-NEGATION I-NEGATION
phosphorylation I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
detected I-NEGATION I-NEGATION
. O O

NF-kappa O O
B O O
activation O O
correlated O O
with O O
the O O
ability O O
of O O
CD40 O O
to O O
induce O O
Ab O O
secretion O O
and O O
the O O
up-regulation O O
of O O
ICAM-1 O O
and O O
LFA-1 O O
. O O

However O O
, O O
NF-kappa O O
B O O
activation O O
was O O
insufficient O B-NEGATION
for O I-NEGATION
CD40-mediated O I-NEGATION
up-regulation O I-NEGATION
of O I-NEGATION
B7-1 O I-NEGATION
, O I-NEGATION
Fas O I-NEGATION
, O I-NEGATION
and O I-NEGATION
CD23 O I-NEGATION
. O O

Extinction O O
of O O
immunoglobulin O O
gene O O
expression O O
in O O
B O O
cells O O
upon O O
fusion O O
with O O
HeLa O O
cells O O
is O O
preceded O O
by O O
rapid O O
nuclear O O
depletion O O
of O O
essential O O
transcription O O
factors O O
and O O
is O O
accompanied O O
by O O
widespread O O
inactivation O O
of O O
genes O O
expressed O O
in O O
a O O
B O O
cell-specific O O
manner O O
. O O

When O O
immunoglobulin O O
( O O
Ig O O
) O O
expressing O O
B O O
cells O O
are O O
fused O O
with O O
non-B O O
cells O O
, O O
Ig O O
expression O O
is O O
rapidly O O
suppressed O O
at O O
the O O
level O O
of O O
transcription O O
, O O
a O O
phenomenon O O
termed O O
extinction O O
. O O

Here O O
we O O
demonstrate O O
that O O
fusion O O
of O O
HeLa O O
cells O O
with O O
either O O
diploid O O
or O O
tetraploid O O
B O O
cells O O
( O O
Daudi O O
) O O
results O O
in O O
widespread O O
extinction O O
of O O
several O O
other O O
B O O
cell-encoded O O
genes O O
that O O
are O O
expressed O O
in O O
a O O
B O O
cell-specific O O
manner O O
. O O

In O O
contrast O O
, O O
expression O O
of O O
B O O
cell-expressed O O
genes O O
that O O
are O O
not B-NEGATION B-NEGATION
dependent I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
cell-specific I-NEGATION I-NEGATION
controls I-NEGATION I-NEGATION
is O O
unaffected O O
. O O

We O O
show O O
that O O
the O B-SPECULATION
molecular O I-SPECULATION
mechanism O I-SPECULATION
( O I-SPECULATION
s O I-SPECULATION
) O I-SPECULATION
underlying O I-SPECULATION
Ig O I-SPECULATION
gene O I-SPECULATION
extinction O I-SPECULATION
can O I-SPECULATION
be O I-SPECULATION
explained O I-SPECULATION
, O I-SPECULATION
at O I-SPECULATION
least O I-SPECULATION
in O I-SPECULATION
part O I-SPECULATION
, O I-SPECULATION
by O I-SPECULATION
a O I-SPECULATION
lack B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
transcription I-NEGATION I-NEGATION
factors I-NEGATION I-NEGATION
that I-NEGATION I-NEGATION
are I-NEGATION I-NEGATION
essential I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
Ig I-NEGATION I-NEGATION
gene I-NEGATION I-NEGATION
transcription I-NEGATION I-NEGATION
. O O

These O B-NEGATION
transcription O I-NEGATION
factors O I-NEGATION
are O I-NEGATION
either B-SPECULATION I-NEGATION
not B-NEGATION I-NEGATION
produced I-NEGATION I-NEGATION
due I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
block I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
transcription I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
their I-NEGATION I-NEGATION
respective I-NEGATION I-NEGATION
genes I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
Oct-2 I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
OBF-1 I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
PU.1 I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
, O I-NEGATION
. O O

By O O
isolating O O
Daudi O O
x O O
HeLa O O
heterokaryons O O
a O O
few O O
hours O O
after O O
fusion O O
, O O
we O O
have O O
studied O O
the O O
initial O O
fate O O
of O O
two O O
B O O
cell-specific O O
transcription O O
factors O O
involved O O
in O O
Ig O O
gene O O
transcription O O
, O O
Oct-2 O O
and O O
NF-kappa O O
B O O
. O O

This O O
report O O
provides O O
the O O
first O O
demonstration O O
that O O
upon O O
fusion O O
with O O
HeLa O O
cells O O
, O O
the O O
nuclear O O
contents O O
of O O
B O O
cell-expressed O O
transcription O O
factors O O
are O O
depleted O O
within O O
a O O
few O O
hours O O
with O O
kinetics O O
that O O
are O O
as O O
fast O O
or O O
faster O O
than O O
that O O
of O O
Ig O O
gene O O
extinction O O
. O O

Thus O O
, O O
the O O
extinguishing O O
mechanism O O
is O O
effective O O
very O O
early O O
after O O
fusion O O
. O O

We O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
extinction I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
Ig I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
part I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
global I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
suppresses I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
differentiation I-SPECULATION I-SPECULATION
program I-SPECULATION I-SPECULATION
foreign I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
HeLa I-SPECULATION I-SPECULATION
phenotype I-SPECULATION I-SPECULATION
. O O

Regulation O O
of O O
Id3 O O
cell O O
cycle O O
function O O
by O O
Cdk-2-dependent O O
phosphorylation O O
. O O

The O O
functions O O
of O O
basic O O
helix-loop-helix O O
( O O
bHLH O O
) O O
transcription O O
factors O O
in O O
activating O O
differentiation-linked O O
gene O O
expression O O
and O O
in O O
inducing O O
G1 O O
cell O O
cycle O O
arrest O O
are O O
negatively O O
regulated O O
by O O
members O O
of O O
the O O
Id O O
family O O
of O O
HLH O O
proteins O O
. O O

These O O
bHLH O O
antagonists O O
are O O
induced O O
during O O
a O O
mitogenic O O
signalling O O
response O O
, O O
and O O
they O O
function O O
by O O
sequestering O O
their O O
bHLH O O
targets O O
in O O
inactive O O
heterodimers O O
that O O
are B-NEGATION O
unable I-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
bind I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
specific I-NEGATION I-NEGATION
gene I-NEGATION I-NEGATION
regulatory I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
E I-NEGATION I-NEGATION
box I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
sequences I-NEGATION I-NEGATION
. O O

Recently O O
, O O
cyclin O O
E-Cdk2 O O
- O O
and O O
cyclin O O
A-Cdk2-dependent O O
phosphorylation O O
of O O
a O O
single O O
conserved O O
serine O O
residue O O
( O O
Ser5 O O
) O O
in O O
Id2 O O
has O O
been O O
shown O O
to O O
occur O O
during O O
late O O
G1-to-S O O
phase O O
transition O O
of O O
the O O
cell O O
cycle O O
, O O
and O O
this O O
neutralizes O O
the O O
function O O
of O O
Id2 O O
in O O
abrogating O O
E-box-dependent O O
bHLH O O
homo O O
- O O
or O O
heterodimer O O
complex O O
formation O O
in O O
vitro O O
( O O
E.Hara O O
, O O
M.Hall O O
, O O
and O O
G.Peters O O
, O O
EMBO O O
J.16:332-342 O O
, O O
1997 O O
) O O
. O O

We O O
now O O
show O O
that O O
an O O
analogous O O
cell-cycle-regulated O O
phosphorylation O O
of O O
Id3 O O
alters O O
the O O
specificity O O
of O O
Id3 O O
for O O
abrogating O O
both O O
E-box-dependent O O
bHLH O O
homo O O
- O O
or O O
heterodimer O O
complex O O
formation O O
in O O
vitro O O
and O O
E-box-dependent O O
reporter O O
gene O O
function O O
in O O
vivo O O
. O O

Furthermore O O
, O O
compared O O
with O O
wild-type O O
Id3 O O
, O O
an B-NEGATION O
Id3 I-NEGATION O
Asp5 I-NEGATION O
mutant I-NEGATION O
( I-NEGATION O
mimicking I-NEGATION O
phosphorylation I-NEGATION O
) I-NEGATION O
is I-NEGATION O
unable I-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
promote I-NEGATION I-NEGATION
cell I-NEGATION I-NEGATION
cycle I-NEGATION I-NEGATION
S I-NEGATION I-NEGATION
phase I-NEGATION I-NEGATION
entry I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
transfected I-NEGATION I-NEGATION
fibroblasts I-NEGATION I-NEGATION
, O O
whereas O O
an O O
Id3 O O
Ala5 O O
mutant O O
( O O
ablating O O
phosphorylation O O
) O O
displays O O
an O O
activity O O
significantly O O
greater O O
than O O
that O O
of O O
wild-type O O
Id3 O O
protein O O
. O O

Cdk2-dependent O O
phosphorylation O O
therefore O O
provides O O
a O O
switch O O
during O O
late O O
G1-to-S O O
phase O O
that O O
both O O
nullifies O O
an O O
early O O
G1 O O
cell O O
cycle O O
regulatory O O
function O O
of O O
Id3 O O
and O O
modulates O O
its O O
target O O
bHLH O O
specificity O O
. O O

These O O
data O O
also O O
demonstrate O O
that O O
the O O
ability O O
of O O
Id3 O O
to O O
promote O O
cell O O
cycle O O
S O O
phase O O
entry O O
is O O
not B-NEGATION O
simply I-NEGATION O
a I-NEGATION O
function I-NEGATION O
of I-NEGATION O
its I-NEGATION O
ability I-NEGATION O
to I-NEGATION O
modulate I-NEGATION O
bHLH I-NEGATION O
heterodimer-dependent I-NEGATION O
gene I-NEGATION O
expression I-NEGATION O
and O O
establish O O
a O O
biologically O O
important O O
mechanism O O
through O O
which O O
Cdk2 O O
and O O
Id-bHLH O O
functions O O
are O O
integrated O O
in O O
the O O
coordination O O
of O O
cell O O
proliferation O O
and O O
differentiation O O
. O O

Nuclear O O
accumulation O O
of O O
NFAT4 O O
opposed O O
by O O
the O O
JNK O O
signal O O
transduction O O
pathway O O
. O O

The O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
( O O
NFAT O O
) O O
group O O
of O O
transcription O O
factors O O
is O O
retained O O
in O O
the O O
cytoplasm O O
of O O
quiescent O O
cells O O
. O O

NFAT O O
activation O O
is O O
mediated O O
in O O
part O O
by O O
induced O O
nuclear O O
import O O
. O O

This O O
process O O
requires O O
calcium-dependent O O
dephosphorylation O O
of O O
NFAT O O
caused O O
by O O
the O O
phosphatase O O
calcineurin O O
. O O

The O O
c-Jun O O
amino-terminal O O
kinase O O
( O O
JNK O O
) O O
phosphorylates O O
NFAT4 O O
on O O
two O O
sites O O
. O O

Mutational O O
removal O O
of O O
the O O
JNK O O
phosphorylation O O
sites O O
caused O O
constitutive O O
nuclear O O
localization O O
of O O
NFAT4 O O
. O O

In O O
contrast O O
, O O
JNK O O
activation O O
in O O
calcineurin-stimulated O O
cells O O
caused O O
nuclear O O
exclusion O O
of O O
NFAT4 O O
. O O

These O O
findings O O
show O O
that O O
the O O
nuclear O O
accumulation O O
of O O
NFAT4 O O
promoted O O
by O O
calcineurin O O
is O O
opposed O O
by O O
the O O
JNK O O
signal O O
transduction O O
pathway O O
. O O

Hypoxia O O
enhances O O
induction O O
of O O
endothelial O O
ICAM-1 O O
: O O
role O O
for O O
metabolic O O
acidosis O O
and O O
proteasomes O O
. O O

Intercellular O O
adhesion O O
molecule O O
1 O O
( O O
ICAM-1 O O
) O O
is O O
an O O
important O O
molecule O O
in O O
promotion O O
of O O
polymorphonuclear O O
neutrophil O O
transendothelial O O
migration O O
during O O
inflammation O O
. O O

Coincident O O
with O O
many O O
inflammatory O O
diseases O O
is O O
tissue O O
hypoxia O O
. O O

Thus O O
we O O
hypothesized B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
combinations I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
hypoxia I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
inflammatory I-SPECULATION I-SPECULATION
stimuli I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
differentially I-SPECULATION I-SPECULATION
regulate I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
endothelial I-SPECULATION I-SPECULATION
ICAM-1 I-SPECULATION I-SPECULATION
. O O

Human O O
endothelial O O
cells O O
were O O
exposed O O
to O O
hypoxia O O
in O O
the O O
presence O O
or O O
absence B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
added I-NEGATION I-NEGATION
lipopolysaccharide I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
LPS I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
and O O
examined O O
for O O
expression O O
of O O
functional O O
ICAM-1 O O
. O O

Although O O
hypoxia O O
alone O O
did O O
not B-NEGATION B-NEGATION
induce I-NEGATION I-NEGATION
ICAM-1 I-NEGATION I-NEGATION
, O O
the O O
combination O O
of O O
LPS O O
and O O
hypoxia O O
enhanced O O
( O O
3 O O
± O O
0.4-fold O O
over O O
normoxia O O
) O O
ICAM-1 O O
expression O O
. O O

Combinations O O
of O O
hypoxia O O
and O O
LPS O O
significantly O O
increased O O
lymphocyte O O
binding O O
, O O
and O O
such O O
increases O O
were O O
inhibited O O
by O O
addition O O
of O O
anti-ICAM-1 O O
antibodies O O
or O O
antisense O O
oligonucleotides O O
. O O

Hypoxic O O
endothelia O O
showed O O
a O O
> O O
10-fold O O
increase O O
in O O
sensitivity O O
to O O
inhibitors O O
of O O
proteasome O O
activation O O
, O O
and O O
combinations O O
of O O
hypoxia O O
and O O
LPS O O
enhanced O O
proteasome-dependent O O
cytoplasmic-to-nuclear O O
localization O O
of O O
the O O
nuclear O O
transcription O O
factor-kappa O O
B O O
p65 O O
( O O
Rel O O
A O O
) O O
subunit O O
. O O

Such O O
proteasome O O
activation O O
correlated O O
with O O
hypoxia-evoked O O
decreases O O
in O O
both O O
extracellular O O
and O O
intracellular O O
pH O O
. O O

We O O
conclude O O
from O O
these O O
studies O O
that O O
endothelial O O
hypoxia O O
provides O O
a O O
novel O O
, O O
proteasome-dependent O O
stimulus O O
for O O
ICAM-1 O O
induction O O
. O O

Modulation O O
of O O
mRNA O O
expression O O
of O O
a O O
novel O O
human O O
myeloid-selective O O
CCAAT O O
/ O O
enhancer O O
binding O O
protein O O
gene O O
( O O
C O O
/ O O
EBP O O
epsilon O O
) O O
. O O

Human O O
C O O
/ O O
EBP O O
epsilon O O
is O O
a O O
newly O O
cloned O O
gene O O
coding O O
for O O
a O O
CCAAT O O
/ O O
enhancer O O
binding O O
protein O O
that O O
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
involved I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
regulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
myeloid I-SPECULATION I-SPECULATION
differentiation I-SPECULATION I-SPECULATION
. O O

Our O O
studies O O
showed O O
that O O
levels O O
of O O
C O O
/ O O
EBP O O
epsilon O O
mRNA O O
were O O
markedly O O
increased O O
in O O
NB4 O O
cells O O
( O O
promyelocytic O O
leukemia O O
line O O
) O O
, O O
because O O
they O O
were O O
induced O O
by O O
9-cis O O
retinoic O O
acid O O
( O O
9-cis O O
RA O O
) O O
to O O
differentiate O O
towards O O
granulocytes O O
. O O

Accumulation O O
of O O
C O O
/ O O
EBP O O
epsilon O O
mRNA O O
occurred O O
as O O
early O O
as O O
1 O O
hour O O
after O O
exposure O O
of O O
NB4 O O
cells O O
to O O
9-cis O O
RA O O
( O O
5 O O
x O O
10 O O
(- O O
7 O O
) O O
mol O O
/ O O
L O O
) O O
; O O
and O O
at O O
48 O O
hours O O
, O O
levels O O
were O O
increased O O
by O O
5.1-fold O O
. O O

Dose-response O O
studies O O
showed O O
that O O
10 O O
(- O O
7 O O
) O O
to O O
10 O O
(- O O
6 O O
) O O
mol O O
/ O O
L O O
9-cis O O
RA O O
( O O
12 O O
hours O O
) O O
resulted O O
in O O
peak O O
levels O O
of O O
C O O
/ O O
EBP O O
epsilon O O
mRNA O O
; O O
but O O
even O O
10 O O
(- O O
10 O O
) O O
mol O O
/ O O
L O O
9-cis O O
RA O O
increased O O
levels O O
of O O
these O O
transcripts O O
. O O

NB4 O O
cells O O
pulse-exposed O O
( O O
30 O O
minutes O O
) O O
to O O
all-trans O O
retinoic O O
acid O O
( O O
ATRA O O
) O O
, O O
washed O O
, O O
and O O
cultured O O
( O O
3 O O
days O O
) O O
with O O
either O O
dimethylsulfoxide O O
( O O
DMSO O O
) O O
or O O
hexamethylene O O
bisacetamide O O
( O O
HMBA O O
) O O
had O O
a O O
prominent O O
increase O O
in O O
levels O O
of O O
C O O
/ O O
EBP O O
epsilon O O
mRNA O O
and O O
an O O
increase O O
in O O
granulocytic O O
differentiation O O
, O O
but O O
exposure O O
to O O
either O O
DMSO O O
or O O
HMBA O O
alone O O
had O O
no B-NEGATION B-NEGATION
effect I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
base I-NEGATION I-NEGATION
levels I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
C I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
EBP I-NEGATION I-NEGATION
epsilon I-NEGATION I-NEGATION
and O O
did O O
not B-NEGATION B-NEGATION
induce I-NEGATION I-NEGATION
differentiation I-NEGATION I-NEGATION
. O O

Macrophage-differentiation O O
of O O
NB4 O O
reduced O O
levels O O
of O O
C O O
/ O O
EBP O O
epsilon O O
mRNA O O
. O O

Nuclear O O
run-off O O
assays O O
and O O
half-life O O
studies O O
showed O O
that O O
accumulation O O
of O O
C O O
/ O O
EBP O O
epsilon O O
mRNA O O
by O O
9-cis O O
RA O O
was O O
due O O
to O O
enhanced O O
transcription O O
. O O

Furthermore O O
, O O
this O O
C O O
/ O O
EBP O O
epsilon O O
mRNA O O
accumulation O O
did O O
not B-NEGATION B-NEGATION
require I-NEGATION I-NEGATION
synthesis I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
new I-NEGATION I-NEGATION
protein I-NEGATION I-NEGATION
factors I-NEGATION I-NEGATION
because O O
9-cis O O
RA O O
induced O O
C O O
/ O O
EBP O O
epsilon O O
mRNA O O
accumulation O O
in O O
the O O
absence B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
new I-NEGATION I-NEGATION
protein I-NEGATION I-NEGATION
synthesis I-NEGATION I-NEGATION
. O O

ATRA O O
also O O
induced O O
expression O O
of O O
C O O
/ O O
EBP O O
epsilon O O
protein O O
in O O
NB4 O O
cells O O
, O O
as O O
shown O O
by O O
Western O O
blotting O O
. O O

In O O
contrast O O
to O O
the O O
increase O O
of O O
C O O
/ O O
EBP O O
epsilon O O
in O O
9-cis O O
RA-mediated O O
granulocytic O O
differentiation O O
, O O
the O O
DMSO-induced O O
differentiation O O
of O O
HL-60 O O
cells O O
down O O
the O O
granulocytic O O
pathway O O
was O O
associated O O
with O O
an O O
initial O O
reduction O O
of O O
C O O
/ O O
EBP O O
epsilon O O
mRNA O O
levels O O
. O O

In O O
summary O O
, O O
we O O
have O O
discovered O O
that O O
expression O O
of O O
C O O
/ O O
EBP O O
epsilon O O
mRNA O O
is O O
markedly O O
enhanced O O
as O O
the O O
NB4 O O
promyelocytes O O
are O O
induced O O
by O O
retinoids O O
to O O
differentiate O O
towards O O
granulocytes O O
. O O

This O O
induction O O
of O O
C O O
/ O O
EBP O O
epsilon O O
mRNA O O
expression O O
is O O
transcriptionally O O
mediated O O
and O O
occurs O O
in O O
the O O
absence B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
synthesis I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
additional I-NEGATION I-NEGATION
protein I-NEGATION I-NEGATION
factors I-NEGATION I-NEGATION
. O O

We O O
suspect B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
C I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
EBP I-SPECULATION I-SPECULATION
epsilon I-SPECULATION I-SPECULATION
promoter I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
enhancer I-SPECULATION I-SPECULATION
contains I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
retinoic I-SPECULATION I-SPECULATION
acid-response I-SPECULATION I-SPECULATION
element I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
directly I-SPECULATION I-SPECULATION
stimulated I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
retinoids I-SPECULATION I-SPECULATION
. O O

Regulation O O
of O O
nuclear O O
factor-kappa O O
B O O
and O O
its O O
inhibitor O O
I O O
kappa O O
B-alpha O O
/ O O
MAD-3 O O
in O O
monocytes O O
by O O
Mycobacterium O O
tuberculosis O O
and O O
during O O
human O O
tuberculosis O O
. O O

Blood O O
monocytes O O
from O O
patients O O
with O O
active O O
tuberculosis O O
are O O
activated O O
in O O
vivo O O
, O O
as O O
evidenced O O
by O O
an O O
increase O O
in O O
the O O
stimulated O O
release O O
of O O
proinflammatory O O
cytokines O O
, O O
such O O
as O O
TNF-alpha O O
, O O
and O O
the O O
spontaneous O O
expression O O
of O O
IL-2R O O
. O O

Further O O
, O O
monocytes O O
from O O
patients O O
demonstrate O O
an O O
augmented O O
susceptibility O O
to O O
a O O
productive O O
infection O O
with O O
HIV-1 O O
in O O
vitro O O
. O O

Mycobacterium O O
tuberculosis O O
and O O
its O O
components O O
are O O
strong O O
signals O O
to O O
activate O O
monocytes O O
to O O
production O O
of O O
cytokines O O
. O O

In O O
this O O
study O O
we O O
examined O O
the O O
basis O O
of O O
activation O O
of O O
monocytes O O
during O O
active O O
tuberculosis O O
and O O
by O O
M. O O
tuberculosis O O
. O O

We O O
found O O
a O O
constitutive O O
degradation O O
of O O
I O O
kappa O O
B-alpha O O
, O O
the O O
major O O
cytoplasmic O O
inhibitor O O
of O O
nuclear O O
factor O O
kappa O O
B O O
( O O
NF-kappa O O
B O O
) O O
, O O
in O O
freshly O O
isolated O O
PBMC O O
and O O
monocytes O O
from O O
patients O O
with O O
tuberculosis O O
. O O

In O O
contrast O O
, O O
I O O
kappa O O
B-alpha O O
levels O O
in O O
PBMC O O
and O O
monocytes O O
from O O
healthy O O
subjects O O
or O O
from O O
patients O O
with O O
nontuberculous O O
pulmonary O O
conditions O O
were O O
intact O O
. O O

Further O O
, O O
by O O
electrophoretic O O
mobility O O
shift O O
assay O O
, O O
NF-kappa O O
B O O
was O O
activated O O
in O O
monocytes O O
from O O
tuberculous O O
patients O O
. O O

The O O
expression O O
of O O
I O O
kappa O O
B-alpha O O
gene O O
, O O
which O O
is O O
responsive O O
to O O
activation O O
by O O
NF-kappa O O
B O O
, O O
was O O
up-regulated O O
in O O
PBMC O O
and O O
monocytes O O
from O O
patients O O
, O O
but O O
not B-NEGATION B-NEGATION
in I-NEGATION I-NEGATION
mononuclear I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
from I-NEGATION I-NEGATION
healthy I-NEGATION I-NEGATION
subjects I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
those I-NEGATION I-NEGATION
with I-NEGATION I-NEGATION
nontuberculous I-NEGATION I-NEGATION
lung I-NEGATION I-NEGATION
diseases I-NEGATION I-NEGATION
. O O

By O O
contrast O O
, O O
the B-NEGATION B-NEGATION
expression I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
other I-NEGATION I-NEGATION
adherence-associated I-NEGATION I-NEGATION
early I-NEGATION I-NEGATION
genes I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
such I-NEGATION I-NEGATION
as I-NEGATION I-NEGATION
IL-8 I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
IL-1 I-NEGATION I-NEGATION
beta I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
up-regulated I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
PBMC I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
tuberculous I-NEGATION I-NEGATION
patients I-NEGATION I-NEGATION
. O O

Further O O
, O O
M. O O
tuberculosis O O
and O O
its O O
tuberculin O O
, O O
purified O O
protein O O
derivative O O
, O O
induced O O
the O O
degradation O O
of O O
I O O
kappa O O
B-alpha O O
and O O
the O O
expression O O
of O O
I O O
kappa O O
B-alpha O O
mRNA O O
, O O
and O O
purified O O
protein O O
derivative O O
induced O O
the O O
activation O O
of O O
NF-kappa O O
B O O
in O O
monocytes O O
. O O

Expression O O
of O O
c-fos O O
correlates O O
with O O
IFN-alpha O O
responsiveness O O
in O O
Philadelphia O O
chromosome O O
positive O O
chronic O O
myelogenous O O
leukemia O O
. O O

This O O
study O O
evaluates O O
( O O
i O O
) O O
constitutive O O
levels O O
of O O
oncogene O O
and O O
p53 O O
transcripts O O
in O O
chronic O O
phase O O
CML O O
patients O O
and O O
( O O
ii O O
) O O
their O O
modulations O O
subsequent O O
to O O
in O O
vivo O O
therapy O O
with O O
rIFN-alpha O O
2c O O
. O O

Peripheral O O
blood O O
mononuclear O O
cells O O
( O O
pbmc O O
) O O
and O O
bone O O
marrow O O
cells O O
of O O
26 O O
patients O O
were O O
examined O O
for O O
c-fos O O
, O O
c-myc O O
, O O
p53 O O
and O O
the O O
hybrid O O
bcr O O
/ O O
abl O O
mRNA O O
levels O O
. O O

Results O O
indicated B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
i I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
constitutive I-SPECULATION I-SPECULATION
c-fos I-SPECULATION I-SPECULATION
transcript I-SPECULATION I-SPECULATION
levels I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
significantly I-SPECULATION I-SPECULATION
higher I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
patients I-SPECULATION I-SPECULATION
subsequently I-SPECULATION I-SPECULATION
responding I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
IFN-alpha I-SPECULATION I-SPECULATION
therapy I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
p I-SPECULATION I-SPECULATION
< I-SPECULATION I-SPECULATION
0.01 I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
positively I-SPECULATION I-SPECULATION
correlated I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
proportion I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
lymphocytes I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
r I-SPECULATION I-SPECULATION
= I-SPECULATION I-SPECULATION
0.6895 I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
p I-SPECULATION I-SPECULATION
< I-SPECULATION I-SPECULATION
0.01 I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
negatively I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
proportion I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
immature I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
r I-SPECULATION I-SPECULATION
= I-SPECULATION I-SPECULATION
- I-SPECULATION I-SPECULATION
0.568 I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
p I-SPECULATION I-SPECULATION
< I-SPECULATION I-SPECULATION
0.01 I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
contained I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
pbmc I-SPECULATION I-SPECULATION
preparations I-SPECULATION I-SPECULATION
tested I-SPECULATION I-SPECULATION
, I-SPECULATION O
( I-SPECULATION O
ii I-SPECULATION O
) I-SPECULATION O
constitutive I-SPECULATION O
mRNA I-SPECULATION O
levels I-SPECULATION O
of I-SPECULATION O
the I-SPECULATION O
hybrid I-SPECULATION O
bcr I-SPECULATION O
/ I-SPECULATION O
abl I-SPECULATION O
, I-SPECULATION O
c-myc I-SPECULATION O
and I-SPECULATION O
p53 I-SPECULATION O
are I-SPECULATION O
positively I-SPECULATION O
correlated I-SPECULATION O
with I-SPECULATION O
each I-SPECULATION O
other I-SPECULATION O
, I-SPECULATION O
but I-SPECULATION O
failed B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
relate I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
disease I-NEGATION I-NEGATION
parameters I-NEGATION I-NEGATION
, O O
and O O
( O O
iii O O
) O O
acute O O
and O O
chronic O O
in O O
vivo O O
exposure O O
to O O
IFN-alpha O O
is O O
accompanied O O
by O O
upregulation O O
of O O
c-fos O O
and O O
downregulation O O
of O O
c-myc O O
mRNA O O
levels O O
in O O
responder O O
patients O O
. O O

Molecular O O
cloning O O
and O O
functional O O
characterization O O
of O O
murine O O
cDNA O O
encoding O O
transcription O O
factor O O
NFATc O O
. O O

Transcription O O
factors O O
of O O
the O O
NFAT O O
( O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
) O O
family O O
play O O
important O O
roles O O
in O O
immune O O
and O O
inflammatory O O
responses O O
by O O
regulating O O
the O O
expression O O
of O O
genes O O
encoding O O
cytokines O O
and O O
immunoregulatory O O
proteins O O
. O O

Here O O
we O O
describe O O
cloning O O
and O O
characterization O O
of O O
full-length O O
cDNA O O
encoding O O
murine O O
( O O
m O O
) O O
NFATc O O
which O O
predicts O O
that O O
the O O
protein O O
has O O
all O O
the O O
conserved O O
structural O O
motifs O O
of O O
NFAT O O
family O O
members O O
, O O
including O O
the O O
rel O O
homology O O
domain O O
, O O
the O O
NFAT O O
homology O O
domain O O
and O O
the O O
nuclear O O
translocation O O
signals O O
. O O

mNFATc O O
complexed O O
with O O
AP-1 O O
bound O O
specifically O O
to O O
the O O
murine O O
IL-2 O O
NFAT O O
recognition O O
sequence O O
and O O
activated O O
transcription O O
from O O
the O O
co-transfected O O
IL-2 O O
promoter O O
in O O
COS-7 O O
cells O O
. O O

Northern O O
blot O O
analysis O O
showed O O
that O O
the O O
cDNA O O
probe O O
hybridized O O
with O O
a O O
4.5 O O
kb O O
transcript O O
which O O
is O O
highly O O
inducible O O
in O O
murine O O
T O O
cells O O
. O O

By O O
Northern O O
and O O
in O O
situ O O
hybridization O O
, O O
mNFATc O O
transcript O O
was O O
detected O O
from O O
the O O
early O O
stage O O
of O O
development O O
. O O

In O O
the O O
mouse O O
embryo O O
, O O
mNFATc O O
transcript O O
was O O
strongly O O
expressed O O
in O O
thymus O O
, O O
lung O O
and O O
submandibular O O
gland O O
and O O
weakly O O
in O O
skeletal O O
muscle O O
and O O
heart O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
mNFATc I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
have I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
both I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
embryogenesis I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
mature I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

Phosphatidylinositol O O
3-kinase O O
couples O O
the O O
interleukin-2 O O
receptor O O
to O O
the O O
cell O O
cycle O O
regulator O O
E2F O O
. O O

Cell O O
cycle O O
progression O O
initiated O O
by O O
interleukin-2 O O
( O O
IL-2 O O
) O O
in O O
T O O
cells O O
is O O
critical O O
for O O
lymphoproliferation O O
and O O
an O O
immune O O
response O O
. O O

Phosphatidyl O O
inositol O O
3-kinase O O
( O O
PI3K O O
) O O
is O O
activated O O
by O O
IL-2 O O
. O O

However O O
, O O
nuclear B-SPECULATION O
targets I-SPECULATION O
for I-SPECULATION O
PI3K I-SPECULATION O
are I-SPECULATION O
not I-SPECULATION B-NEGATION
known I-SPECULATION I-NEGATION
. O O

Here O O
we O O
identify O O
the O O
cell O O
cycle O O
regulator O O
E2F O O
as O O
an O O
IL-2 O O
target O O
in O O
T O O
lymphocytes O O
and O O
PI3K O O
as O O
the O O
critical O O
signaling O O
pathway O O
. O O

We O O
eliminate O O
both O O
Stat5 O O
and O O
Raf O O
/ O O
MEK O O
pathways O O
from O O
E2F O O
regulation O O
. O O

Protein O O
kinase O O
B O O
( O O
PKB O O
) O O
is O O
activated O O
by O O
IL-2 O O
via O O
PI3K O O
. O O

The O O
expression O O
of O O
an O O
active O O
PKB O O
is O O
sufficient O O
to O O
induce O O
E2F O O
activity O O
. O O

Inhibition O O
of O O
PI3K O O
inhibits O O
phosphorylation O O
of O O
Rb O O
, O O
induction O O
of O O
cyclin O O
D3 O O
, O O
and O O
degradation O O
of O O
p27kip1 O O
. O O

These O O
results O O
establish O O
a O O
crucial O O
PI3K O O
/ O O
PKB-mediated O O
link O O
between O O
the O O
IL-2 O O
teceptor O O
and O O
the O O
cell O O
cycle O O
machinery O O
. O O

Thiol O O
modulation O O
inhibits O O
the O O
interleukin O O
( O O
IL O O
)- O O
1-mediated O O
activation O O
of O O
an O O
IL-1 O O
receptor-associated O O
protein O O
kinase O O
and O O
NF-kappa O O
B O O
. O O

The O O
interleukin-1 O O
receptor O O
type O O
I O O
( O O
IL-1RI O O
) O O
is O O
associated O O
with O O
other O O
proteins O O
thus O O
forming O O
a O O
complex O O
system O O
by O O
which O O
IL-1 O O
exerts O O
its O O
various O O
signals O O
. O O

The B-SPECULATION O
initiating I-SPECULATION O
event I-SPECULATION O
is I-SPECULATION O
still I-SPECULATION O
uncertain I-SPECULATION O
, O O
but O O
activation O O
of O O
a O O
recently O O
described O O
receptor-associated O O
protein O O
kinase O O
is O O
one O O
of O O
the O O
earliest O O
events O O
detectable O O
( O O
Martin O O
et O O
al. O O
, O O
Eur.J.Immunol.1994.24 O O
: O O
1566 O O
) O O
. O O

IL-1 O O
signaling O O
is O O
commonly O O
accompanied O O
by O O
oxidative O O
processes O O
and O O
is B-SPECULATION B-SPECULATION
thought I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
subject I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
redox I-SPECULATION I-SPECULATION
regulation I-SPECULATION I-SPECULATION
. O O

We O O
therefore O O
investigated O O
whether B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
IL-1RI-associated I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
kinase I-SPECULATION I-SPECULATION
and O I-SPECULATION
could B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
target I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
redox I-SPECULATION I-SPECULATION
regulation I-SPECULATION I-SPECULATION
whether B-SPECULATION B-SPECULATION
an I-SPECULATION I-SPECULATION
altered I-SPECULATION I-SPECULATION
activity I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
kinase I-SPECULATION I-SPECULATION
could B-SPECULATION B-SPECULATION
influence I-SPECULATION I-SPECULATION
IL-1-mediated I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
. O O

A O O
murine O O
T O O
cell O O
line O O
, O O
EL4 O O
, O O
was O O
stimulated O O
with O O
IL-1 O O
with O O
and O O
without B-NEGATION B-NEGATION
pretreatment I-NEGATION I-NEGATION
with I-NEGATION I-NEGATION
different I-NEGATION I-NEGATION
compounds I-NEGATION I-NEGATION
known I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
influence I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
cellular I-NEGATION I-NEGATION
redox I-NEGATION I-NEGATION
status I-NEGATION I-NEGATION
. O O

Thiol O O
modifying O O
agents O O
like O O
diamide O O
, O O
menadione O O
, O O
pyrrolidine O O
dithiocarbamate O O
( O O
PDTC O O
) O O
, O O
diethyl O O
dithiocarbamate O O
or O O
phenylarsine O O
oxide O O
inhibited O O
the O O
IL-1-induced O O
activation O O
of O O
the O O
IL-1RI-associated O O
protein O O
kinase O O
. O O

N-Acetylcysteine O O
, O O
alpha,alpha O O
'- O O
dipyridyl O O
, O O
aminotriazole O O
or O O
nitrofurantoin O O
did O O
not B-NEGATION B-NEGATION
show I-NEGATION I-NEGATION
any I-NEGATION I-NEGATION
effect I-NEGATION I-NEGATION
. O O

The O O
inhibition O O
by O O
PDTC O O
was O O
reversible O O
unless O O
glutathione O O
synthesis O O
was O O
blocked O O
by O O
buthionine O O
sulfoximine O O
. O O

The O O
described O O
conditions O O
which O O
inhibited O O
or O O
prevented O O
the O O
activation O O
of O O
the O O
IL-1RI-associated O O
kinase O O
similarly O O
impaired O O
the O O
activation O O
of O O
NF-kappa O O
B O O
in O O
EL4 O O
cells O O
. O O

From O O
these O O
observations O O
we O O
conclude O O
that O O
free O O
thiols O O
in O O
the O O
IL-1RI O O
complex O O
are O O
essential O O
for O O
the O O
activation O O
of O O
the O O
IL-1RI-associated O O
protein O O
kinase O O
and O O
that O O
this O O
process O O
is O O
mandatory O O
for O O
IL-1 O O
signaling O O
leading O O
to O O
NF-kappa O O
B O O
activation O O
. O O

ATF1 O O
and O O
CREB O O
trans-activate O O
a O O
cell O O
cycle O O
regulated O O
histone O O
H4 O O
gene O O
at O O
a O O
distal O O
nuclear O O
matrix O O
associated O O
promoter O O
element O O
. O O

Proteins O O
of O O
the O O
ATF O O
/ O O
CREB O O
class O O
of O O
transcription O O
factors O O
stimulate O O
gene O O
expression O O
of O O
several O O
cell O O
growth-related O O
genes O O
through O O
protein O O
kinase O O
A-related O O
cAMP O O
response O O
elements O O
. O O

The O O
promoter O O
activity O O
of O O
cell O O
cycle O O
regulated O O
histone O O
H4 O O
genes O O
is O O
regulated O O
by O O
at O O
least O O
four O O
principal O O
cis-acting O O
elements O O
which O O
mediate O O
G1 O O
/ O O
S O O
phase O O
control O O
and O O
/ O O
or O O
enhancement O O
of O O
transcription O O
during O O
the O O
cell O O
cycle O O
. O O

Using O O
protein-DNA O O
interaction O O
assays O O
we O O
show O O
that O O
the O O
H4 O O
promoter O O
contains O O
two O O
ATF O O
/ O O
CREB O O
recognition O O
motifs O O
which O O
interact O O
with O O
CREB O O
, O O
ATF1 O O
, O O
and O O
ATF2 O O
but O O
not B-NEGATION B-NEGATION
with I-NEGATION I-NEGATION
ATF4 I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
CREB2 I-NEGATION I-NEGATION
. O O

One O O
ATF O O
/ O O
CRE O O
motif O O
is O O
located O O
in O O
the O O
distal O O
promoter O O
at O O
the O O
nuclear O O
matrix-associated O O
Site O O
IV O O
, O O
and O O
the O O
second O O
motif O O
is O O
present O O
in O O
the O O
proximal O O
promoter O O
at O O
Site O O
I O O
. O O

Both O O
ATF O O
/ O O
CRE O O
motifs O O
overlap O O
binding O O
sequences O O
for O O
the O O
multifunctional O O
YY1 O O
transcription O O
factor O O
, O O
which O O
has O O
previously O O
been O O
shown O O
to O O
be O O
nuclear O O
matrix O O
associated O O
. O O

Subnuclear O O
fractionation O O
reveals O O
that O O
there O O
are O O
two O O
ATF1 O O
isoforms O O
which B-SPECULATION B-SPECULATION
appear I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
differ I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
respect I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
DNA I-SPECULATION I-SPECULATION
binding I-SPECULATION I-SPECULATION
activity I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
partition I-SPECULATION I-SPECULATION
selectively I-SPECULATION I-SPECULATION
between I-SPECULATION I-SPECULATION
nuclear I-SPECULATION I-SPECULATION
matrix I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
nonmatrix I-SPECULATION I-SPECULATION
compartments I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
consistent I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
nuclear I-SPECULATION I-SPECULATION
matrix I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
regulating I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
. O O

Site-directed O O
mutational O O
studies O O
demonstrate O O
that O O
Site O O
I O O
and O O
Site O O
IV O O
together O O
support O O
ATF1 O O
- O O
and O O
CREB-induced O O
trans-activation O O
of O O
the O O
H4 O O
promoter O O
. O O

Thus O O
, O O
our O O
data O O
establish O O
that O O
ATF O O
/ O O
CREB O O
factors O O
functionally O O
modulate O O
histone O O
H4 O O
gene O O
transcription O O
at O O
distal O O
and O O
proximal O O
promoter O O
elements O O
. O O

IL-2 O O
and O O
IL-7 O O
induce O O
heterodimerization O O
of O O
STAT5 O O
isoforms O O
in O O
human O O
peripheral O O
blood O O
T O O
lymphoblasts O O
. O O

Despite O O
differences O O
in O O
T O O
cell O O
responses O O
induced O O
by O O
interleukin O O
( O O
IL O O
)- O O
2 O O
and O O
IL-7 O O
, O O
both O O
cytokines O O
modulate O O
T O O
cell O O
functions O O
by O O
activation O O
of O O
signal O O
transducers O O
and O O
activators O O
of O O
transcription O O
( O O
STAT O O
) O O
proteins O O
. O O

We O O
examined O O
the O O
contribution O O
of O O
the O O
two O O
isoforms O O
of O O
STAT5 O O
, O O
STAT5A O O
and O O
STAT5B O O
, O O
to O O
IL-2 O O
- O O
and O O
IL-7-induced O O
activation O O
of O O
human O O
peripheral O O
blood O O
T O O
lymphoblasts O O
. O O

Both O O
cytokines O O
induced O O
assembly O O
of O O
STAT5A O O
and O O
STAT5B O O
containing O O
complexes O O
capable O O
of O O
binding O O
to O O
the O O
interferon-gamma O O
activation O O
sequence O O
( O O
GAS O O
) O O
, O O
and O O
these O O
complexes O O
rapidly O O
translocated O O
( O O
within O O
1 O O
min O O
) O O
into O O
the O O
nucleus O O
of O O
IL-2 O O
- O O
or O O
IL-7-treated O O
cells O O
. O O

The O O
kinetics O O
of O O
this O O
translocation O O
were O O
delayed O O
in O O
IL-7-treated O O
as O O
compared O O
to O O
IL-2-treated O O
cells O O
. O O

IL-2 O O
and O O
IL-7 O O
were O O
equivalent O O
in O O
their O O
ability O O
to O O
induce O O
tyrosine O O
phosphorylation O O
of O O
STAT5A O O
and O O
STAT5B O O
and O O
to O O
facilitate O O
binding O O
of O O
these O O
STATs O O
to O O
an O O
immobilized O O
GAS O O
element O O
. O O

Both O O
IL-2 O O
and O O
IL-7 O O
induced O O
substantial O O
amounts O O
of O O
STAT5A O O
/ O O
STAT5B O O
heterodimerization O O
. O O

Moreover O O
, O O
we O O
observed O O
constitutive O O
association O O
of O O
STAT3 O O
with O O
each O O
STAT5 O O
isomer O O
. O O

These O O
data O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
IL-2 I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
IL-7 I-SPECULATION I-SPECULATION
induce I-SPECULATION I-SPECULATION
assembly I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
STAT I-SPECULATION I-SPECULATION
heterodimers I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
similar I-SPECULATION I-SPECULATION
manner I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
subsequent B-SPECULATION I-SPECULATION
cellular I-SPECULATION I-SPECULATION
responses I-SPECULATION I-SPECULATION
may I-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
driven I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
induction I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
similar I-SPECULATION I-SPECULATION
sets I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
. O O

Molecular O O
mechanisms O O
of O O
anoxia O O
/ O O
reoxygenation-induced O O
neutrophil O O
adherence O O
to O O
cultured O O
endothelial O O
cells O O
. O O

The O O
objectives O O
of O O
this O O
study O O
were O O
to O O
( O O
1 O O
) O O
determine O O
the O O
time O O
course O O
of O O
neutrophil O O
adhesion O O
to O O
monolayers O O
of O O
human O O
umbilical O O
vein O O
endothelial O O
cells O O
( O O
HUVECs O O
) O O
that O O
were O O
exposed O O
to O O
60 O O
minutes O O
of O O
anoxia O O
followed O O
by O O
30 O O
to O O
600 O O
minutes O O
of O O
reoxygenation O O
and O O
( O O
2 O O
) O O
define O O
the O O
mechanisms O O
responsible O O
for O O
both O O
the O O
early O O
( O O
minutes O O
) O O
and O O
late O O
( O O
hours O O
) O O
hyperadhesivity O O
of O O
postanoxic O O
HUVECs O O
to O O
human O O
neutrophils O O
. O O

The O O
results O O
clearly O O
demonstrate O O
that O O
anoxia O O
/ O O
reoxygenation O O
( O O
A O O
/ O O
R O O
) O O
leads O O
to O O
a O O
biphasic O O
increase O O
in O O
neutrophil O O
adhesion O O
to O O
HUVECs O O
, O O
with O O
peak O O
responses O O
occurring O O
at O O
30 O O
minutes O O
( O O
phase O O
1 O O
) O O
and O O
240 O O
minutes O O
( O O
phase O O
2 O O
) O O
after O O
reoxygenation O O
. O O

Oxypurinol O O
and O O
catalase O O
inhibited O O
phase-1 O O
adhesion O O
, O O
suggesting B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
xanthine I-SPECULATION I-SPECULATION
oxidase I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
H2O2 I-SPECULATION I-SPECULATION
. O O

In O O
comparison O O
, O O
platelet O O
activating O O
factor O O
( O O
PAF O O
) O O
contributed O O
to O O
both O O
phases O O
of O O
neutrophil O O
adhesion O O
. O O

Anti-intercellular O O
adhesion O O
molecule-1 O O
( O O
ICAM-1 O O
) O O
and O O
anti-P-selectin O O
antibodies O O
( O O
monoclonal O O
antibodies O O
[ O O
mAbs O O
]) O O
attenuated O O
phase-1 O O
neutrophil O O
adhesion O O
, O O
consistent O O
with O O
roles O O
for O O
constitutively O O
expressed O O
ICAM-1 O O
and O O
enhanced O O
surface O O
expression O O
of O O
preformed O O
P-selectin O O
. O O

Phase-2 O O
neutrophil O O
adhesion O O
was O O
attenuated O O
by O O
an O O
anti-E-selectin O O
mAb O O
, O O
indicating B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
dominant I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
molecule I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
late I-SPECULATION I-SPECULATION
phase I-SPECULATION I-SPECULATION
response I-SPECULATION I-SPECULATION
. O O

Pretreatment O O
with O O
actinomycin O O
D O O
and O O
cycloheximide O O
or O O
with O O
competing O O
ds-oligonucleotides O O
containing O O
the O O
nuclear O O
factor-kappa O O
B O O
or O O
activator O O
protein-1 O O
cognate O O
DNA O O
sequences O O
significantly O O
attenuated O O
phase-2 O O
response O O
, O O
suggesting B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
de I-SPECULATION I-SPECULATION
novo I-SPECULATION I-SPECULATION
macromolecule I-SPECULATION I-SPECULATION
synthesis I-SPECULATION I-SPECULATION
. O O

Surface O O
expression O O
of O O
ICAM-1 O O
, O O
P-selectin O O
, O O
and O O
E-selectin O O
on O O
HUVECs O O
correlated O O
with O O
the O O
phase-1 O O
and O O
- O O
2 O O
neutrophil O O
adhesion O O
responses O O
. O O

Collectively O O
, O O
these O O
findings O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
A I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
R I-SPECULATION I-SPECULATION
elicits I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
two-phase I-SPECULATION I-SPECULATION
neutrophil-endothelial I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
response I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
involves I-SPECULATION I-SPECULATION
transcription-independent I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
transcription-dependent I-SPECULATION I-SPECULATION
surface I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
different I-SPECULATION I-SPECULATION
endothelial I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
molecules I-SPECULATION I-SPECULATION
. O O

c-Rel O O
and O O
p65 O O
subunits O O
bind O O
to O O
an O O
upstream O O
NF-kappaB O O
site O O
in O O
human O O
granulocyte O O
macrophage-colony O O
stimulating O O
factor O O
promoter O O
involved O O
in O O
phorbol O O
ester O O
response O O
in O O
5637 O O
cells O O
. O O

To O O
further O O
clarify O O
the O O
complex O O
transcriptional O O
regulation O O
of O O
the O O
human O O
GM-CSF O O
gene O O
, O O
which O O
was O O
extensively O O
investigated O O
in O O
activated O O
T O O
cells O O
, O O
we O O
have O O
studied O O
the O O
role O O
of O O
an O O
upstream O O
NF-kappaB O O
like O O
site O O
in O O
the O O
5637 O O
non-lymphoid O O
cell O O
line O O
, O O
which O O
derives O O
from O O
a O O
bladder O O
carcinoma O O
and O O
constitutively O O
produces O O
GM-CSF O O
. O O

This O O
sequence O O
, O O
named O O
the O O
A O O
element O O
, O O
has O O
an O O
active O O
role O O
on O O
GM-CSF O O
transcription O O
and O O
is O O
responsive O O
to O O
the O O
tumor O O
promoter O O
PMA O O
in O O
transient O O
transfection O O
experiments O O
. O O

We O O
describe O O
here O O
a O O
heterodimeric O O
binding O O
complex O O
of O O
NF-kappaB O O
subunits O O
( O O
c-Rel O O
and O O
p65 O O
) O O
which O O
is O O
identical O O
to O O
the O O
one O O
obtained O O
using O O
the O O
HIV-LTR-kappaB O O
site O O
as O O
recognition O O
sequence O O
and O O
different O O
from O O
the O O
one O O
( O O
c-Rel O O
and O O
p50 O O
) O O
observed O O
with O O
nuclear O O
extracts O O
from O O
Mo O O
T-lymphoid O O
HTLV-II O O
infected O O
cells O O
. O O

Cyclosporin O O
A O O
inhibits O O
monocyte O O
tissue O O
factor O O
activation O O
in O O
cardiac O O
transplant O O
recipients O O
. O O

BACKGROUND O O
: O O
Fibrin O O
deposition O O
and O O
thrombosis O O
have O O
been O O
implicated O O
in O O
both O O
allograft O O
rejection O O
and O O
vasculopathy O O
after O O
cardiac O O
transplantation O O
. O O

Because O O
monocytes O O
play O O
a O O
pivotal O O
role O O
in O O
the O O
pathophysiology O O
of O O
intravascular O O
coagulation O O
activation O O
through O O
their O O
ability O O
to O O
synthesize O O
tissue O O
factor O O
( O O
TF O O
) O O
, O O
we O O
asked O O
( O O
1 O O
) O O
whether B-SPECULATION B-SPECULATION
monocyte I-SPECULATION I-SPECULATION
TF I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
occurs I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
cardiac I-SPECULATION I-SPECULATION
transplant I-SPECULATION I-SPECULATION
recipients I-SPECULATION I-SPECULATION
and O O
( O O
2 O O
) O O
whether B-SPECULATION B-SPECULATION
monocyte I-SPECULATION I-SPECULATION
TF I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
affected I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
treatment I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
cyclosporin I-SPECULATION I-SPECULATION
A I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
CsA I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
. O O

METHODS O O
AND O O
RESULTS O O
: O O
We O O
measured O O
levels O O
of O O
TF O O
activity O O
in O O
peripheral O O
blood O O
mononuclear O O
cells O O
and O O
highly O O
purified O O
monocytes O O
/ O O
macrophages O O
from O O
10 O O
consecutive O O
cardiac O O
transplant O O
recipients O O
and O O
10 O O
healthy O O
control O O
subjects O O
. O O

TF O O
activity O O
generated O O
by O O
both O O
unstimulated O O
and O O
endotoxin-stimulated O O
cells O O
was O O
significantly O O
higher O O
in O O
transplant O O
recipients O O
than O O
in O O
control O O
subjects O O
( O O
P O O
<. O O
05 O O
) O O
. O O

Increased O O
monocyte O O
TF O O
expression O O
in O O
transplant O O
recipients O O
was O O
shown O O
to O O
be O O
adversely O O
affected O O
by O O
treatment O O
with O O
CsA O O
: O O
TF O O
induction O O
was O O
markedly O O
reduced O O
by O O
CsA O O
serum O O
concentrations O O
reaching O O
peak O O
CsA O O
drug O O
levels O O
. O O

Inhibition O O
of O O
TF O O
induction O O
in O O
the O O
presence O O
of O O
high O O
CsA O O
blood O O
concentrations O O
was O O
also O O
observed O O
when O O
stimulation O O
of O O
cells O O
was O O
performed O O
with O O
interferon-gamma O O
or O O
interleukin-1beta O O
. O O

As O O
shown O O
by O O
reverse O O
transcription-polymerase O O
chain O O
reaction O O
and O O
electrophoretic O O
mobility O O
shift O O
assay O O
, O O
respectively O O
, O O
treatment O O
with O O
CsA O O
leads O O
to O O
decreased O O
TF O O
mRNA O O
expression O O
and O O
reduced O O
activation O O
of O O
the O O
NF-kappaB O O
transcription O O
factor O O
, O O
which O O
is O O
known O O
to O O
contribute O O
to O O
the O O
induction O O
of O O
the O O
TF O O
promotor O O
in O O
human O O
monocytes O O
. O O

CONCLUSIONS O O
: O O
This O O
study O O
demonstrates O O
that O O
TF O O
activation O O
, O O
occurring O O
in O O
mononuclear O O
cells O O
of O O
cardiac O O
transplant O O
recipients O O
, O O
is O O
inhibited O O
by O O
treatment O O
with O O
CsA O O
. O O

Inhibition O O
of O O
monocyte O O
TF O O
induction O O
by O O
CsA O O
may B-SPECULATION B-SPECULATION
contribute I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
its I-SPECULATION I-SPECULATION
successful I-SPECULATION I-SPECULATION
use I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
cardiac I-SPECULATION I-SPECULATION
transplant I-SPECULATION I-SPECULATION
medicine I-SPECULATION I-SPECULATION
and O I-SPECULATION
might B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
useful I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
managing I-SPECULATION I-SPECULATION
further I-SPECULATION I-SPECULATION
settings I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
vascular I-SPECULATION I-SPECULATION
pathology I-SPECULATION I-SPECULATION
also I-SPECULATION I-SPECULATION
known I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
involve I-SPECULATION I-SPECULATION
TF I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
. O O

Agonistic O O
activity O O
of O O
a O O
CD40-specific O O
single-chain O O
Fv O O
constructed O O
from O O
the O O
variable O O
regions O O
of O O
mAb O O
G28-5 O O
. O O

A O O
single-chain O O
Fv O O
( O O
sFv O O
) O O
was O O
expressed O O
from O O
the O O
variable O O
regions O O
of O O
the O O
CD40-specific O O
mAb O O
G28-5 O O
. O O

The O O
molecule O O
bound O O
CD40 O O
with O O
a O O
high O O
affinity O O
( O O
2.2 O O
nM O O
) O O
and O O
was O O
a O O
monomer O O
in O O
solution O O
. O O

Surprisingly O O
, O O
G28-5 O O
sFv O O
was O O
a O O
potent O O
CD40 O O
agonist O O
that O O
rapidly O O
crosslinked O O
CD40 O O
on O O
the O O
cell O O
surface O O
but O O
did O O
not B-NEGATION B-NEGATION
crosslink I-NEGATION I-NEGATION
CD40-Ig I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
solution I-NEGATION I-NEGATION
. O O

G28-5 O O
sFv O O
was O O
a O O
more O O
potent O O
agonist O O
than O O
G28-5 O O
IgG O O
and O O
was O O
able O O
to O O
stimulate O O
CD40 O O
responses O O
by O O
B O O
cells O O
and O O
monocytes O O
. O O

G28-5 O O
IgG O O
partially O O
blocked O O
, O O
whereas O O
G28-5 O O
sFv O O
augmented O O
CD40 O O
responses O O
during O O
stimulation O O
with O O
natural O O
ligand O O
( O O
gp39-CD8 O O
fusion O O
protein O O
) O O
. O O

These O O
results O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
functional I-SPECULATION I-SPECULATION
activity I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
ligands I-SPECULATION I-SPECULATION
built I-SPECULATION I-SPECULATION
from I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
binding I-SPECULATION I-SPECULATION
site I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
G28-5 I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
highly I-SPECULATION I-SPECULATION
dependent I-SPECULATION I-SPECULATION
upon I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
size I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
physical I-SPECULATION I-SPECULATION
properties I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
molecule I-SPECULATION I-SPECULATION
both I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
solution I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
surfaces I-SPECULATION I-SPECULATION
. O O

Competent O O
transcription O O
initiation O O
by O O
RNA O O
polymerase O O
II O O
in O O
cell-free O O
extracts O O
from O O
xeroderma O O
pigmentosum O O
groups O O
B O O
and O O
D O O
in O O
an O O
optimized O O
RNA O O
transcription O O
assay O O
. O O

The O O
human O O
autosomal O O
recessive O O
disease O O
, O O
xeroderma O O
pigmentosum O O
( O O
XP O O
) O O
, O O
can O O
result O O
from O O
mutations O O
in O O
any O O
one O O
of O O
seven O O
genes O O
, O O
designated O O
XPA O O
through O O
XPG O O
. O O

Of O O
these O O
, O O
the O O
XPB O O
and O O
XPD O O
genes O O
encode O O
proteins O O
that O O
are O O
subunits O O
of O O
a O O
general O O
transcription O O
factor O O
, O O
TFIIH O O
, O O
involved O O
in O O
both O O
nucleotide O O
excision O O
repair O O
( O O
NER O O
) O O
and O O
initiation O O
of O O
mRNA O O
transcription O O
by O O
RNA O O
polymerase O O
II O O
. O O

In O O
humans O O
, O O
mutation O O
of O O
the O O
XPB O O
or O O
XPD O O
gene O O
impairs O O
NER O O
, O O
resulting O O
in O O
hyper-sensitivity O O
to O O
sunlight O O
and O O
greatly O O
increased O O
skin O O
tumor O O
formation O O
. O O

However O O
, O O
no B-NEGATION B-NEGATION
transcription I-NEGATION I-NEGATION
deficiency I-NEGATION I-NEGATION
has I-NEGATION I-NEGATION
been I-NEGATION I-NEGATION
demonstrated I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
either I-NEGATION I-NEGATION
XP-B I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
XP-D I-NEGATION I-NEGATION
. O O

We O O
have O O
employed O O
an O O
optimized O O
cell-free O O
RNA O O
transcription O O
assay O O
to O O
analyze O O
transcription O O
activity O O
of O O
XP-B O O
and O O
XP-D O O
. O O

Although O O
the O O
growth O O
rate O O
was O O
normal O O
, O O
the O O
XP-B O O
and O O
XP-D O O
cells O O
contained O O
reduced O O
amounts O O
of O O
TFIIH O O
. O O

Extracts O O
prepared O O
from O O
XP-B O O
and O O
XP-D O O
lymphoblastoid O O
cells O O
exhibited O O
similar O O
transcription O O
activity O O
from O O
the O O
adenovirus O O
major O O
late O O
promoter O O
when O O
compared O O
to O O
that O O
in O O
extracts O O
from O O
normal O O
cells O O
. O O

Thus O O
, O O
we O O
conclude O O
that O O
the O O
XP-B O O
and O O
XP-D O O
lymphoblastoid O O
cells O O
do O O
not B-NEGATION B-NEGATION
have I-NEGATION I-NEGATION
impaired I-NEGATION I-NEGATION
RNA I-NEGATION I-NEGATION
transcription I-NEGATION I-NEGATION
activity I-NEGATION I-NEGATION
. O O

We O O
consider O O
the O O
possible B-SPECULATION B-SPECULATION
consequences I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
reduced I-SPECULATION I-SPECULATION
cellular I-SPECULATION I-SPECULATION
content I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
TFIIH I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
clinical I-SPECULATION I-SPECULATION
symptoms I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
XP-B I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
XP-D I-SPECULATION I-SPECULATION
patients I-SPECULATION I-SPECULATION
, O O
and O O
discuss O O
a O O
' O O
conditional O O
phenotype O O
' O O
that O O
may B-SPECULATION B-SPECULATION
involve I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
impairment I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
cellular I-SPECULATION I-SPECULATION
function I-SPECULATION I-SPECULATION
only I-SPECULATION I-SPECULATION
under I-SPECULATION I-SPECULATION
certain I-SPECULATION I-SPECULATION
growth I-SPECULATION I-SPECULATION
conditions I-SPECULATION I-SPECULATION
. O O

Cyclosporin O O
A O O
inhibits O O
early O O
mRNA O O
expression O O
of O O
G0 O O
/ O O
G1 O O
switch O O
gene O O
2 O O
( O O
G0S2 O O
) O O
in O O
cultured O O
human O O
blood O O
mononuclear O O
cells O O
. O O

Cyclosporin O O
A O O
( O O
CsA O O
) O O
may B-SPECULATION B-SPECULATION
achieve I-SPECULATION I-SPECULATION
its I-SPECULATION I-SPECULATION
immunosuppressive I-SPECULATION I-SPECULATION
effects I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
inhibiting I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
calcium I-SPECULATION I-SPECULATION
- I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
calmodulin-dependent I-SPECULATION I-SPECULATION
phosphatase I-SPECULATION I-SPECULATION
calcineurin I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
required I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
target I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
members I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
NFAT I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
nuclear I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
activated I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
family I-SPECULATION I-SPECULATION
. O O

Among O O
these O O
target O O
genes O O
is O O
the O O
gene O O
encoding O O
interleukin-2 O O
( O O
IL2 O O
) O O
, O O
a O O
cytokine O O
facilitating O O
progression O O
through O O
the O O
G1 O O
phase O O
of O O
the O O
cell O O
cycle O O
. O O

However O O
, O O
IL2 O O
does O O
not B-NEGATION B-NEGATION
reverse I-NEGATION I-NEGATION
CsA I-NEGATION I-NEGATION
inhibition I-NEGATION I-NEGATION
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
at B-SPECULATION I-SPECULATION
least I-SPECULATION I-SPECULATION
one I-SPECULATION I-SPECULATION
other I-SPECULATION I-SPECULATION
NFAT-sensitive I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
may I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
involved I-SPECULATION I-SPECULATION
. O O

The O O
human O O
G0 O O
/ O O
G1 O O
switch O O
gene O O
, O O
G0S2 O O
, O O
has O O
potential B-SPECULATION O
NFAT-binding I-SPECULATION O
sites I-SPECULATION O
in I-SPECULATION O
the I-SPECULATION O
5 I-SPECULATION O
' I-SPECULATION O
flank I-SPECULATION O
and O O
encodes O O
a O O
small O O
basic O O
potential B-SPECULATION O
phosphoprotein I-SPECULATION O
of I-SPECULATION O
unknown B-SPECULATION O
function I-SPECULATION O
. O O

Using O O
a O O
sensitive O O
, O O
reverse O O
transcription-polymerase O O
chain O O
reaction O O
( O O
RT-PCR O O
) O O
assay O O
, O O
G0S2 O O
mRNA O O
levels O O
were O O
assayed O O
in O O
cultured O O
blood O O
mononuclear O O
cells O O
. O O

Freshly O O
isolated O O
cells O O
contain O O
high O O
levels O O
of O O
G0S2 O O
mRNA O O
which O O
rapidly O O
decline O O
. O O

This O O
" O O
spontaneous O O
stimulation O O
" O O
is O O
also O O
noted O O
with O O
some O O
other O O
G0S O O
genes O O
and O O
has O O
been O O
attributed O O
to O O
some O O
aspect O O
of O O
the O O
isolation O O
procedure O O
. O O

In O O
cells O O
that O O
have O O
been O O
preincubated O O
to O O
lower O O
mRNA O O
levels O O
, O O
there O O
is O O
a O O
transient O O
increase O O
in O O
G0S2 O O
mRNA O O
, O O
peaking O O
between O O
1-2 O O
h O O
, O O
in O O
response O O
to O O
Concanavalin-A O O
( O O
ConA O O
) O O
, O O
or O O
to O O
the O O
combination O O
of O O
phorbol O O
ester O O
( O O
TPA O O
) O O
, O O
and O O
the O O
calcium O O
ionophore O O
, O O
ionomycin O O
. O O

Both O O
these O O
responses O O
are O O
inhibited O O
by O O
CsA O O
. O O

Our O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
G0S2 I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
required I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
commit I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
enter I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
G1 I-SPECULATION I-SPECULATION
phase I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
cycle I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
while I-SPECULATION I-SPECULATION
not B-NEGATION I-SPECULATION
excluding I-NEGATION I-SPECULATION
other I-NEGATION I-SPECULATION
, O I-SPECULATION
early O I-SPECULATION
inhibition O I-SPECULATION
of O I-SPECULATION
G0S2 O I-SPECULATION
expression O I-SPECULATION
by O I-SPECULATION
CsA O I-SPECULATION
possible B-SPECULATION B-SPECULATION
targets I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
achieving I-SPECULATION I-SPECULATION
immunosuppression I-SPECULATION I-SPECULATION
. O O

G0S2 O O
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
value I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
reporter I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
analyzing I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
action I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
CsA I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
its I-SPECULATION I-SPECULATION
influence I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
positive I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
negative I-SPECULATION I-SPECULATION
selection I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
lymphocytes I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
response I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
self I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
not-self I-SPECULATION I-SPECULATION
antigens I-SPECULATION I-SPECULATION
. O O

Estrogen O O
receptor O O
diminishes O O
DNA-binding O O
activities O O
of O O
chicken O O
GATA-1 O O
and O O
CACCC-binding O O
proteins O O
. O O

The O O
estrogen O O
receptor O O
( O O
ER O O
) O O
repressed O O
erythroid O O
differentiation O O
and O O
erythroid-specific O O
gene O O
expression O O
. O O

In O O
this O O
study O O
, O O
we O O
investigated O O
the O O
effect O O
of O O
ER O O
alpha O O
( O O
referred O O
to O O
throughout O O
as O O
ER O O
) O O
on O O
DNA-binding O O
activities O O
of O O
transcription O O
factors O O
involved O O
in O O
regulating O O
the O O
expression O O
of O O
erythroid-specific O O
genes O O
, O O
and O O
, O O
in O O
particular O O
, O O
the O O
histone O O
H5 O O
gene O O
. O O

Using O O
electrophoretic O O
mobility O O
shift O O
assays O O
, O O
we O O
found O O
that O O
in O O
the O O
presence O O
of O O
rabbit O O
reticulocyte O O
lysate O O
, O O
human O O
ER O O
reduced O O
the O O
binding O O
activities O O
of O O
chicken O O
immature O O
erythrocyte O O
nuclear O O
extracted O O
proteins O O
to O O
GATA O O
and O O
CACCC O O
sites O O
in O O
the O O
H5 O O
promoter O O
and O O
enhancer O O
. O O

In O O
contrast O O
, O O
the B-NEGATION B-NEGATION
binding I-NEGATION I-NEGATION
activities I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
NF1 I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
Sp1 I-NEGATION I-NEGATION
were I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
affected I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
ER I-NEGATION I-NEGATION
. O O

Binding O O
of O O
ER O O
to O O
an O O
estrogen O O
response O O
element O O
was O O
enhanced O O
by O O
addition O O
of O O
rabbit O O
reticulocyte O O
lysate O O
. O O

This O O
lysate O O
was O O
also O O
necessary O O
for O O
ER O O
to O O
diminish O O
the O O
DNA-binding O O
activity O O
of O O
GATA-1 O O
. O O

These O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
additional I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
s I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
necessary I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
full I-SPECULATION I-SPECULATION
ER I-SPECULATION I-SPECULATION
function I-SPECULATION I-SPECULATION
. O O

Both O O
GATA-1 O O
and O O
CACCC-binding O O
proteins O O
are O O
critical O O
for O O
the O O
developmentally O O
regulated O O
expression O O
of O O
erythroid-specific O O
genes O O
. O O

We O O
hypothesize B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
interference I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
DNA-binding I-SPECULATION I-SPECULATION
activities I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
GATA-1 I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
CACCC-binding I-SPECULATION I-SPECULATION
proteins I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
ER I-SPECULATION I-SPECULATION
inhibits I-SPECULATION I-SPECULATION
regulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
. O O

Constitutive O O
expression O O
c-fos O O
, O O
c-jun O O
, O O
and O O
NF O O
kappa O O
B O O
mRNA O O
is O O
in O O
nucleated O O
fetal O O
blood O O
cells O O
and O O
up-regulation O O
of O O
c-fos O O
and O O
c-jun O O
with O O
anti-CD3 O O
stimulation O O
. O O

Fetal O O
and O O
neonatal O O
lymphocytes O O
are O O
relatively O O
resistant O O
to O O
activation O O
and O O
cytokine O O
production O O
when O O
stimulated O O
either O O
via O O
their O O
T-cell O O
antigen O O
receptors O O
or O O
lectins O O
. O O

The B-SPECULATION B-NEGATION
molecular I-SPECULATION I-NEGATION
mechanism I-SPECULATION I-NEGATION
( I-SPECULATION I-NEGATION
s I-SPECULATION I-NEGATION
) I-SPECULATION I-NEGATION
responsible I-SPECULATION I-NEGATION
for I-SPECULATION I-NEGATION
this I-SPECULATION I-NEGATION
phenomenon I-SPECULATION I-NEGATION
have I-SPECULATION I-NEGATION
not I-SPECULATION I-NEGATION
been I-SPECULATION I-NEGATION
clearly I-SPECULATION I-NEGATION
elucidated I-SPECULATION I-NEGATION
. O O

We O O
have O O
hypothesized B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
such I-SPECULATION I-SPECULATION
defects I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
fetal I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
neonatal I-SPECULATION I-SPECULATION
T-cell I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
due I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
lack B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
expression I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
transcriptional I-NEGATION I-NEGATION
regulatory I-NEGATION I-NEGATION
elements I-NEGATION I-NEGATION
required I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
T-cell I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
. O O

We O O
used O O
reverse O O
transcriptase-polymerase O O
chain O O
reaction O O
to O O
examine O O
both O O
fetal O O
and O O
term O O
neonatal O O
cord O O
bloods O O
for O O
mRNA O O
expression O O
of O O
three O O
transcription O O
factors O O
implicated O O
in O O
T-cell O O
activation O O
: O O
c-jun O O
, O O
c-fos O O
, O O
and O O
NF O O
kappa O O
B O O
( O O
p50 O O
subunit O O
) O O
. O O

We O O
demonstrate O O
that O O
mRNAs O O
for O O
all O O
three O O
of O O
these O O
regulatory O O
factors O O
are O O
expressed O O
in O O
fetal O O
blood O O
cells O O
by O O
the O O
27th O O
week O O
of O O
gestation O O
and O O
in O O
term O O
cord O O
bloods O O
. O O

Activation O O
of O O
term O O
infant O O
cord O O
blood O O
mononuclear O O
cells O O
with O O
anti-CD3 O O
monoclonal O O
antibodies O O
resulted O O
in O O
up-regulation O O
of O O
both O O
c-jun O O
and O O
c-fos O O
mRNAs O O
within O O
15 O O
min O O
of O O
stimulation O O
. O O

However O O
, O O
secretion O O
of O O
IL-2 O O
by O O
anti-CD3-stimulated O O
cord O O
blood O O
mononuclear O O
cells O O
was O O
still O O
blunted O O
compared O O
with O O
control O O
cells O O
from O O
adults O O
. O O

We O O
conclude O O
that O O
fetal O O
nucleated O O
blood O O
cells O O
constitutively O O
express O O
important O O
genes O O
for O O
cytokine O O
regulation O O
and O O
are O O
able O O
to O O
increase O O
intracellular O O
accumulation O O
of O O
the O O
mRNAs O O
for O O
these O O
factors O O
in O O
response O O
to O O
anti-CD3 O O
stimulation O O
. O O

Thus O O
, O O
qualitative B-NEGATION B-NEGATION
differences I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
capacity I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
regulate I-NEGATION I-NEGATION
these I-NEGATION I-NEGATION
factors I-NEGATION I-NEGATION
could I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
be I-NEGATION I-NEGATION
shown I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
fetal I-NEGATION I-NEGATION
blood I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
. O O

Quantitative O O
experiments O O
comparing O O
binding O O
of O O
these O O
transcription O O
factors O O
to O O
the O O
IL-2 O O
promoter O O
are O O
currently O O
under O O
investigation O O
. O O

Replication O O
of O O
human O O
immunodeficiency O O
virus-1 O O
in O O
primary O O
human O O
T O O
cells O O
is O O
dependent O O
on O O
the O O
autocrine O O
secretion O O
of O O
tumor O O
necrosis O O
factor O O
through O O
the O O
control O O
of O O
nuclear O O
factor-kappa O O
B O O
activation O O
. O O

Tumor O O
necrosis O O
factor O O
( O O
TNF O O
)- O O
alpha O O
controls O O
T-cell O O
activation O O
and O O
is O O
a O O
major O O
inducer O O
of O O
human O O
immunodeficiency O O
virus O O
( O O
HIV O O
)- O O
1 O O
replication O O
in O O
chronically O O
infected O O
cells O O
. O O

Therefore O O
, O O
we O O
have O O
investigated O O
its O O
role O O
in O O
primary O O
cultures O O
of O O
HIV-infected O O
human O O
T O O
lymphocytes O O
by O O
using O O
neutralizing O O
anti-TNF-alpha O O
antibodies O O
or O O
TNF-alpha O O
. O O

Primary O O
resting O O
T O O
lymphocytes O O
produced O O
TNF-alpha O O
and O O
supported O O
HIV O O
replication O O
after O O
T-cell O O
receptor O O
activation O O
. O O

Addition O O
of O O
neutralizing O O
anti-TNF-alpha O O
antibodies O O
drastically O O
reduced O O
p24 O O
antigen O O
release O O
and O O
prevented O O
CD4 O O
+ O O
cell O O
depletion O O
associated O O
with O O
infection O O
. O O

Anti-TNF-alpha O O
also O O
prevented O O
nuclear O O
factor-kappa O O
B O O
( O O
NF-kappa O O
B O O
) O O
activation O O
, O O
and O O
a O O
good O O
correlation O O
between O O
this O O
inhibition O O
and O O
inhibition O O
of O O
HIV O O
replication O O
was O O
observed O O
. O O

Moreover O O
, O O
supplementing O O
the O O
cultures O O
with O O
high O O
doses O O
of O O
IL-2 O O
reverted O O
anti-TNF-alpha O O
inhibition O O
of O O
cell O O
proliferation O O
but O O
did O O
not B-NEGATION B-NEGATION
affect I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
inhibition I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
HIV I-NEGATION I-NEGATION
p24 I-NEGATION I-NEGATION
antigen I-NEGATION I-NEGATION
release I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
NF-kappa I-NEGATION I-NEGATION
B I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
same I-NEGATION I-NEGATION
cultures I-NEGATION I-NEGATION
. O O

Moreover O O
, O O
anti-TNF-alpha O O
inhibited O O
HIV-1 O O
long O O
terminal O O
repeat O O
( O O
LTR O O
)- O O
driven O O
transcription O O
of O O
a O O
reporter O O
gene O O
in O O
primary O O
T O O
cells O O
in O O
response O O
to O O
activation O O
, O O
either O O
in O O
the O O
presence O O
or O O
the O O
absence B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
HIV-1 I-NEGATION I-NEGATION
Tat I-NEGATION I-NEGATION
. O O

Our O O
results O O
support O O
an O O
important O O
role O O
for O O
autocrine O O
TNF-alpha O O
secretion O O
in O O
controlling O O
HIV O O
replication O O
in O O
primary O O
T O O
cells O O
because O O
of O O
its O O
ability O O
to O O
maintain O O
NF-kappa O O
B O O
elevated O O
in O O
the O O
nucleus O O
of O O
T O O
cells O O
. O O

A O O
thiol O O
antioxidant O O
regulates O O
IgE O O
isotype O O
switching O O
by O O
inhibiting O O
activation O O
of O O
nuclear O O
factor-kappaB O O
. O O

The O O
binding O O
site O O
for O O
nuclear O O
factor-kappaB O O
( O O
NF-kappaB O O
) O O
is O O
present O O
at O O
the O O
promoter O O
region O O
of O O
the O O
germline O O
Cepsilon O O
gene O O
, O O
but O O
there O O
is O O
little O O
information O O
on O O
whether B-SPECULATION B-SPECULATION
this I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
involved I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
regulating I-SPECULATION I-SPECULATION
IgE I-SPECULATION I-SPECULATION
synthesis I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

Accordingly O O
, O O
we O O
studied O O
the O O
role O O
of O O
NF-kappaB O O
in O O
germline O O
Cepsilon O O
transcription O O
by O O
using O O
two O O
human O O
Burkitt's O O
lymphoma O O
B O O
cell O O
lines O O
, O O
DND39 O O
and O O
DG75 O O
. O O

In O O
both O O
cell O O
lines O O
, O O
n-acetyl-L-cysteine O O
( O O
NAC O O
) O O
, O O
a O O
potent O O
thiol O O
antioxidant O O
, O O
inhibited O O
the O O
triggering O O
of O O
the O O
nuclear O O
expression O O
of O O
NF-kappaB O O
by O O
IL-4 O O
and O O
by O O
anti-CD40 O O
monoclonal O O
antibody O O
. O O

Although O O
IL-4 O O
activated O O
signal O O
transducers O O
and O O
activators O O
of O O
transcription O O
( O O
STAT O O
) O O
6 O O
in O O
addition O O
to O O
NF-kappaB O O
, O O
NAC O O
treatment O O
or O O
the O O
transfection O O
of O O
decoy O O
oligodeoxynucleotides O O
for O O
NF-kappaB O O
or O O
STAT6 O O
only O O
partly O O
blocked O O
IL-4-induced O O
germline O O
Cepsilon O O
transcription O O
. O O

However O O
, O O
these O O
two O O
decoy O O
oligodeoxynucleotides O O
together O O
almost O O
completely O O
abrogated O O
IL-4-induced O O
germline O O
Cepsilon O O
transcription O O
. O O

Of O O
note O O
, O O
CD40-mediated O O
enhancement O O
of O O
IL-4-driven O O
germline O O
Cepsilon O O
transcription O O
was O O
markedly O O
decreased O O
by B-SPECULATION O
NAC I-SPECULATION O
or I-SPECULATION O
by I-SPECULATION O
a I-SPECULATION O
decoy I-SPECULATION O
oligodeoxynucleotide I-SPECULATION O
for I-SPECULATION O
NF-kappaB I-SPECULATION O
. O O

The O O
effect O O
of O O
NAC O O
was O O
also O O
examined O O
on O O
deletional O O
switch O O
recombination O O
underlying O O
the O O
isotype O O
switch O O
to O O
IgE O O
. O O

NAC O O
inhibited O O
the O O
generation O O
of O O
Smu O O
/ O O
Sepsilon O O
switch O O
fragments O O
in O O
normal O O
human O O
B O O
cells O O
costimulated O O
with O O
IL-4 O O
and O O
anti-CD40 O O
monoclonal O O
antibody O O
. O O

It O O
also O O
abolished O O
IL-4-induced O O
upregulation O O
of O O
CD40 O O
but O O
promoted O O
upregulation O O
of O O
CD23 O O
. O O

These O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
coordination B-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
STAT6 I-SPECULATION I-SPECULATION
may I-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
required I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
induction I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
germline I-SPECULATION I-SPECULATION
Cepsilon I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
IL-4 I-SPECULATION I-SPECULATION
, O O
and O O
that O O
CD40-mediated O O
NF-kappaB O O
activation O O
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
regulating I-SPECULATION I-SPECULATION
both I-SPECULATION I-SPECULATION
enhancement I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
germline I-SPECULATION I-SPECULATION
Cepsilon I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
class I-SPECULATION I-SPECULATION
switching I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
IgE I-SPECULATION I-SPECULATION
. O O

Cellular O O
and O O
molecular O O
mechanisms O O
of O O
IL-5 O O
synthesis O O
in O O
atopic O O
diseases O O
: O O
a O O
study O O
with O O
allergen-specific O O
human O O
helper O O
T O O
cells O O
. O O

BACKGROUND O O
: O O
Cytokines O O
produced O O
by O O
helper O O
T O O
cells O O
are O O
intimately O O
involved O O
in O O
chronic O O
allergic O O
diseases O O
associated O O
with O O
eosinophilic O O
inflammation O O
. O O

OBJECTIVE O O
: O O
We O O
investigated O O
the O O
production O O
of O O
IL-5 O O
, O O
a O O
potent O O
growth O O
factor O O
and O O
chemotactic O O
factor O O
for O O
eosinophils O O
, O O
by O O
CD4 O O
+ O O
T O O
lymphocytes O O
in O O
patients O O
with O O
asthma O O
. O O

METHODS O O
: O O
Allergen-specific O O
T O O
cell O O
clones O O
and O O
T O O
cell O O
hybridomas O O
were O O
established O O
from O O
the O O
peripheral O O
blood O O
lymphocytes O O
of O O
patients O O
with O O
asthma O O
, O O
and O O
the O O
responses O O
to O O
various O O
stimuli O O
were O O
determined O O
. O O

RESULTS O O
: O O
After O O
nonspecific O O
stimulation O O
, O O
IL-5 O O
production O O
by O O
CD4 O O
+ O O
T O O
cells O O
from O O
both O O
atopic O O
and O O
nonatopic O O
subjects O O
with O O
asthma O O
was O O
significantly O O
enhanced O O
compared O O
with O O
that O O
by O O
cells O O
from O O
healthy O O
controls O O
. O O

Peripheral O O
blood O O
mononuclear O O
cells O O
from O O
atopic O O
asthma O O
patients O O
both O O
proliferated O O
and O O
produced O O
IL-5 O O
after O O
incubation O O
with O O
mite O O
allergen O O
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
mite-specific I-SPECULATION I-SPECULATION
helper I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
were I-SPECULATION I-SPECULATION
involved I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
eosinophilic I-SPECULATION I-SPECULATION
inflammation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
atopic I-SPECULATION I-SPECULATION
asthma I-SPECULATION I-SPECULATION
. O O

A O O
human O O
IL-5 O O
promoter O O
/ O O
enhancer O O
luciferase O O
gene O O
construct O O
transfected O O
into O O
IL-5-producing O O
T O O
cell O O
clones O O
was O O
clearly O O
transcribed O O
after O O
stimulation O O
, O O
indicating B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
515 I-SPECULATION I-SPECULATION
base I-SPECULATION I-SPECULATION
pair I-SPECULATION I-SPECULATION
IL-5 I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
segment I-SPECULATION I-SPECULATION
upstream I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
coding I-SPECULATION I-SPECULATION
region I-SPECULATION I-SPECULATION
was I-SPECULATION I-SPECULATION
sufficient I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
respond I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
activating I-SPECULATION I-SPECULATION
signals I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
helper I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

The B-NEGATION B-NEGATION
same I-NEGATION I-NEGATION
gene I-NEGATION I-NEGATION
segment I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
transcribed I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
IL-5-nonproducing I-NEGATION I-NEGATION
T I-NEGATION I-NEGATION
cell I-NEGATION I-NEGATION
clones I-NEGATION I-NEGATION
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
IL-5 I-SPECULATION I-SPECULATION
synthesis I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
regulated I-SPECULATION I-SPECULATION
at I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
transcriptional I-SPECULATION I-SPECULATION
level I-SPECULATION I-SPECULATION
. O O

Experiments O O
with O O
T O O
cell O O
hybridomas O O
confirmed O O
these O O
findings O O
and O O
suggested B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
unique I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
essential I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
IL-5 I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
. O O

CONCLUSION O O
: O O
Enhanced B-SPECULATION B-SPECULATION
IL-5 I-SPECULATION I-SPECULATION
production I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
helper I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
seems I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
cause I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
eosinophilic I-SPECULATION I-SPECULATION
inflammation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
both I-SPECULATION I-SPECULATION
atopic I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
nonatopic I-SPECULATION I-SPECULATION
asthma I-SPECULATION I-SPECULATION
. O O

Elucidation O O
of O O
IL-5-specific O O
regulatory O O
mechanisms O O
may B-SPECULATION B-SPECULATION
facilitate I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
development I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
novel I-SPECULATION I-SPECULATION
treatments I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
allergic I-SPECULATION I-SPECULATION
diseases I-SPECULATION I-SPECULATION
associated I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
eosinophilic I-SPECULATION I-SPECULATION
inflammation I-SPECULATION I-SPECULATION
. O O

Regulation O O
of O O
NF-kappa O O
B O O
activity O O
by O O
I O O
kappa O O
B O O
alpha O O
and O O
I O O
kappa O O
B O O
beta O O
stability O O
. O O

Transcription O O
factor O O
NF-kappa O O
B O O
must O O
be O O
released O O
from O O
cytoplasmic O O
inhibitory O O
molecules O O
( O O
I O O
kappa O O
Bs O O
) O O
in O O
order O O
to O O
move O O
to O O
the O O
nucleus O O
and O O
to O O
activate O O
its O O
target O O
genes O O
. O O

Little O O
is O O
known O O
about O O
the O O
mechanisms O O
regulating O O
the O O
maintenance O O
of O O
constitutive O O
nuclear O O
NF-kappa O O
B O O
in O O
some O O
cell-types O O
and O O
of O O
sustained O O
nuclear O O
NF-kappa O O
B O O
activity O O
after O O
stimulation O O
. O O

Increased O O
turnover O O
has O O
been O O
implicated O O
in O O
the O O
regulation O O
of O O
constitutive O O
NF-kappa O O
B O O
activity O O
in O O
mature O O
B O O
cells O O
. O O

We O O
therefore O O
compared O O
the O O
turnover O O
of O O
I O O
kappa O O
B O O
alpha O O
and O O
I O O
kappa O O
B O O
beta O O
in O O
mature O O
B O O
cells O O
and O O
HeLa O O
cells O O
. O O

Both O O
proteins O O
display O O
a O O
high O O
turnover O O
in O O
B O O
cells O O
although O O
I O O
kappa O O
B O O
beta O O
is O O
considerably O O
more O O
stable O O
than O O
I O O
kappa O O
B O O
alpha O O
. O O

The O O
half-life O O
of O O
both O O
inhibitors O O
is O O
increased O O
in O O
HeLa O O
cells O O
. O O

In O O
contrast O O
, O O
all O O
other O O
NF-kappa O O
B O O
/ O O
I O O
kappa O O
B O O
molecules O O
tested O O
are O O
relatively O O
stable O O
in O O
both O O
cell-types O O
. O O

The O O
elevated O O
turnover O O
of O O
endogenous O O
I O O
kappa O O
B O O
alpha O O
in O O
Namalwa O O
cells O O
is O O
inhibited O O
by O O
a O O
proteasome O O
inhibitor O O
and O O
thus O B-SPECULATION
seems B-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
driven I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
same I-SPECULATION I-SPECULATION
degradation I-SPECULATION I-SPECULATION
machinery I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
slower I-SPECULATION I-SPECULATION
turnover I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
non-B I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

Furthermore O O
, O O
we O O
investigated O O
the O O
processes O O
involved O O
in O O
persistent O O
activation O O
of O O
NF-kappa O O
B O O
. O O

TNF-alpha O O
signaling O O
leads O O
to O O
a O O
rapid O O
depletion O O
of O O
cellular O O
I O O
kappa O O
B O O
beta O O
pools O O
. O O

I O O
kappa O O
B O O
alpha O O
is O O
efficiently O O
resynthesized O O
whereas O O
I O O
kappa O O
B O O
beta O O
levels O O
stay O O
low O O
for O O
a O O
prolonged O O
time O O
. O O

NF-kappa O O
B O O
binding O O
activity O O
can O O
be O O
detected O O
for O O
several O O
hours O O
after O O
stimulation O O
. O O

We O O
found O O
that O O
removal O O
of O O
the O O
TNF-alpha O O
containing O O
medium O O
causes O O
a O O
rapid O O
decrease O O
in O O
nuclear O O
NF-kappa O O
B O O
. O O

A O O
phosphoform O O
of O O
newly O O
synthesized O O
I O O
kappa O O
B O O
alpha O O
is O O
visible O O
when O O
degradation O O
by O O
the O O
proteasome O O
is O O
inhibited O O
and O O
new O O
I O O
kappa O O
B O O
alpha O O
displays O O
the O O
same O O
properties O O
regarding O O
phosphorylation O O
and O O
degradation O O
in O O
response O O
to O O
a O O
second O O
inducer O O
. O O

There O O
is O O
no B-NEGATION B-NEGATION
significant I-NEGATION I-NEGATION
difference I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
turnover I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
pre I-NEGATION I-NEGATION
- I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
post-inductive I-NEGATION I-NEGATION
I I-NEGATION I-NEGATION
kappa I-NEGATION I-NEGATION
B I-NEGATION I-NEGATION
alpha I-NEGATION I-NEGATION
. O O

These O O
observations O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
resynthesis I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
I I-SPECULATION I-SPECULATION
kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
alpha I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
removal I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
stimulus I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
obligatory I-SPECULATION I-SPECULATION
steps I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
inactivation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
nuclear I-SPECULATION I-SPECULATION
NF I-SPECULATION I-SPECULATION
kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
. O O

Control O O
of O O
NF-kappa O O
B O O
activity O O
by O O
the O O
I O O
kappa O O
B O O
beta O O
inhibitor O O
. O O

The O O
transcription O O
factor O O
NF-kappa O O
B O O
is O O
maintained O O
in O O
an O O
inactive O O
cytoplasmic O O
state O O
by O O
I O O
kappa O O
B O O
inhibitors O O
. O O

In O O
mammalian O O
cells O O
, O O
I O O
kappa O O
B O O
alpha O O
and O O
I O O
kappa O O
B O O
beta O O
proteins O O
have O O
been O O
purified O O
and O O
shown O O
to O O
be O O
the O O
inhibitors O O
of O O
NF-kappa O O
B O O
through O O
their O O
association O O
with O O
the O O
p65 O O
or O O
c-Rel O O
subunits O O
. O O

In O O
addition O O
, O O
we O O
have O O
isolated O O
a O O
third O O
NF-kappa O O
B O O
inhibitor O O
, O O
I O O
kappa O O
B O O
epsilon O O
( O O
1 O O
) O O
. O O

Upon O O
treatment O O
with O O
a O O
large O O
variety O O
of O O
inducers O O
, O O
I O O
kappa O O
B O O
alpha O O
, O O
I O O
kappa O O
B O O
beta O O
are O O
proteolytically O O
degraded O O
, O O
resulting O O
in O O
NF-kappa O O
B O O
translocation O O
into O O
the O O
nucleus O O
. O O

Here O O
we O O
show O O
that O O
in O O
E29.1 O O
T O O
cell O O
hybridoma O O
I O O
kappa O O
B O O
alpha O O
and O O
I O O
kappa O O
B O O
beta O O
are O O
equally O O
associated O O
with O O
p65 O O
and O O
that O O
I O O
kappa O O
B O O
beta O O
is O O
degraded O O
in O O
response O O
to O O
TNF O O
alpha O O
in O O
contrast O O
to O O
what O O
has O O
been O O
originally O O
published O O
. O O

Our O O
data O O
also O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
unlike I-SPECULATION I-SPECULATION
I I-SPECULATION I-SPECULATION
kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
alpha I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
I I-SPECULATION I-SPECULATION
kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
beta I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
constitutively I-SPECULATION I-SPECULATION
phosphorylated I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
resynthesized I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
hypophosphorylated I-SPECULATION I-SPECULATION
form I-SPECULATION I-SPECULATION
. O O

The O O
absence B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
slow I-NEGATION I-NEGATION
migrating I-NEGATION I-NEGATION
forms I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
I I-NEGATION I-NEGATION
kappa I-NEGATION I-NEGATION
B I-NEGATION I-NEGATION
beta I-NEGATION I-NEGATION
following I-NEGATION I-NEGATION
stimulation I-NEGATION I-NEGATION
suggests B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
phosphorylation I-SPECULATION I-SPECULATION
does I-SPECULATION I-SPECULATION
not I-SPECULATION B-NEGATION
necessarily I-SPECULATION I-NEGATION
constitute I-SPECULATION I-NEGATION
the I-SPECULATION I-NEGATION
signal-induced I-SPECULATION I-NEGATION
event I-SPECULATION I-NEGATION
which I-SPECULATION I-NEGATION
targets I-SPECULATION I-NEGATION
the I-SPECULATION I-NEGATION
molecule I-SPECULATION I-NEGATION
for I-SPECULATION I-NEGATION
proteolysis I-SPECULATION I-NEGATION
. O O

NF-kappa O O
B O O
/ O O
Rel O O
family O O
members O O
regulating O O
the O O
ICAM-1 O O
promoter O O
in O O
monocytic O O
THP-1 O O
cells O O
. O O

A O O
kappa O O
B-site O O
was O O
identified O O
in O O
the O O
promoter O O
of O O
the O O
intercellular O O
adhesion O O
molecule-1 O O
( O O
ICAM-1 O O
) O O
gene O O
, O O
which O O
is O O
involved O O
in O O
regulation O O
of O O
ICAM-1 O O
expression O O
by O O
tumor O O
necrosis O O
factor O O
alpha O O
( O O
TNF-alpha O O
) O O
and O O
glucocorticoids O O
. O O

We O O
now O O
report O O
on O O
the O O
transcription O O
factors O O
which O O
bind O O
and O O
transactivate O O
this O O
enhancer O O
sequence O O
. O O

In O O
vitro O O
, O O
the B-SPECULATION B-SPECULATION
ICAM-1 I-SPECULATION I-SPECULATION
kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
site I-SPECULATION I-SPECULATION
appeared I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
bind I-SPECULATION I-SPECULATION
RelA I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
c-Rel I-SPECULATION I-SPECULATION
homodimers I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
well I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
heterodimers I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B1 I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
but I-SPECULATION I-SPECULATION
weakly I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B1 I-SPECULATION I-SPECULATION
homodimers I-SPECULATION I-SPECULATION
. O O

In O O
addition O O
, O O
both O O
RelA O O
and O O
c-Rel O O
, O O
but O O
not B-NEGATION B-NEGATION
NF-kappa I-NEGATION I-NEGATION
B1 I-NEGATION I-NEGATION
, O O
were O O
shown O O
to O O
transactivate O O
an O O
ICAM-1 O O
kappa O O
B-reporter O O
construct O O
. O O

In O O
monocytic O O
THP-1 O O
cells O O
TNF-alpha O O
induced O O
two O O
nuclear O O
complexes O O
which O O
in O O
vitro O O
bound O O
to O O
the O O
ICAM-1 O O
kappa O O
B O O
site O O
. O O

Using O O
antibodies O O
in O O
an O O
electrophoretic O O
mobility O O
supershift O O
assay O O
, O O
one O O
of O O
these O O
complexes O O
was O O
shown O O
to O O
contain O O
NF-kappa O O
B1 O O
and O O
RelA O O
, O O
and O O
to O O
bind O O
with O O
higher O O
affinity O O
to O O
the O O
consensus O O
kappa O O
B O O
site O O
in O O
the O O
HIV O O
long O O
terminal O O
repeat O O
. O O

The O O
second O O
complex O O
contained O O
RelA O O
, O O
and O O
exhibited O O
higher O O
affinity O O
towards O O
the O O
ICAM-1 O O
kappa O O
B O O
than O O
to O O
the O O
HIV O O
kappa O O
B O O
site O O
. O O

The O O
glucocorticoid O O
receptor O O
was O O
shown O O
to O O
repress O O
activity O O
of O O
both O O
the O O
RelA O O
homodimer O O
and O O
the O O
NF-kappa O O
B1 O O
/ O O
RelA O O
heterodimer O O
. O O

We O O
argue O B-SPECULATION
that O I-SPECULATION
in O I-SPECULATION
vivo O I-SPECULATION
RelA B-SPECULATION I-SPECULATION
homodimers I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
likely I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
play I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
dominant I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
TNF-alpha-induced I-SPECULATION I-SPECULATION
ICAM-1 I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
monocytic I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

LPS O O
tolerance O O
in O O
monocytes O O
/ O O
macrophages O O
: O O
three O O
3 O O
' O O
cytosins O O
are O O
required O O
in O O
the O O
DNA O O
binding O O
motif O O
for O O
detection O O
of O O
upregulated O O
NF-kappa O O
B O O
p50 O O
homodimers O O
. O O

When O O
monocytes O O
are O O
stimulated O O
with O O
LPS O O
( O O
lipopolysaccharide O O
) O O
repeatedly O O
then O O
the O O
initially O O
high O O
expression O O
of O O
the O O
TNF O O
( O O
tumor O O
necrosis O O
factor O O
) O O
gene O O
is O O
only O O
very O O
low O O
, O O
i.e. O O
the O O
cells O O
are O O
tolerant O O
to O O
LPS O O
. O O

Tolerant O O
cells O O
still O O
express O O
the O O
CD14 O O
receptor O O
and O O
they O O
can O O
still O O
be O O
activated O O
to O O
mobilize O O
NF-kappa O O
B O O
into O O
nucleus O O
. O O

Analysis O O
of O O
the O O
binding O O
proteins O O
employing O O
the O O
- O O
605 O O
motif O O
of O O
the O O
human O O
TNF O O
promoter O O
( O O
GGGGCTGTCCC O O
) O O
revealed O O
that O O
in O O
tolerant O O
cells O O
of O O
the O O
human O O
monocytic O O
cell O O
line O O
Mono O O
Mac O O
6 O O
there O O
is O O
a O O
predominance O O
of O O
p50p50 O O
of O O
NF-kappa O O
B O O
. O O

We O O
now O O
show O O
that O O
a O O
mutant O O
motif O O
that O O
exchanges O O
the O O
terminal O O
3 O O
' O O
C O O
for O O
a O O
G O O
fails B-NEGATION O
to I-NEGATION O
bind I-NEGATION O
the I-NEGATION O
p50 I-NEGATION O
homodimer I-NEGATION O
that I-NEGATION O
is I-NEGATION O
upregulated I-NEGATION O
in I-NEGATION O
LPS I-NEGATION O
toler I-NEGATION O
ant I-NEGATION O
human I-NEGATION O
Mono I-NEGATION O
Mac I-NEGATION O
6 I-NEGATION O
cells I-NEGATION O
. O O

The O O
same O O
is O O
true O O
for O O
nuclear O O
extracts O O
taken O O
from O O
the O O
murine O O
P388D1 O O
macrophage O O
cell O O
line O O
when O O
tested O O
with O O
the O O
- O O
516 O O
motif O O
of O O
the O O
murine O O
TNF O O
promoter O O
( O O
GGGGGCTTTCCC O O
) O O
. O O

Here O O
the O O
wild O O
type O O
motif O O
gives O O
efficient O O
binding O O
of O O
p50p50 O O
that O O
again O O
is O O
upregulated O O
in O O
tolerant O O
cells O O
whereas O O
a O O
mutant O O
with O O
a O O
3 O O
' O O
G O O
shows O O
hardly O O
any O O
binding O O
of O O
p50p50 O O
. O O

Conversely O O
, O O
the O O
murine O O
kappa O O
light O O
chain O O
enhancer O O
motif O O
( O O
GGGGACTTTCCG O O
) O O
does O O
not B-NEGATION B-NEGATION
efficiently I-NEGATION I-NEGATION
bind I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
nuclear I-NEGATION I-NEGATION
p50p50 I-NEGATION I-NEGATION
from I-NEGATION I-NEGATION
tolerant I-NEGATION I-NEGATION
murine I-NEGATION I-NEGATION
P388 I-NEGATION I-NEGATION
macrophages I-NEGATION I-NEGATION
. O O

Binding O O
is O O
, O O
however O O
, O O
readily O O
detected O O
when O O
the O O
3 O O
' O O
G O O
is O O
replaced O O
by O O
a O O
C O O
. O O

These O O
data O O
show O O
that O O
the O O
detection O O
of O O
upregulated O O
p50 O O
homodimers O O
in O O
LPS O O
tolerant O O
cells O O
is O O
dependent O O
on O O
subtle O O
differences O O
in O O
the O O
sequence O O
of O O
the O O
DNA O O
binding O O
motif O O
. O O

Temporal O O
control O O
of O O
IgH O O
gene O O
expression O O
in O O
developing O O
B O O
cells O O
by O O
the O O
3 O O
' O O
locus O O
control O O
region O O
. O O

The O O
suggested B-SPECULATION O
roles I-SPECULATION O
of I-SPECULATION O
the I-SPECULATION O
downstream I-SPECULATION O
3 I-SPECULATION O
' I-SPECULATION O
regions I-SPECULATION O
acting I-SPECULATION O
as I-SPECULATION O
a I-SPECULATION O
Locus I-SPECULATION O
Control I-SPECULATION O
Region I-SPECULATION O
( I-SPECULATION O
LCR I-SPECULATION O
) I-SPECULATION O
, O O
have O O
allowed O O
comparisons O O
to O O
be O O
made O O
between O O
the O O
regulation O O
of O O
the O O
IgH O O
locus O O
with O O
other O O
model O O
systems O O
whose O O
gene O O
expression O O
is O O
governed O O
by O O
LCR O O
activity O O
. O O

Here O O
we O O
summarize O O
the O O
importance O O
of O O
the O O
IgH O O
3'LCR O O
and O O
its O O
putative B-SPECULATION B-SPECULATION
functional I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
IgH I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
and O O
compare O O
it O O
with O O
the O O
5'LCR O O
regulatory O O
region O O
of O O
the O O
human O O
beta-globin O O
locus O O
. O O

Expression O O
of O O
transcription O O
factor O O
genes O O
after O O
influenza O O
A O O
virus O O
infection O O
. O O

Infection O O
of O O
human O O
monocytes O O
with O O
influenza O O
A O O
virus O O
induces O O
a O O
broad O O
range O O
of O O
proinflammatory O O
cytokines O O
and O O
mononuclear O O
cell O O
attracting O O
chemokines O O
before O O
the O O
infected O O
cells O O
undergo O O
apoptosis O O
. O O

The O O
underlying O O
mechanisms O O
by O O
which O O
the O O
corresponding O O
genes O O
are O O
transcriptionally O O
initiated O O
after O O
virus O O
infection O O
are O O
still O O
poorly O O
understood O O
. O O

Activation B-SPECULATION B-SPECULATION
of I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
seems I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
play I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
regulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
many I-SPECULATION I-SPECULATION
proinflammatory I-SPECULATION I-SPECULATION
cytokine I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
, O O
but O O
cannot B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
only I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
, O O
since O O
several O O
cytokine O O
genes O O
lack B-NEGATION B-NEGATION
respective I-NEGATION I-NEGATION
binding I-NEGATION I-NEGATION
sites I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
their I-NEGATION I-NEGATION
promoter I-NEGATION I-NEGATION
regions I-NEGATION I-NEGATION
. O O

Therefore O O
, O O
we O O
additionally O O
investigated O O
other O O
transcription O O
factors O O
of O O
possible B-SPECULATION B-SPECULATION
importance I-SPECULATION I-SPECULATION
such O I-SPECULATION
as O I-SPECULATION
CREB O I-SPECULATION
, O I-SPECULATION
CTF O I-SPECULATION
, O I-SPECULATION
OTF-1 O I-SPECULATION
, O I-SPECULATION
and O I-SPECULATION
OTF-2 O I-SPECULATION
. O O

To O O
explore O O
long-term O O
regulatory O O
mechanisms O O
, O O
we O O
investigated O O
the O O
induction O O
of O O
transcription O O
factors O O
on O O
the O O
gene O O
expression O O
level O O
which O O
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
substitute I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
metabolized I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
proteins I-SPECULATION I-SPECULATION
after I-SPECULATION I-SPECULATION
their I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
. O O

We O O
identified O O
a O O
cell-type-specific O O
differential O O
response O O
: O O
CREB O O
, O O
CTF O O
, O O
OTF-1 O O
, O O
OFT-2 O O
, O O
and O O
NF-kappa O O
B O O
genes O O
were O O
strongly O O
induced O O
1 O O
to O O
4 O O
hours O O
after O O
influenza O O
A O O
virus O O
infection O O
in O O
the O O
monocytic O O
cell O O
line O O
Mono O O
Mac O O
6 O O
, O O
while O O
in O O
freshly O O
prepared O O
human O O
monocytes O O
no B-NEGATION B-NEGATION
significant I-NEGATION I-NEGATION
changes I-NEGATION I-NEGATION
were I-NEGATION I-NEGATION
detected I-NEGATION I-NEGATION
. O O

In O O
infected O O
monocytes O O
, O O
which O O
die O O
by O O
apoptosis O O
, O O
the O O
expression O O
of O O
CREB O O
, O O
CTF O O
, O O
and O O
OTF-2 O O
was O O
rather O O
suppressed O O
8 O O
hours O O
after O O
infection O O
. O O

In O O
conclusion O O
, O O
the B-SPECULATION B-SPECULATION
long-term I-SPECULATION I-SPECULATION
regulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
non-proliferating I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
seems I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
minor I-SPECULATION I-SPECULATION
importance I-SPECULATION I-SPECULATION
after I-SPECULATION I-SPECULATION
influenza I-SPECULATION I-SPECULATION
infection I-SPECULATION I-SPECULATION
since O O
in O O
apoptosisprone O O
cells O O
an O O
immediate O O
availability O O
of O O
transcription O O
factor O O
proteins O O
is O O
required O O
. O O

[ O O
Molecular-biologic O O
aspects O O
of O O
interaction O O
between O O
nervous O O
and O O
immune O O
systems O O
] O O

The O O
problem O O
of O O
the O O
neuro-immuno O O
interactions O O
on O O
the O O
level O O
of O O
the O O
protein O O
trans-factors O O
, O O
stimulating O O
interleukin-2 O O
( O O
IL-2 O O
) O O
gene O O
expression O O
was O O
discussed O O
. O O

The O O
physico-chemical O O
and O O
functional O O
parameters O O
of O O
the O O
low O O
molecular O O
nuclear O O
proteins O O
( O O
SP O O
and O O
BP O O
- O O
14 O O
, O O
18 O O
, O O
19 O O
kDs O O
) O O
isolated O O
from O O
splenic O O
and O O
brain O O
cells O O
of O O
immunized O O
rats O O
were O O
studied O O
. O O

The O O
binding O O
of O O
these O O
proteins O O
to O O
the O O
regulatory O O
region O O
of O O
IL-2 O O
gene O O
in O O
vitro O O
and O O
stimulation O O
of O O
the O O
IL-2mRNA O O
synthesis O O
in O O
splenic O O
T-lymphocytes O O
culture O O
in O O
normal O O
conditions O O
were O O
shown O O
. O O

The O O
protective O O
effect O O
of O O
SP O O
and O O
BP O O
on O O
the O O
IL-2mRNA O O
synthesis O O
in O O
stressful O O
conditions O O
and O O
by O O
the O O
T-cells O O
treatment O O
with O O
the O O
CsA O O
was O O
demonstrated O O
. O O

Induction O O
of O O
interleukin-12 O O
p40 O O
transcript O O
by O O
CD40 O O
ligation O O
via O O
activation O O
of O O
nuclear O O
factor-kappaB O O
. O O

Interleukin-12 O O
is O O
produced O O
in O O
response O O
to O O
infection O O
with O O
bacteria O O
or O O
parasites O O
or O O
to O O
bacterial O O
constituents O O
such O O
as O O
LPS O O
in O O
monocytes O O
/ O O
macrophages O O
and O O
dendritic O O
cells O O
, O O
and O O
also O O
generated O O
by O O
the O O
interaction O O
between O O
activated O O
T O O
cells O O
and O O
antigen-presenting O O
cells O O
via O O
CD40-CD40 O O
ligand O O
( O O
CD40L O O
) O O
. O O

So O O
far O O
, O O
transcriptional O O
analyses O O
of O O
p40 O O
have O O
been O O
carried O O
out O O
only O O
using O O
bacterial O O
constituents O O
such O O
as O O
LPS O O
as O O
stimuli O O
. O O

In O O
the O O
present O O
study O O
, O O
we O O
have O O
characterized O O
the O O
transcriptional O O
induction O O
of O O
p40 O O
by O O
CD40 O O
ligation O O
in O O
a O O
human O O
B O O
lymphoblastoid O O
cell O O
line O O
, O O
Daudi O O
, O O
and O O
a O O
human O O
acute O O
monocytic O O
leukemia O O
cell O O
line O O
, O O
THP-1 O O
. O O

These O O
cells O O
, O O
stimulated O O
by O O
an O O
agonistic O O
monoclonal O O
antibody O O
against O O
CD40 O O
or O O
by O O
transfection O O
with O O
a O O
CD40L O O
expression O O
vector O O
, O O
secreted O O
p40 O O
and O O
showed O O
enhanced O O
p40 O O
mRNA O O
expression O O
. O O

Sequence O O
analysis O O
of O O
the O O
p40 O O
promoter O O
region O O
identified O O
two O O
potential B-SPECULATION O
nuclear I-SPECULATION O
factor I-SPECULATION O
( I-SPECULATION O
NF I-SPECULATION O
)- I-SPECULATION O
kappaB I-SPECULATION O
binding I-SPECULATION O
sites I-SPECULATION O
conserved I-SPECULATION O
between I-SPECULATION O
mouse I-SPECULATION O
and I-SPECULATION O
human I-SPECULATION O
. O O

Electrophoretic O O
mobility O O
shift O O
assay O O
revealed O O
that O O
the O O
potential B-SPECULATION O
NF-kappaB I-SPECULATION O
binding I-SPECULATION O
sequence I-SPECULATION O
which I-SPECULATION O
is I-SPECULATION O
located I-SPECULATION O
around I-SPECULATION O
120 I-SPECULATION O
bp I-SPECULATION O
upstream I-SPECULATION O
of I-SPECULATION O
the I-SPECULATION O
transcription I-SPECULATION O
initiation I-SPECULATION O
site I-SPECULATION O
in I-SPECULATION O
murine I-SPECULATION O
and I-SPECULATION O
human I-SPECULATION O
p40 I-SPECULATION O
genes I-SPECULATION O
formed O O
an O O
NF-kappaB O O
complex O O
with O O
nuclear O O
extract O O
from O O
Daudi O O
cells O O
stimulated O O
by O O
CD40 O O
ligation O O
. O O

Moreover O O
, O O
transfection O O
of O O
Daudi O O
cells O O
with O O
the O O
polymerized O O
NF-kappaB O O
binding O O
sequence O O
ligated O O
to O O
a O O
thymidine O O
kinase O O
/ O O
chloramphenicol O O
acetyltransferase O O
( O O
CAT O O
) O O
reporter O O
plasmid O O
greatly O O
induced O O
CAT O O
activity O O
, O O
but O O
transfection O O
with O O
the O O
polymerized O O
mutated O O
NF-kappaB O O
binding O O
sequence O O
did O O
not B-NEGATION B-NEGATION
. O O

These O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
binding I-SPECULATION I-SPECULATION
site I-SPECULATION I-SPECULATION
located I-SPECULATION I-SPECULATION
around I-SPECULATION I-SPECULATION
120 I-SPECULATION I-SPECULATION
bp I-SPECULATION I-SPECULATION
upstream I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
initiation I-SPECULATION I-SPECULATION
site I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
murine I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
p40 I-SPECULATION I-SPECULATION
promoter I-SPECULATION I-SPECULATION
regions I-SPECULATION I-SPECULATION
could B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
p40 I-SPECULATION I-SPECULATION
induction I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
CD40 I-SPECULATION I-SPECULATION
ligation I-SPECULATION I-SPECULATION
via I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
. O O

Oxidants O O
, O O
transcription O O
factors O O
, O O
and O O
intestinal O O
inflammation O O
. O O

It O O
is O O
now O O
well O O
appreciated O O
that O O
chronic O O
gut O O
inflammation O O
is O O
characterized O O
by O O
enhanced O O
production O O
of O O
reactive O O
metabolites O O
of O O
oxygen O O
and O O
nitrogen O O
. O O

Some O O
of O O
these O O
oxidants O O
are O O
known O O
to O O
modulate O O
the O O
expression O O
of O O
a O O
variety O O
of O O
genes O O
that O O
are O O
involved O O
in O O
the O O
immune O O
and O O
inflammatory O O
responses O O
. O O

For O O
example O O
, O O
certain O O
oxidants O O
are O O
known O O
to O O
activate O O
the O O
nuclear O O
transcription O O
factor O O
kappa O O
B O O
, O O
which O O
regulates O O
the O O
expression O O
of O O
a O O
variety O O
of O O
different O O
adhesion O O
molecules O O
, O O
cytokines O O
, O O
and O O
enzymes O O
. O O

Oxidants O O
are O O
also O O
known O O
to O O
activate O O
another O O
transcription O O
factor O O
, O O
activator O O
protein-1 O O
. O O

This O O
transcription O O
factor O O
is O O
composed O O
of O O
products O O
from O O
the O O
fos O O
and O O
jun O O
proto-oncogene O O
family O O
and O O
is B-SPECULATION B-SPECULATION
believed I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
regulating I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
growth I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
proliferation I-SPECULATION I-SPECULATION
. O O

Finally O O
, O O
oxidants B-SPECULATION B-SPECULATION
are I-SPECULATION I-SPECULATION
believed I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
promote I-SPECULATION I-SPECULATION
intestinal I-SPECULATION I-SPECULATION
epithelial I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
apoptosis I-SPECULATION I-SPECULATION
, O I-SPECULATION
and O I-SPECULATION
the B-SPECULATION I-SPECULATION
B-cell I-SPECULATION I-SPECULATION
lymphoma I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
leukemia-2 I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
product I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
believed I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
inhibit I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
phenomenon I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
antioxidant-dependent I-SPECULATION I-SPECULATION
manner I-SPECULATION I-SPECULATION
. O O

Taken O O
together O O
, O O
these O O
observations O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
nontoxic I-SPECULATION I-SPECULATION
concentrations I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
reactive I-SPECULATION I-SPECULATION
metabolites I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
oxygen I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
nitrogen I-SPECULATION I-SPECULATION
play I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
regulating I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
involved I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
inflammatory I-SPECULATION I-SPECULATION
response I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
modulating I-SPECULATION I-SPECULATION
apoptosis I-SPECULATION I-SPECULATION
. O O

Cytokine O O
rescue O O
from O O
glucocorticoid O O
induced O O
apoptosis O O
in O O
T O O
cells O O
is O O
mediated O O
through O O
inhibition O O
of O O
IkappaBalpha O O
. O O

We O O
previously O O
reported O O
that O O
dexamethasone O O
( O O
DEX O O
) O O
, O O
a O O
synthetic O O
glucocorticoid O O
, O O
causes O O
apoptosis O O
in O O
mature O O
Th O O
cell O O
lines O O
, O O
and O O
that O O
this O O
induction O O
of O O
cell O O
death O O
is O O
prevented O O
by O O
specific O O
cytokines O O
, O O
namely O O
, O O
by O O
IL-2 O O
in O O
Th1 O O
cells O O
and O O
by O O
IL-4 O O
in O O
Th2 O O
cells O O
. O O

We O O
now O O
show O O
that O O
this O O
differential O O
rescue O O
by O O
specific O O
cytokines O O
in O O
Th O O
cells O O
correlates O O
with O O
the O O
level O O
of O O
IkappaBalpha O O
that O O
is O O
regulated O O
by O O
DEX O O
and O O
cytokines O O
. O O

In O O
both O O
cell O O
types O O
the O O
cellular O O
levels O O
of O O
IkappaBalpha O O
mRNA O O
and O O
protein O O
were O O
evaluated O O
by O O
DEX O O
treatment O O
. O O

Interestingly O O
, O O
the O O
DEX-mediated O O
IkappaBalpha O O
induction O O
was O O
completely O O
inhibited O O
by O O
IL-2 O O
, O O
but O O
not B-NEGATION B-NEGATION
IL-4 I-NEGATION I-NEGATION
, O O
in O O
Th1 O O
cells O O
, O O
while O O
the O O
reverse O O
profile O O
was O O
seen O O
in O O
Th2 O O
cells O O
. O O

In O O
both O O
cell O O
types O O
, O O
the O O
cytokine O O
that O O
inhibits O O
the O O
induction O O
of O O
IkappaBalpha O O
by O O
DEX O O
, O O
also O O
rescues O O
these O O
cells O O
from O O
DEX-induced O O
apoptosis O O
, O O
although O O
the O O
rescue O O
cytokine O O
is O O
different O O
in O O
Th1 O O
and O O
Th2 O O
cells O O
. O O

Our O O
results O O
imply B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
need I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
maintain I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
certain I-SPECULATION I-SPECULATION
level I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
transcriptional I-SPECULATION I-SPECULATION
activity I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
order I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
survive I-SPECULATION I-SPECULATION
; O O
up O O
- O O
or O O
down-regulation O O
of O O
nuclear O O
NF O O
kappaB O O
through O O
modulation O O
of O O
IkappaBalpha O O
expression O O
by O O
cytokines O O
or O O
DEX O O
may B-SPECULATION B-SPECULATION
lead I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
survival I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
death I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
respectively I-SPECULATION I-SPECULATION
. O O

Xenogeneic O O
human O O
serum O O
promotes O O
leukocyte O O
adhesion O O
to O O
porcine O O
endothelium O O
under O O
flow O O
conditions O O
, O O
possibly B-SPECULATION B-SPECULATION
through I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
. O O

Endothelial O O
cell O O
activation O O
and O O
leukocyte O O
infiltration O O
are O O
a O O
consistent O O
feature O O
of O O
discordant O O
xenograft O O
rejection O O
. O O

Here O O
we O O
evaluated O O
whether B-SPECULATION B-SPECULATION
xenogeneic I-SPECULATION I-SPECULATION
serum I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
source I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
xenoreactive I-SPECULATION I-SPECULATION
natural I-SPECULATION I-SPECULATION
antibodies I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
complement I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
induced I-SPECULATION I-SPECULATION
endothelial I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
consequent I-SPECULATION I-SPECULATION
leukocyte I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
under I-SPECULATION I-SPECULATION
flow I-SPECULATION I-SPECULATION
conditions I-SPECULATION I-SPECULATION
. O O

Porcine O O
aortic O O
endothelial O O
cells O O
( O O
PAEC O O
) O O
were O O
incubated O O
for O O
1 O O
hr O O
30 O O
min O O
or O O
5 O O
hr O O
with O O
10 O O
% O O
homologous O O
porcine O O
serum O O
( O O
control O O
) O O
or O O
10 O O
% O O
xenogeneic O O
human O O
serum O O
and O O
then O O
perfused O O
with O O
total O O
human O O
leukocytes O O
in O O
a O O
parallel O O
plate O O
flow O O
chamber O O
under O O
laminar O O
flow O O
( O O
1.5 O O
dynes O O
/ O O
cm2 O O
) O O
. O O

Adherent O O
cells O O
were O O
counted O O
by O O
digital O O
image O O
analysis O O
. O O

Xenogeneic O O
human O O
serum O O
significantly O O
( O O
P O O
< O O
0.01 O O
) O O
increased O O
the O O
number O O
of O O
adherent O O
leukocytes O O
as O O
compared O O
with O O
porcine O O
serum O O
. O O

A O O
similar O O
adhesive O O
response O O
was O O
elicited O O
by O O
TNF O O
alpha O O
( O O
100 O O
U O O
/ O O
ml O O
) O O
, O O
one O O
of O O
the O O
most O O
potent O O
inducers O O
of O O
endothelial O O
cell O O
adhesive O O
properties O O
, O O
here O O
used O O
as O O
positive O O
control O O
. O O

In O O
order O O
to O O
elucidate O O
possible B-SPECULATION B-SPECULATION
mechanisms I-SPECULATION I-SPECULATION
underlying I-SPECULATION I-SPECULATION
endothelial I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
xenogeneic I-SPECULATION I-SPECULATION
serum I-SPECULATION I-SPECULATION
, O O
we O O
focussed O O
on O O
transcription O O
factor O O
NF-kappa O O
B O O
, O O
a O O
central O O
regulator O O
for O O
the O O
induction O O
of O O
different O O
genes O O
, O O
including O O
adhesive O O
molecules O O
and O O
chemoattractants O O
. O O

By O O
confocal O O
fluorescence O O
microscopy O O
, O O
we O O
observed O O
a O O
positive O O
staining O O
for O O
NF-kappa O O
B O O
( O O
p65 O O
subunit O O
) O O
in O O
the O O
nuclei O O
of O O
PAEC O O
exposed O O
for O O
1 O O
hr O O
30 O O
min O O
to O O
human O O
serum O O
, O O
which O O
indicated O O
NF-kappa O O
B O O
activation O O
in O O
this O O
setting O O
. O O

At O O
variance O O
, O O
in O O
PAEC O O
incubated O O
with O O
the O O
homologous O O
serum O O
, O O
NF-kappa O O
B O O
was O O
strictly O O
localized O O
in O O
the O O
cell O O
cytoplasm O O
. O O

Treatment O O
of O O
PAEC O O
exposed O O
to O O
xenogeneic O O
serum O O
with O O
the O O
NF-kappa O O
B O O
inhibitors O O
pyrrolidinedithiocarbamate O O
( O O
PDTC O O
, O O
25 O O
microM O O
) O O
and O O
tosyl-phechloromethylketone O O
( O O
TPCK O O
, O O
25 O O
microM O O
) O O
significantly O O
( O O
P O O
< O O
0.01 O O
) O O
reduced O O
leukocyte O O
adhesion O O
in O O
respect O O
to O O
PAEC O O
treated O O
with O O
human O O
serum O O
alone O O
. O O

Findings O O
that O O
xenogeneic O O
serum O O
promotes O O
leukocyte-endothelium O O
interaction O O
possibly B-SPECULATION B-SPECULATION
through I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
might B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
relevant I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
designing I-SPECULATION I-SPECULATION
future I-SPECULATION I-SPECULATION
therapeutic I-SPECULATION I-SPECULATION
strategies I-SPECULATION I-SPECULATION
aimed I-SPECULATION I-SPECULATION
at I-SPECULATION I-SPECULATION
prolonging I-SPECULATION I-SPECULATION
xenograft I-SPECULATION I-SPECULATION
survival I-SPECULATION I-SPECULATION
. O O

Role O O
of O O
cyclic O O
AMP O O
response O O
element-binding O O
protein O O
in O O
cyclic O O
AMP O O
inhibition O O
of O O
NF-kappaB-mediated O O
transcription O O
. O O

The O O
NF-kappaB O O
family O O
of O O
transcription O O
factors O O
regulates O O
the O O
inducible O O
expression O O
of O O
a O O
variety O O
of O O
genes O O
. O O

Recently O O
, O O
we O O
showed O O
that O O
elevation O O
of O O
intracellular O O
cyclic O O
AMP O O
inhibits O O
NF-kappaB-mediated O O
transcription O O
in O O
human O O
monocytes O O
and O O
endothelial O O
cells O O
without B-NEGATION B-NEGATION
preventing I-NEGATION I-NEGATION
nuclear I-NEGATION I-NEGATION
translocation I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
NF-kappaB I-NEGATION I-NEGATION
complexes I-NEGATION I-NEGATION
. O O

The O O
present O O
study O O
examined O O
the O O
molecular O O
mechanism O O
of O O
this O O
inhibition O O
. O O

We O O
hypothesized B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
kinase I-SPECULATION I-SPECULATION
A I-SPECULATION I-SPECULATION
signaling I-SPECULATION I-SPECULATION
pathway I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
inhibit I-SPECULATION I-SPECULATION
NF-kappaB-mediated I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
phosphorylating I-SPECULATION I-SPECULATION
proteins I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
such I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
cAMP I-SPECULATION I-SPECULATION
response I-SPECULATION I-SPECULATION
element-binding I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
CREB I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
compete I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
limiting I-SPECULATION I-SPECULATION
amounts I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
coactivator I-SPECULATION I-SPECULATION
CBP I-SPECULATION I-SPECULATION
. O O

Here O O
, O O
we O O
show O O
that O O
the O O
amino-terminal O O
region O O
( O O
amino O O
acids O O
1-450 O O
) O O
of O O
CBP O O
specifically O O
interacts O O
with O O
the O O
carboxyl-terminal O O
region O O
( O O
amino O O
acids O O
286-551 O O
) O O
of O O
NF-kappaB O O
p65 O O
( O O
RelA O O
) O O
both O O
in O O
vitro O O
and O O
in O O
vivo O O
. O O

Functional O O
studies O O
using O O
human O O
endothelial O O
cells O O
demonstrated O O
that O O
overexpression O O
of O O
CBP O O
rescued O O
cAMP O O
inhibition O O
of O O
NF-kappaB-mediated O O
transcription O O
and O O
transcription O O
mediated O O
by O O
a O O
chimeric O O
protein O O
, O O
GAL4-p65 O O
( O O
286-551 O O
) O O
, O O
which O O
contained O O
the O O
GAL4 O O
DNA O O
binding O O
domain O O
fused O O
to O O
the O O
carboxyl-terminal O O
region O O
of O O
p65 O O
( O O
amino O O
acids O O
286-551 O O
) O O
. O O

In O O
contrast O O
, O O
overexpression O O
of O O
CREB O O
inhibited O O
GAL4-p65 O O
( O O
286-551 O O
)- O O
mediated O O
transcription O O
. O O

These O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
kinase I-SPECULATION I-SPECULATION
A I-SPECULATION I-SPECULATION
pathway I-SPECULATION I-SPECULATION
inhibits I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
phosphorylating I-SPECULATION I-SPECULATION
CREB I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
competes I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
p65 I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
limiting I-SPECULATION I-SPECULATION
amounts I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
CBP I-SPECULATION I-SPECULATION
. O O

Differential O O
induction O O
of O O
DNA-binding O O
activities O O
following O O
CD19 O O
cross-linking O O
in O O
human O O
B O O
lineage O O
cells O O
. O O

The O O
B O O
cell-specific O O
cell O O
surface O O
molecule O O
CD19 O O
is O O
expressed O O
at O O
all O O
stages O O
of O O
B O O
cell O O
development O O
, O O
including O O
normal O O
plasma O O
cells O O
, O O
and O O
mediates O O
signal O O
transduction O O
via O O
interaction O O
with O O
cytoplasmic O O
effector O O
proteins O O
. O O

Cross-linking O O
CD19 O O
on O O
early O O
human O O
B O O
lineage O O
cells O O
induces O O
the O O
formation O O
of O O
a O O
CD19 O O
/ O O
Vav O O
/ O O
phosphatidylinositol-3 O O
kinase O O
complex O O
, O O
tyrosine O O
phosphorylation O O
of O O
CD19 O O
and O O
Vav O O
, O O
and O O
activation O O
of O O
the O O
Ras O O
pathway O O
. O O

To O O
further O O
explore O O
the O O
ramifications O O
of O O
CD19 O O
signaling O O
, O O
the O O
current O O
study O O
examined O O
whether B-SPECULATION B-SPECULATION
phosphorylation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
Elk-1 I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
activator I-SPECULATION I-SPECULATION
protein-1 I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
AP-1 I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
nuclear I-SPECULATION I-SPECULATION
factor-kappaB I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factors I-SPECULATION I-SPECULATION
occurred I-SPECULATION I-SPECULATION
following I-SPECULATION I-SPECULATION
CD19 I-SPECULATION I-SPECULATION
cross-linking I-SPECULATION I-SPECULATION
. O O

The O O
cells O O
used O O
were O O
the O O
BLIN-1 O O
pre-B O O
cell O O
line O O
expressing O O
low O O
levels O O
of O O
cell O O
surface O O
mu O O
heavy O O
chain O O
associated O O
with O O
surrogate O O
light O O
chain O O
and O O
the O O
1E8 O O
immature O O
B O O
cell O O
line O O
expressing O O
cell O O
surface O O
mu O O
/ O O
kappa O O
. O O

Lysates O O
from O O
CD19 O O
cross-linked O O
1E8 O O
cells O O
induced O O
robust O O
phosphorylation O O
of O O
an O O
Elk-1 O O
fusion O O
protein O O
in O O
vitro O O
, O O
whereas O O
no B-NEGATION B-NEGATION
phosphorylation I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
Elk-1 I-NEGATION I-NEGATION
fusion I-NEGATION I-NEGATION
protein I-NEGATION I-NEGATION
occurred I-NEGATION I-NEGATION
using I-NEGATION I-NEGATION
lysates I-NEGATION I-NEGATION
from I-NEGATION I-NEGATION
CD19 I-NEGATION I-NEGATION
cross-linked I-NEGATION I-NEGATION
BLIN-1 I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
. O O

An O O
electrophoretic O O
mobility O O
shift O O
assay O O
employing O O
AP-1 O O
and O O
NF-kappaB O O
consensus O O
oligonucleotides O O
was O O
used O O
to O O
demonstrate O O
that O O
AP-1 O O
- O O
binding O O
activity O O
increased O O
, O O
while O O
constitutive B-NEGATION B-NEGATION
NF-kappaB-binding I-NEGATION I-NEGATION
activity I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
enhanced I-NEGATION I-NEGATION
, O I-NEGATION
following O I-NEGATION
2 O I-NEGATION
h O I-NEGATION
of O I-NEGATION
CD19 O I-NEGATION
cross-linking O I-NEGATION
in O I-NEGATION
1E8 O I-NEGATION
cells O I-NEGATION
. O O

Supershift O O
experiments O O
revealed O O
that O O
JunD O O
and O O
c-Fos O O
proteins O O
mediated O O
anti-CD19 O O
induced O O
AP-1-binding O O
activity O O
in O O
1E8 O O
cells O O
. O O

In O O
contrast O O
, O O
CD19 O O
cross-linking O O
in O O
BLIN-1 O O
cells O O
resulted O O
in O O
the O O
induction O O
of O O
NF-kappaB O O
, O O
but O O
had O O
no B-NEGATION B-NEGATION
apparent I-NEGATION I-NEGATION
effect I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
AP-1-binding I-NEGATION I-NEGATION
activity I-NEGATION I-NEGATION
. O O

These O O
data O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
CD19-mediated I-SPECULATION I-SPECULATION
signal I-SPECULATION I-SPECULATION
transduction I-SPECULATION I-SPECULATION
activates I-SPECULATION I-SPECULATION
different I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factors I-SPECULATION I-SPECULATION
at I-SPECULATION I-SPECULATION
juxtaposed I-SPECULATION I-SPECULATION
stages I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
development I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
culminate I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
suppression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
distinct I-SPECULATION I-SPECULATION
sets I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
. O O

Human O O
immunodeficiency O O
virus O O
type O O
1 O O
long O O
terminal O O
repeat O O
quasispecies O O
differ O O
in O O
basal O O
transcription O O
and O O
nuclear O O
factor O O
recruitment O O
in O O
human O O
glial O O
cells O O
and O O
lymphocytes O O
. O O

The O O
generation O O
of O O
genomic O O
diversity O O
during O O
the O O
course O O
of O O
infection O O
has O O
the O O
potential O O
to O O
affect O O
all O O
aspects O O
of O O
HIV-1 O O
replication O O
, O O
including O O
expression O O
of O O
the O O
proviral O O
genome O O
. O O

To O O
gain O O
a O O
better O O
understanding O O
of O O
the O O
impact O O
of O O
long O O
terminal O O
repeat O O
( O O
LTR O O
) O O
sequence O O
diversity O O
on O O
LTR-directed O O
gene O O
expression O O
in O O
cells O O
of O O
the O O
central O O
nervous O O
system O O
( O O
CNS O O
) O O
and O O
immune O O
system O O
, O O
we O O
amplified O O
and O O
cloned O O
LTRs O O
from O O
proviral O O
DNA O O
in O O
HIV-1-infected O O
peripheral O O
blood O O
. O O

Sequence O O
analysis O O
of O O
nineteen O O
LTRs O O
cloned O O
from O O
2 O O
adult O O
and O O
3 O O
pediatric O O
patients O O
revealed O O
an O O
average O O
of O O
33 O O
nucleotide O O
changes O O
( O O
with O O
respect O O
to O O
the O O
sequence O O
of O O
the O O
LAI O O
LTR O O
) O O
within O O
the O O
455-bp O O
U3 O O
region O O
. O O

Transient O O
expression O O
analyses O O
in O O
cells O O
of O O
neuroglial O O
and O O
lymphocytic O O
origin O O
demonstrated O O
that O O
some O O
of O O
these O O
LTRs O O
had O O
activities O O
which O O
varied O O
significantly O O
from O O
the O O
LAI O O
LTR O O
in O O
U-373 O O
MG O O
cells O O
( O O
an O O
astrocytoma O O
cell O O
line O O
) O O
as O O
well O O
as O O
in O O
Jurkat O O
cells O O
( O O
a O O
CD4-positive O O
lymphocyte O O
cell O O
line O O
) O O
. O O

While O O
LTRs O O
which O O
demonstrated O O
the O O
highest O O
activities O O
in O O
U-373 O O
MG O O
cells O O
also O O
yielded O O
high O O
activities O O
in O O
Jurkat O O
cells O O
, O O
the O O
LTRs O O
were O O
generally O O
more O O
active O O
in O O
Jurkat O O
cells O O
when O O
compared O O
to O O
the O O
LAI O O
LTR O O
. O O

Differences O O
in O O
LTR O O
sequence O O
also O O
resulted O O
in O O
differences O O
in O O
transcription O O
factor O O
recruitment O O
to O O
cis-acting O O
sites O O
within O O
the O O
U3 O O
region O O
of O O
the O O
LTR O O
, O O
as O O
demonstrated O O
by O O
electrophoretic O O
mobility O O
shift O O
assays O O
. O O

In O O
particular O O
, O O
naturally O O
occurring O O
sequence O O
variation O O
impacted O O
transcription O O
factor O O
binding O O
to O O
an O O
activating O O
transcription O O
factor O O
/ O O
cAMP O O
response O O
element O O
binding O O
( O O
ATF O O
/ O O
CREB O O
) O O
binding O O
site O O
( O O
located O O
between O O
the O O
LEF-1 O O
and O O
distal O O
NF-kappaB O O
transcription O O
factor O O
binding O O
sites O O
) O O
that O O
we O O
identified O O
in O O
previous O O
studies O O
of O O
the O O
HIV-1 O O
LTR O O
. O O

These O O
findings O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
LTR I-SPECULATION I-SPECULATION
sequence I-SPECULATION I-SPECULATION
changes I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
significantly I-SPECULATION I-SPECULATION
affect I-SPECULATION I-SPECULATION
basal I-SPECULATION I-SPECULATION
LTR I-SPECULATION I-SPECULATION
function I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
recruitment I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
, I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
turn I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
alter I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
course I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
viral I-SPECULATION I-SPECULATION
replication I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
CNS I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
immune I-SPECULATION I-SPECULATION
system I-SPECULATION I-SPECULATION
origin I-SPECULATION I-SPECULATION
. O O

Inhibition O O
of O O
nuclear O O
factor O O
kappaB O O
activation O O
attenuates O O
apoptosis O O
resistance O O
in O O
lymphoid O O
cells O O
. O O

Death-inducing O O
ligands O O
( O O
DILs O O
) O O
such O O
as O O
tumor O O
necrosis O O
factor O O
alpha O O
( O O
TNFalpha O O
) O O
or O O
the O O
cytotoxic O O
drug O O
doxorubicin O O
have O O
been O O
shown O O
to O O
activate O O
a O O
nuclear O O
factor O O
kappaB O O
( O O
NFkappaB O O
)- O O
dependent O O
program O O
that O O
may B-SPECULATION B-SPECULATION
rescue I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
from I-SPECULATION I-SPECULATION
apoptosis I-SPECULATION I-SPECULATION
induction I-SPECULATION I-SPECULATION
. O O

We O O
demonstrate O O
here O O
that O O
TRAIL O O
( O O
TNF-related O O
apoptosis-inducing O O
ligand O O
) O O
, O O
a O O
recently O O
identified O O
DIL O O
, O O
also O O
activates O O
NFkappaB O O
in O O
lymphoid O O
cell O O
lines O O
in O O
a O O
kinetic O O
similar O O
to O O
TNFalpha O O
. O O

NFkappaB O O
activity O O
is O O
independent O O
from O O
FADD O O
, O O
caspases O O
, O O
and O O
apoptosis O O
induction O O
. O O

To O O
study O O
the O O
influence O O
of O O
NFkappaB O O
activity O O
on O O
apoptosis O O
mediated O O
by O O
TRAIL O O
, O O
CD95 O O
, O O
TNFalpha O O
, O O
or O O
doxorubicin O O
, O O
NFkappaB O O
activation O O
was O O
inhibited O O
using O O
the O O
proteasome O O
inhibitor O O
N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal O O
or O O
transient O O
overexpression O O
of O O
mutant O O
IkappaBalpha O O
. O O

Sensitivity O O
for O O
induction O O
of O O
apoptosis O O
was O O
markedly O O
increased O O
by O O
these O O
treatments O O
in O O
apoptosis O O
sensitive O O
cell O O
lines O O
. O O

Moreover O O
, O O
both O O
in O O
cell O O
lines O O
and O O
in O O
primary O O
leukemia O O
cells O O
that O O
are O O
resistant O O
towards O O
induction O O
of O O
apoptosis O O
by O O
DILs O O
and O O
doxorubicin O O
, O O
antagonization O O
of O O
NFkappaB O O
activity O O
partially O O
restored O O
apoptosis O O
sensitivity O O
. O O

These O O
data O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
inhibition I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NFkappaB I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
provide I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
molecular I-SPECULATION I-SPECULATION
approach I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
increase I-SPECULATION I-SPECULATION
apoptosis I-SPECULATION I-SPECULATION
sensitivity I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
anticancer I-SPECULATION I-SPECULATION
treatment I-SPECULATION I-SPECULATION
. O O

IL-2-induced O O
growth O O
of O O
CD8 O O
+ O O
T O O
cell O O
prolymphocytic O O
leukemia O O
cells O O
mediated O O
by O O
NF-kappaB O O
induction O O
and O O
IL-2 O O
receptor O O
alpha O O
expression O O
. O O

The O O
binding O O
of O O
interleukin-2 O O
( O O
IL-2 O O
) O O
to O O
its O O
receptor O O
on O O
normal O O
T O O
cells O O
induces O O
nuclear O O
expression O O
of O O
nuclear O O
factor O O
kappaB O O
( O O
NF-kappaB O O
) O O
, O O
activation O O
of O O
the O O
IL-2 O O
receptor O O
( O O
IL-2R O O
) O O
alpha O O
chain O O
gene O O
, O O
and O O
cell O O
proliferation O O
. O O

In O O
the O O
present O O
study O O
, O O
the O O
role O O
of O O
IL-2R O O
signaling O O
in O O
the O O
growth O O
of O O
CD8 O O
+ O O
T O O
cell O O
prolymphocytic O O
leukemia O O
( O O
T-PLL O O
) O O
cells O O
has O O
been O O
investigated O O
. O O

Flow O O
cytometry O O
revealed O O
that O O
primary O O
leukemia O O
cells O O
from O O
a O O
patient O O
with O O
CD8 O O
+ O O
T-PLL O O
expressed O O
IL-2Ralpha O O
and O O
beta O O
chains O O
, O O
and O O
the O O
cells O O
showed O O
a O O
proliferative O O
response O O
and O O
an O O
increase O O
in O O
IL-2Ralpha O O
expression O O
on O O
culture O O
with O O
exogeneous O O
IL-2 O O
. O O

Northern O O
blot O O
analysis O O
failed B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
detect I-NEGATION I-NEGATION
IL-2 I-NEGATION I-NEGATION
mRNA I-NEGATION I-NEGATION
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
IL-2 I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
act I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
paracrine I-SPECULATION I-SPECULATION
manner I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
vivo I-SPECULATION I-SPECULATION
. O O

Electrophoretic O O
mobility-shift O O
assays O O
revealed O O
that O O
recombinant O O
IL-2 O O
increased O O
NF-kappaB O O
binding O O
activity O O
in O O
nuclear O O
extracts O O
of O O
the O O
leukemia O O
cells O O
, O O
and O O
Northern O O
blot O O
analysis O O
showed O O
that O O
IL-2 O O
increased O O
the O O
abundance O O
of O O
mRNAs O O
encoding O O
the O O
NF-kappaB O O
components O O
c-Rel O O
and O O
KBF1 O O
in O O
these O O
cells O O
. O O

IL-2 O O
binding O O
analysis O O
demonstrated O O
that O O
IL-2 O O
markedly O O
increased O O
the O O
number O O
of O O
low O O
affinity O O
IL-2Rs O O
on O O
the O O
leukemia O O
cells O O
, O O
without B-NEGATION B-NEGATION
an I-NEGATION I-NEGATION
effect I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
number I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
high-affinity I-NEGATION I-NEGATION
IL-2Rs I-NEGATION I-NEGATION
. O O

These O O
results O O
show O O
that O O
IL-2 O O
is O O
capable O O
of O O
inducing O O
the O O
nuclear O O
expression O O
of O O
NF-kappaB O O
in O O
primary O O
CD8 O O
+ O O
T-PLL O O
cells O O
, O O
and O O
that O O
this O O
effect O O
is O O
mediated O O
, O O
at O O
least O O
in O O
part O O
, O O
at O O
a O O
pretranslational O O
level O O
. O O

The O O
human O O
toll O O
signaling O O
pathway O O
: O O
divergence O O
of O O
nuclear O O
factor O O
kappaB O O
and O O
JNK O O
/ O O
SAPK O O
activation O O
upstream O O
of O O
tumor O O
necrosis O O
factor O O
receptor-associated O O
factor O O
6 O O
( O O
TRAF6 O O
) O O
. O O

The O O
human O O
homologue O O
of O O
Drosophila O O
Toll O O
( O O
hToll O O
) O O
is O O
a O O
recently O O
cloned O O
receptor O O
of O O
the O O
interleukin O O
1 O O
receptor O O
( O O
IL-1R O O
) O O
superfamily O O
, O O
and O O
has O O
been O O
implicated O O
in O O
the O O
activation O O
of O O
adaptive O O
immunity O O
. O O

Signaling O O
by O O
hToll O O
is O O
shown O O
to O O
occur O O
through O O
sequential O O
recruitment O O
of O O
the O O
adapter O O
molecule O O
MyD88 O O
and O O
the O O
IL-1R-associated O O
kinase O O
. O O

Tumor O O
necrosis O O
factor O O
receptor-activated O O
factor O O
6 O O
( O O
TRAF6 O O
) O O
and O O
the O O
nuclear O O
factor O O
kappaB O O
( O O
NF-kappaB O O
)- O O
inducing O O
kinase O O
( O O
NIK O O
) O O
are O O
both O O
involved O O
in O O
subsequent O O
steps O O
of O O
NF-kappaB O O
activation O O
. O O

Conversely O O
, O O
a O O
dominant O O
negative O O
version O O
of O O
TRAF6 O O
failed B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
block I-NEGATION I-NEGATION
hToll-induced I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
stress-activated I-NEGATION I-NEGATION
protein I-NEGATION I-NEGATION
kinase I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
c-Jun I-NEGATION I-NEGATION
NH2-terminal I-NEGATION I-NEGATION
kinases I-NEGATION I-NEGATION
, O O
thus O O
suggesting B-SPECULATION B-SPECULATION
an I-SPECULATION I-SPECULATION
early I-SPECULATION I-SPECULATION
divergence I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
two I-SPECULATION I-SPECULATION
pathways I-SPECULATION I-SPECULATION
. O O

Coactivation O O
by O O
OCA-B O O
: O O
definition O O
of O O
critical O O
regions O O
and O O
synergism O O
with O O
general O O
cofactors O O
. O O

Molecular O O
dissection O O
of O O
the O O
B-cell-specific O O
transcription O O
coactivator O O
OCA-B O O
has O O
revealed O O
distinct O O
regions O O
important O O
, O O
respectively O O
, O O
for O O
recruitment O O
to O O
immunoglobulin O O
promoters O O
through O O
interaction O O
with O O
octamer-bound O O
Oct-1 O O
and O O
for O O
subsequent O O
coactivator O O
function O O
. O O

Further O O
analysis O O
of O O
general O O
coactivator O O
requirements O O
showed O O
that O O
selective O O
removal O O
of O O
PC4 O O
from O O
the O O
essential O O
USA O O
fraction O O
severely O O
impairs O O
Oct-1 O O
and O O
OCA-B O O
function O O
in O O
a O O
cell-free O O
system O O
reconstituted O O
with O O
partially O O
purified O O
factors O O
. O O

Full O O
activity O O
can O O
be O O
restored O O
by O O
the O O
combined O O
action O O
of O O
recombinant O O
PC4 O O
and O O
the O O
PC4-depleted O O
USA O O
fraction O O
, O O
thus O O
suggesting B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
joint I-SPECULATION I-SPECULATION
requirement I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
PC4 I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
another I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
USA-derived I-SPECULATION I-SPECULATION
component I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
s I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
optimal I-SPECULATION I-SPECULATION
function I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
Oct-1 I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
OCA-B I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
reconstituted I-SPECULATION I-SPECULATION
system I-SPECULATION I-SPECULATION
. O O

Indeed O O
, O O
USA-derived O O
PC2 O O
was O O
found O O
to O O
act O O
synergistically O O
with O O
PC4 O O
in O O
reproducing O O
the O O
function O O
of O O
intact O O
USA O O
in O O
the O O
assay O O
system O O
. O O

Consistent O O
with O O
the O O
requirement O O
for O O
PC4 O O
in O O
the O O
reconstituted O O
system O O
, O O
OCA-B O O
was O O
found O O
to O O
interact O O
directly O O
with O O
PC4 O O
. O O

Surprisingly O O
, O O
however O O
, O O
removal O O
of O O
PC4 O O
from O O
the O O
unfractionated O O
nuclear O O
extract O O
has O O
no B-NEGATION B-NEGATION
detrimental I-NEGATION I-NEGATION
effect I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
OCA-B I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
Oct-1-dependent I-NEGATION I-NEGATION
transcription I-NEGATION I-NEGATION
. O O

These O O
results O O
lead O O
to O O
a O O
general O O
model O O
for O O
the O O
synergistic O O
function O O
of O O
activation O O
domains O O
in O O
Oct-1 O O
and O O
OCA-B O O
( O O
mediated O O
by O O
the O O
combined O O
action O O
of O O
the O O
multiple O O
USA O O
components O O
) O O
and O O
, O O
further O O
, O O
suggest B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
functional I-SPECULATION I-SPECULATION
redundancy I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
general I-SPECULATION I-SPECULATION
coactivators I-SPECULATION I-SPECULATION
. O O

Limited O O
proteolysis O O
for O O
assaying O O
ligand O O
binding O O
affinities O O
of O O
nuclear O O
receptors O O
. O O

The O O
binding O O
of O O
natural O O
or O O
synthetic O O
ligands O O
to O O
nuclear O O
receptors O O
is O O
the O O
triggering O O
event O O
leading O O
to O O
gene O O
transcription O O
activation O O
or O O
repression O O
. O O

Ligand O O
binding O O
to O O
the O O
ligand O O
binding O O
domain O O
of O O
these O O
receptors O O
induces O O
conformational O O
changes O O
that O O
are O O
evidenced O O
by O O
an O O
increased O O
resistance O O
of O O
this O O
domain O O
to O O
proteases O O
. O O

In O O
vitro O O
labeled O O
receptors O O
were O O
incubated O O
with O O
various O O
synthetic O O
or O O
natural O O
agonists O O
or O O
antagonists O O
and O O
submitted O O
to O O
trypsin O O
digestion O O
. O O

Proteolysis O O
products O O
were O O
separated O O
by O O
SDS-PAGE O O
and O O
quantified O O
. O O

The O O
amount O O
of O O
trypsin-resistant O O
fragments O O
was O O
proportional O O
to O O
receptor O O
occupancy O O
by O O
the O O
ligand O O
, O O
and O O
allowed O O
the O O
determination O O
of O O
dissociation O O
constants O O
( O O
kDa O O
) O O
. O O

Using O O
the O O
wild-type O O
or O O
mutated O O
human O O
retinoic O O
acid O O
receptor O O
alpha O O
as O O
a O O
model O O
, O O
kDa O O
values O O
determined O O
by O O
classical O O
competition O O
binding O O
assays O O
using O O
tritiated O O
ligands O O
are O O
in O O
agreement O O
with O O
those O O
measured O O
by O O
the O O
proteolytic O O
assay O O
. O O

This O O
method O O
was O O
successfully O O
extended O O
to O O
human O O
retinoic O O
X O O
receptor O O
alpha O O
, O O
glucocorticoid O O
receptor O O
, O O
and O O
progesterone O O
receptor O O
, O O
thus O O
providing O O
a O O
basis O O
for O O
a O O
new O O
, O O
faster O O
assay O O
to O O
determine O O
simultaneously O O
the O O
affinity O O
and O O
conformation O O
of O O
receptors O O
when O O
bound O O
to O O
a O O
given O O
ligand O O
. O O

Mycobacterium O O
tuberculosis O O
mannose-capped O O
lipoarabinomannan O O
can O O
induce O O
NF-kappaB-dependent O O
activation O O
of O O
human O O
immunodeficiency O O
virus O O
type O O
1 O O
long O O
terminal O O
repeat O O
in O O
T O O
cells O O
. O O

Tuberculosis O O
has O O
emerged O O
as O O
an O O
epidemic O O
, O O
extended O O
by O O
the O O
large O O
number O O
of O O
individuals O O
infected O O
with O O
human O O
immunodeficiency O O
virus O O
type O O
1 O O
( O O
HIV-1 O O
) O O
. O O

The O O
major O O
goal O O
of O O
this O O
study O O
was O O
to O O
determine O O
whether B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
mycobacterial I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
wall I-SPECULATION I-SPECULATION
component I-SPECULATION I-SPECULATION
mannose-capped I-SPECULATION I-SPECULATION
lipoarabinomannan I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
ManLAM I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
Mycobacterium I-SPECULATION I-SPECULATION
tuberculosis I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
M. I-SPECULATION I-SPECULATION
tuberculosis I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
could I-SPECULATION I-SPECULATION
activate I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
HIV-1 I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
use I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
vitro I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
culture I-SPECULATION I-SPECULATION
system I-SPECULATION I-SPECULATION
. O O

These O O
experiments O O
are O O
of O O
prime O O
importance O O
considering O O
that O O
CD4-expressing O O
T O O
lymphocytes O O
represent O O
the O O
major O O
virus O O
reservoir O O
in O O
the O O
peripheral O O
blood O O
of O O
infected O O
individuals O O
. O O

Using O O
the O O
1G5 O O
cell O O
line O O
harbouring O O
the O O
luciferase O O
reporter O O
gene O O
under O O
the O O
control O O
of O O
the O O
HIV-1 O O
LTR O O
, O O
it O O
was O O
first O O
found O O
that O O
culture O O
protein O O
filtrates O O
( O O
CFP O O
) O O
from O O
M. O O
tuberculosis O O
or O O
purified O O
ManLAM O O
could O O
activate O O
HIV-1 O O
LTR-dependent O O
gene O O
expression O O
unlike O O
similarly O O
prepared O O
CFP O O
extracts O O
devoid O O
of O O
ManLAM O O
. O O

The O O
implication O O
of O O
protein O O
tyrosine O O
kinase O O
( O O
s O O
) O O
, O O
protein O O
kinase O O
A O O
and O O
/ O O
or O O
protein O O
kinase O O
C O O
was O O
highlighted O O
by O O
the O O
abrogation O O
of O O
the O O
ManLAM-mediated O O
activation O O
of O O
HIV-1 O O
LTR-driven O O
gene O O
expression O O
using O O
herbimycin O O
A O O
and O O
H7 O O
. O O

It O O
was O O
also O O
determined O O
, O O
using O O
electrophoresis O O
mobility O O
shift O O
assays O O
, O O
that O O
M. O O
tuberculosis O O
ManLAM O O
led O O
to O O
the O O
nuclear O O
translocation O O
of O O
the O O
transcription O O
factor O O
NF-kappaB O O
. O O

M. O O
tuberculosis O O
ManLAM O O
resulted O O
in O O
clear O O
induction O O
of O O
the O O
luciferase O O
gene O O
placed O O
under O O
the O O
control O O
of O O
the O O
wild-type O O
, O O
but O O
not B-NEGATION B-NEGATION
the I-NEGATION I-NEGATION
kappaB-mutated I-NEGATION I-NEGATION
, O I-NEGATION
HIV-1 O I-NEGATION
LTR O I-NEGATION
region O I-NEGATION
. O O

Finally O O
, O O
the O O
ManLAM-mediated O O
activation O O
of O O
HIV-1 O O
LTR O O
transcription O O
was O O
found O O
to O O
be O O
independent O O
of O O
the O O
autocrine O O
or O O
paracrine O O
action O O
of O O
endogenous O O
TNF-alpha O O
. O O

The O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
M. I-SPECULATION I-SPECULATION
tuberculosis I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
upregulate I-SPECULATION I-SPECULATION
HIV-1 I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
could B-SPECULATION B-SPECULATION
thus I-SPECULATION I-SPECULATION
have I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
potential I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
influence I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
pathogenesis I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
HIV-1 I-SPECULATION I-SPECULATION
infection I-SPECULATION I-SPECULATION
. O O

Oxidative O O
stress O O
suppresses O O
transcription O O
factor O O
activities O O
in O O
stimulated O O
lymphocytes O O
. O O

Effects O O
of O O
oxidative O O
stress O O
on O O
stimulation-dependent O O
signal O O
transduction O O
, O O
leading O O
to O O
IL-2 O O
expression O O
, O O
were O O
studied O O
. O O

Purified O O
quiescent O O
human O O
blood O O
T O O
lymphocytes O O
were O O
subjected O O
to O O
: O O
( O O
i O O
) O O
acute O O
exposure O O
to O O
hydrogen O O
peroxide O O
; O O
( O O
ii O O
) O O
chronic O O
exposure O O
to O O
hydrogen O O
peroxide O O
; O O
and O O
( O O
iii O O
) O O
acute O O
exposure O O
to O O
ionizing O O
radiation O O
. O O

The O O
cells O O
were O O
then O O
stimulated O O
for O O
6 O O
h O O
. O O

DNA-binding O O
activities O O
( O O
determined O O
by O O
the O O
electrophoretic O O
mobility O O
shift O O
assay O O
) O O
of O O
three O O
transcription O O
factors O O
: O O
NFkappaB O O
, O O
AP-1 O O
and O O
NFAT O O
, O O
were O O
abolished O O
in O O
the O O
lymphocytes O O
by O O
all O O
three O O
modes O O
of O O
oxidative O O
stress O O
. O O

The O O
lymphocytes O O
exhibited O O
lipid O O
peroxidation O O
only O O
upon O O
exposure O O
to O O
the O O
lowest O O
level O O
of O O
hydrogen O O
peroxide O O
used O O
( O O
20 O O
microM O O
) O O
. O O

All O O
three O O
modes O O
of O O
oxidative O O
stress O O
induced O O
catalase O O
activity O O
in O O
the O O
lymphocytes O O
. O O

The O O
only O O
exception O O
was O O
hydrogen O O
peroxide O O
at O O
20 O O
microM O O
, O O
which O O
did O O
not B-NEGATION B-NEGATION
induce I-NEGATION I-NEGATION
catalase I-NEGATION I-NEGATION
activity I-NEGATION I-NEGATION
. O O

We O O
conclude O O
that O O
: O O
( O O
i O O
) O O
suppression O O
of O O
specific O O
transcription O O
factor O O
functions O O
can O O
potentially B-SPECULATION B-SPECULATION
serve I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
marker I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
exposure I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
oxidative I-SPECULATION I-SPECULATION
stress I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
its I-SPECULATION I-SPECULATION
effects I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
lymphocytes I-SPECULATION I-SPECULATION
; O O
( O O
ii O O
) O O
lipid O O
peroxidation O O
is O O
only O O
detectable O O
in O O
human O O
lymphocytes O O
upon O O
exposure O O
to O O
weak O O
oxidative O O
stress O O
which O O
does O O
not B-NEGATION B-NEGATION
induce I-NEGATION I-NEGATION
catalase I-NEGATION I-NEGATION
activity I-NEGATION I-NEGATION
; O O
( O O
iii O O
) O O
therefore O O
, O O
transcription O O
factor O O
DNA-binding O O
activities O O
are O O
more O O
sensitive O O
to O O
oxidative O O
stress O O
than O O
lipid O O
peroxidation O O
. O O

DNA O O
damaging O O
agents O O
induce O O
expression O O
of O O
Fas O O
ligand O O
and O O
subsequent O O
apoptosis O O
in O O
T O O
lymphocytes O O
via O O
the O O
activation O O
of O O
NF-kappa O O
B O O
and O O
AP-1 O O
. O O

Apoptosis O O
induced O O
by O O
DNA O O
damage O O
and O O
other O O
stresses O O
can O O
proceed O O
via O O
expression O O
of O O
Fas O O
ligand O O
( O O
FasL O O
) O O
and O O
ligation O O
of O O
its O O
receptor O O
, O O
Fas O O
( O O
CD95 O O
) O O
. O O

We O O
report O O
that O O
activation O O
of O O
the O O
two O O
transcription O O
factors O O
NF-kappa O O
B O O
and O O
AP-1 O O
is O O
crucially O O
involved O O
in O O
FasL O O
expression O O
induced O O
by O O
etoposide O O
, O O
teniposide O O
, O O
and O O
UV O O
irradiation O O
. O O

A O O
nondegradable O O
mutant O O
of O O
I O O
kappa O O
B O O
blocked O O
both O O
FasL O O
expression O O
and O O
apoptosis O O
induced O O
by O O
DNA O O
damage O O
but O O
not B-NEGATION B-NEGATION
Fas I-NEGATION I-NEGATION
ligation I-NEGATION I-NEGATION
. O O

These O O
stimuli O O
also O O
induced O O
the O O
stress-activated O O
kinase O O
pathway O O
( O O
SAPK O O
/ O O
JNK O O
) O O
, O O
which O O
was O O
required O O
for O O
the O O
maximal O O
induction O O
of O O
apoptosis O O
. O O

A O O
1.2 O O
kb O O
FasL O O
promoter O O
responded O O
to O O
DNA O O
damage O O
, O O
as O O
well O O
as O O
coexpression O O
with O O
p65 O O
Rel O O
or O O
Fos O O
/ O O
Jun O O
. O O

Mutations O O
in O O
the O O
relevant O O
NF-kappa O O
B O O
and O O
AP-1 O O
binding O O
sites O O
eliminated O O
these O O
responses O O
. O O

Thus O O
, O O
activation O O
of O O
NF-kappa O O
B O O
and O O
AP-1 O O
contributes O O
to O O
stress-induced O O
apoptosis O O
via O O
the O O
expression O O
of O O
FasL O O
. O O

Thrombopoietin O O
supports O O
in O O
vitro O O
erythroid O O
differentiation O O
via O O
its O O
specific O O
receptor O O
c-Mpl O O
in O O
a O O
human O O
leukemia O O
cell O O
line O O
. O O

Thrombopoietin O O
( O O
TPO O O
) O O
acts O O
on O O
megakaryopoiesis O O
and O O
erythropoiesis O O
in O O
vitro O O
and O O
in O O
vivo O O
. O O

We O O
isolated O O
a O O
novel O O
subline O O
, O O
UT-7 O O
/ O O
GMT O O
, O O
from O O
the O O
human O O
leukemia O O
cell O O
line O O
UT-7 O O
/ O O
GM O O
( O O
N. O O
Komatsu O O
, O O
et O O
al. O O
, O O
Blood O O
, O O
89 O O
: O O
4021-4033 O O
, O O
1997 O O
) O O
. O O

A O O
small O O
population O O
of O O
UT-7 O O
/ O O
GM O O
cells O O
positively O O
stained O O
for O O
hemoglobin O O
( O O
Hb O O
) O O
after O O
a O O
7-day O O
exposure O O
to O O
TPO O O
. O O

More O O
than O O
50 O O
% O O
of O O
TPO-treated O O
UT-7 O O
/ O O
GMT O O
cells O O
positively O O
stained O O
for O O
Hb O O
. O O

Using O O
UT-7 O O
/ O O
GMT O O
cells O O
, O O
we O O
examined O O
how O O
TPO O O
promotes O O
hemoglobinization O O
. O O

TPO O O
induced O O
tyrosine O O
phosphorylation O O
of O O
the O O
TPO O O
receptor O O
but O O
not B-NEGATION B-NEGATION
the I-NEGATION I-NEGATION
erythropoietin I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
EPO I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
receptor I-NEGATION I-NEGATION
. O O

There O O
was O O
no B-NEGATION B-NEGATION
competition I-NEGATION I-NEGATION
between I-NEGATION I-NEGATION
TPO I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
EPO I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
binding I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
EPO I-NEGATION I-NEGATION
receptor I-NEGATION I-NEGATION
. O O

These O O
findings O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
TPO I-SPECULATION I-SPECULATION
has I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
direct I-SPECULATION I-SPECULATION
effect I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
hemoglobinization I-SPECULATION I-SPECULATION
via I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
specific I-SPECULATION I-SPECULATION
receptor I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
UT-7 I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
GMT I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

Isoelectric O O
focusing O O
demonstrated O O
that O O
TPO O O
induced O O
fetal O O
and O O
adult O O
Hb O O
synthesis O O
, O O
whereas O O
EPO O O
induced O O
embryonic O O
, O O
fetal O O
, O O
and O O
adult O O
Hb O O
synthesis O O
. O O

Thus O O
, O O
our O O
data O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
TPO I-SPECULATION I-SPECULATION
has I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
distinct I-SPECULATION I-SPECULATION
action I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
erythropoiesis I-SPECULATION I-SPECULATION
. O O

Redox O O
signals O O
and O O
NF-kappaB O O
activation O O
in O O
T O O
cells O O
. O O

Accumulating O O
data O O
from O O
a O O
number O O
of O O
laboratories O O
have O O
recently O O
indicated B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
response I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
alterations I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
redox I-SPECULATION I-SPECULATION
homeostasis I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
play I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
modulating I-SPECULATION I-SPECULATION
immune I-SPECULATION I-SPECULATION
function I-SPECULATION I-SPECULATION
. O O

The O O
activation O O
of O O
NF-kappaB O O
has O O
been O O
recognized O O
to O O
regulate O O
a O O
number O O
of O O
genes O O
necessary O O
for O O
normal O O
T O O
cell O O
responses O O
including O O
IL-2 O O
, O O
IL-6 O O
, O O
IL-8 O O
, O O
and O O
several O O
T O O
cell O O
surface O O
receptors O O
. O O

Diminished O O
NF-kappaB O O
activity O O
has O O
been O O
shown O O
to O O
occur O O
in O O
T O O
cells O O
with O O
aging O O
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
impaired I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
might B-SPECULATION B-SPECULATION
occur I-SPECULATION I-SPECULATION
during I-SPECULATION I-SPECULATION
cellular I-SPECULATION I-SPECULATION
senescence I-SPECULATION I-SPECULATION
. O O

In O O
addition O O
, O O
aberrancies O O
in O O
NF-kappaB O O
activity O O
have O O
been O O
implicated O O
in O O
the O O
immunopathogenesis O O
of O O
diseases O O
involving O O
immune O O
or O O
inflammatory O O
processes O O
such O O
as O O
atherosclerosis O O
and O O
HIV-1 O O
infection O O
. O O

The O O
role O O
of O O
H2O2 O O
and O O
other O O
reactive O O
oxygen O O
species O O
( O O
ROS O O
) O O
as O O
an O O
integratory O O
secondary O O
messenger O O
for O O
divergent O O
T O O
cell O O
signals O O
has O O
been O O
complicated O O
by O O
the O O
fact O O
that O O
various O O
T O O
cell O O
lines O O
and O O
peripheral O O
blood O O
T O O
cells O O
differ O O
markedly O O
in O O
the O O
levels O O
of O O
NF-kappaB O O
activation O O
induced O O
by O O
oxidant O O
stress O O
. O O

Additionally O O
, O O
proposed O O
pathways O O
of O O
NF-kappaB O O
activation O O
have O O
been O O
based O O
on O O
indirect O O
evidence O O
provided O O
by O O
experiments O O
which O O
used O O
antioxidants O O
to O O
inhibit O O
active O O
NF-kappaB O O
formation O O
. O O

Further O O
, O O
complete O O
activation O O
of O O
T O O
cells O O
requires O O
at O O
least O O
two O O
signals O O
, O O
one O O
that O O
stimulates O O
an O O
increase O O
in O O
intracellular O O
calcium O O
and O O
one O O
that O O
stimulates O O
enzymatic O O
processes O O
including O O
kinases O O
. O O

Similarly O O
, O O
substantial O O
evidence O O
indicates B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
full I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
requires I-SPECULATION I-SPECULATION
dual I-SPECULATION I-SPECULATION
signals I-SPECULATION I-SPECULATION
. O O

The O O
ability O O
of O O
H2O2 O O
or O O
other O O
ROS O O
to O O
induce O O
T O O
cell O O
signals O O
and O O
functional O O
responses O O
by O O
these O O
two O O
mechanisms O O
is O O
reviewed O O
and O O
the O O
specific O O
response O O
of O O
NF-kappaB O O
to O O
redox O O
changes O O
in O O
T O O
cells O O
is O O
examined O O
. O O

Data O O
are O O
also O O
presented O O
to O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
redox I-SPECULATION I-SPECULATION
regulation I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
relevant I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
immune-related I-SPECULATION I-SPECULATION
diseases I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
aging I-SPECULATION I-SPECULATION
. O O

Fibrinogen O O
activates O O
NF-kappa O O
B O O
transcription O O
factors O O
in O O
mononuclear O O
phagocytes O O
. O O

Adhesion O O
to O O
extracellular O O
matrices O O
is O O
known O O
to O O
modulate O O
leukocyte O O
activation O O
, O O
although O O
the B-SPECULATION B-NEGATION
mechanisms I-SPECULATION I-NEGATION
are I-SPECULATION I-NEGATION
not I-SPECULATION I-NEGATION
fully I-SPECULATION I-NEGATION
understood I-SPECULATION I-NEGATION
. O O

Mononuclear O O
phagocytes O O
are O O
exposed O O
to O O
fibrinous O O
provisional O O
matrix O O
throughout O O
migration O O
into O O
inflammatory O O
foci O O
, O O
so O O
this O O
study O O
was O O
undertaken O O
to O O
determine O O
whether B-SPECULATION B-SPECULATION
fibrinogen I-SPECULATION I-SPECULATION
triggers I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factors I-SPECULATION I-SPECULATION
. O O

U937 O O
cells O O
differentiated O O
with O O
PMA O O
in O O
nonadherent O O
culture O O
were O O
shown O O
to O O
express O O
two O O
fibrinogen-binding O O
integrins O O
, O O
predominately O O
CD11b O O
/ O O
CD18 O O
, O O
and O O
to O O
a O O
lesser O O
extent O O
, O O
CD11c O O
/ O O
CD18 O O
. O O

Cells O O
stimulated O O
with O O
fibrinogen O O
( O O
10-100 O O
microg O O
/ O O
ml O O
)/ O O
Mn2 O O
+ O O
( O O
50 O O
microM O O
) O O
for O O
2 O O
h O O
were O O
examined O O
by O O
electrophoretic O O
mobility O O
shift O O
assay O O
. O O

NF-kappa O O
B O O
activation O O
, O O
minimal O O
in O O
unstimulated O O
cells O O
, O O
was O O
substantially O O
up-regulated O O
by O O
fibrinogen O O
. O O

Fibrinogen O O
also O O
caused O O
activation O O
of O O
AP-1 O O
, O O
but O O
not B-NEGATION B-NEGATION
SP1 I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
cAMP I-NEGATION I-NEGATION
response I-NEGATION I-NEGATION
element-binding I-NEGATION I-NEGATION
protein I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
CREB I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
factors I-NEGATION I-NEGATION
. O O

Blocking O O
mAbs O O
against O O
CD18 O O
and O O
CD11b O O
abrogated O O
fibrinogen-induced O O
NF-kappa O O
B O O
activation O O
. O O

To O O
determine O O
the O O
effects O O
on O O
transcriptional O O
regulation O O
, O O
U937 O O
cells O O
were O O
transfected O O
with O O
a O O
plasmid O O
containing O O
the O O
HIV-1 O O
enhancer O O
( O O
bearing O O
two O O
NF-kappa O O
B O O
sites O O
) O O
coupled O O
to O O
a O O
chloramphenicol O O
acetyltransferase O O
( O O
CAT O O
) O O
reporter O O
. O O

Cells O O
were O O
subsequently O O
stimulated O O
with O O
1 O O
) O O
PMA O O
for O O
24 O O
h O O
, O O
inducing O O
CAT O O
activity O O
by O O
2.6-fold O O
, O O
2 O O
) O O
fibrinogen O O
/ O O
Mn2 O O
+ O O
for O O
2 O O
h O O
, O O
inducing O O
CAT O O
activity O O
by O O
3.2-fold O O
, O O
or O O
3 O O
) O O
costimulation O O
with O O
fibrinogen O O
and O O
PMA O O
, O O
inducing O O
5.7-fold O O
the O O
CAT O O
activity O O
induced O O
by O O
PMA O O
alone O O
. O O

We O O
conclude O O
that O O
contact O O
with O O
fibrinogen-derived O O
proteins O O
may B-SPECULATION B-SPECULATION
contribute I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
mononuclear I-SPECULATION I-SPECULATION
phagocyte I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
signaling I-SPECULATION I-SPECULATION
through I-SPECULATION I-SPECULATION
CD11b I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
CD18 I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
resulting I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
selective I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
transcriptional I-SPECULATION I-SPECULATION
regulatory I-SPECULATION I-SPECULATION
factors I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
including I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
. O O

Ex O O
vivo O O
activation O O
of O O
tumor-draining O O
lymph O O
node O O
T O O
cells O O
reverses O O
defects O O
in O O
signal O O
transduction O O
molecules O O
. O O

The O O
adoptive O O
transfer O O
of O O
tumor-draining O O
lymph O O
node O O
( O O
LN O O
) O O
T O O
cells O O
activated O O
ex O O
vivo O O
with O O
anti-CD3 O O
and O O
interleukin O O
2 O O
( O O
IL-2 O O
) O O
mediates O O
the O O
regression O O
of O O
the O O
poorly O O
immunogenic O O
murine O O
melanoma O O
D5 O O
. O O

The O O
efficacy O O
of O O
the O O
activated O O
LN O O
cells O O
is O O
augmented O O
when O O
the O O
sensitizing O O
tumor O O
is O O
a O O
genetically O O
modified O O
variant O O
( O O
designated O O
D5G6 O O
) O O
that O O
secretes O O
granulocyte O O
/ O O
macrophage-colony-stimulating O O
factor O O
. O O

In O O
contrast O O
to O O
anti-CD3 O O
/ O O
IL-2-activated O O
LN O O
cells O O
, O O
adoptive O O
transfer O O
of O O
freshly O O
isolated O O
tumor-draining O O
LN O O
T O O
cells O O
has O O
no B-NEGATION B-NEGATION
therapeutic I-NEGATION I-NEGATION
activity I-NEGATION I-NEGATION
. O O

To O O
determine O O
whether B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
acquisition I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
antitumor I-SPECULATION I-SPECULATION
function I-SPECULATION I-SPECULATION
during I-SPECULATION I-SPECULATION
ex I-SPECULATION I-SPECULATION
vivo I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
associated I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
modifications I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
signal I-SPECULATION I-SPECULATION
transduction I-SPECULATION I-SPECULATION
capacity I-SPECULATION I-SPECULATION
, O O
the O O
protein O O
tyrosine O O
kinases O O
p56lck O O
and O O
p59fyn O O
and O O
proteins O O
of O O
the O O
NF-kappaB O O
family O O
were O O
analyzed O O
in O O
tumor-draining O O
LN O O
T O O
cells O O
. O O

The O O
levels O O
of O O
p56lck O O
and O O
p59fyn O O
were O O
lower O O
in O O
tumor-draining O O
than O O
in O O
normal O O
LN O O
T O O
cells O O
and O O
production O O
of O O
tyrosine-phosphorylated O O
substrates O O
was O O
markedly O O
depressed O O
following O O
anti-CD3 O O
stimulation O O
. O O

After O O
5-day O O
anti-CD3 O O
/ O O
IL-2 O O
activation O O
, O O
levels O O
of O O
p56lck O O
and O O
p59fyn O O
and O O
protein O O
tyrosine O O
kinase O O
activity O O
increased O O
. O O

Interestingly O O
, O O
the O O
levels O O
of O O
p56lck O O
, O O
p59fyn O O
, O O
and O O
tyrosine O O
kinase O O
activity O O
were O O
higher O O
in O O
activated O O
T O O
cells O O
derived O O
from O O
LN O O
that O O
drained O O
D5G6 O O
than O O
they O O
were O O
in O O
those O O
from O O
D5 O O
tumors O O
. O O

In O O
contrast O O
, O O
the O O
cytoplasmic O O
levels O O
of O O
c-Rel O O
and O O
Rel O O
A O O
were O O
normal O O
in O O
freshly O O
isolated O O
tumor-draining O O
LN O O
, O O
as O O
was O O
nuclear O O
kappaB O O
DNA-binding O O
activity O O
induced O O
by O O
anti-CD3 O O
mAb O O
or O O
phorbol O O
myristate O O
acetate O O
. O O

Stimulation O O
of O O
activated O O
LN O O
cells O O
with O O
D5 O O
tumor O O
cells O O
induced O O
the O O
nuclear O O
translocation O O
of O O
NF-kappaB O O
. O O

These O O
findings O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
recovery I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
proteins I-SPECULATION I-SPECULATION
mediating I-SPECULATION I-SPECULATION
signal I-SPECULATION I-SPECULATION
transduction I-SPECULATION I-SPECULATION
through I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
receptor I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
CD3 I-SPECULATION I-SPECULATION
complex I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
LN I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
activated I-SPECULATION I-SPECULATION
ex I-SPECULATION I-SPECULATION
vivo I-SPECULATION I-SPECULATION
was I-SPECULATION I-SPECULATION
associated I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
acquisition I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
antitumor I-SPECULATION I-SPECULATION
function I-SPECULATION I-SPECULATION
. O O

Targeted O O
disruption O O
of O O
the O O
MyD88 O O
gene O O
results O O
in O O
loss O O
of O O
IL-1 O O
- O O
and O O
IL-18-mediated O O
function O O
. O O

MyD88 O O
, O O
originally O O
isolated O O
as O O
a O O
myeloid O O
differentiation O O
primary O O
response O O
gene O O
, O O
is O O
shown O O
to O O
act O O
as O O
an O O
adaptor O O
in O O
interleukin-1 O O
( O O
IL-1 O O
) O O
signaling O O
by O O
interacting O O
with O O
both O O
the O O
IL-1 O O
receptor O O
complex O O
and O O
IL-1 O O
receptor-associated O O
kinase O O
( O O
IRAK O O
) O O
. O O

Mice O O
generated O O
by O O
gene O O
targeting O O
to O O
lack B-NEGATION B-NEGATION
MyD88 I-NEGATION I-NEGATION
have O O
defects O O
in O O
T O O
cell O O
proliferation O O
as O O
well O O
as O O
induction O O
of O O
acute O O
phase O O
proteins O O
and O O
cytokines O O
in O O
response O O
to O O
IL-1 O O
. O O

Increases O O
in O O
interferon-gamma O O
production O O
and O O
natural O O
killer O O
cell O O
activity O O
in O O
response O O
to O O
IL-18 O O
are O O
abrogated O O
. O O

In O O
vivo O O
Th1 O O
response O O
is O O
also O O
impaired O O
. O O

Furthermore O O
, O O
IL-18-induced O O
activation O O
of O O
NF-kappaB O O
and O O
c-Jun O O
N-terminal O O
kinase O O
( O O
JNK O O
) O O
is O O
blocked O O
in O O
MyD88 O O
-/- O O
Th1-developing O O
cells O O
. O O

Taken O O
together O O
, O O
these O O
results O O
demonstrate O O
that O O
MyD88 O O
is O O
a O O
critical O O
component O O
in O O
the O O
signaling O O
cascade O O
that O O
is O O
mediated O O
by O O
IL-1 O O
receptor O O
as O O
well O O
as O O
IL-18 O O
receptor O O
. O O

Epstein-Barr O O
virus-transforming O O
protein O O
latent O O
infection O O
membrane O O
protein O O
1 O O
activates O O
transcription O O
factor O O
NF-kappaB O O
through O O
a O O
pathway O O
that O O
includes O O
the O O
NF-kappaB-inducing O O
kinase O O
and O O
the O O
IkappaB O O
kinases O O
IKKalpha O O
and O O
IKKbeta O O
. O O

The O O
Epstein-Barr O O
virus O O
oncoprotein O O
latent O O
infection O O
membrane O O
protein O O
1 O O
( O O
LMP1 O O
) O O
is O O
a O O
constitutively O O
aggregated O O
pseudo-tumor O O
necrosis O O
factor O O
receptor O O
( O O
TNFR O O
) O O
that O O
activates O O
transcription O O
factor O O
NF-kappaB O O
through O O
two O O
sites O O
in O O
its O O
C-terminal O O
cytoplasmic O O
domain O O
. O O

One O O
site O O
is O O
similar O O
to O O
activated O O
TNFRII O O
in O O
associating O O
with O O
TNFR-associated O O
factors O O
TRAF1 O O
and O O
TRAF2 O O
, O O
and O O
the O O
second O O
site O O
is O O
similar O O
to O O
TNFRI O O
in O O
associating O O
with O O
the O O
TNFRI O O
death O O
domain O O
interacting O O
protein O O
TRADD O O
. O O

TNFRI O O
has O O
been O O
recently O O
shown O O
to O O
activate O O
NF-kappaB O O
through O O
association O O
with O O
TRADD O O
, O O
RIP O O
, O O
and O O
TRAF2 O O
; O O
activation O O
of O O
the O O
NF-kappaB-inducing O O
kinase O O
( O O
NIK O O
) O O
; O O
activation O O
of O O
the O O
IkappaB O O
alpha O O
kinases O O
( O O
IKKalpha O O
and O O
IKKbeta O O
) O O
; O O
and O O
phosphorylation O O
of O O
IkappaB O O
alpha O O
. O O

IkappaB O O
alpha O O
phosphorylation O O
on O O
Ser-32 O O
and O O
Ser-36 O O
is O O
followed O O
by O O
its O O
degradation O O
and O O
NF-kappaB O O
activation O O
. O O

In O O
this O O
report O O
, O O
we O O
show O O
that O O
NF-kappaB O O
activation O O
by O O
LMP1 O O
or O O
by O O
each O O
of O O
its O O
effector O O
sites O O
is O O
mediated O O
by O O
a O O
pathway O O
that O O
includes O O
NIK O O
, O O
IKKalpha O O
, O O
and O O
IKKbeta O O
. O O

Dominant O O
negative O O
mutants O O
of O O
NIK O O
, O O
IKKalpha O O
, O O
or O O
IKKbeta O O
substantially O O
inhibited O O
NF-kappaB O O
activation O O
by O O
LMP1 O O
or O O
by O O
each O O
of O O
its O O
effector O O
sites O O
. O O

Dimethyldithiocarbamate O O
inhibits O O
in O O
vitro O O
activation O O
of O O
primary O O
human O O
CD4 O O
+ O O
T O O
lymphocytes O O
. O O

Dithiocarbamates O O
( O O
DTC O O
) O O
, O O
a O O
diverse O O
group O O
of O O
industrial O O
and O O
therapeutic O O
chemicals O O
, O O
have O O
been O O
reported O O
to O O
inhibit O O
, O O
enhance O O
or O O
have O O
no B-NEGATION B-NEGATION
effect I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
immune I-NEGATION I-NEGATION
system I-NEGATION I-NEGATION
. O O

These O O
apparent O O
inconsistencies O O
reflect O O
the O O
complexity O O
of O O
the O O
DTCs O O
biological O O
activities O O
and O O
are O O
probably B-SPECULATION B-SPECULATION
due I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
part I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
differences I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
dose I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
route I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
exposure I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
animal I-SPECULATION I-SPECULATION
species I-SPECULATION I-SPECULATION
used I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
specific I-SPECULATION I-SPECULATION
compound I-SPECULATION I-SPECULATION
tested I-SPECULATION I-SPECULATION
. O O

The O O
studies O O
described O O
herein O O
were O O
undertaken O O
to O O
investigate O O
the O O
immunotoxicity O O
of O O
one O O
member O O
of O O
this O O
family O O
, O O
dimethyldithiocarbamate O O
( O O
DMDTC O O
) O O
. O O

We O O
demonstrate O O
that O O
0.1-0.5 O O
microM O O
DMDTC O O
inhibits O O
TNF-alpha-induced O O
activation O O
of O O
NF-kappaB O O
in O O
primary O O
human O O
CD4 O O
+ O O
T O O
cells O O
. O O

This B-NEGATION B-NEGATION
inhibition I-NEGATION I-NEGATION
is I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
accompanied I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
a I-NEGATION I-NEGATION
loss I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
viability I-NEGATION I-NEGATION
, O O
and O O
DMDTC-treated O O
T O O
cells O O
retain O O
other O O
active O O
signaling O O
pathways O O
throughout O O
the O O
exposure O O
duration O O
. O O

The O O
inhibition O O
of O O
NF-kappaB O O
is O O
apparently O O
permanent O O
as O O
DMDTC-treated O O
T O O
cells O O
did O O
not B-NEGATION B-NEGATION
regain I-NEGATION I-NEGATION
normal I-NEGATION I-NEGATION
TNF-alpha I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
, I-NEGATION O
even I-NEGATION O
after I-NEGATION O
72 I-NEGATION O
h I-NEGATION O
in I-NEGATION O
culture I-NEGATION O
. O O

DMDTC B-SPECULATION B-SPECULATION
does I-SPECULATION I-SPECULATION
not I-SPECULATION I-SPECULATION
appear I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
alter I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
directly I-SPECULATION I-SPECULATION
as O O
pre-incubation O O
of O O
nuclear O O
extracts O O
with O O
DMDTC O O
does O O
not B-NEGATION B-NEGATION
diminish I-NEGATION I-NEGATION
binding I-NEGATION I-NEGATION
activity I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
this I-NEGATION I-NEGATION
protein I-NEGATION I-NEGATION
. O O

We O O
further O O
demonstrate O O
that O O
0.1-0.5 O O
microM O O
DMDTC O O
inhibits O O
intracellular O O
IL-2 O O
production O O
and O O
decreases O O
surface O O
expression O O
of O O
CD25 O O
( O O
the O O
alpha O O
subunit O O
of O O
the O O
IL-2 O O
receptor O O
) O O
in O O
T O O
cells O O
stimulated O O
with O O
phorbol O O
ester O O
. O O

These O O
data O O
demonstrate O O
that O O
DMDTC O O
is O O
a O O
potent O O
immunosuppressive O O
compound O O
in O O
vitro O O
. O O

The O O
small O O
GTP-binding O O
protein O O
Rho O O
potentiates O O
AP-1 O O
transcription O O
in O O
T O O
cells O O
. O O

The O O
Rho O O
family O O
of O O
small O O
GTP-binding O O
proteins O O
is O O
involved O O
in O O
the O O
regulation O O
of O O
cytoskeletal O O
structure O O
, O O
gene O O
transcription O O
, O O
specific O O
cell O O
fate O O
development O O
, O O
and O O
transformation O O
. O O

We O O
demonstrate O O
in O O
this O O
report O O
that O O
overexpression O O
of O O
an O O
activated O O
form O O
of O O
Rho O O
enhances O O
AP-1 O O
activity O O
in O O
Jurkat O O
T O O
cells O O
in O O
the O O
presence O O
of O O
phorbol O O
myristate O O
acetate O O
( O O
PMA O O
) O O
, O O
but O O
activated O O
Rho O O
( O O
V14Rho O O
) O O
has O O
little O O
or O O
no B-NEGATION B-NEGATION
effect I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
NFAT I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
Oct-1 I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
NF-kappaB I-NEGATION I-NEGATION
enhancer I-NEGATION I-NEGATION
element I-NEGATION I-NEGATION
activities I-NEGATION I-NEGATION
under I-NEGATION I-NEGATION
similar I-NEGATION I-NEGATION
conditions I-NEGATION I-NEGATION
. O O

Overexpression O O
of O O
a O O
V14Rho O O
construct O O
incapable O O
of O O
membrane O O
localization O O
( O O
CAAX O O
deleted O O
) O O
abolishes O O
PMA-induced O O
AP-1 O O
transcriptional O O
activation O O
. O O

The O O
effect O O
of O O
Rho O O
on O O
AP-1 O O
is O O
independent O O
of O O
the O O
mitogen-activated O O
protein O O
kinase O O
pathway O O
, O O
as O O
a O O
dominant-negative O O
MEK O O
and O O
a O O
MEK O O
inhibitor O O
( O O
PD98059 O O
) O O
did O O
not B-NEGATION B-NEGATION
affect I-NEGATION I-NEGATION
Rho-induced I-NEGATION I-NEGATION
AP-1 I-NEGATION I-NEGATION
activity I-NEGATION I-NEGATION
. O O

V14Rho O O
binds O O
strongly O O
to O O
protein O O
kinase O O
Calpha O O
( O O
PKCalpha O O
) O O
in O O
vivo O O
; O O
however O O
, O O
deletion O O
of O O
the O O
CAAX O O
site O O
on O O
V14Rho O O
severely O O
diminished O O
this O O
association O O
. O O

Evidence O O
for O O
a O O
role O O
for O O
PKCalpha O O
as O O
an O O
effector O O
of O O
Rho O O
was O O
obtained O O
by O O
the O O
observation O O
that O O
coexpression O O
of O O
the O O
N-terminal O O
domain O O
of O O
PKCalpha O O
blocked O O
the O O
effects O O
of O O
activated O O
Rho O O
plus O O
PMA O O
on O O
AP-1 O O
transcriptional O O
activity O O
. O O

These O O
data O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
Rho I-SPECULATION I-SPECULATION
potentiates I-SPECULATION I-SPECULATION
AP-1 I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
during I-SPECULATION I-SPECULATION
T-cell I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
. O O

Human O O
T-cell O O
leukemia O O
virus O O
type O O
1 O O
Tax O O
induction O O
of O O
NF-kappaB O O
involves O O
activation O O
of O O
the O O
IkappaB O O
kinase O O
alpha O O
( O O
IKKalpha O O
) O O
and O O
IKKbeta O O
cellular O O
kinases O O
. O O

Tax O O
corresponds O O
to O O
a O O
40-kDa O O
transforming O O
protein O O
from O O
the O O
pathogenic O O
retrovirus O O
human O O
T-cell O O
leukemia O O
virus O O
type O O
1 O O
( O O
HTLV-1 O O
) O O
that O O
activates O O
nuclear O O
expression O O
of O O
the O O
NF-kappaB O O
/ O O
Rel O O
family O O
of O O
transcription O O
factors O O
by O O
an O O
unknown B-SPECULATION O
mechanism I-SPECULATION O
. O O

Tax O O
expression O O
promotes O O
N-terminal O O
phosphorylation O O
and O O
degradation O O
of O O
IkappaB O O
alpha O O
, O O
a O O
principal O O
cytoplasmic O O
inhibitor O O
of O O
NF-kappaB O O
. O O

Our O O
studies O O
now O O
demonstrate O O
that O O
HTLV-1 O O
Tax O O
activates O O
the O O
recently O O
identified O O
cellular O O
kinases O O
IkappaB O O
kinase O O
alpha O O
( O O
IKKalpha O O
) O O
and O O
IKKbeta O O
, O O
which O O
normally O O
phosphorylate O O
IkappaB O O
alpha O O
on O O
both O O
of O O
its O O
N-terminal O O
regulatory O O
serines O O
in O O
response O O
to O O
tumor O O
necrosis O O
factor O O
alpha O O
( O O
TNF-alpha O O
) O O
and O O
interleukin-1 O O
( O O
IL-1 O O
) O O
stimulation O O
. O O

In O O
contrast O O
, O O
a O O
mutant O O
of O O
Tax O O
termed O O
M22 O O
, O O
which O O
does O O
not B-NEGATION B-NEGATION
induce I-NEGATION I-NEGATION
NF-kappaB I-NEGATION I-NEGATION
, O O
fails B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
activate I-NEGATION I-NEGATION
either I-NEGATION I-NEGATION
IKKalpha I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
IKKbeta I-NEGATION I-NEGATION
. O O

Furthermore O O
, O O
endogenous O O
IKK O O
enzymatic O O
activity O O
was O O
significantly O O
elevated O O
in O O
HTLV-1-infected O O
and O O
Tax-expressing O O
T-cell O O
lines O O
. O O

Transfection O O
of O O
kinase-deficient O O
mutants O O
of O O
IKKalpha O O
and O O
IKKbeta O O
into O O
either O O
human O O
Jurkat O O
T O O
or O O
293 O O
cells O O
also O O
inhibits O O
NF-kappaB-dependent O O
reporter O O
gene O O
expression O O
induced O O
by O O
Tax O O
. O O

Similarly O O
, O O
a O O
kinase-deficient O O
mutant O O
of O O
NIK O O
( O O
NF-kappaB-inducing O O
kinase O O
) O O
, O O
which O O
represents O O
an O O
upstream O O
kinase O O
in O O
the O O
TNF-alpha O O
and O O
IL-1 O O
signaling O O
pathways O O
leading O O
to O O
IKKalpha O O
and O O
IKKbeta O O
activation O O
, O O
blocks O O
Tax O O
induction O O
of O O
NF-kappaB O O
. O O

However O O
, O O
plasma O B-NEGATION
membrane-proximal O I-NEGATION
elements O I-NEGATION
in O I-NEGATION
these O I-NEGATION
proinflammatory O I-NEGATION
cytokine O I-NEGATION
pathways O I-NEGATION
are O I-NEGATION
apparently O I-NEGATION
not B-NEGATION I-NEGATION
involved I-NEGATION I-NEGATION
since O O
dominant O O
negative O O
mutants O O
of O O
the O O
TRAF2 O O
and O O
TRAF6 O O
adaptors O O
, O O
which O O
effectively O O
block O O
signaling O O
through O O
the O O
cytoplasmic O O
tails O O
of O O
the O O
TNF-alpha O O
and O O
IL-1 O O
receptors O O
, O O
respectively O O
, O O
do O O
not B-NEGATION B-NEGATION
inhibit I-NEGATION I-NEGATION
Tax I-NEGATION I-NEGATION
induction I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
NF-kappaB I-NEGATION I-NEGATION
. O O

Together O O
, O O
these O O
studies O O
demonstrate O O
that O O
HTLV-1 O O
Tax O O
exploits O O
a O O
distal O O
part O O
of O O
the O O
proinflammatory O O
cytokine O O
signaling O O
cascade O O
leading O O
to O O
induction O O
of O O
NF-kappaB O O
. O O

The O O
pathological O O
alteration O O
of O O
this O O
cytokine O O
pathway O O
leading O O
to O O
NF-kappaB O O
activation O O
by O O
Tax O O
may B-SPECULATION B-SPECULATION
play I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
central I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
HTLV-1-mediated I-SPECULATION I-SPECULATION
transformation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
clinically I-SPECULATION I-SPECULATION
manifested I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
adult I-SPECULATION I-SPECULATION
T-cell I-SPECULATION I-SPECULATION
leukemia I-SPECULATION I-SPECULATION
. O O

A O O
CD28-associated O O
signaling O O
pathway O O
leading O O
to O O
cytokine O O
gene O O
transcription O O
and O O
T O O
cell O O
proliferation O O
without B-NEGATION B-NEGATION
TCR I-NEGATION I-NEGATION
engagement I-NEGATION I-NEGATION
. O O

Stimulation O O
of O O
resting O O
human O O
T O O
cells O O
with O O
the O O
CD28-specific O O
mAb O O
BW O O
828 O O
induces O O
proliferation O O
and O O
cytokine O O
synthesis O O
without B-NEGATION B-NEGATION
further I-NEGATION I-NEGATION
requirement I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
TCR I-NEGATION I-NEGATION
coengagement I-NEGATION I-NEGATION
. O O

This O O
observation O O
prompted O O
us O O
to O O
postulate O B-SPECULATION
that O I-SPECULATION
signal O I-SPECULATION
2 O I-SPECULATION
( O I-SPECULATION
costimulatory O I-SPECULATION
signal O I-SPECULATION
) O I-SPECULATION
alone O I-SPECULATION
without B-NEGATION B-NEGATION
signal I-NEGATION I-NEGATION
1 I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
TCR I-NEGATION I-NEGATION
signal I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
can O I-NEGATION
activate O I-NEGATION
T O I-NEGATION
cells O I-NEGATION
. O O

To O O
test O O
whether B-SPECULATION B-SPECULATION
this I-SPECULATION I-SPECULATION
, O O
we O O
compared O O
early O O
signaling O O
events O O
initiated O O
in O O
resting O O
T O O
cells O O
by O O
the O O
stimulatory O O
mAb O O
BW O O
828 O O
with O O
signals O O
triggered O O
by O O
the O O
nonstimulating O O
CD28 O O
mAb O O
9.3 O O
. O O
putative B-SPECULATION B-SPECULATION
function I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
CD28 I-SPECULATION I-SPECULATION
is O I-SPECULATION
mediated O I-SPECULATION
via O I-SPECULATION
a O I-SPECULATION
particular O I-SPECULATION
signaling O I-SPECULATION
pathway O I-SPECULATION
. O O

Stimulation O O
of O O
T O O
cells O O
with O O
BW O O
828 O O
induced O O
an O O
increase O O
in O O
intracellular O O
Ca2 O O
+ O O
, O O
but O O
did O O
not B-NEGATION B-NEGATION
lead I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
detectable I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
protein I-NEGATION I-NEGATION
kinases I-NEGATION I-NEGATION
p56 I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
lck I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
c-Raf-1 I-NEGATION I-NEGATION
. O O

This O O
pathway O O
resulted O O
in O O
the O O
induction O O
of O O
the O O
transcription O O
factors O O
NF-kappa O O
B O O
, O O
NF-AT O O
, O O
and O O
proteins O O
binding O O
to O O
the O O
CD28 O O
response O O
element O O
of O O
the O O
IL-2 O O
promoter O O
. O O

On O O
the O O
other O O
hand O O
, O O
stimulation O O
of O O
T O O
cells O O
with O O
mAb O O
9.3 O O
increased O O
the O O
level O O
of O O
intracellular O O
Ca2 O O
+ O O
and O O
triggered O O
the O O
activation O O
of O O
p56 O O
( O O
lck O O
) O O
and O O
c-Raf-1 O O
, O O
but O O
was B-NEGATION O
unable I-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
induce I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
binding I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
transcription I-NEGATION I-NEGATION
factors I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
IL-2 I-NEGATION I-NEGATION
promoter I-NEGATION I-NEGATION
. O O

In O O
contrast O O
to O O
the O O
differential O O
signaling O O
of O O
BW O O
828 O O
and O O
9.3 O O
in O O
resting O O
T O O
cells O O
, O O
the O O
two O O
mAbs O O
exhibited O O
a O O
similar O O
pattern O O
of O O
early O O
signaling O O
events O O
in O O
activated O O
T O O
cells O O
and O O
Jurkat O O
cells O O
( O O
p56 O O
( O O
lck O O
) O O
activation O O
, O O
association O O
of O O
phosphatidylinositol O O
3-kinase O O
with O O
CD28 O O
) O O
, O O
indicating B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
signaling I-SPECULATION I-SPECULATION
capacity I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
CD28 I-SPECULATION I-SPECULATION
changes I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
. O O

These O O
data O O
support O O
the O O
view O O
that O O
stimulation O O
through O O
CD28 O O
can O O
induce O O
some O O
effector O O
functions O O
in O O
T O O
cells O O
and O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
capacity I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
associated I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
particular I-SPECULATION I-SPECULATION
pattern I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
early I-SPECULATION I-SPECULATION
signaling I-SPECULATION I-SPECULATION
events I-SPECULATION I-SPECULATION
. O O

Cyclosporin O O
A-resistant O O
transactivation O O
of O O
the O O
IL-2 O O
promoter O O
requires O O
activity O O
of O O
okadaic O O
acid-sensitive O O
serine O O
/ O O
threonine O O
phosphatases O O
. O O

Expression O O
of O O
the O O
IL-2 O O
gene O O
requires O O
activation O O
of O O
T O O
cells O O
through O O
stimulation O O
of O O
the O O
TCR O O
and O O
costimulation O O
through O O
accessory O O
receptors O O
. O O

We O O
have O O
found O O
recently O O
that O O
okadaic O O
acid-sensitive O O
Ser O O
/ O O
Thr O O
phosphatases O O
are O O
involved O O
in O O
a O O
cyclosporin O O
A-insensitive O O
pathway O O
that O O
selectively O O
transmits O O
costimulatory O O
signals O O
. O O

In O O
this O O
study O O
, O O
we O O
analyzed O O
whether B-SPECULATION B-SPECULATION
activities I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
phosphatases I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
necessary I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
IL-2 I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
. O O

In O O
both O O
activated O O
peripheral O O
blood O O
T O O
lymphocytes O O
and O O
activated O O
tumorigenic O O
T O O
cell O O
lines O O
, O O
IL-2 O O
gene O O
expression O O
was O O
blocked O O
at O O
the O O
transcriptional O O
level O O
by O O
okadaic O O
acid O O
. O O

The O O
transcription O O
factors O O
active O O
at O O
the O O
IL-2 O O
promoter O O
were O O
differentially O O
influenced O O
: O O
upon O O
down-modulation O O
of O O
okadaic O O
acid-sensitive O O
phosphatases O O
, O O
transactivation O O
by O O
octamer O O
, O O
NF-kappa O O
B O O
, O O
and O O
NF O O
of O O
activated O O
T O O
cells O O
proteins O O
was O O
abrogated O O
, O O
while O O
transactivation O O
by O O
AP-1 O O
proteins O O
was O O
even O O
enhanced O O
. O O

Inducible O O
nitric O O
oxide O O
: O O
an O O
autoregulatory O O
feedback O O
inhibitor O O
of O O
vascular O O
inflammation O O
. O O

Inducible O O
nitric O O
oxide O O
( O O
iNO O O
) O O
is O O
produced O O
at O O
sites O O
of O O
vascular O O
inflammation O O
by O O
resident O O
and O O
nonresident O O
vascular O O
wall O O
cells O O
, O O
but O O
its B-SPECULATION B-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
inflammatory I-SPECULATION I-SPECULATION
process I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
not I-SPECULATION I-SPECULATION
known I-SPECULATION I-SPECULATION
. O O

In O O
this O O
study O O
, O O
we O O
show O O
that O O
a O O
novel O O
function O O
of O O
iNO O O
is O O
to O O
terminate O O
inflammatory O O
processes O O
. O O

We O O
find O O
that O O
iNO O O
produced O O
by O O
murine O O
macrophage-like O O
cells O O
, O O
RAW264.7 O O
, O O
can O O
inhibit O O
cytokine-induced O O
endothelial O O
cell O O
activation O O
in O O
a O O
separated O O
and O O
mixed O O
endothelial-RAW264.7 O O
coculture O O
system O O
. O O

Both O O
iNO O O
production O O
and O O
endothelial O O
VCAM-1 O O
expression O O
were O O
induced O O
simultaneously O O
with O O
bacterial O O
LPS O O
and O O
murine-specific O O
IFN-gamma O O
. O O

Inhibition O O
of O O
iNO O O
synthase O O
( O O
iNOS O O
) O O
activity O O
with O O
N O O
omega-monomethyl-L-arginine O O
in O O
endothelial-RAW264.7 O O
cocultures O O
, O O
stimulated O O
with O O
murine-specific O O
IFN-gamma O O
and O O
LPS O O
, O O
decreased O O
iNO O O
production O O
by O O
86 O O
% O O
, O O
augmented O O
VCAM-1 O O
and O O
iNOS O O
expression O O
in O O
endothelial O O
and O O
RAW264.7 O O
cells O O
, O O
respectively O O
, O O
and O O
increased O O
monocyte O O
adhesion O O
to O O
the O O
endothelial O O
cell O O
surface O O
. O O

Transient O O
transfection O O
studies O O
using O O
various O O
VCAM-1 O O
promoter O O
constructs O O
demonstrated O O
that O O
inhibitory O O
effects O O
of O O
iNO O O
on O O
VCAM-1 O O
gene O O
transcription O O
were O O
mediated O O
, O O
in O O
part O O
, O O
by O O
inhibitory O O
effects O O
of O O
iNO O O
on O O
kappa O O
B O O
cis-acting O O
elements O O
. O O

Immunofluorescence O O
studies O O
using O O
an O O
Ab O O
to O O
the O O
RelA O O
( O O
p65 O O
) O O
subunit O O
of O O
nuclear O O
factor-kappa O O
B O O
revealed O O
that O O
iNO O O
inhibited O O
the O O
activation O O
of O O
nuclear O O
factor-kappa O O
B O O
. O O

These O O
studies O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
iNO I-SPECULATION I-SPECULATION
attenuates I-SPECULATION I-SPECULATION
iNOS I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
macrophages I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
inhibits I-SPECULATION I-SPECULATION
monocyte I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
endothelial I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
, O O
and O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
endogenously I-SPECULATION I-SPECULATION
derived I-SPECULATION I-SPECULATION
iNO I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
autoregulatory I-SPECULATION I-SPECULATION
inhibitor I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
vascular I-SPECULATION I-SPECULATION
inflammation I-SPECULATION I-SPECULATION
. O O

Characterization O O
of O O
cytokine O O
differential O O
induction O O
of O O
STAT O O
complexes O O
in O O
primary O O
human O O
T O O
and O O
NK O O
cells O O
. O O

Cytokines O O
, O O
IL-2 O O
, O O
IL-4 O O
, O O
IL-6 O O
, O O
IL-7 O O
, O O
IL-12 O O
, O O
and O O
IL-15 O O
are O O
key O O
regulators O O
of O O
human O O
peripheral O O
blood O O
T O O
and O O
NK O O
cell O O
activation O O
and O O
differentiation O O
but O O
the B-SPECULATION B-SPECULATION
precise I-SPECULATION I-SPECULATION
mechanisms I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
give I-SPECULATION I-SPECULATION
rise I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
their I-SPECULATION I-SPECULATION
differential I-SPECULATION I-SPECULATION
activities I-SPECULATION I-SPECULATION
within I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
not I-SPECULATION I-SPECULATION
clear I-SPECULATION I-SPECULATION
. O O

Recent O O
studies O O
reveal O O
that O O
a O O
family O O
of O O
transcription O O
factors O O
, O O
signal O O
transducers O O
and O O
activators O O
of O O
transcription O O
( O O
STATs O O
) O O
directly O O
mediate O O
many O O
cytokine O O
signals O O
. O O

We O O
analyzed O O
the O O
activation O O
of O O
STATs O O
in O O
primary O O
human O O
T O O
and O O
NK O O
cells O O
by O O
a O O
variety O O
of O O
specific O O
cytokines O O
. O O

We O O
demonstrate O O
that O O
IL-12 O O
induces O O
STAT4 O O
only O O
in O O
freshly O O
isolated O O
primary O O
NK O O
cells O O
, O O
but O O
not B-NEGATION B-NEGATION
in I-NEGATION I-NEGATION
primary I-NEGATION I-NEGATION
T I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
, O O
consistent O O
with O O
the O O
lack B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
IL-12 I-NEGATION I-NEGATION
receptor I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
resting I-NEGATION I-NEGATION
T I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
. O O

In O O
contrast O O
, O O
IL-4 O O
induces O O
different O O
C O O
epsilon O O
GAS O O
DNA-protein O O
binding O O
complexes O O
in O O
both O O
T O O
and O O
NK O O
cells O O
. O O

Moreover O O
, O O
IL-4 O O
costimulation O O
with O O
IL-2 O O
or O O
IL-12 O O
does O O
not B-NEGATION B-NEGATION
alter I-NEGATION I-NEGATION
their I-NEGATION I-NEGATION
own I-NEGATION I-NEGATION
preferential I-NEGATION I-NEGATION
GAS-like I-NEGATION I-NEGATION
DNA I-NEGATION I-NEGATION
binding I-NEGATION I-NEGATION
patterns I-NEGATION I-NEGATION
when I-NEGATION I-NEGATION
C I-NEGATION I-NEGATION
epsilon I-NEGATION I-NEGATION
- I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
Fc I-NEGATION I-NEGATION
gamma I-NEGATION I-NEGATION
RI I-NEGATION I-NEGATION
- I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
SIE I-NEGATION I-NEGATION
GAS I-NEGATION I-NEGATION
motif I-NEGATION I-NEGATION
containing I-NEGATION I-NEGATION
oligonucleotide I-NEGATION I-NEGATION
probes I-NEGATION I-NEGATION
are I-NEGATION I-NEGATION
compared I-NEGATION I-NEGATION
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
induction I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
GAS-like I-SPECULATION I-SPECULATION
DNA-protein I-SPECULATION I-SPECULATION
binding I-SPECULATION I-SPECULATION
complexes I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
IL-2 I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
IL-4 I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
IL-12 I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
highly I-SPECULATION I-SPECULATION
selective I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
represents I-SPECULATION I-SPECULATION
one I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
determining I-SPECULATION I-SPECULATION
specific I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
. O O

In O O
addition O O
, O O
IL-6 O O
and O O
IL-2 O O
synergistically O O
induce O O
homo O O
- O O
and O O
heterodimerized O O
STAT1 O O
alpha O O
and O O
STAT3 O O
in O O
both O O
NK O O
and O O
T O O
cells O O
, O O
consistent O O
with O O
their O O
reported O O
synergism O O
in O O
modulating O O
perforin O O
gene O O
expression O O
. O O

We O O
further O O
demonstrated O O
that O O
IL-2 O O
, O O
- O O
7 O O
, O O
and O O
- O O
15 O O
induce O O
multiple O O
STAT O O
proteins O O
, O O
including O O
STAT5a O O
, O O
STAT5b O O
, O O
STAT1 O O
alpha O O
, O O
STAT3 O O
, O O
and O O
another O O
unidentified O O
Fc O O
gamma O O
RI O O
GAS O O
DNA-binding O O
protein O O
. O O

Finally O O
, O O
we O O
observed O O
that O O
activated O O
STAT5a O O
and O O
STAT5b O O
proteins O O
form O O
distinct O O
Fc O O
gamma O O
RI O O
GAS O O
binding O O
patterns O O
in O O
T O O
and O O
NK O O
cells O O
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
they I-SPECULATION I-SPECULATION
might B-SPECULATION B-SPECULATION
have I-SPECULATION I-SPECULATION
different I-SPECULATION I-SPECULATION
roles I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
regulation I-SPECULATION I-SPECULATION
. O O

Our O O
data O O
provide O O
evidence O O
that O O
the O O
differential O O
responses O O
in O O
gene O O
expression O O
and O O
cell O O
activation O O
seen O O
in O O
primary O O
NK O O
and O O
T O O
cells O O
on O O
direct O O
stimulation O O
with O O
different O O
cytokines O O
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
direct I-SPECULATION I-SPECULATION
result I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
distinct I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
STAT I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factors I-SPECULATION I-SPECULATION
. O O

Inhibition O O
of O O
HIV-1 O O
replication O O
by O O
combination O O
of O O
a O O
novel O O
inhibitor O O
of O O
TNF-alpha O O
with O O
AZT O O
. O O

The O O
small O O
molecule O O
S9a O O
was O O
derived O O
from O O
an O O
established O O
tumor O O
necrosis O O
factor-alpha O O
( O O
TNF-alpha O O
) O O
inhibitor O O
( O O
Canventol O O
) O O
by O O
replacement O O
of O O
the O O
isopropylidine O O
group O O
with O O
a O O
phenyl O O
ring O O
. O O

S9a O O
at O O
10 O O
to O O
100 O O
nM O O
inhibited O O
HIV O O
production O O
as O O
potently O O
as O O
3 O O
'- O O
azido-3 O O
'- O O
deoxythymidine O O
( O O
AZT O O
) O O
, O O
an O O
inhibitor O O
of O O
viral O O
reverse O O
transcriptase O O
. O O

Furthermore O O
, O O
S9a O O
and O O
AZT O O
in O O
combination O O
, O O
at O O
noncytoxic O O
concentrations O O
strongly O O
inhibited O O
HIV-1 O O
replication O O
that O O
was O O
more O O
than O O
additive O O
and O O
substantially O O
prolonged O O
the O O
appearance O O
of O O
virus O O
both O O
in O O
acutely O O
infected O O
CD4 O O
+ O O
lymphocytes O O
( O O
SupT O O
) O O
in O O
culture O O
and O O
in O O
peripheral O O
blood O O
mononuclear O O
cells O O
( O O
PBMCs O O
) O O
infected O O
with O O
a O O
primary O O
HIV-1 O O
isolate O O
. O O

S9a O O
inhibited O O
TNF-alpha O O
promoter-driven O O
reporter O O
gene O O
activity O O
. O O

It O O
was O O
proposed B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
antiviral I-SPECULATION I-SPECULATION
action I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
S9a I-SPECULATION I-SPECULATION
was I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
host I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
blocking I-SPECULATION I-SPECULATION
TNF-alpha I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
via I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
Tat-induced I-SPECULATION I-SPECULATION
tar-independent I-SPECULATION I-SPECULATION
loop I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
decreases I-SPECULATION I-SPECULATION
downstream I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
HIV-1 I-SPECULATION I-SPECULATION
long I-SPECULATION I-SPECULATION
terminal I-SPECULATION I-SPECULATION
repeat I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
LTR I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
. O O

S9a O O
was O O
superior O O
to O O
the O O
first O O
generation O O
compound O O
Canventol O O
, O O
which O O
was O O
superior O O
to O O
the O O
natural O O
compound O O
sarcophytol O O
A O O
, O O
demonstrating O O
that O O
further O O
structure-based O O
enhancement O O
of O O
potency O O
of O O
these O O
compounds O O
is O O
feasible O O
. O O

This O O
study O O
suggests B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
therapeutic I-SPECULATION I-SPECULATION
approach I-SPECULATION I-SPECULATION
against I-SPECULATION I-SPECULATION
AIDS I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
application I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
two I-SPECULATION I-SPECULATION
drugs I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
one I-SPECULATION I-SPECULATION
against I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
cellular I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
other I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
viral I-SPECULATION I-SPECULATION
target I-SPECULATION I-SPECULATION
, O O
which O O
may B-SPECULATION B-SPECULATION
provide I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
approach I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
problem I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
frequent I-SPECULATION I-SPECULATION
emergence I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
resistant I-SPECULATION I-SPECULATION
variants I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
combinations I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
drugs I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
target I-SPECULATION I-SPECULATION
only I-SPECULATION I-SPECULATION
HIV I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
. O O

Retinoic O O
acid O O
inhibits O O
CD40 O O
+ O O
interleukin-4-mediated O O
IgE O O
production O O
in O O
vitro O O
. O O

To O O
elucidate O O
the O O
role O O
of O O
retinoic O O
acid O O
( O O
RA O O
) O O
in O O
anti-CD40 O O
+ O O
interleukin-4 O O
( O O
IL-4 O O
)- O O
mediated O O
B-cell O O
activation O O
, O O
the O O
effect O O
of O O
10 O O
(- O O
12 O O
) O O
to O O
10 O O
(- O O
6 O O
) O O
mol O O
/ O O
L O O
RA O O
was O O
studied O O
in O O
anti-CD40 O O
( O O
1 O O
microgram O O
/ O O
mL O O
) O O
+ O O
IL-4 O O
( O O
5 O O
ng O O
/ O O
mL O O
)- O O
mediated O O
proliferation O O
and O O
Ig O O
synthesis O O
by O O
human O O
peripheral O O
blood O O
mononuclear O O
cells O O
( O O
PBMC O O
) O O
and O O
B O O
cells O O
in O O
healthy O O
donors O O
. O O

Anti-CD40 O O
+ O O
IL-4-mediated O O
proliferation O O
of O O
PBMC O O
and O O
B O O
cells O O
was O O
inhibited O O
by O O
RA O O
in O O
a O O
dose-dependent O O
manner O O
, O O
with O O
maximal O O
inhibition O O
of O O
62 O O
% O O
± O O
5 O O
% O O
in O O
PBMC O O
and O O
55 O O
% O O
± O O
4.4 O O
% O O
in O O
B O O
cells O O
by O O
all-trans O O
RA O O
, O O
and O O
58 O O
% O O
± O O
6.7 O O
% O O
and O O
51 O O
% O O
± O O
4.7 O O
% O O
, O O
respectively O O
by O O
13-cis O O
RA O O
. O O

IgE O O
synthesis O O
was O O
even O O
more O O
markedly O O
inhibited O O
by O O
RA O O
starting O O
at O O
concentrations O O
of O O
> O O
10 O O
(- O O
14 O O
) O O
mol O O
/ O O
L O O
for O O
B O O
cells O O
and O O
> O O
10 O O
(- O O
10 O O
) O O
mol O O
/ O O
L O O
for O O
PBMC O O
. O O

Maximal O O
inhibition O O
of O O
IgE O O
production O O
for O O
B O O
cells O O
was O O
at O O
10 O O
(- O O
8 O O
) O O
mol O O
/ O O
L O O
for O O
all-trans O O
RA O O
( O O
94 O O
% O O
± O O
1.8 O O
%) O O
and O O
96 O O
% O O
± O O
3.2 O O
% O O
for O O
13-cis O O
RA O O
. O O

Low O O
concentrations O O
of O O
RA O O
inhibiting O O
IgE O O
synthesis O O
( O O
10 O O
(- O O
10 O O
) O O
mol O O
/ O O
L O O
) O O
affected O O
neither B-NEGATION B-NEGATION
B-cell I-NEGATION I-NEGATION
proliferation I-NEGATION I-NEGATION
. O O

Elucidation O O
of O O
the O O
mechanism O O
involved O O
in O O
this O O
inhibition O O
of O O
IgE O O
production O O
shows O O
that O O
epsilon O O
germline O O
transcription O O
is O O
decreased O O
by O O
RA O O
, O O
whereas O O
production B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
interferon-gamma I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
IFN-gamma I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
enhanced I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
presence I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
RA I-NEGATION I-NEGATION
. O O

To O O
differentiate O O
whether B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
RA I-SPECULATION I-SPECULATION
effect I-SPECULATION I-SPECULATION
was I-SPECULATION I-SPECULATION
mediated I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
RA I-SPECULATION I-SPECULATION
receptors I-SPECULATION I-SPECULATION
alpha I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
beta I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
gamma I-SPECULATION I-SPECULATION
, O O
the O O
expression O O
of O O
the O O
retinoic O O
acid O O
receptors O O
( O O
RAR O O
) O O
was O O
examined O O
by O O
reverse O O
transcriptase-polymerase O O
chain O O
reaction O O
( O O
RT-PCR O O
) O O
. O O

The O O
data O O
show O O
that O O
unstimulated O O
human O O
peripheral O O
B O O
cells O O
express O O
mRNA O O
of O O
the O O
RA O O
receptor O O
alpha O O
, O O
beta O O
, O O
and O O
gamma O O
. O O

Using O O
retinoids O O
with O O
different O O
receptor O O
binding O O
specificity O O
( O O
CD336 O O
, O O
CD437 O O
, O O
CD2019 O O
, O O
CD367 O O
) O O
, O O
dose-dependent O O
inhibition O O
of O O
IgE O O
synthesis O O
was O O
shown O O
by O O
all O O
four O O
derivates O O
, O O
but O O
was O O
most O O
marked O O
by O O
an O O
RA O O
binding O O
the O O
alpha O O
receptor O O
with O O
high O O
specificity O O
. O O

Taken O O
together O O
, O O
this O O
study O O
shows O O
that O O
RA O O
inhibits O O
IgE O O
production O O
of O O
anti-CD40 O O
+ O O
IL-4-stimulated O O
B O O
cells O O
in O O
vitro O O
. O O

Copyright O O
1998 O O
by O O
The O O
American O O
Society O O
of O O
Hematology O O
. O O

Nuclear O O
factor-kappaB O O
induction O O
in O O
CD45RO O O
+ O O
and O O
CD45RA O O
+ O O
T O O
cell O O
subsets O O
during O O
aging O O
. O O

An O O
increase O O
in O O
the O O
ratio O O
of O O
memory O O
to O O
naive O O
T O O
cells O O
has O O
been O O
postulated O O
to O O
underlie O O
immune O O
hyporesponsiveness O O
accompanying O O
aging O O
. O O

Our O O
analyses O O
of O O
the O O
induction O O
of O O
nuclear O O
factor-kappaB O O
( O O
NFkappaB O O
) O O
in O O
activated O O
memory O O
( O O
CD45RO O O
+) O O
and O O
naive O O
( O O
CD45RA O O
+) O O
T O O
cell O O
subsets O O
from O O
young O O
and O O
elderly O O
donors O O
has O O
demonstrated O O
that O O
, O O
regardless O O
of O O
donor O O
age O O
, O O
memory O O
T O O
cells O O
are O O
not O O
significantly O O
altered O O
in O O
their O O
responsiveness O O
to O O
TNF-alpha-mediated O O
induction O O
of O O
NFkappaB O O
. O O

Although O O
treatment O O
with O O
TNF-alpha O O
induced O O
nuclear O O
localization O O
of O O
NFkappaB O O
in O O
both O O
memory O O
and O O
naive O O
T O O
cell O O
subsets O O
, O O
irrespective O O
of O O
the O O
age O O
of O O
the O O
donor O O
, O O
the O O
levels O O
of O O
induced O O
NFkappaB O O
were O O
significantly O O
lower O O
in O O
both O O
subsets O O
of O O
T O O
cells O O
obtained O O
from O O
the O O
elderly O O
, O O
when O O
compared O O
to O O
those O O
in O O
young O O
. O O

Examination O O
of O O
IkappaB O O
alpha O O
regulation O O
revealed O O
that O O
TNF-alpha-mediated O O
degradation O O
of O O
IkappaB O O
alpha O O
in O O
both O O
memory O O
and O O
naive O O
T O O
cells O O
from O O
the O O
elderly O O
was O O
severely O O
impaired O O
, O O
thus O O
contributing O O
to O O
the O O
lowered O O
induction O O
of O O
the O O
observed O O
NFkappaB O O
. O O

In O O
addition O O
, O O
this O O
age-related O O
decrease O O
in O O
induction O O
of O O
nuclear O O
NFkappaB O O
correlated O O
with O O
decrease O O
in O O
intracellular O O
IL-2 O O
receptor O O
expression O O
and O O
anti-CD3-induced O O
proliferation O O
of O O
both O O
memory O O
and O O
naive O O
T O O
cells O O
subsets O O
. O O

Taken O O
together O O
, O O
our O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the B-NEGATION B-NEGATION
age-related I-NEGATION I-NEGATION
hyporesponsiveness I-NEGATION I-NEGATION
cannot I-NEGATION I-NEGATION
be I-NEGATION I-NEGATION
attributed I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
a I-NEGATION I-NEGATION
skewing I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
T I-NEGATION I-NEGATION
cell I-NEGATION I-NEGATION
population I-NEGATION I-NEGATION
towards I-NEGATION I-NEGATION
a I-NEGATION I-NEGATION
memory I-NEGATION I-NEGATION
phenotype I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
elderly I-NEGATION I-NEGATION
. O O

Activation O O
of O O
E2F-mediated O O
transcription O O
by O O
human O O
T-cell O O
leukemia O O
virus O O
type O O
I O O
Tax O O
protein O O
in O O
a O O
p16 O O
( O O
INK4A O O
)- O O
negative O O
T-cell O O
line O O
. O O

The O O
human O O
T-cell O O
leukemia O O
virus O O
type O O
I O O
( O O
HTLV-I O O
) O O
is O O
a O O
causative O O
agent O O
of O O
adult O O
T-cell O O
leukemia O O
. O O

Although O O
the B-SPECULATION B-SPECULATION
exact I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
HTLV-I I-SPECULATION I-SPECULATION
contributes I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
leukemogenesis I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
still I-SPECULATION I-SPECULATION
unclear I-SPECULATION I-SPECULATION
, O O
the B-SPECULATION B-SPECULATION
Tax I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
thought I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
play I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
major I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
process I-SPECULATION I-SPECULATION
. O O

This O O
40-kDa O O
polypeptide O O
is O O
able O O
to O O
interact O O
with O O
the O O
tumor O O
suppressor O O
p16 O O
( O O
INK4A O O
) O O
. O O

Consequently O O
, O O
Tax O O
can O O
activate O O
the O O
signaling O O
pathway O O
that O O
lead O O
to O O
the O O
release O O
of O O
E2F O O
that O O
in O O
turn O O
induces O O
expression O O
of O O
factors O O
required O O
for O O
cell O O
cycle O O
progression O O
. O O

In O O
this O O
paper O O
, O O
we O O
demonstrate O O
that O O
Tax O O
can O O
also O O
activate O O
E2F-mediated O O
transcription O O
independently O O
of O O
p16 O O
( O O
INK4A O O
) O O
. O O

Indeed O O
, O O
when O O
Tax O O
is O O
coexpressed O O
with O O
the O O
E2F-1 O O
transcription O O
factor O O
in O O
CEM O O
T-cells O O
, O O
which O O
lack B-NEGATION B-NEGATION
expression I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
p16 I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
INK4A I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
, O O
it O O
strongly O O
potentiates O O
the O O
E2F-dependent O O
activation O O
of O O
a O O
reporter O O
construct O O
driven O O
by O O
a O O
promoter O O
containing O O
E2F O O
binding O O
sites O O
. O O

This O O
stimulation O O
is O O
abrogated O O
by O O
mutations O O
affecting O O
the O O
E2F-binding O O
sites O O
. O O

In O O
addition O O
, O O
Tax O O
also O O
stimulates O O
the O O
transcription O O
of O O
the O O
E2F-1 O O
gene O O
itself O O
. O O

Using O O
Tax O O
mutants O O
that O O
fail B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
activate I-NEGATION I-NEGATION
either I-NEGATION I-NEGATION
ATF I-NEGATION I-NEGATION
- I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
NF-kappaB-dependent I-NEGATION I-NEGATION
promoters I-NEGATION I-NEGATION
and I-NEGATION O
different I-NEGATION O
5 I-NEGATION O
' I-NEGATION O
truncation I-NEGATION O
mutants I-NEGATION O
of I-NEGATION O
the I-NEGATION O
E2F-1 I-NEGATION O
promoter I-NEGATION O
, O O
we O O
show O O
that O O
the O O
Tax-dependent O O
transcriptional O O
control O O
of O O
the O O
E2F1 O O
gene O O
involves O O
, O O
at O O
least O O
in O O
part O O
, O O
the O O
ATF O O
binding O O
site O O
located O O
in O O
the O O
E2F-1 O O
promoter O O
. O O

Glucocorticoid-induced O O
apoptosis O O
and O O
regulation O O
of O O
NF-kappaB O O
activity O O
in O O
human O O
leukemic O O
T O O
cells O O
. O O

Glucocorticoid-induced O O
apoptosis O O
was O O
investigated O O
in O O
glucocorticoid-sensitive O O
6TG1.1 O O
and O O
resistant O O
ICR27TK.3 O O
human O O
leukemic O O
T O O
cells O O
. O O

Following O O
glucocorticoid O O
treatment O O
of O O
6TG1.1 O O
cells O O
, O O
chromatin O O
fragmentation O O
was O O
observed O O
after O O
a O O
delay O O
of O O
24 O O
h O O
. O O

Fragmentation B-NEGATION B-NEGATION
was I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
observed I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
ICR27TK.3 I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
containing I-NEGATION I-NEGATION
mutant I-NEGATION I-NEGATION
glucocorticoid I-NEGATION I-NEGATION
receptors I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
L753F I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
that I-NEGATION I-NEGATION
are I-NEGATION I-NEGATION
activation-deficient I-NEGATION I-NEGATION
but I-NEGATION O
retain I-NEGATION O
the I-NEGATION O
ability I-NEGATION O
to I-NEGATION O
repress I-NEGATION O
AP-1 I-NEGATION O
activity I-NEGATION O
. O O

Nor B-NEGATION O
was I-NEGATION O
fragmentation I-NEGATION O
observed I-NEGATION O
after I-NEGATION O
treatment I-NEGATION O
with I-NEGATION O
RU38486 I-NEGATION O
, O O
indicating B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
repression B-NEGATION I-SPECULATION
of I-NEGATION I-SPECULATION
AP-1 I-NEGATION I-SPECULATION
activity I-NEGATION I-SPECULATION
is I-NEGATION I-SPECULATION
not I-NEGATION B-NEGATION
involved I-NEGATION I-NEGATION
. O O

As O O
described O O
in O O
other O O
systems O O
, O O
fragmentation O O
required O O
ongoing O O
protein O O
synthesis O O
. O O

However O O
, O O
inhibition O O
of O O
protein O O
synthesis O O
with O O
cycloheximide O O
anytime O O
during O O
the O O
first O O
18 O O
h O O
of O O
steroid O O
treatment O O
was O O
as O O
effective O O
in O O
blocking O O
chromatin O O
fragmentation O O
as O O
inhibition O O
for O O
the O O
entire O O
period O O
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
synthesis I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
component I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
rapid I-SPECULATION I-SPECULATION
turnover I-SPECULATION I-SPECULATION
rate I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
required I-SPECULATION I-SPECULATION
. O O

Dexamethasone O O
treatment O O
completely O O
blocked O O
12-O-tetradecanoylphorbol O O
13-acetate O O
induction O O
of O O
nuclear O O
factor-kappaB O O
( O O
NF-kappaB O O
) O O
activity O O
and O O
elicited O O
an O O
increase O O
in O O
the O O
amount O O
of O O
immunoreactive O O
IkappaB O O
alpha O O
in O O
sensitive O O
6TG1.1 O O
cells O O
but O O
not B-NEGATION B-NEGATION
in I-NEGATION I-NEGATION
resistant I-NEGATION I-NEGATION
ICR27TK.3 I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
. O O

In O O
addition O O
, O O
mild O O
detergent O O
treatment O O
of O O
cell O O
extracts O O
indicated B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
substantial I-SPECULATION I-SPECULATION
amount I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
cytoplasmic I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
complexed I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
IkappaB B-SPECULATION I-SPECULATION
alpha I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
some I-SPECULATION I-SPECULATION
other I-SPECULATION I-SPECULATION
inhibitory I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
. O O

These O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
induction I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
labile I-SPECULATION I-SPECULATION
inhibitory I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
such I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
IkappaB I-SPECULATION I-SPECULATION
alpha I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
contribute I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
glucocorticoid-induced I-SPECULATION I-SPECULATION
apoptosis I-SPECULATION I-SPECULATION
. O O

Peripheral O O
T O O
lymphocytes O O
from O O
women O O
with O O
breast O O
cancer O O
exhibit O O
abnormal O O
protein O O
expression O O
of O O
several O O
signaling O O
molecules O O
. O O

We O O
examined O O
signaling O O
molecules O O
of O O
peripheral O O
blood O O
T O O
lymphocytes O O
obtained O O
from O O
women O O
with O O
breast O O
cancer O O
. O O

In O O
6 O O
of O O
14 O O
patients O O
, O O
T O O
lymphocytes O O
displayed O O
an O O
impaired O O
ability O O
to O O
translocate O O
NFeB O O
p65 O O
( O O
Rel-A O O
) O O
following O O
activation O O
by O O
anti-CD3 O O
and O O
IL-2 O O
. O O

This O O
observation O O
was O O
made O O
despite O O
normal O O
cytoplasmic O O
levels O O
of O O
the O O
Rel-A O O
protein O O
. O O

We O O
also O O
detected O O
abnormally O O
low O O
levels O O
of O O
the O O
signaling O O
molecules O O
T-cell O O
receptor O O
( O O
TCR O O
)- O O
zeta O O
, O O
ZAP-70 O O
and O O
p56lck O O
in O O
4 O O
of O O
14 O O
breast O O
cancer O O
patients O O
, O O
i.e. O O
, O O
defects O O
in O O
T-cell O O
signaling O O
molecules O O
. O O

T O O
lymphocytes O O
from O O
6 O O
of O O
the O O
14 O O
patients O O
also O O
exhibited O O
an O O
increased O O
expression O O
of O O
the O O
dual O O
specificity O O
phosphatase O O
, O O
map O O
kinase O O
phosphatase-1 O O
( O O
MKP-1 O O
) O O
. O O

MKP-1 O O
inactivates O O
MAP O O
kinase O O
and O O
therefore O O
may B-SPECULATION B-SPECULATION
interfere I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
c-jun I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
c-fos I-SPECULATION I-SPECULATION
. O O

Abnormalities O O
of O O
I O O
or O O
more O O
signaling O O
molecules O O
were O O
found O O
in O O
9 O O
of O O
14 O O
patients O O
; O O
however O O
, O O
only O O
3 O O
patients O O
had O O
T O O
cells O O
that O O
exhibited O O
all O O
5 O O
defects O O
. O O

Our O O
data O O
have O O
implications O O
for O O
the O O
detection O O
of O O
potentially B-SPECULATION B-SPECULATION
dysfunctional I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
patients I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
cancer I-SPECULATION I-SPECULATION
. O O

For O O
example O O
, O O
the O O
analysis O O
of O O
only O O
1 O O
signaling O O
molecule O O
may B-SPECULATION B-SPECULATION
allow I-SPECULATION I-SPECULATION
patients I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
significant I-SPECULATION I-SPECULATION
defects I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
T-cell I-SPECULATION I-SPECULATION
signaling I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
go I-SPECULATION I-SPECULATION
unnoticed I-SPECULATION I-SPECULATION
. O O

Finally O O
, O O
despite O O
impaired O O
Rel-A O O
translocation O O
, O O
T O O
cells O O
were O O
capable O O
of O O
transcribing O O
IL-2 O O
. O O

Impairments O O
in O O
the O O
translocation O O
of O O
Rel-B O O
and O O
c-Rel O O
further O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the B-NEGATION I-SPECULATION
NFKB I-NEGATION I-SPECULATION
family I-NEGATION I-SPECULATION
members I-NEGATION I-SPECULATION
Rel-A I-NEGATION I-SPECULATION
, I-NEGATION I-SPECULATION
Rel-B I-NEGATION I-SPECULATION
and I-NEGATION I-SPECULATION
c-Rel I-NEGATION I-SPECULATION
are I-NEGATION I-SPECULATION
not I-NEGATION B-NEGATION
required I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
transcription I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
IL-2 I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
peripheral I-NEGATION I-NEGATION
T I-NEGATION I-NEGATION
lymphocytes I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
patients I-NEGATION I-NEGATION
with I-NEGATION I-NEGATION
breast I-NEGATION I-NEGATION
cancer I-NEGATION I-NEGATION
. O O

Transcription O O
of O O
a O O
minimal O O
promoter O O
from O O
the O O
NF-IL6 O O
gene O O
is O O
regulated O O
by O O
CREB O O
/ O O
ATF O O
and O O
SP1 O O
proteins O O
in O O
U937 O O
promonocytic O O
cells O O
. O O

NF-IL6 O O
is O O
an O O
important O O
transcriptional O O
regulator O O
of O O
genes O O
induced O O
in O O
activated O O
monocytes O O
/ O O
macrophages O O
, O O
and O O
NF-IL6 O O
is O O
the O O
only O O
CCAAT O O
/ O O
enhancer-binding O O
protein O O
( O O
C O O
/ O O
EBP O O
) O O
family O O
member O O
whose O O
steady-state O O
mRNA O O
levels O O
increase O O
upon O O
activation O O
of O O
monocytes O O
( O O
1 O O
) O O
. O O

We O O
show O O
that O O
increased O O
transcription O O
of O O
the O O
NF-IL6 O O
gene O O
is O O
responsible O O
, O O
at O O
least O O
in O O
part O O
, O O
for O O
induction O O
of O O
NF-IL6 O O
mRNA O O
following O O
activation O O
of O O
U937 O O
promonocytic O O
cells O O
. O O

We O O
have O O
identified O O
a O O
104-bp O O
minimal O O
promoter O O
region O O
of O O
the O O
NF-IL6 O O
gene O O
that O O
is O O
sufficient O O
for O O
basal O O
and O O
activation-dependent O O
induction O O
of O O
transcription O O
in O O
U937 O O
cells O O
. O O

This O O
region O O
contains O O
binding O O
sites O O
for O O
the O O
cAMP O O
response O O
element-binding O O
protein O O
/ O O
activation O O
transcription O O
factor O O
( O O
CREB O O
/ O O
ATF O O
) O O
and O O
Sp1 O O
families O O
of O O
transcription O O
factors O O
. O O

Each O O
site O O
is O O
functionally O O
important O O
and O O
contributes O O
independently O O
to O O
transcription O O
of O O
the O O
NF-IL6 O O
gene O O
in O O
U937 O O
cells O O
. O O

CD30 O O
is O O
a O O
CD40-inducible O O
molecule O O
that O O
negatively O O
regulates O O
CD40-mediated O O
immunoglobulin O O
class O O
switching O O
in O O
non-antigen-selected O O
human O O
B O O
cells O O
. O O

We O O
used O O
our O O
monoclonal O O
model O O
of O O
germinal O O
center O O
maturation O O
, O O
CL-01 O O
B O O
cells O O
, O O
to O O
investigate O O
the O O
role O O
of O O
CD30 O O
in O O
human O O
B O O
cell O O
differentiation O O
. O O

CL-01 O O
cells O O
are O O
IgM O O
+ O O
IgD O O
+ O O
CD30 O O
+ O O
and O O
switch O O
to O O
IgG O O
, O O
IgA O O
, O O
and O O
IgE O O
when O O
exposed O O
to O O
CD40L O O
and O O
IL-4 O O
. O O

Switching O O
is O O
hampered O O
by O O
CD30 O O
coengagement O O
, O O
possibly B-SPECULATION B-SPECULATION
through I-SPECULATION I-SPECULATION
interference I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
CD40-mediated I-SPECULATION I-SPECULATION
NF-kappaB-dependent I-SPECULATION I-SPECULATION
transcriptional I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
downstream I-SPECULATION I-SPECULATION
C I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
H I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
. O O

The O O
physiological O O
relevance O O
of O O
this O O
phenomenon O O
is O O
emphasized O O
by O O
similar O O
CD30-mediated O O
effects O O
in O O
naive O O
B O O
cells O O
. O O

Expression O O
of O O
CD30 O O
by O O
these O O
cells O O
is O O
induced O O
by O O
CD40L O O
but O O
is O O
inhibited O O
by O O
B O O
cell O O
receptor O O
coengagement O O
and O O
/ O O
or O O
exposure O O
to O O
IL-6 O O
and O O
IL-12 O O
. O O

Our O O
data O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
CD30 I-SPECULATION I-SPECULATION
critically I-SPECULATION I-SPECULATION
regulates I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
CD40-mediated I-SPECULATION I-SPECULATION
differentiation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
non-antigen-selected I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

Induction O O
of O O
Mn O O
SOD O O
in O O
human O O
monocytes O O
without B-NEGATION B-NEGATION
inflammatory I-NEGATION I-NEGATION
cytokine I-NEGATION I-NEGATION
production I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
a I-NEGATION I-NEGATION
mutant I-NEGATION I-NEGATION
endotoxin I-NEGATION I-NEGATION
. O O

Endotoxin O O
selectively O O
induces O O
monocyte O O
Mn O O
superoxide O O
dismutase O O
( O O
SOD O O
) O O
without B-NEGATION B-NEGATION
affecting I-NEGATION I-NEGATION
levels I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
Cu,Zn I-NEGATION I-NEGATION
SOD I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
catalase I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
glutathione I-NEGATION I-NEGATION
peroxidase I-NEGATION I-NEGATION
. O O

However O O
, O O
little O O
is O O
known O O
about O O
the O O
structure-activity O O
relationship O O
and O O
the O O
mechanism O O
by O O
which O O
endotoxin O O
induces O O
Mn O O
SOD O O
. O O

In O O
this O O
study O O
we O O
demonstrated O O
that O O
a O O
mutant O O
Escherichia O O
coli O O
endotoxin O O
lacking B-NEGATION B-NEGATION
myristoyl I-NEGATION I-NEGATION
fatty I-NEGATION I-NEGATION
acid I-NEGATION I-NEGATION
at I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
3 I-NEGATION I-NEGATION
' I-NEGATION I-NEGATION
R-3-hydroxymyristate I-NEGATION I-NEGATION
position I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
lipid I-NEGATION I-NEGATION
A I-NEGATION I-NEGATION
moiety I-NEGATION I-NEGATION
retained O O
its O O
full O O
capacity O O
to O O
coagulate O O
Limulus O O
amoebocyte O O
lysate O O
compared O O
with O O
the O O
wild-type O O
E. O O
coli O O
endotoxin O O
and O O
markedly O O
stimulated O O
the O O
activation O O
of O O
human O O
monocyte O O
nuclear O O
factor-kappaB O O
and O O
the O O
induction O O
of O O
Mn O O
SOD O O
mRNA O O
and O O
enzyme O O
activity O O
. O O

However O O
, O O
in O O
contrast O O
to O O
the O O
wild-type O O
endotoxin O O
, O O
it O O
failed B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
induce I-NEGATION I-NEGATION
significant I-NEGATION I-NEGATION
production I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
tumor I-NEGATION I-NEGATION
necrosis I-NEGATION I-NEGATION
factor-alpha I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
macrophage I-NEGATION I-NEGATION
inflammatory I-NEGATION I-NEGATION
protein-1alpha I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
monocytes I-NEGATION I-NEGATION
and O O
did O O
not B-NEGATION B-NEGATION
induce I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
phosphorylation I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
nuclear I-NEGATION I-NEGATION
translocation I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
mitogen-activated I-NEGATION I-NEGATION
protein I-NEGATION I-NEGATION
kinase I-NEGATION I-NEGATION
. O O

These O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
1 I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
lipid I-SPECULATION I-SPECULATION
A I-SPECULATION I-SPECULATION
myristoyl I-SPECULATION I-SPECULATION
fatty I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
although I-SPECULATION I-SPECULATION
it I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
induction I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
inflammatory I-SPECULATION I-SPECULATION
cytokine I-SPECULATION I-SPECULATION
production I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
monocytes I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
not B-NEGATION B-NEGATION
necessary I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
induction I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
Mn I-NEGATION I-NEGATION
SOD I-NEGATION I-NEGATION
, O O
2 O O
) O O
endotoxin-mediated O O
induction O O
of O O
Mn O O
SOD O O
and O O
inflammatory O O
cytokines O O
are O O
regulated O O
, O O
at O O
least O O
in O O
part O O
, O O
through O O
different O O
signal O O
transduction O O
pathways O O
, O O
and O O
3 O O
) O O
failure B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
mutant I-NEGATION I-NEGATION
endotoxin I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
induce I-NEGATION I-NEGATION
tumor I-NEGATION I-NEGATION
necrosis I-NEGATION I-NEGATION
factor-alpha I-NEGATION I-NEGATION
production I-NEGATION I-NEGATION
is O O
, O O
at O O
least O O
in O O
part O O
, O O
due O O
to O O
its O O
inability O O
to O O
activate O O
mitogen-activated O O
protein O O
kinase O O
. O O

An O O
allosteric O O
drug O O
, O O
o,o O O
'- O O
bismyristoyl O O
thiamine O O
disulfide O O
, O O
suppresses O O
HIV-1 O O
replication O O
through O O
prevention O O
of O O
nuclear O O
translocation O O
of O O
both O O
HIV-1 O O
Tat O O
and O O
NF-kappa O O
B O O
. O O

The O O
efficacy O O
of O O
o,o O O
'- O O
bismyristoyl O O
thiamine O O
disulfide O O
( O O
BMT O O
) O O
was O O
examined O O
in O O
detail O O
against O O
HIV-1 O O
laboratory O O
isolates O O
( O O
HTLV-IIIB O O
, O O
JRFL O O
, O O
and O O
MN O O
) O O
, O O
primary O O
isolates O O
( O O
KMT O O
and O O
KMO O O
) O O
, O O
and O O
simian O O
immunodeficiency O O
virus O O
( O O
SIVmac251 O O
) O O
in O O
vitro O O
. O O

BMT O O
inhibited O O
the O O
replication O O
of O O
HIV-1 O O
in O O
both O O
laboratory O O
and O O
primary O O
isolates O O
in O O
vitro O O
. O O

In O O
addition O O
, O O
BMT O O
exhibited O O
antiviral O O
activity O O
against O O
SIVmac251 O O
. O O

Minimizing O O
energy O O
studies O O
of O O
BMT O O
structure O O
reveal O O
that O O
a O O
trans-disulfide O O
of O O
thiamine O O
( O O
holo O O
drug O O
) O O
disulfide O O
( O O
TDS O O
, O O
protodrug O O
) O O
is O O
allosterically O O
transited O O
to O O
the O O
reactive O O
twisted O O
disulfide O O
of O O
BMT O O
( O O
allo O O
drug O O
) O O
by O O
o,o O O
'- O O
bismyristoyl O O
esterification O O
of O O
TDS O O
. O O

BMT O O
inhibits O O
nuclear O O
translocation O O
of O O
both O O
HIV-1 O O
transactivator O O
( O O
TAT O O
) O O
and O O
the O O
cellular O O
transcriptional O O
nuclear O O
factor-KB O O
( O O
NF-kappa O O
B O O
) O O
, O O
resulting O O
in O O
the O O
suppression O O
of O O
HIV-1 O O
replication O O
. O O

Retinoid O O
X O O
receptor O O
and O O
c-cerbA O O
/ O O
thyroid O O
hormone O O
receptor O O
regulate O O
erythroid O O
cell O O
growth O O
and O O
differentiation O O
. O O

Nuclear O O
receptors O O
are O O
important O O
regulators O O
of O O
erythroid O O
cell O O
development O O
. O O

Here O O
we O O
investigated O O
the O O
impact O O
of O O
retinoid O O
X O O
receptor O O
( O O
RXR O O
) O O
, O O
retinoic O O
acid O O
receptor O O
( O O
RAR O O
) O O
, O O
and O O
of O O
the O O
c-erbA O O
/ O O
thyroid O O
hormone O O
( O O
T3 O O
) O O
receptor O O
( O O
c-erbA O O
/ O O
TR O O
) O O
on O O
growth O O
and O O
differentiation O O
of O O
erythroid O O
cells O O
using O O
an O O
in O O
vitro O O
culture O O
system O O
of O O
stem O O
cell O O
factor-dependent O O
erythroid O O
progenitors O O
. O O

RXR O O
, O O
RAR O O
, O O
and O O
c-erbA O O
/ O O
TR-specific O O
ligands O O
were O O
found O O
to O O
induce O O
erythroid-specific O O
gene O O
expression O O
and O O
to O O
accelerate O O
erythroid O O
differentiation O O
in O O
culture O O
, O O
with O O
T3 O O
being O O
most O O
effective O O
. O O

Furthermore O O
, O O
while O O
ligand-activated O O
c-erbA O O
/ O O
TR O O
accelerated O O
differentiation O O
, O O
unliganded O O
c-erbA O O
/ O O
TR O O
effectively O O
blocked O O
differentiation O O
and O O
supported O O
sustained O O
progenitor O O
growth O O
in O O
culture O O
. O O

Thus O O
, O O
c-erbA B-SPECULATION B-SPECULATION
/ I-SPECULATION I-SPECULATION
TR I-SPECULATION I-SPECULATION
appears I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
act I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
binary I-SPECULATION I-SPECULATION
switch I-SPECULATION I-SPECULATION
affecting I-SPECULATION I-SPECULATION
erythroid I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
fate I-SPECULATION I-SPECULATION
: O I-SPECULATION
unliganded O I-SPECULATION
c-erbA O I-SPECULATION
/ O I-SPECULATION
TR O I-SPECULATION
supports O I-SPECULATION
growth O I-SPECULATION
while O I-SPECULATION
ligand-activated O I-SPECULATION
c-erbA O I-SPECULATION
/ O I-SPECULATION
TR O I-SPECULATION
induces O I-SPECULATION
differentiation O I-SPECULATION
. O O

Additionally O O
, O O
to O O
determine O O
the O O
impact O O
of O O
RXR O O
for O O
erythroid O O
cell O O
development O O
, O O
dominant O O
interfering O O
mutant O O
RXRs O O
, O O
lacking B-NEGATION B-NEGATION
the I-NEGATION I-NEGATION
transcriptional I-NEGATION I-NEGATION
activator I-NEGATION I-NEGATION
functions I-NEGATION I-NEGATION
AF-1 I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
AF-2 I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
AF-2 I-NEGATION I-NEGATION
only I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
entire I-NEGATION I-NEGATION
DNA-binding I-NEGATION I-NEGATION
domain I-NEGATION I-NEGATION
, O O
were O O
introduced O O
into O O
erythroid O O
progenitor O O
cells O O
via O O
recombinant O O
retrovirus O O
vectors O O
and O O
analyzed O O
for O O
RXR-specific O O
effects O O
. O O

It O O
was O O
found O O
that O O
expression O O
of O O
wild-type O O
RXR O O
and O O
of O O
the O O
RXR O O
mutants O O
devoid O O
of O O
AF-1 O O
and O O
/ O O
or O O
AF-2 O O
supported O O
a O O
transient O O
outgrowth O O
of O O
erythroid O O
cells O O
. O O

In O O
marked O O
contrast O O
, O O
expression O O
of O O
the O O
dominant O O
interfering O O
deltaDNA-binding O O
domain O O
RXR O O
, O O
containing O O
a O O
deletion O O
of O O
the O O
entire O O
DNA-binding O O
domain O O
, O O
was O O
incompatible O O
with O O
erythroid O O
cell O O
growth O O
in O O
vitro O O
, O O
suggesting B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
pivotal I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
RXR I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
erythroid I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
development I-SPECULATION I-SPECULATION
. O O

Phosphatidylinositides O O
bind O O
to O O
plasma O O
membrane O O
CD14 O O
and O O
can O O
prevent O O
monocyte O O
activation O O
by O O
bacterial O O
lipopolysaccharide O O
. O O

Although O O
bacterial O O
lipopolysaccharides O O
( O O
LPS O O
) O O
and O O
several O O
other O O
microbial O O
agonists O O
can O O
bind O O
to O O
mCD14 O O
( O O
membrane O O
CD14 O O
) O O
, O O
a O O
cell-surface O O
receptor O O
found O O
principally O O
on O O
monocytes O O
and O O
neutrophils O O
, O O
host-derived O O
mCD14 O O
ligands O O
are O O
poorly O O
defined O O
. O O

We O O
report O O
here O O
that O O
phosphatidylinositol O O
( O O
PtdIns O O
) O O
, O O
phosphatidylinositol-4-phosphate O O
, O O
and O O
other O O
phosphatidylinositides O O
can O O
bind O O
to O O
mCD14 O O
. O O

Phosphatidylserine O O
( O O
PS O O
) O O
, O O
another O O
anionic O O
glycerophospholipid O O
, O O
binds O O
to O O
mCD14 O O
with O O
lower O O
apparent O O
affinity O O
than O O
does O O
PtdIns O O
. O O

LPS-binding O O
protein O O
, O O
a O O
lipid O O
transfer O O
protein O O
found O O
in O O
serum O O
, O O
facilitates O O
both O O
PS O O
- O O
and O O
PtdIns-mCD14 O O
binding O O
. O O

PtdIns O O
binding O O
to O O
mCD14 O O
can O O
be O O
blocked O O
by O O
anti-CD14 O O
monoclonal O O
antibodies O O
that O O
inhibit O O
LPS-mCD14 O O
binding O O
, O O
and O O
PtdIns O O
can O O
inhibit O O
both O O
LPS-mCD14 O O
binding O O
and O O
LPS-induced O O
responses O O
in O O
monocytes O O
. O O

Serum-equilibrated O O
PtdIns O O
also O O
binds O O
to O O
mCD14-expressing O O
cells O O
, O O
raising B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
possibility I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
endogenous I-SPECULATION I-SPECULATION
PtdIns I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
modulate I-SPECULATION I-SPECULATION
cellular I-SPECULATION I-SPECULATION
responses I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
LPS I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
other I-SPECULATION I-SPECULATION
mCD14 I-SPECULATION I-SPECULATION
ligands I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
vivo I-SPECULATION I-SPECULATION
. O O

Molecular O O
and O O
cellular O O
analysis O O
of O O
human O O
immunodeficiency O O
virus-induced O O
apoptosis O O
in O O
lymphoblastoid O O
T-cell-line-expressing O O
wild-type O O
and O O
mutated O O
CD4 O O
receptors O O
. O O

We O O
have O O
previously O O
shown O O
that O O
the O O
presence O O
of O O
the O O
CD4 O O
cytoplasmic O O
tail O O
is O O
critical O O
for O O
human O O
immunodeficiency O O
virus O O
( O O
HIV O O
)- O O
induced O O
apoptosis O O
( O O
J.Corbeil O O
, O O
M.Tremblay O O
, O O
and O O
D.D.Richman O O
, O O
J.Exp.Med.183:39-48 O O
, O O
1996 O O
) O O
. O O

We O O
have O O
pursued O O
our O O
investigation O O
of O O
the O O
role O O
of O O
the O O
CD4 O O
transduction O O
pathway O O
in O O
HIV-induced O O
apoptosis O O
. O O

To O O
do O O
this O O
, O O
wild-type O O
and O O
mutant O O
forms O O
of O O
the O O
CD4 O O
cytoplasmic O O
tail O O
were O O
stably O O
expressed O O
in O O
the O O
lymphoblastoid O O
T-cell O O
line O O
A2.01 O O
. O O

Apoptosis O O
was O O
prevented O O
when O O
CD4 O O
truncated O O
at O O
residue O O
402 O O
was O O
expressed O O
; O O
however O O
, O O
cells O O
expressing O O
mutated O O
receptors O O
that O O
do O O
not B-NEGATION B-NEGATION
associate I-NEGATION I-NEGATION
with I-NEGATION I-NEGATION
p56 I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
lck I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
mutated I-NEGATION I-NEGATION
at I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
dicysteine I-NEGATION I-NEGATION
motif I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
truncated I-NEGATION I-NEGATION
at I-NEGATION I-NEGATION
residue I-NEGATION I-NEGATION
418 I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
but O O
which O O
conserved O O
proximal O O
domains O O
of O O
the O O
cytoplasmic O O
tail O O
underwent O O
apoptosis O O
like O O
wild O O
- O O
type O O
CD4 O O
. O O

The O B-NEGATION
differences O I-NEGATION
between O I-NEGATION
wild-type O I-NEGATION
and O I-NEGATION
mutated O I-NEGATION
receptors O I-NEGATION
in O I-NEGATION
the O I-NEGATION
induction O I-NEGATION
of O I-NEGATION
apoptosis O I-NEGATION
were O I-NEGATION
not B-NEGATION I-NEGATION
related I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
levels I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
p56 I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
lck I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
NF I-NEGATION I-NEGATION
- I-NEGATION I-NEGATION
kappaB I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
. O O

Initial O O
signaling O O
through O O
the O O
CD4 O O
receptor O O
played O O
a O O
major O O
role O O
in O O
the O O
sensitization O O
of O O
HIV-infected O O
T O O
cells O O
to O O
undergo O O
apoptosis O O
. O O

Incubation O O
of O O
HIV-infected O O
cells O O
with O O
monoclonal O O
antibody O O
( O O
MAb O O
) O O
13B8-2 O O
, O O
which O O
binds O O
to O O
CD4 O O
in O O
a O O
region O O
critical O O
for O O
dimerization O O
of O O
the O O
receptor O O
, O O
prevented O O
apoptosis O O
without B-NEGATION B-NEGATION
inhibiting I-NEGATION I-NEGATION
HIV I-NEGATION I-NEGATION
replication I-NEGATION I-NEGATION
. O O

Moreover O O
, O O
the O B-NEGATION
apoptotic O I-NEGATION
process O I-NEGATION
was O I-NEGATION
not B-NEGATION I-NEGATION
related I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
Fas-Fas I-NEGATION I-NEGATION
ligand I-NEGATION I-NEGATION
interaction I-NEGATION I-NEGATION
; O O
however O O
, O O
an O O
antagonistic O O
anti-Fas O O
MAb O O
( O O
ZB-4 O O
) O O
enhanced O O
apoptosis O O
in O O
HIV-infected O O
cells O O
without B-NEGATION B-NEGATION
inducing I-NEGATION I-NEGATION
apoptosis I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
uninfected I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
. O O

These O O
observations O O
demonstrate O O
that O O
CD4 O O
signaling O O
mediates O O
HIV-induced O O
apoptosis O O
by O O
a O O
mechanism O O
independent O O
of O O
Fas-Fas O O
ligand O O
interaction O O
, O O
does O O
not B-NEGATION B-NEGATION
require I-NEGATION I-NEGATION
p56 I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
lck I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
signaling I-NEGATION I-NEGATION
, O O
and O O
may B-SPECULATION B-SPECULATION
involve I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
critical I-SPECULATION I-SPECULATION
region I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
CD4 I-SPECULATION I-SPECULATION
dimerization I-SPECULATION I-SPECULATION
. O O

Low O O
CD3 O O
+ O O
CD28-induced O O
interleukin-2 O O
production O O
correlates O O
with O O
decreased O O
reactive O O
oxygen O O
intermediate O O
formation O O
in O O
neonatal O O
T O O
cells O O
. O O

The O O
capacity O O
of O O
neonatal O O
T O O
cells O O
to O O
secrete O O
interleukin-2 O O
( O O
IL-2 O O
) O O
has O O
been O O
reported O O
to O O
be O O
variable O O
. O O

We O O
analysed O O
IL-2 O O
production O O
in O O
purified O O
neonatal O O
and O O
adult O O
T O O
cells O O
using O O
polyclonal O O
activator O O
phorbol O O
ester O O
+ O O
calcium O O
ionophore O O
( O O
PDBu O O
+ O O
iono O O
) O O
or O O
receptor-mediated O O
anti-CD3 O O
/ O O
anti-CD3 O O
+ O O
anti-CD28 O O
stimulation O O
. O O

PDBu O O
+ O O
iono O O
induced O O
equally O O
high O O
IL-2 O O
levels O O
in O O
both O O
groups O O
and O O
, O O
when O O
stimulated O O
with O O
plate-bound O O
anti-CD3 O O
monoclonal O O
antibody O O
( O O
mAb O O
) O O
, O O
the O O
IL-2 O O
secretion O O
by O O
neonatal O O
cells O O
was O O
undetectable O O
and O O
adult O O
cells O O
produced O O
low O O
amounts O O
of O O
IL-2 O O
( O O
mean O O
331 O O
± O O
86 O O
pg O O
/ O O
ml O O
) O O
. O O

The O O
addition O O
of O O
anti-CD28 O O
mAb O O
to O O
anti-CD3-stimulated O O
cells O O
markedly O O
increased O O
IL-2 O O
production O O
in O O
both O O
cell O O
types O O
, O O
but O O
levels O O
of O O
IL-2 O O
in O O
neonatal O O
T O O
cells O O
remained O O
clearly O O
lower O O
than O O
those O O
of O O
adult O O
T O O
cells O O
( O O
respective O O
mean O O
values O O
: O O
385 O O
± O O
109 O O
pg O O
/ O O
ml O O
and O O
4494 O O
± O O
1199 O O
pg O O
/ O O
ml O O
) O O
. O O

As O O
NF-kappa O O
B O O
is O O
a O O
critical O O
transcription O O
factor O O
in O O
the O O
control O O
of O O
IL-2 O O
expression O O
, O O
we O O
next O O
analysed O O
its O O
nuclear O O
translocation O O
in O O
neonatal O O
and O O
adult O O
T O O
cells O O
using O O
the O O
electrophoretic O O
mobility O O
shift O O
assay O O
and O O
, O O
because O O
induction O O
of O O
reactive O O
oxygen O O
intermediates O O
( O O
ROI O O
) O O
is O O
required O O
for O O
the O O
activation O O
of O O
NF-kappa O O
B O O
, O O
we O O
also O O
analysed O O
levels O O
of O O
intracellular O O
ROI O O
in O O
these O O
cells O O
using O O
the O O
ROI-reactive O O
fluorochrome O O
DCFH-DA O O
and O O
flow O O
cytometry O O
. O O

In O O
neonatal O O
T O O
cells O O
NF-kappa O O
B O O
activation O O
and O O
ROI O O
formation O O
after O O
anti-CD3 O O
stimulation O O
were O O
low O O
compared O O
with O O
adult O O
T O O
cells O O
and O O
, O O
although O O
addition O O
of O O
anti-CD28 O O
mAb O O
increased O O
induction O O
of O O
NF-kappa O O
B O O
and O O
ROI O O
formation O O
, O O
levels B-NEGATION O
similar I-NEGATION O
to I-NEGATION O
those I-NEGATION O
of I-NEGATION O
adults I-NEGATION O
were I-NEGATION O
not I-NEGATION B-NEGATION
achieved I-NEGATION I-NEGATION
. O O

After O O
PDBu O O
+ O O
iono O O
stimulation O O
, O O
the O O
cells O O
showed O O
similar O O
ROI O O
formation O O
and O O
IL-2 O O
secretion O O
. O O

Our O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
reduced I-SPECULATION I-SPECULATION
IL-2 I-SPECULATION I-SPECULATION
production I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
neonatal I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
specific I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
anti-CD3 I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
anti-CD3 I-SPECULATION I-SPECULATION
+ I-SPECULATION I-SPECULATION
anti-CD28-mediated I-SPECULATION I-SPECULATION
stimulation I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
activators I-SPECULATION I-SPECULATION
cannot B-NEGATION B-NEGATION
effectively I-NEGATION I-NEGATION
activate I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
ROI-NF-kappa I-NEGATION I-NEGATION
B I-NEGATION I-NEGATION
signalling I-NEGATION I-NEGATION
pathway I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
neonatal I-NEGATION I-NEGATION
T I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
. O O

Activated O O
platelets O O
induce O O
monocyte O O
chemotactic O O
protein-1 O O
secretion O O
and O O
surface O O
expression O O
of O O
intercellular O O
adhesion O O
molecule-1 O O
on O O
endothelial O O
cells O O
[ O O
see O O
comments O O
] O O

BACKGROUND O O
: O O
Platelet O O
/ O O
endothelium O O
interaction O O
plays O O
an O O
important O O
role O O
in O O
the O O
pathophysiology O O
of O O
inflammation O O
and O O
atherosclerosis O O
. O O

The O O
role O O
of O O
platelets O O
for O O
monocyte O O
chemotactic O O
protein-1 O O
( O O
MCP-1 O O
) O O
secretion O O
and O O
surface O O
expression O O
of O O
intercellular O O
adhesion O O
molecule-1 O O
( O O
ICAM-1 O O
) O O
on O O
endothelial O O
cells O O
has O O
been O O
assessed O O
. O O

METHODS O O
AND O O
RESULTS O O
: O O
Monolayers O O
of O O
human O O
umbilical O O
vein O O
endothelial O O
cells O O
were O O
incubated O O
with O O
nonstimulated O O
or O O
ADP-activated O O
platelets O O
for O O
6 O O
hours O O
, O O
and O O
secretion O O
of O O
MCP-1 O O
and O O
surface O O
expression O O
of O O
ICAM-1 O O
were O O
determined O O
by O O
ELISA O O
and O O
flow O O
cytometry O O
, O O
respectively O O
. O O

In O O
the O O
presence O O
of O O
ADP-activated O O
platelets O O
, O O
both O O
MCP-1 O O
secretion O O
and O O
ICAM-1 O O
surface O O
expression O O
were O O
significantly O O
increased O O
compared O O
with O O
nonstimulated O O
platelets O O
( O O
P O O
< O O
0.02 O O
) O O
. O O

Activation O O
of O O
the O O
transcription O O
factor O O
nuclear O O
factor-kappaB O O
( O O
NF-kappaB O O
) O O
determined O O
by O O
electrophoretic O O
mobility O O
shift O O
assay O O
and O O
kappaB-dependent O O
transcriptional O O
activity O O
was O O
enhanced O O
in O O
the O O
presence O O
of O O
activated O O
platelets O O
. O O

In O O
addition O O
, O O
ADP-activated O O
platelets O O
induced O O
MCP-1 O O
and O O
ICAM-1 O O
promoter-dependent O O
transcription O O
. O O

Liposomal O O
transfection O O
of O O
a O O
double-stranded O O
kappaB O O
phosphorothioate O O
oligonucleotide O O
, O O
but O O
not B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
mutated I-NEGATION I-NEGATION
form I-NEGATION I-NEGATION
, O O
inhibited O O
MCP-1 O O
secretion O O
and O O
surface O O
expression O O
of O O
ICAM-1 O O
on O O
activated O O
endothelium O O
( O O
P O O
< O O
0.05 O O
) O O
. O O

CONCLUSIONS O O
: O O
The O O
present O O
study O O
indicates B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
activated I-SPECULATION I-SPECULATION
platelets I-SPECULATION I-SPECULATION
modulate I-SPECULATION I-SPECULATION
chemotactic I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
MCP-1 I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
adhesive I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
ICAM-1 I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
properties I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
endothelial I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
via I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
NF-kappaB-dependent I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
. O O

Platelet-induced O O
activation O O
of O O
the O O
NF-kappaB O O
system O O
might B-SPECULATION B-SPECULATION
contribute I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
early I-SPECULATION I-SPECULATION
inflammatory I-SPECULATION I-SPECULATION
events I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
atherogenesis I-SPECULATION I-SPECULATION
. O O

Altered O O
DNA-binding O O
specificity O O
mutants O O
of O O
EKLF O O
and O O
Sp1 O O
show O O
that O O
EKLF O O
is O O
an O O
activator O O
of O O
the O O
beta-globin O O
locus O O
control O O
region O O
in O O
vivo O O
. O O

The O O
locus O O
control O O
region O O
of O O
the O O
beta-globin O O
cluster O O
contains O O
five O O
DNase O O
I O O
hypersensitive O O
sites O O
( O O
5'HS1-5 O O
) O O
required O O
for O O
locus O O
activation O O
. O O

5'HS3 O O
contains O O
six O O
G-rich O O
motifs O O
that O O
are O O
essential O O
for O O
its O O
activity O O
. O O

Members O O
of O O
a O O
protein O O
family O O
, O O
characterized O O
by O O
three O O
zinc O O
fingers O O
highly O O
homologous O O
to O O
those O O
found O O
in O O
transcription O O
factor O O
Sp1 O O
, O O
interact O O
with O O
these O O
motifs O O
. O O

Because O O
point O O
mutagenesis O O
cannot B-NEGATION B-NEGATION
distinguish I-NEGATION I-NEGATION
between I-NEGATION I-NEGATION
family I-NEGATION I-NEGATION
members I-NEGATION I-NEGATION
, O O
it O O
is O O
not B-SPECULATION B-SPECULATION
known I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
activates I-SPECULATION I-SPECULATION
5'HS3 I-SPECULATION I-SPECULATION
. O O

We O O
show O O
that O O
the O O
function O O
of O O
such O O
closely O O
related O O
proteins O O
can O O
be O O
distinguished O O
in O O
vivo O O
by O O
matching O O
point O O
mutations O O
in O O
5'HS3 O O
with O O
amino O O
acid O O
changes O O
in O O
the O O
zinc O O
fingers O O
of O O
Sp1 O O
and O O
EKLF O O
. O O

Testing O O
their O O
activity O O
in O O
transgenic O O
mice O O
shows O O
that O O
EKLF O O
is O O
a O O
direct O O
activator O O
of O O
5'HS3 O O
. O O

NF-kappaB O O
only O O
partially O O
mediates O O
Epstein-Barr O O
virus O O
latent O O
membrane O O
protein O O
1 O O
activation O O
of O O
B O O
cells O O
. O O

The O O
latent O O
membrane O O
protein O O
1 O O
( O O
LMP1 O O
) O O
of O O
Epstein-Barr O O
virus O O
( O O
EBV O O
) O O
is O O
required O O
for O O
EBV-induced O O
immortalization O O
of O O
human O O
B O O
cells O O
and O O
causes O O
tumorigenic O O
transformation O O
of O O
cell O O
lines O O
. O O

LMP1 O O
expression O O
induces O O
phenotypic O O
changes O O
resembling O O
B O O
cell O O
activation O O
, O O
such O O
as O O
cell O O
size O O
increase O O
and O O
up-regulation O O
of O O
cell O O
surface O O
activation O O
markers O O
. O O

LMP1 O O
contains O O
two O O
domains O O
that O O
activate O O
the O O
transcription O O
factor O O
NF-kappaB O O
, O O
one O O
through O O
interactions O O
with O O
TRAF O O
proteins O O
and O O
the O O
other O O
with O O
the O O
TRADD O O
protein O O
. O O

The O O
purpose O O
of O O
the O O
present O O
study O O
was O O
to O O
investigate O O
the O O
importance O O
of O O
NF-kappaB O O
induction O O
in O O
the O O
up-regulation O O
of O O
the O O
B O O
cell O O
activation O O
markers O O
ICAM-1 O O
and O O
CD71 O O
by O O
LMP1 O O
. O O

This O O
study O O
shows O O
that O O
expression O O
of O O
LMP1 O O
activates O O
transcription O O
from O O
p50 O O
/ O O
p65 O O
- O O
and O O
c-Rel O O
- O O
responsive O O
promoters O O
, O O
and O O
that O O
this O O
activity O O
can O O
be O O
completely O O
inhibited O O
by O O
expression O O
of O O
a O O
dominant O O
inhibitory O O
IkappaB O O
mutant O O
. O O

ICAM-1 O O
and O O
CD71 O O
are O O
nevertheless O O
up-regulated O O
by O O
LMP1 O O
in O O
primary O O
B O O
cells O O
and O O
cell O O
lines O O
expressing O O
the O O
dominant O O
IkappaB O O
. O O

Furthermore O O
, O O
LMP1-induced O O
cell O O
size O O
increase O O
of O O
primary O O
B O O
cells O O
was O O
unaffected O O
by O O
IkappaB O O
expression O O
. O O

It O O
was O O
concluded O O
that O O
even O O
when O O
LMP1 B-NEGATION O
is I-NEGATION O
unable I-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
activate I-NEGATION I-NEGATION
NF-kappaB I-NEGATION I-NEGATION
, O O
it O O
is O O
still O O
capable O O
of O O
inducing O O
certain O O
characteristics O O
of O O
activated O O
B O O
cells O O
, O O
strongly O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
LMP1 I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
also I-SPECULATION I-SPECULATION
activate I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
independently I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
. O O

Activation O O
of O O
distinct O O
transcription O O
factors O O
in O O
neutrophils O O
by O O
bacterial O O
LPS O O
, O O
interferon-gamma O O
, O O
and O O
GM-CSF O O
and O O
the O O
necessity O O
to O O
overcome O O
the O O
action O O
of O O
endogenous O O
proteases O O
. O O

Human O O
neutrophils O O
can O O
be O O
induced O O
to O O
actively O O
transcribe O O
a O O
number O O
of O O
early-response O O
genes O O
, O O
in O O
particular O O
those O O
encoding O O
cytokines O O
, O O
chemokines O O
, O O
and O O
the O O
high-affinity O O
surface O O
receptor O O
for O O
IgG O O
, O O
FcgammaRI O O
. O O

Although O O
little O O
is O O
known O O
to O O
date O O
about O O
the O O
regulation O O
of O O
gene O O
transcription O O
in O O
neutrophils O O
, O O
several O O
indications O O
point O O
to O O
a O O
role O O
for O O
distinct O O
transcription O O
factors O O
, O O
such O O
as O O
members O O
of O O
the O O
NF-kappaB O O
and O O
STAT O O
families O O
. O O

In O O
this O O
study O O
, O O
we O O
investigated O O
whether B-SPECULATION B-SPECULATION
these I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factors I-SPECULATION I-SPECULATION
become I-SPECULATION I-SPECULATION
activated I-SPECULATION I-SPECULATION
under I-SPECULATION I-SPECULATION
stimulatory I-SPECULATION I-SPECULATION
conditions I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
known I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
induce I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
neutrophils I-SPECULATION I-SPECULATION
. O O

Unexpectedly O O
, O O
we O O
found O O
that O O
conventional O O
procedures O O
employed O O
to O O
prepare O O
cellular O O
extracts O O
cause O O
the O O
release O O
of O O
proteolytic O O
activities O O
that O O
are O O
normally O O
stored O O
in O O
intracellular O O
granules O O
, O O
resulting O O
in O O
the O O
degradation O O
of O O
various O O
NF-kappaB O O
/ O O
Rel O O
and O O
STAT O O
proteins O O
. O O

To O O
circumvent O O
this O O
problem O O
, O O
we O O
developed O O
an O O
alternative O O
procedure O O
which O O
allowed O O
us O O
to O O
show O O
that O O
in O O
neutrophils O O
, O O
LPS O O
and O O
TNFalpha O O
induce O O
a O O
NF-kappaB O O
DNA-binding O O
activity O O
which O O
essentially O O
consists O O
of O O
p50 O O
/ O O
RelA O O
dimers O O
, O O
and O O
that O O
IFNgamma O O
promotes O O
the O O
binding O O
of O O
STAT1 O O
homodimers O O
to O O
the O O
IFNgamma O O
response O O
region O O
of O O
the O O
FcgammaRI O O
promoter O O
. O O

Moreover O O
, O O
we O O
report O O
that O O
neutrophil O O
stimulation O O
with O O
GM-CSF O O
results O O
in O O
the O O
formation O O
of O O
a O O
STAT5-containing O O
DNA-binding O O
activity O O
. O O

Collectively O O
, O O
the O O
current O O
findings O O
open O O
new O O
perspectives O O
about O O
mechanisms O O
that B-SPECULATION B-SPECULATION
are I-SPECULATION I-SPECULATION
likely I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
regulate I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
neutrophils I-SPECULATION I-SPECULATION
. O O

In O O
addition O O
, O O
the O O
procedure O O
described O O
herein O O
could B-SPECULATION B-SPECULATION
prove I-SPECULATION I-SPECULATION
useful I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
other I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
types I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
express I-SPECULATION I-SPECULATION
high I-SPECULATION I-SPECULATION
levels I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
endogenous I-SPECULATION I-SPECULATION
proteases I-SPECULATION I-SPECULATION
. O O

The O O
PEBP2betaMYH11 O O
fusion O O
created O O
by O O
Inv O O
( O O
16 O O
)( O O
p13 O O
; O O
q22 O O
) O O
in O O
myeloid O O
leukemia O O
impairs O O
neutrophil O O
maturation O O
and O O
contributes O O
to O O
granulocytic O O
dysplasia O O
. O O

Chromosomal O O
translocations O O
involving O O
the O O
genes O O
encoding O O
the O O
alpha O O
and O O
beta O O
subunits O O
of O O
the O O
Pebp2 O O
/ O O
Cbf O O
transcription O O
factor O O
have O O
been O O
associated O O
with O O
human O O
acute O O
myeloid O O
leukemia O O
and O O
the O O
preleukemic O O
condition O O
, O O
myelodysplasia O O
. O O

Inv O O
( O O
16 O O
)( O O
p13 O O
; O O
q22 O O
) O O
fuses O O
the O O
gene O O
encoding O O
the O O
beta O O
subunit O O
of O O
Pebp2 O O
to O O
the O O
MYH11 O O
gene O O
encoding O O
a O O
smooth O O
muscle O O
myosin O O
heavy O O
chain O O
( O O
Smmhc O O
) O O
. O O

To O O
examine O O
the O O
effect O O
of O O
the O O
inv O O
( O O
16 O O
)( O O
p13 O O
; O O
q22 O O
) O O
on O O
myelopoiesis O O
, O O
we O O
used O O
the O O
hMRP8 O O
promoter O O
element O O
to O O
generate O O
transgenic O O
mice O O
expressing O O
the O O
Pebp2beta O O
Smmhc O O
chimeric O O
fusion O O
protein O O
in O O
myeloid O O
cells O O
. O O

Neutrophil O O
maturation O O
was O O
impaired O O
in O O
PEBP2betaMYH11 O O
transgenic O O
mice O O
. O O

Although O O
the O O
transgenic O O
mice O O
had O O
normal O O
numbers O O
of O O
circulating O O
neutrophils O O
, O O
their O O
bone O O
marrow O O
contained O O
increased O O
numbers O O
of O O
immature O O
neutrophilic O O
cells O O
, O O
which O O
exhibited O O
abnormal O O
characteristics O O
. O O

In O O
addition O O
, O O
PEBP2betaMYH11 O O
inhibited O O
neutrophilic O O
differentiation O O
in O O
colonies O O
derived O O
from O O
hematopoietic O O
progenitors O O
. O O

Coexpression O O
of O O
both O O
PEBP2betaMYH11 O O
and O O
activated O O
NRAS O O
induced O O
a O O
more O O
severe O O
phenotype O O
characterized O O
by O O
abnormal O O
nuclear O O
morphology O O
indicative O O
of O O
granulocytic O O
dysplasia O O
. O O

These O O
results O O
show O O
that O O
PEBP2betaMYH11 O O
can O O
impair O O
neutrophil O O
development O O
and O O
provide O O
evidence O O
that O O
alterations O O
of O O
Pebp2 O O
can O B-SPECULATION
contribute O I-SPECULATION
to O I-SPECULATION
the O I-SPECULATION
genesis O I-SPECULATION
of O I-SPECULATION
myelodysplasia O I-SPECULATION
. O O

Transcription O O
factor O O
activation O O
in O O
lymphokine O O
activated O O
killer O O
cells O O
and O O
lymphocytes O O
from O O
patients O O
receiving O O
IL-2 O O
immunotherapy O O
. O O

Administration O O
of O O
the O O
cytokine O O
interleukin-2 O O
( O O
IL-2 O O
) O O
can O O
result O O
in O O
therapeutic O O
benefits O O
for O O
individuals O O
with O O
renal O O
cell O O
carcinoma O O
and O O
melanoma O O
. O O

Here O O
we O O
report O O
an O O
analysis O O
of O O
the O O
transcription O O
factor O O
families O O
AP-1 O O
, O O
Sp1 O O
, O O
NF-kappaB O O
, O O
and O O
signal O O
transducers O O
and O O
activators O O
of O O
transcription O O
( O O
STAT O O
) O O
in O O
cancer O O
patients' O O
lymphocytes O O
before O O
and O O
after O O
IL-2 O O
immunotherapy O O
, O O
as O O
assessed O O
by O O
a O O
gel-shift O O
assay O O
. O O

An O O
in O O
vitro O O
surrogate O O
of O O
IL-2 O O
immunotherapy O O
is O O
the O O
incubation O O
of O O
fresh O O
peripheral O O
blood O O
mononuclear O O
cells O O
( O O
PBMC O O
) O O
from O O
healthy O O
individuals O O
in O O
IL-2 O O
for O O
several O O
days O O
, O O
resulting O O
in O O
the O O
production O O
of O O
lymphokine-activated O O
killer O O
( O O
LAK O O
) O O
activity O O
in O O
these O O
cultures O O
. O O

One O O
purpose O O
of O O
this O O
study O O
was O O
to O O
describe O O
the O O
profile O O
of O O
transcription O O
factor O O
activation O O
in O O
these O O
different O O
populations O O
, O O
and O O
assess O O
whether B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
patterns I-SPECULATION I-SPECULATION
observed I-SPECULATION I-SPECULATION
correlated I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
functional I-SPECULATION I-SPECULATION
differences I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

Prior O O
to O O
in O O
vivo O O
IL-2 O O
administration O O
, O O
the O O
typical O O
binding O O
pattern O O
of O O
transcription O O
factors O O
in O O
PBMC O O
from O O
patients O O
resembled O O
that O O
seen O O
in O O
fresh O O
PBMC O O
from O O
healthy O O
individuals O O
. O O

Over O O
a O O
3-week O O
course O O
of O O
IL-2 O O
therapy O O
, O O
in O O
most O O
patients O O
the O O
binding O O
patterns O O
of O O
AP-1 O O
, O O
Sp1 O O
, O O
and O O
NF-kappaB O O
proteins O O
changed O O
to O O
resemble O O
those O O
seen O O
in O O
PBMC O O
activated O O
by O O
IL-2 O O
in O O
vitro O O
. O O

However O O
, O O
the O O
cells O O
obtained O O
from O O
IL-2-treated O O
patients O O
did O O
not B-NEGATION B-NEGATION
have I-NEGATION I-NEGATION
low-level I-NEGATION I-NEGATION
constitutive I-NEGATION I-NEGATION
expression I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
STAT I-NEGATION I-NEGATION
binding I-NEGATION I-NEGATION
factors I-NEGATION I-NEGATION
as O O
did O O
LAK O O
cells O O
. O O

When O O
these O O
patient O O
cells O O
were O O
further O O
stimulated O O
by O O
IL-2 O O
in O O
vitro O O
, O O
additional O O
differences O O
in O O
STAT O O
induction O O
patterns O O
were O O
noted O O
. O O

These O O
data O O
provide O O
further O O
information O O
on O O
the O O
molecular O O
events O O
occurring O O
in O O
immune O O
cells O O
generated O O
through O O
in O O
vivo O O
and O O
in O O
vitro O O
administration O O
of O O
IL-2 O O
, O O
and O O
further O O
document O O
that O O
there O O
is O O
not B-NEGATION B-NEGATION
a I-NEGATION I-NEGATION
precise I-NEGATION I-NEGATION
congruence I-NEGATION I-NEGATION
between I-NEGATION I-NEGATION
PBMC I-NEGATION I-NEGATION
activated I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
vivo I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
vitro I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
IL-2 I-NEGATION I-NEGATION
. O O

A O O
critical O O
role O O
of O O
the O O
p75 O O
tumor O O
necrosis O O
factor O O
receptor O O
( O O
p75TNF-R O O
) O O
in O O
organ O O
inflammation O O
independent O O
of O O
TNF O O
, O O
lymphotoxin O O
alpha O O
, O O
or O O
the O O
p55TNF-R O O
. O O

Despite O O
overwhelming O O
evidence O O
that O O
enhanced O O
production O O
of O O
the O O
p75 O O
tumor O O
necrosis O O
factor O O
receptor O O
( O O
p75TNF-R O O
) O O
accompanies O O
development O O
of O O
specific O O
human O O
inflammatory O O
pathologies O O
such O O
as O O
multi-organ O O
failure O O
during O O
sepsis O O
, O O
inflammatory O O
liver O O
disease O O
, O O
pancreatitis O O
, O O
respiratory O O
distress O O
syndrome O O
, O O
or O O
AIDS O O
, O O
the O O
function O O
of O O
this O O
receptor O O
remains O O
poorly O O
defined O O
in O O
vivo O O
. O O

We O O
show O O
here O O
that O O
at O O
levels O O
relevant O O
to O O
human O O
disease O O
, O O
production O O
of O O
the O O
human O O
p75TNF-R O O
in O O
transgenic O O
mice O O
results O O
in O O
a O O
severe O O
inflammatory O O
syndrome O O
involving O O
mainly O O
the O O
pancreas O O
, O O
liver O O
, O O
kidney O O
, O O
and O O
lung O O
, O O
and O O
characterized O O
by O O
constitutively O O
increased O O
NF-kappaB O O
activity O O
in O O
the O O
peripheral O O
blood O O
mononuclear O O
cell O O
compartment O O
. O O

This O O
process O O
is O O
shown O O
to O O
evolve O O
independently O O
of O O
the O O
presence O O
of O O
TNF O O
, O O
lymphotoxin O O
alpha O O
, O O
or O O
the O O
p55TNF-R O O
, O O
although O O
coexpression O O
of O O
a O O
human O O
TNF O O
transgene O O
accelerated O O
pathology O O
. O O

These O O
results O O
establish O O
an O O
independent O O
role O O
for O O
enhanced O O
p75TNF-R O O
production O O
in O O
the O O
pathogenesis O O
of O O
inflammatory O O
disease O O
and O O
implicate O O
the O O
direct O O
involvement O O
of O O
this O O
receptor O O
in O O
a O O
wide O O
range O O
of O O
human O O
inflammatory O O
pathologies O O
. O O

Potent O O
inhibition O O
of O O
HIV O O
type O O
1 O O
replication O O
by O O
an O O
antiinflammatory O O
alkaloid O O
, O O
cepharanthine O O
, O O
in O O
chronically O O
infected O O
monocytic O O
cells O O
. O O

Cepharanthine O O
is O O
a O O
biscoclaurine O O
alkaloid O O
isolated O O
from O O
Stephania O O
cepharantha O O
Hayata O O
and O O
has O O
been O O
shown O O
to O O
have O O
antiinflammatory O O
, O O
antiallergic O O
, O O
and O O
immunomodulatory O O
activities O O
in O O
vivo O O
. O O

As O O
several O O
inflammatory O O
cytokines O O
and O O
oxidative O O
stresses O O
are O O
involved O O
in O O
the O O
pathogenesis O O
of O O
HIV-1 O O
infection O O
, O O
we O O
investigated O O
the O O
inhibitory O O
effects O O
of O O
cepharanthine O O
on O O
tumor O O
necrosis O O
factor O O
alpha O O
( O O
TNF-alpha O O
)- O O
and O O
phorbol O O
12-myristate O O
13-acetate O O
( O O
PMA O O
)- O O
induced O O
HIV-1 O O
replication O O
in O O
chronically O O
infected O O
cell O O
lines O O
. O O

Two O O
chronically O O
HIV-1-infected O O
cell O O
lines O O
, O O
U1 O O
( O O
monocytic O O
) O O
and O O
ACH-2 O O
( O O
T O O
lymphocytic O O
) O O
, O O
were O O
stimulated O O
with O O
TNF-alpha O O
or O O
PMA O O
and O O
cultured O O
in O O
the O O
presence O O
of O O
various O O
concentrations O O
of O O
the O O
compound O O
. O O

HIV-1 O O
replication O O
was O O
determined O O
by O O
p24 O O
antigen O O
level O O
. O O

The O O
inhibitory O O
effects O O
of O O
cepharanthine O O
on O O
HIV-1 O O
long O O
terminal O O
repeat O O
( O O
LTR O O
)- O O
driven O O
gene O O
expression O O
and O O
nuclear O O
factor O O
kappaB O O
( O O
NF-kappaB O O
) O O
activation O O
were O O
also O O
examined O O
. O O

Cepharanthine O O
dose O O
dependently O O
inhibited O O
HIV-1 O O
replication O O
in O O
TNF-alpha O O
- O O
and O O
PMA-stimulated O O
U1 O O
cells O O
but O O
not B-NEGATION B-NEGATION
in I-NEGATION I-NEGATION
ACH-2 I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
. O O

Its O O
50 O O
% O O
effective O O
and O O
cytotoxic O O
concentrations O O
were O O
0.016 O O
and O O
2.2 O O
microg O O
/ O O
ml O O
in O O
PMA-stimulated O O
U1 O O
cells O O
, O O
respectively O O
. O O

Cepharanthine O O
was O O
found O O
to O O
suppress O O
HIV-1 O O
LTR-driven O O
gene O O
expression O O
through O O
the O O
inhibition O O
of O O
NF-kappaB O O
activation O O
. O O

These O O
results O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
cepharanthine I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
highly I-SPECULATION I-SPECULATION
potent I-SPECULATION I-SPECULATION
inhibitor I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
HIV-1 I-SPECULATION I-SPECULATION
replication I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
chronically I-SPECULATION I-SPECULATION
infected I-SPECULATION I-SPECULATION
monocytic I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
line I-SPECULATION I-SPECULATION
. O O

Since O O
biscoclaurine O O
alkaloids O O
, O O
containing O O
cepharanthine O O
as O O
a O O
major O O
component O O
, O O
are O O
widely O O
used O O
for O O
the O O
treatment O O
of O O
patients O O
with O O
various O O
inflammatory O O
diseases O O
in O O
Japan O O
, O O
cepharanthine B-SPECULATION O
should I-SPECULATION O
be I-SPECULATION O
further I-SPECULATION O
pursued I-SPECULATION O
for I-SPECULATION O
its I-SPECULATION O
chemotherapeutic I-SPECULATION O
potential I-SPECULATION O
in I-SPECULATION O
HIV-1-infected I-SPECULATION O
patients I-SPECULATION O
. O O

Prostaglandin O O
E2 O O
Up-regulates O O
HIV-1 O O
long O O
terminal O O
repeat-driven O O
gene O O
activity O O
in O O
T O O
cells O O
via O O
NF-kappaB-dependent O O
and O O
- O O
independent O O
signaling O O
pathways O O
. O O

Replication O O
of O O
human O O
immunodeficiency O O
virus O O
type-1 O O
( O O
HIV-1 O O
) O O
is O O
highly O O
dependent O O
on O O
the O O
state O O
of O O
activation O O
of O O
the O O
infected O O
cells O O
and O O
is O O
modulated O O
by O O
interactions O O
between O O
viral O O
and O O
host O O
cellular O O
factors O O
. O O

Prostaglandin O O
E2 O O
( O O
PGE2 O O
) O O
, O O
a O O
pleiotropic O O
immunomodulatory O O
molecule O O
, O O
is O O
observed O O
at O O
elevated O O
levels O O
during O O
HIV-1 O O
infection O O
as O O
well O O
as O O
during O O
the O O
course O O
of O O
other O O
pathogenic O O
infections O O
. O O

In O O
1G5 O O
, O O
a O O
Jurkat-derived O O
T O O
cell O O
line O O
stably O O
transfected O O
with O O
a O O
luciferase O O
gene O O
driven O O
by O O
HIV-1 O O
long O O
terminal O O
repeat O O
( O O
LTR O O
) O O
, O O
we O O
found O O
that O O
PGE2 O O
markedly O O
enhanced O O
HIV-1 O O
LTR-mediated O O
reporter O O
gene O O
activity O O
. O O

Experiments O O
have O O
been O O
conducted O O
to O O
identify O O
second O O
messengers O O
involved O O
in O O
this O O
PGE2-dependent O O
up-regulating O O
effect O O
on O O
the O O
regulatory O O
element O O
of O O
HIV-1 O O
. O O

In O O
this O O
study O O
, O O
we O O
present O O
evidence O O
indicating B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
signal I-SPECULATION I-SPECULATION
transduction I-SPECULATION I-SPECULATION
pathways I-SPECULATION I-SPECULATION
induced I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
PGE2 I-SPECULATION I-SPECULATION
necessitate I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
participation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
cyclic I-SPECULATION I-SPECULATION
AMP I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
kinase I-SPECULATION I-SPECULATION
A I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
Ca2 I-SPECULATION I-SPECULATION
+ I-SPECULATION I-SPECULATION
. O O

Experiments O O
conducted O O
with O O
different O O
HIV-1 O O
LTR-based O O
vectors O O
suggested B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
PGE2-mediated I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
effect I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
HIV-1 I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
was I-SPECULATION I-SPECULATION
transduced I-SPECULATION I-SPECULATION
via I-SPECULATION I-SPECULATION
both I-SPECULATION I-SPECULATION
NF-kappaB-dependent I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
- I-SPECULATION I-SPECULATION
independent I-SPECULATION I-SPECULATION
signaling I-SPECULATION I-SPECULATION
pathways I-SPECULATION I-SPECULATION
. O O

The O O
involvement O O
of O O
NF-kappaB O O
in O O
the O O
PGE2-dependent O O
activating O O
effect O O
on O O
HIV-1 O O
transcription O O
was O O
further O O
confirmed O O
using O O
a O O
kappaB-regulated O O
luciferase O O
encoding O O
vector O O
and O O
by O O
electrophoretic O O
mobility O O
shift O O
assays O O
. O O

Results O O
from O O
Northern O O
blot O O
and O O
flow O O
cytometric O O
analyses O O
, O O
as O O
well O O
as O O
the O O
use O O
of O O
a O O
selective O O
antagonist O O
indicated B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
PGE2 I-SPECULATION I-SPECULATION
modulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
HIV-1 I-SPECULATION I-SPECULATION
LTR-driven I-SPECULATION I-SPECULATION
reporter I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
activity I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
studied I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
lymphoid I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
transduced I-SPECULATION I-SPECULATION
via I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
EP4 I-SPECULATION I-SPECULATION
receptor I-SPECULATION I-SPECULATION
subtype I-SPECULATION I-SPECULATION
. O O

These O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
secretion I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
PGE2 I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
macrophages I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
response I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
infection I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
inflammatory I-SPECULATION I-SPECULATION
activators I-SPECULATION I-SPECULATION
could B-SPECULATION B-SPECULATION
induce I-SPECULATION I-SPECULATION
signaling I-SPECULATION I-SPECULATION
events I-SPECULATION I-SPECULATION
resulting I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
proviral I-SPECULATION I-SPECULATION
DNA I-SPECULATION I-SPECULATION
present I-SPECULATION I-SPECULATION
into I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
latently I-SPECULATION I-SPECULATION
infected I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
HIV-1 I-SPECULATION I-SPECULATION
. O O

Fcgamma O O
receptor-mediated O O
mitogen-activated O O
protein O O
kinase O O
activation O O
in O O
monocytes O O
is O O
independent O O
of O O
Ras O O
. O O

Receptors O O
for O O
the O O
Fc O O
portion O O
of O O
immunoglobulin O O
molecules O O
( O O
FcR O O
) O O
present O O
on O O
leukocyte O O
cell O O
membranes O O
mediate O O
a O O
large O O
number O O
of O O
cellular O O
responses O O
that O O
are O O
very O O
important O O
in O O
host O O
defense O O
, O O
including O O
phagocytosis O O
, O O
cell O O
cytotoxicity O O
, O O
production O O
and O O
secretion O O
of O O
inflammatory O O
mediators O O
, O O
and O O
modulation O O
of O O
the O O
immune O O
response O O
. O O

Cross-linking O O
of O O
FcR O O
with O O
immune O O
complexes O O
leads O O
, O O
first O O
to O O
activation O O
of O O
protein-tyrosine O O
kinases O O
. O O

The O O
molecular O O
events O O
that O O
follow O O
and O O
that O O
transduce O O
signals O O
from O O
these O O
receptors O O
to O O
the O O
nucleus O O
are O O
still O O
poorly O O
defined O O
. O O

We O O
have O O
investigated O O
the O O
signal O O
transduction O O
pathway O O
from O O
Fc O O
receptors O O
that O O
leads O O
to O O
gene O O
activation O O
and O O
production O O
of O O
cytokines O O
in O O
monocytes O O
. O O

Cross-linking O O
of O O
FcR O O
, O O
on O O
the O O
THP-1 O O
monocytic O O
cell O O
line O O
, O O
by O O
immune O O
complexes O O
resulted O O
in O O
both O O
activation O O
of O O
the O O
transcription O O
factor O O
NF-kappaB O O
and O O
interleukin O O
1 O O
production O O
. O O

These O O
responses O O
were O O
completely O O
blocked O O
by O O
tyrosine O O
kinase O O
inhibitors O O
. O O

In O O
contrast O O
, O O
expression O O
of O O
dominant O O
negative O O
mutants O O
of O O
Ras O O
and O O
Raf-1 O O
, O O
in O O
these O O
cells O O
, O O
did O O
not B-NEGATION B-NEGATION
have I-NEGATION I-NEGATION
any I-NEGATION I-NEGATION
effect I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
FcR-mediated I-NEGATION I-NEGATION
nuclear I-NEGATION I-NEGATION
factor I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the B-NEGATION I-SPECULATION
mitogen-activated I-NEGATION I-SPECULATION
protein I-NEGATION I-SPECULATION
kinase I-NEGATION I-SPECULATION
( I-NEGATION I-SPECULATION
MAPK I-NEGATION I-SPECULATION
) I-NEGATION I-SPECULATION
signaling I-NEGATION I-SPECULATION
pathway I-NEGATION I-SPECULATION
was I-NEGATION I-SPECULATION
not I-NEGATION B-NEGATION
used I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
these I-NEGATION I-NEGATION
receptors I-NEGATION I-NEGATION
. O O

However O O
, O O
MAPK O O
activation O O
was O O
easily O O
detected O O
by O O
in O O
vitro O O
kinase O O
assays O O
, O O
after O O
FcR O O
cross-linking O O
with O O
immune O O
complexes O O
. O O

Using O O
the O O
specific O O
MAPK O O
/ O O
extracellular O O
signal-regulated O O
kinase O O
kinase O O
( O O
MAPK O O
kinase O O
) O O
inhibitor O O
PD98059 O O
, O O
we O O
found O O
that O O
MAPK O O
activation O O
is O O
necessary O O
for O O
FcR-dependent O O
activation O O
of O O
the O O
nuclear O O
factor O O
NF-kappaB O O
. O O

These O O
results O O
strongly O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
signaling I-SPECULATION I-SPECULATION
pathway I-SPECULATION I-SPECULATION
from I-SPECULATION I-SPECULATION
Fc I-SPECULATION I-SPECULATION
receptors I-SPECULATION I-SPECULATION
leading I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
different I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
leukocyte I-SPECULATION I-SPECULATION
biology I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
initiates I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
tyrosine I-SPECULATION I-SPECULATION
kinases I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
requires I-SPECULATION I-SPECULATION
MAPK I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
; I-SPECULATION I-SPECULATION
but I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
contrast I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
other I-SPECULATION I-SPECULATION
tyrosine I-SPECULATION I-SPECULATION
kinase I-SPECULATION I-SPECULATION
receptors I-SPECULATION I-SPECULATION
, I-SPECULATION O
FcR-mediated I-SPECULATION O
MAPK I-SPECULATION O
activation I-SPECULATION O
does I-SPECULATION O
not B-NEGATION B-NEGATION
involve I-NEGATION I-NEGATION
Ras I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
Raf I-NEGATION I-NEGATION
. O O

Differential O O
RNA O O
display O O
identifies O O
novel O O
genes O O
associated O O
with O O
decreased O O
vitamin O O
D O O
receptor O O
expression O O
. O O

To O O
characterize O O
further O O
the O O
function O O
of O O
the O O
intracellular O O
vitamin O O
D O O
receptor O O
( O O
VDR O O
) O O
, O O
we O O
have O O
developed O O
stable O O
transfectant O O
variants O O
of O O
a O O
vitamin O O
D-responsive O O
cell O O
line O O
( O O
U937 O O
) O O
which O O
express O O
either O O
decreased O O
or O O
increased O O
numbers O O
of O O
VDR O O
. O O

In O O
this O O
study O O
we O O
have O O
analyzed O O
changes O O
in O O
gene O O
expression O O
associated O O
with O O
this O O
variable O O
VDR O O
expression O O
. O O

Initial O O
experiments O O
indicated B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
50 I-SPECULATION I-SPECULATION
% I-SPECULATION I-SPECULATION
decrease I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
VDR I-SPECULATION I-SPECULATION
levels I-SPECULATION I-SPECULATION
was I-SPECULATION I-SPECULATION
associated I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
2-fold I-SPECULATION I-SPECULATION
increase I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
proliferation I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
similar I-SPECULATION I-SPECULATION
rise I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
c-myc I-SPECULATION I-SPECULATION
mRNA I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
. O O

Further O O
studies O O
were O O
carried O O
out O O
using O O
differential O O
RNA O O
display O O
( O O
DD O O
) O O
. O O

Sequence O O
analysis O O
of O O
DD O O
products O O
revealed O O
two O O
cDNAs O O
with O O
identity O O
to O O
known O O
gene O O
products O O
: O O
the O O
catalytic O O
sub-unit O O
of O O
DNA-protein O O
kinase O O
( O O
DNA-PK O O
( O O
CS O O
)) O O
, O O
and O O
the O O
peroxisomal O O
enzyme O O
17beta-hydroxysteroid O O
dehydrogenase O O
type O O
IV O O
( O O
17beta-HSD O O
IV O O
) O O
. O O

Northern O O
analysis O O
confirmed O O
that O O
expression O O
of O O
both O O
mRNAs O O
was O O
reduced O O
in O O
cells O O
with O O
decreased O O
numbers O O
of O O
VDR O O
. O O

Down-regulation O O
of O O
17beta-HSD O O
IV O O
mRNA O O
expression O O
was O O
associated O O
with O O
enhanced O O
estradiol O O
inactivation O O
by O O
U937 O O
cells O O
, O O
suggesting B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
link I-SPECULATION I-SPECULATION
between I-SPECULATION I-SPECULATION
estrogenic I-SPECULATION I-SPECULATION
pathways I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
proliferation I-SPECULATION I-SPECULATION
. O O

Further O O
Northern O O
analyses O O
indicated B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
there I-SPECULATION I-SPECULATION
was I-SPECULATION I-SPECULATION
no B-NEGATION B-NEGATION
significant I-NEGATION I-NEGATION
change I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
17beta-HSD I-NEGATION I-NEGATION
IV I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
DNA-PK I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
CS I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
mRNA I-NEGATION I-NEGATION
levels I-NEGATION I-NEGATION
following I-NEGATION I-NEGATION
treatment I-NEGATION I-NEGATION
with I-NEGATION I-NEGATION
1,25 I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
OH I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
2D3 I-NEGATION I-NEGATION
, O O
although O O
expression O O
of O O
both O O
genes O O
varied O O
with O O
changes O O
in O O
cell O O
proliferation O O
. O O

These O O
data O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
addition I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
its I-SPECULATION I-SPECULATION
established I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
hormone-dependent I-SPECULATION I-SPECULATION
trans-activator I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
VDR I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
influence I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
ligand-independent I-SPECULATION I-SPECULATION
mechanisms I-SPECULATION I-SPECULATION
. O O

Downstream O O
activation O O
of O O
a O O
TATA-less O O
promoter O O
by O O
Oct-2 O O
, O O
Bob1 O O
, O O
and O O
NF-kappaB O O
directs O O
expression O O
of O O
the O O
homing O O
receptor O O
BLR1 O O
to O O
mature O O
B O O
cells O O
. O O

The O O
chemokine O O
receptor O O
, O O
BLR1 O O
, O O
is O O
a O O
major O O
regulator O O
of O O
the O O
microenvironmental O O
homing O O
of O O
B O O
cells O O
in O O
lymphoid O O
organs O O
. O O

In O O
vitro O O
studies O O
identify O O
three O O
essential O O
elements O O
of O O
the O O
TATA-less O O
blr1 O O
core O O
promoter O O
that O O
confer O O
cell O O
type O O
- O O
and O O
differentiation-specific O O
expression O O
in O O
the O O
B O O
cells O O
of O O
both O O
humans O O
and O O
mice O O
, O O
a O O
functional O O
promoter O O
region O O
(- O O
36 O O
with O O
respect O O
to O O
the O O
transcription O O
start O O
site O O
) O O
, O O
a O O
NF-kappaB O O
motif O O
(+ O O
44 O O
) O O
, O O
and O O
a O O
noncanonical O O
octamer O O
motif O O
(+ O O
157 O O
) O O
. O O

The O O
importance O O
of O O
these O O
sites O O
was O O
confirmed O O
by O O
in O O
vivo O O
studies O O
in O O
gene-targeted O O
mice O O
deficient O O
of O O
either O O
Oct-2 O O
, O O
Bob1 O O
, O O
or O O
both O O
NF-kappaB O O
subunits O O
p50 O O
and O O
p52 O O
. O O

In O O
all O O
of O O
these O O
animals O O
, O O
the O O
expression O O
of O O
BLR1 O O
was O O
reduced O O
or O O
absent B-NEGATION O
. O O

In O O
mice O O
deficient O O
only O O
of O O
p52 O O
/ O O
NF-kappaB O O
, O O
BLR1 O O
expression O O
was O O
unaffected O O
. O O

Thus O O
our O O
data O O
demonstrate O O
that O O
BLR1 O O
is O O
a O O
target O O
gene O O
for O O
Oct-2 O O
, O O
Bob1 O O
, O O
and O O
members O O
of O O
the O O
NF-kappaB O O
/ O O
Rel O O
family O O
and O O
provides O O
a O O
link O O
to O O
the O O
impaired O O
B O O
cell O O
functions O O
in O O
mice O O
deficient O O
for O O
these O O
factors O O
. O O

Inhibition O O
of O O
RNA O O
polymerase O O
II O O
transcription O O
in O O
human O O
cells O O
by O O
synthetic O O
DNA-binding O O
ligands O O
[ O O
see O O
comments O O
] O O

Sequence-specific O O
DNA-binding O O
small O O
molecules O O
that O O
can O O
permeate O O
human O O
cells O O
potentially B-SPECULATION B-SPECULATION
could B-SPECULATION B-SPECULATION
regulate I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
specific I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
. O O

Multiple O O
cellular O O
DNA-binding O O
transcription O O
factors O O
are O O
required O O
by O O
HIV O O
type O O
1 O O
for O O
RNA O O
synthesis O O
. O O

Two O O
pyrrole-imidazole O O
polyamides O O
were O O
designed O O
to O O
bind O O
DNA O O
sequences O O
immediately O O
adjacent O O
to O O
binding O O
sites O O
for O O
the O O
transcription O O
factors O O
Ets-1 O O
, O O
lymphoid-enhancer O O
binding O O
factor O O
1 O O
, O O
and O O
TATA-box O O
binding O O
protein O O
. O O

These O O
synthetic O O
ligands O O
specifically O O
inhibit O O
DNA-binding O O
of O O
each O O
transcription O O
factor O O
and O O
HIV O O
type O O
1 O O
transcription O O
in O O
cell-free O O
assays O O
. O O

When O O
used O O
in O O
combination O O
, O O
the O O
polyamides O O
inhibit O O
virus O O
replication O O
by O O
> O O
99 O O
% O O
in O O
isolated O O
human O O
peripheral O O
blood O O
lymphocytes O O
, O O
with O O
no B-NEGATION B-NEGATION
detectable I-NEGATION I-NEGATION
cell I-NEGATION I-NEGATION
toxicity I-NEGATION I-NEGATION
. O O

The O O
ability O O
of O O
small O O
molecules O O
to O O
target O O
predetermined O O
DNA O O
sequences O O
located O O
within O O
RNA O O
polymerase O O
II O O
promoters O O
suggests B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
general I-SPECULATION I-SPECULATION
approach I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
regulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
well I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
inhibition I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
viral I-SPECULATION I-SPECULATION
replication I-SPECULATION I-SPECULATION
. O O

Relationship O O
between O O
IkappaBalpha O O
constitutive O O
expression O O
, O O
TNFalpha O O
synthesis O O
, O O
and O O
apoptosis O O
in O O
EBV-infected O O
lymphoblastoid O O
cells O O
. O O

In O O
order O O
to O O
understand O O
the O O
role O O
of O O
NF-kappaB O O
in O O
EBV O O
transformation O O
we O O
have O O
established O O
stably O O
transfected O O
IkappaBalpha O O
into O O
lymphoblastoid O O
cells O O
. O O

Two O O
clones O O
were O O
obtained O O
in O O
which O O
the O O
loss O O
of O O
NF-kappaB O O
binding O O
activity O O
correlated O O
with O O
the O O
constitutive O O
expression O O
of O O
the O O
transgenic O O
IkappaBalpha O O
. O O

Protein O O
latency O O
expression O O
was O O
determined O O
by O O
immunocytochemistry O O
. O O

Expression O O
of O O
surface O O
markers O O
, O O
intracytoplasmic O O
content O O
of O O
cytokines O O
cell O O
cycle O O
analysis O O
after O O
BrdU O O
incorporation O O
and O O
DNA O O
staining O O
with O O
propidium O O
iodide O O
were O O
studied O O
by O O
flow O O
cytometry O O
. O O

Percentage O O
of O O
apoptotic O O
cells O O
was O O
determined O O
by O O
in-situ O O
labelling O O
of O O
DNA O O
strand O O
breaks O O
. O O

No B-NEGATION B-NEGATION
significative I-NEGATION I-NEGATION
changes I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
EBV I-NEGATION I-NEGATION
latency I-NEGATION I-NEGATION
nor B-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
cell I-NEGATION I-NEGATION
surface I-NEGATION I-NEGATION
marker I-NEGATION I-NEGATION
expression I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
found I-NEGATION I-NEGATION
. O O

In O O
contrast O O
, O O
intracytoplasmic O O
TNFalpha O O
levels O O
were O O
strongly O O
reduced O O
in O O
transfected O O
clones O O
. O O

Furthermore O O
, O O
30 O O
% O O
of O O
IkappaBalpha O O
transfected O O
cells O O
were O O
apoptotic O O
after O O
8 O O
h O O
of O O
TNFalpha O O
treatment O O
. O O

This O O
correlated O O
with O O
a O O
strong O O
reduction O O
of O O
BrdU O O
incorporation O O
after O O
24 O O
h O O
of O O
TNFalpha O O
treatment O O
. O O

No B-NEGATION B-NEGATION
effect I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
seen I-NEGATION I-NEGATION
with I-NEGATION I-NEGATION
non I-NEGATION I-NEGATION
transfected I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
with I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
transfected I-NEGATION I-NEGATION
with I-NEGATION I-NEGATION
a I-NEGATION I-NEGATION
control I-NEGATION I-NEGATION
plasmid I-NEGATION I-NEGATION
. O O

Our O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
TNFalpha I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
could B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
one I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
targets I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
EBV I-SPECULATION I-SPECULATION
infected I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
and O I-SPECULATION
that O I-SPECULATION
NF-kappaB O I-SPECULATION
protects O I-SPECULATION
EBV-infected O I-SPECULATION
cells O I-SPECULATION
from O I-SPECULATION
apoptosis O I-SPECULATION
induced O I-SPECULATION
by O I-SPECULATION
TNFalpha O I-SPECULATION
, O I-SPECULATION
which O I-SPECULATION
may B-SPECULATION B-SPECULATION
favour I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
proliferative I-SPECULATION I-SPECULATION
effect I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
cytokine I-SPECULATION I-SPECULATION
. O O

Uncoupling O O
activation-dependent O O
HS1 O O
phosphorylation O O
from O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
transcriptional O O
activation O O
in O O
Jurkat O O
T O O
cells O O
: O O
differential O O
signaling O O
through O O
CD3 O O
and O O
the O O
costimulatory O O
receptors O O
CD2 O O
and O O
CD28 O O
. O O

CD3 O O
, O O
CD2 O O
, O O
and O O
CD28 O O
are O O
functionally O O
distinct O O
receptors O O
on O O
T O O
lymphocytes O O
. O O

Engagement O O
of O O
any O O
of O O
these O O
receptors O O
induces O O
the O O
rapid O O
tyrosine O O
phosphorylation O O
of O O
a O O
shared O O
group O O
of O O
intracellular O O
signaling O O
proteins O O
, O O
including O O
Vav O O
, O O
Cbl O O
, O O
p85 O O
phosphoinositide O O
3-kinase O O
, O O
and O O
the O O
Src O O
family O O
kinases O O
Lck O O
and O O
Fyn O O
. O O

Ligation O O
of O O
CD3 O O
also O O
induces O O
the O O
tyrosine O O
phosphorylation O O
of O O
HS1 O O
, O O
a O O
75-kDa O O
hematopoietic O O
cell-specific O O
intracellular O O
signaling O O
protein O O
of O O
unknown B-SPECULATION O
function I-SPECULATION O
. O O

We O O
have O O
examined O O
changes O O
in O O
HS1 O O
phosphorylation O O
after O O
differential O O
stimulation O O
of O O
CD3 O O
, O O
CD2 O O
, O O
and O O
CD28 O O
to O O
elucidate O O
its O O
role O O
in O O
T O O
cells O O
and O O
to O O
further O O
delineate O O
the O O
signaling O O
pathways O O
recruited O O
by O O
these O O
receptors O O
. O O

Unlike O O
ligation O O
of O O
CD3 O O
, O O
stimulation O O
with O O
anti-CD28 O O
mAb O O
or O O
CHO O O
cells O O
expressing O O
the O O
CD28 O O
ligands O O
CD80 O O
or O O
CD86 O O
did O O
not B-NEGATION B-NEGATION
lead I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
tyrosine I-NEGATION I-NEGATION
phosphorylation I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
HS1 I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
Jurkat I-NEGATION I-NEGATION
T I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
. O O

Additionally O O
, O O
no B-NEGATION B-NEGATION
tyrosine I-NEGATION I-NEGATION
phosphorylation I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
HS1 I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
induced I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
mitogenic I-NEGATION I-NEGATION
pairs I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
anti-CD2 I-NEGATION I-NEGATION
mAbs I-NEGATION I-NEGATION
capable I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
activating I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
transcription I-NEGATION I-NEGATION
factor I-NEGATION I-NEGATION
NFAT I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
nuclear I-NEGATION I-NEGATION
factor I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
activated I-NEGATION I-NEGATION
T I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
. O O

Costimulation O O
through O O
CD28 O O
and O O
/ O O
or O O
CD2 O O
did O O
not B-NEGATION B-NEGATION
modulate I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
CD3-dependent I-NEGATION I-NEGATION
phosphorylation I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
HS1 I-NEGATION I-NEGATION
. O O

In O O
vivo O O
studies O O
indicated B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
CD3-induced I-SPECULATION I-SPECULATION
HSI I-SPECULATION I-SPECULATION
phosphorylation I-SPECULATION I-SPECULATION
was I-SPECULATION I-SPECULATION
dependent I-SPECULATION I-SPECULATION
upon I-SPECULATION I-SPECULATION
both I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
Src I-SPECULATION I-SPECULATION
family I-SPECULATION I-SPECULATION
tyrosine I-SPECULATION I-SPECULATION
kinase I-SPECULATION I-SPECULATION
Lck I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
tyrosine I-SPECULATION I-SPECULATION
phosphatase I-SPECULATION I-SPECULATION
CD45 I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
did I-SPECULATION I-SPECULATION
not B-NEGATION B-NEGATION
require I-NEGATION I-NEGATION
MEK1 I-NEGATION I-NEGATION
kinase I-NEGATION I-NEGATION
activity I-NEGATION I-NEGATION
, O O
and O O
was O O
regulated O O
by O O
protein O O
kinase O O
C O O
activation O O
. O O

Thus O O
, O O
although O O
CD3 O O
, O O
CD28 O O
, O O
and O O
CD2 O O
activate O O
many O O
of O O
the O O
same O O
signaling O O
molecules O O
, O O
they O O
differed O O
in O O
their O O
capacity O O
to O O
induce O O
the O O
tyrosine O O
phosphorylation O O
of O O
HSI O O
. O O

Furthermore O O
, O O
activation-dependent O B-NEGATION
tyrosine O I-NEGATION
phosphorylation O I-NEGATION
of O I-NEGATION
HS1 O I-NEGATION
was O I-NEGATION
not B-NEGATION I-NEGATION
required I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
NFAT I-NEGATION I-NEGATION
transcriptional I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
. O O

IL-7 O O
reconstitutes O O
multiple O O
aspects O O
of O O
v-Abl-mediated O O
signaling O O
. O O

The B-SPECULATION B-SPECULATION
mechanism I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
early I-SPECULATION I-SPECULATION
lymphoid I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
selectively I-SPECULATION I-SPECULATION
transformed I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
v-Abl I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
currently I-SPECULATION I-SPECULATION
unknown I-SPECULATION I-SPECULATION
. O O

Previous O O
studies O O
have O O
shown O O
constitutive O O
activation O O
of O O
IL-4 O O
and O O
IL-7 O O
signaling O O
pathways O O
, O O
as O O
measured O O
by O O
activation O O
of O O
Janus O O
protein O O
kinase O O
( O O
JAK O O
) O O
1 O O
, O O
JAK3 O O
, O O
STAT5 O O
, O O
and O O
STAT6 O O
, O O
in O O
pre-B O O
cells O O
transformed O O
by O O
v-Abl O O
. O O

To O O
determine O O
whether B-SPECULATION B-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
cytokine I-SPECULATION I-SPECULATION
signaling I-SPECULATION I-SPECULATION
pathways I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
v-Abl I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
cellular I-SPECULATION I-SPECULATION
events I-SPECULATION I-SPECULATION
induced I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
Abelson I-SPECULATION I-SPECULATION
murine I-SPECULATION I-SPECULATION
leukemia I-SPECULATION I-SPECULATION
virus I-SPECULATION I-SPECULATION
, O O
the O O
effects O O
of O O
IL-4 O O
and O O
IL-7 O O
on O O
pre-B O O
cells O O
transformed O O
with O O
a O O
temperature-sensitive O O
v-Abl O O
mutant O O
were O O
examined O O
. O O

Whereas O O
IL-4 O O
had O O
little O O
or O O
no B-NEGATION B-NEGATION
effect I-NEGATION I-NEGATION
, O O
IL-7 O O
delayed O O
both O O
the O O
apoptosis O O
and O O
cell O O
cycle O O
arrest O O
that O O
occur O O
upon O O
v-Abl O O
kinase O O
inactivation O O
. O O

IL-7 O O
also O O
delayed O O
the O O
decreases O O
in O O
the O O
levels O O
of O O
c-Myc O O
, O O
Bcl-2 O O
, O O
and O O
Bcl-xL O O
that O O
occur O O
upon O O
loss O O
of O O
v-Abl O O
kinase O O
activity O O
. O O

IL-7 O O
did O O
not B-NEGATION B-NEGATION
maintain I-NEGATION I-NEGATION
v-Abl-mediated I-NEGATION I-NEGATION
differentiation I-NEGATION I-NEGATION
arrest I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
pre-B I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
, O O
as O O
activation O O
of O O
NF-kappaB O O
and O O
RAG O O
gene O O
transcription O O
was O O
unaffected O O
by O O
IL-7 O O
. O O

These O O
results O O
identify O O
a O O
potential B-SPECULATION B-SPECULATION
role I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
IL-7 I-SPECULATION I-SPECULATION
signaling I-SPECULATION I-SPECULATION
pathways I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
transformation I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
v-Abl I-SPECULATION I-SPECULATION
while O O
demonstrating O O
that O O
a O O
combination O O
of O O
IL-4 O O
and O O
IL-7 O O
signaling O O
cannot B-NEGATION B-NEGATION
substitute I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
an I-NEGATION I-NEGATION
active I-NEGATION I-NEGATION
v-Abl I-NEGATION I-NEGATION
kinase I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
transformed I-NEGATION I-NEGATION
pre-B I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
. O O

p21ras O O
initiates O O
Rac-1 O O
but O O
not B-NEGATION B-NEGATION
phosphatidyl I-NEGATION I-NEGATION
inositol I-NEGATION I-NEGATION
3 I-NEGATION I-NEGATION
kinase I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
PKB I-NEGATION I-NEGATION
, O O
mediated O O
signaling O O
pathways O O
in O O
T O O
lymphocytes O O
. O O

p21ras O O
is O O
activated O O
by O O
the O O
T O O
cell O O
antigen O O
receptor O O
( O O
TCR O O
) O O
and O O
then O O
co-ordinates O O
important O O
signaling O O
pathways O O
for O O
T O O
lymphocyte O O
activation O O
. O O

Effector O O
pathways O O
for O O
this O O
guanine O O
nucleotide O O
binding O O
protein O O
in O O
T O O
cells O O
are O O
mediated O O
by O O
the O O
serine O O
/ O O
threonine O O
kinase O O
Raf-1 O O
and O O
the O O
Ras-related O O
GTPase O O
Rac-1 O O
. O O

In O O
fibroblasts O O
, O O
an O O
important O O
effector O O
for O O
the O O
Ras O O
oncogene O O
is O O
Phosphatidylinositol O O
3-kinase O O
( O O
PtdIns O O
3-kinase O O
) O O
. O O

Activation O O
of O O
this O O
lipid O O
kinase O O
is O O
able O O
to O O
induce O O
critical O O
Rac-1 O O
signaling O O
pathways O O
and O O
can O O
couple O O
p21ras O O
to O O
cell O O
survival O O
mechanisms O O
via O O
the O O
serine O O
/ O O
threonine O O
kinase O O
Akt O O
/ O O
PKB O O
. O O

The B-NEGATION B-NEGATION
role I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
PtdIns I-NEGATION I-NEGATION
3-kinase I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
Ras I-NEGATION I-NEGATION
signaling I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
T I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
has I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
been I-NEGATION I-NEGATION
explored I-NEGATION I-NEGATION
. O O

In O O
the O O
present O O
study O O
, O O
we O O
examined O O
the O O
ability O O
of O O
PtdIns O O
3-kinase O O
to O O
initiate O O
the O O
Rac-1 O O
signaling O O
pathways O O
important O O
for O O
T O O
cell O O
activation O O
. O O

We O O
also O O
examined O O
the O O
possibility B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
Akt I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
PKB I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
regulated I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
Ras I-SPECULATION I-SPECULATION
signaling I-SPECULATION I-SPECULATION
pathways I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
lymphocytes I-SPECULATION I-SPECULATION
. O O

The O O
results O O
show O O
that O O
Ras O O
can O O
initiate O O
a O O
Rac-1 O O
mediated O O
pathway O O
that O O
regulates O O
the O O
transcriptional O O
function O O
of O O
AP-1 O O
complexes O O
. O O

PtdIns O O
3-kinase O O
signals O O
cannot B-NEGATION B-NEGATION
mimic I-NEGATION I-NEGATION
p21ras I-NEGATION I-NEGATION
and I-NEGATION O
induce I-NEGATION O
the I-NEGATION O
Rac I-NEGATION O
mediated I-NEGATION O
responses I-NEGATION O
of I-NEGATION O
AP-1 I-NEGATION O
transcriptional I-NEGATION O
activation I-NEGATION O
. O O

Moreover O O
, O O
neither B-NEGATION B-NEGATION
TCR I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
Ras I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
AP-1 I-NEGATION I-NEGATION
is I-NEGATION I-NEGATION
dependent I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
PtdIns I-NEGATION I-NEGATION
3-kinase I-NEGATION I-NEGATION
. O O

PKB O O
is O O
activated O O
in O O
response O O
to O O
triggering O O
of O O
the O O
T O O
cell O O
antigen O O
receptor O O
; O O
PtdIns O O
3-kinase O O
activity O O
is O O
both O O
required O O
and O O
sufficient O O
for O O
this O O
TCR O O
response O O
. O O

In O O
contrast O O
, O O
p21ras B-NEGATION O
signals I-NEGATION O
are I-NEGATION O
unable I-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
induce I-NEGATION I-NEGATION
Akt I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
PKB I-NEGATION I-NEGATION
activity I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
T I-NEGATION I-NEGATION
cell I-NEGATION I-NEGATION
nor B-NEGATION O
is I-NEGATION O
Ras I-NEGATION O
function I-NEGATION O
required I-NEGATION O
for I-NEGATION O
Akt I-NEGATION O
/ I-NEGATION O
PKB I-NEGATION O
activation I-NEGATION O
in I-NEGATION O
response I-NEGATION O
to I-NEGATION O
the I-NEGATION O
TCR I-NEGATION O
. O O

The O O
present O O
data O O
thus O O
highlight O O
that O O
PtdIns O O
3-kinase O O
and O O
Akt O O
/ O O
PKB O O
are O O
not B-NEGATION B-NEGATION
universal I-NEGATION I-NEGATION
Ras I-NEGATION I-NEGATION
effector I-NEGATION I-NEGATION
molecules I-NEGATION I-NEGATION
. O O

Ras O O
can O O
initiate O O
Rac-1 O O
regulated O O
signaling O O
pathways O O
in O O
the O O
context O O
of O O
T O O
cell O O
antigen O O
receptor O O
function O O
independently O O
of O O
PtdIns O O
3-kinase O O
activity O O
. O O

Signal O O
transduction O O
abnormalities O O
in O O
T O O
lymphocytes O O
from O O
patients O O
with O O
advanced O O
renal O O
carcinoma O O
: O O
clinical O O
relevance O O
and O O
effects O O
of O O
cytokine O O
therapy O O
. O O

Studies O O
have O O
demonstrated O O
abnormalities O O
of O O
the O O
CD3 O O
/ O O
T-cell O O
antigen O O
receptor O O
( O O
TCR O O
) O O
and O O
pathways O O
of O O
signal O O
transduction O O
in O O
T O O
lymphocytes O O
from O O
animals O O
and O O
patients O O
with O O
advanced O O
malignancy O O
. O O

Diminished O O
expression O O
of O O
TCRzeta O O
and O O
p56 O O
( O O
lck O O
) O O
that O O
are O O
associated O O
with O O
the O O
TCR O O
and O O
reduced O O
nuclear O O
localization O O
of O O
RelA O O
containing O O
nuclear O O
factor O O
kappaB O O
( O O
NFkappaB O O
) O O
complexes O O
have O O
been O O
noted O O
. O O

These O O
defects O O
have O O
been O O
described O O
in O O
T O O
cells O O
from O O
patients O O
with O O
malignant O O
melanoma O O
, O O
renal O O
cell O O
carcinoma O O
( O O
RCC O O
) O O
, O O
ovarian O O
cancer O O
, O O
and O O
colorectal O O
cancer O O
. O O

Preliminary O O
observations O O
also O O
indicate O O
possible B-SPECULATION B-SPECULATION
correlation I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
clinical I-SPECULATION I-SPECULATION
variables I-SPECULATION I-SPECULATION
such I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
stage I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
selected I-SPECULATION I-SPECULATION
instances I-SPECULATION I-SPECULATION
. O O

To O O
further O O
characterize O O
altered O O
expression O O
of O O
TCRzeta O O
, O O
p56 O O
( O O
lck O O
) O O
, O O
and O O
impaired O O
activation O O
of O O
NFkappaB O O
, O O
T O O
lymphocytes O O
were O O
obtained O O
from O O
65 O O
patients O O
with O O
RCC O O
, O O
the O O
majority O O
of O O
whom O O
were O O
receiving O O
combination O O
cytokine O O
therapy O O
[ O O
interleukin O O
( O O
IL O O
)- O O
2 O O
, O O
IFN O O
alpha-containing O O
regimens O O
] O O
and O O
37 O O
control O O
individuals O O
. O O

In O O
29 O O
of O O
these O O
patients O O
, O O
levels O O
of O O
TCRzeta O O
and O O
p56 O O
( O O
lck O O
) O O
were O O
determined O O
by O O
Western O O
blots O O
of O O
T-cell O O
lysates O O
and O O
semiquantitated O O
using O O
densitometry O O
. O O

Relative O O
levels O O
were O O
then O O
correlated O O
with O O
a O O
series O O
of O O
clinical O O
variables O O
including O O
response O O
to O O
therapy O O
, O O
performance O O
status O O
, O O
survival O O
, O O
disease O O
sites O O
, O O
age O O
, O O
and O O
others O O
. O O

In O O
another O O
group O O
of O O
28 O O
patients O O
( O O
three O O
individuals O O
from O O
the O O
first O O
group O O
) O O
, O O
the O O
frequency O O
of O O
abnormal O O
NFkappaB O O
activation O O
was O O
studied O O
using O O
electrophoretic O O
mobility O O
shift O O
assays O O
after O O
activation O O
of O O
T O O
cells O O
with O O
phorbol O O
myristate O O
acetate O O
/ O O
ionomycin O O
or O O
anti-CD3 O O
monoclonal O O
antibody O O
. O O

Changes O O
in O O
these O O
signaling O O
molecules O O
during O O
cytokine O O
treatment O O
were O O
also O O
investigated O O
. O O

TCRzeta O O
and O O
p56 O O
( O O
lck O O
) O O
were O O
detected O O
in O O
the O O
peripheral O O
blood O O
T O O
cells O O
in O O
27 O O
of O O
29 O O
patients O O
, O O
and O O
overall O O
, O O
reduced O O
levels O O
were O O
noted O O
visually O O
in O O
12 O O
of O O
29 O O
( O O
41 O O
%) O O
and O O
13 O O
of O O
29 O O
( O O
45 O O
%) O O
individuals O O
, O O
respectively O O
. O O

When O O
levels O O
were O O
semiquantitated O O
using O O
densitometry O O
, O O
significant O O
decreases O O
of O O
TCRzeta O O
( O O
P O O
= O O
0.029 O O
) O O
and O O
p56 O O
( O O
lck O O
) O O
( O O
P O O
= O O
0.029 O O
) O O
but O O
not B-NEGATION B-NEGATION
CD3epsilon I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
P I-NEGATION I-NEGATION
= I-NEGATION I-NEGATION
0.131 I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
, O O
compared O O
with O O
control O O
levels O O
, O O
were O O
found O O
. O O

In O O
patients O O
treated O O
with O O
IL-2 O O
/ O O
IFN O O
alpha-based O O
therapy O O
, O O
relative O O
levels O O
of O O
TCRzeta O O
increased O O
significantly O O
( O O
P O O
= O O
0.002 O O
) O O
on O O
day O O
15 O O
of O O
cycle O O
one O O
compared O O
with O O
the O O
baseline O O
. O O

Correlations B-NEGATION O
of I-NEGATION O
TCRzeta I-NEGATION O
or I-NEGATION O
p56 I-NEGATION O
( I-NEGATION O
lck I-NEGATION O
) I-NEGATION O
levels I-NEGATION O
with I-NEGATION O
response I-NEGATION O
or I-NEGATION O
disease I-NEGATION O
variables I-NEGATION O
, I-NEGATION O
except I-NEGATION B-NEGATION
for I-NEGATION I-NEGATION
lower I-NEGATION I-NEGATION
TCRzeta I-NEGATION I-NEGATION
levels I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
P I-NEGATION I-NEGATION
< I-NEGATION I-NEGATION
0.001 I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
presence I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
bone I-NEGATION I-NEGATION
metastases I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
were I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
found I-NEGATION I-NEGATION
. O O

Abnormal O O
NFkappaB O O
activation O O
after O O
stimulation O O
with O O
phorbol O O
myristate O O
acetate O O
/ O O
ionomycin O O
and O O
/ O O
or O O
anti-CD3 O O
monoclonal O O
antibody O O
was O O
found O O
in O O
59 O O
% O O
of O O
patients O O
( O O
17 O O
of O O
28 O O
) O O
and O O
was B-NEGATION B-NEGATION
not I-NEGATION I-NEGATION
accounted I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
advanced I-NEGATION I-NEGATION
age I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
study I-NEGATION I-NEGATION
cohort I-NEGATION I-NEGATION
. O O

Activation O O
of O O
NFkappaB O O
in O O
peripheral O O
blood O O
T O O
cells O O
was O O
inducible O O
during O O
cytokine O O
therapy O O
in O O
four O O
of O O
six O O
individuals O O
who O O
displayed O O
impaired O O
NFkappaB O O
activity O O
prior O O
to O O
therapy O O
. O O

Moreover O O
, O O
impaired B-SPECULATION B-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NFkappaB I-SPECULATION I-SPECULATION
does I-SPECULATION I-SPECULATION
not I-SPECULATION I-SPECULATION
appear I-SPECULATION I-SPECULATION
linked I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
reduction I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
TCRzeta I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
, O O
because O O
in O O
five O O
patients O O
, O O
normal O O
TCRzeta O O
levels O O
were O O
present O O
although O O
kappaB B-NEGATION O
binding I-NEGATION O
was I-NEGATION O
not I-NEGATION B-NEGATION
inducible I-NEGATION I-NEGATION
. O O

In O O
the O O
majority O O
of O O
patients O O
with O O
advanced O O
RCC O O
, O O
peripheral O O
blood O O
T O O
cells O O
express O O
TCRzeta O O
and O O
p56 O O
( O O
lck O O
) O O
, O O
and O O
in O O
a O O
subset O O
, O O
reduced O O
levels O O
of O O
these O O
TCRzeta O O
associated O O
molecules O O
are O O
seen O O
that O O
may B-SPECULATION B-SPECULATION
increase I-SPECULATION I-SPECULATION
during I-SPECULATION I-SPECULATION
cytokine-based I-SPECULATION I-SPECULATION
therapy I-SPECULATION I-SPECULATION
. O O

Abnormal O O
activation O O
of O O
NFkappaB O O
is O O
also O O
present O O
in O O
> O O
50 O O
% O O
of O O
patients O O
and O O
may B-SPECULATION B-SPECULATION
also I-SPECULATION I-SPECULATION
revert I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
normal I-SPECULATION I-SPECULATION
during I-SPECULATION I-SPECULATION
IL-2 I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
IFN I-SPECULATION I-SPECULATION
alpha-based I-SPECULATION I-SPECULATION
treatment I-SPECULATION I-SPECULATION
. O O

This O O
alteration O O
in O O
NFkappaB O O
activation O O
occurred O O
in O O
the O O
presence O O
of O O
normal O O
expression O O
of O O
TCRzeta-associated O O
signaling O O
elements O O
. O O

The B-SPECULATION B-SPECULATION
clinical I-SPECULATION I-SPECULATION
significance I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
findings I-SPECULATION I-SPECULATION
remains I-SPECULATION I-SPECULATION
unclear I-SPECULATION I-SPECULATION
. O O

Transcriptional O O
regulation O O
of O O
lysosomal O O
acid O O
lipase O O
in O O
differentiating O O
monocytes O O
is O O
mediated O O
by O O
transcription O O
factors O O
Sp1 O O
and O O
AP-2 O O
. O O

Human O O
lysosomal O O
acid O O
lipase O O
( O O
LAL O O
) O O
is O O
a O O
hydrolase O O
required O O
for O O
the O O
cleavage O O
of O O
cholesteryl O O
esters O O
and O O
triglycerides O O
derived O O
from O O
plasma O O
lipoproteins O O
. O O

It O O
is O O
shown O O
here O O
that O O
during O O
monocyte O O
to O O
macrophage O O
differentiation O O
, O O
the O O
expression O O
of O O
LAL-mRNA O O
is O O
induced O O
. O O

This O O
induction O O
is O O
dependent O O
on O O
protein O O
kinase O O
C O O
activity O O
and O O
protein O O
synthesis O O
. O O

The O O
cell O O
type-specific O O
increase O O
in O O
LAL O O
expression O O
is O O
further O O
investigated O O
in O O
the O O
THP-1 O O
cell O O
line O O
with O O
respect O O
to O O
transcriptional O O
regulation O O
. O O

The O O
human O O
monocytic O O
leukemia O O
cell O O
line O O
THP-1 O O
differentiates O O
into O O
macrophage-like O O
cells O O
when O O
treated O O
with O O
phorbol O O
esters O O
. O O

In O O
order O O
to O O
determine O O
the O O
cis-acting O O
elements O O
necessary O O
for O O
both O O
basal O O
and O O
phorbol O O
12-myristate-13 O O
acetate O O
( O O
PMA O O
)- O O
enhanced O O
promoter O O
activity O O
, O O
we O O
performed O O
deletion O O
analysis O O
and O O
reporter O O
gene O O
assays O O
. O O

A O O
PMA O O
responsive O O
element O O
has O O
been O O
identified O O
between O O
- O O
182 O O
bp O O
and O O
- O O
107 O O
bp O O
upstream O O
of O O
the O O
major O O
transcription O O
start O O
site O O
. O O

Gel O O
mobility O O
shift O O
assays O O
demonstrated O O
that O O
binding O O
of O O
Sp1 O O
and O O
AP-2 O O
to O O
the O O
LAL O O
promoter O O
is O O
increased O O
by O O
PMA O O
in O O
THP-1 O O
cells O O
. O O

Co-transfections O O
with O O
expression O O
plasmids O O
for O O
Sp1 O O
and O O
AP-2 O O
further O O
emphasized O O
the O O
important O O
role O O
of O O
these O O
transcription O O
factors O O
in O O
both O O
basal O O
and O O
PMA-enhanced O O
LAL O O
expression O O
. O O

Our O O
data O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
differentiation I-SPECULATION I-SPECULATION
dependent I-SPECULATION I-SPECULATION
increase I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
lysosomal I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
lipase I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
LAL I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
THP-1 I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
mediated I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
concerted I-SPECULATION I-SPECULATION
action I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
Sp1 I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
AP-2 I-SPECULATION I-SPECULATION
. O O

A O O
nongenomic O O
mechanism O O
for O O
progesterone-mediated O O
immunosuppression O O
: O O
inhibition O O
of O O
K O O
+ O O
channels O O
, O O
Ca2 O O
+ O O
signaling O O
, O O
and O O
gene O O
expression O O
in O O
T O O
lymphocytes O O
. O O

The B-SPECULATION O
mechanism I-SPECULATION O
by I-SPECULATION O
which I-SPECULATION O
progesterone I-SPECULATION O
causes I-SPECULATION O
localized I-SPECULATION O
suppression I-SPECULATION O
of I-SPECULATION O
the I-SPECULATION O
immune I-SPECULATION O
response I-SPECULATION O
during I-SPECULATION O
pregnancy I-SPECULATION O
has I-SPECULATION O
remained I-SPECULATION O
elusive I-SPECULATION O
. O O

Using O O
human O O
T O O
lymphocytes O O
and O O
T O O
cell O O
lines O O
, O O
we O O
show O O
that O O
progesterone O O
, O O
at O O
concentrations O O
found O O
in O O
the O O
placenta O O
, O O
rapidly O O
and O O
reversibly O O
blocks O O
voltage-gated O O
and O O
calcium-activated O O
K O O
+ O O
channels O O
( O O
KV O O
and O O
KCa O O
, O O
respectively O O
) O O
, O O
resulting O O
in O O
depolarization O O
of O O
the O O
membrane O O
potential O O
. O O

As O O
a O O
result O O
, O O
Ca2 O O
+ O O
signaling O O
and O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
( O O
NF-AT O O
)- O O
driven O O
gene O O
expression O O
are O O
inhibited O O
. O O

Progesterone O O
acts O O
distally O O
to O O
the O O
initial O O
steps O O
of O O
T O O
cell O O
receptor O O
( O O
TCR O O
)- O O
mediated O O
signal O O
transduction O O
, O O
since O O
it O O
blocks O O
sustained O O
Ca2 O O
+ O O
signals O O
after O O
thapsigargin O O
stimulation O O
, O O
as O O
well O O
as O O
oscillatory O O
Ca2 O O
+ O O
signals O O
, O O
but O O
not B-NEGATION B-NEGATION
the I-NEGATION I-NEGATION
Ca2 I-NEGATION I-NEGATION
+ I-NEGATION I-NEGATION
transient I-NEGATION I-NEGATION
after I-NEGATION I-NEGATION
TCR I-NEGATION I-NEGATION
stimulation I-NEGATION I-NEGATION
. O O

K O O
+ O O
channel O O
blockade O O
by O O
progesterone O O
is O O
specific O O
; O O
other O O
steroid O O
hormones O O
had O O
little O O
or O O
no B-NEGATION B-NEGATION
effect I-NEGATION I-NEGATION
, O O
although O O
the O O
progesterone O O
antagonist O O
RU O O
486 O O
also O O
blocked O O
KV O O
and O O
KCa O O
channels O O
. O O

Progesterone O O
effectively O O
blocked O O
a O O
broad O O
spectrum O O
of O O
K O O
+ O O
channels O O
, O O
reducing O O
both O O
Kv1.3 O O
and O O
charybdotoxin-resistant O O
components O O
of O O
KV O O
current O O
and O O
KCa O O
current O O
in O O
T O O
cells O O
, O O
as O O
well O O
as O O
blocking O O
several O O
cloned O O
KV O O
channels O O
expressed O O
in O O
cell O O
lines O O
. O O

Progesterone O O
had O O
little O O
or O O
no B-NEGATION B-NEGATION
effect I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
a I-NEGATION I-NEGATION
cloned I-NEGATION I-NEGATION
voltage-gated I-NEGATION I-NEGATION
Na I-NEGATION I-NEGATION
+ I-NEGATION I-NEGATION
channel I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
an I-NEGATION I-NEGATION
inward I-NEGATION I-NEGATION
rectifier I-NEGATION I-NEGATION
K I-NEGATION I-NEGATION
+ I-NEGATION I-NEGATION
channel I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
lymphocyte I-NEGATION I-NEGATION
Ca2 I-NEGATION I-NEGATION
+ I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
Cl I-NEGATION I-NEGATION
- I-NEGATION I-NEGATION
channels I-NEGATION I-NEGATION
. O O

We O O
propose B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
direct I-SPECULATION I-SPECULATION
inhibition I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
K I-SPECULATION I-SPECULATION
+ I-SPECULATION I-SPECULATION
channels I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
progesterone I-SPECULATION I-SPECULATION
contributes I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
progesterone-induced I-SPECULATION I-SPECULATION
immunosuppression I-SPECULATION I-SPECULATION
. O O

Role O O
of O O
IKK1 O O
and O O
IKK2 O O
in O O
lipopolysaccharide O O
signaling O O
in O O
human O O
monocytic O O
cells O O
. O O

Mononuclear O O
phagocytes O O
play O O
a O O
major O O
role O O
in O O
immune O O
and O O
inflammatory O O
responses O O
. O O

Bacterial O O
lipopolysaccharide O O
( O O
LPS O O
) O O
induces O O
monocytes O O
to O O
express O O
a O O
variety O O
of O O
genes O O
by O O
activating O O
the O O
NF-kappaB O O
/ O O
Rel O O
transcription O O
factor O O
family O O
. O O

Recently O O
, O O
we O O
have O O
reported O O
that O O
the O O
tumor O O
necrosis O O
factor O O
and O O
interleukin O O
1 O O
signaling O O
pathways O O
activate O O
two O O
kinases O O
, O O
IKK1 O O
and O O
IKK2 O O
. O O

Phosphorylation O O
of O O
the O O
IkappaB O O
cytoplasmic O O
inhibitors O O
, O O
IkappaBalpha O O
, O O
IkappaBbeta O O
, O O
and O O
IkappaBepsilon O O
, O O
by O O
these O O
kinases O O
triggers O O
proteolytic O O
degradation O O
and O O
the O O
release O O
of O O
NF-kappaB O O
/ O O
Rel O O
proteins O O
into O O
the O O
nucleus O O
. O O

At O O
present O O
, O O
the B-NEGATION B-NEGATION
role I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
IKKs I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
LPS I-NEGATION I-NEGATION
signaling I-NEGATION I-NEGATION
has I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
been I-NEGATION I-NEGATION
investigated I-NEGATION I-NEGATION
. O O

Here O O
, O O
we O O
report O O
that O O
LPS O O
induces O O
IKK O O
activity O O
in O O
human O O
monocytes O O
and O O
THP-1 O O
monocytic O O
cells O O
. O O

The O O
kinetics O O
of O O
activation O O
of O O
kinase O O
activity O O
in O O
monocytic O O
cells O O
are O O
relatively O O
slow O O
with O O
maximal O O
activity O O
observed O O
at O O
60 O O
min O O
, O O
which O O
coincides O O
with O O
the O O
degradation O O
of O O
IkappaBs O O
and O O
the O O
nuclear O O
translocation O O
of O O
NF-kappaB O O
. O O

In O O
transfection O O
experiments O O
, O O
overexpression O O
of O O
wild O O
type O O
IKK1 O O
, O O
a O O
dominant O O
negative O O
mutant O O
IKK1 O O
( O O
K44M O O
) O O
, O O
or O O
wild O O
type O O
IKK2 O O
did O O
not B-NEGATION B-NEGATION
affect I-NEGATION I-NEGATION
LPS-induced I-NEGATION I-NEGATION
kappaB-dependent I-NEGATION I-NEGATION
transcription I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
monocytic I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
. O O

In O O
contrast O O
, O O
a O O
dominant O O
negative O O
mutant O O
of O O
IKK2 O O
inhibited O O
LPS O O
induction O O
of O O
kappaB-dependent O O
transcription O O
in O O
a O O
dose-dependent O O
manner O O
. O O

These O O
results O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
LPS I-SPECULATION I-SPECULATION
induction I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
kappaB-dependent I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
monocytic I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
requires I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
IKK2 I-SPECULATION I-SPECULATION
. O O

Effects O O
of O O
overexpression O O
of O O
IL-1 O O
receptor-associated O O
kinase O O
on O O
NFkappaB O O
activation O O
, O O
IL-2 O O
production O O
and O O
stress-activated O O
protein O O
kinases O O
in O O
the O O
murine O O
T O O
cell O O
line O O
EL4 O O
. O O

The O O
association O O
and O O
activation O O
of O O
the O O
IL-1 O O
receptor-associated O O
protein O O
kinase O O
( O O
IRAK O O
) O O
to O O
the O O
IL-1 O O
receptor O O
complex O O
is O O
one O O
of O O
the O O
earliest O O
events O O
detectable O O
in O O
IL-1 O O
signal O O
transduction O O
. O O

We O O
generated O O
permanent O O
clones O O
of O O
the O O
murine O O
T O O
cell O O
line O O
EL4 O O
6.1 O O
overexpressing O O
human O O
( O O
h O O
) O O
IRAK O O
to O O
evaluate O O
the O O
role O O
of O O
this O O
kinase O O
in O O
IL-1 O O
signaling O O
. O O

Overexpression O O
of O O
hIRAK O O
enhanced O O
IL-1-stimulated O O
activation O O
of O O
the O O
transcription O O
factor O O
NFkappaB O O
, O O
whereas O O
a O O
truncated O O
form O O
( O O
N-IRAK O O
) O O
specifically O O
inhibited O O
IL-1-dependent O O
NFkappaB O O
activity O O
. O O

In O O
clones O O
stably O O
overexpressing O O
hIRAK O O
a O O
weak O O
constitutive O O
activation O O
of O O
NFkappaB O O
correlated O O
with O O
a O O
low O O
basal O O
IL-2 O O
production O O
which O O
was O O
enhanced O O
in O O
an O O
IL-1-dependent O O
manner O O
. O O

Compared O O
to O O
the O O
parental O O
cell O O
line O O
the O O
dose-response O O
curve O O
of O O
IL-1-induced O O
IL-2 O O
production O O
was O O
shifted O O
in O O
both O O
potency O O
and O O
efficacy O O
. O O

These O O
results O O
demonstrate O O
that O O
IRAK O O
directly O O
triggers O O
NFkappaB-mediated O O
gene O O
expression O O
in O O
EL4 O O
cells O O
. O O

Qualitatively O O
different O O
effects O O
were O O
observed O O
for O O
the O O
IL-1-induced O O
activation O O
of O O
stress-activated O O
protein O O
( O O
SAP O O
) O O
kinases O O
: O O
permanent O O
overexpression O O
of O O
IRAK O O
did O O
not B-NEGATION B-NEGATION
affect I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
dose I-NEGATION I-NEGATION
dependence I-NEGATION I-NEGATION
but O O
prolonged O O
the O O
kinetics O O
of O O
IL-1-induced O O
activation O O
of O O
SAP O O
kinases O O
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
signaling I-SPECULATION I-SPECULATION
branch I-SPECULATION I-SPECULATION
may B-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
regulated I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
distinct I-SPECULATION I-SPECULATION
mechanisms I-SPECULATION I-SPECULATION
. O O

Decreased O O
IL-12 O O
production O O
and O O
Th1 O O
cell O O
development O O
by O O
acetyl O O
salicylic O O
acid-mediated O O
inhibition O O
of O O
NF-kappaB O O
. O O

IL-12 O O
is O O
a O O
75-kDa O O
heterodimeric O O
cytokine O O
composed O O
of O O
two O O
covalently O O
linked O O
p35 O O
and O O
p40 O O
chains O O
. O O

This O O
pro-inflammatory O O
cytokine O O
plays O O
a O O
prominent O O
role O O
in O O
the O O
development O O
of O O
Th1 O O
cell-mediated O O
immune O O
responses O O
. O O

Th1 O O
cell-mediated O O
immune O O
responses O O
have O O
been O O
implicated O O
in O O
the O O
pathogenesis O O
of O O
chronic O O
inflammatory O O
autoimmune O O
diseases O O
. O O

Thus O O
, O O
IL-12 B-SPECULATION B-SPECULATION
appears I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
critical I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
generation I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
maintenance I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
chronic I-SPECULATION I-SPECULATION
inflammatory I-SPECULATION I-SPECULATION
conditions I-SPECULATION I-SPECULATION
. O O

In O O
this O O
study O O
, O O
we O O
investigated O O
the O O
effects O O
of O O
a O O
commonly O O
prescribed O O
anti-inflammatory O O
drug O O
, O O
acetyl O O
salicylic O O
acid O O
( O O
ASA O O
) O O
, O O
on O O
IL-12 O O
production O O
and O O
Th1 O O
cell O O
development O O
. O O

ASA O O
was O O
found O O
to O O
inhibit O O
secretion O O
of O O
the O O
IL-12 O O
heterodimer O O
as O O
well O O
as O O
p40 O O
monomer O O
by O O
human O O
monocytic O O
cells O O
. O O

This O O
was O O
associated O O
with O O
the O O
down-regulation O O
of O O
IL-12p40 O O
mRNA O O
expression O O
. O O

Analysis O O
of O O
the O O
regulation O O
of O O
the O O
p40 O O
gene O O
promoter O O
revealed O O
that O O
ASA O O
inhibited O O
NF-kappaB O O
activation O O
and O O
binding O O
to O O
the O O
p40-kappaB O O
site O O
in O O
the O O
p40 O O
promoter O O
, O O
leading O O
to O O
transcriptional O O
repression O O
of O O
the O O
p40 O O
gene O O
. O O

Addition O O
of O O
ASA O O
to O O
an O O
in O O
vitro O O
T O O
helper O O
cell O O
differentiation O O
system O O
, O O
at O O
concentrations O O
compatible O O
with O O
plasma O O
levels O O
reached O O
during O O
anti-inflammatory O O
therapy O O
, O O
resulted O O
in O O
reduced O O
development O O
of O O
Th1 O O
cells O O
. O O

These O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
inhibition I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
ASA I-SPECULATION I-SPECULATION
leads I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
down-regulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
IL-12 I-SPECULATION I-SPECULATION
production I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
inhibition I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
Th1 I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
development I-SPECULATION I-SPECULATION
. O O

YM268 O O
increases O O
the O O
glucose O O
uptake O O
, O O
cell O O
differentiation O O
, O O
and O O
mRNA O O
expression O O
of O O
glucose O O
transporter O O
in O O
3T3-L1 O O
adipocytes O O
. O O

The O O
purpose O O
of O O
this O O
study O O
was O O
to O O
examine O O
the O O
effects O O
of O O
bis O O
[ O O
4 O O
-[ O O
2,4-dioxo-5-thiazolidinyl O O
) O O
methyl O O
] O O
phenyl O O
] O O
methane O O
( O O
YM-268 O O
) O O
, O O
a O O
thiazolidinedione O O
derivative O O
, O O
on O O
glucose O O
uptake O O
, O O
adipocyte O O
differentiation O O
through O O
peroxisome O O
proliferator-activated O O
receptor O O
gamma O O
( O O
PPARgamma O O
) O O
, O O
and O O
phosphatidylinositol O O
3-kinase O O
( O O
PI O O
3-kinase O O
) O O
activity O O
in O O
cultured O O
cells O O
. O O

YM268 O O
and O O
pioglitazone O O
dose-dependently O O
increased O O
the O O
2-deoxyglucose O O
uptake O O
in O O
3T3-L1 O O
cells O O
. O O

YM268 O O
facilitated O O
the O O
insulin-stimulated O O
triglyceride O O
accumulation O O
in O O
3T3-L1 O O
adipocytes O O
and O O
increased O O
the O O
mRNA O O
expression O O
of O O
fatty O O
acid-binding O O
protein O O
. O O

YM268 O O
, O O
with O O
and O O
without B-NEGATION B-NEGATION
insulin I-NEGATION I-NEGATION
, O O
increased O O
the O O
mRNA O O
expression O O
of O O
glucose O O
transporter O O
isoforms O O
such O O
as O O
GLUT1 O O
and O O
GLUT4 O O
, O O
indicating O B-SPECULATION
enhancement O I-SPECULATION
of O I-SPECULATION
adipocyte O I-SPECULATION
differentiation O I-SPECULATION
. O O

Additionally O O
, O O
YM268 O O
and O O
pioglitazone O O
showed O O
activity O O
of O O
the O O
PPARgamma O O
ligand O O
, O O
a O O
member O O
of O O
the O O
nuclear O O
receptor O O
superfamily O O
responsible O O
for O O
adipogenesis O O
. O O

To O O
examine O O
the O O
possible B-SPECULATION B-SPECULATION
involvement I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
increased I-SPECULATION I-SPECULATION
activity I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
PI I-SPECULATION I-SPECULATION
3-kinase I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
YM268-stimulated I-SPECULATION I-SPECULATION
glucose I-SPECULATION I-SPECULATION
uptake I-SPECULATION I-SPECULATION
, O O
the O O
enzyme O O
activity O O
was O O
estimated O O
by O O
measuring O O
the O O
phosphatidylinositol-3,4,5-trisphosphate O O
( O O
PI-3,4,5-P3 O O
) O O
concentration O O
in O O
human O O
monocytic O O
cells O O
. O O

Insulin O O
dose-dependently O O
increased O O
the O O
PI-3,4,5-P3 O O
production O O
but O O
YM268 O O
had O O
no B-NEGATION B-NEGATION
significant I-NEGATION I-NEGATION
effect I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
insulin-dependent I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
- I-NEGATION I-NEGATION
independent I-NEGATION I-NEGATION
PI I-NEGATION I-NEGATION
3-kinase I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
. O O

These O O
results O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
YM268 I-SPECULATION I-SPECULATION
increased I-SPECULATION I-SPECULATION
glucose I-SPECULATION I-SPECULATION
uptake I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
may B-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
accounted I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
part I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
enhancement I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
GLUT1 I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
GLUT4 I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
through I-SPECULATION I-SPECULATION
PPARgamma I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
. O O

Interaction O O
of O O
sickle O O
erythrocytes O O
with O O
endothelial O O
cells O O
in O O
the O O
presence O O
of O O
endothelial O O
cell O O
conditioned O O
medium O O
induces O O
oxidant O O
stress O O
leading O O
to O O
transendothelial O O
migration O O
of O O
monocytes O O
. O O

The B-SPECULATION B-SPECULATION
abnormal I-SPECULATION I-SPECULATION
adherence I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
sickle I-SPECULATION I-SPECULATION
red I-SPECULATION I-SPECULATION
blood I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
SS I-SPECULATION I-SPECULATION
RBC I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
endothelial I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
has I-SPECULATION I-SPECULATION
been I-SPECULATION I-SPECULATION
thought I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
contribute I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
vascular I-SPECULATION I-SPECULATION
occlusion I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
major I-SPECULATION I-SPECULATION
cause I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
morbidity I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
sickle I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
disease I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
SCD I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
. O O

We O O
determined O O
whether B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
interaction I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
SS I-SPECULATION I-SPECULATION
RBC I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
cultured I-SPECULATION I-SPECULATION
endothelial I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
induced I-SPECULATION I-SPECULATION
cellular I-SPECULATION I-SPECULATION
oxidant I-SPECULATION I-SPECULATION
stress I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
would B-SPECULATION B-SPECULATION
culminate I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
molecules I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
CAMs I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
involved I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
diapedesis I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
monocytes I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
adherence I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
SS I-SPECULATION I-SPECULATION
reticulocytes I-SPECULATION I-SPECULATION
. O O

We O O
showed O O
that O O
the O O
interaction O O
of O O
SS O O
RBC O O
at O O
2 O O
% O O
concentration O O
in O O
the O O
presence O O
of O O
multimers O O
of O O
von O O
Willebrand O O
factor O O
( O O
vWf O O
) O O
, O O
derived O O
from O O
endothelial O O
cell-derived O O
conditioned O O
medium O O
( O O
E-CM O O
) O O
with O O
cultured O O
human O O
umbilical O O
vein O O
endothelial O O
cells O O
( O O
HUVEC O O
) O O
, O O
resulted O O
in O O
a O O
fivefold O O
increased O O
formation O O
of O O
thiobarbituric O O
acid-reactive O O
substances O O
( O O
TBARS O O
) O O
and O O
activation O O
of O O
the O O
transcription O O
factor O O
NF-kB O O
, O O
both O O
indicators O O
of O O
cellular O O
oxidant O O
stress O O
. O O

Normal O O
RBC O O
show O O
none B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
these I-NEGATION I-NEGATION
phenomena I-NEGATION I-NEGATION
. O O

The O O
oxidant O O
stress-induced O O
signaling O O
resulted O O
in O O
an O O
increased O O
surface O O
expression O O
of O O
a O O
subset O O
of O O
CAMs O O
, O O
ICAM-1 O O
, O O
E-selectin O O
, O O
and O O
VCAM-1 O O
in O O
HUVEC O O
. O O

The O O
addition O O
of O O
oxygen O O
radical O O
scavenger O O
enzymes O O
( O O
catalase O O
, O O
superoxide O O
dismutase O O
) O O
and O O
antioxidant O O
( O O
probucol O O
) O O
inhibited O O
these O O
events O O
. O O

Additionally O O
, O O
preincubation O O
of O O
HUVEC O O
with O O
a O O
synthetic O O
peptide O O
Arg-Gly-Asp O O
( O O
RGD O O
) O O
that O O
prevents O O
vWf-mediated O O
adhesion O O
of O O
SS O O
RBC O O
reduced O O
the O O
surface O O
expression O O
of O O
VCAM-1 O O
and O O
NF-kB O O
activation O O
. O O

Furthermore O O
, O O
SS O O
RBC-induced O O
oxidant O O
stress O O
resulted O O
in O O
a O O
twofold O O
increase O O
in O O
the O O
transendothelial O O
migration O O
of O O
both O O
monocyte-like O O
HL-60 O O
cells O O
and O O
human O O
peripheral O O
blood O O
monocytes O O
, O O
and O O
approximately O O
a O O
sixfold O O
increase O O
in O O
platelet-endothelial O O
cell O O
adhesion O O
molecule-1 O O
( O O
PECAM-1 O O
) O O
phosphorylation O O
, O O
each O O
of O O
which O O
was O O
blocked O O
by O O
protein O O
kinase O O
C O O
inhibitor O O
and O O
antioxidants O O
. O O

These O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
adherence I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
contact I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
SS I-SPECULATION I-SPECULATION
RBC I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
endothelial I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
large I-SPECULATION I-SPECULATION
vessel I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
generate I-SPECULATION I-SPECULATION
enhanced I-SPECULATION I-SPECULATION
oxidant I-SPECULATION I-SPECULATION
stress I-SPECULATION I-SPECULATION
leading I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
increased I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
diapedesis I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
monocytes I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
well I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
heightened I-SPECULATION I-SPECULATION
adherence I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
SS I-SPECULATION I-SPECULATION
reticulocytes I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
indicating B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
injury I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
endothelium I-SPECULATION I-SPECULATION
can I-SPECULATION B-SPECULATION
contribute I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
vaso-occlusion I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
SCD I-SPECULATION I-SPECULATION
. O O

Tobacco O O
smoke O O
induces O O
coordinate O O
activation O O
of O O
HSF O O
and O O
inhibition O O
of O O
NFkappaB O O
in O O
human O O
monocytes O O
: O O
effects O O
on O O
TNFalpha O O
release O O
. O O

Tobacco O O
smoke O O
( O O
TS O O
) O O
exposure O O
is O O
a O O
major O O
risk O O
factor O O
for O O
human O O
disease O O
, O O
and O O
macrophages O O
of O O
healthy O O
smokers O O
have O O
a O O
depressed O O
capacity O O
to O O
release O O
cytokines O O
, O O
including O O
tumor O O
necrosis O O
factor O O
( O O
TNF O O
) O O
alpha O O
. O O

TS O O
induces O O
the O O
synthesis O O
of O O
heat O O
shock O O
( O O
HS O O
)/ O O
stress O O
proteins O O
( O O
HSP O O
) O O
, O O
and O O
, O O
in O O
particular O O
, O O
of O O
Hsp70 O O
. O O

We O O
determined O O
whether B-SPECULATION B-SPECULATION
Hsp70 I-SPECULATION I-SPECULATION
induction I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
TS I-SPECULATION I-SPECULATION
was I-SPECULATION I-SPECULATION
mediated I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
HS I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
HSF I-SPECULATION I-SPECULATION
. O O

HSF O O
activation O O
has O O
been O O
shown O O
to O O
inhibit O O
NFkappaB O O
. O O

Thus O O
, O O
we O O
also O O
determined O O
the O O
effects O O
of O O
TS O O
on O O
NFkappaB O O
. O O

U937 O O
cells O O
and O O
human O O
peripheral O O
blood O O
monocytes O O
were O O
exposed O O
to O O
TS O O
, O O
binding O O
activities O O
of O O
the O O
respective O O
transcription O O
factors O O
were O O
analyzed O O
, O O
and O O
Hsp70 O O
expression O O
and O O
TNFalpha O O
release O O
were O O
determined O O
in O O
parallel O O
. O O

TS O O
activated O O
HSF O O
, O O
which O O
was O O
associated O O
with O O
Hsp70 O O
overexpression O O
and O O
inhibition O O
of O O
NFkappaB O O
binding O O
activity O O
and O O
TNFalpha O O
release O O
. O O

The O O
altered O O
cytokine O O
profile O O
observed O O
in O O
smokers O O
may B-SPECULATION B-SPECULATION
relate I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
HSF I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
Hsp70-mediated I-SPECULATION I-SPECULATION
inhibition I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NFkappaB I-SPECULATION I-SPECULATION
activity I-SPECULATION I-SPECULATION
. O O

Copyright O O
1998 O O
Academic O O
Press O O
. O O

Transcriptional O O
regulation O O
of O O
the O O
beta-casein O O
gene O O
by O O
cytokines O O
: O O
cross-talk O O
between O O
STAT5 O O
and O O
other O O
signaling O O
molecules O O
. O O

The O O
beta-casein O O
promoter O O
has O O
been O O
widely O O
used O O
to O O
monitor O O
the O O
activation O O
of O O
STAT O O
( O O
signal O O
transducer O O
and O O
activator O O
of O O
transcription O O
) O O
5 O O
since O O
STAT5 O O
was O O
originally O O
found O O
as O O
a O O
mediator O O
of O O
PRL-inducible O O
beta-casein O O
expression O O
. O O

However O O
, O O
not O O
only O O
is O O
expression O O
of O O
the O O
beta-casein O O
gene O O
regulated O O
by O O
STAT5 O O
but O O
it O O
is O O
also O O
affected O O
by O O
other O O
molecules O O
such O O
as O O
glucocorticoid O O
and O O
Ras O O
. O O

In O O
this O O
report O O
, O O
we O O
describe O O
the O O
transcriptional O O
regulation O O
of O O
the O O
beta-casein O O
gene O O
by O O
cytokines O O
in O O
T O O
cells O O
. O O

We O O
have O O
found O O
that O O
the O O
beta-casein O O
gene O O
is O O
expressed O O
in O O
a O O
cytotoxic O O
T O O
cell O O
line O O
, O O
CTLL-2 O O
, O O
in O O
response O O
to O O
interleukin-2 O O
( O O
IL-2 O O
) O O
, O O
which O O
activates O O
STAT5 O O
. O O

While O O
IL-4 O O
does O O
not B-NEGATION B-NEGATION
activate I-NEGATION I-NEGATION
STAT5 I-NEGATION I-NEGATION
, O O
it O O
induces O O
expression O O
of O O
STAT5-regulated O O
genes O O
in O O
CTLL-2 O O
, O O
i.e. O O
beta-casein O O
, O O
a O O
cytokine-inducible O O
SH2-containing O O
protein O O
( O O
CIS O O
) O O
, O O
and O O
oncostatin O O
M O O
( O O
OSM O O
) O O
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
STAT6 I-SPECULATION I-SPECULATION
activated I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
IL-4 I-SPECULATION I-SPECULATION
substitutes I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
function I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
STAT5 I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

IL-2-induced O O
beta-casein O O
expression O O
was O O
enhanced O O
by O O
dexamethasone O O
, O O
and O O
this O O
synergistic O O
effect O O
of O O
Dexamethasone O O
requires O O
the O O
sequence O O
between O O
- O O
155 O O
and O O
- O O
193 O O
in O O
the O O
beta-casein O O
promoter O O
. O O

Coincidentally O O
, O O
a O O
deletion O O
of O O
this O O
region O O
enhanced O O
the O O
IL-2-induced O O
expression O O
of O O
beta-casein O O
. O O

Expression O O
of O O
an O O
active O O
form O O
of O O
Ras O O
, O O
Ras O O
( O O
G12V O O
) O O
, O O
suppressed O O
the O O
IL-2-induced O O
beta-casein O O
and O O
OSM O O
gene O O
expression O O
, O O
and O O
the O O
negative O O
effect O O
of O O
Ras O O
is O O
mediated O O
by O O
the O O
region O O
between O O
- O O
105 O O
and O O
- O O
193 O O
in O O
the O O
beta-casein O O
promoter O O
. O O

In O O
apparent O O
contradiction O O
, O O
expression O O
of O O
a O O
dominant O O
negative O O
form O O
of O O
Ras O O
, O O
RasN17 O O
, O O
also O O
inhibited O O
IL-2-induced O O
activation O O
of O O
the O O
promoter O O
containing O O
the O O
minimal O O
beta-casein O O
STAT5 O O
element O O
as O O
well O O
as O O
the O O
promoters O O
of O O
CIS O O
and O O
OSM O O
. O O

In O O
addition O O
, O O
Ras O O
( O O
G12V O O
) O O
complemented O O
signaling O O
by O O
an O O
erythropoietin O O
receptor O O
mutant O O
defective O O
in O O
Ras O O
activation O O
and O O
augmented O O
the O O
activation O O
of O O
the O O
beta-casein O O
promoter O O
by O O
the O O
mutant O O
erythropoietin O O
receptor O O
signaling O O
, O O
suggesting B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
possible B-SPECULATION B-SPECULATION
role I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
Ras I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
Stat5-mediated I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
. O O

These O O
results O O
collectively O O
reveal O O
a O O
complex O O
interaction O O
of O O
STAT5 O O
with O O
other O O
signaling O O
pathways O O
and O O
illustrate O O
that O O
regulation O O
of O O
gene O O
expression O O
requires O O
integration O O
of O O
opposing O O
signals O O
. O O

Transcription O O
factor O O
NF-kappaB O O
regulation O O
of O O
renal O O
fibrosis O O
during O O
ureteral O O
obstruction O O
. O O

Irrespective O O
of O O
the O O
etiology O O
, O O
many O O
kidney O O
diseases O O
result O O
in O O
inflammation O O
and O O
fibrosis O O
of O O
the O O
tubulointerstitium O O
, O O
with O O
the O O
subsequent O O
loss O O
of O O
renal O O
function O O
. O O

To O O
initiate O O
any O O
disease O O
process O O
or O O
for O O
any O O
disease O O
process O O
to O O
progress O O
, O O
there O O
must O O
be O O
changes O O
in O O
the O O
transcription O O
of O O
genes O O
within O O
the O O
affected O O
tissue O O
. O O

The O O
nuclear O O
factor-kappa O O
B O O
( O O
NF-kappaB O O
) O O
family O O
of O O
transcription O O
factors O O
regulates O O
genes O O
involved O O
in O O
inflammation O O
, O O
cell O O
proliferation O O
, O O
and O O
cell O O
differentiation O O
. O O

This O O
review O O
discusses O O
the O O
NF-kappaB O O
transcription O O
factor O O
family O O
in O O
general O O
and O O
the O O
association O O
of O O
NF-kappaB O O
activation O O
with O O
cellular O O
/ O O
molecular O O
events O O
of O O
renal O O
inflammation O O
and O O
fibrosis O O
. O O

TAL1 O O
and O O
LIM-only O O
proteins O O
synergistically O O
induce O O
retinaldehyde O O
dehydrogenase O O
2 O O
expression O O
in O O
T-cell O O
acute O O
lymphoblastic O O
leukemia O O
by O O
acting O O
as O O
cofactors O O
for O O
GATA3 O O
. O O

Previously O O
, O O
we O O
have O O
shown O O
that O O
TAL1 O O
and O O
the O O
LIM-only O O
protein O O
gene O O
( O O
LMO O O
) O O
are O O
regularly O O
coactivated O O
in O O
T-cell O O
acute O O
lymphoblastic O O
leukemia O O
( O O
T-ALL O O
) O O
. O O

This B-SPECULATION B-SPECULATION
observation I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
likely I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
relate I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
findings I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
TAL1 I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
LMO I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
highly I-SPECULATION I-SPECULATION
synergistic I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
T-cell I-SPECULATION I-SPECULATION
tumorigenesis I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
double-transgenic I-SPECULATION I-SPECULATION
mice I-SPECULATION I-SPECULATION
. O O

To O O
understand O O
the O O
molecular O O
mechanisms O O
of O O
functional O O
synergy O O
between O O
TAL1 O O
and O O
LMO O O
in O O
tumorigenesis O O
and O O
transcriptional O O
regulation O O
, O O
we O O
tried O O
to O O
identify O O
downstream O O
target O O
genes O O
regulated O O
by O O
TAL1 O O
and O O
LMO O O
by O O
a O O
subtractive O O
PCR O O
method O O
. O O

One O O
of O O
the O O
isolated O O
genes O O
, O O
that O O
for O O
retinaldehyde O O
dehydrogenase O O
2 O O
( O O
RALDH2 O O
) O O
, O O
was O O
regularly O O
expressed O O
in O O
most O O
of O O
the O O
T-ALL O O
cell O O
lines O O
that O O
coexpressed O O
TAL1 O O
and O O
LMO O O
. O O

Exogenously O O
transfected O O
TAL1 O O
and O O
LMO O O
, O O
but O O
not B-NEGATION B-NEGATION
either I-NEGATION I-NEGATION
alone I-NEGATION I-NEGATION
, O O
induced O O
RALDH2 O O
expression O O
in O O
a O O
T-ALL O O
cell O O
line O O
, O O
HPB-ALL O O
, O O
not B-NEGATION B-NEGATION
expressing I-NEGATION I-NEGATION
endogeneous I-NEGATION I-NEGATION
TAL1 I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
LMO I-NEGATION I-NEGATION
. O O

The O O
RALDH2 O O
transcripts O O
in O O
T-ALL O O
were O O
, O O
however O O
, O O
mostly O O
initiated O O
within O O
the O O
second O O
intron O O
. O O

Promoter O O
analysis O O
revealed O O
that O O
a O O
GATA O O
site O O
in O O
a O O
cryptic O O
promoter O O
in O O
the O O
second O O
intron O O
was O O
essential O O
and O O
sufficient O O
for O O
the O O
TAL1 O O
- O O
and O O
LMO-dependent O O
transcriptional O O
activation O O
, O O
and O O
GATA3 O O
binds O O
to O O
this O O
site O O
. O O

In O O
addition O O
, O O
forced O O
expression O O
of O O
GATA3 O O
potentiated O O
the O O
induction O O
of O O
RALDH2 O O
by O O
TAL1 O O
and O O
LMO O O
, O O
and O O
these O O
three O O
factors O O
formed O O
a O O
complex O O
in O O
vivo O O
. O O

Furthermore O O
, O O
a O O
TAL1 O O
mutant O O
not B-NEGATION B-NEGATION
binding I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
DNA I-NEGATION I-NEGATION
also O O
activated O O
the O O
transcription O O
of O O
RALDH2 O O
in O O
the O O
presence O O
of O O
LMO O O
and O O
GATA3 O O
. O O

Collectively O O
, O O
we O O
have O O
identified O O
the O O
RALDH2 O O
gene O O
as O O
a O O
first O O
example O O
of O O
direct O O
transcriptional O O
target O O
genes O O
regulated O O
by O O
TAL1 O O
and O O
LMO O O
in O O
T-ALL O O
. O O

In O O
this O O
case O O
, O O
TAL1 O O
and O O
LMO O O
act O O
as O O
cofactors O O
for O O
GATA3 O O
to O O
activate O O
the O O
transcription O O
of O O
RALDH2 O O
. O O

Granulocyte O O
colony-stimulating O O
factor O O
activates O O
a O O
72-kDa O O
isoform O O
of O O
STAT3 O O
in O O
human O O
neutrophils O O
. O O

Granulocyte O O
colony-stimulating O O
factor O O
( O O
G-CSF O O
) O O
signaling O O
involves O O
activation O O
of O O
STATs O O
, O O
proteins O O
that O O
serve O O
the O O
dual O O
function O O
of O O
signal O O
transduction O O
and O O
activation O O
of O O
transcription O O
. O O

We O O
previously O O
demonstrated O O
that O O
G-CSF O O
activated O O
a O O
distinct O O
Stat3-like O O
protein O O
in O O
immature O O
and O O
mature O O
normal O O
myeloid O O
cells O O
, O O
StatG O O
. O O

StatG O O
in O O
normal O O
immature O O
human O O
myeloid O O
cells O O
, O O
i.e. O O
adult O O
CD34 O O
+ O O
bone O O
marrow O O
cells O O
, O O
was O O
composed O O
of O O
Stat3beta O O
. O O

This O O
investigation O O
was O O
undertaken O O
to O O
determine O O
the O O
composition O O
of O O
StatG O O
in O O
mature O O
normal O O
human O O
myeloid O O
cells O O
, O O
i.e. O O
polymorphonuclear O O
neutrophilic O O
granulocytes O O
( O O
PMN O O
) O O
. O O

These O O
studies O O
revealed O O
that O O
the O O
major O O
protein O O
in O O
extracts O O
of O O
PMN O O
activated O O
by O O
G-CSF O O
to O O
bind O O
the O O
high-affinity O O
serum-inducible O O
element O O
( O O
hSIE O O
) O O
is O O
a O O
72-kDa O O
protein O O
that O O
cross-reacts O O
with O O
Stat3 O O
monoclonal O O
antibody O O
, O O
which O O
we O O
have O O
designated O O
Stat3gamma O O
. O O

Stat3gamma O O
is O O
derived O O
from O O
Stat3alpha O O
by O O
limited O O
proteolysis O O
and O O
lacks B-NEGATION B-NEGATION
the I-NEGATION I-NEGATION
carboxyl-terminal I-NEGATION I-NEGATION
portion I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
Stat3alpha I-NEGATION I-NEGATION
. O O

Because O O
this O O
region O O
of O O
Stat3alpha O O
is O O
involved O O
in O O
transcriptional O O
activation O O
, O O
our O O
findings O O
suggest B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
possibility B-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
Stat3gamma I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
transcriptionally I-SPECULATION I-SPECULATION
inactive I-SPECULATION I-SPECULATION
and O O
may B-SPECULATION B-SPECULATION
compete I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
Stat3alpha I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
Stat3 I-SPECULATION I-SPECULATION
binding I-SPECULATION I-SPECULATION
sites I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
terminally I-SPECULATION I-SPECULATION
differentiated I-SPECULATION I-SPECULATION
myeloid I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

Differential O O
effects O O
of O O
protein O O
kinase O O
C O O
inhibitors O O
on O O
fibronectin-induced O O
interleukin-beta O O
gene O O
transcription O O
, O O
protein O O
synthesis O O
and O O
secretion O O
in O O
human O O
monocytic O O
cells O O
. O O

Human O O
monocytic O O
cells O O
express O O
interleukin-1beta O O
( O O
IL-1beta O O
) O O
when O O
stimulated O O
with O O
the O O
extracellular O O
matrix O O
glycoprotein O O
, O O
fibronectin O O
( O O
FN O O
) O O
. O O

Protein O O
kinase O O
C O O
( O O
PKC O O
) O O
activation O O
is O O
considered O O
important O O
for O O
this O O
process O O
; O O
however O O
, O O
the B-SPECULATION B-SPECULATION
metabolic I-SPECULATION I-SPECULATION
steps I-SPECULATION I-SPECULATION
at I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
PKC I-SPECULATION I-SPECULATION
acts I-SPECULATION I-SPECULATION
upon I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
mediate I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
FN-induced I-SPECULATION I-SPECULATION
IL-1beta I-SPECULATION I-SPECULATION
response I-SPECULATION I-SPECULATION
remain I-SPECULATION I-SPECULATION
unclear I-SPECULATION I-SPECULATION
. O O

We O O
performed O O
an O O
analysis O O
of O O
the O O
mechanisms O O
by O O
which O O
two O O
PKC O O
inhibitors O O
, O O
Calphostin O O
C O O
and O O
Staurosporine O O
, O O
prevent O O
the O O
FN-induced O O
IL-1beta O O
response O O
. O O

Both O O
inhibitors O O
blocked O O
the O O
secretion O O
of O O
IL-1beta O O
protein O O
into O O
the O O
media O O
of O O
peripheral O O
blood O O
mononuclear O O
cells O O
exposed O O
to O O
FN O O
. O O

Immunoprecipitation O O
analysis O O
revealed O O
that O O
under O O
these O O
circumstances O O
, O O
Calphostin O O
C O O
inhibited O O
the O O
production O O
of O O
IL-1beta O O
protein O O
, O O
whereas O O
Staurosporine O O
allowed O O
protein O O
production O O
, O O
but O O
inhibited O O
its O O
secretion O O
. O O

To O O
determine O O
the O O
mechanisms O O
responsible O O
for O O
these O O
differences O O
, O O
we O O
turned O O
to O O
human O O
U937 O O
promonocytic O O
cells O O
. O O

U937 O O
cells O O
transfected O O
with O O
the O O
human O O
full-length O O
IL-1beta O O
promoter O O
connected O O
to O O
a O O
luciferase O O
reporter O O
gene O O
were O O
submitted O O
to O O
transcription O O
assays O O
, O O
Northern O O
blotting O O
, O O
and O O
DNA O O
electrophoresis O O
mobility O O
gel O O
shift O O
assays O O
. O O

These O O
studies O O
revealed O O
that O O
Calphostin O O
C O O
inhibited O O
the O O
nuclear O O
translocation O O
of O O
the O O
transcription O O
factor O O
activator O O
protein-1 O O
( O O
AP-1 O O
) O O
which O O
is O O
considered O O
necessary O O
for O O
FN O O
induction O O
of O O
IL-1beta O O
gene O O
transcription O O
, O O
and O O
prevented O O
the O O
transcription O O
of O O
the O O
IL-1beta O O
gene O O
. O O

In O O
contrast O O
, O O
Staurosporine O O
alone O O
induced O O
AP-1 O O
translocation O O
and O O
stimulation O O
of O O
the O O
gene O O
. O O

Overall O O
, O O
our O O
data O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
Calphostin I-SPECULATION I-SPECULATION
C I-SPECULATION I-SPECULATION
prevents I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
IL-1beta I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
thereby I-SPECULATION I-SPECULATION
inhibiting I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
synthesis I-SPECULATION I-SPECULATION
. O O

Based O O
on O O
the O O
high O O
specificity O O
of O O
this O O
compound O O
for O O
PKC O O
, O O
we O O
conclude O O
that O O
PKC O O
is O O
necessary O O
for O O
FN-induced O O
IL-1beta O O
protein O O
production O O
. O O

In O O
contrast O O
, O O
Staurosporine O O
prevented O O
secretion O O
of O O
IL-1beta O O
by O O
unknown B-SPECULATION O
mechanisms I-SPECULATION O
. O O

Membrane-associated O O
lymphotoxin O O
on O O
natural O O
killer O O
cells O O
activates O O
endothelial O O
cells O O
via O O
an O O
NF-kappaB-dependent O O
pathway O O
. O O

BACKGROUND O O
: O O
Inhibition O O
of O O
complement O O
in O O
small O O
animal O O
models O O
of O O
xenotransplantation O O
has O O
demonstrated O O
graft O O
infiltration O O
with O O
natural O O
killer O O
( O O
NK O O
) O O
cells O O
and O O
monocytes O O
associated O O
with O O
endothelial O O
cell O O
( O O
EC O O
) O O
activation O O
. O O

We O O
have O O
previously O O
demonstrated O O
that O O
human O O
NK O O
cells O O
activate O O
porcine O O
EC O O
in O O
vitro O O
, O O
which O O
results O O
in O O
adhesion O O
molecule O O
expression O O
and O O
cytokine O O
secretion O O
. O O

In O O
this O O
study O O
, O O
we O O
used O O
the O O
NK O O
cell O O
line O O
NK92 O O
to O O
define O O
the O O
molecular O O
and O O
cellular O O
basis O O
of O O
NK O O
cell-mediated O O
EC O O
activation O O
. O O

METHODS O O
: O O
EC O O
were O O
transfected O O
with O O
either O O
reporter O O
constructs O O
containing O O
the O O
luciferase O O
gene O O
driven O O
either O O
by O O
E-selectin O O
or O O
interleukin O O
( O O
IL O O
)- O O
8 O O
promoters O O
or O O
a O O
synthetic O O
NF-kappaB-dependent O O
promoter O O
. O O

In O O
addition O O
, O O
a O O
dominant-negative O O
mutant O O
tumor O O
necrosis O O
factor O O
receptor O O
I O O
( O O
TNFRI O O
) O O
expression O O
vector O O
was O O
co-transfected O O
in O O
inhibition O O
studies O O
. O O

Forty-eight O O
hours O O
after O O
transfection O O
, O O
EC O O
were O O
stimulated O O
with O O
NK O O
cells O O
or O O
NK O O
cell O O
membrane O O
extracts O O
for O O
7 O O
hr O O
and O O
activation O O
was O O
measured O O
by O O
a O O
luciferase O O
assay O O
. O O

RESULTS O O
: O O
Co-culture O O
of O O
NK O O
cells O O
with O O
transfected O O
EC O O
enhanced O O
E-selectin O O
, O O
IL-8 O O
, O O
and O O
NF-kappaB-dependent O O
promoter O O
activity O O
. O O

NK O O
cell O O
membrane O O
extracts O O
retained O O
the O O
capacity O O
to O O
activate O O
EC O O
and O O
induced O O
nuclear O O
translocation O O
of O O
NF-kappaB O O
( O O
p50 O O
and O O
p65 O O
) O O
. O O

Western O O
blotting O O
of O O
NK O O
cell O O
and O O
membrane O O
extracts O O
detected O O
the O O
presence O O
of O O
Lymphotoxin-alpha O O
( O O
LTalpha O O
) O O
but O O
not B-NEGATION B-NEGATION
tumor I-NEGATION I-NEGATION
necrosis I-NEGATION I-NEGATION
factor-alpha I-NEGATION I-NEGATION
. O O

Furthermore O O
, O O
LTalpha O O
was O O
secreted O O
in O O
NK O O
: O O
EC O O
co-cultures O O
. O O

Co-transfection O O
with O O
dominant-negative O O
mutant O O
TNFRI O O
inhibited O O
EC O O
activation O O
by O O
NK O O
cell O O
membrane O O
extracts O O
and O O
by O O
NK O O
cells O O
by O O
80 O O
% O O
and O O
47 O O
% O O
, O O
respectively O O
. O O

The O O
same O O
pattern O O
of O O
inhibition O O
was O O
observed O O
using O O
anti-human O O
LT O O
sera O O
. O O

CONCLUSIONS O O
: O O
Human O O
NK O O
cell O O
membrane-bound O O
LT O O
signals O O
across O O
species O O
via O O
TNFRI O O
, O O
leading O O
to O O
NF-kappaB O O
nuclear O O
translocation O O
and O O
transcription O O
of O O
E-selectin O O
and O O
IL-8 O O
, O O
which O O
results O O
in O O
EC O O
activation O O
. O O

The O O
discrepancy O O
in O O
the O O
degree O O
of O O
inhibition O O
by O O
membrane O O
extracts O O
and O O
NK O O
cells O O
with O O
mutant O O
TNFRI O O
suggests B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
additional I-SPECULATION I-SPECULATION
pathways I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
utilized I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
NK I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
activate I-SPECULATION I-SPECULATION
EC I-SPECULATION I-SPECULATION
. O O

Cloning O O
of O O
ARE-containing O O
genes O O
by O O
AU-motif-directed O O
display O O
. O O

A O O
procedure O O
suitable O O
for O O
cloning O O
labile O O
mRNAs O O
that O O
contain O O
AU O O
motifs O O
is O O
presented O O
( O O
AU-DD O O
) O O
. O O

These O O
motifs O O
are O O
regulatory O O
sequences O O
within O O
the O O
so-called O O
AU-rich O O
elements O O
( O O
AREs O O
) O O
often O O
found O O
in O O
3 O O
' O O
untranslated O O
regions O O
of O O
genes O O
such O O
as O O
cytokines O O
, O O
proto-oncogenes O O
, O O
and O O
transcription O O
factors O O
. O O

AU-DD O O
is O O
an O O
AU-motif-directed O O
differential O O
display O O
that O O
permits O O
the O O
identification O O
of O O
ARE-containing O O
genes O O
differentially O O
expressed O O
after O O
cell O O
activation O O
. O O

It O O
has O O
been O O
applied O O
to O O
peripheral O O
blood O O
monocytes O O
and O O
a O O
T O O
cell O O
clone O O
to O O
isolate O O
59 O O
cDNA O O
fragments O O
associated O O
to O O
activation O O
. O O

Fourteen O O
percent O O
of O O
isolated O O
fragments O O
belong O O
to O O
already O O
known O O
genes O O
that O O
certainly O O
are O O
cytokines O O
and O O
transduction O O
/ O O
transcription O O
factors O O
. O O

The O O
remaining O O
86 O O
% O O
correspond O O
to O O
unknown O O
genes O O
of O O
which O O
92 O O
% O O
have O O
been O O
confirmed O O
to O O
be O O
differentially O O
expressed O O
. O O

These O O
data O O
demonstrate O O
the O O
efficiency O O
of O O
the O O
system O O
and O O
support O O
the O O
notion B-SPECULATION O
that I-SPECULATION O
numerous I-SPECULATION O
genes I-SPECULATION O
falling I-SPECULATION O
into I-SPECULATION O
those I-SPECULATION O
categories I-SPECULATION O
remain I-SPECULATION O
unidentified I-SPECULATION O
and I-SPECULATION O
that I-SPECULATION O
they I-SPECULATION O
can I-SPECULATION O
be I-SPECULATION O
cloned I-SPECULATION O
by I-SPECULATION O
this I-SPECULATION O
method I-SPECULATION O
. O O

Copyright O O
1998 O O
Academic O O
Press O O
. O O

Signaling O O
pathways O O
mediated O O
by O O
the O O
TNF O O
- O O
and O O
cytokine-receptor O O
families O O
target O O
a O O
common O O
cis-element O O
of O O
the O O
IFN O O
regulatory O O
factor O O
1 O O
promoter O O
. O O

CD40 O O
activation O O
of O O
B O O
cells O O
is O O
strongly O O
influenced O O
by O O
the O O
presence O O
of O O
cytokines O O
. O O

However O O
, O O
the B-SPECULATION B-NEGATION
molecular I-SPECULATION I-NEGATION
basis I-SPECULATION I-NEGATION
for I-SPECULATION I-NEGATION
the I-SPECULATION I-NEGATION
interplay I-SPECULATION I-NEGATION
between I-SPECULATION I-NEGATION
these I-SPECULATION I-NEGATION
distinct I-SPECULATION I-NEGATION
stimuli I-SPECULATION I-NEGATION
is I-SPECULATION I-NEGATION
not I-SPECULATION I-NEGATION
clearly I-SPECULATION I-NEGATION
delineated I-SPECULATION I-NEGATION
. O O

IFN O O
regulatory O O
factor O O
1 O O
( O O
IRF-1 O O
) O O
is O O
a O O
transcription O O
factor O O
activated O O
by O O
either O O
CD40 O O
or O O
cytokines O O
. O O

We O O
have O O
found O O
that O O
these O O
different O O
sets O O
of O O
signals O O
target O O
a O O
common O O
cis-acting O O
element O O
in O O
the O O
promoter O O
of O O
this O O
gene O O
, O O
the O O
IRF-1 O O
gamma-activated O O
site O O
( O O
GAS O O
) O O
. O O

Targeting B-NEGATION O
of I-NEGATION O
the I-NEGATION O
IRF-1 I-NEGATION O
GAS I-NEGATION O
is I-NEGATION O
not I-NEGATION B-NEGATION
confined I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
via I-NEGATION I-NEGATION
CD40 I-NEGATION I-NEGATION
but O O
extends O O
to O O
other O O
stimuli O O
that O O
mimic O O
the O O
CD40 O O
signaling O O
cascade O O
, O O
like O O
TNF-alpha O O
and O O
EBV O O
. O O

In O O
contrast O O
to O O
induction O O
of O O
STATs O O
by O O
cytokines O O
, O O
the O O
IRF-1 O O
GAS-binding O O
complex O O
activated O O
by O O
CD40 B-SPECULATION O
, I-SPECULATION O
TNF-alpha I-SPECULATION O
, I-SPECULATION O
or I-SPECULATION O
EBV I-SPECULATION O
contains O O
Rel O O
proteins O O
, O O
specifically O O
p50 O O
and O O
p65 O O
. O O

In O O
this O O
system O O
, O O
simultaneous O O
exposure O O
to O O
CD40L O O
together O O
with O O
either O O
IL-4 O O
or O O
IFN-gamma O O
does O O
not B-NEGATION B-NEGATION
lead I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
novel I-NEGATION I-NEGATION
Rel I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
STAT I-NEGATION I-NEGATION
complexes I-NEGATION I-NEGATION
. O O

Given O O
the O O
importance O O
of O O
IRF-1 O O
in O O
a O O
variety O O
of O O
biologic O O
functions O O
from O O
proliferation O O
to O O
apoptosis O O
, O O
our O O
findings O O
support O O
the O O
notion B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
modulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
IRF-1 I-SPECULATION I-SPECULATION
levels I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
critical I-SPECULATION I-SPECULATION
control I-SPECULATION I-SPECULATION
point I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
. O O

Regulation O O
of O O
NF-kappa O O
B O O
, O O
AP-1 O O
, O O
NFAT O O
, O O
and O O
STAT1 O O
nuclear O O
import O O
in O O
T O O
lymphocytes O O
by O O
noninvasive O O
delivery O O
of O O
peptide O O
carrying O O
the O O
nuclear O O
localization O O
sequence O O
of O O
NF-kappa O O
B O O
p50 O O
. O O

Activation O O
of O O
T O O
lymphocytes O O
by O O
Ags O O
or O O
cytokines O O
results O O
in O O
translocation O O
of O O
the O O
transcription O O
factors O O
NF-kappa O O
B O O
, O O
AP-1 O O
, O O
NFAT O O
, O O
and O O
STAT O O
from O O
the O O
cytoplasm O O
into O O
the O O
nucleus O O
. O O

The O O
first O O
step O O
in O O
the O O
nuclear O O
import O O
process O O
is O O
recognition O O
of O O
a O O
nuclear O O
localization O O
sequence O O
( O O
NLS O O
) O O
within O O
the O O
karyophilic O O
protein O O
by O O
a O O
cytoplasmic O O
receptor O O
such O O
as O O
the O O
importin O O
( O O
karyopherin O O
)- O O
alpha O O
subunit O O
. O O

The O O
NLSs O O
of O O
NF-kappa O O
B O O
, O O
AP-1 O O
, O O
and O O
NFAT O O
differ O O
and O O
the B-NEGATION B-NEGATION
NLS I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
STAT1 I-NEGATION I-NEGATION
has I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
yet I-NEGATION I-NEGATION
been I-NEGATION I-NEGATION
identified I-NEGATION I-NEGATION
. O O

Herein O O
we O O
demonstrate O O
that O O
the O O
inducible O O
nuclear O O
import O O
of O O
NF-kappa O O
B O O
, O O
AP-1 O O
, O O
NFAT O O
, O O
and O O
STAT1 O O
in O O
Jurkat O O
T O O
lymphocytes O O
is O O
significantly O O
inhibited O O
by O O
a O O
cell-permeable O O
peptide O O
carrying O O
the O O
NLS O O
of O O
the O O
NF-kappa O O
B O O
p50 O O
subunit O O
. O O

NLS O O
peptide-mediated O O
disruption O O
of O O
the O O
nuclear O O
import O O
of O O
these O O
transcription O O
factors O O
results O O
in O O
inhibition O O
of O O
I O O
kappa O O
B O O
alpha O O
and O O
IL-2 O O
gene O O
expression O O
, O O
processes O O
dependent O O
on O O
NF-kappa O O
B O O
or O O
the O O
combination O O
of O O
NF-kappa O O
B O O
, O O
AP-1 O O
, O O
and O O
NFAT O O
. O O

Further O O
, O O
we O O
show O O
that O O
inhibitory O O
NLS O O
peptide O O
interacts O O
in O O
vitro O O
with O O
a O O
cytoplasmic O O
NLS O O
receptor O O
complex O O
comprised O O
of O O
the O O
Rch1 O O
/ O O
importin O O
( O O
karyopherin O O
)- O O
beta O O
heterodimer O O
expressed O O
in O O
Jurkat O O
T O O
cells O O
. O O

Taken O O
together O O
, O O
these O O
data O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
inducible I-SPECULATION I-SPECULATION
nuclear I-SPECULATION I-SPECULATION
import I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
AP-1 I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
NFAT I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
STAT1 I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
Jurkat I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
regulated I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
NLS I-SPECULATION I-SPECULATION
peptide I-SPECULATION I-SPECULATION
delivered I-SPECULATION I-SPECULATION
noninvasively I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
cytoplasm I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
Jurkat I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
target I-SPECULATION I-SPECULATION
members I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
importin I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
karyopherin I-SPECULATION I-SPECULATION
)- I-SPECULATION I-SPECULATION
alpha I-SPECULATION I-SPECULATION
beta I-SPECULATION I-SPECULATION
NLS I-SPECULATION I-SPECULATION
receptor I-SPECULATION I-SPECULATION
complex I-SPECULATION I-SPECULATION
. O O

Epithelial O O
cell-initiated O O
inflammation O O
plays O O
a O O
crucial O O
role O O
in O O
early O O
tissue O O
damage O O
in O O
amebic O O
infection O O
of O O
human O O
intestine O O
. O O

BACKGROUND O O
& O O
AIMS O O
: O O
Entamoeba O O
histolytica O O
infection O O
of O O
the O O
intestine O O
can O O
induce O O
severe O O
gut O O
inflammation O O
. O O

The O O
aims O O
of O O
this O O
study O O
were O O
to O O
assess O O
the O O
role O O
of O O
the O O
host O O
inflammatory O O
response O O
in O O
the O O
tissue O O
damage O O
observed O O
with O O
amebiasis O O
and O O
the O O
role O O
of O O
the O O
intestinal O O
epithelial O O
cell O O
in O O
initiating O O
that O O
response O O
. O O

METHODS O O
: O O
E. O O
histolytica O O
infection O O
was O O
established O O
in O O
human O O
intestinal O O
xenografts O O
in O O
severe O O
combined O O
immunodeficient O O
( O O
SCID-HU-INT O O
) O O
mice O O
. O O

Human O O
intestinal O O
epithelial O O
cell O O
inflammatory O O
responses O O
to O O
amebic O O
infection O O
were O O
inhibited O O
by O O
the O O
intraluminal O O
administration O O
of O O
an O O
antisense O O
oligonucleotide O O
to O O
the O O
human O O
p65 O O
subunit O O
of O O
nuclear O O
factor O O
kappaB O O
, O O
and O O
the O O
role O O
of O O
neutrophils O O
in O O
tissue O O
damage O O
observed O O
with O O
amebiasis O O
was O O
studied O O
by O O
depleting O O
neutrophils O O
from O O
SCID-HU-INT O O
mice O O
. O O

RESULTS O O
: O O
Administration O O
of O O
the O O
antisense O O
oligonucleotide O O
blocked O O
the O O
production O O
of O O
human O O
interleukin O O
1beta O O
and O O
interleukin O O
8 O O
by O O
intestinal O O
epithelial O O
cells O O
and O O
inhibited O O
neutrophil O O
influx O O
into O O
the O O
E. O O
histolytica-infected O O
intestinal O O
xenografts O O
. O O

Inhibition O O
of O O
the O O
gut O O
inflammatory O O
response O O
by O O
the O O
antisense O O
oligonucleotide O O
or O O
the O O
depletion O O
of O O
neutrophils O O
from O O
SCID-HU O O
- O O
INT O O
mice O O
blocked O O
the O O
increase O O
in O O
intestinal O O
permeability O O
observed O O
with O O
amebic O O
infection O O
. O O

CONCLUSIONS O O
: O O
Intestinal O O
epithelial O O
cells O O
initiate O O
an O O
inflammatory O O
response O O
with O O
resulting O O
neutrophil-mediated O O
tissue O O
damage O O
in O O
response O O
to O O
E. O O
histolytica O O
infection O O
; O O
this O O
inflammatory O O
cascade O O
can O O
be O O
blocked O O
by O O
inhibiting O O
the O O
transcription O O
of O O
genes O O
regulated O O
by O O
nuclear O O
factor O O
kappaB O O
. O O

In O O
vitro O O
suppression O O
of O O
programmed O O
cell O O
death O O
of O O
B O O
cells O O
by O O
tissue O O
inhibitor O O
of O O
metalloproteinases-1 O O
. O O

Cellular O O
pathways O O
for O O
induction O O
of O O
programmed O O
cell O O
death O O
( O O
PCD O O
) O O
have O O
been O O
identified O O
, O O
but O O
little O O
is O O
known O O
about O O
specific O O
extracellular O O
matrix O O
processes O O
that O O
may B-SPECULATION B-SPECULATION
affect I-SPECULATION I-SPECULATION
apoptosis I-SPECULATION I-SPECULATION
along I-SPECULATION I-SPECULATION
those I-SPECULATION I-SPECULATION
pathways I-SPECULATION I-SPECULATION
. O O

In O O
this O O
study O O
, O O
a O O
series O O
of O O
Burkitt's O O
lymphoma O O
( O O
BL O O
) O O
cell O O
lines O O
were O O
assayed O O
for O O
their O O
expression O O
of O O
tissue O O
inhibitor O O
of O O
metalloproteinases O O
( O O
TIMP O O
)- O O
1 O O
. O O

Results O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
TIMP-1-positive I-SPECULATION I-SPECULATION
BL I-SPECULATION I-SPECULATION
lines I-SPECULATION I-SPECULATION
show I-SPECULATION I-SPECULATION
resistance I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
cold-shock-induced I-SPECULATION I-SPECULATION
apoptosis I-SPECULATION I-SPECULATION
. O O

Furthermore O O
, O O
recombinant O O
TIMP-1 O O
, O O
but O O
not B-NEGATION B-NEGATION
, O O
confers O O
resistance O O
to O O
apoptosis O O
induced O O
by O O
both O O
CD95-dependent O O
and O O
- O O
independent O O
( O O
cold O O
shock O O
, O O
serum O O
deprivation O O
, O O
and O O
gamma-radiation O O
) O O
pathways O O
in O O
TIMP-1-negative O O
BL O O
lines O O
. O O
TIMP-2 B-SPECULATION B-SPECULATION
or I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
synthetic I-SPECULATION I-SPECULATION
metalloproteinase I-SPECULATION I-SPECULATION
inhibitor I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
BB-94 I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
. O O

TIMP-1 O O
suppression O O
of O O
PCD O O
is O O
not B-NEGATION B-NEGATION
due I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
metalloproteinase I-NEGATION I-NEGATION
inhibition I-NEGATION I-NEGATION
, O O
as O O
reduction O O
and O O
alkylation O O
of O O
the O O
TIMP-1 O O
did O O
not B-NEGATION B-NEGATION
abolish I-NEGATION I-NEGATION
this I-NEGATION I-NEGATION
activity I-NEGATION I-NEGATION
. O O

Retroviral O O
induction O O
of O O
TIMP-1 O O
not O O
only O O
resulted O O
in O O
cell O O
survival O O
but O O
also O O
in O O
continued O O
DNA O O
synthesis O O
for O O
up O O
to O O
5 O O
d O O
in O O
the O O
absence O O
of O O
serum O O
, O O
while O O
controls O O
underwent O O
apoptosis O O
. O O

This O O
resistance O O
to O O
apoptosis O O
is O O
reversed O O
by O O
anti-TIMP-1 O O
antibodies O O
, O O
demonstrating O O
that O O
secreted O O
TIMP-1 O O
is O O
active O O
in O O
blocking O O
apoptosis O O
. O O

Furthermore O O
, O O
TIMP-1 O O
upregulation O O
induced O O
expression O O
of O O
Bcl-XL O O
but O O
not B-NEGATION B-NEGATION
Bcl-2 I-NEGATION I-NEGATION
as O O
well O O
as O O
decreased O O
NF-kappaB O O
activity O O
as O O
compared O O
with O O
controls O O
. O O

These O O
results O O
demonstrate O O
that O O
TIMP-1 O O
suppresses O O
apoptosis O O
in O O
B O O
cells O O
and O O
suggests B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
novel I-SPECULATION I-SPECULATION
activity I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
TIMP-1 I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
tissue I-SPECULATION I-SPECULATION
homeostasis I-SPECULATION I-SPECULATION
. O O

Interleukin-12 O O
expression O O
in O O
B O O
cells O O
by O O
transformation O O
with O O
Epstein-Barr O O
virus O O
. O O

Although O O
interleukin O O
( O O
IL O O
)- O O
12 O O
was O O
originally O O
purified O O
from O O
an O O
Epstein-Barr O O
( O O
EBV O O
)- O O
transformed O O
B O O
cell O O
line O O
and O O
the B-SPECULATION O
high I-SPECULATION O
correlation I-SPECULATION O
of I-SPECULATION O
EBV I-SPECULATION O
infection I-SPECULATION O
and I-SPECULATION O
IL-12 I-SPECULATION O
expression I-SPECULATION O
has I-SPECULATION O
been I-SPECULATION O
suggested I-SPECULATION O
, O O
no B-NEGATION O
study I-NEGATION O
has I-NEGATION O
reported I-NEGATION O
whether B-SPECULATION B-SPECULATION
EBV I-SPECULATION I-SPECULATION
infection I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
directly I-SPECULATION I-SPECULATION
linked I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
IL-12 I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
. O O

To O O
address O O
this O O
issue O O
, O O
we O O
have O O
investigated O O
IL-12 O O
expression O O
in O O
B O O
cells O O
during O O
in O O
vitro O O
transformation O O
with O O
EBV O O
. O O

Human O O
peripheral O O
B O O
cells O O
became O O
capable O O
of O O
constitutively O O
producing O O
p40 O O
by O O
in O O
vitro O O
transformation O O
with O O
EBV O O
, O O
coincident O O
with O O
the O O
expression O O
of O O
latent O O
membrane O O
protein O O
1 O O
( O O
LMP1 O O
) O O
of O O
EBV O O
. O O

These O O
B O O
cells O O
expressed O O
p40 O O
and O O
p35 O O
mRNA O O
, O O
and O O
phorbol O O
myristate O O
acetate O O
( O O
PMA O O
) O O
stimulation O O
strongly O O
enhanced O O
p40 O O
and O O
p70 O O
production O O
. O O

Furthermore O O
, O O
transfection O O
with O O
LMP1 O O
expression O O
vector O O
into O O
a O O
human O O
B O O
lymphoma O O
cell O O
line O O
, O O
Daudi O O
, O O
led O O
to O O
p40 O O
production O O
with O O
nuclear O O
factor O O
( O O
NF O O
)- O O
kappaB O O
activation O O
. O O

These O O
results O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
transformation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
primary I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
EBV I-SPECULATION I-SPECULATION
induces I-SPECULATION I-SPECULATION
IL-12 I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
potentially B-SPECULATION B-SPECULATION
through I-SPECULATION I-SPECULATION
LMP1 I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
. O O

Copyright O O
1998 O O
Academic O O
Press O O
. O O

Anaphylatoxins O O
C5a O O
and O O
C3a O O
induce O O
nuclear O O
factor O O
kappaB O O
activation O O
in O O
human O O
peripheral O O
blood O O
monocytes O O
. O O

The O O
anaphylatoxins O O
C5a O O
and O O
C3a O O
are O O
involved O O
in O O
the O O
regulation O O
of O O
cytokine O O
production O O
. O O

In O O
this O O
study O O
the O O
capability O O
of O O
C5a O O
and O O
C3a O O
to O O
induce O O
transcription O O
factor O O
activation O O
was O O
examined O O
. O O

C5a O O
and O O
C3a O O
stimulation O O
of O O
human O O
peripheral O O
blood O O
monocytes O O
resulted O O
in O O
nuclear O O
expression O O
of O O
a O O
DNA O O
binding O O
activity O O
with O O
specificity O O
to O O
the O O
kappaB O O
sequence O O
. O O

The O O
p50 O O
and O O
p65 O O
proteins O O
, O O
constituents O O
of O O
the O O
prototypic O O
nuclear O O
factor O O
kappaB O O
, O O
were O O
identified O O
as O O
components O O
of O O
the O O
DNA-protein O O
complexes O O
by O O
anti-peptide O O
antibodies O O
in O O
gel O O
supershift O O
assays O O
. O O

C5a O O
induced O O
kappaB O O
binding O O
activity O O
was O O
detected O O
15 O O
min O O
after O O
agonist O O
stimulation O O
, O O
peaked O O
at O O
30-40 O O
min O O
, O O
and O O
remained O O
detectable O O
at O O
2 O O
h O O
. O O

Binding O O
to O O
kappaB O O
sequence O O
was O O
accompanied O O
by O O
an O O
initial O O
decrease O O
and O O
subsequent O O
increase O O
in O O
the O O
cytoplasmic O O
IkappaBalpha O O
levels O O
, O O
as O O
detected O O
by O O
Western O O
blotting O O
using O O
an O O
anti-IkappaBalpha O O
antibody O O
. O O

Pertussis O O
toxin O O
treatment O O
markedly O O
decreased O O
kappaB O O
binding O O
activities O O
induced O O
by O O
both O O
C5a O O
and O O
C3a O O
, O O
whereas O O
cholera O O
toxin O O
displayed O O
no B-NEGATION B-NEGATION
inhibitory I-NEGATION I-NEGATION
effect I-NEGATION I-NEGATION
. O O

Neither B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
two I-NEGATION I-NEGATION
toxins I-NEGATION I-NEGATION
affected I-NEGATION I-NEGATION
kappaB I-NEGATION I-NEGATION
binding I-NEGATION I-NEGATION
activity I-NEGATION I-NEGATION
induced I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
TNFalpha I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
same I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
. O O

These O O
results O O
imply B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
potential B-SPECULATION B-SPECULATION
role I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
anaphylatoxins I-SPECULATION I-SPECULATION
C5a I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
C3a I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
regulating I-SPECULATION I-SPECULATION
leukocytes I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
through I-SPECULATION I-SPECULATION
G I-SPECULATION I-SPECULATION
protein-coupled I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
. O O

Tpl-2 O O
induces O O
IL-2 O O
expression O O
in O O
T-cell O O
lines O O
by O O
triggering O O
multiple O O
signaling O O
pathways O O
that O O
activate O O
NFAT O O
and O O
NF-kappaB O O
. O O

The O O
Tpl-2 O O
kinase O O
activates O O
the O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
( O O
NFAT O O
) O O
and O O
induces O O
IL-2 O O
expression O O
in O O
T-cell O O
lines O O
. O O

Here O O
we O O
show O O
that O O
the O O
activation O O
of O O
the O O
IL-2 O O
promoter O O
by O O
Tpl-2 O O
is O O
inhibited O O
by O O
mutant O O
signaling O O
molecules O O
that O O
inhibit O O
the O O
mitogen-activated O O
protein O O
kinase O O
( O O
MAPK O O
) O O
or O O
the O O
calcineurin O O
/ O O
NFAT O O
pathways O O
and O O
is O O
promoted O O
by O O
combinations O O
of O O
signaling O O
molecules O O
that O O
activate O O
these O O
pathways O O
. O O

We O O
, O O
therefore O O
, O O
conclude O O
that O O
signals O O
generated O O
by O O
the O O
convergence O O
of O O
the O O
MAPK O O
and O O
the O O
calcineurin O O
/ O O
NFAT O O
pathway O O
are O O
necessary O O
and O O
sufficient O O
for O O
the O O
activation O O
of O O
the O O
IL-2 O O
promoter O O
by O O
Tpl-2 O O
. O O

The O O
activation O O
of O O
both O O
the O O
IL-2 O O
promoter O O
and O O
an O O
NFAT-driven O O
minimal O O
promoter O O
were O O
shown O O
to O O
depend O O
on O O
signals O O
transduced O O
by O O
Raf1 O O
. O O

However O O
, O O
it O O
was O O
only O O
the O O
IL-2 O O
promoter O O
whose O O
activation O O
by O O
Tpl-2 O O
was O O
fully O O
blocked O O
by O O
the O O
dominant O O
negative O O
mutant O O
MEK1S218 O O
/ O O
222A O O
and O O
the O O
MEK1 O O
/ O O
MEK2 O O
inhibitor O O
PD098059 O O
. O O

Since O O
the O O
activation O O
of O O
NFAT O O
is O O
MAPK-dependent O O
these O O
findings O O
suggested B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
MAPK I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
Tpl-2 I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
either B-SPECULATION I-SPECULATION
independent I-SPECULATION I-SPECULATION
on O I-SPECULATION
MEK1 O I-SPECULATION
and O I-SPECULATION
MEK2 O I-SPECULATION
. O O

In O O
addition O O
, O O
they O O
suggested B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
IL-2 I-SPECULATION I-SPECULATION
promoter I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
under I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
control I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
not I-SPECULATION I-SPECULATION
only I-SPECULATION I-SPECULATION
NFAT I-SPECULATION I-SPECULATION
but I-SPECULATION I-SPECULATION
also I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
second I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
whose I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
MEK-dependent I-SPECULATION I-SPECULATION
. O O

Experiments O O
in O O
COS-1 O O
and O O
EL-4 O O
cells O O
confirmed O O
both O O
hypotheses O O
and O O
revealed O O
that O O
the O O
second O O
factor O O
activated O O
by O O
Tpl-2 O O
is O O
NF-kappaB O O
. O O

While O O
the O O
activation O O
of O O
the O O
IL-2 O O
promoter O O
and O O
an O O
NFAT-driven O O
minimal O O
promoter O O
by O O
Tpl-2 O O
was O O
fully O O
blocked O O
by O O
the O O
dominant O O
negative O O
mutant O O
NFAT O O
delta418 O O
, O O
it O O
was O O
only O O
partially O O
blocked O O
by O O
the O O
calcineurin O O
inhibitor O O
cyclosporin O O
A O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
Tpl-2-mediated I-SPECULATION I-SPECULATION
NFAT I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
under I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
control I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
combination I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
calcineurin-dependent I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
independent I-SPECULATION I-SPECULATION
pathways I-SPECULATION I-SPECULATION
. O O

Both O O
pathways O O
were O O
fully O O
blocked O O
by O O
Bcl-2 O O
or O O
Bcl-X O O
( O O
L O O
) O O
. O O

Activation O O
of O O
human O O
macrophages O O
by O O
mechanical O O
ventilation O O
in O O
vitro O O
. O O

Positive-pressure O O
mechanical O O
ventilation O O
supports O O
gas O O
exchange O O
in O O
patients O O
with O O
respiratory O O
failure O O
but O O
is O O
also O O
responsible O O
for O O
significant O O
lung O O
injury O O
. O O

In O O
this O O
study O O
, O O
we O O
have O O
developed O O
an O O
in O O
vitro O O
model O O
in O O
which O O
isolated O O
lung O O
cells O O
can O O
be O O
submitted O O
to O O
a O O
prolonged O O
cyclic O O
pressure-stretching O O
strain O O
resembling O O
that O O
of O O
conventional O O
mechanical O O
ventilation O O
. O O

In O O
this O O
model O O
, O O
cells O O
cultured O O
on O O
a O O
Silastic O O
membrane O O
were O O
elongated O O
up O O
to O O
7 O O
% O O
of O O
their O O
initial O O
diameter O O
, O O
corresponding O O
to O O
a O O
12 O O
% O O
increase O O
in O O
cell O O
surface O O
. O O

The O O
lung O O
macrophage O O
was O O
identified O O
as O O
the O O
main O O
cellular O O
source O O
for O O
critical O O
inflammatory O O
mediators O O
such O O
as O O
tumor O O
necrosis O O
factor-alpha O O
, O O
the O O
chemokines O O
interleukin O O
( O O
IL O O
)- O O
8 O O
and O O
- O O
6 O O
, O O
and O O
matrix O O
metalloproteinase-9 O O
in O O
this O O
model O O
system O O
of O O
mechanical O O
ventilation O O
. O O

These O O
mediators O O
were O O
measured O O
in O O
supernatants O O
from O O
ventilated O O
alveolar O O
macrophages O O
, O O
monocyte-derived O O
macrophages O O
, O O
and O O
promonocytic O O
THP-1 O O
cells O O
. O O

Nuclear O O
factor-kappaB O O
was O O
found O O
to O O
be O O
activated O O
in O O
ventilated O O
macrophages O O
. O O

Synergistic O O
proinflammatory O O
effects O O
of O O
mechanical O O
stress O O
and O O
molecules O O
such O O
as O O
bacterial O O
endotoxin O O
were O O
observed O O
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
mechanical I-SPECULATION I-SPECULATION
ventilation I-SPECULATION I-SPECULATION
might B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
particularly I-SPECULATION I-SPECULATION
deleterious I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
preinjured I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
infected I-SPECULATION I-SPECULATION
lungs I-SPECULATION I-SPECULATION
. O O

Dexamethasone O O
prevented O O
IL-8 O O
and O O
tumor O O
necrosis O O
factor-alpha O O
secretion O O
in O O
ventilated O O
macrophages O O
. O O

Mechanical O O
ventilation O O
induced O O
low O O
levels O O
of O O
IL-8 O O
secretion O O
by O O
alveolar O O
type O O
II-like O O
cells O O
. O O

Other O O
lung O O
cell O O
types O O
such O O
as O O
endothelial O O
cells O O
, O O
bronchial O O
cells O O
, O O
and O O
fibroblasts O O
failed B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
produce I-NEGATION I-NEGATION
IL-8 I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
response I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
a I-NEGATION I-NEGATION
prolonged I-NEGATION I-NEGATION
cyclic I-NEGATION I-NEGATION
pressure-stretching I-NEGATION I-NEGATION
load I-NEGATION I-NEGATION
. O O

This O O
model O O
is O O
of O O
particular O O
value O O
for O O
exploring O O
physical O O
stress-induced O O
signaling O O
pathways O O
, O O
as O O
well O O
as O O
for O O
testing O O
the O O
effects O O
of O O
novel O O
ventilatory O O
strategies O O
or O O
adjunctive O O
substances O O
aimed O O
at O O
modulating O O
cell O O
activation O O
induced O O
by O O
mechanical O O
ventilation O O
. O O

Stat6 O O
inhibits O O
human O O
interleukin-4 O O
promoter O O
activity O O
in O O
T O O
cells O O
. O O

The O O
differentiation O O
of O O
naive O O
T-helper O O
( O O
Th O O
) O O
cells O O
into O O
cytokine-secreting O O
effector O O
Th O O
cells O O
requires O O
exposure O O
to O O
multiple O O
signals O O
, O O
including O O
exogenous O O
cytokines O O
. O O

Interleukin-4 O O
( O O
IL-4 O O
) O O
plays O O
a O O
major O O
role O O
in O O
this O O
process O O
by O O
promoting O O
the O O
differentiation O O
of O O
IL-4-secreting O O
Th2 O O
cells O O
. O O

In O O
Th2 O O
cells O O
, O O
IL-4 O O
gene O O
expression O O
is O O
tightly O O
controlled O O
at O O
the O O
level O O
of O O
transcription O O
by O O
the O O
coordinated O O
binding O O
of O O
multiple O O
transcription O O
factors O O
to O O
regulatory O O
elements O O
in O O
the O O
proximal O O
promoter O O
region O O
. O O

Nuclear O O
factor O O
of O O
activated O O
T O O
cell O O
( O O
NFAT O O
) O O
family O O
members O O
play O O
a O O
critical O O
role O O
in O O
regulating O O
IL-4 O O
transcription O O
and O O
interact O O
with O O
up O O
to O O
five O O
sequences O O
( O O
termed O O
P0 O O
through O O
P4 O O
) O O
in O O
the O O
IL-4 O O
promoter O O
. O O

The B-SPECULATION B-SPECULATION
molecular I-SPECULATION I-SPECULATION
mechanisms I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
IL-4 I-SPECULATION I-SPECULATION
induces I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
IL-4 I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
not I-SPECULATION I-SPECULATION
known I-SPECULATION I-SPECULATION
, O O
although O O
the O O
IL-4-activated O O
transcription O O
factor O O
signal O O
transducer O O
and O O
activator O O
of O O
transcription O O
6 O O
( O O
Stat6 O O
) O O
is O O
required O O
for O O
this O O
effect O O
. O O

We O O
report O O
here O O
that O O
Stat6 O O
interacts O O
with O O
three O O
binding O O
sites O O
in O O
the O O
human O O
IL-4 O O
promoter O O
by O O
electrophoretic O O
mobility O O
shift O O
assays O O
. O O

These O O
sites O O
overlap O O
the O O
P1 O O
, O O
P2 O O
, O O
and O O
P4 O O
NFAT O O
elements O O
. O O

To O O
investigate O O
the O O
role O O
of O O
Stat6 O O
in O O
regulating O O
IL-4 O O
transcription O O
, O O
we O O
used O O
Stat6-deficient O O
Jurkat O O
T O O
cells O O
with O O
different O O
intact O O
IL-4 O O
promoter O O
constructs O O
in O O
cotransfection O O
assays O O
. O O

We O O
show O O
that O O
, O O
whereas O O
a O O
multimerized O O
response O O
element O O
from O O
the O O
germline O O
IgE O O
promoter O O
was O O
highly O O
induced O O
by O O
IL-4 O O
in O O
Stat6-expressing O O
Jurkat O O
cells O O
, O O
the O O
intact O O
human O O
IL-4 O O
promoter O O
was O O
repressed O O
under O O
similar O O
conditions O O
. O O

We O O
conclude O O
that O O
the O O
function O O
of O O
Stat6 O O
is O O
highly O O
dependent O O
on O O
promoter O O
context O O
and O O
that O O
this O O
factor O O
promotes O O
IL-4 O O
gene O O
expression O O
in O O
an O O
indirect O O
manner O O
. O O

Interleukin-10 O O
and O O
transforming O O
growth O O
factor-beta O O
promoter O O
polymorphisms O O
in O O
allergies O O
and O O
asthma O O
. O O

Interleukin-10 O O
( O O
IL-10 O O
) O O
and O O
transforming O O
growth O O
factor O O
beta O O
( O O
TGF-beta O O
) O O
are O O
inhibitory O O
for O O
B O O
and O O
T O O
cells O O
, O O
IgE O O
production O O
, O O
and O O
mast O O
cell O O
proliferation O O
, O O
and O O
they O O
induce O O
apoptosis O O
in O O
eosinophils O O
. O O

These O O
cytokines O O
are O O
therefore O O
candidate O O
genes O O
which O O
could B-SPECULATION B-SPECULATION
contribute I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
development I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
asthma I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
allergies I-SPECULATION I-SPECULATION
. O O

We O O
investigated O O
the O O
hypothesis B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
polymorphic I-SPECULATION I-SPECULATION
nucleotides I-SPECULATION I-SPECULATION
within I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
IL-10 I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
TGF-beta I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
promoters I-SPECULATION I-SPECULATION
would B-SPECULATION B-SPECULATION
link I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
allergies I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
asthma I-SPECULATION I-SPECULATION
. O O

DNA O O
taken O O
from O O
families O O
with O O
an O O
asthmatic O O
proband O O
was O O
examined O O
for O O
base O O
exchanges O O
by O O
single-stranded O O
conformational O O
polymorphism O O
( O O
SSCP O O
) O O
. O O

We O O
demonstrated O O
the O O
presence O O
of O O
a O O
polymorphism O O
in O O
the O O
promoter O O
region O O
of O O
the O O
IL-10 O O
gene O O
and O O
four O O
in O O
the O O
TGF-beta O O
gene O O
promoters O O
( O O
3 O O
in O O
TGF-beta1 O O
and O O
1 O O
in O O
TGF-beta2 O O
) O O
. O O

The O O
IL-10 O O
gene O O
polymorphism O O
was O O
a O O
C-to-A O O
exchange O O
571 O O
base O O
pairs O O
upstream O O
from O O
the O O
translation O O
start O O
site O O
and O O
was O O
present O O
between O O
consensus O O
binding O O
sequences O O
for O O
Sp1 O O
and O O
elevated O O
total O O
serum O O
. O O

This O O
polymorphism O O
was O O
associated O O
with O O
elevated O O
total O O
serum O O
IgE O O
in O O
subjects O O
heterozygotic O O
or O O
homozygotic O O
for O O
this O O
base O O
exchange O O
( O O
p O O
< O O
0.009 O O
) O O
. O O

The O O
base O O
exchange O O
at O O
- O O
509 O O
( O O
from O O
the O O
transcription O O
initiation O O
site O O
) O O
in O O
the O O
TGF-beta O O
promoter O O
also O O
linked O O
to O O
elevated O O
total O O
IgE O O
( O O
p O O
< O O
0.01 O O
) O O
. O O

This O O
polymorphism O O
represented O O
a O O
C-to-T O O
base O O
exchange O O
which O O
induced O O
a O O
YY1 O O
consensus O O
sequence O O
and O O
is O O
present O O
in O O
a O O
region O O
of O O
the O O
promoter O O
associated O O
with O O
negative O O
transcription O O
regulation O O
. O O

The O O
involvement O O
of O O
multiple O O
tumor O O
necrosis O O
factor O O
receptor O O
( O O
TNFR O O
)- O O
associated O O
factors O O
in O O
the O O
signaling O O
mechanisms O O
of O O
receptor O O
activator O O
of O O
NF-kappaB O O
, O O
a O O
member O O
of O O
the O O
TNFR O O
superfamily O O
. O O

Receptor O O
activator O O
of O O
NF-kappaB O O
( O O
RANK O O
) O O
is O O
a O O
recently O O
identified O O
member O O
of O O
the O O
tumor O O
necrosis O O
factor O O
receptor O O
superfamily O O
and O O
is O O
expressed O O
on O O
activated O O
T O O
cells O O
and O O
dendritic O O
cells O O
. O O

Its O O
cognate O O
ligand O O
( O O
RANKL O O
) O O
plays O O
significant O O
roles O O
in O O
the O O
activation O O
of O O
dendritic O O
cell O O
function O O
and O O
osteoclast O O
differentiation O O
. O O

We O O
demonstrate O O
here O O
the O O
interaction O O
of O O
RANK O O
with O O
tumor O O
necrosis O O
factor O O
receptor-associated O O
factors O O
( O O
TRAFs O O
) O O
1 O O
, O O
2 O O
, O O
3 O O
, O O
5 O O
, O O
and O O
6 O O
both O O
in O O
vitro O O
and O O
in O O
cells O O
. O O

Mapping O O
of O O
the O O
structural O O
requirements O O
for O O
TRAF O O
/ O O
RANK O O
interaction O O
revealed O O
multiple O O
TRAF O O
binding O O
sites O O
clustered O O
in O O
two O O
distinct O O
domains O O
in O O
the O O
RANK O O
cytoplasmic O O
tail O O
. O O

These O O
TRAF O O
binding O O
domains O O
were O O
shown O O
to O O
be O O
functionally O O
important O O
for O O
the O O
RANK-dependent O O
induction O O
of O O
NF-kappaB O O
and O O
c-Jun O O
NH2-terminal O O
kinase O O
activities O O
. O O

Site-directed O O
mutagenesis O O
demonstrated O O
that O O
these O O
TRAF O O
binding O O
sites O O
exhibited O O
selective O O
binding O O
for O O
different O O
TRAF O O
proteins O O
. O O

In O O
particular O O
, O O
TRAF6 O O
interacted O O
with O O
membrane-proximal O O
determinants O O
distinct O O
from O O
those O O
binding O O
TRAFs O O
1 O O
, O O
2 O O
, O O
3 O O
, O O
and O O
5 O O
. O O

When O O
this O O
membrane-proximal O O
TRAF6 O O
interaction O O
domain O O
was O O
deleted O O
, O O
RANK-mediated O O
NF-kappaB O O
signaling O O
was O O
completely O O
inhibited O O
while O O
c-Jun O O
NH2-terminal O O
kinase O O
activation O O
was O O
partially O O
inhibited O O
. O O

An O O
NH2-terminal O O
truncation O O
mutant O O
of O O
TRAF6 O O
inhibited O O
RANKL-mediated O O
NF-kappaB O O
activation O O
, O O
but O O
failed B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
affect I-NEGATION I-NEGATION
constitutive I-NEGATION I-NEGATION
signaling I-NEGATION I-NEGATION
induced I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
receptor I-NEGATION I-NEGATION
overexpression I-NEGATION I-NEGATION
, O O
revealing O O
a O O
selective O O
role O O
for O O
TRAF6 O O
in O O
ligand-induced O O
activation O O
events O O
. O O

The O O
control O O
of O O
lytic O O
replication O O
of O O
Epstein-Barr O O
virus O O
in O O
B O O
lymphocytes O O
( O O
Review O O
) O O
. O O

Uncontrolled O O
replication O O
of O O
a O O
virus O O
, O O
which O O
is O O
harmful O O
to O O
the O O
host O O
is O O
also O O
disadvantageous O O
to O O
the O O
virus O O
. O O

Most O O
viruses O O
cannot B-NEGATION B-NEGATION
compete I-NEGATION I-NEGATION
with I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
various I-NEGATION I-NEGATION
immune I-NEGATION I-NEGATION
mechanisms I-NEGATION I-NEGATION
and O O
become O O
eliminated O O
in O O
the O O
course O O
of O O
infection O O
. O O

Therefore O O
, O O
only O O
the O O
time O O
between O O
infection O O
and O O
eradication O O
remains O O
for O O
these O O
viruses O O
to O O
proliferate O O
. O O

A O O
few O O
viruses O O
, O O
like O O
the O O
Herpesviruses O O
or O O
the O O
papillomaviruses O O
, O O
however O O
, O O
have O O
developed O O
a O O
sophisticated O O
strategy O O
for O O
persisting O O
lifelong O O
, O O
usually O O
asymptomatically O O
in O O
the O O
host O O
, O O
hiding O O
from O O
the O O
immune O O
system O O
and O O
producing O O
infectious O O
progeny O O
at O O
the O O
same O O
time O O
. O O

This O O
strategy O O
depends O O
on O O
a O O
separation O O
of O O
latency O O
and O O
the O O
lytic O O
replication O O
, O O
either O O
by O O
time O O
due O O
to O O
differentiation-dependent O O
mechanisms O O
or O O
by O O
spatial O O
separation O O
as O O
the O O
result O O
of O O
different O O
host O O
cell O O
types O O
. O O

Both O O
are O O
true O O
for O O
the O O
Epstein-Barr O O
virus O O
( O O
EBV O O
) O O
. O O

B O O
cells O O
and O O
epithelial O O
cells O O
have O O
a O O
pivotal O O
role O O
in O O
the O O
life O O
cycle O O
of O O
the O O
virus O O
. O O

The O O
former O O
can O O
become O O
latently O O
infected O O
and O O
are B-SPECULATION B-SPECULATION
thought I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
virus I-SPECULATION I-SPECULATION
reservoir I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
vivo I-SPECULATION I-SPECULATION
, O O
whereas O O
the O O
latter O O
were O O
shown O O
to O O
be O O
permissive O O
for O O
lytic O O
replication O O
. O O

However O O
, O O
replication O O
of O O
EBV O O
in O O
vivo O O
is O O
controlled O O
primarily O O
by O O
host O O
immune O O
mechanisms O O
selecting O O
for O O
cells O O
that O O
are O O
not B-NEGATION B-NEGATION
permissive I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
viral I-NEGATION I-NEGATION
replication I-NEGATION I-NEGATION
as O I-NEGATION
the O I-NEGATION
result O I-NEGATION
of O I-NEGATION
a O I-NEGATION
particular O I-NEGATION
set O I-NEGATION
of O I-NEGATION
transcription O I-NEGATION
factors O I-NEGATION
. O O

These O O
factors O O
control O O
the O O
activity O O
of O O
the O O
regulatory O O
immediate-early O O
genes O O
and O O
, O O
in O O
addition O O
, O O
lytic O O
and O O
latent O O
cycle O O
regulatory O O
genes O O
negatively O O
interfere O O
with O O
each O O
other O O
and O O
thus O O
link O O
cellular O O
and O O
viral O O
gene O O
regulatory O O
mechanisms O O
. O O

Disturbance O O
of O O
both O O
the O O
immune O O
surveillance O O
as O O
well O O
as O O
viral O O
gene O O
regulation O O
may B-SPECULATION B-SPECULATION
result I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
EBV-associated I-SPECULATION I-SPECULATION
disease I-SPECULATION I-SPECULATION
. O O

Human O O
immunodeficiency O O
virus O O
type-1 O O
transcription O O
: O O
role O O
of O O
the O O
5 O O
'- O O
untranslated O O
leader O O
region O O
( O O
review O O
) O O
. O O

Human O O
immunodeficiency O O
virus O O
type-1 O O
( O O
HIV-1 O O
) O O
transcription O O
is O O
dependent O O
on O O
the O O
interaction O O
of O O
host-cell O O
transcription O O
factors O O
with O O
cis-regulatory O O
DNA O O
elements O O
within O O
the O O
viral O O
long O O
terminal O O
repeat O O
( O O
LTR O O
) O O
. O O

Much O O
attention O O
has O O
focused O O
on O O
the O O
series O O
of O O
sequence O O
elements O O
upstream O O
of O O
the O O
transcriptional O O
initiation O O
site O O
in O O
the O O
U3 O O
region O O
of O O
the O O
LTR O O
including O O
the O O
Sp1 O O
and O O
NF-kappaB O O
binding O O
sites O O
. O O

Recent O O
studies O O
, O O
however O O
, O O
demonstrate O O
that O O
the O O
transcribed O O
5 O O
'- O O
untranslated O O
leader O O
region O O
( O O
5 O O
'- O O
UTR O O
) O O
also O O
contains O O
important O O
transcriptional O O
elements O O
. O O

These O O
regulatory O O
elements O O
situated O O
downstream O O
of O O
transcription O O
interact O O
with O O
constitutive O O
and O O
inducible O O
transcription O O
factors O O
, O O
mediate O O
transmission O O
of O O
cellular O O
activation O O
signals O O
, O O
and O O
are O O
important O O
for O O
efficient O O
HIV-1 O O
transcription O O
and O O
replication O O
. O O

The O O
5 O O
'- O O
UTR O O
contains O O
binding O O
sites O O
for O O
the O O
transcription O O
factors O O
AP-1 O O
, O O
NF-kappaB O O
, O O
NF-AT O O
, O O
IRF O O
, O O
and O O
Sp1 O O
. O O

Mutations O O
in O O
these O O
binding O O
sites O O
can O O
interfere O O
with O O
the O O
viral O O
response O O
to O O
cell O O
activation O O
signals O O
, O O
decrease O O
LTR O O
transcription O O
, O O
and O O
inhibit O O
viral O O
replication O O
. O O

The O O
5 O O
'- O O
UTR O O
also O O
interacts O O
with O O
a O O
specific O O
nucleosome O O
that O O
is O O
rapidly O O
displaced O O
during O O
transcriptional O O
activation O O
of O O
the O O
latent O O
provirus O O
. O O

We O O
propose B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
inducible I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
binding I-SPECULATION I-SPECULATION
sites I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
5 I-SPECULATION I-SPECULATION
'- I-SPECULATION I-SPECULATION
UTR I-SPECULATION I-SPECULATION
comprise I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
downstream I-SPECULATION I-SPECULATION
enhancer I-SPECULATION I-SPECULATION
domain I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
function I-SPECULATION I-SPECULATION
independent B-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
concert I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
, O I-SPECULATION
the O I-SPECULATION
LTR O I-SPECULATION
promoter O I-SPECULATION
to O I-SPECULATION
rapidly O I-SPECULATION
increase O I-SPECULATION
latent O I-SPECULATION
proviral O I-SPECULATION
transcription O I-SPECULATION
in O I-SPECULATION
response O I-SPECULATION
to O I-SPECULATION
cell O I-SPECULATION
activation O I-SPECULATION
signals O I-SPECULATION
. O O

In O O
this O O
review O O
, O O
we O O
describe O O
the O O
host-cell O O
transcription O O
factors O O
that O O
interact O O
with O O
the O O
5 O O
'- O O
UTR O O
and O O
discuss O O
their O O
role O O
in O O
the O O
transcriptional O O
regulation O O
of O O
HIV-1 O O
gene O O
expression O O
. O O

Molecular O O
cloning O O
of O O
FKHRL1P2 O O
, O O
a O O
member O O
of O O
the O O
developmentally O O
regulated O O
fork O O
head O O
domain O O
transcription O O
factor O O
family O O
. O O

Here O O
we O O
report O O
the O O
expression O O
of O O
a O O
fork O O
head O O
domain O O
protein O O
in O O
human O O
T O O
helper O O
cells O O
. O O

We O O
cloned O O
and O O
characterized O O
a O O
fork O O
head O O
cDNA O O
from O O
human O O
T O O
helper O O
cell O O
mRNA O O
using O O
differential O O
display O O
RT-PCR O O
. O O

The O O
cDNA O O
contains O O
a O O
546-nucleotide O O
( O O
nt O O
) O O
open O O
reading O O
frame O O
( O O
ORF O O
) O O
that O O
codes O O
for O O
the O O
carboxyl-terminal O O
180 O O
amino O O
acids O O
( O O
aa O O
) O O
of O O
the O O
recently O O
identified O O
fkhrl1 O O
gene O O
. O O

This O O
ORF O O
does O O
not B-NEGATION B-NEGATION
contain I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
characteristic I-NEGATION I-NEGATION
DNA-binding I-NEGATION I-NEGATION
domain I-NEGATION I-NEGATION
found I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
members I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
forkhead I-NEGATION I-NEGATION
protein I-NEGATION I-NEGATION
family I-NEGATION I-NEGATION
. O O

In-vitro O O
transcription O O
/ O O
translation O O
of O O
this O O
cDNA O O
expressed O O
a O O
protein O O
of O O
approximately O O
20 O O
kDa O O
. O O

We O O
have O O
generated O O
antibodies O O
that O O
specifically O O
immunoprecipitated O O
the O O
in-vitro-translated O O
20-kDa O O
protein O O
. O O

This O O
antibody O O
also O O
recognizes O O
in O O
human O O
T O O
lymphocytes O O
a O O
70-kDa O O
protein O O
corresponding O O
in O O
size O O
to O O
that O O
predicted O O
for O O
the O O
fkhrl1 O O
gene O O
product O O
. O O

The O O
mRNA O O
levels O O
for O O
fkhrl1 O O
is O O
elevated O O
in O O
T O O
helper-induced O O
lymphocytes O O
in O O
comparison O O
to O O
PHA-stimulated O O
T O O
lymphocytes O O
. O O

Further O O
characterization O O
of O O
FKHRL1 O O
and O O
its O O
related O O
family O O
members O O
should B-SPECULATION B-SPECULATION
shed I-SPECULATION I-SPECULATION
light I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
transcriptional I-SPECULATION I-SPECULATION
mechanisms I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
fork I-SPECULATION I-SPECULATION
head I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
subfamily I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
their I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
helper I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
differentiation I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
regulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
growth I-SPECULATION I-SPECULATION
. O O

Activation O O
of O O
the O O
human O O
delta-globin O O
gene O O
promoter O O
in O O
primary O O
adult O O
erythroid O O
cells O O
. O O

Restoration O O
of O O
the O O
CCAAT O O
box O O
or O O
insertion O O
of O O
an O O
erythroid O O
Kruppel-like O O
factor O O
( O O
EKLF O O
) O O
binding O O
site O O
in O O
the O O
delta O O
promoter O O
activates O O
its O O
expression O O
in O O
several O O
erythroid O O
cell O O
lines O O
. O O

We O O
extended O O
these O O
studies O O
using O O
a O O
novel O O
primary O O
human O O
adult O O
erythroid O O
cell O O
( O O
hAEC O O
) O O
system O O
to O O
investigate O O
these O O
effects O O
at O O
the O O
late O O
erythroblast O O
stage O O
. O O

Restoration O O
of O O
the O O
CCAAT O O
box O O
at O O
- O O
70 O O
bp O O
, O O
or O O
insertion O O
of O O
an O O
EKLF O O
binding O O
site O O
at O O
- O O
85 O O
bp O O
or O O
- O O
95 O O
bp O O
in O O
the O O
promoter O O
significantly O O
increased O O
delta O O
globin O O
gene O O
expression O O
in O O
hAEC O O
. O O

Our O O
results O O
demonstrate O O
that O O
the O O
altered O O
CCAAT O O
box O O
( O O
CCAAC O O
) O O
and O O
the O O
lack B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
an I-NEGATION I-NEGATION
EKLF I-NEGATION I-NEGATION
binding I-NEGATION I-NEGATION
site I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
delta-globin I-NEGATION I-NEGATION
contribute O O
to O O
its O O
low O O
level O O
of O O
expression O O
in O O
the O O
hAEC O O
model O O
as O O
well O O
. O O

Interactions O O
between O O
the O O
class O O
II O O
transactivator O O
and O O
CREB O O
binding O O
protein O O
increase O O
transcription O O
of O O
major O O
histocompatibility O O
complex O O
class O O
II O O
genes O O
. O O

Class O O
II O O
major O O
histocompatibility O O
( O O
class O O
II O O
) O O
genes O O
are O O
regulated O O
in O O
a O O
B-cell-specific O O
and O O
gamma O O
interferon-inducible O O
fashion O O
. O O

The O O
master O O
switch O O
for O O
the O O
expression O O
of O O
these O O
genes O O
is O O
the O O
class O O
II O O
transactivator O O
( O O
CIITA O O
) O O
. O O

In O O
this O O
report O O
, O O
we O O
demonstrate O O
that O O
one O O
of O O
the O O
functions O O
of O O
CIITA O O
is O O
to O O
recruit O O
the O O
CREB O O
binding O O
protein O O
( O O
CBP O O
) O O
to O O
class O O
II O O
promoters O O
. O O

Not O O
only O O
functional O O
but O O
also O O
specific O O
binding O O
interactions O O
between O O
CIITA O O
and O O
CBP O O
were O O
demonstrated O O
. O O

Moreover O O
, O O
a O O
dominant O O
negative O O
form O O
of O O
CBP O O
decreased O O
the O O
activity O O
of O O
class O O
II O O
promoters O O
and O O
levels O O
of O O
class O O
II O O
determinants O O
on O O
the O O
surface O O
of O O
cells O O
. O O

Finally O O
, O O
the O B-SPECULATION
inhibition O I-SPECULATION
of O I-SPECULATION
class O I-SPECULATION
II O I-SPECULATION
gene O I-SPECULATION
expression O I-SPECULATION
by O I-SPECULATION
the O I-SPECULATION
glucocorticoid O I-SPECULATION
hormone O I-SPECULATION
could O I-SPECULATION
be O I-SPECULATION
attributed O I-SPECULATION
to O I-SPECULATION
the O I-SPECULATION
squelching O I-SPECULATION
of O I-SPECULATION
CBP O I-SPECULATION
by O I-SPECULATION
the O I-SPECULATION
glucocorticoid O I-SPECULATION
receptor O I-SPECULATION
. O O

We O O
conclude O O
that O O
CBP O O
, O O
a O O
histone O O
acetyltransferase O O
, O O
plays O O
an O O
important O O
role O O
in O O
the O O
transcription O O
of O O
class O O
II O O
genes O O
. O O

Nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
and O O
AP-1 O O
are O O
insufficient O O
for O O
IL-2 O O
promoter O O
activation O O
: O O
requirement O O
for O O
CD28 O O
up-regulation O O
of O O
RE O O
/ O O
AP O O
. O O

IL-2 O O
gene O O
transcription O O
in O O
T O O
cells O O
requires O O
both O O
TCR O O
and O O
costimulatory O O
signals O O
. O O

IL-2 O O
promoter O O
activation O O
in O O
Jurkat O O
T O O
cells O O
stimulated O O
with O O
superantigen O O
presented O O
by O O
Raji O O
B O O
cells O O
requires O O
CD28 O O
activation O O
. O O

The O O
addition O O
of O O
rCTLA4Ig O O
, O O
which O O
blocks O O
CD28 O O
binding O O
to O O
its O O
ligand O O
, O O
to O O
the O O
cultures O O
decreased O O
IL-2 O O
promoter O O
activation O O
by O O
> O O
80 O O
% O O
. O O

Interestingly O O
, O O
CTLA4Ig O O
did O O
not O O
significantly O O
inhibit O O
the O O
activation O O
of O O
either O O
NF O O
of O O
activated O O
T O O
cells O O
( O O
NFAT O O
) O O
or O O
AP-1 O O
reporters O O
. O O

Therefore O O
, O O
activation O O
of O O
NFAT O O
and O O
AP-1 O O
is O O
insufficient O O
for O O
IL-2 O O
promoter O O
activation O O
. O O

In O O
contrast O O
, O O
an O O
RE O O
/ O O
AP O O
reporter O O
was O O
blocked O O
by O O
CTLA4Ig O O
by O O
> O O
90 O O
% O O
. O O

Thus O O
, O O
the B-SPECULATION B-SPECULATION
requirement I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
CD28 I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
IL-2 I-SPECULATION I-SPECULATION
promoter I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
appears I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
due I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
RE I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
AP I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
not B-NEGATION B-NEGATION
the I-NEGATION I-NEGATION
NFAT I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
AP-1 I-NEGATION I-NEGATION
sites I-NEGATION I-NEGATION
. O O

In O O
addition O O
, O O
these O O
data O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
transcriptional B-NEGATION B-NEGATION
activation I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
RE I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
AP I-NEGATION I-NEGATION
is I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
mediated I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
NFAT I-NEGATION I-NEGATION
, O O
because O O
activation B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
a I-NEGATION I-NEGATION
NFAT I-NEGATION I-NEGATION
reporter I-NEGATION I-NEGATION
is I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
affected I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
addition I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
CTLA4Ig I-NEGATION I-NEGATION
. O O

Phenylarsine O O
oxide O O
inhibits O O
ex O O
vivo O O
HIV-1 O O
expression O O
. O O

Phenylarsine O O
oxide O O
( O O
PAO O O
) O O
, O O
which O O
is O O
described O O
as O O
an O O
inhibitor O O
of O O
tyrosine O O
phosphatase O O
activity O O
, O O
inhibits O O
H2O2 O O
release O O
from O O
human O O
peripheral O O
blood O O
mononuclear O O
cells O O
( O O
PBMCs O O
) O O
as O O
measured O O
by O O
electrochemistry O O
. O O

Since O O
human O O
immunodeficiency O O
virus O O
type O O
1 O O
( O O
HIV-1 O O
) O O
replication O O
is O O
known O O
to O O
be O O
favored O O
under O O
oxidative O O
stress O O
conditions O O
, O O
ex O O
vivo O O
experiments O O
using O O
uninfected O O
PBMCs O O
, O O
primary O O
monocytes O O
or O O
a O O
latently O O
infected O O
promonocytic O O
U1 O O
cell O O
line O O
show O O
that O O
HIV-1 O O
replication O O
and O O
reactivation O O
, O O
monitored O O
by O O
p24 O O
antigen O O
measurement O O
, O O
are O O
inhibited O O
by O O
PAO O O
in O O
a O O
time O O
- O O
and O O
concentration-dependent O O
manner O O
. O O

These O O
observations O O
can O O
be O O
linked O O
with O O
the O O
inhibition O O
of O O
NF-kappa O O
B O O
activation O O
when O O
uninfected O O
monocytes O O
are O O
induced O O
by O O
either O O
tumor O O
necrosis O O
factor O O
alpha O O
( O O
TNF-alpha O O
) O O
phorbol O O
12-myristate O O
13-acetate O O
( O O
PMA O O
) O O
or O O
lipopolysaccharide O O
( O O
LPS O O
) O O
. O O

Interleukin-10 O O
stabilizes O O
inhibitory O O
kappaB-alpha O O
in O O
human O O
monocytes O O
. O O

Interleukin-10 O O
( O O
IL-10 O O
) O O
protects O O
animals O O
from O O
lethal O O
endotoxemia O O
. O O

This O O
beneficial O O
effect O O
is O O
mediated O O
, O O
in O O
part O O
, O O
by O O
inhibition O O
of O O
inflammatory O O
cytokine O O
production O O
, O O
including O O
tumor O O
necrosis O O
factor-alpha O O
( O O
TNF-alpha O O
) O O
. O O

Evidence O O
suggests B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
IL-10 I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
inhibit I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
nuclear I-SPECULATION I-SPECULATION
factor-kappaB I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
through I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
unknown B-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
. O O

NF-kappaB O O
activation O O
in O O
response O O
to O O
inflammatory O O
signals O O
is O O
dependent O O
upon O O
degradation O O
of O O
its O O
associated O O
inhibitory O O
peptide O O
, O O
inhibitory O O
kappaB-alpha O O
( O O
IkappaB-alpha O O
) O O
. O O

We O O
hypothesized B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
IL-10 I-SPECULATION I-SPECULATION
prevents I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
monocyte I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
resultant I-SPECULATION I-SPECULATION
TNF-alpha I-SPECULATION I-SPECULATION
production I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
stabilization I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
IkappaB-alpha I-SPECULATION I-SPECULATION
. O O

The O O
purpose O O
of O O
this O O
study O O
was O O
to O O
determine O O
the O O
effect O O
of O O
IL-10 O O
on O O
lipopolysaccharide O O
( O O
LPS O O
)- O O
induced O O
human O O
monocyte O O
TNF-alpha O O
production O O
, O O
NF-kappaB O O
activation O O
, O O
and O O
IkappaB-alpha O O
degradation O O
. O O

Monocytes O O
were O O
isolated O O
from O O
human O O
donors O O
. O O

Cells O O
were O O
stimulated O O
with O O
endotoxin O O
( O O
LPS O O
, O O
100 O O
ng O O
/ O O
mL O O
) O O
with O O
and O O
without B-NEGATION B-NEGATION
human I-NEGATION I-NEGATION
IL-10 I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
10 I-NEGATION I-NEGATION
ng I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
mL I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
. O O

Following O O
stimulation O O
, O O
TNF-alpha O O
was O O
measured O O
in O O
cell O O
supernatants O O
by O O
ELISA O O
, O O
NF-kappaB O O
activity O O
by O O
electrophoretic O O
mobility O O
shift O O
assay O O
, O O
and O O
IkappaB-alpha O O
levels O O
by O O
Western O O
blot O O
. O O

We O O
observed O O
that O O
after O O
LPS O O
stimulation O O
of O O
human O O
monocytes O O
, O O
TNF-alpha O O
increased O O
to O O
798 O O
+/- O O
67 O O
pg O O
/ O O
mL O O
( O O
p O O
< O O
. O O
001 O O
versus O O
control O O
) O O
. O O

IL-10 O O
attenuated O O
LPS-stimulated O O
TNF-alpha O O
production O O
( O O
297 O O
+/- O O
54 O O
; O O
p O O
< O O
. O O
001 O O
versus O O
LPS O O
alone O O
) O O
. O O

After O O
LPS O O
stimulation O O
in O O
human O O
monocytes O O
, O O
IkappaB-alpha O O
protein O O
levels O O
decreased O O
, O O
and O O
NF-kappaB O O
DNA O O
binding O O
increased O O
. O O

IL-10 O O
pretreatment O O
prevented O O
LPS-induced O O
decreases O O
in O O
IkappaB-alpha O O
protein O O
levels O O
and O O
attenuated O O
NF-kappaB O O
DNA O O
binding O O
. O O

IL-10 B-SPECULATION B-SPECULATION
appears I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
prevent I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
preserving I-SPECULATION I-SPECULATION
IkappaB-alpha I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
levels I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
leading I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
reduction I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
TNF-alpha I-SPECULATION I-SPECULATION
release I-SPECULATION I-SPECULATION
. O O

Regulation O O
of O O
fas-ligand O O
expression O O
during O O
activation-induced O O
cell O O
death O O
in O O
T O O
lymphocytes O O
via O O
nuclear O O
factor O O
kappaB O O
. O O

T O O
cell O O
receptor O O
engagement O O
activates O O
transcription O O
factors O O
important O O
for O O
cytokine O O
gene O O
regulation O O
. O O

Additionally O O
, O O
this O O
signaling O O
pathway O O
also O O
leads O O
to O O
activation-induced O O
apoptosis O O
in O O
T O O
lymphocytes O O
that O O
is O O
dependent O O
on O O
FasL O O
transcription O O
and O O
expression O O
. O O

Here O O
we O O
demonstrate O O
that O O
nuclear O O
factor O O
kappaB O O
( O O
NF-kappaB O O
) O O
, O O
which O O
is O O
involved O O
in O O
the O O
transcriptional O O
regulation O O
of O O
many O O
cytokine O O
genes O O
expressed O O
in O O
activated O O
lymphocytes O O
, O O
also O O
plays O O
a O O
role O O
in O O
T O O
cell O O
activation-induced O O
FasL O O
expression O O
. O O

Inhibition O O
of O O
NF-kappaB O O
activity O O
in O O
a O O
T O O
cell O O
hybridoma O O
leads O O
to O O
decreased O O
FasL O O
expression O O
and O O
apoptosis O O
upon O O
T O O
cell O O
receptor O O
stimulation O O
. O O

We O O
identified O O
the O O
NF-kappaB O O
site O O
in O O
the O O
FasL O O
promoter O O
that O O
contributes O O
to O O
such O O
regulation O O
. O O

Co-expression O O
of O O
p65 O O
( O O
Rel O O
A O O
) O O
with O O
the O O
FasL O O
promoter O O
enhanced O O
its O O
activity O O
, O O
and O O
co-expression O O
of O O
IkappaB O O
dramatically O O
inhibited O O
the O O
inducible O O
promoter O O
activity O O
. O O

In O O
contrast O O
, O O
the B-NEGATION B-NEGATION
transcription I-NEGATION I-NEGATION
factor I-NEGATION I-NEGATION
AP-1 I-NEGATION I-NEGATION
is I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
required I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
activation-induced I-NEGATION I-NEGATION
FasL I-NEGATION I-NEGATION
promoter I-NEGATION I-NEGATION
activity I-NEGATION I-NEGATION
. O O

These O O
results O O
define O O
a O O
role O O
for O O
NF-kappaB O O
in O O
mediating O O
FasL O O
expression O O
during O O
T O O
cell O O
activation O O
. O O

X-rays-induced O O
secretion O O
of O O
cellular O O
factor O O
( O O
s O O
) O O
that O O
enhance O O
( O O
s O O
) O O
HIV-1 O O
promoter O O
transcription O O
in O O
various O O
non-irradiated O O
transfected O O
cell O O
lines O O
. O O

Various O O
cellular O O
stress O O
agents O O
like O O
ionizing O O
radiation O O
exposure O O
could O O
activate O O
human O O
immunodeficiency O O
virus O O
type O O
1 O O
( O O
HIV O O
- O O
1 O O
) O O
replication O O
or O O
reporter O O
gene O O
expression O O
. O O

In O O
addition O O
, O O
extracellular O O
factor O O
( O O
s O O
) O O
released O O
by O O
X-ray-treated O O
human O O
colonic O O
carcinoma O O
cell O O
line O O
( O O
HT29 O O
) O O
might B-SPECULATION B-SPECULATION
activate I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
long I-SPECULATION I-SPECULATION
terminal I-SPECULATION I-SPECULATION
repeat I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
LTR I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
HIV-1 I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
non-irradiated I-SPECULATION I-SPECULATION
HT29 I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

In O O
the O O
present O O
report O O
we O O
show O O
that O O
in O O
various O O
transiently O O
or O O
stably O O
transfected O O
cell O O
lines O O
, O O
X-ray O O
irradiation O O
up-regulates O O
HIV-1 O O
LTR O O
transcription O O
through O O
the O O
kappaB O O
regulatory O O
elements O O
. O O

A O O
factor O O
( O O
s O O
) O O
, O O
which O O
is O O
processed O O
by O O
and O O
acts O O
upon O O
a O O
variety O O
of O O
cell O O
types O O
, O O
was O O
detected O O
by O O
addition O O
to O O
non-irradiated O O
cells O O
of O O
either O O
X-ray-treated O O
cells O O
or O O
a O O
conditioned O O
medium O O
taken O O
from O O
irradiated O O
cultures O O
. O O

The O O
magnitude O O
of O O
responsiveness O O
is O O
cell O O
type O O
dependent O O
. O O

In O O
addition O O
, O O
X-ray O O
activation O O
of O O
HIV-1 O O
LTR O O
in O O
transiently O O
or O O
stably O O
transfected O O
cell O O
lines O O
is O O
inhibited O O
by O O
a O O
potent O O
antioxidant O O
drug O O
, O O
pyrrolidine O O
dithiocarbamate O O
and O O
by O O
another O O
drug O O
, O O
known O O
for O O
its O O
role O O
in O O
the O O
trapping O O
of O O
growth O O
factors O O
, O O
suramin O O
. O O

The O O
importance O O
of O O
these O O
observations O O
in O O
the O O
pathophysiology O O
of O O
patients O O
with O O
AIDS-related O O
cancers O O
treated O O
by O O
radiotherapy O O
remains O O
to O O
be O O
established O O
. O O

Reactivation O O
of O O
Kaposi's O O
sarcoma-associated O O
herpesvirus O O
infection O O
from O O
latency O O
by O O
expression O O
of O O
the O O
ORF O O
50 O O
transactivator O O
, O O
a O O
homolog O O
of O O
the O O
EBV O O
R O O
protein O O
. O O

Kaposi's O O
sarcoma O O
( O O
KS O O
)- O O
associated O O
herpesvirus O O
( O O
KSHV O O
) O O
, O O
or O O
human O O
herpesvirus O O
8 O O
, O O
is O O
a O O
lymphotropic O O
virus O O
strongly O O
linked O O
to O O
several O O
AIDS-related O O
neoplasms O O
. O O

The O O
primary O O
reservoir O O
of O O
infection O O
consists O O
of O O
latently O O
infected O O
B O O
lymphocytes O O
and O O
possibly B-SPECULATION B-SPECULATION
other I-SPECULATION I-SPECULATION
mononuclear I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

Viral B-SPECULATION O
reactivation I-SPECULATION O
from I-SPECULATION O
latency I-SPECULATION O
and I-SPECULATION O
spread I-SPECULATION O
from I-SPECULATION O
this I-SPECULATION O
lymphoid I-SPECULATION O
reservoir I-SPECULATION O
is I-SPECULATION O
presumably I-SPECULATION B-SPECULATION
required I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
development I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
nonlymphoid I-SPECULATION I-SPECULATION
tumors I-SPECULATION I-SPECULATION
like I-SPECULATION I-SPECULATION
KS I-SPECULATION I-SPECULATION
. O O

Here O O
we O O
show O O
that O O
deregulated O O
expression O O
of O O
a O O
single O O
viral O O
gene O O
, O O
ORF O O
50 O O
, O O
which O O
encodes O O
a O O
transactivator O O
able O O
to O O
selectively O O
upregulate O O
delayed-early O O
viral O O
genes O O
, O O
suffices O O
to O O
disrupt O O
latency O O
and O O
induce O O
the O O
lytic O O
gene O O
cascade O O
in O O
latently O O
infected O O
B O O
cells O O
. O O

The O O
identification O O
of O O
this O O
gene O O
opens O O
the O O
way O O
to O O
studies O O
of O O
the O O
physiologic O O
mechanisms O O
controlling O O
reactvation O O
of O O
KSHV O O
from O O
latency O O
. O O

Copyright O O
1998 O O
Academic O O
Press O O
. O O

Regulation O O
of O O
interleukin-1beta O O
transcription O O
by O O
Epstein-Barr O O
virus O O
involves O O
a O O
number O O
of O O
latent O O
proteins O O
via O O
their O O
interaction O O
with O O
RBP O O
. O O

Epstein-Barr O O
virus O O
( O O
EBV O O
) O O
infects O O
B O O
cells O O
, O O
resulting O O
in O O
the O O
outgrowth O O
of O O
immortalised O O
lymphoblastoid O O
cell O O
lines O O
( O O
LCLs O O
) O O
. O O

Here O O
, O O
we O O
demonstrate O O
through O O
the O O
use O O
of O O
intracellular O O
staining O O
that O O
interleukin-1beta O O
( O O
IL-1beta O O
) O O
is O O
expressed O O
in O O
LCLs O O
and O O
investigate O O
the O O
influence O O
of O O
the O O
individual O O
latent O O
proteins O O
on O O
the O O
expression O O
of O O
IL-1beta O O
. O O

Using O O
RT-PCR O O
, O O
IL-1beta O O
was O O
shown O O
to O O
be O O
up-regulated O O
in O O
EBV-transformed O O
LCLs O O
as O O
well O O
as O O
in O O
group O O
III O O
Burkitt's O O
lymphoma O O
( O O
BL O O
) O O
cell O O
lines O O
, O O
compared O O
with O O
group O O
I O O
BL O O
cell O O
lines O O
. O O

The O O
up-regulation O O
of O O
IL-1beta O O
message O O
could O O
be O O
mediated O O
by O O
the O O
latent O O
membrane O O
protein-1 O O
, O O
EBV O O
nuclear O O
proteins O O
2 O O
, O O
3 O O
, O O
4 O O
, O O
and O O
6 O O
genes O O
. O O

Electrophoretic O O
mobility O O
shift O O
assays O O
( O O
EMSAs O O
) O O
demonstrated O O
that O O
the O O
- O O
300 O O
region O O
of O O
the O O
IL-1beta O O
promoter O O
, O O
which O O
contains O O
a O O
nuclear O O
factor-kappaB O O
( O O
NF-kappaB O O
) O O
binding O O
site O O
, O O
contained O O
a O O
functional O O
RBP O O
binding O O
site O O
. O O

Binding O O
of O O
RBP O O
to O O
this O O
site O O
could O O
be O O
inhibited O O
by O O
addition O O
of O O
EBV O O
nuclear O O
proteins O O
3 O O
and O O
6 O O
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
proteins I-SPECULATION I-SPECULATION
displace I-SPECULATION I-SPECULATION
RBP I-SPECULATION I-SPECULATION
from I-SPECULATION I-SPECULATION
its I-SPECULATION I-SPECULATION
recognition I-SPECULATION I-SPECULATION
sequence I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
removing I-SPECULATION I-SPECULATION
transcriptional I-SPECULATION I-SPECULATION
repression I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
allowing I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
occur I-SPECULATION I-SPECULATION
. O O

In O O
group O O
I O O
BL O O
cells O O
, O O
containing O O
low O O
levels O O
of O O
NF-kappaB O O
, O O
only O O
RBP O O
binding O O
was O O
observed O O
in O O
EMSAs O O
, O O
whereas O O
NF-kappaB O O
binding O O
could O O
be O O
demonstrated O O
in O O
EBV-transformed O O
B O O
cell O O
lines O O
containing O O
high O O
levels O O
of O O
activated O O
NF-kappaB O O
. O O

In O O
addition O O
, O O
the O O
expression O O
of O O
latent O O
membrane O O
protein-1 O O
led O O
to O O
activation O O
of O O
NF-kappaB O O
that O O
was O O
capable O O
of O O
binding O O
the O O
IL-1beta O O
promoter O O
. O O

The O O
study O O
demonstrates O O
that O O
EBV O O
can O O
up-regulate O O
IL-1beta O O
expression O O
, O O
possibly B-SPECULATION B-SPECULATION
by I-SPECULATION I-SPECULATION
using I-SPECULATION I-SPECULATION
RBP B-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
both I-SPECULATION I-SPECULATION
. O O

Copyright O O
1998 O O
Academic O O
Press O O
. O O

Characterization O O
of O O
the O O
human O O
elk-1 O O
promoter O O
. O O

Potential B-SPECULATION B-SPECULATION
role I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
downstream I-SPECULATION I-SPECULATION
intronic I-SPECULATION I-SPECULATION
sequence I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
elk-1 I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
monocytes I-SPECULATION I-SPECULATION
. O O

To O O
characterize O O
the O O
human O O
elk-1 O O
promoter O O
, O O
we O O
mapped O O
the O O
transcriptional O O
start O O
site O O
and O O
isolated O O
elk-1-specific O O
genomic O O
phage O O
clones O O
that O O
contained O O
extensive O O
upstream O O
and O O
downstream O O
sequences O O
. O O

A O O
TATA-like O O
motif O O
was O O
identified O O
immediately O O
upstream O O
of O O
the O O
transcriptional O O
start O O
site O O
. O O

Functional O O
analyses O O
of O O
DNA O O
fragments O O
containing O O
the O O
TATA O O
element O O
and O O
the O O
identification O O
of O O
a O O
DNase O O
I-hypersensitive O O
chromatin O O
site O O
( O O
HS O O
1 O O
) O O
in O O
close O O
proximity O O
to O O
the O O
TATA O O
box O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
identified I-SPECULATION I-SPECULATION
TATA I-SPECULATION I-SPECULATION
motif I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
elk-1 I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
vivo I-SPECULATION I-SPECULATION
. O O

Sequences O O
upstream O O
and O O
downstream O O
from O O
the O O
TATA O O
box O O
were O O
found O O
to O O
contribute O O
to O O
elk-1 O O
promoter O O
activity O O
. O O

A O O
second O O
hypersensitive O O
site O O
( O O
HS O O
2 O O
) O O
was O O
identified O O
within O O
the O O
first O O
intron O O
in O O
pre-monocytic O O
cells O O
, O O
which O O
express O O
Elk-1 O O
only O O
when O O
differentiating O O
to O O
monocytes O O
. O O

In O O
a O O
variety O O
of O O
other O O
cell O O
types O O
, O O
which O O
display O O
a O O
constitutive O O
Elk-1 O O
expression O O
, O O
HS O O
2 O O
did O O
not B-NEGATION B-NEGATION
exist I-NEGATION I-NEGATION
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
inducibility I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
elk-1 I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
associated I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
presence I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
HS I-SPECULATION I-SPECULATION
2 I-SPECULATION I-SPECULATION
. O O

Egr-1 O O
and O O
the O O
serum O O
response O O
factor O O
were O O
found O O
to O O
interact O O
specifically O O
with O O
the O O
intronic O O
sequence O O
at O O
+ O O
265 O O
and O O
+ O O
448 O O
, O O
respectively O O
. O O

Because O O
Egr-1 O O
mRNA O O
and O O
protein O O
levels O O
were O O
observed O O
to O O
increase O O
significantly O O
before O O
induction O O
of O O
elk-1 O O
expression O O
, O O
we O O
propose B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
Egr-1 I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
regulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
elk-1 I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
differentiating I-SPECULATION I-SPECULATION
monocytes I-SPECULATION I-SPECULATION
. O O

Human O O
T-cell O O
leukemia O O
virus O O
type O O
1 O O
tax O O
protein O O
abrogates O O
interleukin-2 O O
dependence O O
in O O
a O O
mouse O O
T-cell O O
line O O
. O O

Human O O
T-cell O O
leukemia O O
virus O O
type O O
1 O O
( O O
HTLV-1 O O
) O O
is O O
the O O
etiologic O O
agent O O
of O O
adult O O
T-cell O O
leukemia O O
. O O

Tax B-SPECULATION B-SPECULATION
, I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
viral I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
thought I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
crucial I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
development I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
disease I-SPECULATION I-SPECULATION
, O O
since O O
it O O
transforms O O
healthy O O
T O O
cells O O
in O O
vitro O O
and O O
induces O O
tumors O O
in O O
transgenic O O
animals O O
. O O

We O O
examined O O
the O O
effect O O
of O O
Tax O O
activity O O
on O O
the O O
growth O O
of O O
the O O
interleukin-2 O O
( O O
IL-2 O O
)- O O
dependent O O
T-cell O O
line O O
CTLL-2 O O
. O O

Stable O O
expression O O
of O O
Tax O O
in O O
CTLL-2 O O
transformed O O
cell O O
growth O O
from O O
being O O
IL-2 O O
dependent O O
to O O
IL-2 O O
independent O O
. O O

Tax O O
stimulated O O
transcription O O
through O O
NF-kappaB O O
and O O
the O O
cyclic O O
AMP-responsive O O
element-like O O
sequence O O
in O O
the O O
HTLV-1 O O
promoter O O
. O O

The O O
finding O O
of O O
Tax O O
mutants O O
segregating O O
these O O
two O O
pathways O O
suggested B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
pathway I-SPECULATION I-SPECULATION
was I-SPECULATION I-SPECULATION
essential I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
IL-2-independent I-SPECULATION I-SPECULATION
growth I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
CTLL-2 I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
while I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
CRE I-SPECULATION I-SPECULATION
pathway I-SPECULATION I-SPECULATION
was I-SPECULATION I-SPECULATION
unnecessary I-SPECULATION I-SPECULATION
. O O

However O O
, O O
both O O
pathways O O
were O O
necessary O O
for O O
another O O
transformation-related O O
activity O O
( O O
colony O O
formation O O
in O O
soft O O
agar O O
) O O
of O O
CTLL-2 O O
/ O O
Tax O O
. O O

Our O O
results O O
show O O
that O O
Tax O O
has O O
at O O
least O O
two O O
distinct O O
activities O O
on O O
T O O
cells O O
, O O
and O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
Tax I-SPECULATION I-SPECULATION
plays I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
crucial I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
IL-2-independent I-SPECULATION I-SPECULATION
T-cell I-SPECULATION I-SPECULATION
transformation I-SPECULATION I-SPECULATION
induced I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
HTLV-1 I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
addition I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
its I-SPECULATION I-SPECULATION
well-known I-SPECULATION I-SPECULATION
IL-2-dependent I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
transformation I-SPECULATION I-SPECULATION
. O O

Mildly O O
oxidized O O
low-density O O
lipoproteins O O
decrease O O
early O O
production O O
of O O
interleukin O O
2 O O
and O O
nuclear O O
factor O O
kappaB O O
binding O O
to O O
DNA O O
in O O
activated O O
T-lymphocytes O O
. O O

Activated O O
T-lymphocytes O O
are O O
found O O
early O O
in O O
atherosclerosis O O
lesions O O
, O O
but O O
little O O
is O O
known O O
about O O
their O O
role O O
. O O

Oxidized O B-SPECULATION
low-density O I-SPECULATION
lipoproteins O I-SPECULATION
( O I-SPECULATION
oxLDLs O I-SPECULATION
) O I-SPECULATION
are O I-SPECULATION
considered O I-SPECULATION
to O I-SPECULATION
be O I-SPECULATION
involved O I-SPECULATION
in O I-SPECULATION
the O I-SPECULATION
pathogenesis O I-SPECULATION
of O I-SPECULATION
the O I-SPECULATION
lesions O I-SPECULATION
, O O
and O O
we O O
have O O
previously O O
demonstrated O O
that O O
oxLDLs O O
inhibit O O
not O O
only O O
interleukin O O
( O O
IL O O
)- O O
2-receptor O O
expression O O
on O O
the O O
surface O O
of O O
in O O
vitro-activated O O
T-lymphocytes O O
but O O
also O O
their O O
proliferation O O
. O O

We O O
have O O
now O O
investigated O O
the O O
effect O O
of O O
oxLDLs O O
on O O
blast O O
differentiation O O
, O O
on O O
IL-2 O O
synthesis O O
and O O
on O O
the O O
activation O O
of O O
the O O
nuclear O O
factor O O
kappaB O O
( O O
NF-kappaB O O
) O O
system O O
in O O
activated O O
lymphocytes O O
. O O

Mildly O O
oxLDLs O O
( O O
50 O O
and O O
100 O O
microgram O O
/ O O
ml O O
) O O
decreased O O
the O O
number O O
of O O
lymphoblasts O O
and O O
the O O
level O O
of O O
IL-2 O O
concentration O O
in O O
the O O
culture O O
supernatants O O
after O O
activation O O
of O O
lymphocytes O O
by O O
phytohaemagglutinin O O
and O O
PMA O O
+ O O
ionomycin O O
. O O

The O O
inhibition O O
of O O
IL-2 O O
production O O
was O O
observed O O
in O O
the O O
CD3 O O
(+) O O
T-lymphocyte O O
cytoplasm O O
as O O
early O O
as O O
4 O O
h O O
after O O
activation O O
by O O
PMA O O
+ O O
ionomycin O O
. O O

The O O
study O O
of O O
NF-kappaB O O
showed O O
that O O
oxLDLs O O
led O O
to O O
a O O
decrease O O
of O O
activation-induced O O
p65 O O
/ O O
p50 O O
NF-kappaB O O
heterodimer O O
binding O O
to O O
DNA O O
, O O
whereas O O
the O O
presence O O
of O O
the O O
constitutive O O
nuclear O O
form O O
of O O
p50 O O
dimer O O
was O O
unchanged O O
. O O

This O O
was O O
correlated O O
with O O
an O O
unchanged O O
level O O
of O O
the O O
active O O
form O O
of O O
the O O
cytosolic O O
inhibitor O O
protein O O
IkappaB-alpha O O
. O O

Taken O O
together O O
, O O
these O O
observations O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
immunosuppressive I-SPECULATION I-SPECULATION
effect I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
oxLDLs I-SPECULATION I-SPECULATION
might B-SPECULATION B-SPECULATION
operate I-SPECULATION I-SPECULATION
via I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
dysregulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
T-lymphocyte I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
mechanisms I-SPECULATION I-SPECULATION
. O O

Binding O O
of O O
HMG-I O O
( O O
Y O O
) O O
elicits O O
structural O O
changes O O
in O O
a O O
silencer O O
of O O
the O O
human O O
beta-globin O O
gene O O
. O O

Proteins O O
involved O O
in O O
repression O O
of O O
the O O
human O O
beta-globin O O
gene O O
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
useful I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
treatment I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
sickle I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
anemia I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
conjunction I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
therapy I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
reactivate I-SPECULATION I-SPECULATION
fetal I-SPECULATION I-SPECULATION
globin I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
. O O

If O O
there O O
is O O
a O O
reciprocal O O
elevation O O
of O O
gamma-globin O O
expression O O
upon O O
repression O O
, O O
this O O
approach O O
could B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
useful I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
additional I-SPECULATION I-SPECULATION
hemoglobinopathies I-SPECULATION I-SPECULATION
. O O

We O O
previously O O
showed O O
that O O
repression B-SPECULATION B-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
beta-globin I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
appears I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
mediated I-SPECULATION I-SPECULATION
through I-SPECULATION I-SPECULATION
two I-SPECULATION I-SPECULATION
DNA I-SPECULATION I-SPECULATION
sequences I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
silencers I-SPECULATION I-SPECULATION
I I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
II I-SPECULATION I-SPECULATION
, O O
and O O
identified O O
a O O
protein O O
termed O O
BP1 O O
which O O
binds O O
to O O
both O O
silencer O O
sequences O O
. O O

In O O
this O O
study O O
, O O
we O O
cloned O O
two O O
cDNAs O O
encoding O O
proteins O O
which O O
bind O O
to O O
an O O
oligonucleotide O O
in O O
silencer O O
I O O
containing O O
a O O
BP1 O O
binding O O
site O O
. O O

These O O
cDNAs O O
correspond O O
to O O
HMG-I O O
and O O
HMG-Y O O
, O O
isoforms O O
regarded O O
as O O
architectural O O
proteins O O
. O O

We O O
demonstrate O O
that O O
binding O O
of O O
HMG-I O O
( O O
Y O O
) O O
to O O
this O O
oligonucleotide O O
causes O O
bending O O
/ O O
flexure O O
of O O
the O O
DNA O O
. O O

HMG-I O O
( O O
Y O O
) O O
also O O
binds O O
to O O
a O O
second O O
oligonucleotide O O
containing O O
a O O
BP1 O O
binding O O
site O O
located O O
in O O
a O O
negative O O
control O O
region O O
upstream O O
of O O
the O O
delta-globin O O
gene O O
, O O
suggesting B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
HMG-I I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
Y I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
repression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
adult I-SPECULATION I-SPECULATION
globin I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
. O O

Expression O O
studies O O
revealed O O
that O O
HMG-I O O
( O O
Y O O
) O O
is O O
ubiquitously O O
expressed O O
in O O
human O O
tissues O O
that O O
do O O
not B-NEGATION B-NEGATION
express I-NEGATION I-NEGATION
beta-globin I-NEGATION I-NEGATION
, O O
being O O
present O O
in O O
48 O O
of O O
50 O O
tissues O O
and O O
six O O
hematopoietic O O
cell O O
lines O O
examined O O
. O O

Furthermore O O
, O O
HMG-I O O
( O O
Y O O
) O O
expression O O
is O O
down-regulated O O
during O O
differentiation O O
of O O
primary O O
erythroid O O
cells O O
. O O

We O O
present O O
a O O
model O O
in O O
which O O
HMG-I O O
( O O
Y O O
) O O
alters O O
DNA O O
conformation O O
to O O
allow O O
binding O O
of O O
repressor O O
proteins O O
, O O
and O O
in O O
which O O
the O O
relative O O
amount O O
of O O
HMG-I O O
( O O
Y O O
) O O
helps O O
to O O
determine O O
the O O
repressive O O
state O O
of O O
the O O
beta-globin O O
gene O O
. O O

Regulation O O
of O O
IL-6 O O
synthesis O O
in O O
human O O
peripheral O O
blood O O
mononuclear O O
cells O O
by O O
C3a O O
and O O
C3a O O
( O O
desArg O O
) O O
. O O

The O O
anaphylatoxin O O
C3a O O
has O O
been O O
reported O O
to O O
have O O
immunomodulatory O O
effects O O
on O O
a O O
number O O
of O O
different O O
cell O O
types O O
. O O

In O O
this O O
study O O
we O O
investigated O O
the O O
effects O O
of O O
C3a O O
and O O
C3a O O
( O O
desArg O O
) O O
on O O
gene O O
expression O O
and O O
protein O O
secretion O O
of O O
IL-6 O O
in O O
human O O
PBMCs O O
, O O
either O O
alone O O
or O O
in O O
combination O O
with O O
LPS O O
or O O
IL-1beta O O
. O O

C3a O O
or O O
C3a O O
( O O
desArg O O
) O O
alone O O
exhibited O O
no B-NEGATION B-NEGATION
effect I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
expression I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
secretion I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
IL-6 I-NEGATION I-NEGATION
. O O

However O O
, O O
when O O
PBMC O O
were O O
stimulated O O
with O O
LPS O O
or O O
IL-1beta O O
, O O
both O O
C3a O O
and O O
C3a O O
( O O
desArg O O
) O O
were O O
found O O
to O O
enhance O O
IL-6 O O
release O O
by O O
PBMC O O
in O O
a O O
dose-dependent O O
manner O O
. O O

Since O O
C3a O O
has O O
been O O
shown O O
to O O
induce O O
PGE2 O O
production O O
by O O
monocytes O O
, O O
and O O
PGE2 O O
has O O
been O O
shown O O
to O O
influence O O
cytokine O O
production O O
, O O
we O O
investigated O O
the O O
potential B-SPECULATION B-SPECULATION
role I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
PGE2 I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
C3a-mediated I-SPECULATION I-SPECULATION
enhancement I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
LPS I-SPECULATION I-SPECULATION
- I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
IL-1beta-induced I-SPECULATION I-SPECULATION
IL-6 I-SPECULATION I-SPECULATION
production I-SPECULATION I-SPECULATION
. O O

Indomethacin O O
blocked O O
PGE2 O O
release O O
, O O
but O O
had O O
no B-NEGATION B-NEGATION
influence I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
observed I-NEGATION I-NEGATION
effects I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
C3a I-NEGATION I-NEGATION
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
effects I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
C3a I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
IL-6 I-SPECULATION I-SPECULATION
production I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
independent I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
PGE2 I-SPECULATION I-SPECULATION
formation I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
monocytes I-SPECULATION I-SPECULATION
. O O

Northern O O
blot O O
analysis O O
showed O O
that O O
C3a O O
as O O
well O O
as O O
C3a O O
( O O
desArg O O
) O O
enhanced O O
LPS-induced O O
mRNA O O
levels O O
for O O
IL-6 O O
. O O

Pretreatment O O
of O O
PBMCs O O
with O O
pertussis O O
toxin O O
blocked O O
the O O
functions O O
of O O
C3a O O
and O O
C3a O O
( O O
desArg O O
) O O
, O O
indicating B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
actions I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
two I-SPECULATION I-SPECULATION
molecules I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
mediated I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
G I-SPECULATION I-SPECULATION
protein-coupled I-SPECULATION I-SPECULATION
pathway I-SPECULATION I-SPECULATION
. O O

Furthermore O O
, O O
we O O
investigated O O
the O O
effects O O
of O O
C3a O O
and O O
C3a O O
( O O
desArg O O
) O O
on O O
induction O O
of O O
NF-kappaB O O
and O O
activating O O
protein-1 O O
binding O O
. O O

Both O O
molecules O O
enhanced O O
LPS-induced O O
NF-kappaB O O
and O O
activating O O
protein-1 O O
binding O O
activity O O
. O O

These O O
results O O
demonstrate O O
the O O
capacity O O
of O O
intact O O
C3a O O
and O O
its O O
circulating O O
des-Arg O O
form O O
to O O
exert O O
immunmodulatory O O
effects O O
in O O
vitro O O
. O O

Differential O O
monocyte O O
adhesion O O
and O O
adhesion O O
molecule O O
expression O O
in O O
venous O O
and O O
arterial O O
endothelial O O
cells O O
. O O

We O O
compared O O
U-937 O O
cell O O
adhesion O O
and O O
adhesion O O
molecule O O
expression O O
in O O
human O O
umbilical O O
venous O O
( O O
HUVECs O O
) O O
and O O
arterial O O
( O O
HUAECs O O
) O O
endothelial O O
cells O O
exposed O O
to O O
tumor O O
necrosis O O
factor O O
( O O
TNF O O
) O O
, O O
interleukin-1 O O
, O O
and O O
lipopolysaccharide O O
( O O
LPS O O
) O O
. O O

TNF O O
and O O
LPS O O
stimulated O O
vascular O O
cell O O
adhesion O O
molecule O O
( O O
VCAM O O
)- O O
1 O O
surface O O
expression O O
and O O
adhesion O O
of O O
U-937 O O
monocyte-like O O
cells O O
to O O
HUVECs O O
but O O
not B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
HUAECs I-NEGATION I-NEGATION
. O O

Antibody O O
studies O O
demonstrated O O
that O O
in O O
HUVECs O O
at O O
least O O
75 O O
% O O
of O O
the O O
adhesion O O
response O O
is O O
VCAM-1 O O
mediated O O
. O O

Interleukin-1 O O
stimulated O O
U-937 O O
cell O O
adhesion O O
to O O
and O O
VCAM-1 O O
surface O O
expression O O
in O O
both O O
HUVECs O O
and O O
HUAECs O O
. O O

Pyrrolidinedithiocarbamate O O
and O O
the O O
proteasome O O
inhibitor O O
MG-132 O O
blocked O O
TNF O O
- O O
and O O
LPS-stimulated O O
U-937 O O
cell O O
adhesion O O
to O O
HUVECs O O
. O O

These O O
agents O O
also O O
significantly O O
decreased O O
TNF O O
- O O
and O O
LPS-stimulated O O
increases O O
in O O
HUVEC O O
surface O O
VCAM-1 O O
. O O

TNF O O
increased O O
VCAM-1 O O
protein O O
and O O
mRNA O O
in O O
HUVECs O O
that O O
was O O
blocked O O
by O O
pyrrolidinedithiocarbamate O O
. O O

However O O
, O O
neither B-NEGATION B-NEGATION
TNF I-NEGATION I-NEGATION
. O O

TNF O O
stimulated O O
expression O O
of O O
both O O
intercellular O O
adhesion O O
molecule-1 O O
and O O
E-selectin O O
in O O
HUVECs O O
, O O
but O O
in O O
HUAECs O O
, O O
only O O
intercellular O O
adhesion O O
molecule-1 O O
was O O
increased O O
. O O

Electrophoretic O O
mobility O O
shift O O
assays O O
demonstrated O O
no B-NEGATION B-NEGATION
difference I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
pattern I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
TNF-stimulated I-NEGATION I-NEGATION
nuclear I-NEGATION I-NEGATION
factor-kappaB I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
between I-NEGATION I-NEGATION
HUVECs I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
HUAECs I-NEGATION I-NEGATION
. O O

These O O
studies O O
demonstrate O O
a O O
novel O O
and O O
striking O O
insensitivity O O
of O O
arterial O O
endothelium O O
to O O
the O O
effects O O
of O O
TNF O O
and O O
LPS O O
and O O
indicate B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
dissociation I-SPECULATION I-SPECULATION
between I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
ability I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
HUAECs I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
upregulate I-SPECULATION I-SPECULATION
nuclear I-SPECULATION I-SPECULATION
factor-kappaB I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
VCAM-1 I-SPECULATION I-SPECULATION
. O O

Tissue O O
factor O O
expression O O
of O O
human O O
monocytes O O
is O O
suppressed O O
by O O
lysophosphatidylcholine O O
. O O

The O O
expression O O
of O O
tissue O O
factor O O
( O O
TF O O
) O O
, O O
the O O
principal O O
initiator O O
of O O
coagulation O O
, O O
is O O
increased O O
during O O
inflammation O O
and O O
atherosclerosis O O
. O O

Both O O
conditions O O
are O O
promoted O O
by O O
lysophosphatidylcholine O O
( O O
lysoPC O O
) O O
. O O

We O O
observed O O
in O O
the O O
present O O
study O O
that O O
lysoPC O O
( O O
1 O O
to O O
10 O O
micromol O O
/ O O
L O O
) O O
dose-dependently O O
reduced O O
TF O O
activity O O
in O O
human O O
monocytes O O
, O O
as O O
elicited O O
by O O
lipopolysaccharide O O
( O O
LPS O O
) O O
. O O

Lysophosphatidylethanolamine O O
( O O
lysoPE O O
) O O
and O O
other O O
lysophospholipids O O
did O O
not B-NEGATION B-NEGATION
affect I-NEGATION I-NEGATION
LPS-induced I-NEGATION I-NEGATION
TF I-NEGATION I-NEGATION
activity I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
human I-NEGATION I-NEGATION
monocytes I-NEGATION I-NEGATION
. O O

TF O O
antigen O O
expression O O
as O O
elicited O O
by O O
LPS O O
was O O
also O O
lowered O O
by O O
lysoPC O O
. O O

Phospholipid O O
analyses O O
indicated O B-SPECULATION
a O I-SPECULATION
selective O I-SPECULATION
increase O I-SPECULATION
in O I-SPECULATION
the O I-SPECULATION
lysoPC O I-SPECULATION
content O I-SPECULATION
of O I-SPECULATION
the O I-SPECULATION
monocytes O I-SPECULATION
after O I-SPECULATION
preincubation O I-SPECULATION
with O I-SPECULATION
the O I-SPECULATION
lysophospholipid O I-SPECULATION
. O O

LysoPC O O
inhibited O O
the O O
TF O O
activity O O
of O O
Mono O O
Mac-6 O O
cells O O
to O O
a O O
similar O O
extent O O
as O O
in O O
the O O
monocytes O O
. O O

LPS B-NEGATION B-NEGATION
binding I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
plasma I-NEGATION I-NEGATION
membrane I-NEGATION I-NEGATION
receptors I-NEGATION I-NEGATION
and I-NEGATION I-NEGATION
internalization I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
LPS I-NEGATION I-NEGATION
into I-NEGATION I-NEGATION
monocytes I-NEGATION I-NEGATION
were I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
affected I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
lysoPC I-NEGATION I-NEGATION
. O O

In O O
contrast O O
, O O
LPS-mediated O O
nuclear O O
binding O O
of O O
nuclear O O
factor-kappaB O O
/ O O
Rel O O
to O O
a O O
TF-specific O O
kappaB O O
site O O
was O O
inhibited O O
by O O
lysoPC O O
. O O

Induction O B-SPECULATION
of O I-SPECULATION
TF O I-SPECULATION
mRNA O I-SPECULATION
expression O I-SPECULATION
by O I-SPECULATION
LPS O I-SPECULATION
tended O I-SPECULATION
to O I-SPECULATION
be O I-SPECULATION
partially O I-SPECULATION
reduced O I-SPECULATION
by O I-SPECULATION
the O I-SPECULATION
lysophospholipid O I-SPECULATION
. O O

Preincubation O O
with O O
lysoPC O O
increased O O
monocytic O O
cAMP O O
levels O O
. O O

Inhibition O O
of O O
adenylyl O O
cyclase O O
by O O
pretreatment O O
with O O
2 O O
'- O O
deoxy-3 O O
'- O O
adenosine O O
monophosphate O O
partially O O
reversed O O
the O O
inhibition O O
of O O
TF O O
activity O O
promoted O O
by O O
lysoPC O O
. O O

In O O
conclusion O O
, O O
lysoPC O O
markedly O O
decreases O O
LPS-mediated O O
TF O O
expression O O
of O O
human O O
monocytes O O
, O O
the O O
effect O O
probably B-SPECULATION B-SPECULATION
being I-SPECULATION I-SPECULATION
mediated I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
both I-SPECULATION I-SPECULATION
transcriptional I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
posttranscriptional I-SPECULATION I-SPECULATION
mechanisms I-SPECULATION I-SPECULATION
. O O

LysoPC O O
may B-SPECULATION B-SPECULATION
thus I-SPECULATION I-SPECULATION
attenuate I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
coagulation I-SPECULATION I-SPECULATION
during I-SPECULATION I-SPECULATION
inflammation I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
atherosclerosis I-SPECULATION I-SPECULATION
. O O

Intranuclear O O
targeted O O
delivery O O
of O O
functional O O
NF-kappaB O O
by O O
70 O O
kDa O O
heat O O
shock O O
protein O O
. O O

The O O
70 O O
kDa O O
heat O O
shock O O
protein O O
( O O
Hsp70 O O
) O O
is O O
a O O
highly O O
conserved O O
, O O
ubiquitous O O
protein O O
involved O O
in O O
chaperoning O O
proteins O O
to O O
various O O
cellular O O
organelles O O
. O O

Here O O
we O O
show O O
that O O
when O O
added O O
exogenously O O
to O O
cells O O
, O O
Hsp70 O O
is O O
readily O O
imported O O
into O O
both O O
cytoplasmic O O
and O O
nuclear O O
compartments O O
in O O
a O O
cell-type-specific O O
fashion O O
. O O

We O O
exploited O O
this O O
ability O O
of O O
Hsp70 O O
to O O
deliver O O
NF-kappaB O O
, O O
a O O
key O O
transcriptional O O
regulator O O
of O O
inflammatory O O
responses O O
. O O

We O O
demonstrate O O
that O O
a O O
fusion O O
protein O O
composed O O
of O O
a O O
C-terminal O O
Hsp70 O O
peptide O O
and O O
the O O
p50 O O
subunit O O
of O O
NF-kappaB O O
was O O
directed O O
into O O
the O O
nucleus O O
of O O
cells O O
, O O
could O O
bind O O
DNA O O
specifically O O
, O O
and O O
activated O O
Igkappa O O
expression O O
and O O
TNFalpha O O
production O O
. O O

We O O
therefore O O
propose B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
Hsp70 I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
used I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
vehicle I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
intracytoplasmic I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
intranuclear I-SPECULATION I-SPECULATION
delivery I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
proteins I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
DNA I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
modulate I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
thereby I-SPECULATION I-SPECULATION
control I-SPECULATION I-SPECULATION
immune I-SPECULATION I-SPECULATION
responses I-SPECULATION I-SPECULATION
. O O

CD2 O O
signalling O O
induces O O
phosphorylation O O
of O O
CREB O O
in O O
primary O O
lymphocytes O O
. O O

Promoter O O
sequences O O
responsive O O
to O O
cyclic O O
AMP O O
( O O
cAMP O O
) O O
are O O
found O O
in O O
a O O
number O O
of O O
cellular O O
genes O O
, O O
and O O
bind O O
transcription O O
factors O O
of O O
the O O
cAMP O O
response O O
element O O
binding O O
protein O O
( O O
CREB O O
)/ O O
activating O O
transcription O O
factor-1 O O
( O O
ATF-1 O O
) O O
family O O
. O O

We O O
have O O
used O O
a O O
human O O
T-lymphotropic O O
virus O O
type O O
1 O O
( O O
HTLV-1 O O
) O O
model O O
of O O
cAMP O O
response O O
element O O
( O O
CRE O O
) O O
transcription O O
to O O
investigate O O
the O O
influence O O
of O O
lymphocyte O O
activation O O
on O O
transcription O O
from O O
homologous O O
regions O O
in O O
the O O
viral O O
promoter O O
. O O

We O O
previously O O
demonstrated O O
increased O O
HTLV-1 O O
transcription O O
following O O
CD2 O O
but O O
not B-NEGATION B-NEGATION
CD3 I-NEGATION I-NEGATION
receptor I-NEGATION I-NEGATION
cross-linking I-NEGATION I-NEGATION
. O O

We O O
hypothesized B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
increased I-SPECULATION I-SPECULATION
viral I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
was I-SPECULATION I-SPECULATION
mediated I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
part I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
through I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
phosphorylation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
CREB I-SPECULATION I-SPECULATION
. O O

Therefore O O
, O O
we O O
investigated O O
CD2 O O
and O O
CD3 O O
receptor-mediated O O
signalling O O
in O O
primary O O
human O O
peripheral O O
blood O O
mononuclear O O
cells O O
( O O
PBMC O O
) O O
. O O

CD2 O O
, O O
but O O
not B-NEGATION B-NEGATION
CD3 I-NEGATION I-NEGATION
, O O
cross-linking O O
increased O O
cAMP O O
detected O O
by O O
competitive O O
enzyme-linked O O
immunosorbent O O
assay O O
( O O
ELISA O O
) O O
approximately O O
fourfold O O
. O O

CD2 O O
cross-linking O O
concurrently O O
increased O O
phosphorylation O O
of O O
CREB O O
detected O O
by O O
immunoblot O O
assay O O
eightfold O O
. O O

Consistent O O
with O O
post-translational O O
regulation O O
, O O
no B-NEGATION B-NEGATION
change I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
total I-NEGATION I-NEGATION
level I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
CREB I-NEGATION I-NEGATION
protein I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
observed I-NEGATION I-NEGATION
. O O

Phosphorylation O O
of O O
CREB O O
occurred O O
through O O
a O O
herbimycin O O
A O O
and O O
Rp-cAMP-sensitive O O
pathway O O
, O O
suggesting B-SPECULATION B-SPECULATION
phosphorylation I-SPECULATION I-SPECULATION
required I-SPECULATION I-SPECULATION
antecedent I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
both I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
tyrosine I-SPECULATION I-SPECULATION
kinases I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
PTK I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
kinase I-SPECULATION I-SPECULATION
A I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
PKA I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
. O O

Both O O
CD2 O O
and O O
CD3 O O
cross-linking O O
increased O O
binding O O
of O O
nuclear O O
proteins O O
to O O
a O O
radiolabelled O O
CRE O O
oligonucleotide O O
probe O O
in O O
electrophoretic O O
mobility O O
shift O O
assays O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
lymphocyte I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
enhances I-SPECULATION I-SPECULATION
binding I-SPECULATION I-SPECULATION
independently I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
phosphorylation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
CREB I-SPECULATION I-SPECULATION
at I-SPECULATION I-SPECULATION
serine I-SPECULATION I-SPECULATION
133 I-SPECULATION I-SPECULATION
. O O

These O O
data O O
indicate B-SPECULATION B-SPECULATION
specific I-SPECULATION I-SPECULATION
modulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
CREB I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
ATF-1 I-SPECULATION I-SPECULATION
family I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factors I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
CD2 I-SPECULATION I-SPECULATION
signalling I-SPECULATION I-SPECULATION
pathway I-SPECULATION I-SPECULATION
and O O
suggest B-SPECULATION B-SPECULATION
CD2 I-SPECULATION I-SPECULATION
receptor I-SPECULATION I-SPECULATION
modulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
CRE-mediated I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
following I-SPECULATION I-SPECULATION
ligand I-SPECULATION I-SPECULATION
engagement I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
e.g. I-SPECULATION I-SPECULATION
cell-to-cell I-SPECULATION I-SPECULATION
contact I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
. O O

Anoxia O O
/ O O
reoxygenation-induced O O
tolerance O O
with O O
respect O O
to O O
polymorphonuclear O O
leukocyte O O
adhesion O O
to O O
cultured O O
endothelial O O
cells O O
. O O

A O O
nuclear O O
factor-kappaB-mediated O O
phenomenon O O
. O O

Exposing O O
human O O
umbilical O O
vein O O
endothelial O O
cells O O
( O O
HUVECs O O
) O O
to O O
anoxia O O
/ O O
reoxygenation O O
( O O
A O O
/ O O
R O O
) O O
results O O
in O O
an O O
increase O O
in O O
polymorphonuclear O O
leukocyte O O
( O O
PMN O O
) O O
adhesion O O
to O O
HUVECs O O
. O O

This O O
A O O
/ O O
R-induced O O
hyperadhesion O O
is O O
completely O O
prevented O O
by O O
a O O
previous O O
( O O
24 O O
hours O O
earlier O O
) O O
exposure O O
of O O
HUVECs O O
to O O
A O O
/ O O
R O O
. O O

This O O
phenomenon O O
has O O
been O O
termed O O
" O O
A O O
/ O O
R O O
tolerance O O
. O O
" O O

Exposing O O
HUVECs O O
to O O
A O O
/ O O
R O O
induces O O
an O O
increase O O
in O O
nuclear O O
factor O O
kappaB O O
( O O
NF-kappaB O O
) O O
in O O
HUVEC O O
nuclei O O
within O O
4 O O
hours O O
. O O

Interfering O O
with O O
either O O
NF-kappaB O O
activation O O
( O O
proteasome O O
inhibitor O O
) O O
or O O
translocation O O
( O O
double-stranded O O
oligonucleotides O O
containing O O
NF-kappaB O O
binding O O
sequence O O
) O O
prevents O O
the O O
development O O
of O O
A O O
/ O O
R O O
tolerance O O
( O O
ie O O
, O O
the O O
increase O O
in O O
A O O
/ O O
R-induced O O
PMN O O
adhesion O O
to O O
HUVECs O O
is O O
the O O
same O O
after O O
the O O
first O O
and O O
second O O
A O O
/ O O
R O O
challenges O O
) O O
. O O

NO O O
production O O
by O O
HUVECs O O
is O O
increased O O
after O O
the O O
second O O
A O O
/ O O
R O O
challenge O O
, O O
but O O
not B-NEGATION B-NEGATION
after I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
first I-NEGATION I-NEGATION
A I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
R I-NEGATION I-NEGATION
challenge I-NEGATION I-NEGATION
. O O

Inhibition O O
of O O
NO O O
synthase O O
( O O
NOS O O
) O O
during O O
the O O
second O O
A O O
/ O O
R O O
challenge O O
prevents O O
the O O
development O O
of O O
A O O
/ O O
R O O
tolerance O O
with O O
respect O O
to O O
PMN O O
adhesion O O
. O O

However O O
, O O
while O O
HUVECs O O
contained O O
endothelial O O
NOS O O
protein O O
, O O
no B-NEGATION B-NEGATION
inducible I-NEGATION I-NEGATION
NOS I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
detected I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
either I-NEGATION I-NEGATION
tolerant I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
nontolerant I-NEGATION I-NEGATION
cells I-NEGATION I-NEGATION
. O O

Further O O
studies O O
indicated B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
inhibition I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
GTP-cyclohydrolase I-SPECULATION I-SPECULATION
I I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
enzyme I-SPECULATION I-SPECULATION
involved I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
de I-SPECULATION I-SPECULATION
novo I-SPECULATION I-SPECULATION
synthesis I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
important I-SPECULATION I-SPECULATION
cofactor I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
NOS I-SPECULATION I-SPECULATION
activity I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
tetrahydrobiopterin I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
prevented I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
generation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
NO I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
A I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
R-tolerant I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

Extracellular O O
generation O O
of O O
NO O O
( O O
NO O O
donor O O
) O O
did O O
not B-NEGATION B-NEGATION
effect I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
hyperadhesion I-NEGATION I-NEGATION
response I-NEGATION I-NEGATION
induced I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
initial I-NEGATION I-NEGATION
A I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
R I-NEGATION I-NEGATION
challenge I-NEGATION I-NEGATION
. O O

A O O
/ O O
R O O
also O O
induced O O
an O O
oxidant O O
stress O O
in O O
naive O O
HUVECs O O
, O O
but O O
not B-NEGATION B-NEGATION
in I-NEGATION I-NEGATION
A I-NEGATION I-NEGATION
/ I-NEGATION I-NEGATION
R-tolerant I-NEGATION I-NEGATION
HUVECs I-NEGATION I-NEGATION
. O O

Inhibition O O
of O O
NOS O O
during O O
the O O
second O O
A O O
/ O O
R O O
insult O O
results O O
in O O
the O O
generation O O
of O O
an O O
oxidant O O
stress O O
similar O O
to O O
that O O
observed O O
after O O
the O O
first O O
A O O
/ O O
R O O
challenge O O
. O O

Taken O O
together O O
, O O
the O O
findings O O
of O O
the O O
present O O
study O O
are O O
consistent O O
with O O
a O O
role O O
for O O
NF-kappaB O O
in O O
the O O
development O O
of O O
A O O
/ O O
R O O
tolerance O O
( O O
with O O
respect O O
to O O
PMN O O
adhesion O O
) O O
, O O
perhaps O B-SPECULATION
by O I-SPECULATION
transcriptional O I-SPECULATION
regulation O I-SPECULATION
of O I-SPECULATION
GTP-cyclohydrolase O I-SPECULATION
. O O

The O O
increased O O
NO O O
production O O
during O O
the O O
second O O
A O O
/ O O
R O O
insult O O
reduces O O
PMN O O
adhesion O O
most O O
likely B-SPECULATION B-SPECULATION
by I-SPECULATION I-SPECULATION
reducing I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
intracellular I-SPECULATION I-SPECULATION
oxidant I-SPECULATION I-SPECULATION
stress I-SPECULATION I-SPECULATION
induced I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
A I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
R I-SPECULATION I-SPECULATION
. O O

Role O O
of O O
Egr-2 O O
in O O
up-regulation O O
of O O
Fas O O
ligand O O
in O O
normal O O
T O O
cells O O
and O O
aberrant O O
double-negative O O
lpr O O
and O O
gld O O
T O O
cells O O
. O O

We O O
previously O O
identified O O
a O O
Fas O O
ligand O O
regulatory O O
element O O
( O O
FLRE O O
) O O
in O O
the O O
Fas O O
ligand O O
( O O
fasL O O
) O O
promoter O O
that O O
binds O O
Egr O O
family O O
proteins O O
and O O
demonstrated O O
that O O
Egr-3 O O
( O O
PILOT O O
) O O
but O O
not B-NEGATION B-NEGATION
Egr-1 I-NEGATION I-NEGATION
( I-NEGATION I-NEGATION
NGFI-A I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
Krox-24 I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
Tis-8 I-NEGATION I-NEGATION
, I-NEGATION O
and I-NEGATION O
Zif-268 I-NEGATION O
) I-NEGATION O
induces O O
transcription O O
of O O
fasL O O
. O O

The O O
aberrant O O
CD4 O O
(-) O O
CD8 O O
(-) O O
T O O
cells O O
from O O
lpr O O
/ O O
lpr O O
and O O
gld O O
/ O O
gld O O
mice O O
, O O
which O O
have O O
mutations O O
in O O
the O O
genes O O
encoding O O
Fas O O
and O O
FasL O O
, O O
respectively O O
, O O
have O O
an O O
activated O O
phenotype O O
and O O
constitutively O O
express O O
high O O
levels O O
of O O
fasL O O
mRNA O O
, O O
prompting O O
us O O
to O O
ask O O
what O O
role O O
if O B-SPECULATION
any O I-SPECULATION
the O I-SPECULATION
FLRE O I-SPECULATION
and O I-SPECULATION
Egr O I-SPECULATION
family O I-SPECULATION
proteins O I-SPECULATION
have O I-SPECULATION
in O I-SPECULATION
this O I-SPECULATION
aberrant O I-SPECULATION
expression O I-SPECULATION
of O I-SPECULATION
fasL O I-SPECULATION
. O O

Unstimulated O O
MRL-lpr O O
/ O O
lpr O O
and O O
C3H-gld O O
/ O O
gld O O
CD4 O O
(-) O O
CD8 O O
(-) O O
T O O
cells O O
constitutively O O
contained O O
high O O
levels O O
of O O
two O O
proteins O O
that O O
bound O O
to O O
the O O
FLRE O O
. O O

Supershift O O
analysis O O
revealed O O
these O O
proteins O O
to O O
be O O
Egr-1 O O
and O O
Egr-2 O O
( O O
Krox-20 O O
) O O
; O O
Egr-3 B-NEGATION B-NEGATION
was I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
detected I-NEGATION I-NEGATION
. O O

Activation O O
of O O
normal O O
lymph O O
node O O
cells O O
resulted O O
in O O
increased O O
expression O O
of O O
Egr-1 O O
, O O
- O O
2 O O
, O O
and O O
- O O
3 O O
. O O

As O O
with O O
egr-3 O O
, O O
expression O O
of O O
egr-2 O O
was O O
blocked O O
by O O
cyclosporin O O
A O O
. O O

Although O O
overexpressed O O
Egr-1 O O
was O O
ineffective O O
, O O
overexpressed O O
Egr-2 O O
was O O
as O O
potent O O
as O O
Egr-3 O O
in O O
inducing O O
fasL O O
promoter-dependent O O
reporter O O
constructs O O
in O O
T O O
cell O O
hybridomas O O
and O O
HeLa O O
cells O O
, O O
and O O
both O O
up-regulated O O
endogenous O O
fasL O O
mRNA O O
in O O
HeLa O O
cells O O
. O O

FasL-dependent O O
reporter O O
constructs O O
in O O
MRL-lpr O O
/ O O
lpr O O
and O O
C3H-gld O O
/ O O
gld O O
CD4 O O
(-) O O
CD8 O O
(-) O O
T O O
cells O O
were O O
constitutively O O
active O O
, O O
and O O
this O O
activity O O
was O O
largely O O
prevented O O
by O O
mutation O O
of O O
the O O
critical O O
Egr O O
family O O
binding O O
element O O
. O O

Thus O O
, O O
Egr-2 O O
, O O
in O O
addition O O
to O O
Egr-3 O O
, O O
regulates O O
FasL O O
expression O O
in O O
activated O O
normal O O
T O O
cells O O
, O O
and O O
Egr-2 B-SPECULATION B-SPECULATION
is I-SPECULATION I-SPECULATION
likely I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
play I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
direct I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
aberrant I-SPECULATION I-SPECULATION
fasL I-SPECULATION I-SPECULATION
up-regulation I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
lpr I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
lpr I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
gld I-SPECULATION I-SPECULATION
/ I-SPECULATION I-SPECULATION
gld I-SPECULATION I-SPECULATION
CD4 I-SPECULATION I-SPECULATION
(-) I-SPECULATION I-SPECULATION
CD8 I-SPECULATION I-SPECULATION
(-) I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

Involvement O O
of O O
mitogen-activated O O
protein O O
kinase O O
pathways O O
in O O
interleukin-8 O O
production O O
by O O
human O O
monocytes O O
and O O
polymorphonuclear O O
cells O O
stimulated O O
with O O
lipopolysaccharide O O
or O O
Mycoplasma O O
fermentans O O
membrane O O
lipoproteins O O
. O O

Interleukin-8 O O
( O O
IL-8 O O
) O O
is O O
a O O
chemokine O O
that O O
belongs O O
to O O
the O O
alpha-chemokine O O
or O O
CXC O O
subfamily O O
and O O
is O O
produced O O
by O O
a O O
wide O O
variety O O
of O O
human O O
cells O O
, O O
including O O
monocytes O O
and O O
polymorphonuclear O O
cells O O
( O O
PMN O O
) O O
. O O

IL-8 O O
is O O
secreted O O
in O O
response O O
to O O
inflammatory O O
stimuli O O
, O O
notably O O
bacterial O O
products O O
such O O
as O O
lipopolysaccharide O O
( O O
LPS O O
) O O
, O O
but O O
little O O
is O O
known O O
about O O
the O O
mechanisms O O
by O O
which O O
these O O
agents O O
mediate O O
IL-8 O O
induction O O
. O O

In O O
this O O
report O O
, O O
we O O
show O O
that O O
Mycoplasma O O
fermentans O O
lipid-associated O O
membrane O O
proteins O O
( O O
LAMPf O O
) O O
induce O O
the O O
production O O
of O O
high O O
levels O O
of O O
IL-8 O O
by O O
THP-1 O O
( O O
human O O
monocyte O O
) O O
cells O O
and O O
PMN O O
at O O
the O O
same O O
extent O O
as O O
LPS O O
. O O

It O O
was O O
previously O O
demonstrated O O
that O O
stimulation O O
of O O
monocytic O O
cells O O
with O O
either O O
LPS O O
or O O
LAMPf O O
led O O
to O O
a O O
series O O
of O O
common O O
downstream O O
signaling O O
events O O
, O O
including O O
the O O
activation O O
of O O
protein O O
tyrosine O O
kinase O O
and O O
of O O
mitogen-activated O O
protein O O
kinase O O
cascades O O
. O O

By O O
using O O
PD-98059 O O
and O O
SB203580 O O
, O O
two O O
potent O O
and O O
selective O O
inhibitors O O
of O O
MEK1 O O
( O O
a O O
kinase O O
upstream O O
of O O
ERK1 O O
/ O O
2 O O
) O O
and O O
p38 O O
, O O
respectively O O
, O O
we O O
have O O
demonstrated O O
that O O
both O O
ERK1 O O
/ O O
2 O O
and O O
p38 O O
cascades O O
play O O
a O O
key O O
role O O
in O O
the O O
production O O
of O O
IL-8 O O
by O O
monocytes O O
and O O
PMN O O
stimulated O O
with O O
bacterial O O
fractions O O
. O O

T O O
cell O O
priming O O
enhances O O
IL-4 O O
gene O O
expression O O
by O O
increasing O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
. O O

The O O
repetitive O O
activation O O
of O O
T O O
cells O O
( O O
priming O O
) O O
enhances O O
the O O
expression O O
of O O
many O O
cytokines O O
, O O
such O O
as O O
IL-4 O O
, O O
but O O
not B-NEGATION B-NEGATION
others I-NEGATION I-NEGATION
, I-NEGATION I-NEGATION
such I-NEGATION I-NEGATION
as I-NEGATION I-NEGATION
IL-2 I-NEGATION I-NEGATION
. O O

Molecular O O
mechanisms O O
underlying O O
selective O O
expression O O
of O O
cytokines O O
by O O
T O O
cells O O
remain O O
poorly O O
understood O O
. O O

Here O O
we O O
show O O
that O O
priming O O
of O O
CD4 O O
T O O
cells O O
selectively O O
enhances O O
IL-4 O O
expression O O
relative O O
to O O
IL-2 O O
expression O O
by O O
a O O
transcriptional O O
mechanism O O
involving O O
nuclear O O
factor O O
of O O
activated O O
T O O
cells O O
( O O
NFAT O O
) O O
proteins O O
. O O

As O O
detected O O
by O O
in O O
vivo O O
footprinting O O
, O O
priming O O
markedly O O
increases O O
the O O
activation-dependent O O
engagement O O
of O O
the O O
P0 O O
and O O
P1 O O
NFAT-binding O O
elements O O
of O O
the O O
IL-4 O O
promoter O O
. O O

Moreover O O
, O O
each O O
proximal O O
P O O
element O O
is O O
essential O O
for O O
optimal O O
IL-4 O O
promoter O O
activity O O
. O O

Activated O O
primed O O
CD4 O O
T O O
cells O O
contain O O
more O O
NFAT1 O O
and O O
support O O
greater O O
NFAT-directed O O
transcription O O
than O O
unprimed O O
CD4 O O
T O O
cells O O
, O O
while O O
activator O O
protein O O
1 O O
binding O O
and O O
activator O O
protein O O
1-mediated O O
transcription O O
by O O
both O O
cell O O
types O O
is O O
similar O O
. O O

Increased O O
expression O O
of O O
wild-type O O
NFAT1 O O
substantially O O
increases O O
IL-4 O O
promoter O O
activity O O
in O O
unprimed O O
CD4 O O
T O O
cells O O
, O O
suggesting B-SPECULATION B-SPECULATION
NFAT1 I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
limiting I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
IL-4 I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
type I-SPECULATION I-SPECULATION
. O O

Furthermore O O
, O O
a O O
truncated O O
form O O
of O O
NFAT1 O O
acts O O
as O O
a O O
dominant-negative O O
, O O
reducing O O
IL-4 O O
promoter O O
activity O O
in O O
primed O O
CD4 O O
T O O
cells O O
and O O
confirming O O
the O O
importance O O
of O O
endogenous O O
NFAT O O
to O O
increased O O
IL-4 O O
gene O O
expression O O
by O O
effector O O
T O O
cells O O
. O O

NFAT1 B-SPECULATION B-SPECULATION
appears I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
major I-SPECULATION I-SPECULATION
NFAT I-SPECULATION I-SPECULATION
family I-SPECULATION I-SPECULATION
member I-SPECULATION I-SPECULATION
responsible I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
initial I-SPECULATION I-SPECULATION
increased I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
IL-4 I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
primed I-SPECULATION I-SPECULATION
CD4 I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
. O O

Inhibition O O
of O O
NF-kappa O O
B O O
activation O O
in O O
vitro O O
and O O
in O O
vivo O O
: O O
role O O
of O O
26S O O
proteasome O O
. O O

It O O
is O O
becoming O O
increasingly O O
apparent O O
that O O
NF-kappa O O
B O O
plays O O
a O O
critical O O
role O O
in O O
regulating O O
the O O
inflammatory O O
response O O
. O O

Data O O
obtained O O
from O O
studies O O
in O O
our O O
laboratories O O
demonstrate O O
that O O
the O O
proteasome O O
plays O O
an O O
important O O
role O O
in O O
the O O
inflammatory O O
cascade O O
by O O
regulating O O
the O O
activation O O
of O O
NF-kappa O O
B O O
. O O

Indeed O O
, O O
the O O
availability O O
of O O
selective O O
and O O
orally O O
active O O
proteasome O O
inhibitors O O
should B-SPECULATION B-SPECULATION
prove I-SPECULATION I-SPECULATION
useful I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
delineating I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
roles I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
proteasome I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
NF-kappa I-SPECULATION I-SPECULATION
B I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
other I-SPECULATION I-SPECULATION
pathophysiological I-SPECULATION I-SPECULATION
conditions I-SPECULATION I-SPECULATION
such I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
cancer I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
heart I-SPECULATION I-SPECULATION
disease I-SPECULATION I-SPECULATION
. O O

Comparison O O
of O O
HTLV-I O O
basal O O
transcription O O
and O O
expression O O
of O O
CREB O O
/ O O
ATF-1 O O
/ O O
CREM O O
family O O
members O O
in O O
peripheral O O
blood O O
mononuclear O O
cells O O
and O O
Jurkat O O
T O O
cells O O
. O O

HTLV-I O O
is O O
the O O
etiologic O O
agent O O
of O O
adult O O
T-cell O O
leukemia O O
/ O O
lymphoma O O
and O O
is O O
associated O O
with O O
tropical O O
spastic O O
paraparesis O O
/ O O
HTLV-I-associated O O
myelopathy O O
. O O

Following O O
integration O O
into O O
the O O
host O O
cell O O
genome O O
, O O
HTLV-I O O
replication O O
is O O
regulated O O
by O O
both O O
host O O
and O O
viral O O
mechanisms O O
that O O
control O O
transcription O O
. O O

Low O O
levels O O
of O O
viral O O
transcription O O
( O O
basal O O
transcription O O
) O O
occur O O
before O O
expression O O
of O O
the O O
virally O O
encoded O O
Tax O O
protein O O
( O O
Tax-mediated O O
transcription O O
) O O
. O O

Members O O
of O O
the O O
cyclic O O
adenosine O O
monophosphate O O
( O O
cAMP O O
) O O
response O O
element O O
binding O O
( O O
CREB O O
)/ O O
activating O O
transcription O O
factor O O
1 O O
( O O
ATF-1 O O
) O O
family O O
of O O
transcription O O
factors O O
bind O O
three O O
21-bp O O
repeats O O
( O O
Tax-responsive O O
element-1 O O
, O O
or O O
TRE-1 O O
) O O
within O O
the O O
viral O O
promoter O O
and O O
are O O
important O O
for O O
basal O O
and O O
Tax-mediated O O
transcription O O
. O O

Using O O
mitogen O O
stimulated O O
and O O
quiescent O O
peripheral O O
blood O O
mononuclear O O
cells O O
( O O
PBMC O O
) O O
and O O
Jurkat O O
cells O O
, O O
we O O
compared O O
differences O O
in O O
basal O O
transcription O O
and O O
amounts O O
and O O
binding O O
of O O
transcription O O
factors O O
with O O
TRE-1 O O
. O O

We O O
demonstrate O O
that O O
amounts O O
of O O
transcriptionally O O
active O O
phosphorylated O O
CREB O O
protein O O
( O O
P-CREB O O
) O O
differ O O
between O O
activated O O
PBMC O O
and O O
Jurkat O O
cells O O
. O O

Following O O
stimulation O O
, O O
P-CREB O O
levels O O
remain O O
elevated O O
in O O
PBMC O O
for O O
up O O
to O O
24 O O
hours O O
whereas O O
CREB O O
is O O
dephosphorylated O O
in O O
Jurkat O O
cells O O
within O O
4 O O
hours O O
following O O
stimulation O O
. O O

The O O
differences O O
in O O
P-CREB O O
levels O O
between O O
PBMC O O
and O O
Jurkat O O
cells O O
were O O
directly O O
correlated O O
with O O
basal O O
transcription O O
of O O
HTLV-I O O
in O O
the O O
two O O
cell O O
types O O
. O O

Using O O
electrophoretic O O
mobility O O
shift O O
assays O O
, O O
we O O
determined O O
that O O
the O O
pattern O O
of O O
band O O
migration O O
differed O O
between O O
the O O
two O O
cell O O
types O O
. O O

These O O
data O O
demonstrate O O
that O O
PBMC O O
differentially O O
regulate O O
basal O O
HTLV-I O O
transcription O O
compared O O
with O O
Jurkat O O
T O O
cells O O
, O O
and O O
this O O
differential O O
regulation O O
is O O
due O O
, O O
in O O
part O O
to O O
differential O O
phosphorylation O O
and O O
binding O O
of O O
CREB O O
/ O O
ATF-1 O O
to O O
TRE-1 O O
in O O
the O O
HTLV-I O O
promoter O O
. O O

We O O
demonstrate O O
the O O
utility O O
of O O
using O O
primary O O
lymphocyte O O
models O O
to O O
study O O
HTLV-I O O
transcription O O
in O O
the O O
context O O
of O O
cell O O
signaling O O
and O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
activated I-SPECULATION I-SPECULATION
PBMC I-SPECULATION I-SPECULATION
maintain I-SPECULATION I-SPECULATION
elevated I-SPECULATION I-SPECULATION
levels I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
P-CREB I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
promote I-SPECULATION I-SPECULATION
basal I-SPECULATION I-SPECULATION
HTLV-I I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
enhance I-SPECULATION I-SPECULATION
viral I-SPECULATION I-SPECULATION
persistence I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
vivo I-SPECULATION I-SPECULATION
. O O

NF-kappaB O O
activation O O
is O O
a O O
critical O O
regulator O O
of O O
human O O
granulocyte O O
apoptosis O O
in O O
vitro O O
. O O

During O O
beneficial O O
inflammation O O
, O O
potentially B-SPECULATION B-SPECULATION
tissue-damaging I-SPECULATION I-SPECULATION
granulocytes O I-SPECULATION
undergo O I-SPECULATION
apoptosis O I-SPECULATION
before O I-SPECULATION
being O I-SPECULATION
cleared O I-SPECULATION
by O I-SPECULATION
phagocytes O I-SPECULATION
in O I-SPECULATION
a O I-SPECULATION
non-phlogistic O I-SPECULATION
manner O I-SPECULATION
. O O

Here O O
we O O
show O O
that O O
the O O
rate O O
of O O
constitutive O O
apoptosis O O
in O O
human O O
neutrophils O O
and O O
eosinophils O O
is O O
greatly O O
accelerated O O
in O O
both O O
a O O
rapid O O
and O O
concentration-dependent O O
manner O O
by O O
the O O
fungal O O
metabolite O O
gliotoxin O O
, O O
but O O
not B-NEGATION B-NEGATION
by I-NEGATION I-NEGATION
its I-NEGATION I-NEGATION
inactive I-NEGATION I-NEGATION
analog I-NEGATION I-NEGATION
methylthiogliotoxin I-NEGATION I-NEGATION
. O O

This O O
induction O O
of O O
apoptosis O O
was O O
abolished O O
by O O
the O O
caspase O O
inhibitor O O
zVAD-fmk O O
, O O
correlated O O
with O O
the O O
inhibition O O
of O O
nuclear O O
factor-kappa O O
B O O
( O O
NF-kappaB O O
) O O
, O O
and O O
was O O
mimicked O O
by O O
a O O
cell O O
permeable O O
inhibitory O O
peptide O O
of O O
NF-kappaB O O
, O O
SN-50 O O
; O O
other O O
NF-kappaB O O
inhibitors O O
, O O
curcumin O O
and O O
pyrrolidine O O
dithiocarbamate O O
; O O
and O O
the O O
proteasome O O
inhibitor O O
, O O
MG-132 O O
. O O

Gliotoxin O O
also O O
augmented O O
dramatically O O
the O O
early O O
( O O
2-6 O O
h O O
) O O
pro-apoptotic O O
effects O O
of O O
tumor O O
necrosis O O
factor-alpha O O
( O O
TNF-alpha O O
) O O
in O O
neutrophils O O
and O O
unmasked O O
the O O
ability O O
of O O
TNF-alpha O O
to O O
induce O O
eosinophil O O
apoptosis O O
. O O

In O O
neutrophils O O
, O O
TNF-alpha O O
caused O O
a O O
gliotoxin-inhibitable O O
activation O O
of O O
an O O
inducible O O
form O O
of O O
NF-kappaB O O
, O O
a O O
response O O
that O O
may B-SPECULATION B-SPECULATION
underlie I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
ability I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
TNF-alpha I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
delay I-SPECULATION I-SPECULATION
apoptosis I-SPECULATION I-SPECULATION
at I-SPECULATION I-SPECULATION
later I-SPECULATION I-SPECULATION
times I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
12-24 I-SPECULATION I-SPECULATION
h I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
limit I-SPECULATION I-SPECULATION
its I-SPECULATION I-SPECULATION
early I-SPECULATION I-SPECULATION
killing I-SPECULATION I-SPECULATION
effect I-SPECULATION I-SPECULATION
. O O

Furthermore O O
, O O
cycloheximide O O
displayed O O
a O O
similar O O
capacity O O
to O O
enhance O O
TNF-alpha O O
induced O O
neutrophil O O
apoptosis O O
even O O
at O O
time O O
points O O
when O O
cycloheximide O O
alone O O
had O O
no B-NEGATION B-NEGATION
pro-apoptotic I-NEGATION I-NEGATION
effect I-NEGATION I-NEGATION
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
regulate I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
production I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
s I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
protect I-SPECULATION I-SPECULATION
neutrophils I-SPECULATION I-SPECULATION
from I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
cytotoxic I-SPECULATION I-SPECULATION
effects I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
TNF-alpha I-SPECULATION I-SPECULATION
. O O

These O O
data O O
shed O O
light O O
on O O
the O O
biochemical O O
and O O
molecular O O
mechanisms O O
regulating O O
human O O
granulocyte O O
apoptosis O O
and O O
, O O
in O O
particular O O
, O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factor I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
plays I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
crucial I-SPECULATION I-SPECULATION
role I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
regulating I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
physiological I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
death I-SPECULATION I-SPECULATION
pathway I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
granulocytes I-SPECULATION I-SPECULATION
. O O

Lactobacilli O O
and O O
vaginal O O
host O O
defense O O
: O O
activation O O
of O O
the O O
human O O
immunodeficiency O O
virus O O
type O O
1 O O
long O O
terminal O O
repeat O O
, O O
cytokine O O
production O O
, O O
and O O
NF-kappaB O O
. O O

Lactobacilli O O
, O O
a O O
component O O
of O O
the O O
normal O O
vaginal O O
flora O O
, O O
can O O
activate O O
the O O
human O O
immunodeficiency O O
virus O O
( O O
HIV O O
)- O O
1 O O
long O O
terminal O O
repeat O O
( O O
LTR O O
) O O
in O O
the O O
Jurkat O O
T O O
lymphocyte O O
and O O
THP-1 O O
macrophage O O
cell O O
lines O O
. O O

Activation O O
of O O
the O O
LTR O O
in O O
Jurkat O O
cells O O
was O O
strongly O O
enhanced O O
by O O
vanadate O O
and O O
inhibited O O
by O O
catalase O O
, O O
implicating O O
H2O2 O O
. O O

In O O
contrast O O
, O O
activation O O
in O O
THP-1 O O
cells O O
occurred O O
in O O
the O O
absence B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
vanadate I-NEGATION I-NEGATION
and O O
was O O
unaffected O O
by O O
catalase O O
. O O

The O O
active O O
material O O
partitioned O O
into O O
the O O
phenol O O
layer O O
on O O
hot O O
aqueous O O
phenol O O
extraction O O
. O O

Lactobacilli O O
also O O
increased O O
tumor O O
necrosis O O
factor-alphaand O O
interleukin-1betaproduction O O
and O O
activated O O
NF-kappaB O O
in O O
THP-1 O O
cells O O
and O O
increased O O
tumor O O
necrosis O O
factor-alphaproduction O O
by O O
human O O
monocytes O O
. O O

Human O O
vaginal O O
fluid O O
specimens O O
had O O
comparable O O
properties O O
, O O
which O O
correlated O O
with O O
their O O
bacterial O O
content O O
. O O

These O O
findings O O
suggest B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
presence I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
vaginal I-SPECULATION I-SPECULATION
fluid I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
agent I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
s I-SPECULATION I-SPECULATION
) I-SPECULATION I-SPECULATION
derived I-SPECULATION I-SPECULATION
from I-SPECULATION I-SPECULATION
indigenous I-SPECULATION I-SPECULATION
bacteria I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
activate I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
HIV-1 I-SPECULATION I-SPECULATION
LTR I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
cytokine I-SPECULATION I-SPECULATION
production I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
macrophage I-SPECULATION I-SPECULATION
lineage I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
possible B-SPECULATION B-SPECULATION
influence I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
vaginal I-SPECULATION I-SPECULATION
physiology I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
host I-SPECULATION I-SPECULATION
defense I-SPECULATION I-SPECULATION
. O O

High-level O O
replication O O
of O O
human O O
immunodeficiency O O
virus O O
in O O
thymocytes O O
requires O O
NF-kappaB O O
activation O O
through O O
interaction O O
with O O
thymic O O
epithelial O O
cells O O
. O O

We O O
have O O
previously O O
demonstrated O O
that O O
interaction O O
of O O
infected O O
thymocytes O O
with O O
autologous O O
thymic O O
epithelial O O
cells O O
( O O
TEC O O
) O O
is O O
a O O
prerequisite O O
for O O
a O O
high O O
level O O
of O O
human O O
immunodeficiency O O
virus O O
type O O
1 O O
( O O
HIV-1 O O
) O O
replication O O
in O O
thymocytes O O
( O O
M.Rothe O O
, O O
L.Chene O O
, O O
M.Nugeyre O O
, O O
F.Barre-Sinoussi O O
, O O
and O O
N.Israel O O
, O O
J.Virol.72:5852-5861 O O
, O O
1998 O O
) O O
. O O

We O O
report O O
here O O
that O O
this O O
activation O O
of O O
HIV O O
replication O O
takes O O
place O O
at O O
the O O
transcriptional O O
level O O
through O O
activation O O
of O O
the O O
Rel O O
/ O O
NF-kappaB O O
transcription O O
factors O O
. O O

We O O
first O O
demonstrate O O
that O O
an O O
HIV-1 O O
provirus O O
( O O
SF-2 O O
strain O O
) O O
very O O
effectively O O
replicates O O
in O O
thymocytes O O
cocultured O O
with O O
TEC O O
whereas O O
this O O
provirus O O
, O O
with O O
kappaB O O
sites O O
deleted O O
, O O
fails B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
replicate I-NEGATION I-NEGATION
. O O

We O O
provide O O
evidence O O
that O O
several O O
NF-kappaB O O
complexes O O
are O O
constitutively O O
found O O
in O O
the O O
nuclei O O
of O O
thymocytes O O
either O O
freshly O O
isolated O O
from O O
the O O
thymus O O
or O O
maintained O O
in O O
coculture O O
with O O
autologous O O
or O O
heterologous O O
TEC O O
. O O

The O O
prevalent O O
complex O O
is O O
the O O
heterodimer O O
p50-p65 O O
. O O

NF-kappaB O O
activity O O
is O O
tightly O O
correlated O O
with O O
the O O
transcriptional O O
activity O O
of O O
a O O
long O O
terminal O O
repeat O O
( O O
LTR O O
) O O
of O O
HIV-1 O O
transfected O O
in O O
thymocytes O O
. O O

The O O
cotransfection O O
of O O
this O O
LTR O O
with O O
a O O
mutated O O
IkappaBalpha O O
molecule O O
formally O O
demonstrates O O
that O O
LTR O O
transactivation O O
is O O
regulated O O
by O O
members O O
of O O
the O O
Rel O O
/ O O
NF-kappaB O O
family O O
in O O
thymocytes O O
. O O

We O O
also O O
showed O O
that O O
tumor O O
necrosis O O
factor O O
( O O
TNF O O
) O O
and O O
to O O
a O O
lesser O O
extent O O
interleukin-1 O O
( O O
IL-1 O O
) O O
, O O
secreted O O
within O O
the O O
coculture O O
, O O
induce O O
NF-kappaB O O
activity O O
and O O
a O O
correlative O O
LTR O O
transactivation O O
. O O

However O O
IL-7 O O
, O O
a O O
crucial O O
factor O O
for O O
thymopoiesis O O
that O O
is O O
secreted O O
mainly O O
by O O
TEC O O
, O O
is O O
a O O
necessary O O
cofactor O O
for O O
NF-kappaB O O
activation O O
elicited O O
by O O
TNF O O
or O O
IL-1 O O
. O O

Together O O
, O O
these O O
data O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
NF-kappaB I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
required I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
high I-SPECULATION I-SPECULATION
level I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
HIV I-SPECULATION I-SPECULATION
replication I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
thymocytes I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
regulated I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
specific I-SPECULATION I-SPECULATION
manner I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
thymic I-SPECULATION I-SPECULATION
microenvironment I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
provides I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
necessary I-SPECULATION I-SPECULATION
cytokines I-SPECULATION I-SPECULATION
: I-SPECULATION I-SPECULATION
TNF I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
IL-1 I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
IL-7 I-SPECULATION I-SPECULATION
. O O

Cross-linking O O
of O O
CD44 O O
on O O
rheumatoid O O
synovial O O
cells O O
up-regulates O O
VCAM-1 O O
. O O

CD44 O O
is O O
a O O
ubiquitous O O
molecule O O
also O O
known O O
as O O
hyaluronic O O
acid O O
or O O
homing O O
receptor O O
. O O

However O O
, O O
the B-SPECULATION O
cellular I-SPECULATION O
functions I-SPECULATION O
and I-SPECULATION O
its I-SPECULATION O
role I-SPECULATION O
in I-SPECULATION O
inflammation I-SPECULATION O
, I-SPECULATION O
for I-SPECULATION O
example I-SPECULATION O
, I-SPECULATION O
rheumatoid I-SPECULATION O
synovitis I-SPECULATION O
, I-SPECULATION O
are I-SPECULATION O
currently I-SPECULATION O
unknown I-SPECULATION O
. O O

In O O
this O O
study O O
, O O
we O O
propose O B-SPECULATION
a O I-SPECULATION
novel O I-SPECULATION
function O I-SPECULATION
for O I-SPECULATION
CD44 O I-SPECULATION
. O O

Using O O
synovial O O
cells O O
from O O
rheumatoid O O
arthritis O O
( O O
RA O O
) O O
patients O O
, O O
we O O
demonstrated O O
that O O
CD44 O O
cross-linking O O
and O O
binding O O
to O O
hyaluronan O O
augmented O O
VCAM-1 O O
expression O O
and O O
subsequently O O
VCAM-1-mediated O O
cell O O
adhesion O O
. O O

Briefly O O
, O O
we O O
found O O
that O O
1 O O
) O O
rheumatoid O O
synovial O O
cells O O
highly O O
expressed O O
CD44 O O
; O O
2 O O
) O O
cross-linking O O
of O O
CD44 O O
markedly O O
but O O
transiently O O
augmented O O
VCAM-1 O O
expression O O
and O O
its O O
mRNA O O
transcription O O
much O O
more O O
than O O
did O O
IL-1beta O O
and O O
TNF-alpha O O
; O O
3 O O
) O O
hyaluronan O O
, O O
especially O O
when O O
fragmented O O
, O O
also O O
up-regulated O O
VCAM-1 O O
; O O
4 O O
) O O
CD44 O O
activated O O
the O O
transcription O O
factor O O
AP-1 O O
; O O
and O O
5 O O
) O O
the O O
integrin-dependent O O
adhesive O O
function O O
of O O
RA O O
synovial O O
cells O O
to O O
T O O
cells O O
was O O
also O O
amplified O O
by O O
CD44 O O
cross-linking O O
. O O

These O O
results O O
indicate B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
RA I-SPECULATION I-SPECULATION
synovial I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
matrices I-SPECULATION I-SPECULATION
such I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
hyaluronic I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
through I-SPECULATION I-SPECULATION
CD44 I-SPECULATION I-SPECULATION
could I-SPECULATION I-SPECULATION
up-regulate I-SPECULATION I-SPECULATION
VCAM-1 I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
VCAM-1-mediated I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
might B-SPECULATION B-SPECULATION
in I-SPECULATION I-SPECULATION
turn I-SPECULATION I-SPECULATION
cause I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
T I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
synovial I-SPECULATION I-SPECULATION
cells I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
RA I-SPECULATION I-SPECULATION
synovitis I-SPECULATION I-SPECULATION
. O O

We O O
therefore O O
propose B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
such I-SPECULATION I-SPECULATION
cross-talking I-SPECULATION I-SPECULATION
among I-SPECULATION I-SPECULATION
distinct I-SPECULATION I-SPECULATION
adhesion I-SPECULATION I-SPECULATION
molecules I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
involved I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
pathogenesis I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
inflammation I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
including I-SPECULATION I-SPECULATION
RA I-SPECULATION I-SPECULATION
synovitis I-SPECULATION I-SPECULATION
. O O

Oleic O O
acid O O
inhibits O O
endothelial O O
activation O O
: O O
A O O
direct O O
vascular O O
antiatherogenic O O
mechanism O O
of O O
a O O
nutritional O O
component O O
in O O
the O O
mediterranean O O
diet O O
. O O

Because O O
oleic O O
acid O O
is O O
implicated O O
in O O
the O O
antiatherogenic O O
effects O O
attributed O O
to O O
the O O
Mediterranean O O
diet O O
, O O
we O O
investigated O O
whether B-SPECULATION B-SPECULATION
this I-SPECULATION I-SPECULATION
fatty I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
modulate I-SPECULATION I-SPECULATION
endothelial I-SPECULATION I-SPECULATION
activation I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
ie I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
concerted I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
products I-SPECULATION I-SPECULATION
involved I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
leukocyte I-SPECULATION I-SPECULATION
recruitment I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
early I-SPECULATION I-SPECULATION
atherogenesis I-SPECULATION I-SPECULATION
. O O

We O O
incubated O O
sodium O O
oleate O O
with O O
human O O
umbilical O O
vein O O
endothelial O O
cells O O
for O O
0 O O
to O O
72 O O
hours O O
, O O
followed O O
by O O
coincubation O O
of O O
oleate O O
with O O
human O O
recombinant O O
tumor O O
necrosis O O
factor O O
, O O
interleukin O O
( O O
IL O O
)- O O
1alpha O O
, O O
IL-1beta O O
, O O
IL-4 O O
, O O
Escherichia O O
coli O O
lipopolysaccharide O O
( O O
LPS O O
) O O
, O O
or O O
phorbol O O
12-myristate O O
13-acetate O O
for O O
a O O
further O O
6 O O
to O O
24 O O
hours O O
. O O

The O O
endothelial O O
expression O O
of O O
vascular O O
cell O O
adhesion O O
molecule-1 O O
( O O
VCAM-1 O O
) O O
, O O
E-selectin O O
, O O
and O O
intercellular O O
adhesion O O
molecule-1 O O
was O O
monitored O O
by O O
cell O O
surface O O
enzyme O O
immunoassays O O
or O O
flow O O
cytometry O O
, O O
and O O
steady-state O O
levels O O
of O O
VCAM-1 O O
mRNA O O
were O O
assessed O O
by O O
Northern O O
blot O O
analysis O O
. O O

At O O
10 O O
to O O
100 O O
micromol O O
/ O O
L O O
for O O
> O O
24 O O
hours O O
, O O
oleate O O
inhibited O O
the O O
expression O O
of O O
all O O
adhesion O O
molecules O O
tested O O
. O O

After O O
a O O
72-hour O O
incubation O O
with O O
oleate O O
and O O
a O O
further O O
16-hour O O
incubation O O
with O O
oleate O O
plus O O
1 O O
microg O O
/ O O
mL O O
LPS O O
, O O
VCAM-1 O O
expression O O
was O O
reduced O O
by O O
> O O
40 O O
% O O
compared O O
with O O
control O O
. O O

Adhesion O O
of O O
monocytoid O O
U937 O O
cells O O
to O O
LPS-treated O O
endothelial O O
cells O O
was O O
reduced O O
concomitantly O O
. O O

Oleate O O
also O O
produced O O
a O O
quantitatively O O
similar O O
reduction O O
of O O
VCAM-1 O O
mRNA O O
levels O O
on O O
Northern O O
blot O O
analysis O O
and O O
inhibited O O
nuclear O O
factor-kappaB O O
activation O O
on O O
electrophoretic O O
mobility O O
shift O O
assays O O
. O O

Incubation O O
of O O
endothelial O O
cells O O
with O O
oleate O O
for O O
72 O O
hours O O
decreased O O
the O O
relative O O
proportions O O
of O O
saturated O O
( O O
palmitic O O
and O O
stearic O O
) O O
acids O O
in O O
total O O
cell O O
lipids O O
and O O
increased O O
the O O
proportions O O
of O O
oleate O O
in O O
total O O
cell O O
lipids O O
without B-NEGATION B-NEGATION
significantly I-NEGATION I-NEGATION
changing I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
relative I-NEGATION I-NEGATION
proportions I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
polyunsaturated I-NEGATION I-NEGATION
fatty I-NEGATION I-NEGATION
acids I-NEGATION I-NEGATION
. O O

Although O O
less O O
potent O O
than O O
polyunsaturated O O
fatty O O
acids O O
in O O
inhibiting O O
endothelial O O
activation O O
, O O
oleic O O
acid O O
may B-SPECULATION B-SPECULATION
contribute I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
prevention I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
atherogenesis I-SPECULATION I-SPECULATION
through I-SPECULATION I-SPECULATION
selective I-SPECULATION I-SPECULATION
displacement I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
saturated I-SPECULATION I-SPECULATION
fatty I-SPECULATION I-SPECULATION
acids I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
cell I-SPECULATION I-SPECULATION
membrane I-SPECULATION I-SPECULATION
phospholipids I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
consequent I-SPECULATION I-SPECULATION
modulation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
expression I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
molecules I-SPECULATION I-SPECULATION
involved I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
monocyte I-SPECULATION I-SPECULATION
recruitment I-SPECULATION I-SPECULATION
. O O

Functional O O
association O O
of O O
Nmi O O
with O O
Stat5 O O
and O O
Stat1 O O
in O O
IL-2 O O
- O O
and O O
IFNgamma-mediated O O
signaling O O
. O O

Using O O
the O O
coiled-coil O O
region O O
of O O
Stat5b O O
as O O
the O O
bait O O
in O O
a O O
yeast O O
two-hybrid O O
screen O O
, O O
we O O
identified O O
the O O
association O O
of O O
Nmi O O
, O O
a O O
protein O O
of O O
unknown B-SPECULATION O
function I-SPECULATION O
previously O O
reported O O
as O O
an O O
N-Myc O O
interactor O O
. O O

We O O
further O O
show O O
that O O
Nmi O O
interacts O O
with O O
all O O
STATs O O
except O O
Stat2 O O
. O O

We O O
evaluated O O
two O O
cytokine O O
systems O O
, O O
IL-2 O O
and O O
IFNgamma O O
, O O
and O O
demonstrate O O
that O O
Nmi O O
augments O O
STAT-mediated O O
transcription O O
in O O
response O O
to O O
these O O
cytokines O O
. O O

Interestingly O O
, O O
Nmi O O
lacks B-NEGATION B-NEGATION
an I-NEGATION I-NEGATION
intrinsic I-NEGATION I-NEGATION
transcriptional I-NEGATION I-NEGATION
activation I-NEGATION I-NEGATION
domain I-NEGATION I-NEGATION
; O O
instead O O
, O O
Nmi O O
enhances O O
the O O
association O O
of O O
CBP O O
/ O O
p300 O O
coactivator O O
proteins O O
with O O
Stat1 O O
and O O
Stat5 O O
, O O
and O O
together O O
with O O
CBP O O
/ O O
p300 O O
can O O
augment O O
IL-2 O O
- O O
and O O
IFNgamma-dependent O O
transcription O O
. O O

Therefore O O
, O O
our O O
data O O
not O O
only O O
reveal O O
that O O
Nmi O O
can O O
potentiate O O
STAT-dependent O O
transcription O O
, O O
but O O
also O O
suggest B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
it I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
augment I-SPECULATION I-SPECULATION
coactivator I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
recruitment I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
at I-SPECULATION I-SPECULATION
least I-SPECULATION I-SPECULATION
some I-SPECULATION I-SPECULATION
members I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
group I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
sequence-specific I-SPECULATION I-SPECULATION
transcription I-SPECULATION I-SPECULATION
factors I-SPECULATION I-SPECULATION
. O O

Mining O O
prokaryotic O O
genomes O O
for O O
unknown O O
amino O O
acids O O
: O O
a O O
stop-codon-based O O
approach O O

Abstract O O

Background O O

Selenocysteine O O
and O O
pyrrolysine O O
are O O
the O O
21st O O
and O O
22nd O O
amino O O
acids O O
, O O
which O O
are O O
genetically O O
encoded O O
by O O
stop O O
codons O O
. O O

Since O O
a O O
number O O
of O O
microbial O O
genomes O O
have O O
been O O
completely O O
sequenced O O
to O O
date O O
, O O
it O O
is O O
tempting O O
to O O
ask O O
whether B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
23rd I-SPECULATION I-SPECULATION
amino I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
left I-SPECULATION I-SPECULATION
undiscovered I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
genomes I-SPECULATION I-SPECULATION
. O O

Recently O O
, O O
a O O
computational O O
study O O
addressed O O
this O O
question O O
and O O
reported O O
that O O
no B-NEGATION B-NEGATION
tRNA I-NEGATION I-NEGATION
gene I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
unknown I-NEGATION I-NEGATION
amino I-NEGATION I-NEGATION
acid I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
found I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
genome I-NEGATION I-NEGATION
sequences I-NEGATION I-NEGATION
available I-NEGATION I-NEGATION
. O O

However O O
, O O
performance B-SPECULATION O
of I-SPECULATION O
the I-SPECULATION O
tRNA I-SPECULATION O
prediction I-SPECULATION O
program I-SPECULATION O
on I-SPECULATION O
an I-SPECULATION O
unknown I-SPECULATION O
tRNA I-SPECULATION O
family I-SPECULATION O
, I-SPECULATION O
which I-SPECULATION O
unclear I-SPECULATION O
, O O
thereby O O
rendering O O
their O O
result O O
inconclusive O O
. O O
may B-SPECULATION B-SPECULATION
have I-SPECULATION I-SPECULATION
atypical I-SPECULATION I-SPECULATION
sequence I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
structure I-SPECULATION I-SPECULATION
, O O
is O O
. O O

A O O
protein-level O O
study O O
will O O
provide O O
independent O O
insight O O
into O O
the O O
novel O O
amino O O
acid O O
. O O

Results O O

Assuming B-SPECULATION O
that I-SPECULATION O
the I-SPECULATION O
23rd I-SPECULATION O
amino I-SPECULATION O
acid I-SPECULATION O
is I-SPECULATION O
also I-SPECULATION O
encoded I-SPECULATION O
by I-SPECULATION O
a I-SPECULATION O
stop I-SPECULATION O
codon I-SPECULATION O
, O O
we O O
systematically O O
predicted O O
proteins O O
that O O
contain O O
stop-codon-encoded O O
amino O O
acids O O
from O O
191 O O
prokaryotic O O
genomes O O
. O O

Since O O
our O O
prediction O O
method O O
relies O O
only O O
on O O
the O O
conservation O O
patterns O O
of O O
primary O O
sequences O O
, O O
it O O
also O O
provides O O
an O O
opportunity O O
to O O
search O O
novel O O
selenoproteins O O
and O O
other O O
readthrough O O
proteins O O
. O O

It O O
successfully O O
recovered O O
many O O
of O O
currently O O
known O O
selenoproteins O O
and O O
pyrrolysine O O
proteins O O
. O O

However O O
, O O
no B-NEGATION B-NEGATION
promising I-NEGATION I-NEGATION
candidate I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
23rd I-NEGATION I-NEGATION
amino I-NEGATION I-NEGATION
acid I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
detected I-NEGATION I-NEGATION
, O O
and O O
only O O
one O O
novel O O
selenoprotein O O
was O O
predicted O O
. O O

Conclusion O O

Our O O
result O O
suggests B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
, O I-SPECULATION
which O I-SPECULATION
is O I-SPECULATION
in O I-SPECULATION
agreement O I-SPECULATION
with O I-SPECULATION
the O I-SPECULATION
previous O I-SPECULATION
study O I-SPECULATION
on O I-SPECULATION
tRNA O I-SPECULATION
. O O
the B-SPECULATION B-SPECULATION
unknown I-SPECULATION I-SPECULATION
amino I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
encoded I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
stop I-SPECULATION I-SPECULATION
codons I-SPECULATION I-SPECULATION
does I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
its I-SPECULATION I-SPECULATION
phylogenetic I-SPECULATION I-SPECULATION
distribution I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
rather I-SPECULATION I-SPECULATION
limited I-SPECULATION I-SPECULATION
not B-NEGATION B-NEGATION
exist I-NEGATION I-NEGATION
, O I-NEGATION
. O O

The O O
method O O
described O O
here O O
can O O
be O O
used O O
in O O
future O O
studies O O
to O O
explore O O
novel O O
readthrough O O
events O O
from O O
complete O O
genomes O O
, O O
which O O
are O O
rapidly O O
growing O O
. O O

Background O O

Stop O O
codon O O
readthrough O O
is O O
a O O
phenomenon O O
in O O
which O O
the O O
translation O O
process O O
does O O
not B-NEGATION B-NEGATION
terminate I-NEGATION I-NEGATION
at I-NEGATION I-NEGATION
a I-NEGATION I-NEGATION
stop I-NEGATION I-NEGATION
codon I-NEGATION I-NEGATION
, O O
and O O
an O O
amino O O
acid O O
is O O
inserted O O
there O O
instead O O
12 O O
. O O

In O O
some O O
cases O O
, O O
the O O
inserted O O
amino O O
acid O O
is O O
not B-NEGATION B-NEGATION
one I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
20 I-NEGATION I-NEGATION
amino I-NEGATION I-NEGATION
acids I-NEGATION I-NEGATION
but O O
a O O
noncanonical O O
one O O
. O O

Two O O
such O O
amino O O
acids O O
have O O
been O O
discovered O O
to O O
date O O
: O O
selenocysteine O O
34 O O
and O O
pyrrolysine O O
56 O O
. O O

Because O O
each O O
of O O
them O O
have O O
specialized O O
tRNA O O
genes O O
for O O
decoding O O
and O O
can O O
be O O
considered O O
extensions O O
of O O
the O O
standard O O
genetic O O
code O O
, O O
they O O
are O O
called O O
the O O
21st O O
and O O
22nd O O
amino O O
acids O O
, O O
respectively O O
. O O

Selenocysteine O O
, O O
the O O
21st O O
amino O O
acid O O
, O O
is O O
encoded O O
by O O
stop O O
codon O O
UGA O O
, O O
and O O
organisms O O
that O O
use O O
selenocysteine O O
have O O
been O O
found O O
from O O
all O O
three O O
domains O O
of O O
life O O
. O O

Its O O
insertion O O
into O O
UGA O O
is O O
directed O O
by O O
SECIS O O
( O O
selenocysteine O O
insertion O O
sequence O O
) O O
elements O O
, O O
a O O
stem-loop O O
structure O O
on O O
the O O
selenoprotein O O
mRNA O O
. O O

Along O O
with O O
the O O
progress O O
of O O
genome O O
sequencing O O
projects O O
, O O
computational O O
prediction O O
methods O O
of O O
selenocysteine-containing O O
proteins O O
( O O
selenoproteins O O
) O O
have O O
been O O
developed O O
by O O
several O O
research O O
groups O O
78910 O O
, O O
and O O
the O O
repertoire O O
of O O
selenoproteins O O
has O O
been O O
greatly O O
expanded O O
1112 O O
. O O

Pyrrolysine O O
, O O
the O O
22nd O O
amino O O
acid O O
encoded O O
by O O
stop O O
codon O O
UAG O O
, O O
was O O
recently O O
discovered O O
from O O
a O O
methanogenic O O
archaea O O
56 O O
. O O

Currently O O
, O O
only O O
methanogenic O O
archaea O O
of O O
the O O
order O O
Methanosarcinales O O
and O O
one O O
bacterium O O
are O O
considered O O
to O O
utilize O O
pyrrolysine O O
13 O O
. O O

The O O
limited O O
phylogenetic O O
distribution O O
of O O
pyrrolysine O O
suggests B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
its I-SPECULATION I-SPECULATION
incorporation I-SPECULATION I-SPECULATION
into I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
genetic I-SPECULATION I-SPECULATION
code I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
methanogen I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
relatively I-SPECULATION I-SPECULATION
recent I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
insertion I-SPECULATION I-SPECULATION
mechanism I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
novel I-SPECULATION I-SPECULATION
amino I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
can B-SPECULATION I-SPECULATION
evolve I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
shorter I-SPECULATION I-SPECULATION
period I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
time I-SPECULATION I-SPECULATION
than I-SPECULATION I-SPECULATION
anticipated I-SPECULATION I-SPECULATION
. O O

This O O
raises B-SPECULATION B-SPECULATION
an I-SPECULATION I-SPECULATION
interesting I-SPECULATION I-SPECULATION
question I-SPECULATION I-SPECULATION
: I-SPECULATION O
: I-SPECULATION O
"" I-SPECULATION O
Is I-SPECULATION O
there I-SPECULATION O
a I-SPECULATION O
23rd I-SPECULATION O
amino I-SPECULATION O
acid I-SPECULATION O
" I-SPECULATION O
?" O O
. O O

If O O
such O O
an O O
amino O O
acid O O
is O O
discovered O O
, O O
it O O
will O O
deepen O O
our O O
understanding O O
of O O
the O O
evolution O O
and O O
diversity O O
of O O
the O O
genetic O O
code O O
. O O

Because O O
genome O O
sequences O O
of O O
various O O
prokaryotes O O
are O O
available O O
today O O
, O O
there O O
will O O
be O O
a O O
chance O O
to O O
discover O O
the O O
novel O O
amino O O
acid O O
via O O
analysis O O
of O O
these O O
genomes O O
. O O

Since O O
both O O
the O O
21st O O
and O O
22nd O O
amino O O
acids O O
are O O
encoded O O
by O O
stop O O
codons O O
, O O
the O O
prime O O
suspect O O
is O O
other O O
stop O O
codons O O
( O O
e.g. O O
stop O O
codon O O
UAA O O
) O O
, O O
although O O
the O O
possibility O O
of O O
sense O O
codons O O
certainly O O
remains O O
. O O

Using O O
this O O
clue O O
, O O
computational O O
screening O O
methods O O
of O O
the O O
23rd O O
amino O O
acid O O
can O O
be O O
designed O O
. O O

Recently O O
, O O
Lobanov O O
et O O
al. O O
addressed O O
this O O
problem O O
by O O
searching O O
tRNAs O O
with O O
anticodons O O
corresponding O O
to O O
stop O O
codons O O
14 O O
. O O

They O O
analyzed O O
146 O O
prokaryotic O O
genomes O O
, O O
but O O
no B-NEGATION B-NEGATION
likely I-NEGATION B-SPECULATION
tRNA I-NEGATION I-SPECULATION
of I-NEGATION I-SPECULATION
the I-NEGATION I-SPECULATION
novel I-NEGATION I-SPECULATION
amino I-NEGATION I-SPECULATION
acid I-NEGATION I-SPECULATION
was I-NEGATION I-SPECULATION
detected I-NEGATION I-SPECULATION
. O O

They O O
concluded O O
that O O
the O O
23rd O O
amino O O
acid O O
would B-SPECULATION B-SPECULATION
have I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
limited I-SPECULATION I-SPECULATION
phylogenetic I-SPECULATION I-SPECULATION
distribution I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
if I-SPECULATION I-SPECULATION
it I-SPECULATION I-SPECULATION
exists I-SPECULATION I-SPECULATION
. O O

However O O
, O O
programs O O
for O O
tRNA O O
identification O O
are O O
based O O
on O O
the O O
features O O
of O O
known O O
tRNAs O O
and O O
do O O
not O B-NEGATION
necessarily O I-NEGATION
perform O I-NEGATION
well O I-NEGATION
on O I-NEGATION
unknown O I-NEGATION
ones O I-NEGATION
. O O

Actually O O
, O O
tRNASec O O
and O O
tRNAPyl O O
have O O
unusual O O
secondary O O
structures O O
515 O O
and O O
often O O
escape O O
detection O O
by O O
programs O O
without B-NEGATION B-NEGATION
special I-NEGATION I-NEGATION
consideration I-NEGATION I-NEGATION
. O O

Lobanov O O
et O O
al. O O
thus O O
developed O O
a O O
sensitive O O
search O O
method O O
to O O
deal O O
with O O
this O O
problem O O
, O O
but O O
they O O
also O O
admitted O O
that O O
it O O
would B-SPECULATION B-SPECULATION
fail B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
identify I-NEGATION I-NEGATION
highly I-NEGATION I-NEGATION
unusual I-NEGATION I-NEGATION
tRNAs I-NEGATION I-NEGATION
. O O

There O O
is O O
another O O
approach O O
to O O
searching O O
for O O
the O O
23rd O O
amino O O
acid O O
. O O

By O O
enumerating O O
ORFs O O
that O O
have O O
an O O
inframe O O
stop O O
codon O O
from O O
genomes O O
and O O
examining O O
their O O
evolutionary O O
conservation O O
, O O
candidate O O
proteins O O
can O O
be O O
predicted O O
. O O

Because O O
such O O
an O O
ORF-based O O
study O O
is O O
independent O O
from O O
the O O
tRNA O O
analysis O O
, O O
it O O
can O O
either B-SPECULATION O
identify I-SPECULATION O
candidate I-SPECULATION O
organisms I-SPECULATION O
missed I-SPECULATION O
by I-SPECULATION O
the I-SPECULATION O
previous I-SPECULATION O
study I-SPECULATION O
. O O

Here O O
we O O
report O O
a O O
comprehensive O O
analysis O O
of O O
prokaryotic O O
ORFs O O
that O O
contain O O
an O O
inframe O O
stop O O
codon O O
. O O

Through O O
enumeration O O
of O O
theoretical O O
ORFs O O
and O O
inspection O O
of O O
their O O
evolutionary O O
conservation O O
, O O
candidates O O
of O O
readthrough O O
proteins O O
were O O
predicted O O
. O O

They O O
contained O O
many O O
of O O
the O O
known O O
proteins O O
with O O
stop-codon-encoded O O
amino O O
acids O O
, O O
but O O
almost O O
no O B-NEGATION
novel O I-NEGATION
candidates O I-NEGATION
were O I-NEGATION
identified O I-NEGATION
. O O

Therefore O O
, O O
the B-SPECULATION O
unknown I-SPECULATION O
amino I-SPECULATION O
acid I-SPECULATION O
, I-SPECULATION O
if I-SPECULATION O
it I-SPECULATION O
is I-SPECULATION O
encoded I-SPECULATION O
by I-SPECULATION O
a I-SPECULATION O
stop I-SPECULATION O
codon I-SPECULATION O
, I-SPECULATION O
is I-SPECULATION O
unlikely I-SPECULATION B-SPECULATION
to I-SPECULATION I-SPECULATION
exist I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
current I-SPECULATION I-SPECULATION
databases I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
microbial I-SPECULATION I-SPECULATION
genomes I-SPECULATION I-SPECULATION
. O O

The O O
consequences O O
for O O
selenoproteins O O
and O O
other O O
readthrough O O
genes O O
are O O
also O O
discussed O O
. O O

Results O O

Basic O O
ideas O O

In O O
this O O
study O O
, O O
we O O
focus O O
on O O
theoretical O O
ORFs O O
with O O
one O O
inframe O O
stop O O
codon O O
, O O
termed O O
" O O
interrupted O O
ORFs O O
" O O
( O O
iORFs O O
) O O
( O O
Figure O O
1a O O
) O O
. O O

If O O
we O O
enumerate O O
all O O
iORFs O O
from O O
microbial O O
genomes O O
, O O
most O O
of O O
the O O
readthrough O O
genes O O
will O O
be O O
included O O
in O O
them O O
. O O

However O O
, O O
the O O
vast O O
majority O O
of O O
the O O
enumerated O O
iORFs O O
will O O
be O O
biologically O O
meaningless O O
. O O

To O O
filter O O
out O O
such O O
meaningless O O
iORFs O O
, O O
we O O
required O O
the O O
iORFs O O
to O O
have O O
at O O
least O O
one O O
homolog O O
in O O
other O O
genomes O O
, O O
because O O
evolutionary O O
conservation O O
of O O
primary O O
sequence O O
is O O
a O O
strong O O
indicator O O
of O O
functional O O
importance O O
. O O

However O O
, O O
this O O
condition O O
is O O
not B-NEGATION B-NEGATION
sufficient I-NEGATION I-NEGATION
, O O
since O O
two O O
major O O
problems O O
remain O O
: O O
: O O
pseudogenes O O
and O O
two O O
adjacent O O
genes O O
. O O

The O O
first O O
problem O O
is O O
that O O
even O O
if O O
an O O
iORF O O
has O O
homologs O O
in O O
other O O
species O O
, O O
it O B-SPECULATION
could B-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
a B-SPECULATION I-SPECULATION
pseudogene I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
product I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
sequencing I-SPECULATION I-SPECULATION
error I-SPECULATION I-SPECULATION
. O O

The O O
second O O
problem O O
is O O
that O O
adjacent O O
genes O O
on O O
the O O
same O O
reading O O
frame O O
may B-SPECULATION B-SPECULATION
satisfy I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
condition I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
conserved I-SPECULATION I-SPECULATION
iORFs I-SPECULATION I-SPECULATION
. O O

In O O
particular O O
, O O
gene O O
pairs O O
within O O
an O O
operon O O
are O O
problematic O O
because O O
their O O
gene O O
arrangement O O
is O O
often O O
conserved O O
. O O

If O O
the B-SPECULATION O
intergenic I-SPECULATION O
distance I-SPECULATION O
between I-SPECULATION O
two I-SPECULATION O
genes I-SPECULATION O
in I-SPECULATION O
an I-SPECULATION O
operon I-SPECULATION O
happens I-SPECULATION O
to I-SPECULATION O
be I-SPECULATION O
a I-SPECULATION O
multiple I-SPECULATION O
of I-SPECULATION O
three I-SPECULATION O
, O O
they O O
look B-SPECULATION O
like I-SPECULATION O
a I-SPECULATION O
conserved I-SPECULATION O
readthrough I-SPECULATION O
gene I-SPECULATION O
. O O

Basic O O
ideas O O
of O O
the O O
prediction O O
method O O

Basic O O
ideas O O
of O O
the O O
prediction O O
method O O
. O O

( O O
a O O
) O O
Schematic O O
illustration O O
of O O
an O O
interrupted O O
ORF O O
( O O
iORF O O
) O O
. O O

( O O
b O O
) O O
Readthrough O O
genes O O
can O O
be O O
distinguished O O
from O O
two O O
adjacent O O
genes O O
based O O
on O O
the O O
results O O
of O O
BLAST O O
searches O O
. O O

Boxes O O
denote O O
iORFs O O
, O O
and O O
× O O
indicates O O
the O O
inframe O O
stop O O
codon O O
. O O

Shaded O O
regions O O
represent O O
actual O O
protein-coding O O
regions O O
. O O

If O O
an O O
iORF O O
codes O O
a O O
readthrough O O
protein O O
, O O
BLAST O O
hits O O
from O O
other O O
organisms O O
will O O
cover O O
the O O
inframe O O
stop O O
codon O O
. O O

In O O
contrast O O
, O O
if O O
the O O
iORF O O
consists O O
of O O
two O O
adjacent O O
genes O O
, O O
many O O
hits O O
that O O
do O O
not B-NEGATION B-NEGATION
cover I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
inframe I-NEGATION I-NEGATION
stop I-NEGATION I-NEGATION
codon I-NEGATION I-NEGATION
will O I-NEGATION
be O I-NEGATION
found O I-NEGATION
. O O

To O O
discriminate O O
them O O
from O O
true O O
readthrough O O
genes O O
, O O
evolutionary O O
information O O
was O O
exploited O O
. O O

In O O
order O O
to O O
eliminate O O
pseudogenes O O
and O O
sequencing O O
errors O O
, O O
conservation O O
of O O
iORFs O O
and O O
their O O
inframe O O
stop O O
codons O O
was O O
examined O O
. O O

Since O O
pseudogenes O O
are O O
less O O
conserved O O
, O O
and O O
sequencing O O
errors O O
are O O
relatively O O
rare O O
events O O
, O O
they O O
will O O
not B-NEGATION B-NEGATION
have I-NEGATION I-NEGATION
homologous I-NEGATION I-NEGATION
iORFs I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
other I-NEGATION I-NEGATION
species I-NEGATION I-NEGATION
. O O

Even O O
if O O
they O O
do O O
, O O
the O O
position O O
or O O
type O O
( O O
UAA O O
, O O
UAG O O
or O O
UGA O O
) O O
of O O
their O O
inframe O O
stop O O
codons O O
will O O
not B-NEGATION B-NEGATION
coincide I-NEGATION I-NEGATION
. O O

In O O
this O O
way O O
, O O
they O O
can O O
be O O
eliminated O O
as O O
candidates O O
. O O

A O O
drawback O O
of O O
this O O
criterion O O
is O O
that O O
it O O
limits O O
the O O
target O O
of O O
our O O
study O O
to O O
readthrough O O
genes O O
conserved O O
across O O
two O O
or O O
more O O
species O O
. O O

In O O
other O O
words O O
, O O
species-specific O O
readthrough O O
genes O O
are O O
not B-NEGATION B-NEGATION
in I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
scope I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
this I-NEGATION I-NEGATION
study I-NEGATION I-NEGATION
. O O

To O O
address O O
the O O
second O O
problem O O
, O O
adjacent O O
gene O O
pairs O O
were O O
filtered O O
out O O
by O O
examining O O
boundaries O O
of O O
sequence O O
alignments O O
between O O
iORFs O O
and O O
its O O
homologs O O
( O O
Figure O O
1b O O
) O O
. O O

The O O
stop-codon-encoded O O
amino O O
acids O O
of O O
prokaryotes O O
are O O
usually O O
located O O
inside O O
domains O O
, O O
the O O
units O O
of O O
evolutionary O O
sequence O O
conservation O O
. O O

Therefore O O
, O O
the O O
aligned O O
regions O O
of O O
readthrough O O
proteins O O
contain O O
their O O
inframe O O
stop O O
codon O O
. O O

Based O O
on O O
this O O
observation O O
, O O
each O O
iORF O O
was O O
required O O
to O O
have O O
: O O
: O O
( O O
i O O
) O O
at O O
least O O
one O O
homolog O O
from O O
other O O
organisms O O
that O O
covers O O
the O O
inframe O O
stop O O
codon O O
and O O
( O O
ii O O
) O O
no B-NEGATION B-NEGATION
homolog I-NEGATION I-NEGATION
that I-NEGATION I-NEGATION
does I-NEGATION I-NEGATION
not B-NEGATION B-NEGATION
cover I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
stop I-NEGATION I-NEGATION
codon I-NEGATION I-NEGATION
. O O

Note O O
that O O
, O O
however O O
, O O
if O O
the O O
whole O O
length O O
of O O
an O O
iORF O O
was O O
used O O
as O O
a O O
query O O
sequence O O
, O O
this O O
procedure O O
will O O
erroneously O O
discard O O
multidomain O O
readthrough O O
proteins O O
. O O

To O O
avoid O O
this O O
problem O O
, O O
a O O
partial O O
sequence O O
around O O
the O O
inframe O O
stop O O
codon O O
was O O
used O O
as O O
a O O
query O O
. O O

Prediction O O
procedure O O

The O O
prediction O O
schema O O
is O O
shown O O
in O O
Figure O O
2 O O
. O O

A O O
total O O
of O O
191 O O
prokaryotes O O
were O O
analyzed O O
in O O
this O O
study O O
, O O
of O O
which O O
166 O O
are O O
bacteria O O
and O O
25 O O
are O O
archaea O O
. O O

They O O
were O O
selected O O
from O O
328 O O
prokaryotes O O
with O O
completely O O
sequenced O O
genomes O O
by O O
excluding O O
closely O O
related O O
species O O
. O O

From O O
the O O
genome O O
sequences O O
of O O
the O O
191 O O
organisms O O
, O O
all O O
possible O O
iORFs O O
were O O
enumerated O O
. O O

Two O O
conditions O O
were O O
imposed O O
on O O
the O O
geometry O O
of O O
the O O
iORFs O O
( O O
Figure O O
1a O O
) O O
. O O

First O O
, O O
only O O
iORFs O O
longer O O
than O O
80 O O
codons O O
were O O
extracted O O
. O O

Secondly O O
, O O
margins O O
between O O
the O O
inframe O O
stop O O
codon O O
and O O
both O O
termini O O
of O O
the O O
iORF O O
must O O
be O O
longer O O
than O O
10 O O
codons O O
. O O

The O O
total O O
number O O
of O O
iORFs O O
extracted O O
under O O
these O O
conditions O O
was O O
2,969,958 O O
. O O

Next O O
, O O
iORFs O O
that O O
overlap O O
RNA O O
genes O O
or O O
protein-coding O O
genes O O
in O O
different O O
reading O O
frames O O
were O O
discarded O O
. O O

This O O
test O O
significantly O O
reduced O O
the O O
number O O
of O O
iORFs O O
to O O
390,926 O O
. O O

A O O
flowchart O O
of O O
the O O
prediction O O
procedure O O

A O O
flowchart O O
of O O
the O O
prediction O O
procedure O O
. O O

Several O O
steps O O
are O O
omitted O O
for O O
simplicity O O
. O O

Detailed O O
explanation O O
is O O
given O O
in O O
the O O
text O O
. O O

As O O
noted O O
above O O
, O O
the O O
target O O
of O O
this O O
study O O
is O O
evolutionarily O O
conserved O O
iORFs O O
. O O

Thus O O
, O O
it O O
was O O
examined O O
whether B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
iORFs I-SPECULATION I-SPECULATION
have I-SPECULATION I-SPECULATION
homologous I-SPECULATION I-SPECULATION
regions I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
other I-SPECULATION I-SPECULATION
genomes I-SPECULATION I-SPECULATION
. O O

The O O
390,926 O O
iORFs O O
were O O
translated O O
into O O
amino O O
acid O O
sequences O O
and O O
subjected O O
to O O
TBLASTN O O
16 O O
against O O
the O O
191 O O
genome O O
sequences O O
. O O

Instead B-NEGATION O
of I-NEGATION O
the I-NEGATION O
whole I-NEGATION O
length I-NEGATION O
of I-NEGATION O
the I-NEGATION O
amino I-NEGATION O
acid I-NEGATION O
sequence I-NEGATION O
, O O
a O O
window O O
of O O
101 O O
residues O O
centered O O
at O O
the O O
inframe O O
stop O O
codon O O
was O O
used O O
as O O
a O O
BLAST O O
query O O
. O O

After O O
the O O
BLAST O O
searches O O
, O O
iORFs O O
that O O
have O O
at O O
least O O
one O O
interspecific O O
hit O O
that O O
contains O O
the O O
inframe O O
stop O O
codon O O
were O O
collected O O
. O O

Whether B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
codon I-SPECULATION I-SPECULATION
aligned I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
inframe I-SPECULATION I-SPECULATION
stop I-SPECULATION I-SPECULATION
codon I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
was O I-SPECULATION
neglected O I-SPECULATION
at O I-SPECULATION
this O I-SPECULATION
stage O I-SPECULATION
. O O
a B-SPECULATION B-SPECULATION
nonsense I-SPECULATION I-SPECULATION
codon I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
not B-NEGATION B-NEGATION
. O O

There O O
were O O
94,690 O O
iORFs O O
that O O
have O O
interspecific O O
hits O O
. O O

The O O
result O O
of O O
the O O
above O O
homology O O
searches O O
was O O
also O O
used O O
for O O
the O O
boundary O O
analysis O O
( O O
Figure O O
1b O O
) O O
. O O

An O O
iORF O O
was O O
discarded O O
if O O
there O O
were O O
any O O
BLAST O O
hits O O
that O O
do O O
not B-NEGATION B-NEGATION
cover I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
inframe I-NEGATION I-NEGATION
stop I-NEGATION I-NEGATION
codon I-NEGATION I-NEGATION
. O O

A O O
total O O
of O O
26,003 O O
iORF O O
satisfied O O
the O O
above O O
criteria O O
. O O

To O O
examine O O
intrafamily O O
conservation O O
of O O
the O O
inframe O O
stop O O
codons O O
, O O
these O O
iORFs O O
were O O
clustered O O
into O O
protein O O
families O O
based O O
on O O
sequence O O
similarity O O
. O O

After O O
removal O O
of O O
singletons O O
, O O
679 O O
clusters O O
with O O
two O O
or O O
more O O
members O O
were O O
obtained O O
. O O

A O O
cluster O O
was O O
discarded O O
unless O O
all O O
members O O
of O O
the O O
cluster O O
had O O
the O O
same O O
type O O
of O O
inframe O O
stop O O
codons O O
( O O
UAA O O
, O O
UAG O O
or O O
UGA O O
) O O
. O O

The O O
locations O O
of O O
the O O
inframe O O
stop O O
codons O O
were O O
also O O
required O O
to O O
be O O
identical O O
in O O
the O O
multiple O O
sequence O O
alignment O O
of O O
the O O
cluster O O
members O O
. O O

These O O
conditions O O
reduced O O
the O O
number O O
of O O
clusters O O
to O O
273 O O
. O O

Manual O O
inspection O O
of O O
these O O
273 O O
clusters O O
revealed O O
that O O
they O O
still O O
contain O O
many O O
false O O
positives O O
that O O
are O O
unrelated O O
to O O
stop-codon-encoded O O
amino O O
acids O O
. O O

Hence O O
, O O
three-step O O
filtering O O
procedures O O
were O O
applied O O
to O O
remove O O
the O O
false O O
positives O O
. O O

Briefly O O
, O O
the O O
first O O
filter O O
assesses O O
protein-likeliness O O
based O O
on O O
the O O
signal O O
of O O
purifying O O
selection O O
, O O
while O O
the O O
second O O
and O O
third O O
filters O O
try O O
to O O
remove O O
adjacent O O
gene O O
pairs O O
using O O
the O O
pattern O O
of O O
BLAST O O
alignments O O
( O O
for O O
details O O
, O O
see O O
Materials O O
and O O
Methods O O
) O O
. O O

As O O
a O O
result O O
of O O
the O O
filtering O O
, O O
the O O
number O O
of O O
candidate O O
clusters O O
was O O
reduced O O
to O O
32 O O
. O O

Through O O
manual O O
inspection O O
of O O
the O O
BLAST O O
alignments O O
, O O
11 O O
clusters O O
were O O
discarded O O
because O O
they B-SPECULATION O
are I-SPECULATION O
highly I-SPECULATION O
unlikely I-SPECULATION B-SPECULATION
to I-SPECULATION I-SPECULATION
code I-SPECULATION I-SPECULATION
readthrough I-SPECULATION I-SPECULATION
proteins I-SPECULATION I-SPECULATION
. O O

Known O O
proteins O O
in O O
the O O
predicted O O
clusters O O

The O O
clusters O O
predicted O O
by O O
our O O
method O O
are O O
summarized O O
in O O
Table O O
1 O O
. O O

Of O O
the O O
21 O O
clusters O O
, O O
15 O O
were O O
known O O
selenoproteins O O
, O O
and O O
four O O
were O O
known O O
pyrrolysine O O
proteins O O
. O O

To O O
assess O O
the O O
sensitivity O O
of O O
our O O
method O O
, O O
the O O
result O O
was O O
compared O O
with O O
a O O
list O O
of O O
prokaryotic O O
selenoproteins O O
reported O O
by O O
Kryukov O O
and O O
Gladyshev O O
12 O O
. O O

Since O O
our O O
target O O
is O O
readthrough O O
genes O O
conserved O O
across O O
two O O
or O O
more O O
species O O
, O O
such O O
selenoprotein O O
families O O
were O O
selected O O
from O O
their O O
list O O
. O O

There O O
were O O
15 O O
families O O
satisfying O O
this O O
criterion O O
, O O
but O O
one O O
family O O
, O O
proline O O
reductase O O
, O O
was O O
excluded O O
because O O
it O O
was O O
found O O
in O O
only O O
one O O
organism O O
in O O
our O O
dataset O O
. O O

Of O O
the O O
14 O O
families O O
, O O
11 O O
were O O
found O O
in O O
our O O
prediction O O
result O O
. O O

The O O
three O O
families O O
we O O
failed B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
find I-NEGATION I-NEGATION
were O I-NEGATION
SelW-like O I-NEGATION
protein O I-NEGATION
, O I-NEGATION
peroxiredoxin O I-NEGATION
and O I-NEGATION
thiol O I-NEGATION
: O I-NEGATION
protein O I-NEGATION
disulphide O I-NEGATION
oxidoreductase O I-NEGATION
. O O

SelW-like O O
protein O O
was O O
below O O
the O O
threshold O O
of O O
detection O O
, O O
because O O
its O O
stop O O
codon O O
is O O
near O O
the O O
N-terminus O O
and O O
the O O
amino O O
acid O O
sequences O O
of O O
its O O
members O O
are O O
too O O
divergent O O
. O O

The O O
reason O O
why O O
the B-NEGATION B-NEGATION
two I-NEGATION I-NEGATION
other I-NEGATION I-NEGATION
families I-NEGATION I-NEGATION
were I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
detected I-NEGATION I-NEGATION
is O O
more O O
complex O O
. O O

Since O O
these O O
two O O
families O O
are O O
homologous O O
, O O
they O O
were O O
grouped O O
into O O
an O O
identical O O
cluster O O
at O O
the O O
clustering O O
stage O O
of O O
our O O
method O O
. O O

However O O
, O O
the O O
positions O O
of O O
selenocysteine O O
were O O
different O O
between O O
the O O
two O O
families O O
( O O
Figure O O
3 O O
) O O
. O O

The O O
cluster O O
was O O
thus O O
discarded O O
because O O
of O O
an O O
apparent B-SPECULATION O
lack B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
stop I-NEGATION I-NEGATION
codon I-NEGATION I-NEGATION
conservation I-NEGATION I-NEGATION
. O O

To O O
deal O O
with O O
a O O
situation O O
like O O
this O O
, O O
a O O
reexamination O O
of O O
the O O
clustering O O
threshold O O
and O O
subdivision O O
of O O
clusters O O
will O O
be O O
required O O
. O O

Predicted O O
clusters O O
of O O
readthrough O O
proteins O O

A O O
plus O O
sign O O
in O O
a O O
locus O O
indicates B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
genomic I-SPECULATION I-SPECULATION
coordinates I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
iORF I-SPECULATION I-SPECULATION
can I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
described I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
concatenation I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
two I-SPECULATION I-SPECULATION
genes B-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
regions I-SPECULATION I-SPECULATION
. O O

For O O
example O O
, O O
" O O
GSU2293 O O
+ O O
downstream O O
" O O
means O O
that O O
the O O
iORF O O
consists O O
of O O
the O O
gene O O
GSU2293 O O
and O O
its O O
downstream O O
sequence O O
. O O

HesB B-NEGATION B-NEGATION
family I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
clustered I-NEGATION I-NEGATION
into I-NEGATION I-NEGATION
one I-NEGATION I-NEGATION
family I-NEGATION I-NEGATION
, O O
because O O
their O O
sequences O O
were O O
too O O
short O O
and O O
diverged O O
. O O

Selenoprotein B-NEGATION O
families I-NEGATION O
we I-NEGATION O
failed I-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
detect I-NEGATION I-NEGATION
because O O
of O O
nonconserved O O
location O O
of O O
stop O O
codons O O
. O O

Selenoprotein B-NEGATION O
families I-NEGATION O
we I-NEGATION O
failed I-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
detect I-NEGATION I-NEGATION
because O O
of O O
nonconserved O O
location O O
of O O
stop O O
codons O O
. O O

Selenocysteine O O
residues O O
of O O
Peroxiredoxin-like O O
protein O O
families O O
constitute O O
homologous O O
redox O O
motifs O O
( O O
TXXU O O
and O O
UXXC O O
) O O
, O O
but O O
their O O
positions O O
are O O
different O O
between O O
two O O
families O O
. O O

Columns O O
are O O
colored O O
according O O
to O O
sequence O O
conservation O O
. O O

Selenocysteine O O
residues O O
are O O
shown O O
in O O
red O O
, O O
and O O
the O O
other O O
residues O O
in O O
the O O
redox O O
motifs O O
are O O
shown O O
in O O
yellow O O
. O O

Prx O O
; O O
Peroxiredoxin O O
, O O
TPO O O
; O O
thiol O O
: O O
protein O O
disulphide O O
oxidereductase O O
, O O
Adeh O O
; O O
Anaeromyxobacter O O
dehalogenans O O
, O O
Gmet O O
; O O
Geobacter O O
metallireducens O O
, O O
Gsul O O
; O O
G. O O
sulfurreducens O O
, O O
Dpsy O O
; O O
Desulfotalea O O
psychrophila O O
. O O

The O O
alignments O O
were O O
computed O O
using O O
ClustalW O O
, O O
and O O
the O O
figures O O
were O O
generated O O
using O O
Jalview O O
. O O

Of O O
the O O
four O O
pyrrolysine O O
proteins O O
detected O O
, O O
three O O
methylamine O O
methyltransferases O O
have O O
been O O
experimentally O O
confirmed O O
to O O
contain O O
pyrrolysine O O
617 O O
. O O

The O O
rest O O
is O O
a O O
cluster O O
of O O
TetR-like O O
transcriptional O O
regulators O O
from O O
Methanosarcina O O
acetivorans O O
and O O
M. O O
barkeri O O
. O O

Since O O
the O O
genome O O
annotation O O
of O O
M. O O
acetivorans O O
describes O O
this O O
protein O O
as O O
a O O
gene O O
containing O O
an O O
inframe O O
amber O O
codon O O
, O O
we O O
classified O O
it O O
as O O
a O O
'' O O
known O O
'' O O
candidate O O
, O O
although O O
it O O
is O O
still O O
unclear B-SPECULATION B-SPECULATION
whether B-SPECULATION B-SPECULATION
it I-SPECULATION I-SPECULATION
really I-SPECULATION I-SPECULATION
contains I-SPECULATION I-SPECULATION
pyrrolysine I-SPECULATION I-SPECULATION
. O O

The O O
genome O O
annotation O O
of O O
M. O O
acetivorans O O
also O O
includes O O
several O O
amber-containing O O
genes O O
that B-NEGATION O
were I-NEGATION O
absent I-NEGATION O
from I-NEGATION O
our I-NEGATION O
prediction I-NEGATION O
result I-NEGATION O
. O O

They O O
are O O
a O O
methlycobamide O O
: O O
CoM O O
methylase O O
and O O
four O O
transposases O O
18 O O
. O O

The O B-NEGATION
reason O I-NEGATION
why O I-NEGATION
they B-NEGATION I-NEGATION
were I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
detected I-NEGATION I-NEGATION
is O O
that O O
only O O
one O O
species O O
in O O
our O O
dataset O O
had O O
an O O
amber-containing O O
form O O
of O O
these O O
proteins O O
. O O

This O O
is O O
unavoidable O O
because O O
of O O
the O O
inability O O
of O O
our O O
method O O
to O O
detect O O
species-specific O O
readthrough O O
events O O
. O O

It O O
is O O
the O O
price O O
for O O
reliably O O
excluding O O
pseudogenes O O
and O O
sequencing O O
errors O O
. O O

Unknown O O
candidates O O
in O O
the O O
predicted O O
clusters O O

The O O
successful O O
detection O O
of O O
many O O
known O O
proteins O O
is O O
encouraging O O
, O O
because O O
our O O
method O O
relies O O
only O O
on O O
general O O
properties O O
of O O
proteins O O
that O O
contain O O
stop-codon-encoded O O
amino O O
acids O O
, O O
but O O
not B-NEGATION B-NEGATION
on I-NEGATION I-NEGATION
specific I-NEGATION I-NEGATION
features I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
selenocysteine I-NEGATION I-NEGATION
or I-NEGATION I-NEGATION
pyrrolysine I-NEGATION I-NEGATION
. O O

Therefore O O
, O O
unknown O O
clusters O O
in O O
our O O
candidates O O
have O O
possibilities O O
for O O
the O O
23rd O O
amino O O
acid O O
or O O
novel O O
readthrough O O
proteins O O
. O O

There O O
were O O
two O O
such O O
clusters O O
( O O
Table O O
1 O O
) O O
. O O

The O O
first O O
cluster O O
is O O
comprised O O
of O O
c-type O O
cytochromes O O
from O O
δ-proteobacteria O O
Geobacter O O
sulfurreducens O O
and O O
G. O O
metallireducens O O
. O O

The O O
N-terminal O O
part O O
of O O
the O O
sequence O O
contains O O
five O O
CXXCH O O
heme-biding O O
motifs O O
, O O
while O O
the O O
C-terminal O O
part O O
has O O
no B-NEGATION B-NEGATION
similarity I-NEGATION I-NEGATION
with I-NEGATION I-NEGATION
any I-NEGATION I-NEGATION
characterized I-NEGATION I-NEGATION
proteins I-NEGATION I-NEGATION
. O O

Homology O O
search O O
against O O
unfinished O O
microbial O O
genomes O O
identified O O
seven O O
homologous O O
proteins O O
from O O
four O O
other O O
δ-proteobacteria O O
species O O
. O O

Multiple O O
sequence O O
alignment O O
of O O
these O O
sequences O O
is O O
shown O O
in O O
Figure O O
4a O O
. O O

Multiple O O
sequence O O
alignments O O
of O O
novel O O
candidate O O
proteins O O

Multiple O O
sequence O O
alignments O O
of O O
novel O O
candidate O O
proteins O O
. O O

( O O
a O O
) O O
A O O
selenoprotein O O
candidate O O
from O O
Geobacter O O
sulfurreducens O O
and O O
its O O
homologs O O
. O O

The O O
possible B-SPECULATION B-SPECULATION
selenocysteine I-SPECULATION I-SPECULATION
residues I-SPECULATION I-SPECULATION
are O O
shown O O
in O O
red O O
, O O
and O O
putative B-SPECULATION O
heme-binding I-SPECULATION O
motifs I-SPECULATION O
are O O
underlined O O
. O O

Note O O
that O O
sequence O O
conservation O O
near O O
the O O
selenocysteine O O
is O O
comparable O O
to O O
that O O
of O O
the O O
N-terminal O O
cytochrome O O
domain O O
. O O

A O O
protein O O
Dpro O O
_ O O
2 O O
contains O O
yet O O
another O O
inframe O O
stop O O
codon O O
( O O
TAG O O
) O O
at O O
the O O
column O O
189 O O
. O O

It O O
will O O
be O O
either B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
sequencing I-SPECULATION I-SPECULATION
error I-SPECULATION I-SPECULATION
. O O

Gsul O O
; O O
G. O O
sulfurreducens O O
, O O
Gmet O O
; O O
G. O O
metallireducens O O
, O O
Gura O O
; O O
G. O O
uraniumreducens O O
, O O
Gfrc O O
; O O
Geobacter O O
sp. O O
FRC-32 O O
, O O
Dace O O
; O O
Desulfuromonas O O
acetoxidans O O
, O O
Dpro O O
; O O
Delta O O
proteobacterium O O
MLMS-1 O O
. O O

( O O
b O O
) O O
Hypothetical O O
proteins O O
from O O
Geobacter O O
species O O
. O O

The O O
inframe O O
stop O O
codons O O
( O O
TAG O O
) O O
are O O
shown O O
in O O
red O O
. O O

This O O
cluster O O
is O O
probably B-SPECULATION B-SPECULATION
an I-SPECULATION I-SPECULATION
artifact I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
close I-SPECULATION I-SPECULATION
phylogenetic I-SPECULATION I-SPECULATION
relationship I-SPECULATION I-SPECULATION
. O O

We O O
expect B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
cluster I-SPECULATION I-SPECULATION
may B-SPECULATION B-SPECULATION
represent I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
novel I-SPECULATION I-SPECULATION
selenoprotein I-SPECULATION I-SPECULATION
family I-SPECULATION I-SPECULATION
. O O

This O O
is O O
because O O
the O O
inframe O O
stop O O
codons O O
of O O
these O O
proteins O O
are O O
exclusively O O
TGA O O
, O O
and O O
all O O
of O O
the O O
above O O
organisms O O
possess O O
selenocysteine O O
insertion O O
machinery O O
( B-NEGATION O
data I-NEGATION O
not I-NEGATION B-NEGATION
shown I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
. O O

High O O
conservation O O
of O O
residues O O
near O O
the O O
inframe O O
stop O O
codon O O
also O O
suggests B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
importance I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
region I-SPECULATION I-SPECULATION
. O O

If O O
they O O
are O O
true O O
selenoproteins O O
, O O
this O O
protein O O
family O O
becomes O O
a O O
rare O O
instance O O
of O O
selenoprotein O O
that O O
lacks B-NEGATION B-NEGATION
non-selenocysteine I-NEGATION I-NEGATION
homologs I-NEGATION I-NEGATION
. O O

However O O
, O O
computational O O
analysis O O
of O O
sequences O O
immediately O O
downstream O O
of O O
the O O
inframe O O
stop O O
codons O O
failed B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
identify I-NEGATION I-NEGATION
SECIS I-NEGATION I-NEGATION
elements I-NEGATION I-NEGATION
, O O
which O O
is O O
a O O
hallmark O O
of O O
selenocysteine-containing O O
genes O O
. O O

Therefore O O
, O O
yet O O
another O O
possibility B-SPECULATION B-SPECULATION
is I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
they I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
highly I-SPECULATION I-SPECULATION
conserved I-SPECULATION I-SPECULATION
operon I-SPECULATION I-SPECULATION
. O O

An O O
experimental O O
verification O O
is O O
necessary O O
to O O
distinguish O O
these O O
two O O
possibilities O O
. O O

The O O
second O O
cluster O O
consists O O
of O O
two O O
hypothetical O O
proteins O O
, O O
again O O
from O O
G. O O
sulfurreducens O O
and O O
G. O O
metallireducens O O
( O O
Figure O O
4b O O
) O O
. O O

In O O
contrast O O
to O O
the O O
first O O
cluster O O
, O O
no B-NEGATION B-NEGATION
homolog I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
identified I-NEGATION I-NEGATION
from I-NEGATION I-NEGATION
other I-NEGATION I-NEGATION
species I-NEGATION I-NEGATION
. O O

This O O
cluster O O
is O O
probably B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
false I-SPECULATION I-SPECULATION
positive I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
not B-NEGATION B-NEGATION
readthrough I-NEGATION I-NEGATION
proteins I-NEGATION I-NEGATION
. O O

This O O
is O O
because O O
the O O
residues O O
near O O
the O O
inframe O O
stop O O
codons O O
are O O
poorly O O
conserved O O
. O O

Moreover O O
, O O
the O O
C-terminal O O
extensions O O
are O O
quite O O
short O O
( O O
about O O
20 O O
aa O O
) O O
. O O

The O O
sequence O O
conservation O O
in O O
this O O
region O O
can O O
be O O
easily O O
explained O O
by O O
the O O
close O O
phylogenetic O O
relationship O O
between O O
the O O
two O O
species O O
. O O

In O O
summary O O
, O O
although O O
a O O
possible O B-SPECULATION
selenoprotein O I-SPECULATION
was O I-SPECULATION
newly O I-SPECULATION
identified O I-SPECULATION
, O O
there O O
was O O
no B-NEGATION B-NEGATION
promising I-NEGATION I-NEGATION
candidate I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
an I-NEGATION I-NEGATION
unknown I-NEGATION I-NEGATION
amino I-NEGATION I-NEGATION
acid I-NEGATION I-NEGATION
encoded I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
a I-NEGATION I-NEGATION
stop I-NEGATION I-NEGATION
codon I-NEGATION I-NEGATION
. O O

Stop O O
codon O O
usage O O
in O O
the O O
pre-filtering O O
clusters O O

The B-SPECULATION B-SPECULATION
above I-SPECULATION I-SPECULATION
negative I-SPECULATION I-SPECULATION
result I-SPECULATION I-SPECULATION
could I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
explained I-SPECULATION I-SPECULATION
if I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
filtering I-SPECULATION I-SPECULATION
process I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
which I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
final I-SPECULATION I-SPECULATION
step I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
prediction I-SPECULATION I-SPECULATION
method I-SPECULATION I-SPECULATION
( I-SPECULATION O
Figure I-SPECULATION O
2 I-SPECULATION O
) I-SPECULATION O
, I-SPECULATION O
was I-SPECULATION O
too I-SPECULATION O
strict I-SPECULATION O
. O O

Although O O
the O O
raw O O
output O O
of O O
the O O
search O O
for O O
evolutionarily O O
conserved O O
iORFs O O
was O O
273 O O
clusters O O
, O O
most O O
of O O
them O O
were O O
discarded O O
at O O
the O O
subsequent O O
filtering O O
stage O O
. O O

Because O O
we O O
have O O
no B-NEGATION B-NEGATION
a I-NEGATION I-NEGATION
priori I-NEGATION I-NEGATION
knowledge I-NEGATION I-NEGATION
about I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
23rd I-NEGATION I-NEGATION
amino I-NEGATION I-NEGATION
acid I-NEGATION I-NEGATION
, O O
cutoff O O
thresholds O O
for O O
the O O
filtering O O
procedures O O
were O O
determined O O
based O O
on O O
the O O
known O O
readthrough O O
proteins O O
. O O

This O O
is O O
practically O O
indispensable O O
for O O
objective O O
classification O O
of O O
candidates O O
, O O
but O O
there O O
is O O
no B-SPECULATION B-SPECULATION
guarantee I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
unknown I-SPECULATION I-SPECULATION
proteins I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
23rd I-SPECULATION I-SPECULATION
amino I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
will I-SPECULATION I-SPECULATION
score I-SPECULATION I-SPECULATION
higher I-SPECULATION I-SPECULATION
than I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
thresholds I-SPECULATION I-SPECULATION
. O O

To O O
explore O O
whether B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
number I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
good I-SPECULATION I-SPECULATION
candidates I-SPECULATION I-SPECULATION
lie I-SPECULATION I-SPECULATION
below I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
thresholds I-SPECULATION I-SPECULATION
, O O
the O O
273 O O
clusters O O
were O O
analyzed O O
in O O
a O O
way O O
independent O O
from O O
filtering O O
. O O

If O O
an O O
organism O O
has O O
many O O
readthrough O O
proteins O O
, O O
proteins O O
from O O
the O O
organism O O
will O O
frequently O O
appear O O
in O O
the O O
273 O O
clusters O O
. O O

Moreover O O
, O O
relative O O
usage O O
of O O
the O O
inframe O O
stop O O
codons O O
will O O
deviate O O
from O O
that O O
of O O
usual O O
termination O O
signals O O
in O O
the O O
proteome O O
. O O

Figure O O
5 O O
shows O O
the O O
discrepancies O O
between O O
relative O O
usage O O
of O O
the O O
inframe O O
and O O
C-terminal O O
stop O O
codons O O
of O O
127 O O
organisms O O
in O O
the O O
pre-filtering O O
clusters O O
. O O

Only O O
seven O O
organisms O O
had O O
statistically O O
significant O O
discrepancies O O
( O O
P O O
< O O
0.05 O O
) O O
, O O
and O O
all O O
of O O
them O O
are O O
known O O
to O O
utilize O O
selenocysteine O O
or O O
pyrrolysine O O
. O O

Discrepancies O O
of O O
stop O O
codon O O
usages O O
between O O
the O O
inframe O O
and O O
C-terminal O O
stop O O
codons O O

Discrepancies O O
of O O
stop O O
codon O O
usages O O
between O O
the O O
inframe O O
and O O
C-terminal O O
stop O O
codons O O
. O O

The O O
inframe O O
stop O O
codon O O
usage O O
is O O
taken O O
from O O
the O O
pre-filtering O O
clusters O O
, O O
and O O
the O O
C-terminal O O
usage O O
is O O
computed O O
based O O
on O O
the O O
annotated O O
proteins O O
of O O
the O O
organism O O
. O O

Red O O
circle O O
: O O
an O O
organism O O
with O O
pyrrolysine O O
, O O
blue O O
; O O
selenocysteine O O
, O O
yellow O O
; O O
both O O
pyrrolysine O O
and O O
selenocysteine O O
, O O
white O O
; O O
neither B-NEGATION B-NEGATION
pyrrolysine I-NEGATION I-NEGATION
. O O

The O O
organisms O O
are O O
ordered O O
by O O
their O O
discrepancy O O
scores O O
. O O

The O O
discrepancy O O
score O O
is O O
the O O
negative O O
logarithm O O
of O O
a O O
p-value O O
of O O
Fisher's O O
exact O O
test O O
. O O

The O O
dotted O O
line O O
indicates O O
significance O O
level O O
0.05 O O
after O O
a O O
correction O O
for O O
multiple O O
testing O O
. O O

When O O
top O O
ten O O
organisms O O
were O O
examined O O
, O O
only O O
Gluconobacter O O
oxydans O O
was O O
an O O
organism O O
not B-NEGATION B-NEGATION
known I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
have I-NEGATION I-NEGATION
stop-codon-encoded I-NEGATION I-NEGATION
amino I-NEGATION I-NEGATION
acids I-NEGATION I-NEGATION
. O O

An O O
inspection O O
of O O
the O O
G. O O
oxydans O O
iORFs O O
in O O
the O O
273 O O
clusters O O
revealed O O
that O O
their O O
inframe O O
stop O O
codons O O
are O O
dominated O O
by O O
TAA O O
, O O
but O O
all O O
of O O
them O O
belong O O
to O O
a O O
single O O
protein O O
cluster O O
associated O O
with O O
transposable O O
elements O O
. O O

Because O O
it O O
seems B-SPECULATION B-SPECULATION
unlikely I-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
an I-SPECULATION I-SPECULATION
insertion I-SPECULATION I-SPECULATION
system I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
novel I-SPECULATION I-SPECULATION
amino I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
evolves I-SPECULATION I-SPECULATION
solely I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
transposable I-SPECULATION I-SPECULATION
elements I-SPECULATION I-SPECULATION
, O O
this B-NEGATION B-NEGATION
organism I-NEGATION I-NEGATION
cannot I-NEGATION I-NEGATION
be O I-NEGATION
considered B-SPECULATION I-NEGATION
as I-SPECULATION I-NEGATION
a I-SPECULATION I-NEGATION
good I-SPECULATION I-NEGATION
candidate I-SPECULATION I-NEGATION
of I-SPECULATION I-NEGATION
the I-SPECULATION I-NEGATION
23rd I-SPECULATION I-NEGATION
amino I-SPECULATION I-NEGATION
acid I-SPECULATION I-NEGATION
. O O

Sensitivity O O
of O O
this O O
test O O
is O O
not O B-NEGATION
high O I-NEGATION
because O O
many O O
organisms O O
that O O
utilize O O
selenocysteine O O
were O O
below O O
the O O
defined O O
threshold O O
. O O

However O O
, O O
the O O
result O O
agrees O O
with O O
the O O
filtering-dependent O O
analysis O O
that O O
no B-NEGATION B-NEGATION
candidate I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
novel I-NEGATION I-NEGATION
stop-codon-encoded I-NEGATION I-NEGATION
amino I-NEGATION I-NEGATION
acid I-NEGATION I-NEGATION
is I-NEGATION I-NEGATION
detectable I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
current I-NEGATION I-NEGATION
dataset I-NEGATION I-NEGATION
. O O

Discussion O O

As O O
the O O
number O O
of O O
completely O O
sequenced O O
genomes O O
increases O O
, O O
several O O
research O O
groups O O
started O O
to O O
predict O O
proteins O O
that O O
contain O O
stop-codon-encoded O O
amino O O
acids O O
through O O
computational O O
analyses O O
. O O

Most O O
of O O
them O O
are O O
aimed O O
at O O
identification O O
of O O
selenoproteins O O
, O O
reflecting O O
concerns O O
from O O
the O O
scientific O O
community O O
and O O
accumulated O O
knowledge O O
on O O
selenocysteine O O
. O O

In O O
order O O
to O O
improve O O
prediction O O
specificity O O
, O O
they O O
have O O
fully O O
exploited O O
the O O
known O O
features O O
of O O
selenocysteine O O
, O O
such O O
as O O
the O O
SECIS O O
elements O O
or O O
cysteine O O
homologs O O
, O O
which O O
have O O
cysteine O O
in O O
place O O
of O O
selenocysteine O O
. O O

However O O
, O O
since O O
the O O
target O O
of O O
this O O
study O O
is O O
the O O
23rd O O
amino O O
acid O O
, O O
and O O
there O O
is O O
no B-NEGATION B-NEGATION
a I-NEGATION I-NEGATION
priori I-NEGATION I-NEGATION
knowledge I-NEGATION I-NEGATION
, O O
only O O
general O O
properties O O
of O O
stop-codon-encoded O O
amino O O
acids O O
can O O
be O O
used O O
for O O
prediction O O
. O O

Such O O
general-purpose O O
algorithms O O
have O O
also O O
been O O
developed O O
to O O
date O O
. O O

The O O
method O O
of O O
Chaudhuri O O
and O O
Yeates O O
10 O O
extracts O O
iORFs O O
from O O
microbial O O
genomes O O
and O O
analyzes O O
sequence O O
conservation O O
around O O
the O O
inframe O O
stop O O
codon O O
. O O

Their O O
method O O
is O O
thus O O
similar O O
to O O
ours O O
and O O
applicable O O
to O O
both O O
selenocysteine O O
and O O
pyrrolysine O O
. O O

Perrodou O O
et O O
al. O O
19 O O
constructed O O
a O O
database O O
of O O
predicted O O
recoding O O
events O O
in O O
microbes O O
. O O

Their O O
method O O
is O O
applicable O O
not O O
only O O
to O O
stop O O
codon O O
readthrough O O
but O O
also O O
to O O
frameshift O O
. O O

However O O
, O O
both O O
of O O
them O O
did O O
not B-NEGATION B-NEGATION
apply I-NEGATION I-NEGATION
their I-NEGATION I-NEGATION
methods I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
search I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
novel I-NEGATION I-NEGATION
amino I-NEGATION I-NEGATION
acids I-NEGATION I-NEGATION
. O O

Therefore O O
, O O
the B-NEGATION B-NEGATION
question I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
23rd I-NEGATION I-NEGATION
amino I-NEGATION I-NEGATION
acid I-NEGATION I-NEGATION
has I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
been I-NEGATION I-NEGATION
investigated I-NEGATION I-NEGATION
from I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
viewpoint I-NEGATION I-NEGATION
of I-NEGATION I-NEGATION
coding I-NEGATION I-NEGATION
sequences I-NEGATION I-NEGATION
. O O

Additionally O O
, O O
the O O
previous O O
methods O O
cannot B-NEGATION B-NEGATION
effectively I-NEGATION I-NEGATION
discriminate I-NEGATION I-NEGATION
pseudogenes I-NEGATION I-NEGATION
from I-NEGATION I-NEGATION
readthrough I-NEGATION I-NEGATION
genes I-NEGATION I-NEGATION
. O O

For O O
instance O O
, O O
Chaudhuri O O
and O O
Yeates O O
reported O O
a O O
homolog O O
of O O
cobalamin O O
biosynthesis O O
protein O O
CobN O O
as O O
a O O
novel O O
candidate O O
of O O
pyrrolysine O O
protein O O
. O O

However O O
, O O
the O O
gene O O
is O O
probably B-SPECULATION B-SPECULATION
a I-SPECULATION I-SPECULATION
pseudogene I-SPECULATION I-SPECULATION
because O O
it O O
contains O O
an O O
inframe O O
TAA O O
codon O O
in O O
addition O O
to O O
the O O
TAG O O
codon O O
, O O
and O O
only O B-SPECULATION
one B-SPECULATION I-SPECULATION
species I-SPECULATION I-SPECULATION
seems I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
have I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
amber-containing I-SPECULATION I-SPECULATION
form I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
gene I-SPECULATION I-SPECULATION
. O O

The O O
previous O O
methods O O
also O O
assume B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
proteins I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
stop-codon-encoded I-SPECULATION I-SPECULATION
amino I-SPECULATION I-SPECULATION
acids I-SPECULATION I-SPECULATION
will I-SPECULATION I-SPECULATION
have I-SPECULATION I-SPECULATION
non-readthrough I-SPECULATION I-SPECULATION
homologs I-SPECULATION I-SPECULATION
( I-SPECULATION I-SPECULATION
i.e. I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
homologous I-SPECULATION I-SPECULATION
proteins I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
do I-SPECULATION I-SPECULATION
not B-NEGATION B-NEGATION
have I-NEGATION I-NEGATION
inframe I-NEGATION I-NEGATION
stop I-NEGATION I-NEGATION
codons I-NEGATION I-NEGATION
) I-NEGATION I-NEGATION
. O O

However O O
, O O
that O O
is O O
not O B-SPECULATION
necessarily O I-SPECULATION
true O I-SPECULATION
. O O

For O O
example O O
, O O
pyrrolysine-containing O O
monomethylamine O O
methyltransferases O O
adopt O O
TIM O O
barrel O O
fold O O
6 O O
, O O
but O O
their O O
primary O O
sequences O O
do O O
not B-NEGATION B-NEGATION
exhibit I-NEGATION I-NEGATION
detectable I-NEGATION I-NEGATION
similarity I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
other I-NEGATION I-NEGATION
TIM I-NEGATION I-NEGATION
barrel I-NEGATION I-NEGATION
proteins I-NEGATION I-NEGATION
because O O
of O O
evolutionary O O
divergence O O
. O O

Dimethylamine O O
methyltransferases O O
also O O
lack B-NEGATION B-NEGATION
non-readthrough I-NEGATION I-NEGATION
homologs I-NEGATION I-NEGATION
. O O

Yet O O
another O O
example O O
is O O
glycine O O
reductase O O
selenoprotein O O
A O O
. O O

Only O O
the O O
selenocysteine-containing O O
form O O
of O O
the O O
enzyme O O
is O O
currently O O
known O O
20 O O
. O O

Therefore O O
, O O
it O O
is O O
important O O
not B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
assume I-NEGATION I-NEGATION
non-readthrough I-NEGATION I-NEGATION
homologs I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
exploring I-NEGATION I-NEGATION
novel I-NEGATION I-NEGATION
candidates I-NEGATION I-NEGATION
. O O

If O O
any O O
non-readthrough O O
homologs O O
are O O
registered O O
in O O
public O O
sequence O O
databases O O
, O O
a O O
careful O O
annotation O O
process O O
of O O
a O O
newly O O
sequenced O O
genome O O
will O O
be O O
able O O
to O O
detect O O
readthrough O O
genes O O
, O O
even O O
though O O
they B-SPECULATION B-SPECULATION
may I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
annotated I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
pseudogenes I-SPECULATION I-SPECULATION
. O O

However O O
, O O
if O O
all O O
members O O
of O O
a O O
gene O O
family O O
have O O
stop O O
codon O O
readthrough O O
, O O
correct O O
annotation O O
of O O
their O O
gene O O
structure O O
will O O
be O O
extremely O O
difficult O O
, O O
and O O
all O O
of O O
them O O
will O O
be O O
split O O
into O O
two O O
distinct O O
genes O O
. O O

The O O
method O O
reported O O
here O O
is O O
unique O O
in O O
that O O
it O O
does O O
not B-NEGATION B-NEGATION
assume I-NEGATION I-NEGATION
non-readthrough I-NEGATION I-NEGATION
homologs I-NEGATION I-NEGATION
. O O

Using O O
this O O
method O O
, O O
a O O
systematic O O
screening O O
of O O
the O O
23rd O O
amino O O
acid O O
and O O
other O O
readthrough O O
genes O O
was O O
carried O O
out O O
. O O

Many O O
of O O
the O O
currently O O
known O O
selenoproteins O O
and O O
pyrrolysine O O
proteins O O
were O O
recovered O O
, O O
indicating O O
the O O
effectiveness O O
of O O
this O O
approach O O
. O O

In O O
particular O O
, O O
successful O O
detection O O
of O O
pyrrolysine-containing O O
methyltransferases O O
and O O
selenoprotein O O
A O O
should O O
be O O
noted O O
. O O

However O O
, O O
almost O O
no O B-NEGATION
novel O I-NEGATION
candidates O I-NEGATION
for O I-NEGATION
readthrough O I-NEGATION
genes O I-NEGATION
were O I-NEGATION
predicted O I-NEGATION
. O O

What O O
can O O
be O O
concluded O O
from O O
this O O
result O O
? O O

The O O
most O O
likely B-SPECULATION B-SPECULATION
explanation I-SPECULATION I-SPECULATION
is O I-SPECULATION
that O I-SPECULATION
the B-SPECULATION I-SPECULATION
23rd I-SPECULATION I-SPECULATION
amino I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
does I-SPECULATION I-SPECULATION
or I-SPECULATION I-SPECULATION
its I-SPECULATION I-SPECULATION
distribution I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
tree I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
life I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
rather I-SPECULATION I-SPECULATION
limited I-SPECULATION I-SPECULATION
not B-NEGATION B-NEGATION
exist I-NEGATION I-NEGATION
, O I-NEGATION
. O O

Although O O
a O O
broad O O
spectrum O O
of O O
taxonomic O O
groups O O
has O O
been O O
subjected O O
to O O
genome O O
sequencing O O
, O O
the O O
genomes O O
of O O
most O O
microbial O O
species O O
on O O
the O O
earth O O
have O O
yet O O
to O O
be O O
determined O O
. O O

The B-SPECULATION B-SPECULATION
unknown I-SPECULATION I-SPECULATION
amino I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
may I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
used I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
species I-SPECULATION I-SPECULATION
. O O

Alternatively O O
, O O
only O O
one O O
organism O O
in O O
our O O
dataset O O
may B-SPECULATION B-SPECULATION
have I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
23rd I-SPECULATION I-SPECULATION
amino I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
. O O

This O O
is O O
because O O
our O O
method O O
is O O
limited O O
to O O
readthrough O O
genes O O
conserved O O
across O O
two O O
or O O
more O O
species O O
. O O

If O O
the O B-SPECULATION
novel O I-SPECULATION
amino O I-SPECULATION
acid O I-SPECULATION
appears O I-SPECULATION
in O I-SPECULATION
younger O I-SPECULATION
, O I-SPECULATION
non-conserved O I-SPECULATION
sequences O I-SPECULATION
, O I-SPECULATION
our O I-SPECULATION
technique O I-SPECULATION
will O I-SPECULATION
miss O I-SPECULATION
them O I-SPECULATION
. O O

In O O
either O O
case O O
, O O
the O O
distribution O O
of O O
the O O
23rd O O
amino O O
acid O O
will O O
be O O
significantly O O
narrower O O
than O O
that O O
of O O
selenocysteine O O
, O O
which O O
has O O
scattered O O
but O O
wide O O
distribution O O
21 O O
. O O

This O O
conclusion O O
coincides O O
with O O
and O O
strengthens O O
that O O
of O O
the O O
previous O O
research O O
on O O
tRNA O O
14 O O
. O O

Yet O O
another O O
possibility B-SPECULATION B-SPECULATION
is I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
23rd I-SPECULATION I-SPECULATION
amino I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
exists I-SPECULATION I-SPECULATION
but I-SPECULATION I-SPECULATION
is I-SPECULATION B-NEGATION
not B-NEGATION I-NEGATION
encoded I-NEGATION I-NEGATION
by I-NEGATION I-NEGATION
stop I-NEGATION I-NEGATION
codons I-NEGATION I-NEGATION
. O O

It O O
is O O
well O O
known O O
that O O
the O O
genetic O O
code O O
varies O O
in O O
several O O
organisms O O
22 O O
. O O

Thus O O
, O O
certain O O
organisms O O
may B-SPECULATION B-SPECULATION
use I-SPECULATION I-SPECULATION
one I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
sense I-SPECULATION I-SPECULATION
codons I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
novel I-SPECULATION I-SPECULATION
amino I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
. O O

Because O O
codons O O
for O O
most O O
amino O O
acids O O
are O O
degenerate O O
, O O
redefinition O O
of O O
one B-SPECULATION O
of I-SPECULATION O
them I-SPECULATION O
is I-SPECULATION O
feasible I-SPECULATION O
. O O

However O O
, O O
that O O
possibility O O
is O O
beyond O O
the O O
scope O O
of O O
this O O
study O O
and O O
is O O
left O O
as O O
an O O
open O O
problem O O
. O O

Bioinformatics O O
analysis O O
of O O
unusual O O
tRNA O O
genes O O
and O O
codon O O
usage O O
may B-SPECULATION B-SPECULATION
provide I-SPECULATION I-SPECULATION
insights I-SPECULATION I-SPECULATION
into I-SPECULATION I-SPECULATION
this I-SPECULATION I-SPECULATION
problem I-SPECULATION I-SPECULATION
. O O

In O O
addition O O
to O O
the O O
23rd O O
amino O O
acid O O
, O O
our O O
method O O
can O O
simultaneously O O
explore O O
selenoproteins O O
and O O
other O O
readthrough O O
proteins O O
. O O

A O O
common O O
assumption B-SPECULATION O
in I-SPECULATION O
microbial I-SPECULATION O
selenoprotein I-SPECULATION O
predictions I-SPECULATION O
is I-SPECULATION O
that I-SPECULATION O
selenoproteins I-SPECULATION O
will I-SPECULATION O
have I-SPECULATION O
cysteine I-SPECULATION O
homologs I-SPECULATION O
. O O

Zhang O O
et O O
al. O O
20 O O
examined O O
the O O
validity O O
of O O
this O O
assumption O O
using O O
a O O
SECIS-based O O
method O O
and O O
concluded O O
that O O
selenoproteins O O
without B-NEGATION B-NEGATION
cysteine I-NEGATION I-NEGATION
homologs I-NEGATION I-NEGATION
will O B-SPECULATION
be O I-SPECULATION
extremely O I-SPECULATION
rare O I-SPECULATION
. O O

Our O O
method O O
can O O
reassess O O
this O O
assumption O O
in O O
a O O
SECIS-independent O O
way O O
. O O

Such O O
selenoproteins O O
identified O O
through O O
our O O
screening O O
of O O
nearly O O
200 O O
microbial O O
genomes O O
were O O
selenoprotein O O
A O O
and O O
only O O
one O O
uncertain O O
candidate O O
. O O

Therefore O O
, O O
selenoproteins O O
that O O
lack B-NEGATION B-NEGATION
cysteine I-NEGATION I-NEGATION
homologs I-NEGATION I-NEGATION
will O I-NEGATION
be O I-NEGATION
scarce O I-NEGATION
, O O
as O O
previously O O
reported O O
. O O

Other O O
readthrough O O
proteins O O
with O O
canonical O O
amino O O
acids O O
( O O
i.e. O O
, O O
proteins O O
that O O
have O O
canonical O O
amino O O
acids O O
at O O
their O O
inframe O O
stop O O
codons O O
) O O
are O O
quite O O
rare O O
in O O
prokaryotes O O
1 O O
. O O

The O O
result O O
reported O O
here O O
is O O
in O O
agreement O O
, O O
but O O
it O O
is O O
not B-NEGATION B-NEGATION
conclusive I-NEGATION I-NEGATION
. O O

This O O
is O O
because O O
our O O
method O O
assumes B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
stop-codon-encoded I-SPECULATION I-SPECULATION
amino I-SPECULATION I-SPECULATION
acid I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
located I-SPECULATION I-SPECULATION
inside I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
domain I-SPECULATION I-SPECULATION
, O O
but O O
it O O
is O O
unclear B-SPECULATION B-SPECULATION
whether B-SPECULATION B-SPECULATION
it I-SPECULATION I-SPECULATION
holds I-SPECULATION I-SPECULATION
true I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
prokaryotic I-SPECULATION I-SPECULATION
readthrough I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
canonical I-SPECULATION I-SPECULATION
amino I-SPECULATION I-SPECULATION
acids I-SPECULATION I-SPECULATION
. O O

At O O
least O O
, O O
only O O
one O O
experimentally-confirmed O O
example O O
from O O
a O O
pathogenic O O
strain O O
of O O
Escherichia O O
coli O O
23 O O
, O O
whose B-NEGATION B-NEGATION
genome I-NEGATION I-NEGATION
is I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
yet I-NEGATION I-NEGATION
determined I-NEGATION I-NEGATION
, O O
does O O
not B-NEGATION B-NEGATION
obey I-NEGATION I-NEGATION
this I-NEGATION I-NEGATION
rule I-NEGATION I-NEGATION
. O O

What O B-SPECULATION
can O I-SPECULATION
be O I-SPECULATION
concluded O I-SPECULATION
from O I-SPECULATION
our O I-SPECULATION
result O I-SPECULATION
is O I-SPECULATION
that O I-SPECULATION
this O I-SPECULATION
type O I-SPECULATION
of O I-SPECULATION
readthrough O I-SPECULATION
will O I-SPECULATION
be O I-SPECULATION
located O I-SPECULATION
outside O I-SPECULATION
of O I-SPECULATION
domains O I-SPECULATION
, O I-SPECULATION
such O I-SPECULATION
as O I-SPECULATION
a O I-SPECULATION
linker O I-SPECULATION
between O I-SPECULATION
two O I-SPECULATION
domains O I-SPECULATION
. O O

Such O O
a O O
stop O O
codon O O
may B-SPECULATION B-SPECULATION
behave I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
switch I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
regulates I-SPECULATION I-SPECULATION
production I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
short I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
long I-SPECULATION I-SPECULATION
isoforms I-SPECULATION I-SPECULATION
from I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
single I-SPECULATION I-SPECULATION
mRNA I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
readthrough I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
from I-SPECULATION I-SPECULATION
viruses I-SPECULATION I-SPECULATION
24 O O
. O O

Conclusion O O

To O O
explore O O
the O O
possibility O O
of O O
a O O
23rd O O
amino O O
acid O O
, O O
ORFs O O
in O O
prokaryotic O O
genomes O O
were O O
investigated O O
in O O
a O O
comprehensive O O
way O O
. O O

Although O O
many O O
of O O
the O O
currently O O
known O O
selenoproteins O O
and O O
pyrrolysine O O
proteins O O
were O O
successfully O O
detected O O
, O O
no B-NEGATION B-NEGATION
candidate I-NEGATION I-NEGATION
for I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
23rd I-NEGATION I-NEGATION
amino I-NEGATION I-NEGATION
acid I-NEGATION I-NEGATION
was I-NEGATION I-NEGATION
discovered I-NEGATION I-NEGATION
. O O

Therefore O O
, O O
if O O
such O O
an O O
amino O O
acid O O
exists O O
, O O
it O O
will O O
have O O
limited O O
distribution O O
in O O
the O O
tree O O
of O O
life O O
. O O

Alternatively O O
, O O
it B-SPECULATION B-SPECULATION
may I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
encoded I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
one I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
sense I-SPECULATION I-SPECULATION
codons I-SPECULATION I-SPECULATION
. O O

From O O
the O O
viewpoint O O
of O O
selenoprotein O O
prediction O O
, O O
the O O
sensitivity O O
of O O
our O O
method O O
was O O
lower O O
than O O
an O O
existing O O
method O O
. O O

However O O
, O O
our O O
method O O
has O O
several O O
unique O O
features O O
. O O

It O O
is O O
applicable O O
to O O
general O O
readthrough O O
genes O O
and O O
rigorously O O
excludes O O
pseudogenes O O
and O O
sequencing O O
errors O O
. O O

Moreover O O
, O O
it O O
does O O
not B-NEGATION O
assume I-NEGATION O
the I-NEGATION O
occurrence I-NEGATION O
of I-NEGATION O
non-readthrough I-NEGATION O
homologs I-NEGATION O
in I-NEGATION O
the I-NEGATION O
public I-NEGATION O
databases I-NEGATION O
. O O

It O O
will O O
help O O
in O O
identification O O
of O O
novel O O
readthrough O O
genes O O
from O O
the O O
rapidly O O
expanding O O
collection O O
of O O
complete O O
microbial O O
genomes O O
. O O

Methods O O

Enumeration O O
of O O
iORFs O O
from O O
prokaryotic O O
genomes O O

A O O
total O O
of O O
328 O O
complete O O
genome O O
sequences O O
of O O
prokaryotes O O
were O O
downloaded O O
from O O
the O O
KEGG O O
FTP O O
site O O
25 O O
in O O
April O O
2006 O O
. O O

From O O
them O O
, O O
191 O O
representative O O
organisms O O
were O O
selected O O
by O O
excluding O O
close O O
relatives O O
. O O

The O O
threshold O O
was O O
set O O
to O O
average O O
sequence O O
identity O O
90 O O
% O O
of O O
two O O
house-keeping O O
genes O O
, O O
DNA O O
polymerase O O
III O O
α O O
subunit O O
and O O
alanyl-tRNA O O
synthetase O O
. O O

From O O
these O O
191 O O
genomes O O
, O O
iORFs O O
longer O O
than O O
80 O O
codons O O
were O O
enumerated O O
using O O
inhouse O O
software O O
, O O
which O O
is O O
available O O
from O O
the O O
author's O O
web O O
site O O
26 O O
. O O

Both O O
upstream O O
and O O
downstream O O
regions O O
of O O
its O O
inframe O O
stop O O
codon O O
were O O
required O O
to O O
be O O
longer O O
than O O
10 O O
codons O O
. O O

Two O O
stop O O
codons O O
of O O
an O O
iORF O O
( O O
i.e. O O
the O O
inframe O O
and O O
C-terminal O O
stops O O
) O O
can O O
be O O
any O O
combination O O
of O O
canonical O O
stop O O
codons O O
( O O
TAA O O
, O O
TAG O O
, O O
TGA O O
) O O
. O O

However O O
, O O
for O O
Mycoplasma O O
, O O
only O O
TAA O O
and O O
TAG O O
were O O
used O O
. O O

Three O O
codons O O
ATG O O
, O O
TTG O O
and O O
GTG O O
were O O
allowed O O
to O O
be O O
start O O
signals O O
. O O

The O O
iORFs O O
of O O
each O O
organism O O
were O O
compared O O
with O O
protein-coding O O
genes O O
of O O
the O O
organism O O
using O O
BLASTX O O
. O O

If O O
an O O
iORF O O
matched O O
any O O
protein-coding O O
genes O O
( O O
E-value O O
< O O
10-3 O O
) O O
and O O
their O O
reading O O
frames O O
did O O
not B-NEGATION B-NEGATION
coincide I-NEGATION I-NEGATION
, O O
the O O
iORF O O
was O O
discarded O O
. O O

Similarly O O
, O O
iORFs O O
were O O
compared O O
with O O
RNA O O
genes O O
using O O
BLASTN O O
, O O
and O O
those O O
matched O O
with O O
the O O
RNAs O O
were O O
removed O O
. O O

Remaining O O
iORFs O O
were O O
translated O O
into O O
amino O O
acid O O
sequences O O
. O O

We O O
translated O O
all O O
three O O
types O O
of O O
nonsense O O
codons O O
into O O
the O O
one-letter O O
code O O
U O O
, O O
so O O
as O O
to O O
simplify O O
visual O O
inspection O O
of O O
sequence O O
alignments O O
. O O

Although O O
the O O
code O O
U O O
is O O
usually O O
for O O
selenocysteine O O
, O O
it O O
will O O
be O O
harmless O O
because O O
U O O
is O O
automatically O O
converted O O
into O O
× O O
inside O O
the O O
BLAST O O
programs O O
. O O

Construction O O
of O O
clusters O O
of O O
conserved O O
iORFs O O

To O O
examine O O
evolutionary O O
conservation O O
of O O
the O O
iORFs O O
, O O
a O O
window O O
of O O
101 O O
residues O O
around O O
the O O
inframe O O
stop O O
codon O O
was O O
extracted O O
and O O
subjected O O
to O O
TBLASTN O O
searches O O
against O O
the O O
above O O
191 O O
genome O O
sequences O O
. O O

If O O
there O O
were O O
any O O
hits O O
( O O
E-value O O
< O O
0.01 O O
) O O
in O O
other O O
organisms O O
, O O
and O O
if O O
the O O
hit O O
includes O O
10 O O
upstream O O
and O O
10 O O
downstream O O
residues O O
of O O
the O O
inframe O O
stop O O
codon O O
, O O
then O O
the O O
iORF O O
was O O
retained O O
. O O

However O O
, O O
if O O
there O O
were O O
any O O
hits O O
( O O
E-value O O
< O O
10-5 O O
) O O
that O O
did O O
not B-NEGATION B-NEGATION
cover I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
inframe I-NEGATION I-NEGATION
stop I-NEGATION I-NEGATION
codon I-NEGATION I-NEGATION
, O O
the O O
iORF O O
was O O
discarded O O
. O O

Eligible O O
iORFs O O
were O O
then O O
clustered O O
using O O
BLASTCLUST O O
with O O
score O O
density O O
0.5 O O
and O O
minimum O O
length O O
coverage O O
0.6 O O
. O O

After O O
removing O O
singleton O O
clusters O O
, O O
multiple O O
sequence O O
alignments O O
of O O
the O O
remaining O O
clusters O O
were O O
computed O O
using O O
MAFFT O O
27 O O
with O O
the O O
L-INS-i O O
option O O
. O O

Subsequently O O
, O O
conservation O O
of O O
the O O
inframe O O
stop O O
codons O O
in O O
each O O
cluster O O
was O O
examined O O
. O O

If O O
the O O
location O O
or O O
type O O
of O O
stop O O
codons O O
was O O
not B-NEGATION B-NEGATION
identical I-NEGATION I-NEGATION
, O O
the O O
cluster O O
was O O
discarded O O
. O O

Three-step O O
filtering O O
of O O
the O O
candidate O O
clusters O O

The O O
first O O
filter O O
examines O O
protein-likeliness O O
of O O
the O O
iORFs O O
. O O

This O O
filter O O
is O O
mainly O O
designed O O
to O O
remove O O
conserved O O
non-coding O O
sequences O O
( O O
CNS O O
) O O
immediately O O
downstream O O
of O O
non-readthrough O O
genes O O
. O O

If O O
we O O
measure O O
purifying O O
selection O O
for O O
amino O O
acid O O
sequences O O
by O O
the O O
ratio O O
of O O
nonsynonymous O O
to O O
synonymous O O
substitution O O
rates O O
( O O
dN O O
/ O O
dS O O
) O O
, O O
a O O
protein O O
with O O
a O O
stop-codon-encoded O O
amino O O
acid O O
will O O
indicate O O
the O O
sign O O
of O O
selection O O
, O O
while O O
CNS O O
will O O
not B-NEGATION B-NEGATION
. O O

The O O
dN O O
/ O O
dS O O
was O O
calculated O O
for O O
each O O
of O O
the O O
two O O
parts O O
flanking O O
the O O
inframe O O
stop O O
codon O O
in O O
an O O
iORF O O
using O O
codeml O O
program O O
in O O
the O O
PAML O O
package O O
28 O O
. O O

Statistical O O
significance O O
was O O
estimated O O
by O O
likelihood O O
ratio O O
test O O
29 O O
. O O

The O O
observed O O
alignment O O
was O O
fitted O O
to O O
two O O
distinct O O
substitution O O
models O O
, O O
one O O
of O O
which O O
estimates O O
dN O O
/ O O
dS O O
from O O
the O O
data O O
, O O
and O O
the O O
other O O
fixes O O
it O O
to O O
1.0 O O
. O O

Let O O
lfree O O
and O O
lfix O O
denote O O
log O O
likelihood O O
of O O
these O O
models O O
. O O

Then O O
, O O
2Δl O O
= O O
2 O O
( O O
lfree O O
– O O
lfix O O
) O O
approximately O O
follows O O
the O O
χ2 O O
distribution O O
with O O
one O O
degree O O
of O O
freedom O O
. O O

If O O
dN O O
/ O O
dS O O
was O O
less O O
than O O
1.0 O O
, O O
and O O
the O O
statistics O O
2Δl O O
was O O
larger O O
than O O
a O O
threshold O O
, O O
we O O
regard O O
it O O
as O O
a O O
sign O O
of O O
purifying O O
selection O O
. O O

In O O
this O O
study O O
, O O
the O O
threshold O O
was O O
set O O
to O O
5.0 O O
( O O
corresponds O O
to O O
P O O
< O O
0.025 O O
) O O
so O O
that O O
the O O
known O O
readthrough O O
proteins O O
score O O
higher O O
than O O
the O O
threshold O O
. O O

For O O
each O O
of O O
the O O
above O O
clusters O O
, O O
an O O
all-against-all O O
comparison O O
of O O
cluster O O
members O O
was O O
performed O O
. O O

If O O
any O O
pair O O
exhibits O O
such O O
signals O O
in O O
both O O
the O O
N O O
- O O
and O O
C-terminal O O
parts O O
, O O
the O O
cluster O O
was O O
retained O O
. O O

Even O O
if O O
both O O
the O O
upstream O O
and O O
downstream O O
regions O O
of O O
the O O
inframe O O
stop O O
codon O O
code O O
proteins O O
, O O
they O O
may B-SPECULATION B-SPECULATION
be I-SPECULATION I-SPECULATION
two I-SPECULATION I-SPECULATION
adjacent I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
instead B-NEGATION I-SPECULATION
of I-NEGATION I-SPECULATION
a I-NEGATION I-SPECULATION
readthrough I-NEGATION I-SPECULATION
protein I-NEGATION I-SPECULATION
. O O

The O O
second O O
and O O
third O O
filtering O O
processes O O
remove O O
such O O
genes O O
based O O
on O O
BLAST O O
alignment O O
patterns O O
. O O

Although O O
the O O
boundary O O
analysis O O
applied O O
previously O O
has O O
the O O
same O O
goal O O
( O O
Figure O O
1b O O
) O O
, O O
some O O
gene O O
pairs O O
escaped O O
elimination O O
. O O

To O O
enhance O O
sensitivity O O
of O O
the O O
filters O O
, O O
the O O
whole O O
length O O
of O O
an O O
iORF O O
was O O
used O O
as O O
a O O
BLAST O O
query O O
instead B-NEGATION O
of I-NEGATION O
the I-NEGATION O
partial I-NEGATION O
sequence I-NEGATION O
, O O
and O O
the O O
size O O
of O O
the O O
BLAST O O
database O O
was O O
increased O O
from O O
the O O
191 O O
nonredundant O O
genomes O O
to O O
the O O
328 O O
complete O O
genomes O O
in O O
GenomeNet O O
and O O
246 O O
draft O O
genome O O
sequences O O
downloaded O O
from O O
GenBank O O
in O O
May O O
2006 O O
. O O

The O O
second O O
filter O O
inspects O O
synteny O O
of O O
iORFs O O
. O O

If O O
the O O
N O O
- O O
and O O
C-terminal O O
parts O O
of O O
an O O
iORF O O
have O O
distinct O O
but O O
closely O O
arranged O O
BLAST O O
hits O O
in O O
other O O
genomes O O
, O O
it O O
strongly O O
suggests B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
iORF I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
actually I-SPECULATION I-SPECULATION
two I-SPECULATION I-SPECULATION
adjacent I-SPECULATION I-SPECULATION
genes I-SPECULATION I-SPECULATION
. O O

Translated O O
sequences O O
of O O
iORFs O O
in O O
the O O
pre-filtering O O
clusters O O
were O O
subjected O O
to O O
TBLASTN O O
searches O O
against O O
the O O
genome O O
database O O
. O O

If O O
both O O
the O O
best O O
hits O O
of O O
the O O
N O O
- O O
and O O
C-terminal O O
parts O O
are O O
statistically O O
significant O O
( O O
E-value O O
< O O
10-5 O O
) O O
, O O
and O O
distance O O
between O O
them O O
is O O
less O O
than O O
1 O O
kbp O O
, O O
we O O
call O O
these O O
hits O O
' O O
syntenic O O
hits O O
' O O
. O O

If O O
any O O
syntenic O O
hits O O
with O O
non-coinciding O O
reading O O
frames O O
were O O
found O O
, O O
the O O
cluster O O
was O O
removed O O
. O O

The O O
third O O
filter O O
uses O O
co-occurrence O O
of O O
residues O O
around O O
the O O
inframe O O
stop O O
codon O O
as O O
another O O
source O O
of O O
information O O
for O O
screening O O
stop O O
codon O O
readthrough O O
. O O

Suppose O O
a O O
window O O
of O O
21 O O
residues O O
centered O O
at O O
the O O
inframe O O
stop O O
codon O O
. O O

In O O
prokaryotes O O
, O O
most O O
stop-codon-encoded O O
amino O O
acids O O
are O O
located O O
inside O O
a O O
domain O O
, O O
the O O
unit O O
of O O
evolutionary O O
sequence O O
conservation O O
. O O

Therefore O O
, O O
in O O
an O O
ideal O O
situation O O
the O O
presence O O
or O O
absence B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
21 I-NEGATION I-NEGATION
residues I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
alignments I-NEGATION I-NEGATION
will O I-NEGATION
be O I-NEGATION
synchronized O I-NEGATION
. O O

In O O
contrast O O
, O O
if O O
the O O
iORF O O
is O O
actually O O
two O O
adjacent O O
genes O O
, O O
then O O
upstream O B-SPECULATION
and O I-SPECULATION
downstream O I-SPECULATION
residues O I-SPECULATION
of O I-SPECULATION
the O I-SPECULATION
stop O I-SPECULATION
codon O I-SPECULATION
will O I-SPECULATION
appear O I-SPECULATION
separately O I-SPECULATION
in O I-SPECULATION
many O I-SPECULATION
alignments O I-SPECULATION
. O O

We O O
defined O O
a O O
co-occurrence O O
matrix O O
as O O
a O O
21 O O
× O O
21 O O
matrix O O
whose O O
( O O
i,j O O
)- O O
th O O
element O O
represents O O
how O O
often O O
residue O O
i O O
and O O
j O O
appeared O O
simultaneously O O
in O O
N O O
alignments O O
. O O

The O O
matrix O O
elements O O
were O O
subsequently O O
normalized O O
to O O
the O O
number O O
of O O
alignments O O
N O O
. O O

By O O
definition O O
, O O
the O O
more O O
often O O
the O O
upstream O O
and O O
downstream O O
residues O O
of O O
the O O
inframe O O
stop O O
codon O O
co-occur O O
in O O
the O O
alignments O O
, O O
the O O
higher O O
the O O
density O O
in O O
the O O
upper O O
right O O
quarter O O
of O O
the O O
matrix O O
. O O

If O O
average O O
density O O
in O O
the O O
quarter O O
was O O
lower O O
than O O
0.85 O O
, O O
the O O
cluster O O
was O O
filtered O O
out O O
. O O

Stop O O
codon O O
usage O O

For O O
each O O
organism O O
, O O
its O O
iORFs O O
were O O
extracted O O
from O O
the O O
pre-filtering O O
clusters O O
, O O
and O O
codon O O
usage O O
at O O
the O O
inframe O O
stop O O
positions O O
was O O
counted O O
. O O

Codon O O
usage O O
at O O
the O O
C-terminal O O
stop O O
codons O O
in O O
its O O
proteome O O
was O O
also O O
computed O O
using O O
data O O
of O O
coding O O
sequences O O
downloaded O O
from O O
KEGG O O
GENES O O
25 O O
. O O

These O O
data O O
were O O
combined O O
into O O
a O O
3 O O
× O O
2 O O
matrix O O
, O O
and O O
Fisher's O O
exact O O
test O O
was O O
applied O O
. O O

The O O
p-value O O
was O O
corrected O O
for O O
multiple O O
testing O O
using O O
the O O
Bonferroni O O
correction O O
because O O
there O O
were O O
127 O O
organisms O O
in O O
the O O
pre-filtering O O
clusters O O
. O O

Probabilistic O O
prediction O O
and O O
ranking O O
of O O
human O O
protein-protein O O
interactions O O

Abstract O O

Background O O

Although O O
the O O
prediction O O
of O O
protein-protein O O
interactions O O
has O O
been O O
extensively O O
investigated O O
for O O
yeast O O
, O O
few O O
such O O
datasets O O
exist O O
for O O
the O O
far O O
larger O O
proteome O O
in O O
human O O
. O O

Furthermore O O
, O O
it O O
has O O
recently O O
been O O
estimated B-SPECULATION O
that I-SPECULATION O
the I-SPECULATION O
overall I-SPECULATION O
average I-SPECULATION O
false I-SPECULATION O
positive I-SPECULATION O
rate I-SPECULATION O
of I-SPECULATION O
available I-SPECULATION O
computational I-SPECULATION O
and I-SPECULATION O
high-throughput I-SPECULATION O
experimental I-SPECULATION O
interaction I-SPECULATION O
datasets I-SPECULATION O
is I-SPECULATION O
as I-SPECULATION O
high I-SPECULATION O
as I-SPECULATION O
90 I-SPECULATION O
% I-SPECULATION O
. O O

Results O O

The O O
prediction O O
of O O
human O O
protein-protein O O
interactions O O
was O O
investigated O O
by O O
combining O O
orthogonal O O
protein O O
features O O
within O O
a O O
probabilistic O O
framework O O
. O O

The O O
features O O
include O O
co-expression O O
, O O
orthology O O
to O O
known O O
interacting O O
proteins O O
and O O
the O O
full-Bayesian O O
combination O O
of O O
subcellular O O
localization O O
, O O
co-occurrence O O
of O O
domains O O
and O O
post-translational O O
modifications O O
. O O

A O O
novel O O
scoring O O
function O O
for O O
local O O
network O O
topology O O
was O O
also O O
investigated O O
. O O

This O O
topology O O
feature O O
greatly O O
enhanced O O
the O O
predictions O O
and O O
together O O
with O O
the O O
full-Bayes O O
combined O O
features O O
, O O
made O O
the O O
largest O O
contribution O O
to O O
the O O
predictions O O
. O O

Using O O
a O O
conservative O O
threshold O O
, O O
our O O
most O O
accurate O O
predictor O O
identifies O O
37606 O O
human O O
interactions O O
, O O
32892 O O
( O O
80 O O
%) O O
of O O
which O O
are O O
not B-NEGATION B-NEGATION
present I-NEGATION I-NEGATION
in I-NEGATION I-NEGATION
other I-NEGATION I-NEGATION
publicly I-NEGATION I-NEGATION
available I-NEGATION I-NEGATION
large I-NEGATION I-NEGATION
human I-NEGATION I-NEGATION
interaction I-NEGATION I-NEGATION
datasets I-NEGATION I-NEGATION
, O O
thus O O
substantially O O
increasing O O
the O O
coverage O O
of O O
the O O
human O O
interaction O O
map O O
. O O

A O O
subset O O
of O O
the O O
32892 O O
novel O O
predicted O O
interactions O O
have O O
been O O
independently O O
validated O O
. O O

Comparison O O
of O O
the O O
prediction O O
dataset O O
to O O
other O O
available O O
human O O
interaction O O
datasets O O
estimates B-SPECULATION O
the I-SPECULATION O
false I-SPECULATION O
positive I-SPECULATION O
rate I-SPECULATION O
of I-SPECULATION O
the I-SPECULATION O
new I-SPECULATION O
method I-SPECULATION O
to I-SPECULATION O
be I-SPECULATION O
below I-SPECULATION O
80 I-SPECULATION O
% I-SPECULATION O
which I-SPECULATION O
is I-SPECULATION O
competitive I-SPECULATION O
with I-SPECULATION O
other I-SPECULATION O
methods I-SPECULATION O
. O O

Since O O
the O O
new O O
method O O
scores O O
and O O
ranks O O
all O O
human O O
protein O O
pairs O O
, O O
smaller O O
subsets O O
of O O
higher O O
quality O O
can O O
be O O
generated O O
thus O O
leading O O
to O O
even O O
lower O O
false O O
positive O O
prediction O O
rates O O
. O O

Conclusion O O

The O O
set O O
of O O
interactions O O
predicted O O
in O O
this O O
work O O
increases O O
the O O
coverage O O
of O O
the O O
human O O
interaction O O
map O O
and O O
will O O
help O O
determine O O
the O O
highest O O
confidence O O
human O O
interactions O O
. O O

Background O O

Protein-protein O O
interactions O O
perform O O
and O O
regulate O O
fundamental O O
cellular O O
processes O O
. O O

The O O
comprehensive O O
study O O
of O O
such O O
interactions O O
on O O
a O O
genome-wide O O
scale O O
will O O
lead O O
to O O
a O O
clearer O O
understanding O O
of O O
diverse O O
cellular O O
processes O O
and O O
of O O
the O O
molecular O O
mechanisms O O
of O O
disease O O
. O O

Although O O
the O O
determination O O
of O O
interactions O O
by O O
small-scale O O
laboratory O O
techniques O O
is O O
impractical O O
for O O
a O O
complete O O
proteome O O
on O O
the O O
grounds O O
of O O
cost O O
and O O
time O O
, O O
several O O
experimental O O
techniques O O
now O O
exist O O
to O O
determine O O
protein-protein O O
interactions O O
in O O
a O O
high-throughput O O
manner O O
1 O O
. O O

High-throughput O O
datasets O O
have O O
been O O
generated O O
for O O
model O O
organisms O O
such O O
as O O
yeast O O
23456 O O
, O O
worm O O
7 O O
and O O
fly O O
89 O O
as O O
well O O
as O O
Escherichia O O
coli O O
10 O O
. O O

In O O
addition O O
, O O
the O O
first O O
broad-focus O O
experimental O O
datasets O O
for O O
the O O
human O O
interactome O O
have O O
recently O O
been O O
published O O
1112 O O
. O O

Interactions B-SPECULATION O
determined I-SPECULATION O
by I-SPECULATION O
high-throughput I-SPECULATION O
methods I-SPECULATION O
are I-SPECULATION O
generally I-SPECULATION O
considered I-SPECULATION O
to I-SPECULATION O
be I-SPECULATION O
less I-SPECULATION O
reliable I-SPECULATION O
than I-SPECULATION O
those I-SPECULATION O
obtained I-SPECULATION O
by I-SPECULATION O
low-throughput I-SPECULATION O
studies I-SPECULATION O
1314 O O
and O O
as O O
a O O
consequence O O
efforts O O
are O O
also O O
underway O O
to O O
extract O O
evidence O O
for O O
interactions O O
from O O
the O O
literature O O
151617 O O
. O O

Analysis O O
of O O
the O O
high-throughput O O
datasets O O
has O O
shown O O
that O O
they O O
overlap O O
very O O
little O O
with O O
each O O
other O O
, O O
suggesting B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
their I-SPECULATION I-SPECULATION
coverage I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
low I-SPECULATION I-SPECULATION
. O O

Indeed O O
, O O
it O O
has O O
been O O
estimated B-SPECULATION O
recently I-SPECULATION O
that I-SPECULATION O
the I-SPECULATION O
current I-SPECULATION O
yeast I-SPECULATION O
and I-SPECULATION O
human I-SPECULATION O
protein I-SPECULATION O
interaction I-SPECULATION O
maps I-SPECULATION O
are I-SPECULATION O
only I-SPECULATION O
50 I-SPECULATION O
% I-SPECULATION O
and I-SPECULATION O
10 I-SPECULATION O
% I-SPECULATION O
complete I-SPECULATION O
, I-SPECULATION O
respectively I-SPECULATION O
18 O O
. O O

The O O
low O O
coverage O O
and O O
variable O O
quality O O
of O O
the O O
experimental O O
interaction O O
datasets O O
have O O
prompted O O
many O O
groups O O
to O O
investigate O O
computational O O
methods O O
to O O
predict O O
interactions O O
or O O
to O O
determine O O
the O O
most O O
likely O B-SPECULATION
interactions O I-SPECULATION
seen O I-SPECULATION
in O I-SPECULATION
the O I-SPECULATION
high-throughput O I-SPECULATION
datasets O I-SPECULATION
. O O

The O O
different O O
approaches O O
to O O
predict O O
interactions O O
can O O
be O O
grouped O O
into O O
five O O
main O O
categories O O
: O O

1 O O
) O O
Predictors O O
based O O
on O O
sequence O O
and O O
structure O O
exploit O O
the O O
observation O O
that O O
some O O
pairs O O
of O O
sequence O O
motifs O O
, O O
domains O O
and O O
structural O O
families O O
tend O B-SPECULATION
to O I-SPECULATION
interact O I-SPECULATION
preferentially O I-SPECULATION
. O O

Some O O
methods O O
predict O O
interaction O O
from O O
sequence-motifs O O
found O O
to O O
be O O
over-represented O O
in O O
interacting O O
protein O O
pairs O O
19 O O
, O O
or O O
by O O
considering O O
the O O
physico-chemical O O
properties O O
and O O
the O O
location O O
of O O
groups O O
of O O
amino O O
acids O O
in O O
the O O
sequence O O
2021 O O
. O O

Others O O
investigate O O
the O O
co-occurrence O O
in O O
interacting O O
proteins O O
of O O
specific O O
protein O O
domains O O
or O O
their O O
structural O O
family O O
classification O O
2223 O O
. O O

When O O
three-dimensional O O
structures O O
are O O
available O O
for O O
both B-SPECULATION O
proteins I-SPECULATION O
thought I-SPECULATION O
to I-SPECULATION O
interact I-SPECULATION O
, O O
high B-SPECULATION O
quality I-SPECULATION O
predictions I-SPECULATION O
and I-SPECULATION O
additional I-SPECULATION O
information I-SPECULATION O
such I-SPECULATION O
as I-SPECULATION O
the I-SPECULATION O
residues I-SPECULATION O
involved I-SPECULATION O
in I-SPECULATION O
the I-SPECULATION O
interaction I-SPECULATION O
and I-SPECULATION O
their I-SPECULATION B-SPECULATION
binding I-SPECULATION I-SPECULATION
affinity I-SPECULATION I-SPECULATION
may I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
estimated I-SPECULATION I-SPECULATION
( O O
reviewed O O
in O O
24 O O
) O O
. O O

Similarly O O
, O O
when O O
two O O
proteins O O
show O O
clear O O
sequence O O
similarity O O
to O O
proteins O O
that O O
exist O O
in O O
a O O
complex O O
for O O
which O O
the O O
three-dimensional O O
structure O O
is O O
known O O
, O O
detailed B-SPECULATION B-SPECULATION
predictions I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
atomic-level I-SPECULATION I-SPECULATION
interactions I-SPECULATION I-SPECULATION
may I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
made I-SPECULATION I-SPECULATION
. O O

For O O
example O O
, O O
the O O
major O O
complexes O O
in O O
yeast O O
have O O
been O O
predicted O O
by O O
this O O
strategy O O
25 O O
. O O

2 O O
) O O
Predictors O O
based O O
on O O
comparative O O
genomics O O
have O O
been O O
exploited O O
primarily O O
in O O
prokaryotes O O
. O O

They O O
consider O O
the O O
physical O O
location O O
of O O
genes O O
, O O
as O O
well O O
as O O
their O O
pattern O O
of O O
occurrence O O
and O O
evolutionary O O
rate O O
, O O
to O O
predict O O
interactions O O
or O O
functional O O
relationships O O
between O O
protein O O
pairs O O
. O O

Some O O
predictors O O
make O O
use O O
of O O
the O O
observation O O
that O O
neighboring B-SPECULATION O
genes I-SPECULATION O
whose I-SPECULATION B-SPECULATION
relative I-SPECULATION I-SPECULATION
location I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
conserved I-SPECULATION I-SPECULATION
across I-SPECULATION I-SPECULATION
several I-SPECULATION I-SPECULATION
prokaryotic I-SPECULATION I-SPECULATION
organisms I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
likely I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
interact I-SPECULATION I-SPECULATION
26 O O
. O O

Other O O
predictors O O
exploit O O
the O O
observation O O
that O O
gene B-SPECULATION O
pairs I-SPECULATION O
that I-SPECULATION O
co-occur I-SPECULATION O
in I-SPECULATION O
related I-SPECULATION O
species I-SPECULATION O
or I-SPECULATION O
that I-SPECULATION O
co-evolve I-SPECULATION O
also I-SPECULATION O
tend I-SPECULATION B-SPECULATION
to I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
more I-SPECULATION I-SPECULATION
likely I-SPECULATION B-SPECULATION
to I-SPECULATION I-SPECULATION
interact I-SPECULATION I-SPECULATION
27282930 O I-SPECULATION
. O O

In O O
addition O O
, O O
domains O O
that O O
exist O O
as O O
separate O O
proteins O O
in O O
some O O
genomes O O
but O O
are O O
also O O
seen O O
fused O O
in O O
a O O
single O O
protein O O
in O O
other O O
genomes O O
have O O
been O O
used O O
to O O
suggest B-SPECULATION B-SPECULATION
the I-SPECULATION I-SPECULATION
isolated I-SPECULATION I-SPECULATION
domains I-SPECULATION I-SPECULATION
3132 O I-SPECULATION
. O O
may B-SPECULATION B-SPECULATION
interact I-SPECULATION I-SPECULATION
. O O

3 O O
) O O
Predictors O O
based O O
on O O
orthology O O
work O O
on O O
the O O
assumption B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
orthologs I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
pair I-SPECULATION I-SPECULATION
that I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
known I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
interact I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
one I-SPECULATION I-SPECULATION
organism I-SPECULATION I-SPECULATION
will I-SPECULATION I-SPECULATION
also I-SPECULATION I-SPECULATION
interact I-SPECULATION I-SPECULATION
. O O

Such O O
relationships O O
are O O
often O O
referred O O
to O O
as O O
interologs O O
33 O O
. O O

For O O
example O O
, O O
at O O
BLAST O O
e-values O O
below O O
10-10 O O
, O O
it O O
has O O
been O O
shown O O
that O O
16 O O
– O O
30 O O
% O O
of O O
yeast O O
interactions O O
can O O
be O O
transferred O O
to O O
the O O
worm O O
34 O O
while O O
further O O
studies O O
have O O
estimated B-SPECULATION O
that I-SPECULATION O
a I-SPECULATION O
joint I-SPECULATION O
e-value I-SPECULATION O
below I-SPECULATION O
10-70 I-SPECULATION O
is I-SPECULATION O
required I-SPECULATION O
to I-SPECULATION O
transfer I-SPECULATION O
interactions I-SPECULATION O
reliably I-SPECULATION O
between I-SPECULATION O
organisms I-SPECULATION O
35 O O
. O O

Interologs O O
have O O
been O O
used O O
to O O
predict O O
protein-protein O O
interactions O O
in O O
human O O
36 O O
. O O

4 O O
) O O
Predictors O O
based O O
on O O
functional O O
features O O
exploit O O
non-sequence O O
information O O
to O O
infer O O
interactions O O
. O O

Some O O
predictors O O
exploit O O
the O O
observation O O
that O O
there O O
is O O
a O O
significant O O
correlation O O
in O O
the O O
expression O O
levels O O
of O O
transcripts O O
encoding O O
proteins O O
that O O
interact O O
37 O O
. O O

Since O O
proteins O O
must O O
be O O
co-localized O O
in O O
order O O
to O O
interact O O
, O O
protein O O
subcellular O O
localization O O
has O O
often O O
been O O
used O O
to O O
assess O O
the O O
quality O O
of O O
interaction O O
datasets O O
3839 O O
. O O

Similarly O O
, O O
interacting O O
proteins O O
are O O
also O O
often O O
involved O O
in O O
similar O O
cellular O O
processes O O
, O O
so O O
Gene O O
Ontology O O
" O O
process O O
" O O
and O O
" O O
function O O
" O O
annotations O O
have O O
been O O
exploited O O
to O O
predict O O
interactions O O
and O O
validate O O
high-throughput O O
datasets O O
163638 O O
. O O

5 O O
) O O
Predictors O O
have O O
exploited O O
similarities O O
in O O
the O O
network O O
topology O O
of O O
known O O
interaction O O
datasets O O
to O O
predict O O
novel O O
interactions O O
. O O

In O O
one O O
study O O
, O O
the O O
local O O
topology O O
of O O
small-world O O
networks O O
has O O
been O O
used O O
to O O
assess O O
the O O
quality O O
of O O
interaction O O
datasets O O
and O O
predict O O
novel O O
interactions O O
40 O O
while O O
Gerstein O O
and O O
colleagues O O
have O O
investigated O O
the O O
prediction O O
of O O
interactions O O
by O O
the O O
identification O O
of O O
missing O O
edges O O
in O O
almost O O
fully O O
connected O O
complexes O O
41 O O
. O O

In O O
addition O O
to O O
these O O
diverse O O
approaches O O
, O O
some O O
groups O O
have O O
combined O O
concepts O O
from O O
several O O
of O O
the O O
above O O
categories O O
in O O
integrative O O
frameworks O O
. O O

The O O
first O O
such O O
predictor O O
integrated O O
co-expression O O
data O O
, O O
co-essentiality O O
as O O
well O O
as O O
biological O O
function O O
in O O
a O O
naïve O O
Bayes O O
network O O
to O O
provide O O
proteome-wide O O
de O O
novo O O
prediction O O
of O O
yeast O O
protein O O
interactions O O
37 O O
. O O

Subsequently O O
, O O
the O O
combination O O
of O O
many O O
more O O
diverse O O
features O O
was O O
investigated O O
using O O
different O O
frameworks O O
to O O
predict O O
yeast O O
protein-protein O O
interactions O O
, O O
increasing O O
the O O
prediction O O
accuracy O O
and O O
allowing O O
an O O
assessment O O
of O O
the O O
limits O O
of O O
genomic O O
integration O O
424344 O O
. O O

The O O
integration O O
of O O
diverse O O
genomic O O
features O O
has O O
also O O
been O O
useful O O
in O O
the O O
investigation O O
of O O
the O O
related O O
but O O
broader O O
problem O O
of O O
predicting O O
protein-protein O O
associations O O
as O O
well O O
as O O
complex O O
and O O
pathway O O
membership O O
( O O
see O O
for O O
example O O
45 O O
) O O
. O O

Although O O
, O O
many O O
computational O O
methods O O
have O O
investigated O O
the O O
prediction O O
of O O
protein-protein O O
interactions O O
, O O
few O O
have O O
so O O
far O O
been O O
applied O O
to O O
the O O
human O O
proteome O O
. O O

The O O
first O O
large-scale O O
prediction O O
of O O
the O O
human O O
interactome O O
map O O
involved O O
transferring O O
interactions O O
from O O
model O O
organisms O O
36 O O
. O O

This O O
resulted O O
in O O
over O O
70000 O O
predicted O O
physical O O
interactions O O
involving O O
approximately O O
6200 O O
human O O
proteins O O
. O O

A O O
second O O
method O O
integrated O O
expression O O
data O O
, O O
orthology O O
, O O
protein O O
domain O O
data O O
and O O
functional O O
annotations O O
into O O
a O O
probabilistic O O
framework O O
and O O
resulted O O
in O O
the O O
prediction B-SPECULATION O
of I-SPECULATION O
nearly I-SPECULATION O
40000 I-SPECULATION O
human I-SPECULATION O
protein I-SPECULATION O
interactions I-SPECULATION O
46 O O
. O O

It O O
has O O
recently O O
been O O
estimated O O
that O O
the O O
false-positive O O
rates O O
of O O
these O O
computational O O
datasets O O
as O O
well O O
as O O
of O O
available O O
high-throughput O O
human O O
interaction O O
datasets O O
are O O
, O O
on O O
average O O
, O O
as O O
high O O
as O O
90 O O
% O O
and O O
their O O
coverage O O
is O O
only O O
approximately O O
10 O O
% O O
, O O
indicating B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
more I-SPECULATION I-SPECULATION
such I-SPECULATION I-SPECULATION
efforts I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
needed I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
increase I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
coverage I-SPECULATION I-SPECULATION
and I-SPECULATION I-SPECULATION
confidence I-SPECULATION I-SPECULATION
we I-SPECULATION I-SPECULATION
have I-SPECULATION I-SPECULATION
in I-SPECULATION I-SPECULATION
current I-SPECULATION I-SPECULATION
maps I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
interactome I-SPECULATION I-SPECULATION
18 O O
. O O

In O O
this O O
paper O O
, O O
the O O
prediction O O
of O O
physical O O
interactions O O
between O O
human O O
proteins O O
has O O
been O O
investigated O O
by O O
integrating O O
in O O
a O O
Bayesian O O
framework O O
several O O
different O O
pieces O O
of O O
evidence O O
including O O
orthology O O
, O O
functional O O
features O O
and O O
local O O
network O O
topology O O
. O O

In O O
order O O
to O O
increase O O
the O O
accuracy O O
and O O
coverage O O
of O O
the O O
predictions O O
, O O
different O O
types O O
of O O
negative O O
data O O
( O O
non-interacting O O
protein O O
pairs O O
) O O
were O O
explored O O
to O O
train O O
the O O
predictor O O
. O O

The O O
most O O
accurate O O
of O O
the O O
predictors O O
was O O
then O O
used O O
to O O
assess O O
the O O
likelihood O O
of O O
pair-wise O O
interaction O O
for O O
over O O
20000 O O
human O O
proteins O O
from O O
the O O
IPI O O
( O O
International O O
Protein O O
Index O O
) O O
database O O
. O O

These O O
predictions O O
provide O O
a O O
likelihood B-SPECULATION O
of I-SPECULATION O
interaction I-SPECULATION O
for I-SPECULATION O
over I-SPECULATION O
260 I-SPECULATION O
million I-SPECULATION O
human I-SPECULATION O
protein I-SPECULATION O
pairs I-SPECULATION O
and O O
lead O O
to O O
the O O
prediction B-SPECULATION O
of I-SPECULATION O
over I-SPECULATION O
37000 I-SPECULATION O
human I-SPECULATION O
interactions I-SPECULATION O
. O O

They O O
should B-SPECULATION B-SPECULATION
thus I-SPECULATION I-SPECULATION
augment I-SPECULATION I-SPECULATION
current I-SPECULATION I-SPECULATION
knowledge I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
interactome I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
well I-SPECULATION I-SPECULATION
as I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
understanding I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
relationship I-SPECULATION I-SPECULATION
between I-SPECULATION I-SPECULATION
distinct I-SPECULATION I-SPECULATION
cellular I-SPECULATION I-SPECULATION
processes I-SPECULATION I-SPECULATION
. O O

Results O O
and O O
discussion O O

Architecture O O
of O O
the O O
predictor O O
and O O
training O O
of O O
the O O
modules O O

The O O
prediction O O
of O O
human O O
protein-protein O O
interactions O O
was O O
investigated O O
in O O
a O O
Bayesian O O
framework O O
by O O
considering O O
combinations O O
of O O
individual O O
protein O O
features O O
known O O
to O O
be O O
indicative O O
of O O
interaction O O
. O O

The O O
seven O O
individual O O
features O O
considered O O
are O O
summarized O O
in O O
Table O O
1 O O
and O O
detailed O O
in O O
the O O
Methods O O
section O O
. O O

As O O
indicated O O
in O O
Table O O
1 O O
, O O
the O O
different O O
features O O
were O O
grouped O O
into O O
five O O
distinct O O
modules O O
: O O
Expression O O
( O O
E O O
) O O
, O O
Orthology O O
( O O
O O O
) O O
, O O
Combined O O
( O O
C O O
) O O
, O O
Disorder O O
( O O
D O O
) O O
and O O
Transitive O O
( O O
T O O
) O O
. O O

Figure O O
1 O O
illustrates O O
the O O
training O O
scheme O O
and O O
architecture O O
of O O
the O O
method O O
. O O

The O O
Expression O O
, O O
Orthology O O
, O O
Combined O O
and O O
Disorder O O
modules O O
can O O
calculate O O
likelihood O O
ratios O O
( O O
LR O O
) O O
of O O
interaction O O
independently O O
and O O
are O O
referred O O
to O O
as O O
the O O
Group O O
A O O
modules O O
( O O
Figure O O
1A O O
) O O
. O O

The O O
product O O
of O O
their O O
likelihood O O
ratios O O
is O O
referred O O
to O O
as O O
the O O
Preliminary O O
Score O O
. O O

The O O
Transitive O O
module O O
considers O O
the O O
local O O
topology O O
of O O
the O O
network O O
predicted O O
by O O
the O O
group O O
A O O
modules O O
and O O
thus O O
requires O O
the O O
completion O O
of O O
their O O
analysis O O
to O O
calculate O O
its O O
own O O
likelihood O O
ratios O O
of O O
interaction O O
( O O
Figure O O
1B O O
) O O
. O O

As O O
such O O
, O O
all O O
combinations O O
of O O
the O O
Group O O
A O O
modules O O
can O O
be O O
used O O
to O O
predict O O
interaction O O
in O O
the O O
presence O O
or O O
absence B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
the I-NEGATION I-NEGATION
Transitive I-NEGATION I-NEGATION
module I-NEGATION I-NEGATION
. O O

In O O
the O O
absence B-NEGATION O
of I-NEGATION O
the I-NEGATION O
Transitive I-NEGATION O
module I-NEGATION O
, O O
the O O
Preliminary O O
Score O O
is O O
used O O
as O O
the O O
final O O
likelihood O O
ratio O O
output O O
by O O
the O O
predictor O O
. O O

Features O O
considered O O
in O O
the O O
prediction O O
of O O
interactions O O
for O O
each O O
module O O

Architecture O O
of O O
the O O
predictor O O
and O O
likelihoods O O
of O O
the O O
modules O O

Architecture O O
of O O
the O O
predictor O O
and O O
likelihoods O O
of O O
the O O
modules O O
. O O

The O O
predictor O O
consists O O
of O O
two O O
different O O
parts O O
( O O
A O O
and O O
B O O
) O O
which O O
are O O
trained O O
consecutively O O
. O O

The O O
Group O O
A O O
modules O O
( O O
shown O O
in O O
panel O O
A O O
) O O
are O O
trained O O
in O O
parallel O O
. O O

The O O
likelihood O O
ratios O O
( O O
LR O O
) O O
for O O
most O O
of O O
their O O
states O O
are O O
shown O O
in O O
panel O O
A O O
( O O
their O O
complete O O
likelihood O O
ratios O O
are O O
available O O
in O O
Additional O O
File O O
4 O O
) O O
. O O

The O O
product O O
of O O
the O O
likelihood O O
ratios O O
of O O
all O O
Group O O
A O O
modules O O
considered O O
in O O
a O O
given O O
prediction O O
is O O
referred O O
to O O
as O O
the O O
preliminary O O
score O O
( O O
PS O O
) O O
and O O
can O O
be O O
calculated O O
for O O
all O O
human O O
protein O O
pairs O O
. O O

If O O
the B-NEGATION B-NEGATION
Transitive I-NEGATION I-NEGATION
module I-NEGATION I-NEGATION
is I-NEGATION I-NEGATION
not I-NEGATION I-NEGATION
considered I-NEGATION I-NEGATION
, O O
the O O
final O O
likelihood O O
ratios O O
assigned O O
to O O
all O O
protein O O
pairs O O
is O O
the O O
preliminary O O
score O O
( O O
PS O O
) O O
. O O

If O O
the O O
Transitive O O
module O O
is O O
considered O O
, O O
the O O
local O O
topology O O
of O O
the O O
network O O
determined O O
by O O
the O O
assignment O O
of O O
preliminary O O
scores O O
to O O
all O O
protein O O
pairs O O
considered O O
in O O
the O O
training O O
set O O
is O O
used O O
to O O
calculate O O
the O O
likelihood O O
ratios O O
for O O
the O O
transitive O O
module O O
( O O
shown O O
in O O
panel O O
B O O
) O O
for O O
every O O
protein O O
pair O O
in O O
the O O
training O O
set O O
. O O

The O O
final O O
likelihood O O
ratio O O
is O O
then O O
the O O
product O O
of O O
the O O
preliminary O O
score O O
calculated O O
in O O
panel O O
A O O
and O O
the O O
likelihood O O
ratio O O
output O O
by O O
the O O
transitive O O
module O O
in O O
panel O O
B O O
. O O

For O O
the O O
Orthology O O
module O O
: O O
YL O O
, O O
YM O O
, O O
YH O O
: O O
yeast O O
low O O
, O O
medium O O
and O O
high O O
scoring O O
bins O O
; O O
FL O O
, O O
FM O O
, O O
FH O O
: O O
fly O O
low O O
, O O
medium O O
and O O
high O O
scoring O O
bins O O
; O O
WL O O
, O O
WM O O
, O O
WH O O
: O O
worm O O
low O O
, O O
medium O O
and O O
high O O
scoring O O
bins O O
; O O
HM O O
and O O
HL O O
: O O
medium O O
and O O
low O O
scoring O O
bins O O
for O O
human O O
protein O O
pairs O O
that O O
have O O
human O O
paralogs O O
; O O
> O O
1 O O
organism O O
: O O
bin O O
for O O
human O O
protein O O
pairs O O
that O O
have O O
interologs O O
in O O
more O O
than O O
one O O
organism O O
. O O

For O O
the O O
Combined O O
module O O
, O O
–— O O
refers O O
to O O
the O O
lowest O O
scoring O O
bin O O
( O O
for O O
the O O
domain O O
( O O
Dom O O
) O O
, O O
post-translational O O
modification O O
( O O
PTM O O
) O O
and O O
subcellular O O
localization O O
( O O
Loc O O
) O O
features O O
) O O
, O O
– O O
refers O O
to O O
the O O
second O O
lowest O O
scoring O O
bin O O
and O O
+ O O
, O O
++ O O
, O O
+++ O O
refer O O
respectively O O
to O O
the O O
third O O
highest O O
, O O
second O O
highest O O
and O O
highest O O
scoring O O
bins O O
. O O

The O O
likelihood O O
ratios O O
of O O
interaction O O
are O O
evaluated O O
for O O
each O O
module O O
by O O
considering O O
the O O
relative O O
proportions O O
of O O
positive O O
and O O
negative O O
training O O
examples O O
that O O
have O O
a O O
specific O O
state O O
( O O
i.e. O O
that O O
fall O O
in O O
a O O
particular O O
bin O O
of O O
a O O
module O O
) O O
. O O

The O O
datasets O O
used O O
to O O
train O O
the O O
predictor O O
consisted O O
of O O
26896 O O
known O O
human O O
protein O O
interactions O O
extracted O O
from O O
the O O
Human O O
Protein O O
Reference O O
Database O O
( O O
HPRD O O
) O O
15 O O
and O O
approximately O O
100 O O
times O O
more O O
randomly O O
chosen O O
protein O O
pairs O O
used O O
as O O
negative O O
examples O O
. O O

The O O
composition O O
of O O
the O O
datasets O O
and O O
likelihood O O
ratio O O
calculations O O
are O O
explained O O
in O O
greater O O
detail O O
in O O
the O O
Methods O O
section O O
. O O

Once O O
the O O
final O O
likelihood O O
ratio O O
of O O
interaction O O
( O O
LRfinal O O
) O O
is O O
calculated O O
for O O
a O O
given O O
protein O O
pair O O
as O O
shown O O
in O O
Figure O O
1B O O
, O O
it O O
is O O
possible B-SPECULATION B-SPECULATION
to I-SPECULATION I-SPECULATION
estimate I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
posterior I-SPECULATION I-SPECULATION
odds I-SPECULATION I-SPECULATION
ratio I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
interaction I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
multiplying I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
final I-SPECULATION I-SPECULATION
likelihood I-SPECULATION I-SPECULATION
ratio I-SPECULATION I-SPECULATION
by I-SPECULATION I-SPECULATION
the I-SPECULATION I-SPECULATION
prior I-SPECULATION I-SPECULATION
odds I-SPECULATION I-SPECULATION
ratio I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
interaction I-SPECULATION I-SPECULATION
. O O

Protein B-SPECULATION O
pairs I-SPECULATION O
that I-SPECULATION O
have I-SPECULATION O
a I-SPECULATION O
posterior I-SPECULATION O
odds I-SPECULATION O
of I-SPECULATION O
interaction I-SPECULATION O
above I-SPECULATION O
1 I-SPECULATION O
are I-SPECULATION O
more I-SPECULATION O
likely I-SPECULATION B-SPECULATION
to I-SPECULATION I-SPECULATION
interact I-SPECULATION I-SPECULATION
than I-SPECULATION I-SPECULATION
, O O
thus O O
providing O O
an O O
obvious O O
threshold O O
to O O
predict O O
interacting O O
proteins O O
. O O
not B-NEGATION B-NEGATION
to I-NEGATION I-NEGATION
interact I-NEGATION I-NEGATION
. O O

Estimates O O
for O O
the O O
prior O O
odds O O
ratio O O
of O O
interaction O O
vary O O
. O O

Previous O O
interaction O O
studies O O
on O O
yeast O O
and O O
human O O
use O O
prior O O
odds O O
ratios O O
that O O
range O O
from O O
1 O O
/ O O
600 O O
to O O
> O O
1 O O
/ O O
400 O O
37434647 O O
. O O

The O O
evaluation O O
of O O
this O O
ratio O O
is O O
difficult O O
because O O
not O O
all O O
true O O
interactions O O
are O O
known O O
. O O

As O O
detailed O O
in O O
Methods O O
, O O
the O O
prior O O
odds O O
ratio O O
for O O
human O O
protein O O
interaction O O
was O O
explored O O
by O O
considering O O
different O O
versions O O
and O O
subsets O O
of O O
human O O
interaction O O
datasets O O
. O O

This O O
suggested B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
there I-SPECULATION I-SPECULATION
is I-SPECULATION I-SPECULATION
insufficient I-SPECULATION I-SPECULATION
data I-SPECULATION I-SPECULATION
currently I-SPECULATION I-SPECULATION
available I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
determine I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
reliable I-SPECULATION I-SPECULATION
ratio I-SPECULATION I-SPECULATION
for I-SPECULATION I-SPECULATION
human I-SPECULATION I-SPECULATION
. O O

Accordingly O O
, O O
we O O
selected O O
a O O
prior O O
odds O O
ratio O O
of O O
interaction O O
of O O
1 O O
/ O O
400 O O
which O O
is O O
similar O O
to O O
current O O
estimates O O
for O O
yeast O O
and O O
is O O
probably B-SPECULATION B-SPECULATION
still I-SPECULATION I-SPECULATION
quite I-SPECULATION I-SPECULATION
conservative I-SPECULATION I-SPECULATION
. O O

Thus O O
, O O
the O O
likelihood O O
ratio O O
threshold O O
to O O
predict O O
interactions O O
is O O
400 O O
. O O

Likelihood O O
ratios O O
of O O
the O O
modules O O

Figure O O
1 O O
summarizes O O
the O O
likelihood O O
ratios O O
computed O O
for O O
the O O
five O O
modules O O
. O O

The O O
different O O
modules O O
differ O O
in O O
the O O
range O O
of O O
likelihood O O
ratio O O
values O O
achieved O O
by O O
their O O
different O O
states O O
. O O

The O O
Orthology O O
and O O
Combined O O
modules O O
both O O
have O O
states O O
that O O
achieve O O
likelihood O O
ratios O O
above O O
400 O O
( O O
as O O
high O O
as O O
1207 O O
for O O
the O O
Orthology O O
module O O
and O O
613 O O
for O O
the O O
Combined O O
module O O
) O O
, O O
indicating B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
both I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
modules I-SPECULATION I-SPECULATION
can B-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
on I-SPECULATION I-SPECULATION
their I-SPECULATION I-SPECULATION
own I-SPECULATION I-SPECULATION
, I-SPECULATION I-SPECULATION
predict I-SPECULATION I-SPECULATION
some I-SPECULATION I-SPECULATION
interacting I-SPECULATION I-SPECULATION
protein I-SPECULATION I-SPECULATION
pairs I-SPECULATION I-SPECULATION
with I-SPECULATION I-SPECULATION
a I-SPECULATION I-SPECULATION
posterior I-SPECULATION I-SPECULATION
odds I-SPECULATION I-SPECULATION
ratio I-SPECULATION I-SPECULATION
above I-SPECULATION I-SPECULATION
1 I-SPECULATION I-SPECULATION
. O O

The O O
Expression O O
module O O
follows O O
trends O O
seen O O
in O O
previous O O
studies O O
with O O
increasing O O
likelihood O O
ratios O O
of O O
interaction O O
reflecting O O
increasing O O
expression O O
correlation O O
3746 O O
. O O

However O O
, O O
since O O
the O O
highest O O
likelihood O O
ratio O O
for O O
the O O
expression O O
datasets O O
that O O
we O O
consider O O
is O O
33 O O
, O O
they O O
are O O
not B-NEGATION B-NEGATION
sufficient I-NEGATION I-NEGATION
on I-NEGATION I-NEGATION
their I-NEGATION I-NEGATION
own I-NEGATION I-NEGATION
to I-NEGATION I-NEGATION
predict I-NEGATION I-NEGATION
interacting I-NEGATION I-NEGATION
protein I-NEGATION I-NEGATION
pairs I-NEGATION I-NEGATION
with I-NEGATION I-NEGATION
a I-NEGATION I-NEGATION
posterior I-NEGATION I-NEGATION
odds I-NEGATION I-NEGATION
ratio I-NEGATION I-NEGATION
above I-NEGATION I-NEGATION
1 I-NEGATION I-NEGATION
. O O

Similarly O O
, O O
but O O
in O O
a O O
much O O
more O O
pronounced O O
way O O
, O O
the O O
Disorder O O
module O O
is O O
only O O
slightly O O
predictive O O
of O O
interaction O O
, O O
with O O
a O O
maximum O O
likelihood O O
ratio O O
of O O
1.8 O O
. O O

Most O O
states O O
of O O
the O O
Orthology O O
module O O
achieve O O
higher O O
likelihood O O
ratios O O
than O O
the O O
highest O O
obtained O O
by O O
the O O
Expression O O
and O O
Disorder O O
modules O O
. O O

This O O
is O O
not B-NEGATION O
surprising I-NEGATION O
as O O
the O O
transfer O O
of O O
interacting O O
orthologs O O
( O O
known O O
as O O
interologs O O
33 O O
) O O
from O O
one O O
organism O O
to O O
another O O
is O O
a O O
popular O O
method O O
to O O
predict O O
interactions O O
( O O
see O O
for O O
example O O
3448 O O
) O O
, O O
particularly O O
in O O
the O O
case O O
of O O
organisms O O
like O O
human O O
for O O
which O O
only O O
a O O
small O O
proportion O O
of O O
interactions O O
are O O
known O O
. O O

The O O
direct O O
transfer O O
of O O
interactions O O
to O O
human O O
from O O
either O O
yeast O O
, O O
fly O O
or O O
worm O O
does O O
not O B-NEGATION
alone O I-NEGATION
result O I-NEGATION
in O I-NEGATION
a O I-NEGATION
posterior O I-NEGATION
odds O I-NEGATION
ratio O I-NEGATION
above O I-NEGATION
1 O I-NEGATION
( O O
as O O
the O O
likelihood O O
ratios O O
of O O
interaction O O
for O O
all O O
yeast O O
, O O
fly O O
and O O
worm O O
bins O O
in O O
the O O
Orthology O O
module O O
are O O
below O O
400 O O
) O O
. O O

This O O
is O O
not B-NEGATION O
surprising I-NEGATION O
as O O
previous O O
studies O O
have O O
indicated B-SPECULATION B-SPECULATION
that I-SPECULATION I-SPECULATION
quite I-SPECULATION I-SPECULATION
stringent I-SPECULATION I-SPECULATION
joint I-SPECULATION I-SPECULATION
E-values I-SPECULATION I-SPECULATION
must I-SPECULATION I-SPECULATION
be I-SPECULATION I-SPECULATION
used I-SPECULATION I-SPECULATION
to I-SPECULATION I-SPECULATION
transfer I-SPECULATION I-SPECULATION
interactions I-SPECULATION I-SPECULATION
safely I-SPECULATION I-SPECULATION
between I-SPECULATION I-SPECULATION
organisms I-SPECULATION I-SPECULATION
3435 O I-SPECULATION
. O O

In O O
contrast O O
, O O
the O O
consideration O O
of O O
human O O
interactions O O
paralogous O O
to O O
the O O
human O O
protein O O
pairs O O
under O O
investigation O O
results O O
in O O
likelihood O O
ratios O O
of O O
431 O O
and O O
1034 O O
( O O
depending O O
on O O
how O O
close O O
the O O
paralogs O O
are O O
as O O
described O O
in O O
Methods O O
) O O
which O O
is O O
much O O
higher O O
than O O
those O O
obtained O O
for O O
any O O
single O O
model O O
organism O O
. O O

This O O
agrees O O
with O O
a O O
recent O O
report O O
that O O
suggested B-SPECULATION B-SPECULATION
protein-protein I-SPECULATION I-SPECULATION
interactions I-SPECULATION I-SPECULATION
are I-SPECULATION I-SPECULATION
more I-SPECULATION I-SPECULATION
conserved I-SPECULATION I-SPECULATION
within I-SPECULATION I-SPECULATION
species I-SPECULATION I-SPECULATION
than I-SPECULATION I-SPECULATION
across I-SPECULATION I-SPECULATION
species I-SPECULATION I-SPECULATION
49 O O
. O O

The O O
Combined O O
module O O
uses O O
domain O O
co-occurrence O O
, O O
post-translational O O
modification O O
( O O
PTM O O
) O O
co-occurrence O O
and O O
subcellular O O
localization O O
information O O
to O O
predict O O
interaction O O
. O O

These O O
features O O
were O O
originally O O
investigated O O
separately O O
, O O
as O O
shown O O
in O O
Figure O O
3 O O
, O O
but O O
their O O
combination O O
into O O
one O O
module O O
that O O
considers O O
all O O
dependencies O O
between O O
them O O
achieves O O
higher O O
accuracy O O
( B-NEGATION O
data I-NEGATION O
not I-NEGATION O
shown I-NEGATION O
) I-NEGATION O
and O O
higher O O
likelihood O O
ratios O O
( O O
as O O
can O O
be O O
seen O O
by O O
comparing O O
to O O
Figure O O
1 O O
) O O
while O O
still O O
being O O
computationally O O
feasible O O
. O O

Additionally O O
, O O
this O O
combination O O
circumvents O O
possible B-SPECULATION B-SPECULATION
problems I-SPECULATION I-SPECULATION
of I-SPECULATION I-SPECULATION
dependence I-SPECULATION I-SPECULATION
between I-SPECULATION I-SPECULATION
these I-SPECULATION I-SPECULATION
features I-SPECULATION I-SPECULATION
. O O

Likelihood O O
ratios O O
of O O
the O O
features O O
that O O
form O O
the O O
Combined O O
module O O
, O O
considered O O
separately O O

Likelihood O O
ratios O O
of O O
the O O
features O O
that O O
form O O
the O O
Combined O O
module O O
, O O
considered O O
separately O O
. O O

The O O
Combined O O
module O O
considers O O
simultaneously O O
three O O
distinct O O
features O O
: O O
the O O
co-occurrence O O
of O O
both O O
domains O O
and O O
PTMs O O
as O O
well O O
as O O
the O O
subcellular O O
co-localization O O
of O O
proteins O O
. O O

Here O O
the O O
likelihood O O
ratios O O
of O O
these O O
features O O
considered O O
separately O O
are O O
shown O O
. O O

In O O
panel O O
A O O
, O O
all O O
domain O O
pairs O O
considered O O
were O O
given O O
scores O O
and O O
likelihood O O
ratios O O
were O O
estimated O O
for O O
different O O
values O O
of O O
these O O
scores O O
. O O

Similarly O O
, O O
shown O O
in O O
panel O O
B O O
are O O
the O O
likelihood O O
ratios O O
for O O
different O O
values O O
of O O
PTM O O
co-occurrence O O
scores O O
. O O

Panel O O
C O O
shows O O
the O O
likelihood O O
ratios O O
for O O
protein O O
pairs O O
localized O O
to O O
different O O
sets O O
of O O
cellular O O
compartments O O
. O O

Previous O O
methods O O
have O O
investigated O O
the O O
use O O
of O O
co-occurring O O
domains O O
to O O
predict O O
interaction O O
( O O
see O O
for O O
example O O
2346 O O
) O O
. O O

Many O O
pairs O O
of O O
domains O O
co-occur O O
in O O
proteins O O
known O O
to O O
interact O O
. O O

When O O
investigated O O
as O O
a O O
separate O O
feature O O
, O O
the O O
chi-square O O
score O O
of O O
co-occurrence O O
of O O
domain O O
pairs O O
correlates O O
well O O
with O O
the O O
likelihood O O
of O O
interaction O O
of O O
protein O O
pairs O O
that O O
contain O O
these O O
domains O O
, O O
with O O
the O O
highest O O
chi-square O O
score O O
bin O O
obtaining O O
a O O
likelihood O O
ratio O O
of O O
14 O O
, O O
as O O
shown O O
in O O
Figure O O
3A O O
. O O

Similarly O O
, O O
the O O
co-occurrence O O
of O O
PTMs O O
is O O
also O O
predictive O O
of O O
interaction O O
, O O
with O O
its O O
highest O O
scoring O O
bin O O
obtaining O O
a O O
likelihood O O
ratio O O
of O O
6 O O
as O O
shown O O
in O O
Figure O O
3B O O
. O O

Lists O O
of O O
high O O
scoring O O
domain O O
pairs O O
and O O
PTM O O
pairs O O
are O O
shown O O
in O O
Additional O O
Files O O
1 O O
and O O
2 O O
. O O

Subcellular O O
localization O O
has O O
been O O
extensively O O
used O O
both O O
to O O
assess O O
the O O
quality O O
of O O
interaction O O
datasets O O
115051 O O
and O O
to O O
generate O O
examples O O
of O O
non-interacting O O
protein O O
pairs O O
to O O
use O O
as O O
negative O O
datasets O O
when O O
training O O
and O O
testing O O
predictors O O
3746 O O
. O O

In O O
the O O
present O O
study O O
, O O
the O O
use O O
of O O
localization O O
was O O
investigated O O
as O O
a O O
feature O O
predictive O O
of O O
interaction O O
. O O

Four O O
possible B-SPECULATION B-SPECULATION
localization I-SPECULATION I-SPECULATION
states I-SPECULATION I-SPECULATION
were O I-SPECULATION
considered O I-SPECULATION
for O I-SPECULATION
protein O I-SPECULATION
pairs O I-SPECULATION
: O O
: O O
same O O
compartment O O
, O O
neighboring O O
compartments O O
, O O
different O O
non-neighboring O O
compartments O O
and O O
absence B-NEGATION B-NEGATION
of I-NEGATION I-NEGATION
localization I-NEGATION I-NEGATION
annotation I-NEGATION I-NEGATION
( O O
more O O
details O O
are O O
given O O
in O O
the O O
Methods O O
section O O
) O O
. O O

As O O
shown O O
in O O
Figure O O
3C O O
, O O
the O O
likelihood O O
ratio O O
of O O
same O O
compartment O O
protein O O
pairs O O
was O O
found O O
to O O
be O O
twice O O
as O O
high O O
as O O
that O O
of O O
randomly O O
chosen O O
or O O
non-annotated O O
protein O O
pairs O O
whereas O O
different O O
non-neighboring O O
protein O O
pairs O O
are O O
more O O
than O O
three O O
times O O
less O O
likely O B-SPECULATION
to O I-SPECULATION
interact O I-SPECULATION
than O I-SPECULATION
random O I-SPECULATION
protein O I-SPECULATION
pairs O I-SPECULATION
. O O

Individual O O
localization O O
features O O
achieve O O
low O O
interaction O O
likelihood O O
ratios O O
. O O

However O O
, O O
when O O
integrated O O
into O O
the O O
Combined O O
module O O
, O O
domain O O
, O O
PTM O O
and O O
localization O O
information O O
together O O
achieve O O
likelihood O O
ratios O O
that O O
are O O
high O O
enough O O
to O O
predict O O
interaction O O
on O O
their O O
own O O
( O O
i.e. O O
above O O
400 O O
) O O
. O O

As O O
expected O O
, O O
the O O
highest O O
likelihood O O
ratio O O
bins O O
for O O
the O O
Combined O O
module O O
are O O
those O O
representing O O
the O O
highest O O
combinations O O
of O O
the O O
three O O
features O O
separately O O
. O O

